data_2mct_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mct _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.536 0.44 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.07 158.86 13.54 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.738 2.292 . . . . 0.0 111.723 154.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.5 mt -98.21 95.92 4.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 N-CA-C 104.724 -2.325 . . . . 0.0 104.724 165.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.9 166.15 35.36 Favored Pre-proline 0 C--O 1.237 0.428 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 172.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.48 ' HB2' HD22 ' A' ' 10' ' ' ASN . 56.0 Cg_endo -56.89 173.09 0.59 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 121.15 1.234 . . . . 0.0 111.204 157.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.409 ' HE3' ' CG ' ' A' ' 9' ' ' GLU . 11.7 mtmt -56.87 172.33 0.27 Allowed 'General case' 0 C--N 1.345 0.393 0 O-C-N 120.859 -1.15 . . . . 0.0 110.538 166.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.0 -53.97 8.89 Favored 'General case' 0 C--O 1.221 -0.438 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 158.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.409 ' CG ' ' HE3' ' A' ' 7' ' ' LYS . 1.1 pt-20 -70.56 -7.06 41.07 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 -162.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.48 HD22 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -100.02 -1.01 38.1 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.983 1.713 . . . . 0.0 112.278 177.066 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.411 ' N ' HD21 ' A' ' 10' ' ' ASN . 56.0 t -78.36 124.07 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 176.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -78.65 -54.03 6.55 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.761 1.624 . . . . 0.0 106.869 -176.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -152.47 167.31 29.19 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.524 1.13 . . . . 0.0 108.658 160.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.8 mt -120.36 127.71 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 164.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.11 136.84 45.09 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 175.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.2 mt -131.08 100.24 4.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.93 113.31 12.08 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 163.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -67.17 176.44 2.19 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.619 1.168 . . . . 0.0 110.099 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.32 -34.14 77.47 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.521 -1.362 . . . . 0.0 112.117 177.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.8 p30 -80.13 -154.69 0.1 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.922 1.689 . . . . 0.0 110.75 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.5 p -91.82 10.63 27.76 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.621 -1.3 . . . . 0.0 113.656 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.9 mt -107.16 151.26 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -170.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -136.46 149.6 48.3 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 173.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.9 143.56 50.93 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 174.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.1 mp -118.25 127.62 75.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -104.03 100.05 9.81 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 -176.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -125.98 -8.81 6.59 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.275 1.03 . . . . 0.0 111.88 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.58 149.99 36.55 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.154 0.982 . . . . 0.0 109.028 167.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.1 m -44.84 -57.02 4.02 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 124.392 1.077 . . . . 0.0 111.447 165.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.97 -29.96 70.92 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.605 0.762 . . . . 0.0 111.79 -174.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.4 p -71.09 -47.56 57.46 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 78.3 mt -63.38 -54.07 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 126.003 1.721 . . . . 0.0 109.169 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -59.19 -37.23 76.9 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 123.479 0.712 . . . . 0.0 111.332 -172.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.95 -50.48 73.6 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.741 0.816 . . . . 0.0 110.353 175.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 91.8 mt -55.49 -55.65 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 174.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.5 -12.19 2.51 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 t -78.08 -67.55 0.72 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 120.265 1.393 . . . . 0.0 109.321 166.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -66.0 -27.03 67.82 Favored 'General case' 0 C--O 1.223 -0.313 0 O-C-N 121.167 -0.958 . . . . 0.0 111.094 -171.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.1 mm -72.01 -18.3 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 O-C-N 119.998 -1.689 . . . . 0.0 111.832 173.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.81 -3.78 31.93 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.895 1.278 . . . . 0.0 113.692 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.6 t -68.78 -36.16 77.95 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.878 0.871 . . . . 0.0 111.235 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.3 170.28 53.42 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 124.232 0.92 . . . . 0.0 112.429 -170.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -119.45 111.62 18.36 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 -177.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -61.08 -12.94 13.82 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 171.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.0 p 65.57 -176.36 0.18 Allowed 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 127.681 2.392 . . . . 0.0 109.728 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -88.4 6.0 39.54 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 120.541 -1.349 . . . . 0.0 113.453 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.6 mtpt -64.62 173.46 2.17 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.681 1.192 . . . . 0.0 112.45 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -109.93 119.4 39.21 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.6 m -79.73 85.18 5.45 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 167.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.8 pt -85.81 35.94 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 125.166 1.387 . . . . 0.0 110.113 176.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -142.27 165.86 26.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 128.695 2.798 . . . . 0.0 107.34 -172.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -132.7 0.4 3.57 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.403 1.081 . . . . 0.0 111.665 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -146.45 164.72 22.91 Favored Pre-proline 0 C--O 1.238 0.457 0 C-N-CA 126.847 2.059 . . . . 0.0 108.304 -173.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -74.15 170.92 19.04 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.021 2.48 . . . . 0.0 111.039 169.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -110.9 4.18 19.48 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.296 1.038 . . . . 0.0 111.607 166.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.85 173.25 10.17 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 120.573 -1.329 . . . . 0.0 109.992 161.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.5 -22.8 4.94 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.869 1.668 . . . . 0.0 110.637 177.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -105.4 113.63 27.32 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 174.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -160.73 168.0 25.72 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.123 1.369 . . . . 0.0 108.492 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -96.34 157.06 21.35 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 168.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.6 m -103.96 130.95 51.62 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 mp -126.97 137.26 58.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 123.502 0.721 . . . . 0.0 109.909 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.12 114.52 18.49 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 168.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 72.6 mt -88.95 91.53 3.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 104.35 -2.463 . . . . 0.0 104.35 162.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -70.32 123.61 22.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 171.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -153.02 133.04 13.35 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.558 1.143 . . . . 0.0 109.637 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 55.48 31.89 17.9 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.636 1.174 . . . . 0.0 110.656 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.35 -11.42 4.04 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.904 1.716 . . . . 0.0 115.018 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.91 -173.75 45.34 Favored Glycine 0 C--N 1.332 0.337 0 O-C-N 120.5 -1.588 . . . . 0.0 110.029 166.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -145.09 157.57 44.07 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.907 -0.76 . . . . 0.0 111.507 168.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 83.5 m -96.73 109.2 21.9 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 154.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.7 m -74.53 147.12 42.08 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 160.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.9 ptm -163.07 170.74 17.48 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.009 1.724 . . . . 0.0 108.298 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -143.59 151.74 40.55 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -129.57 158.01 40.47 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 121.072 1.76 . . . . 0.0 110.655 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -159.21 178.28 10.16 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.457 1.48 . . . . 0.0 111.889 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -106.62 139.48 41.0 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.61 1.564 . . . . 0.0 108.007 167.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -141.68 131.3 24.03 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.246 1.022 . . . . 0.0 109.169 167.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 57.77 4.75 0.28 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.374 1.87 . . . . 0.0 114.769 175.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.09 2.4 21.96 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.744 1.64 . . . . 0.0 113.97 176.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -113.94 157.67 22.12 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 125.952 1.701 . . . . 0.0 108.052 167.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -103.25 159.45 15.53 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -145.63 155.06 42.78 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.682 0.793 . . . . 0.0 111.025 -172.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 mp -126.49 126.31 68.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 C-N-CA 125.973 1.709 . . . . 0.0 108.417 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -73.36 152.5 40.85 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 127.063 2.145 . . . . 0.0 110.19 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -177.16 167.53 1.26 Allowed Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 128.553 2.741 . . . . 0.0 107.973 176.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.41 ' O ' ' N ' ' A' ' 89' ' ' LYS . 41.1 Cg_endo -61.09 -162.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.815 1 C-N-CA 125.378 4.052 . . . . 0.0 109.671 166.173 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -43.06 -13.41 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.271 2.228 . . . . 0.0 116.955 -162.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.456 ' N ' ' HE3' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -115.18 45.0 1.71 Allowed 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 171.218 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -124.95 68.74 0.5 Allowed Glycine 0 C--O 1.228 -0.276 0 O-C-N 120.724 -1.235 . . . . 0.0 113.285 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.4 mt -135.23 50.97 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 168.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -74.37 91.12 2.19 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.224 -0.922 . . . . 0.0 108.569 -175.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -64.72 120.06 11.74 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 167.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.1 pt -118.44 158.36 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 125.968 1.707 . . . . 0.0 107.8 164.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -104.36 -1.5 26.8 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.522 0.729 . . . . 0.0 112.37 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -118.89 162.28 18.76 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.742 1.217 . . . . 0.0 111.22 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -74.82 153.13 38.86 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.461 0.704 . . . . 0.0 110.72 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -79.87 -57.99 3.38 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.295 -0.878 . . . . 0.0 112.395 170.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.02 -20.18 66.37 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -163.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -84.87 -17.43 37.99 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.194 0.906 . . . . 0.0 111.722 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 10.7 mmt -95.91 -18.26 20.45 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.894 1.277 . . . . 0.0 111.351 -172.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 9.4 pt . . . . . 0 C--O 1.247 0.974 0 C-N-CA 124.534 1.134 . . . . 0.0 110.103 177.481 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 m . . . . . 0 CA--C 1.549 0.937 0 CA-C-O 119.034 -0.508 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.56 161.91 43.12 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 CA-C-N 121.275 1.491 . . . . 0.0 111.799 -170.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.6 mt -109.45 117.54 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 170.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.27 160.7 56.25 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 127.402 2.281 . . . . 0.0 108.396 -176.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.49 -178.33 1.83 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.038 2.492 . . . . 0.0 111.504 174.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.2 mtmt -58.42 175.88 0.21 Allowed 'General case' 0 C--N 1.349 0.546 0 O-C-N 121.223 -0.923 . . . . 0.0 109.896 167.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.51 -59.19 2.84 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 157.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -70.75 -13.6 62.12 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -159.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.427 HD21 ' N ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -88.13 -1.4 57.98 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.173 1.389 . . . . 0.0 111.926 176.098 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.427 ' N ' HD21 ' A' ' 10' ' ' ASN . 90.7 t -86.91 116.08 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 175.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -70.75 -44.03 67.6 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.991 0.807 . . . . 0.0 109.825 173.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.8 p -153.95 154.07 33.14 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 118.43 0.559 . . . . 0.0 111.671 162.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.1 mt -95.23 140.43 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 157.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.6 t -126.35 113.89 17.5 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 53.5 mt -109.5 115.46 49.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -90.04 123.16 33.68 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 167.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -77.13 174.72 10.37 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.358 1.063 . . . . 0.0 109.912 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 p -61.01 -52.48 64.82 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.334 -0.854 . . . . 0.0 109.263 171.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -66.4 153.85 41.66 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 127.101 2.16 . . . . 0.0 107.761 169.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 94.1 p -86.51 45.98 1.3 Allowed 'General case' 0 C--O 1.237 0.408 0 O-C-N 121.71 -0.619 . . . . 0.0 111.62 -152.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.2 mt -122.17 133.79 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 -171.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -126.99 111.84 14.55 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -174.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.401 ' HE2' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -103.06 138.67 39.61 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -178.332 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.7 mp -115.97 135.85 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 -175.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.401 ' CE1' ' HE2' ' A' ' 24' ' ' LYS . 69.5 m-85 -122.99 90.77 3.35 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 103.438 -2.801 . . . . 0.0 103.438 -168.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -116.62 -16.67 10.71 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.697 1.599 . . . . 0.0 110.369 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.53 136.37 56.31 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.34 1.856 . . . . 0.0 106.475 170.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.8 t -55.88 -44.05 77.79 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 120.014 1.279 . . . . 0.0 111.821 -171.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -68.99 -32.02 71.29 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.95 0.9 . . . . 0.0 110.995 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 p -61.5 -45.98 91.93 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 70.3 mt -65.0 -53.61 39.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.563 1.545 . . . . 0.0 109.042 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -48.84 -51.68 28.26 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.044 0.838 . . . . 0.0 113.045 -168.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.2 -42.38 86.04 Favored 'General case' 0 C--O 1.227 -0.1 0 C-N-CA 123.771 0.828 . . . . 0.0 111.568 -175.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.6 mt -62.3 -51.52 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -177.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 mt -59.19 -26.9 65.21 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.728 1.149 . . . . 0.0 110.913 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.38 -69.03 0.2 Allowed 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.502 1.121 . . . . 0.0 109.22 171.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -75.69 -16.78 60.12 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -171.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.8 mm -67.09 -39.86 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 O-C-N 119.929 -1.732 . . . . 0.0 109.127 171.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.13 3.02 53.25 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 120.73 -1.231 . . . . 0.0 113.907 -171.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.1 p -73.21 -45.87 53.74 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.153 173.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.13 145.22 48.54 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 123.989 0.804 . . . . 0.0 111.615 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -123.11 106.03 10.44 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 -166.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.6 ppt_? -62.72 -13.01 27.56 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 174.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.1 p 65.46 -174.85 0.18 Allowed 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 127.61 2.364 . . . . 0.0 110.436 177.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -69.89 -11.99 61.29 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 119.287 -2.133 . . . . 0.0 112.946 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -63.17 166.48 6.02 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.084 1.353 . . . . 0.0 112.135 -174.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.57 122.72 38.36 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.732 1.613 . . . . 0.0 110.731 176.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.7 t -70.46 160.37 32.51 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 127.443 2.297 . . . . 0.0 107.817 163.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.7 pt -144.6 22.88 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 126.912 2.085 . . . . 0.0 110.45 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -114.32 164.36 14.02 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 120.805 -1.184 . . . . 0.0 108.612 175.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -111.28 -20.62 12.23 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.261 175.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -143.23 160.01 53.55 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-N 119.483 1.038 . . . . 0.0 109.807 -168.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.95 171.87 15.77 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.711 2.941 . . . . 0.0 113.031 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.4 p -119.56 -15.73 8.96 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.575 1.55 . . . . 0.0 112.768 -177.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.9 159.4 33.78 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.932 0.787 . . . . 0.0 110.211 171.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -84.77 -28.31 26.28 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.381 0.672 . . . . 0.0 111.143 172.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -115.05 100.77 8.42 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -134.35 168.26 19.22 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 127.94 2.496 . . . . 0.0 106.278 171.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.52 175.1 15.7 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 169.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -107.99 142.31 38.32 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.471 1.109 . . . . 0.0 108.109 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.7 mt -113.12 133.82 57.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 158.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -128.78 144.23 51.12 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 171.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.5 mt -124.57 90.69 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 174.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -66.05 109.58 2.62 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 171.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . 0.284 3.9 p30 -133.1 -152.2 0.48 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 126.97 2.108 . . . . 0.0 107.579 -174.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -46.04 50.21 0.0 OUTLIER 'General case' 0 C--O 1.24 0.575 1 C-N-CA 136.65 5.98 . . . . 0.0 114.551 -171.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.43 31.54 68.4 Favored Glycine 0 N--CA 1.437 -1.269 0 O-C-N 120.413 -1.429 . . . . 0.0 112.084 -171.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -164.04 171.28 39.57 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 117.454 0.627 . . . . 0.0 112.353 168.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 83.2 mtp -125.15 112.23 16.23 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.597 1.559 . . . . 0.0 108.283 -176.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.4 m -69.86 109.83 4.66 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 157.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.4 m -112.99 143.2 44.69 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 124.106 0.879 . . . . 0.0 109.338 171.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.3 ptp -151.95 170.97 18.55 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 127.449 2.3 . . . . 0.0 106.311 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -129.15 174.29 9.7 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.401 1.48 . . . . 0.0 108.03 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -156.39 140.98 16.88 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.591 0.756 . . . . 0.0 109.706 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -153.6 162.86 40.86 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.748 1.219 . . . . 0.0 110.835 172.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -79.26 134.89 36.64 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 172.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -131.41 114.87 15.48 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 122.017 0.913 . . . . 0.0 110.038 171.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.02 -7.7 0.61 Allowed 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.953 2.501 . . . . 0.0 114.941 171.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.96 -6.09 5.1 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 117.635 -1.647 . . . . 0.0 113.449 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.28 166.31 10.62 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 120.454 2.127 . . . . 0.0 109.072 164.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -112.51 152.79 28.39 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -145.02 172.24 13.34 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 122.537 0.335 . . . . 0.0 110.179 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.3 mp -131.11 140.35 48.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 124.497 1.119 . . . . 0.0 109.21 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.88 165.15 25.41 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.833 1.653 . . . . 0.0 112.174 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -179.98 168.97 0.7 Allowed Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 127.82 2.448 . . . . 0.0 107.499 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -56.61 -162.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.799 2.332 . . . . 0.0 109.419 153.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -44.06 -8.26 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.994 2.518 . . . . 0.0 117.386 -169.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -98.71 15.65 24.59 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 120.173 -1.58 . . . . 0.0 114.27 168.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -88.91 65.7 3.21 Favored Glycine 0 C--O 1.226 -0.36 0 CA-C-N 120.608 1.549 . . . . 0.0 113.786 -174.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.4 mt -140.62 41.87 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 171.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -70.27 102.71 2.19 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 174.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -74.35 127.39 32.89 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 164.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.5 pt -114.28 159.67 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 157.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -108.47 5.27 25.11 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.336 -0.853 . . . . 0.0 112.349 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -133.92 157.02 47.06 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.041 0.936 . . . . 0.0 109.469 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -72.03 133.04 45.05 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.625 1.17 . . . . 0.0 110.118 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -74.03 -44.49 54.17 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.497 1.119 . . . . 0.0 113.459 -177.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -62.08 -29.68 70.48 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.258 1.39 . . . . 0.0 110.784 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -72.95 -15.6 61.56 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 125.877 1.671 . . . . 0.0 112.989 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 9.5 ptm -110.51 1.05 17.96 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.168 0.987 . . . . 0.0 113.091 -175.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 25.5 pt . . . . . 0 C--O 1.249 1.06 0 CA-C-N 119.018 0.826 . . . . 0.0 109.45 176.208 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p . . . . . 0 CA--C 1.551 1.014 0 N-CA-C 116.496 2.035 . . . . 0.0 116.496 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -67.05 169.89 14.13 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 124.388 3.392 . . . . 0.0 113.006 167.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.0 mm -94.22 91.89 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 167.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.1 152.24 39.35 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.222 176.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.525 ' HB2' HD22 ' A' ' 10' ' ' ASN . 74.5 Cg_endo -67.6 160.75 46.64 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.202 1.935 . . . . 0.0 110.602 171.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -60.05 168.8 1.74 Allowed 'General case' 0 C--N 1.344 0.335 0 C-N-CA 123.677 0.791 . . . . 0.0 112.028 174.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.03 -49.02 31.17 Favored 'General case' 0 C--O 1.219 -0.523 0 O-C-N 121.157 -0.964 . . . . 0.0 109.48 168.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -66.48 -14.79 62.73 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 -172.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.525 HD22 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -102.87 -2.74 27.32 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.037 0.935 . . . . 0.0 111.352 178.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.0 t -82.19 135.81 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.248 1.419 . . . . 0.0 107.3 170.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.83 -67.92 0.78 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 166.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.42 121.88 5.76 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.33 0.514 . . . . 0.0 110.429 -170.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.4 mt -82.27 131.22 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.7 t -107.5 139.61 41.75 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 168.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.0 mt -131.98 122.23 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 170.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -115.07 102.4 9.9 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 -173.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -63.04 171.68 2.13 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.373 0.669 . . . . 0.0 111.328 -170.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.4 p -52.43 -52.89 51.61 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.541 1.137 . . . . 0.0 109.976 168.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.05 162.6 25.78 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 126.877 2.071 . . . . 0.0 107.192 174.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 p -90.1 59.57 4.53 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 123.252 1.501 . . . . 0.0 108.896 -163.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.7 mt -124.66 142.96 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 102.502 -3.147 . . . . 0.0 102.502 176.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -140.96 143.33 34.47 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.69 122.36 23.29 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 176.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.9 mp -94.45 138.55 20.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 171.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -118.07 82.38 1.83 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 103.31 -2.848 . . . . 0.0 103.31 176.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -83.31 -19.1 36.87 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.55 1.14 . . . . 0.0 110.109 163.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.37 133.67 35.94 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.186 1.794 . . . . 0.0 109.093 -169.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.6 -55.83 17.01 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.306 1.042 . . . . 0.0 112.513 -176.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -68.58 -20.63 64.53 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.521 -0.737 . . . . 0.0 110.985 -174.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.4 m -80.12 -41.34 25.65 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.108 1.763 . . . . 0.0 110.826 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.4 mt -67.78 -45.93 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.951 1.7 . . . . 0.0 110.043 172.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.99 -24.63 67.15 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -171.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -64.29 -68.08 0.38 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 117.923 -1.037 . . . . 0.0 108.35 166.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 72.5 mt -44.85 -44.81 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 126.057 1.743 . . . . 0.0 112.039 -170.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.0 mt -54.37 -20.0 6.55 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.7 t -76.72 -58.36 3.33 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.322 2.249 . . . . 0.0 109.396 172.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.9 mp0 -63.34 -29.32 70.65 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.758 0.708 . . . . 0.0 110.896 -177.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.1 mm -61.95 -37.75 79.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 O-C-N 120.652 -1.28 . . . . 0.0 110.173 171.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.56 -10.6 26.87 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.681 1.192 . . . . 0.0 113.705 -171.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 t -62.6 -39.84 95.02 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.382 0.673 . . . . 0.0 110.829 -171.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.51 161.54 40.84 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-O 122.787 1.215 . . . . 0.0 112.316 -171.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -125.76 114.47 18.66 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -64.15 -9.28 15.79 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.753 1.621 . . . . 0.0 113.89 172.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 p 65.59 -172.9 0.18 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 128.407 2.683 . . . . 0.0 111.478 173.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -78.69 -2.2 38.09 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.164 1.786 . . . . 0.0 112.029 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -67.02 168.06 10.7 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 119.849 1.204 . . . . 0.0 109.816 172.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -120.25 156.4 31.28 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.42 1.088 . . . . 0.0 109.768 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.32 134.35 46.26 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -159.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.2 pt -133.88 28.32 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 118.958 0.799 . . . . 0.0 112.225 -164.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -147.99 166.32 28.08 Favored 'General case' 0 C--O 1.242 0.66 0 O-C-N 121.446 -0.783 . . . . 0.0 110.23 -175.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.03 -10.42 15.03 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.602 1.161 . . . . 0.0 111.926 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -143.97 159.53 52.87 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.233 1.013 . . . . 0.0 111.95 -170.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.34 178.45 7.0 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.291 3.328 . . . . 0.0 112.838 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.51 -16.66 12.37 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.503 1.521 . . . . 0.0 111.46 173.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.66 163.08 7.59 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 120.792 -1.192 . . . . 0.0 110.29 168.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -108.43 -15.28 14.49 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.206 1.403 . . . . 0.0 110.902 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -126.29 103.03 7.44 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.465 2.306 . . . . 0.0 106.815 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -150.06 162.39 40.49 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.954 2.102 . . . . 0.0 107.918 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -101.14 166.0 18.73 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 173.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.2 m -110.32 134.86 51.86 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 118.9 1.35 . . . . 0.0 108.482 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.9 mp -120.14 136.17 58.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -126.76 140.82 52.09 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 125.063 1.345 . . . . 0.0 108.9 172.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.4 mt -123.66 87.56 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 172.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -58.84 106.73 0.44 Allowed 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.303 1.041 . . . . 0.0 108.648 165.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -139.96 133.9 30.78 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.946 1.698 . . . . 0.0 109.654 175.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 52.62 28.12 5.84 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.894 1.678 . . . . 0.0 111.978 -176.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.07 13.43 69.85 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.074 1.321 . . . . 0.0 113.813 -176.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -107.58 170.35 15.4 Favored Glycine 0 C--N 1.334 0.418 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 163.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.27 136.4 27.98 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 118.707 1.253 . . . . 0.0 113.172 168.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.2 t -75.93 161.27 29.09 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 168.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.5 m -135.92 142.0 44.6 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.669 1.188 . . . . 0.0 108.164 169.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -153.43 171.51 18.55 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.794 1.638 . . . . 0.0 109.169 170.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -140.56 148.35 40.86 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.385 2.274 . . . . 0.0 106.3 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.487 ' CD1' HG13 ' A' ' 84' ' ' ILE . 1.5 m-85 -128.27 158.37 38.35 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.904 1.229 . . . . 0.0 109.51 177.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -159.53 175.51 13.18 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.892 0.877 . . . . 0.0 111.49 -178.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -102.98 144.08 31.72 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.56 1.544 . . . . 0.0 109.497 165.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -148.61 119.4 7.56 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.846 1.259 . . . . 0.0 108.719 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 62.67 -0.17 0.58 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.8 2.04 . . . . 0.0 115.237 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.94 8.43 17.88 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.754 1.169 . . . . 0.0 113.026 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.63 156.68 24.27 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 120.257 2.028 . . . . 0.0 108.821 164.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -96.79 152.45 18.67 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 168.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -139.84 167.58 21.79 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.751 0.82 . . . . 0.0 110.911 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.487 HG13 ' CD1' ' A' ' 75' ' ' TYR . 3.3 mp -123.77 128.13 74.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 125.367 1.467 . . . . 0.0 108.592 172.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -81.25 151.21 28.22 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.611 1.564 . . . . 0.0 109.213 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -176.2 166.26 1.66 Allowed Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.311 1.844 . . . . 0.0 107.638 -177.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -59.62 -161.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.762 1 C-N-CA 126.495 4.797 . . . . 0.0 110.417 172.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -42.82 -12.65 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.458 2.303 . . . . 0.0 115.86 -172.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.68 68.72 0.72 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 120.215 1.371 . . . . 0.0 112.121 161.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -140.83 67.4 0.49 Allowed Glycine 0 C--O 1.222 -0.622 0 CA-C-N 119.78 1.173 . . . . 0.0 115.287 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.6 mt -141.59 47.24 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.711 1.205 . . . . 0.0 107.846 173.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -72.23 103.85 3.49 Favored 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 120.668 -1.27 . . . . 0.0 108.267 -175.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -69.2 125.63 27.26 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 164.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 21.7 pt -119.69 175.29 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.913 1.285 . . . . 0.0 108.63 159.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -117.45 2.14 12.41 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.632 0.773 . . . . 0.0 112.096 -175.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -139.35 157.48 45.81 Favored 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 120.752 -1.217 . . . . 0.0 108.768 -168.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -80.9 114.35 19.72 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -52.77 -45.05 66.96 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.791 1.236 . . . . 0.0 110.887 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -75.33 -7.46 54.04 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -167.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -106.91 -16.87 14.35 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.172 0.989 . . . . 0.0 111.813 166.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 66.2 mmm -70.86 -37.65 73.09 Favored 'General case' 0 C--O 1.239 0.51 0 O-C-N 120.345 -1.472 . . . . 0.0 109.255 169.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.9 pt . . . . . 0 C--O 1.25 1.084 0 O-C-N 121.564 -0.71 . . . . 0.0 109.825 168.666 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.7 m . . . . . 0 C--O 1.24 0.555 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -52.48 167.09 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-O 122.603 1.001 . . . . 0.0 112.248 152.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.1 mt -111.61 109.41 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -107.03 162.53 19.38 Favored Pre-proline 0 C--O 1.243 0.714 0 C-N-CA 123.276 0.63 . . . . 0.0 110.361 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.516 ' HB2' HD22 ' A' ' 10' ' ' ASN . 37.3 Cg_endo -61.85 174.69 2.19 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.192 1.928 . . . . 0.0 111.61 164.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.55 169.1 1.88 Allowed 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.427 -0.796 . . . . 0.0 109.068 165.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.9 -60.32 2.31 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 153.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.37 -14.95 63.39 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -160.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.516 HD22 ' HB2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -89.45 1.2 56.18 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 120.086 1.312 . . . . 0.0 113.46 175.182 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.0 t -78.14 143.19 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.82 -62.95 1.49 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 168.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.3 p -152.47 171.22 18.41 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.45 1.1 . . . . 0.0 109.62 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.5 mt -124.23 142.21 41.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 170.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.1 t -122.71 142.98 50.11 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 165.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.1 mt -130.97 104.28 9.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 104.142 -2.54 . . . . 0.0 104.142 173.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -87.61 113.09 22.97 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 172.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -67.27 177.9 1.69 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.897 1.679 . . . . 0.0 111.033 -173.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.68 -50.77 67.43 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.712 -1.242 . . . . 0.0 111.031 171.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -76.85 160.99 28.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 127.844 2.458 . . . . 0.0 108.085 173.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 p -88.22 61.11 6.08 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 123.032 1.396 . . . . 0.0 109.062 -164.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.8 mt -140.09 139.79 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 102.335 -3.209 . . . . 0.0 102.335 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.16 157.58 41.39 Favored 'General case' 0 N--CA 1.414 -2.255 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.447 ' HE2' ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -130.04 130.26 44.7 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 175.516 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.6 mt -106.16 134.92 46.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.447 ' CE2' ' HE2' ' A' ' 24' ' ' LYS . 23.3 m-85 -115.96 97.42 6.08 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 -175.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -123.63 11.53 9.17 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 128.324 2.65 . . . . 0.0 110.556 -176.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -103.8 141.03 36.82 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 166.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.8 t -55.85 -47.68 76.85 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.128 0.971 . . . . 0.0 110.654 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -59.47 -46.29 89.21 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.896 0.878 . . . . 0.0 110.939 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.2 m -61.07 -36.55 79.91 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.354 1.462 . . . . 0.0 111.906 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 74.7 mt -66.99 -55.66 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 172.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -57.79 -32.79 67.87 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.198 0.908 . . . . 0.0 112.75 -175.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.53 -49.18 62.47 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.684 1.594 . . . . 0.0 109.346 175.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.2 mt -68.76 -51.89 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 117.602 -1.19 . . . . 0.0 110.785 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.92 -26.61 15.53 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.39 1.45 . . . . 0.0 112.469 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.97 -69.46 0.32 Allowed 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 125.688 1.595 . . . . 0.0 111.145 170.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -69.09 -7.07 32.54 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.602 1.092 . . . . 0.0 113.135 -173.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.6 mm -83.57 -29.64 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 O-C-N 120.197 -1.564 . . . . 0.0 111.046 168.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.8 -12.75 35.47 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 119.411 1.005 . . . . 0.0 113.184 -173.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.8 p -69.01 -41.4 77.82 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.737 1.615 . . . . 0.0 110.791 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.34 138.6 41.08 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt -116.94 111.69 19.97 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -175.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -61.6 -4.18 1.3 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 173.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p 58.99 -174.07 0.1 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.309 2.244 . . . . 0.0 109.693 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -89.96 5.07 48.04 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.178 -0.951 . . . . 0.0 112.339 174.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -65.96 171.29 4.6 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.33 1.052 . . . . 0.0 110.323 167.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -126.13 131.86 51.97 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.716 1.207 . . . . 0.0 110.821 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.1 m -80.57 158.13 25.84 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.483 0.713 . . . . 0.0 109.098 170.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.0 pt -141.75 32.47 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 125.813 1.645 . . . . 0.0 110.699 175.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -141.52 167.66 21.63 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.721 2.009 . . . . 0.0 107.876 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -121.53 -4.69 9.3 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.817 1.247 . . . . 0.0 111.155 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -149.53 156.48 39.18 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 125.835 1.654 . . . . 0.0 110.169 -170.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.07 176.38 9.61 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.27 3.313 . . . . 0.0 112.529 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.99 1.79 6.56 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.863 1.665 . . . . 0.0 112.245 177.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.21 149.08 43.15 Favored 'General case' 0 C--N 1.338 0.103 0 O-C-N 120.621 -1.299 . . . . 0.0 109.848 168.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.01 -31.8 44.84 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 122.564 0.346 . . . . 0.0 111.175 169.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -114.24 104.59 12.24 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.454 1.502 . . . . 0.0 107.442 -173.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -138.46 173.95 11.06 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.886 2.074 . . . . 0.0 109.623 176.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.08 165.68 12.74 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 164.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.8 m -123.37 127.55 48.63 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.415 1.086 . . . . 0.0 108.906 -166.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mp -123.72 110.82 26.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 124.909 1.284 . . . . 0.0 109.603 -166.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 58.9 m-20 -119.03 122.03 41.23 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.566 1.146 . . . . 0.0 108.763 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 74.3 mt -107.19 96.9 5.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 171.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.64 118.05 11.15 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 172.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -146.0 125.94 13.62 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.606 1.163 . . . . 0.0 110.027 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 54.53 41.83 31.7 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.035 1.734 . . . . 0.0 111.83 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.82 3.87 56.67 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.213 0.911 . . . . 0.0 114.394 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -118.95 -173.53 15.67 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 169.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -147.16 166.14 27.86 Favored 'General case' 0 CA--C 1.517 -0.296 0 O-C-N 121.68 -0.894 . . . . 0.0 111.242 172.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.0 m -106.34 133.44 51.03 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 157.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 m -106.92 145.49 32.16 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.6 ptp -154.88 174.67 14.79 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.763 1.225 . . . . 0.0 108.429 160.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.553 ' H ' ' HG3' ' A' ' 85' ' ' GLU . 34.4 m-85 -135.97 164.8 27.13 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 128.196 2.598 . . . . 0.0 106.768 174.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -134.47 156.29 48.86 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.958 1.303 . . . . 0.0 108.146 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -159.4 179.95 8.49 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 118.709 0.686 . . . . 0.0 110.34 169.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -101.62 133.08 46.88 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.942 1.697 . . . . 0.0 107.642 175.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -133.59 111.28 10.52 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.08 0.943 . . . . 0.0 109.556 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.85 -1.08 2.14 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.641 1.976 . . . . 0.0 114.111 174.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.7 -14.76 6.36 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.123 1.344 . . . . 0.0 113.547 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.78 169.71 9.82 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 120.143 1.971 . . . . 0.0 108.651 164.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -109.85 155.55 21.52 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 171.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -144.12 172.65 12.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -122.13 143.36 35.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 C-N-CA 125.266 1.426 . . . . 0.0 107.486 172.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.553 ' HG3' ' H ' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -85.41 173.75 10.04 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.018 1.327 . . . . 0.0 110.029 179.204 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 176.84 168.56 0.43 Allowed Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 128.756 2.822 . . . . 0.0 106.728 175.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 89' ' ' LYS . 93.9 Cg_endo -54.13 -160.59 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.328 1 C-N-CA 125.306 4.004 . . . . 0.0 109.639 157.731 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -42.83 -4.99 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 129.245 3.018 . . . . 0.0 117.176 -171.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 87' ' ' PRO . 5.5 ptpt -119.5 25.44 10.06 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 129.281 3.032 . . . . 0.0 115.249 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -115.14 61.23 0.38 Allowed Glycine 0 C--N 1.32 -0.331 0 N-CA-C 116.776 1.47 . . . . 0.0 116.776 -167.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.0 mt -131.58 42.69 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 117.716 0.758 . . . . 0.0 110.045 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -76.43 104.7 7.08 Favored 'General case' 0 C--O 1.222 -0.374 0 O-C-N 120.691 -1.256 . . . . 0.0 110.716 -173.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -68.81 122.88 19.51 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 165.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.5 pt -111.5 -172.61 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 126.463 1.905 . . . . 0.0 108.381 160.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -100.16 -44.61 5.91 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -147.1 176.26 10.08 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.803 1.241 . . . . 0.0 108.898 -172.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -61.8 116.6 4.96 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 118.552 0.614 . . . . 0.0 111.271 -172.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -52.78 -35.5 56.73 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.617 1.967 . . . . 0.0 112.477 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -68.06 -13.29 62.08 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 119.873 -1.767 . . . . 0.0 113.189 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -95.03 -18.6 20.89 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.64 0.776 . . . . 0.0 111.888 174.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 21.6 ptp -91.76 -10.92 38.23 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.224 0.92 . . . . 0.0 112.963 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 29.8 pt . . . . . 0 C--O 1.252 1.225 0 C-N-CA 124.593 1.157 . . . . 0.0 112.136 -179.634 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.3 p . . . . . 0 CA--C 1.546 0.805 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -70.62 172.65 13.07 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.331 2.021 . . . . 0.0 113.095 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.0 mt -112.51 121.39 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 175.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.88 164.26 40.77 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 126.864 2.066 . . . . 0.0 111.544 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.479 ' HB2' HD22 ' A' ' 10' ' ' ASN . 18.9 Cg_endo -59.12 161.43 16.17 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 123.919 3.08 . . . . 0.0 113.693 175.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -59.38 156.07 13.56 Favored 'General case' 0 C--N 1.347 0.468 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 172.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.67 -34.27 77.83 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 121.331 -0.855 . . . . 0.0 109.124 165.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -80.09 -25.4 40.02 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 118.669 -1.213 . . . . 0.0 112.33 -165.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.479 HD22 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -86.31 -0.47 55.93 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.323 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 26.9 t -69.98 138.59 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 176.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -76.39 -67.35 0.7 Allowed 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 166.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 p -157.85 149.47 21.71 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.408 0.549 . . . . 0.0 111.14 164.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.2 mt -85.53 141.02 15.08 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 169.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.5 t -126.66 130.16 49.88 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 167.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.7 mt -120.32 109.08 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.43 120.51 27.85 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 173.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -68.47 173.15 5.22 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.22 1.008 . . . . 0.0 109.998 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.51 -52.11 65.98 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 121.23 -0.919 . . . . 0.0 109.752 169.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.28 169.69 15.69 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 173.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.5 p -71.66 24.7 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 129.291 3.036 . . . . 0.0 115.92 -157.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.9 mt -135.14 149.72 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 129.4 3.08 . . . . 0.0 105.781 -159.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.81 164.93 21.98 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 126.573 1.949 . . . . 0.0 109.485 175.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.403 ' HE2' ' CE1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -128.98 143.79 50.98 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 162.087 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.7 mp -114.92 130.68 68.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.403 ' CE1' ' HE2' ' A' ' 24' ' ' LYS . 3.9 m-85 -116.14 79.39 1.3 Allowed 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 103.994 -2.595 . . . . 0.0 103.994 -174.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -85.23 -17.17 37.84 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.612 1.165 . . . . 0.0 110.235 161.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.9 125.09 24.85 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -176.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.8 t -51.97 -49.57 62.96 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.872 0.869 . . . . 0.0 111.527 -172.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -75.4 -16.13 60.39 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.114 -0.991 . . . . 0.0 112.257 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.7 m -79.63 -39.24 31.97 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.453 1.901 . . . . 0.0 110.357 171.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 93.4 mt -63.33 -53.8 41.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 169.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -60.0 -32.74 71.14 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.731 1.212 . . . . 0.0 112.25 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.8 tptt -60.79 -64.97 0.77 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 119.441 1.019 . . . . 0.0 109.642 167.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 82.2 mt -53.91 -46.71 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 119.177 -0.439 . . . . 0.0 110.985 -171.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.37 -22.95 55.51 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -177.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.86 -55.7 10.26 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.255 0.934 . . . . 0.0 109.614 167.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -73.75 -16.74 61.16 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -171.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.1 mm -68.37 -21.29 26.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.829 1.652 . . . . 0.0 110.195 168.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -118.88 8.68 11.77 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.114 1.366 . . . . 0.0 113.186 -168.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.2 t -80.05 -42.2 24.18 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.221 0.464 . . . . 0.0 110.921 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.15 169.35 54.67 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 127.181 2.324 . . . . 0.0 113.766 -166.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -127.01 102.59 7.05 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -171.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.76 -13.65 61.67 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.807 1.243 . . . . 0.0 113.985 168.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 65.38 -172.82 0.18 Allowed 'General case' 0 CA--C 1.547 0.829 0 O-C-N 125.506 1.754 . . . . 0.0 110.283 173.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -83.27 0.59 44.93 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 120.242 -1.536 . . . . 0.0 113.869 172.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.0 mmmt -60.52 165.14 3.93 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 122.207 1.004 . . . . 0.0 112.111 -177.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -99.88 128.47 45.97 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 124.586 1.155 . . . . 0.0 108.332 -175.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.02 51.04 1.22 Allowed 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 123.914 0.886 . . . . 0.0 109.674 -170.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.7 pt -68.11 5.66 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 126.718 2.007 . . . . 0.0 113.532 -172.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -70.98 165.1 24.16 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 126.056 1.742 . . . . 0.0 110.697 166.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -124.48 -9.78 7.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.154 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -145.4 161.08 43.01 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 124.626 1.17 . . . . 0.0 111.367 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.429 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 18.9 Cg_endo -68.35 170.85 13.9 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 124.433 3.422 . . . . 0.0 111.681 171.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 98.8 p -99.33 -16.27 18.51 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.381 0.672 . . . . 0.0 112.499 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.03 146.24 39.61 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 121.46 -0.775 . . . . 0.0 109.418 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -81.81 -16.41 50.98 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 119.339 -0.362 . . . . 0.0 111.881 172.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -131.05 102.16 5.91 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.199 1.399 . . . . 0.0 108.937 -174.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.429 ' CE2' ' HG2' ' A' ' 54' ' ' PRO . 43.5 p90 -134.0 175.22 9.67 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 126.343 1.857 . . . . 0.0 108.708 176.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.74 -167.54 11.31 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 169.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.92 141.11 49.24 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.571 1.148 . . . . 0.0 109.321 -148.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.9 mt -115.23 136.0 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 160.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -127.81 130.2 48.26 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 171.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.9 mt -117.84 92.29 2.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 170.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -70.72 124.31 23.98 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 172.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -156.5 134.58 11.21 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.342 1.457 . . . . 0.0 108.99 -177.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 54.01 27.59 7.65 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.512 1.525 . . . . 0.0 113.321 173.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.43 13.11 63.96 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 119.571 1.078 . . . . 0.0 114.414 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -142.54 171.51 24.71 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 119.448 1.624 . . . . 0.0 110.293 176.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 31.5 mtm -131.84 126.96 35.57 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.284 1.034 . . . . 0.0 110.318 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 53.8 m -80.64 113.49 18.87 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 156.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.42 152.91 25.94 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 124.337 1.023 . . . . 0.0 108.378 163.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.5 ptp -155.19 163.92 39.54 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.059 1.744 . . . . 0.0 107.639 154.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -119.87 172.67 7.55 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.799 1.24 . . . . 0.0 109.725 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -147.16 157.69 43.69 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.31 1.844 . . . . 0.0 108.449 175.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -157.38 -164.51 1.59 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.77 1.628 . . . . 0.0 108.859 171.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -122.91 124.3 42.9 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.648 1.179 . . . . 0.0 108.214 169.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -113.52 117.43 31.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.688 0.756 . . . . 0.0 109.576 173.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 64.81 -0.75 0.93 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.018 2.127 . . . . 0.0 114.595 175.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 123.99 -17.51 7.61 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 125.586 1.565 . . . . 0.0 112.77 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -90.32 157.45 17.64 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 120.278 2.039 . . . . 0.0 109.656 169.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -101.31 143.29 31.55 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.35 1.06 . . . . 0.0 108.537 174.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -139.78 169.36 17.87 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.936 0.495 . . . . 0.0 110.208 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.1 mp -127.38 121.27 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.871 0.868 . . . . 0.0 110.782 -176.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -66.49 157.72 31.41 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.459 -1.4 . . . . 0.0 110.733 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -175.31 167.9 1.75 Allowed Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 128.592 2.757 . . . . 0.0 105.416 -172.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' A' ' 89' ' ' LYS . 66.3 Cg_endo -57.86 -160.97 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.448 0 C-N-CA 124.479 3.453 . . . . 0.0 109.657 160.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -42.68 0.75 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 130.221 3.408 . . . . 0.0 117.397 -175.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 87' ' ' PRO . 0.8 OUTLIER -124.58 30.92 5.84 Favored 'General case' 0 N--CA 1.44 -0.947 1 C-N-CA 132.117 4.167 . . . . 0.0 113.763 176.581 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -109.26 61.03 0.31 Allowed Glycine 0 C--O 1.23 -0.148 0 C-N-CA 124.858 1.218 . . . . 0.0 115.41 -176.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.4 mt -136.69 44.73 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.536 1.135 . . . . 0.0 108.101 171.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -68.87 108.11 3.34 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 175.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -75.04 130.74 39.83 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 159.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.0 pt -112.25 167.15 5.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 151.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -121.98 17.19 10.9 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.128 0.971 . . . . 0.0 112.407 -172.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -153.62 168.32 26.59 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 122.855 0.462 . . . . 0.0 110.872 165.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -67.01 118.49 10.54 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.713 0.805 . . . . 0.0 110.729 -173.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -56.39 -47.02 79.81 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.97 0.908 . . . . 0.0 110.444 173.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -66.95 -26.42 66.82 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.332 0.653 . . . . 0.0 112.514 -170.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.2 20.02 19.58 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 118.407 0.549 . . . . 0.0 112.066 173.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 16.6 ptt? -108.29 -37.3 6.04 Favored 'General case' 0 C--N 1.342 0.256 0 O-C-N 121.437 -0.789 . . . . 0.0 112.648 160.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.996 0 C-N-CA 124.137 0.975 . . . . 0.0 112.007 -174.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.8 p . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -61.39 175.92 1.36 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.578 1.519 . . . . 0.0 111.889 165.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.4 mt -111.67 108.28 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.26 156.44 63.4 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 126.283 1.833 . . . . 0.0 110.984 -171.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.561 ' HB2' HD22 ' A' ' 10' ' ' ASN . 91.4 Cg_endo -74.15 162.18 39.28 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.732 2.954 . . . . 0.0 112.488 -178.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.0 mtmt -63.04 142.57 58.33 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 119.076 0.853 . . . . 0.0 111.269 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.12 -14.81 18.83 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -94.57 -31.3 13.95 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.831 1.196 . . . . 0.0 112.752 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.561 HD22 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -88.45 -6.07 57.87 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.47 1.032 . . . . 0.0 111.525 -174.068 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.5 t -62.48 116.36 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 C-N-CA 128.336 2.654 . . . . 0.0 107.682 160.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -71.11 -67.68 0.49 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.715 1.606 . . . . 0.0 106.784 165.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.6 p -153.91 160.23 42.05 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.936 0.789 . . . . 0.0 110.495 -177.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.3 mt -125.84 125.77 68.86 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 -176.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.4 t -108.49 132.83 53.42 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.9 mt -133.35 97.03 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.98 115.68 18.81 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 164.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -68.29 -178.46 1.08 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.542 1.537 . . . . 0.0 109.994 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.9 p -59.19 -45.89 89.88 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.972 -1.08 . . . . 0.0 112.189 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -74.3 -174.0 1.86 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.546 1.139 . . . . 0.0 110.22 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 98.4 p -67.32 5.03 0.81 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.282 1.833 . . . . 0.0 114.76 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.1 mm -113.15 153.89 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 128.144 2.578 . . . . 0.0 108.606 -159.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -143.16 162.76 34.72 Favored 'General case' 0 N--CA 1.418 -2.073 0 C-N-CA 125.968 1.707 . . . . 0.0 110.587 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.11 142.16 44.24 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 125.129 1.371 . . . . 0.0 107.358 164.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.3 mp -109.66 138.17 38.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 170.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -111.96 108.94 18.45 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 103.166 -2.901 . . . . 0.0 103.166 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -135.9 41.3 2.69 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 126.472 1.909 . . . . 0.0 106.183 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.94 123.44 17.16 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 103.614 -2.736 . . . . 0.0 103.614 -170.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.6 t -53.76 -39.6 65.49 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.684 0.794 . . . . 0.0 112.009 -171.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -77.67 -33.76 53.23 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.084 -1.01 . . . . 0.0 111.297 -177.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.2 m -57.94 -41.32 82.53 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.139 1.376 . . . . 0.0 110.491 168.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.4 mt -67.15 -54.58 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 124.716 1.206 . . . . 0.0 109.072 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -51.29 -41.76 60.69 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.131 0.572 . . . . 0.0 111.335 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -57.84 11.08 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 57.4 mt -54.68 -49.8 64.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 C-N-CA 123.392 0.677 . . . . 0.0 112.111 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.11 -17.91 30.77 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.804 0.842 . . . . 0.0 112.169 -171.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.65 -61.18 2.1 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.497 1.119 . . . . 0.0 110.913 166.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -67.24 -30.53 70.47 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.01 1.277 . . . . 0.0 111.545 -174.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.8 mm -54.87 -24.74 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.396 0.678 . . . . 0.0 110.05 172.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.19 3.64 13.49 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.139 1.776 . . . . 0.0 113.908 -174.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 t -79.4 -29.69 42.13 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.654 1.115 . . . . 0.0 111.276 -172.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.33 166.14 41.77 Favored Glycine 0 C--N 1.336 0.574 0 O-C-N 120.755 -1.215 . . . . 0.0 112.539 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -126.62 121.47 32.28 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -63.34 -3.42 1.96 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.579 1.152 . . . . 0.0 114.063 172.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p 58.04 -174.16 0.08 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 127.457 2.303 . . . . 0.0 110.761 -177.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -86.58 3.52 44.03 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.059 1.343 . . . . 0.0 111.59 176.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -69.22 164.94 21.56 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.87 1.214 . . . . 0.0 109.488 169.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -114.57 157.52 22.91 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.116 1.366 . . . . 0.0 108.182 174.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.53 150.04 50.35 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 -163.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.8 pt -145.83 17.6 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 122.457 0.303 . . . . 0.0 111.482 -163.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -131.61 167.4 19.5 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.389 1.076 . . . . 0.0 109.24 -171.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.22 -5.57 9.43 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.842 1.257 . . . . 0.0 112.334 -177.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -144.5 164.14 30.12 Favored Pre-proline 0 C--O 1.235 0.319 0 C-N-CA 126.011 1.724 . . . . 0.0 108.624 -174.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -70.69 -179.89 3.68 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.373 2.049 . . . . 0.0 110.803 174.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.0 p -110.34 -8.44 14.71 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.835 1.254 . . . . 0.0 111.911 175.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.86 159.45 20.37 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 124.266 1.026 . . . . 0.0 111.343 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -94.87 -13.6 25.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.255 1.022 . . . . 0.0 112.1 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -128.34 110.8 12.69 Favored 'General case' 0 C--O 1.231 0.083 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 175.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -147.32 160.75 42.15 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.59 1.556 . . . . 0.0 108.942 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.93 170.64 20.08 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.842 1.21 . . . . 0.0 110.315 171.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.3 m -131.98 121.1 23.39 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.031 1.732 . . . . 0.0 108.572 -163.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.2 mp -124.75 127.29 72.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 124.052 0.941 . . . . 0.0 109.266 -166.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -120.05 145.83 46.48 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 124.927 1.291 . . . . 0.0 109.244 171.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 30.5 mt -125.24 88.34 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -71.82 108.4 5.09 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.963 1.305 . . . . 0.0 108.041 177.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -137.34 134.24 35.8 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.515 1.126 . . . . 0.0 109.264 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 62.84 -3.32 0.32 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.283 1.833 . . . . 0.0 115.861 173.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.77 10.82 8.94 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 120.163 1.347 . . . . 0.0 113.692 -174.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -149.22 -178.6 24.38 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.59 145.32 24.3 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 118.653 1.227 . . . . 0.0 113.065 -173.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 t -73.72 166.09 23.93 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 162.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.8 m -142.47 142.66 32.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 163.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 17.2 ptp -156.0 169.62 24.04 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.795 2.038 . . . . 0.0 108.391 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.405 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 54.8 m-85 -139.16 148.87 43.76 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.477 1.911 . . . . 0.0 108.077 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -127.94 151.77 48.7 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.921 1.237 . . . . 0.0 110.155 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -156.99 177.77 11.13 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.033 1.333 . . . . 0.0 110.001 -171.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -107.83 147.78 30.43 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.165 1.386 . . . . 0.0 107.843 167.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.5 tp10 -142.28 117.4 10.06 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.685 0.794 . . . . 0.0 109.383 171.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 61.77 -11.95 0.06 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 127.999 2.519 . . . . 0.0 115.612 -176.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.7 2.35 3.96 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 117.76 -1.578 . . . . 0.0 115.555 -177.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -110.17 160.39 16.53 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 121.018 2.409 . . . . 0.0 109.274 159.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -97.48 145.74 25.91 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -140.36 162.43 35.33 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.883 0.873 . . . . 0.0 110.622 -174.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mp -133.08 132.29 58.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.802 1.241 . . . . 0.0 109.508 -169.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.405 ' HB3' ' H ' ' A' ' 74' ' ' PHE . 5.3 tm-20 -77.36 154.41 32.8 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.846 2.058 . . . . 0.0 110.624 177.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -173.22 167.97 2.61 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 129.276 3.03 . . . . 0.0 106.415 174.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.452 ' C ' ' H ' ' A' ' 89' ' ' LYS . 90.9 Cg_endo -54.12 -162.02 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 125.215 3.943 . . . . 0.0 110.239 162.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -43.35 -5.69 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 128.284 2.634 . . . . 0.0 116.529 -175.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.452 ' H ' ' C ' ' A' ' 87' ' ' PRO . 9.2 mmtt -120.97 52.09 1.21 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.686 1.994 . . . . 0.0 111.776 171.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -129.14 59.39 0.69 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 116.719 1.448 . . . . 0.0 116.719 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.7 mt -130.19 55.18 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 118.649 1.224 . . . . 0.0 108.131 171.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -76.32 119.14 19.79 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 177.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -87.91 113.53 23.65 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 163.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 27.9 pt -98.91 171.15 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 158.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -122.78 -13.82 7.82 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.925 -0.484 . . . . 0.0 112.032 -173.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -123.53 150.22 44.27 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 173.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -70.12 128.44 36.29 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 123.926 0.89 . . . . 0.0 109.974 -172.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -60.89 -46.13 91.84 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.665 1.186 . . . . 0.0 111.402 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -64.91 -29.48 70.43 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.945 0.898 . . . . 0.0 111.504 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -78.97 -18.94 52.86 Favored 'General case' 0 C--O 1.24 0.594 0 O-C-N 121.683 -0.636 . . . . 0.0 112.471 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 19.9 mmt -85.29 -27.29 26.07 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.233 1.013 . . . . 0.0 111.468 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 28.2 pt . . . . . 0 C--O 1.251 1.181 0 CA-C-N 119.681 1.128 . . . . 0.0 111.601 -174.289 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 CA--C 1.548 0.879 0 CA-C-O 119.17 -0.443 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -65.95 -178.4 1.03 Allowed 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 124.528 3.485 . . . . 0.0 113.875 168.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.0 mt -106.94 122.5 61.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 164.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.28 166.12 11.62 Favored Pre-proline 0 C--O 1.238 0.495 0 C-N-CA 125.669 1.588 . . . . 0.0 109.641 168.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.464 ' HB2' HD22 ' A' ' 10' ' ' ASN . 73.1 Cg_endo -62.88 -176.84 0.28 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 121.702 1.601 . . . . 0.0 111.124 167.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -55.8 169.44 0.35 Allowed 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.092 -1.005 . . . . 0.0 108.88 159.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.71 -49.96 9.85 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 161.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -66.8 -22.89 66.01 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -167.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.464 HD22 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -79.27 -3.21 44.91 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.316 0.962 . . . . 0.0 113.356 175.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.44 ' N ' HD21 ' A' ' 10' ' ' ASN . 17.0 t -85.5 122.6 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -70.48 -54.62 11.51 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.122 1.769 . . . . 0.0 108.121 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.7 p -157.22 155.93 31.7 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.183 0.516 . . . . 0.0 110.59 174.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.1 mt -109.66 139.21 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 170.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -129.71 106.13 8.5 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.6 mt -101.83 108.61 24.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -93.5 115.29 27.8 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.019 2.128 . . . . 0.0 107.32 174.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -79.8 172.1 14.23 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.809 0.844 . . . . 0.0 111.21 -172.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.95 -53.22 60.43 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.573 1.149 . . . . 0.0 110.182 170.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -71.23 149.15 46.54 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.998 1.719 . . . . 0.0 106.506 166.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.2 p -88.44 53.44 2.73 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.824 0.821 . . . . 0.0 110.627 -151.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.2 mt -126.32 134.27 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 -170.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -129.79 110.38 11.69 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -170.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.445 ' HE2' ' CE1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -101.81 130.54 48.27 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -176.193 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.1 mt -100.51 134.96 38.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.445 ' CE1' ' HE2' ' A' ' 24' ' ' LYS . 9.6 m-85 -117.16 84.59 2.18 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 103.146 -2.909 . . . . 0.0 103.146 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -94.46 -6.91 42.88 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 127.459 2.304 . . . . 0.0 110.349 170.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.59 132.27 35.3 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 t -58.03 -42.34 85.1 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.541 -0.724 . . . . 0.0 111.45 -171.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -73.53 -36.43 65.68 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.264 -0.897 . . . . 0.0 111.506 -174.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.6 m -53.53 -51.75 61.86 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 126.612 1.965 . . . . 0.0 110.756 167.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.8 mt -58.18 -50.08 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 123.526 0.73 . . . . 0.0 109.206 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -55.64 -45.57 77.6 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 118.552 -0.737 . . . . 0.0 112.051 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.46 -51.81 68.3 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-N 118.303 0.501 . . . . 0.0 109.813 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 94.2 mt -55.95 -45.12 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.955 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 mt -57.0 -25.65 58.89 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.989 1.268 . . . . 0.0 113.013 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.2 m -73.57 -52.78 12.31 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 120.244 1.384 . . . . 0.0 109.883 169.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -65.05 -24.11 67.38 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.809 1.186 . . . . 0.0 112.732 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.9 mm -83.39 -7.55 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.183 1.793 . . . . 0.0 110.754 175.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.13 1.62 9.19 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.242 1.417 . . . . 0.0 114.33 -175.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.5 p -66.36 -31.25 71.91 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.588 1.086 . . . . 0.0 111.517 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.9 163.14 43.47 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-O 122.606 1.114 . . . . 0.0 113.924 -164.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.5 pttt -112.24 97.65 6.78 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 127.183 2.193 . . . . 0.0 109.629 176.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -60.08 -11.88 7.02 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 124.746 1.218 . . . . 0.0 113.216 167.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.1 p 64.98 -175.23 0.17 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 126.738 2.015 . . . . 0.0 111.663 175.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -95.9 14.15 24.44 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.295 0.638 . . . . 0.0 112.531 165.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -64.63 147.99 51.83 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 120.558 -1.339 . . . . 0.0 110.67 156.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -83.55 121.7 27.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 168.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.1 t -73.0 147.94 44.67 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.743 -1.576 . . . . 0.0 106.743 152.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.9 pt -140.16 13.4 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 126.4 1.88 . . . . 0.0 110.024 170.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -86.39 164.17 17.19 Favored 'General case' 0 C--O 1.238 0.5 0 O-C-N 120.954 -1.091 . . . . 0.0 110.013 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.43 -15.05 10.95 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 118.088 -0.958 . . . . 0.0 112.235 175.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -153.95 165.5 17.76 Favored Pre-proline 0 N--CA 1.469 0.481 0 C-N-CA 125.331 1.452 . . . . 0.0 110.537 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -72.11 147.17 47.96 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.62 2.214 . . . . 0.0 111.591 168.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.11 -31.15 61.08 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.899 0.48 . . . . 0.0 112.103 171.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.26 155.2 25.41 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 121.799 0.809 . . . . 0.0 111.085 -173.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -84.76 -35.26 22.55 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.651 171.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -110.22 94.99 5.3 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -172.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -139.06 171.81 13.76 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 128.613 2.765 . . . . 0.0 107.063 172.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.71 -177.13 14.73 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 166.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.7 m -123.96 122.91 39.19 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.519 1.128 . . . . 0.0 109.449 -165.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mp -97.52 133.82 37.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 170.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -130.57 137.75 49.83 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.853 1.261 . . . . 0.0 107.899 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.4 mt -128.12 92.35 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 105.45 -2.055 . . . . 0.0 105.45 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -70.24 109.46 4.68 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 170.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -139.52 138.58 36.44 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.341 1.056 . . . . 0.0 108.552 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 48.8 36.18 7.64 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.246 1.018 . . . . 0.0 111.721 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.45 18.49 79.91 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 118.939 -0.923 . . . . 0.0 115.119 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.05 156.23 24.28 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 120.355 2.077 . . . . 0.0 110.328 173.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 81.4 mtp -112.33 96.76 6.2 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 123.845 0.858 . . . . 0.0 109.825 -173.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 m -62.88 105.79 0.72 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 165.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.8 m -103.65 156.16 18.0 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -176.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.8 ptp -153.88 171.05 19.58 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.828 1.651 . . . . 0.0 107.185 167.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -126.28 -177.98 4.16 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.233 1.413 . . . . 0.0 107.491 173.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -150.51 156.27 41.09 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -158.76 169.5 24.23 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 162.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -89.87 121.56 32.1 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 169.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -109.67 119.16 38.54 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 169.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.27 4.02 2.0 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.777 1.631 . . . . 0.0 114.463 164.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.01 -13.82 6.0 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.73 1.634 . . . . 0.0 113.4 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.8 tptt -115.16 163.2 15.98 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 120.034 1.917 . . . . 0.0 109.987 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -107.47 142.96 36.52 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -138.43 160.89 38.38 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.261 0.624 . . . . 0.0 109.988 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.78 133.83 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.936 0.894 . . . . 0.0 111.825 -173.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -71.98 161.33 31.08 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.121 -0.987 . . . . 0.0 112.379 -176.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -175.23 169.17 1.58 Allowed Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 126.896 2.078 . . . . 0.0 108.051 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -58.18 -162.54 0.02 OUTLIER 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.081 1.854 . . . . 0.0 110.54 155.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -43.28 -14.31 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.465 2.706 . . . . 0.0 116.705 -171.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -105.03 49.8 0.8 Allowed 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.272 -0.893 . . . . 0.0 111.888 168.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -125.16 69.18 0.5 Allowed Glycine 0 C--O 1.222 -0.608 0 CA-C-N 119.876 1.216 . . . . 0.0 112.247 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.6 mt -133.63 49.27 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 163.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -74.87 110.95 9.59 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -78.08 125.17 28.96 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 160.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.7 pt -106.93 164.48 4.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 152.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -123.65 48.21 1.9 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.351 0.661 . . . . 0.0 110.021 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -164.36 174.29 11.23 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.111 0.965 . . . . 0.0 111.757 159.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -70.2 122.94 20.45 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.091 0.956 . . . . 0.0 108.888 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -63.12 -47.88 80.87 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.511 0.596 . . . . 0.0 110.572 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -58.99 -35.03 72.54 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.451 -0.781 . . . . 0.0 112.871 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -72.69 -23.7 60.91 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.245 0.93 . . . . 0.0 110.827 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.2 mmt -70.59 -36.11 73.37 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 121.593 -0.692 . . . . 0.0 110.413 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.0 pt . . . . . 0 C--O 1.249 1.044 0 CA-C-N 119.172 0.896 . . . . 0.0 112.48 -167.677 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 m . . . . . 0 CA--C 1.545 0.751 0 CA-C-O 119.559 -0.258 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -67.29 165.04 28.19 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 CA-C-N 120.075 1.063 . . . . 0.0 111.352 167.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.6 mt -101.99 111.68 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 158.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.48 152.88 46.55 Favored Pre-proline 0 C--O 1.241 0.608 0 C-N-CA 125.878 1.671 . . . . 0.0 108.701 177.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.522 ' HB2' HD22 ' A' ' 10' ' ' ASN . 95.5 Cg_endo -73.7 159.88 44.86 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.807 2.338 . . . . 0.0 111.436 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.409 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -70.32 149.71 47.09 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 123.455 0.702 . . . . 0.0 112.048 -173.714 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.1 -12.86 43.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 118.592 -0.718 . . . . 0.0 111.945 170.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -95.13 -6.26 42.26 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.509 1.05 . . . . 0.0 112.123 -178.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.522 HD22 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -129.39 -2.54 4.95 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.58 1.152 . . . . 0.0 112.242 -173.23 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 37.5 t -78.88 111.22 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 170.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -74.8 -43.01 57.0 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.135 1.374 . . . . 0.0 108.605 176.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.8 p -160.24 171.89 18.37 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.593 1.088 . . . . 0.0 112.613 168.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.6 mt -130.02 137.69 55.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 127.335 2.254 . . . . 0.0 105.832 172.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.8 t -116.44 151.2 36.52 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 159.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.0 mt -131.41 101.64 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 168.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.3 117.39 20.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 169.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -75.33 177.02 6.88 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.262 1.029 . . . . 0.0 110.6 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.9 p -60.81 -15.29 28.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.078 2.151 . . . . 0.0 113.363 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 48.2 p30 -118.22 -166.76 1.25 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.515 1.926 . . . . 0.0 110.086 -170.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.2 p -82.44 24.95 0.65 Allowed 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.273 -1.517 . . . . 0.0 111.809 -173.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.5 mt -124.89 149.39 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.463 -1.681 . . . . 0.0 106.463 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -135.3 164.9 26.68 Favored 'General case' 0 N--CA 1.417 -2.084 0 C-N-CA 127.476 2.31 . . . . 0.0 107.906 170.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.25 134.92 30.1 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.8 mp -106.52 148.88 10.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -129.81 34.72 4.25 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.147 0.979 . . . . 0.0 109.664 -170.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -57.47 -20.65 32.17 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.384 2.274 . . . . 0.0 113.019 -175.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.97 123.85 21.74 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 129.542 3.137 . . . . 0.0 109.117 175.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.3 t -46.22 -48.08 17.79 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.133 1.373 . . . . 0.0 113.746 -175.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -69.54 -27.57 65.26 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.004 -1.06 . . . . 0.0 111.566 -175.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.6 m -72.58 -34.86 67.74 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.297 1.839 . . . . 0.0 111.019 172.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.0 mt -65.23 -52.86 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -65.37 -14.05 59.97 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -66.82 -78.66 0.06 Allowed 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 157.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.3 mt -50.58 -39.76 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 125.018 1.327 . . . . 0.0 112.578 -160.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 41.5 mt -51.64 -23.0 3.81 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.1 t -64.46 -63.83 1.03 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.168 1.387 . . . . 0.0 108.494 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 56.7 mp0 -64.5 -27.39 68.94 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.4 1.48 . . . . 0.0 111.158 -175.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.5 mm -62.26 -35.5 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 O-C-N 121.297 -0.877 . . . . 0.0 110.245 173.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.63 0.12 30.31 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 120.726 -1.234 . . . . 0.0 113.587 -169.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.7 t -64.81 -44.91 88.39 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.006 0.523 . . . . 0.0 110.919 -176.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.61 168.24 54.06 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-O 122.493 1.051 . . . . 0.0 112.432 -175.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -132.76 130.74 40.34 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 176.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -68.15 0.3 3.83 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.7 p 60.03 -172.54 0.12 Allowed 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 126.751 2.02 . . . . 0.0 108.847 -174.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -91.31 2.75 56.16 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.095 -1.003 . . . . 0.0 112.034 176.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt -69.03 170.07 10.58 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.084 0.856 . . . . 0.0 110.894 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.11 150.29 34.3 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.07 1.748 . . . . 0.0 109.019 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.87 149.87 43.64 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 -169.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 35.4 pt -138.31 17.78 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 118.957 0.799 . . . . 0.0 112.523 -165.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -139.97 -173.24 3.59 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.181 0.992 . . . . 0.0 108.761 -169.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.38 -6.38 1.56 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.481 1.112 . . . . 0.0 110.651 171.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -140.63 150.23 59.62 Favored Pre-proline 0 N--CA 1.469 0.485 0 CA-C-N 120.21 1.368 . . . . 0.0 111.29 -168.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.26 167.27 27.34 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.666 2.911 . . . . 0.0 114.928 -164.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 t -100.11 23.01 10.51 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.386 2.274 . . . . 0.0 110.72 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -126.6 150.41 48.9 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 125.268 1.427 . . . . 0.0 110.626 -174.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -90.03 -24.79 21.1 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.484 1.114 . . . . 0.0 110.871 172.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -125.34 102.44 7.43 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -145.01 166.99 23.72 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 128.383 2.673 . . . . 0.0 106.163 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.48 166.93 13.74 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 168.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.5 m -112.46 140.05 47.52 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.572 1.149 . . . . 0.0 108.553 -170.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.5 mp -125.81 128.83 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 -174.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -115.1 135.68 53.94 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.2 mt -126.03 87.65 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 171.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -70.22 116.03 10.11 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 125.418 1.487 . . . . 0.0 107.23 174.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -140.91 113.28 8.01 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.036 0.934 . . . . 0.0 109.97 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 74.52 -14.99 0.66 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 130.446 3.499 . . . . 0.0 115.639 171.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 123.21 23.68 2.14 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 118.843 0.747 . . . . 0.0 111.352 -165.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -145.1 171.7 26.14 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 106.609 -2.596 . . . . 0.0 106.609 160.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.08 139.24 34.01 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 118.772 1.286 . . . . 0.0 111.031 172.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 91.3 m -76.55 128.48 34.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 161.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.6 m -102.59 146.68 27.81 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 164.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.6 ptm -159.5 165.51 32.85 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.485 1.514 . . . . 0.0 108.47 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -144.64 140.66 28.83 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.826 1.65 . . . . 0.0 106.841 -174.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -129.21 152.24 49.0 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 120.015 1.279 . . . . 0.0 109.35 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -153.81 -175.56 5.43 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.12 0.968 . . . . 0.0 111.264 -178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -115.55 142.79 46.25 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.609 1.964 . . . . 0.0 108.586 173.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.427 ' CD ' HD21 ' A' ' 79' ' ' ASN . 14.1 tm-20 -141.71 127.68 19.47 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 125.393 1.477 . . . . 0.0 108.431 175.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.427 HD21 ' CD ' ' A' ' 78' ' ' GLU . 7.0 m-80 57.76 14.7 2.59 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.957 1.303 . . . . 0.0 112.936 -177.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.21 18.98 58.22 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 117.921 -1.488 . . . . 0.0 113.32 -175.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.26 148.43 45.91 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 128.612 2.765 . . . . 0.0 107.493 177.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -104.65 143.01 33.66 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.541 1.519 . . . . 0.0 111.305 -169.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -138.12 150.07 46.5 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.24 0.616 . . . . 0.0 111.22 -171.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mp -123.16 120.02 59.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 125.133 1.373 . . . . 0.0 108.931 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -73.69 153.19 40.19 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.419 1.088 . . . . 0.0 110.475 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -172.53 168.07 2.96 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 128.428 2.691 . . . . 0.0 106.072 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -57.92 -161.26 0.02 OUTLIER 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 125.268 3.979 . . . . 0.0 110.386 165.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -42.72 -8.82 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 127.572 2.349 . . . . 0.0 117.055 -175.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -121.13 46.74 1.97 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.016 1.326 . . . . 0.0 112.194 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -126.57 70.11 0.5 Allowed Glycine 0 C--O 1.224 -0.508 0 C-N-CA 125.762 1.648 . . . . 0.0 113.715 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.5 mt -131.09 53.07 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 164.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -75.42 125.95 30.03 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -119.31 102.47 8.71 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 -171.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.7 pt -115.75 146.71 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.655 1.582 . . . . 0.0 109.073 -175.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -91.82 -5.71 52.96 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -171.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -130.51 153.65 48.62 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.114 0.87 . . . . 0.0 112.638 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -57.86 135.72 56.9 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 126.383 1.873 . . . . 0.0 110.655 174.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -82.02 -49.86 9.76 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.029 1.332 . . . . 0.0 110.884 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -67.99 -13.81 62.47 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -165.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -97.7 -10.25 25.28 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.414 1.006 . . . . 0.0 112.576 173.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 38.7 mmm -76.81 -37.42 55.77 Favored 'General case' 0 C--O 1.233 0.222 0 O-C-N 120.626 -1.297 . . . . 0.0 111.167 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 12.8 pt . . . . . 0 C--O 1.243 0.73 0 C-N-CA 126.558 1.943 . . . . 0.0 114.229 -153.693 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.54 0.577 0 CA-C-O 119.251 -0.404 . . . . 0.0 111.76 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.44 163.3 39.31 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.707 1.604 . . . . 0.0 112.157 169.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.0 mt -96.56 105.67 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 162.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.4 mt -126.19 165.64 26.43 Favored Pre-proline 0 C--O 1.24 0.585 0 C-N-CA 125.396 1.478 . . . . 0.0 108.462 174.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.417 ' HB2' HD22 ' A' ' 10' ' ' ASN . 34.4 Cg_endo -62.07 163.56 19.35 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.014 1.81 . . . . 0.0 111.248 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -61.88 179.69 0.25 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.265 0.626 . . . . 0.0 111.405 170.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.77 -45.9 33.78 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 155.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.34 3.94 3.31 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.305 1.442 . . . . 0.0 114.037 -163.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.417 HD22 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -124.96 4.13 8.02 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.298 2.239 . . . . 0.0 112.516 179.568 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 37.8 t -84.25 141.77 14.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -92.4 -52.75 4.51 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 173.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.51 161.34 42.32 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.907 0.883 . . . . 0.0 111.923 170.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.6 mt -123.89 140.81 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 164.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 54.4 m -134.42 115.74 14.36 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 -168.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.7 mt -119.55 120.11 62.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -112.06 102.42 10.63 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -72.27 168.17 18.87 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.623 1.569 . . . . 0.0 110.031 -165.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.0 p -45.87 -39.62 8.86 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.767 1.627 . . . . 0.0 112.97 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -51.09 -153.62 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 131.41 3.884 . . . . 0.0 112.07 164.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 93.3 p -122.07 25.15 9.21 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 119.863 -1.773 . . . . 0.0 110.596 160.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.3 mt -84.65 134.47 26.93 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 172.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -125.69 129.34 49.35 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.55 125.98 54.79 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 175.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.3 mp -99.8 135.64 34.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 173.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -118.26 87.12 2.66 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -118.19 52.16 1.03 Allowed 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.812 1.645 . . . . 0.0 107.148 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.45 146.49 40.14 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.614 1.566 . . . . 0.0 107.377 168.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.2 t -46.69 -53.99 10.55 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.949 1.699 . . . . 0.0 112.266 177.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -76.42 -27.5 56.29 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 121.65 -0.656 . . . . 0.0 112.027 -171.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 51.5 m -65.78 -48.76 70.71 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.428 1.491 . . . . 0.0 109.187 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 76.9 mt -57.9 -53.19 48.51 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 C-N-CA 125.599 1.56 . . . . 0.0 108.849 171.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -61.1 -28.45 69.1 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 120.541 1.519 . . . . 0.0 113.309 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.18 -60.14 3.08 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.1 mt -47.59 -49.69 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.642 1.577 . . . . 0.0 110.984 175.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.45 -28.07 12.1 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -176.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.5 t -63.93 -62.13 1.83 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.952 0.796 . . . . 0.0 109.16 172.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -63.62 -32.18 73.57 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.411 -0.805 . . . . 0.0 111.894 -174.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.0 mm -62.24 -25.85 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.801 1.24 . . . . 0.0 111.036 174.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.65 -5.73 12.17 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -175.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 t -62.15 -26.91 68.59 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.871 1.214 . . . . 0.0 112.038 -169.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.68 169.67 43.15 Favored Glycine 0 C--N 1.335 0.494 0 O-C-N 120.987 -1.07 . . . . 0.0 114.238 -167.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -112.1 106.72 15.42 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 125.907 1.683 . . . . 0.0 108.336 174.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -3.33 1.16 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.134 0.974 . . . . 0.0 112.923 165.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.1 p 66.27 -164.77 0.23 Allowed 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 125.378 1.471 . . . . 0.0 108.056 174.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -105.42 12.66 31.28 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.593 1.088 . . . . 0.0 111.473 169.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -63.67 170.53 3.22 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 122.166 0.984 . . . . 0.0 110.527 164.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -122.51 144.52 49.02 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 125.604 1.562 . . . . 0.0 110.526 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.02 157.56 16.25 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 125.028 1.331 . . . . 0.0 108.604 172.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 26.7 pt -137.77 17.36 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 125.771 1.628 . . . . 0.0 111.284 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.02 176.88 8.31 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.369 1.468 . . . . 0.0 110.701 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.9 -4.67 6.33 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.749 2.42 . . . . 0.0 110.944 -175.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -140.31 150.05 59.94 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-N 119.202 0.91 . . . . 0.0 109.814 -175.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.43 167.73 25.5 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.141 1.894 . . . . 0.0 110.06 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.2 20.19 16.45 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.401 1.08 . . . . 0.0 110.367 170.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.58 173.83 11.09 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.037 -1.04 . . . . 0.0 109.022 157.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.97 -24.04 5.7 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 127.455 2.302 . . . . 0.0 110.082 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -118.87 112.74 20.05 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.502 1.921 . . . . 0.0 106.114 174.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -149.41 173.83 13.12 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 126.956 2.103 . . . . 0.0 106.706 170.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -114.66 166.17 12.13 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 167.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.58 147.66 22.8 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.397 0.679 . . . . 0.0 109.701 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.0 mp -134.84 128.95 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 172.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -132.26 141.53 49.05 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 53.7 mt -129.24 97.39 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 -177.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -71.31 131.3 43.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 170.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -158.79 -166.04 1.78 Allowed 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -45.51 -32.83 2.4 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.724 1.609 . . . . 0.0 114.133 175.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.23 2.47 81.47 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-O 119.311 -0.716 . . . . 0.0 111.873 -173.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.47 -138.05 22.68 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 107.619 -2.192 . . . . 0.0 107.619 -153.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 11.5 mtt -105.44 112.52 25.64 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.181 0.991 . . . . 0.0 110.682 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 47.9 m -60.04 124.86 21.53 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 149.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.6 m -112.87 143.42 44.17 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.971 1.708 . . . . 0.0 107.073 173.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.5 ptm -163.94 167.71 20.24 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.539 1.535 . . . . 0.0 108.677 -172.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -149.23 129.53 13.75 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.738 1.215 . . . . 0.0 109.098 -169.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -120.18 145.43 46.98 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.751 1.614 . . . . 0.0 110.164 -172.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -151.13 179.51 8.22 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.682 1.593 . . . . 0.0 110.938 -169.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -112.86 148.72 34.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.474 1.51 . . . . 0.0 108.987 168.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -144.72 119.42 9.81 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.686 1.194 . . . . 0.0 108.398 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 58.57 5.44 0.46 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.6 1.96 . . . . 0.0 114.856 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.22 1.8 28.1 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 119.838 1.199 . . . . 0.0 113.536 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -106.17 149.93 26.34 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 119.227 1.513 . . . . 0.0 108.131 163.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -93.85 151.85 19.3 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 174.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -140.47 159.05 43.05 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.599 0.714 . . . . 0.0 111.312 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.5 mp -119.65 124.69 73.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 125.26 1.424 . . . . 0.0 108.86 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -70.71 147.65 48.83 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 122.231 1.015 . . . . 0.0 111.596 168.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -171.55 167.6 3.7 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 128.39 2.676 . . . . 0.0 107.881 174.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.41 ' O ' ' N ' ' A' ' 89' ' ' LYS . 45.9 Cg_endo -53.19 -160.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.609 1 C-N-CA 126.199 4.599 . . . . 0.0 110.672 166.002 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -42.63 -13.78 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.756 2.423 . . . . 0.0 115.58 -173.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -110.04 67.42 0.65 Allowed 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 127.875 2.47 . . . . 0.0 113.074 164.1 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -130.72 38.71 1.9 Allowed Glycine 0 N--CA 1.463 0.457 0 N-CA-C 116.251 1.26 . . . . 0.0 116.251 -173.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.3 mt -129.34 39.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 O-C-N 121.72 -0.871 . . . . 0.0 109.049 -170.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -75.84 101.62 5.19 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -171.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -72.28 125.82 28.28 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 166.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 24.5 pt -114.99 179.44 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 125.976 1.71 . . . . 0.0 108.753 165.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -107.09 -18.19 13.97 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -178.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -136.67 168.74 18.93 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.792 0.837 . . . . 0.0 111.749 -165.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -77.7 121.44 24.01 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.239 1.016 . . . . 0.0 109.937 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -62.76 -47.77 82.07 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.365 1.066 . . . . 0.0 111.781 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -62.53 -32.02 72.89 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.45 0.7 . . . . 0.0 111.881 -172.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -71.19 -21.01 62.2 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.142 -0.974 . . . . 0.0 111.738 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.1 mmt -98.57 -4.58 33.8 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.128 1.371 . . . . 0.0 112.531 -170.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 23.0 pt . . . . . 0 C--O 1.253 1.286 0 C-N-CA 124.69 1.196 . . . . 0.0 111.321 -175.663 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 CA--C 1.534 0.332 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -55.21 158.63 11.59 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 CA-C-N 121.292 1.497 . . . . 0.0 111.824 164.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 mp -80.32 135.87 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 158.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.63 165.11 24.4 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 126.393 1.877 . . . . 0.0 108.851 174.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -64.8 175.8 3.41 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.096 2.531 . . . . 0.0 112.485 174.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.586 ' H ' ' HE2' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -67.16 -172.28 0.2 Allowed 'General case' 0 C--N 1.344 0.364 0 O-C-N 120.386 -1.446 . . . . 0.0 109.922 167.363 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.7 -36.81 12.73 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.548 0.739 . . . . 0.0 110.957 161.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -76.06 -17.68 59.54 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.206 -0.934 . . . . 0.0 113.223 -171.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.535 HD21 ' N ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -88.12 -3.89 58.83 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.854 1.261 . . . . 0.0 112.421 176.043 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.535 ' N ' HD21 ' A' ' 10' ' ' ASN . 29.1 t -88.3 118.48 33.95 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 -172.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -83.89 -49.43 9.03 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.081 1.352 . . . . 0.0 107.817 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.3 m -157.03 176.95 12.07 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.618 1.099 . . . . 0.0 111.523 163.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 53.9 mt -126.81 145.05 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 167.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.8 t -125.58 141.08 52.22 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.472 1.109 . . . . 0.0 108.516 169.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.6 mt -134.47 105.76 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 176.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -93.75 109.24 20.91 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 171.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -67.9 169.63 9.52 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.846 1.258 . . . . 0.0 109.846 -173.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.5 p -50.3 -35.71 28.6 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.153 0.981 . . . . 0.0 111.76 176.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -58.86 -154.75 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 131.367 3.867 . . . . 0.0 111.27 172.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.2 p -108.91 4.69 23.66 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 119.992 -1.693 . . . . 0.0 111.947 163.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.4 mt -75.63 133.62 30.91 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -132.26 110.06 10.35 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -177.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.8 125.26 50.79 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -177.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.1 mp -101.19 127.48 54.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 175.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -106.26 83.31 1.87 Allowed 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 102.023 -3.325 . . . . 0.0 102.023 174.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -89.93 -13.4 36.34 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.902 0.881 . . . . 0.0 111.337 174.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.01 135.98 33.32 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.598 1.559 . . . . 0.0 109.877 -165.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.4 t -49.17 -48.09 45.35 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.689 1.196 . . . . 0.0 113.756 -171.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -71.56 -33.48 69.14 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 120.706 -1.247 . . . . 0.0 111.425 -174.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.4 m -62.26 -34.99 77.6 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.753 2.021 . . . . 0.0 110.943 170.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.5 mt -68.2 -49.13 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -59.33 -33.4 71.08 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 117.907 -1.044 . . . . 0.0 112.133 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.438 ' HE3' ' C ' ' A' ' 102' ' ' ILE . 0.0 OUTLIER -64.61 -62.28 1.68 Allowed 'General case' 0 C--N 1.343 0.311 0 CA-C-N 119.699 1.136 . . . . 0.0 109.492 172.735 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 40.5 mt -51.95 -50.12 35.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 124.006 0.922 . . . . 0.0 111.068 -173.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.72 -16.23 10.38 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.1 0.96 . . . . 0.0 113.015 -173.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.2 t -61.42 -59.11 5.77 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.64 1.109 . . . . 0.0 110.203 168.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -65.36 -31.1 72.04 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.58 1.152 . . . . 0.0 110.697 -176.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 39.2 mm -62.13 -16.19 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 121.164 -0.96 . . . . 0.0 111.762 173.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.89 7.82 14.57 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.536 1.534 . . . . 0.0 113.074 175.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 t -78.6 -30.93 46.89 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 120.272 1.396 . . . . 0.0 109.951 -177.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.38 161.61 34.19 Favored Glycine 0 N--CA 1.447 -0.629 0 O-C-N 120.841 -1.162 . . . . 0.0 114.717 -162.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.46 99.79 7.05 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -170.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.506 ' HB3' ' CE2' ' A' ' 92' ' ' TYR . 9.5 ptt180 -60.12 -8.23 2.31 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.583 1.538 . . . . 0.0 114.311 -177.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.8 p 65.19 176.71 0.2 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.638 2.375 . . . . 0.0 110.115 -175.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -74.34 -9.95 59.1 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.607 -1.308 . . . . 0.0 111.45 172.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -58.41 161.38 4.48 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.985 1.374 . . . . 0.0 110.705 -177.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -108.44 149.95 28.06 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.007 -1.451 . . . . 0.0 107.362 165.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.86 119.98 32.15 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.45 -2.055 . . . . 0.0 105.45 -165.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.8 pt -105.28 12.13 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 119.195 -0.431 . . . . 0.0 111.939 -162.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.56 179.91 6.54 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.385 1.874 . . . . 0.0 108.553 -174.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -127.55 -7.1 5.73 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.148 2.179 . . . . 0.0 110.56 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -140.15 149.22 57.52 Favored Pre-proline 0 C--O 1.238 0.495 0 C-N-CA 124.02 0.928 . . . . 0.0 111.455 -170.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -67.7 155.35 70.35 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.677 2.251 . . . . 0.0 114.104 -171.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 m -100.43 10.39 41.27 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.783 2.033 . . . . 0.0 111.86 162.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.66 166.8 22.98 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 120.501 -1.374 . . . . 0.0 110.072 162.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -105.31 -34.78 7.76 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 127.343 2.257 . . . . 0.0 109.68 165.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -116.12 98.16 6.47 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 -165.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -154.39 162.74 40.99 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 126.05 1.74 . . . . 0.0 109.289 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.64 166.62 15.03 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.908 0.766 . . . . 0.0 111.218 175.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.6 m -107.72 124.67 50.37 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -176.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.71 135.15 56.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 124.445 1.098 . . . . 0.0 108.362 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -121.16 135.1 55.22 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 163.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.1 mt -117.1 100.5 10.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 102.718 -3.067 . . . . 0.0 102.718 166.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -78.93 107.18 11.48 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.879 1.672 . . . . 0.0 106.596 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.56 158.22 43.87 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 123.779 0.831 . . . . 0.0 108.962 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 48.94 30.03 2.59 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.616 1.566 . . . . 0.0 113.925 169.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.44 47.63 85.62 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 120.925 -1.11 . . . . 0.0 111.2 -175.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -156.89 -173.09 24.9 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 126.092 1.805 . . . . 0.0 109.37 168.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.04 137.57 53.08 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.876 0.846 . . . . 0.0 109.213 159.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.4 m -84.01 97.43 9.28 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 103.612 -2.736 . . . . 0.0 103.612 164.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.1 m -83.87 140.25 32.11 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 2.0 ptm -162.67 163.52 26.94 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.053 1.341 . . . . 0.0 108.768 -177.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -139.69 148.55 42.52 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -136.29 151.84 50.06 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 121.385 1.902 . . . . 0.0 109.528 177.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -147.02 173.4 12.49 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.278 1.031 . . . . 0.0 111.731 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -93.99 146.72 23.73 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 159.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -138.34 126.91 23.4 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 162.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 60.3 6.64 1.07 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.805 1.642 . . . . 0.0 114.412 171.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.17 3.53 31.33 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.963 1.268 . . . . 0.0 113.782 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.56 153.93 24.43 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 120.03 1.915 . . . . 0.0 108.81 161.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -98.74 155.2 17.46 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 174.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -141.25 159.88 41.28 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 119.039 -0.505 . . . . 0.0 111.882 -176.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.1 mp -124.45 131.49 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.534 1.534 . . . . 0.0 111.755 172.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -82.6 164.38 20.84 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.198 1.799 . . . . 0.0 111.457 172.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.57 169.2 0.47 Allowed Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.842 1.657 . . . . 0.0 108.656 -162.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' A' ' 89' ' ' LYS . 20.7 Cg_endo -63.23 -164.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.363 0 CA-C-N 121.904 1.716 . . . . 0.0 108.953 158.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -43.65 -5.55 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 129.121 2.969 . . . . 0.0 118.71 -165.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -113.48 43.75 1.71 Allowed 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 128.314 2.646 . . . . 0.0 111.734 170.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -113.42 53.05 0.61 Allowed Glycine 0 C--N 1.334 0.471 0 CA-C-N 120.11 1.323 . . . . 0.0 114.823 -176.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.1 mt -129.93 52.33 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 170.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.506 ' CE2' ' HB3' ' A' ' 44' ' ' ARG . 77.4 m-85 -74.39 99.37 3.5 Favored 'General case' 0 CA--C 1.499 -0.984 0 O-C-N 120.957 -1.089 . . . . 0.0 108.641 176.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -61.89 128.21 35.12 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 158.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.1 pt -128.78 152.07 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 125.413 1.485 . . . . 0.0 108.251 167.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -80.7 -39.81 26.47 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -112.09 164.75 12.8 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.843 1.257 . . . . 0.0 111.07 -169.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -71.4 131.33 43.21 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 122.377 0.271 . . . . 0.0 110.282 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -64.85 -45.97 83.84 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 122.157 -0.339 . . . . 0.0 110.58 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -69.02 -31.24 69.9 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -168.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -77.71 -25.75 49.59 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.097 -1.002 . . . . 0.0 110.686 177.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 22.7 mmt -81.89 -12.71 58.31 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.742 0.817 . . . . 0.0 112.81 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.438 ' C ' ' HE3' ' A' ' 34' ' ' LYS . 29.1 pt . . . . . 0 C--O 1.25 1.097 0 CA-C-N 120.94 1.7 . . . . 0.0 109.894 172.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.9 p . . . . . 0 C--O 1.24 0.564 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -47.93 153.43 2.6 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 120.654 0.902 . . . . 0.0 111.642 154.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 80.3 mt -80.7 133.33 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 157.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.04 164.43 39.1 Favored Pre-proline 0 C--O 1.242 0.701 0 C-N-CA 125.061 1.344 . . . . 0.0 107.792 176.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.521 ' HB2' HD22 ' A' ' 10' ' ' ASN . 60.7 Cg_endo -58.81 169.82 3.12 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 121.395 1.397 . . . . 0.0 109.93 160.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.462 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -55.5 175.66 0.07 Allowed 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 120.47 -1.394 . . . . 0.0 110.941 164.011 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.2 -55.3 5.86 Favored 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 156.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -62.63 -16.23 55.71 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -163.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.521 HD22 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -95.32 1.85 54.53 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.028 1.731 . . . . 0.0 114.542 176.324 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 72.3 t -84.14 130.08 36.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 177.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.42 -58.18 3.46 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 169.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 63.6 p -153.23 163.54 39.71 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.611 171.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 56.1 mt -106.08 125.65 61.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 164.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.6 t -91.56 138.36 31.63 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 163.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.0 mt -125.0 107.52 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 166.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -86.06 121.91 29.34 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 169.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -67.96 164.91 18.91 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.039 0.936 . . . . 0.0 110.734 -176.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -57.9 -27.77 63.61 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 118.512 -0.756 . . . . 0.0 112.404 168.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.427 ' CG ' ' H ' ' A' ' 21' ' ' SER . 9.6 p-10 -87.89 -79.38 0.29 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.929 1.24 . . . . 0.0 111.21 -177.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.427 ' H ' ' CG ' ' A' ' 20' ' ' ASN . 21.9 t -175.93 -3.84 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.963 2.105 . . . . 0.0 112.584 -176.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.0 mm -73.31 150.06 8.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 169.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -139.46 122.19 16.44 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.576 ' HE2' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -121.19 131.53 54.3 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -171.26 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.4 mp -112.14 145.81 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -177.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.576 ' CE1' ' HE2' ' A' ' 24' ' ' LYS . 53.4 m-85 -123.41 95.69 4.69 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 103.841 -2.652 . . . . 0.0 103.841 -172.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -123.29 49.94 1.63 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.811 2.044 . . . . 0.0 108.732 -175.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.06 163.41 34.33 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.438 1.895 . . . . 0.0 107.61 170.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.9 m -50.6 -58.52 5.62 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.445 0.698 . . . . 0.0 111.884 166.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -68.89 -35.33 76.74 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.758 -0.589 . . . . 0.0 111.487 -169.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.4 p -67.24 -43.26 82.42 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.5 mt -67.11 -48.53 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 123.575 0.75 . . . . 0.0 109.609 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -48.52 -50.39 32.08 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.364 1.866 . . . . 0.0 111.898 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.421 ' HE2' ' O ' ' A' ' 101' ' ' MET . 0.0 OUTLIER -59.46 -47.49 85.29 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 122.921 0.489 . . . . 0.0 110.386 -176.329 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.3 mt -60.68 -51.18 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.917 176.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 mt -49.59 -39.44 35.35 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.441 1.019 . . . . 0.0 111.025 -177.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.1 t -57.13 -57.05 14.29 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.428 0.691 . . . . 0.0 110.412 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -72.21 -19.05 61.79 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.435 1.094 . . . . 0.0 112.35 -175.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.1 mm -81.9 -19.57 10.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.217 1.407 . . . . 0.0 110.872 173.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.67 -12.66 13.86 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -175.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.2 t -58.07 -31.64 67.26 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.311 0.96 . . . . 0.0 111.267 176.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.42 154.92 44.78 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-O 122.783 1.213 . . . . 0.0 112.118 -171.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.44 108.79 19.43 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 174.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -63.4 -13.59 41.37 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 167.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 p 65.53 -174.0 0.18 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.826 1.329 . . . . 0.0 109.926 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -68.31 -17.22 64.22 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.013 -1.054 . . . . 0.0 112.032 175.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -64.26 154.21 35.79 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 119.354 0.979 . . . . 0.0 112.093 -171.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -100.55 133.15 45.43 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 172.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.8 160.11 33.16 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 153.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 pt -136.07 12.51 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.679 1.192 . . . . 0.0 111.164 168.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.8 178.64 4.33 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.11 1.364 . . . . 0.0 108.834 175.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -121.12 -5.32 9.49 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.176 0.99 . . . . 0.0 111.676 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -145.67 160.1 45.43 Favored Pre-proline 0 C--N 1.345 0.378 0 C-N-CA 125.626 1.57 . . . . 0.0 110.344 -171.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -69.36 160.99 47.68 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 121.304 1.336 . . . . 0.0 109.882 177.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.6 t -107.22 13.53 27.14 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.52 0.728 . . . . 0.0 110.862 172.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.03 171.9 13.68 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.523 0.677 . . . . 0.0 111.303 168.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -111.56 -29.22 7.83 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.487 1.915 . . . . 0.0 109.615 172.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -112.62 115.78 29.14 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 127.066 2.146 . . . . 0.0 105.987 172.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -149.53 167.3 26.67 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 171.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.47 169.8 15.08 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 169.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.6 m -123.42 123.14 40.0 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -158.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 mp -122.19 111.72 31.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 124.141 0.976 . . . . 0.0 108.4 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -109.54 113.9 27.07 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.931 1.692 . . . . 0.0 106.728 -175.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.4 mt -98.95 100.38 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 170.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -71.41 119.74 15.99 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 164.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -148.06 136.49 21.49 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.596 0.758 . . . . 0.0 110.172 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 53.24 23.45 3.18 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.265 1.426 . . . . 0.0 111.156 -174.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.04 -8.22 39.16 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 127.608 2.527 . . . . 0.0 114.075 -176.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -87.8 -177.29 48.01 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 108.726 -1.749 . . . . 0.0 108.726 166.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.1 ptt? -145.56 142.74 29.42 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.563 1.181 . . . . 0.0 113.248 174.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.1 m -91.41 111.1 22.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 165.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.5 m -84.12 130.73 34.84 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.572 1.949 . . . . 0.0 106.944 166.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.9 ptp -154.0 173.24 16.26 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.325 1.45 . . . . 0.0 109.36 164.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.569 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 43.0 m-85 -135.72 -179.79 5.86 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.437 1.895 . . . . 0.0 108.477 -178.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -138.79 158.04 44.95 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.375 1.07 . . . . 0.0 108.946 170.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -161.44 171.48 18.12 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.408 1.004 . . . . 0.0 110.616 163.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -99.34 139.24 35.28 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 125.681 1.593 . . . . 0.0 107.945 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -135.23 111.29 9.53 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.641 0.734 . . . . 0.0 109.625 175.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 66.96 10.73 7.89 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.381 1.872 . . . . 0.0 113.3 172.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.1 -8.7 31.31 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-O 118.021 -1.433 . . . . 0.0 113.172 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.97 157.78 15.74 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 119.342 1.571 . . . . 0.0 108.075 163.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -109.15 150.06 28.43 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -141.13 171.79 13.57 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 123.364 0.415 . . . . 0.0 110.146 178.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.2 mp -121.99 150.53 25.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 124.628 1.171 . . . . 0.0 108.057 172.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.569 ' HB3' ' H ' ' A' ' 74' ' ' PHE . 3.4 tm-20 -90.49 159.33 16.57 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.149 2.58 . . . . 0.0 110.045 -173.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 174.81 167.43 0.34 Allowed Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 128.78 2.832 . . . . 0.0 108.774 178.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.405 ' O ' ' N ' ' A' ' 89' ' ' LYS . 23.0 Cg_endo -60.45 -161.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.935 1 C-N-CA 125.446 4.097 . . . . 0.0 110.152 165.333 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -42.9 -8.79 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 128.259 2.623 . . . . 0.0 117.08 -169.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -114.43 33.28 5.4 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 120.637 1.562 . . . . 0.0 114.509 167.189 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -113.41 75.38 0.23 Allowed Glycine 0 C--O 1.223 -0.556 0 CA-C-N 119.671 1.123 . . . . 0.0 113.176 -174.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.0 mt -145.28 46.7 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 174.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -72.19 100.91 2.68 Favored 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 121.05 -1.032 . . . . 0.0 109.74 -171.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.92 122.23 18.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 170.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.2 pt -116.13 174.84 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 127.248 2.219 . . . . 0.0 108.42 162.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -106.31 -14.37 15.13 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -175.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -131.45 167.78 18.74 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.273 0.942 . . . . 0.0 110.0 -169.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -69.98 139.31 52.77 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.951 0.341 . . . . 0.0 110.324 174.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -68.12 -52.42 35.07 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.776 0.83 . . . . 0.0 112.447 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -66.01 -28.42 68.86 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.748 0.704 . . . . 0.0 112.253 -171.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -67.94 -14.51 63.02 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.866 -0.521 . . . . 0.0 111.875 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.421 ' O ' ' HE2' ' A' ' 34' ' ' LYS . 26.3 mmt -103.02 -10.51 18.87 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 117.071 -1.443 . . . . 0.0 113.322 -175.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.9 pp . . . . . 0 C--O 1.254 1.31 0 CA-C-N 121.11 1.777 . . . . 0.0 112.862 -163.86 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 p . . . . . 0 CA--C 1.549 0.933 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.531 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -57.54 164.12 7.77 Favored 'Trans proline' 0 C--N 1.353 0.809 0 CA-C-N 121.58 1.6 . . . . 0.0 110.763 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.9 mm -99.21 127.25 52.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 105.31 -2.108 . . . . 0.0 105.31 171.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.22 161.5 63.38 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 126.54 1.936 . . . . 0.0 110.646 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -61.17 172.28 3.31 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.158 1.239 . . . . 0.0 110.698 170.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.17 179.11 0.21 Allowed 'General case' 0 N--CA 1.467 0.421 0 O-C-N 120.313 -1.492 . . . . 0.0 112.27 171.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.02 -50.07 17.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 155.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.82 -26.34 68.58 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -159.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.48 -5.72 57.07 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 126.414 1.886 . . . . 0.0 115.02 -178.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.2 t -76.89 108.83 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.59 -39.37 93.61 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.001 0.921 . . . . 0.0 109.607 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 p -174.44 136.89 0.48 Allowed 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.177 0.991 . . . . 0.0 108.873 158.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.9 mt -75.34 154.38 6.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 164.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.6 t -131.93 133.79 44.94 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.477 -2.046 . . . . 0.0 105.477 166.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.4 mt -128.99 110.8 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 176.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.41 119.92 22.41 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 105.245 -2.131 . . . . 0.0 105.245 166.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -63.01 -179.83 0.32 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.882 1.273 . . . . 0.0 110.49 173.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.3 p -75.17 0.39 16.5 Favored 'General case' 0 CA--C 1.549 0.904 0 O-C-N 119.97 -1.706 . . . . 0.0 112.305 171.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -122.67 158.56 29.79 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 128.616 2.766 . . . . 0.0 105.479 168.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.4 p -79.26 -2.8 42.92 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 120.243 1.383 . . . . 0.0 112.464 -154.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.4 mt -61.81 134.89 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 164.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -120.14 166.07 13.91 Favored 'General case' 0 N--CA 1.422 -1.832 0 C-N-CA 125.122 1.369 . . . . 0.0 107.505 171.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.569 ' HE2' ' CE2' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -137.1 151.72 49.19 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 170.265 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.5 mp -109.74 139.76 31.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.569 ' CE2' ' HE2' ' A' ' 24' ' ' LYS . 72.4 m-85 -128.8 91.72 3.27 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 -173.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -119.99 -7.66 9.89 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.78 2.432 . . . . 0.0 110.973 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -64.95 138.27 58.26 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 170.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.9 t -56.97 -42.84 80.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.98 0.809 . . . . 0.0 109.729 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -67.38 -36.7 81.87 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.362 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 52.2 p -55.2 -48.45 73.82 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.026 0.83 . . . . 0.0 109.038 175.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.6 mt -70.48 -54.71 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-O 118.568 -0.729 . . . . 0.0 109.093 -177.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -59.64 -30.64 68.87 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.528 1.058 . . . . 0.0 112.172 -176.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -68.64 -63.82 0.99 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 117.857 -1.068 . . . . 0.0 109.027 170.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.3 mt -47.92 -46.18 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 123.643 0.777 . . . . 0.0 109.967 -176.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -47.73 -31.22 4.53 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.007 1.723 . . . . 0.0 113.08 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.4 t -61.03 -55.15 36.11 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 119.113 0.869 . . . . 0.0 109.584 174.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -75.6 -11.59 60.04 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.021 0.828 . . . . 0.0 112.252 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.5 mm -70.55 -23.92 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 O-C-N 120.9 -1.125 . . . . 0.0 110.141 162.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.35 -18.03 11.14 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -168.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.2 p -69.57 -28.91 66.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 119.817 1.189 . . . . 0.0 112.746 -170.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.78 165.98 50.08 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 119.536 1.062 . . . . 0.0 114.381 -166.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.5 pttm -112.13 103.56 11.75 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 125.518 1.527 . . . . 0.0 111.184 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -58.03 -15.16 8.2 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 170.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.7 p 60.27 175.24 0.09 Allowed 'General case' 0 CA--C 1.551 0.99 0 O-C-N 124.162 0.914 . . . . 0.0 109.597 -171.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -85.68 3.69 39.9 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 119.363 -2.085 . . . . 0.0 111.795 176.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -60.66 156.43 16.74 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.65 0.78 . . . . 0.0 111.786 177.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -89.88 113.99 25.69 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.701 1.6 . . . . 0.0 107.2 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.9 t -80.14 140.66 36.29 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 163.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.2 pt -144.4 39.53 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.649 1.579 . . . . 0.0 107.727 176.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -116.64 177.24 4.77 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.835 1.254 . . . . 0.0 110.682 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.87 -4.58 2.82 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.172 1.389 . . . . 0.0 111.547 177.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -153.35 165.38 17.84 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 126.752 2.021 . . . . 0.0 108.089 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.28 174.3 11.7 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.381 1.387 . . . . 0.0 111.097 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 t -102.17 -7.8 21.89 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.005 1.322 . . . . 0.0 110.804 175.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.04 150.89 31.77 Favored 'General case' 0 CA--C 1.527 0.09 0 O-C-N 121.028 -1.045 . . . . 0.0 110.796 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.46 -22.25 30.39 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.248 1.019 . . . . 0.0 111.232 173.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.79 107.32 9.06 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -129.48 153.58 47.83 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 126.389 1.876 . . . . 0.0 108.943 176.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.02 154.92 25.97 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 108.17 -1.972 . . . . 0.0 108.17 167.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.2 m -127.38 131.73 50.28 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.137 0.975 . . . . 0.0 108.807 -164.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.05 125.62 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -166.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -115.42 144.76 43.34 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 161.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.0 mt -127.48 83.49 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -58.77 120.45 8.99 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 171.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -146.91 114.76 6.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 59.61 20.54 9.13 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.613 1.165 . . . . 0.0 112.375 -173.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.15 3.58 12.4 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.522 1.058 . . . . 0.0 113.506 -171.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.96 170.39 44.03 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 145.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -143.84 163.38 33.55 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 121.308 -1.113 . . . . 0.0 109.469 169.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.2 m -130.07 132.16 46.06 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 174.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -120.83 126.41 50.0 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.196 0.998 . . . . 0.0 108.686 -172.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.6 ptp -146.85 170.65 16.6 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.156 0.983 . . . . 0.0 109.207 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -146.47 148.7 32.52 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 -175.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.92 154.32 50.54 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.364 0.984 . . . . 0.0 109.758 175.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -157.77 172.61 18.18 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.813 1.645 . . . . 0.0 109.545 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -102.84 139.15 38.79 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.657 1.583 . . . . 0.0 108.072 171.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -135.85 120.46 18.27 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 172.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 55.79 -4.59 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 128.153 2.581 . . . . 0.0 117.341 -174.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 136.97 -33.48 2.31 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 125.751 1.644 . . . . 0.0 112.49 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -71.58 151.42 43.82 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 171.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -100.12 150.6 22.32 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 168.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -136.77 153.11 50.92 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.514 0.725 . . . . 0.0 111.182 -176.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mp -123.15 117.9 53.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 125.162 1.385 . . . . 0.0 107.63 -170.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.46 154.81 38.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.625 1.17 . . . . 0.0 109.736 176.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 179.79 167.73 0.73 Allowed Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 127.963 2.505 . . . . 0.0 107.443 -169.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -57.15 -163.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 124.37 3.38 . . . . 0.0 110.728 166.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -44.76 -11.78 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 117.079 2.251 . . . . 0.0 117.079 -174.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -96.78 11.64 34.89 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.023 1.729 . . . . 0.0 115.293 172.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.94 77.54 0.4 Allowed Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 120.259 1.391 . . . . 0.0 113.508 -170.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.9 mt -139.51 42.88 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 169.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -76.24 107.53 8.55 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 121.212 -0.93 . . . . 0.0 109.758 -172.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -69.66 127.26 32.31 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 159.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 41.0 pt -112.19 168.23 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 148.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -122.32 21.34 10.36 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.848 0.832 . . . . 0.0 112.871 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -140.98 167.42 22.23 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 127.149 2.18 . . . . 0.0 110.214 170.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -84.29 116.22 22.88 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.213 1.005 . . . . 0.0 109.601 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -48.97 -47.33 44.13 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.833 1.253 . . . . 0.0 109.564 172.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -68.43 -17.42 64.2 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.126 0.97 . . . . 0.0 112.692 -171.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -91.49 -13.78 31.59 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 121.334 -0.854 . . . . 0.0 109.937 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 11.9 mmt -106.66 -6.59 17.81 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.789 1.636 . . . . 0.0 112.462 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 24.3 pt . . . . . 0 C--O 1.25 1.126 0 CA-C-N 119.332 0.969 . . . . 0.0 111.397 174.092 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 CA--C 1.538 0.486 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.02 179.89 2.07 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 124.586 3.524 . . . . 0.0 112.504 156.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 53.1 mt -108.54 131.83 58.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 126.258 1.823 . . . . 0.0 106.341 164.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.13 161.76 61.65 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 128.143 2.577 . . . . 0.0 109.959 175.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -62.17 176.62 1.43 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.998 2.466 . . . . 0.0 112.914 176.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.516 ' N ' ' HE3' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -65.35 -175.1 0.21 Allowed 'General case' 0 C--O 1.236 0.383 0 O-C-N 119.983 -1.698 . . . . 0.0 110.351 169.203 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.6 -42.75 16.39 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 118.984 -0.531 . . . . 0.0 111.219 167.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -85.69 -21.83 28.13 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 118.48 -1.288 . . . . 0.0 111.652 -164.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.491 HD21 ' N ' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -73.39 -5.96 43.19 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.64 1.176 . . . . 0.0 112.471 174.632 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.491 ' N ' HD21 ' A' ' 10' ' ' ASN . 25.0 t -80.11 131.58 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 173.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -81.75 -61.43 1.92 Allowed 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 171.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.63 130.2 5.0 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.612 1.096 . . . . 0.0 109.827 171.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.7 mt -81.25 139.38 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.4 t -116.37 140.83 48.92 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 172.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.2 mt -135.57 105.13 5.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 173.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -81.39 108.07 14.69 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 173.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -71.03 -176.76 1.46 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.549 0.69 . . . . 0.0 109.267 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.4 p -62.25 -46.75 87.42 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.492 -1.38 . . . . 0.0 111.394 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.411 ' C ' ' H ' ' A' ' 22' ' ' ILE . 51.7 t-20 -73.74 179.79 4.02 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.752 2.021 . . . . 0.0 109.952 178.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.6 p -69.84 8.01 0.79 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.239 1.416 . . . . 0.0 112.83 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.411 ' H ' ' C ' ' A' ' 20' ' ' ASN . 12.6 mt -98.5 137.25 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -170.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -145.93 137.88 25.2 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 -176.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.5 132.21 53.85 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 -173.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.5 mp -105.84 119.74 55.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 176.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.426 ' CG ' HD13 ' A' ' 35' ' ' ILE . 81.6 m-85 -93.06 81.15 4.54 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 102.657 -3.09 . . . . 0.0 102.657 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -96.9 -28.82 14.04 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.998 0.919 . . . . 0.0 110.457 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.53 141.61 53.83 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.1 t -55.03 -46.92 75.32 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.143 0.883 . . . . 0.0 112.481 -175.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -68.65 -24.84 64.58 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.591 1.156 . . . . 0.0 110.899 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.9 p -69.87 -40.97 75.41 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.766 0.712 . . . . 0.0 109.482 176.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 53.9 mt -66.06 -46.65 87.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.566 1.146 . . . . 0.0 108.304 177.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.97 -24.87 67.28 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -165.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.426 ' HE2' ' O ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -65.73 -54.85 21.68 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 123.132 0.573 . . . . 0.0 109.49 172.251 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.426 HD13 ' CG ' ' A' ' 26' ' ' TYR . 18.6 mt -57.01 -40.42 72.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 125.674 1.59 . . . . 0.0 109.307 -169.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.37 -21.48 5.88 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.837 1.655 . . . . 0.0 113.399 175.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.8 t -64.46 -68.36 0.36 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 120.434 1.47 . . . . 0.0 109.011 164.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -65.98 -24.93 66.88 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.05 0.54 . . . . 0.0 111.41 -168.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.5 mm -59.56 -29.43 42.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 O-C-N 120.751 -1.218 . . . . 0.0 110.549 172.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.33 -8.74 41.11 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 120.347 1.431 . . . . 0.0 113.441 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 t -69.93 -16.84 63.28 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.018 0.927 . . . . 0.0 113.337 -164.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.28 156.47 18.5 Favored Glycine 0 C--N 1.335 0.512 0 O-C-N 120.75 -1.219 . . . . 0.0 112.865 -171.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.7 pttm -112.83 111.2 21.8 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 175.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.8 ptt-85 -58.49 -5.11 0.48 Allowed 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.982 0.81 . . . . 0.0 112.594 169.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . 0.259 10.4 p 64.44 -164.67 0.25 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.545 1.538 . . . . 0.0 107.819 -176.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -101.21 4.5 41.97 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.909 1.231 . . . . 0.0 111.845 171.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -67.77 153.27 44.08 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 122.066 0.936 . . . . 0.0 110.357 176.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -85.77 121.32 28.27 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.989 1.716 . . . . 0.0 107.68 169.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.2 t -74.09 152.04 40.01 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 158.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.2 pt -138.14 11.79 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 126.083 1.753 . . . . 0.0 110.28 172.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -99.91 173.87 6.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.738 1.215 . . . . 0.0 109.577 178.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.55 -7.42 2.87 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.05 1.74 . . . . 0.0 110.446 174.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -151.72 158.93 33.9 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 127.329 2.251 . . . . 0.0 109.359 -174.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.01 -179.76 5.74 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.467 3.445 . . . . 0.0 112.425 178.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.87 -6.67 11.0 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.855 1.662 . . . . 0.0 112.021 176.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.14 149.82 40.8 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 120.818 -1.176 . . . . 0.0 109.496 173.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -75.03 -30.5 61.09 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.509 0.723 . . . . 0.0 109.756 169.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -114.43 108.09 16.42 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.774 1.63 . . . . 0.0 107.471 -172.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -137.15 168.72 19.06 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 126.521 1.929 . . . . 0.0 107.099 169.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.23 166.52 13.0 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 161.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 73.8 m -124.92 120.68 32.3 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.157 0.983 . . . . 0.0 108.873 -167.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.81 126.37 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -171.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -121.17 128.79 52.84 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 171.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 19.6 mt -114.94 88.61 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 171.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -56.38 106.77 0.31 Allowed 'General case' 0 C--O 1.239 0.52 0 C-N-CA 126.886 2.074 . . . . 0.0 108.217 163.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -153.43 148.68 26.94 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.671 1.189 . . . . 0.0 109.93 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 54.76 28.49 10.3 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.02 41.25 71.8 Favored Glycine 0 CA--C 1.527 0.833 0 O-C-N 121.151 -0.968 . . . . 0.0 110.768 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.69 -172.13 36.71 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 127.676 2.56 . . . . 0.0 108.458 174.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -147.15 146.73 29.99 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 119.045 1.423 . . . . 0.0 113.281 174.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.2 t -82.61 164.27 20.9 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 165.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.4 m -135.83 146.36 47.42 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 126.661 1.984 . . . . 0.0 106.912 171.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.0 ptp -165.39 167.99 17.17 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.017 1.727 . . . . 0.0 108.249 168.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -140.25 142.15 35.8 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.563 1.545 . . . . 0.0 107.96 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.435 ' CD1' HG13 ' A' ' 84' ' ' ILE . 0.3 OUTLIER -125.9 153.61 43.96 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.833 1.197 . . . . 0.0 109.623 176.791 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -155.32 -175.7 5.57 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.625 1.57 . . . . 0.0 107.554 -175.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -111.86 144.62 40.88 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.708 1.603 . . . . 0.0 108.571 170.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -144.76 110.64 5.41 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 122.524 1.154 . . . . 0.0 111.096 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 66.92 4.84 3.7 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.286 1.834 . . . . 0.0 113.995 176.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 121.77 -5.34 10.63 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.573 1.082 . . . . 0.0 113.5 171.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -105.37 157.82 17.07 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 119.132 1.466 . . . . 0.0 108.443 162.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -93.82 152.4 18.93 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 169.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -143.71 162.29 36.36 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.298 0.639 . . . . 0.0 110.648 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.435 HG13 ' CD1' ' A' ' 75' ' ' TYR . 3.9 mp -117.65 124.68 73.39 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 C-N-CA 125.581 1.552 . . . . 0.0 107.824 -178.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -68.06 151.43 47.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 122.41 1.1 . . . . 0.0 109.033 168.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -169.85 167.61 4.96 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 128.729 2.812 . . . . 0.0 106.433 167.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -56.19 -161.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.817 1 C-N-CA 125.905 4.404 . . . . 0.0 110.237 164.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -43.41 -12.16 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.682 1.993 . . . . 0.0 116.009 -172.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.9 mtmt -112.1 62.3 0.62 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 120.432 1.469 . . . . 0.0 111.869 163.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -141.55 61.89 0.53 Allowed Glycine 0 C--N 1.336 0.549 0 CA-C-N 119.679 1.127 . . . . 0.0 114.304 -175.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.2 mt -136.26 46.86 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 173.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -74.99 109.48 8.49 Favored 'General case' 0 CA--C 1.507 -0.701 0 O-C-N 120.967 -1.083 . . . . 0.0 110.851 -175.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -75.57 122.1 23.39 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 165.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.6 pt -115.87 -179.93 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 125.41 1.484 . . . . 0.0 108.157 160.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -137.5 8.82 2.88 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -170.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -135.71 166.54 23.02 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 126.332 1.853 . . . . 0.0 109.134 173.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -78.28 125.51 29.45 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 170.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -62.87 -46.42 87.95 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.93 -0.481 . . . . 0.0 110.258 -178.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -69.2 -11.68 61.01 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.239 1.015 . . . . 0.0 113.052 -175.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -91.06 -14.16 31.83 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.521 1.528 . . . . 0.0 110.642 175.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 5.6 mmt -105.95 -5.22 19.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.887 1.675 . . . . 0.0 112.448 -172.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 15.9 pt . . . . . 0 C--O 1.253 1.266 0 C-N-CA 125.843 1.657 . . . . 0.0 109.555 173.898 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.546 0.821 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -57.17 167.06 3.62 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.334 1.356 . . . . 0.0 112.051 174.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 64.3 mt -96.74 134.87 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 167.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.28 155.25 61.42 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 128.272 2.629 . . . . 0.0 108.132 -172.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.12 175.45 9.86 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.903 2.402 . . . . 0.0 112.273 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.489 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -77.71 153.63 32.83 Favored 'General case' 0 C--N 1.34 0.189 0 O-C-N 120.624 -1.298 . . . . 0.0 110.412 171.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.26 7.48 6.34 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.658 1.183 . . . . 0.0 112.645 175.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -133.86 5.47 3.63 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.811 1.244 . . . . 0.0 111.037 -169.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -122.94 0.65 9.19 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.927 2.091 . . . . 0.0 112.62 170.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 t -70.65 147.08 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 167.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -85.14 -63.5 1.32 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 161.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.6 p -153.4 170.75 19.92 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.483 0.713 . . . . 0.0 109.343 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.9 mt -125.93 126.49 69.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 173.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.9 t -100.03 133.22 44.73 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 171.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.2 mt -125.99 101.47 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 169.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.06 115.01 21.68 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 104.747 -2.316 . . . . 0.0 104.747 167.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -65.75 173.04 3.05 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.283 1.433 . . . . 0.0 109.927 176.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.0 p -69.67 -20.06 63.58 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 119.667 -1.896 . . . . 0.0 112.017 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 53.4 p30 -85.48 -165.4 1.21 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.731 0.812 . . . . 0.0 110.079 173.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.2 p -76.32 -2.51 31.99 Favored 'General case' 0 C--O 1.239 0.521 0 O-C-N 120.695 -1.253 . . . . 0.0 113.258 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.9 mt -100.47 150.52 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -166.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.78 158.79 43.51 Favored 'General case' 0 N--CA 1.417 -2.076 0 C-N-CA 125.886 1.674 . . . . 0.0 108.812 177.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.65 139.52 42.08 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 174.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.1 mp -111.17 137.77 42.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -111.26 76.12 0.96 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 103.081 -2.933 . . . . 0.0 103.081 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -82.44 -32.37 29.03 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 171.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.92 134.43 48.39 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.226 1.81 . . . . 0.0 108.334 -169.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.0 m -51.09 -47.95 61.78 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.567 0.747 . . . . 0.0 111.777 -174.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -76.82 -17.6 58.91 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.577 0.751 . . . . 0.0 111.557 -173.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 64.9 m -80.34 -38.64 30.15 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.905 1.282 . . . . 0.0 110.433 171.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.49 -53.66 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 171.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -57.79 -30.02 65.33 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.874 0.869 . . . . 0.0 112.515 -173.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.67 -61.33 2.69 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 124.008 0.923 . . . . 0.0 109.239 170.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.0 mt -45.2 -53.83 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 125.15 1.38 . . . . 0.0 111.999 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mp -53.61 -24.73 14.84 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 120.192 1.36 . . . . 0.0 114.354 -175.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.8 t -55.6 -69.74 0.13 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.054 0.843 . . . . 0.0 109.745 172.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -75.88 -10.47 59.46 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.837 1.255 . . . . 0.0 111.169 -167.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.6 mm -69.56 -37.08 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 O-C-N 121.121 -0.987 . . . . 0.0 110.316 168.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.72 -11.73 30.82 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -164.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 52.5 p -62.41 -41.06 98.41 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.541 0.61 . . . . 0.0 111.558 -173.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.89 162.93 54.11 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-O 124.006 1.892 . . . . 0.0 113.354 -166.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.415 ' C ' ' H ' ' A' ' 45' ' ' THR . 20.9 mtmm -125.51 109.08 12.26 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 -174.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 -59.61 -1.8 0.28 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 176.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.415 ' H ' ' C ' ' A' ' 43' ' ' LYS . 16.1 p 64.7 -164.19 0.25 Allowed 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.595 1.958 . . . . 0.0 107.937 -177.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -95.89 -2.54 47.1 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.577 0.626 . . . . 0.0 110.85 168.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -58.32 159.69 5.9 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 119.36 0.982 . . . . 0.0 111.506 -177.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -109.76 116.5 31.79 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.163 -169.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.1 t -98.12 68.85 1.99 Allowed 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 125.481 1.512 . . . . 0.0 108.354 -172.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.2 pt -73.59 19.59 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 126.498 1.919 . . . . 0.0 111.536 -175.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.74 173.96 7.42 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 126.264 1.825 . . . . 0.0 109.728 -167.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.12 -4.16 10.05 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.517 0.727 . . . . 0.0 110.746 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -146.79 155.85 48.14 Favored Pre-proline 0 C--O 1.234 0.266 0 CA-C-N 118.771 0.714 . . . . 0.0 110.24 -172.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -60.03 168.09 6.43 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.18 2.587 . . . . 0.0 110.376 168.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 t -104.03 23.0 13.63 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.913 1.285 . . . . 0.0 108.841 -176.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -114.66 168.95 9.43 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 128.099 2.56 . . . . 0.0 109.139 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -99.38 -29.25 12.88 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.732 1.213 . . . . 0.0 111.143 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -131.58 115.24 15.84 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -173.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -140.9 161.82 36.92 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 125.306 1.443 . . . . 0.0 107.152 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -95.78 166.7 25.15 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.24 108.21 13.02 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -159.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.1 mp -111.19 134.93 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -176.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -132.28 119.06 20.28 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 161.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.2 mt -85.99 112.23 22.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 159.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -79.85 130.28 35.18 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 167.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -149.05 127.09 11.96 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.623 1.569 . . . . 0.0 109.678 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 46.9 45.24 15.17 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.357 1.863 . . . . 0.0 111.93 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.04 -1.59 17.07 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.498 1.047 . . . . 0.0 115.008 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -105.69 -176.73 23.96 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 168.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.2 ptp -154.57 146.94 23.92 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 120.934 -1.333 . . . . 0.0 112.838 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.1 m -103.29 96.24 6.63 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.097 2.159 . . . . 0.0 106.672 176.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.1 m -80.21 151.46 29.65 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.555 0.742 . . . . 0.0 109.249 171.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.25 165.4 5.97 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.947 2.499 . . . . 0.0 108.591 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.533 ' H ' ' HG3' ' A' ' 85' ' ' GLU . 14.1 m-85 -135.78 148.33 48.72 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 127.189 2.196 . . . . 0.0 108.04 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -125.16 162.1 25.38 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.327 0.967 . . . . 0.0 108.628 171.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -158.33 169.07 25.31 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.663 1.185 . . . . 0.0 109.553 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -97.28 142.13 29.54 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.186 1.794 . . . . 0.0 108.285 163.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -148.85 145.13 27.35 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.27 1.028 . . . . 0.0 108.516 169.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 53.43 0.42 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.681 1.992 . . . . 0.0 115.052 -174.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.79 19.35 37.47 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.104 -1.387 . . . . 0.0 113.374 -169.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -118.18 169.67 9.5 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 121.022 2.411 . . . . 0.0 107.571 161.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -108.58 145.57 34.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -142.7 162.22 36.02 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.414 0.685 . . . . 0.0 109.607 -175.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.0 mp -127.38 125.14 65.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 125.533 1.533 . . . . 0.0 108.205 -172.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.533 ' HG3' ' H ' ' A' ' 74' ' ' PHE . 0.5 OUTLIER -75.24 163.62 27.31 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.999 0.904 . . . . 0.0 108.955 172.057 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 178.74 168.5 0.58 Allowed Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 130.136 3.374 . . . . 0.0 104.783 175.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -53.76 -160.45 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.623 1 C-N-CA 125.407 4.071 . . . . 0.0 110.801 164.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -42.31 -10.18 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 128.887 2.875 . . . . 0.0 115.459 -175.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.3 59.94 0.68 Allowed 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.301 1.84 . . . . 0.0 112.678 166.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -137.53 54.19 0.71 Allowed Glycine 0 C--N 1.338 0.679 0 CA-C-N 119.819 1.191 . . . . 0.0 116.04 -174.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.7 mt -137.96 48.04 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 118.32 1.06 . . . . 0.0 108.66 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -76.65 137.05 39.19 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -118.56 91.56 3.59 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -176.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 16.0 pt -95.18 152.11 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 177.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -105.56 16.24 25.74 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.804 0.812 . . . . 0.0 112.279 -173.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -146.05 160.96 41.16 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.096 1.759 . . . . 0.0 111.004 -175.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -87.1 130.32 34.55 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.443 0.565 . . . . 0.0 111.722 -176.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -66.89 -46.57 74.51 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.549 0.739 . . . . 0.0 111.538 175.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -71.52 -19.84 62.13 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -168.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -95.54 -5.7 42.13 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 121.358 -0.839 . . . . 0.0 112.023 172.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 15.5 mmt -90.75 -28.14 18.47 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 117.387 -1.292 . . . . 0.0 112.013 169.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.7 pt . . . . . 0 C--O 1.253 1.258 0 CA-C-N 120.22 1.373 . . . . 0.0 109.594 164.709 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 CA--C 1.546 0.806 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -65.24 177.4 2.58 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.94 2.427 . . . . 0.0 112.227 163.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.6 mm -125.47 74.88 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 127.492 2.317 . . . . 0.0 105.716 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.84 165.94 42.31 Favored Pre-proline 0 N--CA 1.469 0.509 0 O-C-N 120.687 -1.258 . . . . 0.0 110.756 -177.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.564 ' HB2' HD22 ' A' ' 10' ' ' ASN . 38.3 Cg_endo -58.7 165.09 8.55 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 120.686 0.924 . . . . 0.0 109.997 158.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.461 ' HA ' ' HE2' ' A' ' 7' ' ' LYS . 7.0 mmpt? -53.53 169.01 0.14 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.16 0.984 . . . . 0.0 111.174 169.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.9 -57.24 5.29 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 156.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -57.73 -23.04 49.93 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.411 1.484 . . . . 0.0 114.456 -165.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.564 HD22 ' HB2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -95.87 -0.59 50.82 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -178.206 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.4 t -78.83 153.17 4.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 173.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -108.63 -46.52 3.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 118.501 -0.762 . . . . 0.0 110.163 171.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.4 p -155.27 166.45 33.53 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.039 0.836 . . . . 0.0 110.812 163.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.7 mt -122.07 119.32 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 172.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -103.95 128.68 51.49 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.522 0.729 . . . . 0.0 109.703 175.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.1 mt -127.29 112.21 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -94.1 120.15 33.95 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 165.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -70.47 -171.91 0.54 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.584 1.554 . . . . 0.0 109.987 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 p -69.15 -1.15 7.09 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 119.697 -1.877 . . . . 0.0 113.927 170.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -104.04 -154.57 0.51 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.686 1.994 . . . . 0.0 109.599 -160.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.8 p -81.12 -5.01 57.18 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 129.302 3.041 . . . . 0.0 114.273 155.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.8 mt -104.05 145.63 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.676 1.59 . . . . 0.0 110.583 -159.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -140.52 134.94 31.37 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 120.897 -1.127 . . . . 0.0 109.86 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.04 141.02 47.05 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.3 mm -124.02 156.1 31.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -174.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -142.17 87.97 2.06 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 -165.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -100.53 -21.22 15.39 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.51 1.524 . . . . 0.0 111.457 178.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.12 146.02 46.0 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 t -50.51 -47.06 57.51 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.664 0.786 . . . . 0.0 110.61 171.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -68.5 -31.88 71.46 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.524 -0.735 . . . . 0.0 111.393 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 73.1 m -72.46 -47.43 48.95 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.48 1.512 . . . . 0.0 110.511 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 90.3 mt -59.4 -46.72 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.279 1.432 . . . . 0.0 108.892 174.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.47 -26.28 68.65 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 117.426 -1.273 . . . . 0.0 114.008 -175.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -63.03 -60.01 4.03 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 168.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.0 mt -52.62 -51.03 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 O-C-N 123.879 0.737 . . . . 0.0 109.378 -170.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.8 -14.69 60.02 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -178.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.9 t -76.31 -59.33 2.81 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 120.188 1.358 . . . . 0.0 108.495 163.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -61.21 -7.78 3.07 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.91 1.684 . . . . 0.0 113.558 -176.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.6 mm -114.62 -14.18 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 126.324 1.85 . . . . 0.0 111.212 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.36 -10.66 56.03 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 120.277 -1.514 . . . . 0.0 112.567 171.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.8 t -68.87 -30.4 68.9 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.845 1.258 . . . . 0.0 112.669 -170.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.56 168.41 45.89 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-O 122.089 0.827 . . . . 0.0 112.774 -176.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.98 120.83 20.79 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 124.502 1.121 . . . . 0.0 108.041 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -67.26 1.8 1.95 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.8 p 61.13 -163.8 0.25 Allowed 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 -175.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -108.86 13.18 25.03 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.333 0.653 . . . . 0.0 112.169 161.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.15 158.86 8.2 Favored 'General case' 0 C--O 1.239 0.529 0 O-C-N 120.519 -1.363 . . . . 0.0 108.534 161.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -119.83 130.01 54.7 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 121.305 -0.872 . . . . 0.0 109.222 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.36 160.01 30.35 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 161.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.9 pt -136.01 11.04 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.149 1.379 . . . . 0.0 110.808 168.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.16 175.83 6.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.768 1.227 . . . . 0.0 111.034 -172.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -116.82 -11.86 10.85 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.071 1.348 . . . . 0.0 111.194 -174.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -142.71 160.05 54.95 Favored Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 125.483 1.513 . . . . 0.0 109.857 -172.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -70.95 169.16 21.09 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.202 1.935 . . . . 0.0 112.694 -175.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.18 10.84 34.48 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.449 1.1 . . . . 0.0 111.809 -177.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -107.14 161.94 14.31 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.871 1.269 . . . . 0.0 113.469 -169.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.97 -29.89 35.23 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 126.108 1.763 . . . . 0.0 110.422 165.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -134.88 108.12 7.74 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.907 1.283 . . . . 0.0 109.623 -165.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -145.77 159.9 42.52 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.159 1.384 . . . . 0.0 109.06 -177.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.33 158.56 30.16 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 172.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.84 134.46 44.99 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.475 1.11 . . . . 0.0 108.606 174.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.96 123.64 54.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.11 137.37 46.21 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 159.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 64.7 mt -109.94 105.92 19.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 102.79 -3.041 . . . . 0.0 102.79 160.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -78.12 132.49 37.7 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 169.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -147.37 -171.94 3.9 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.839 1.656 . . . . 0.0 107.573 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.527 ' ND2' ' H ' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -60.09 80.31 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.811 1 C-N-CA 133.867 4.867 . . . . 0.0 110.469 -168.614 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.02 1.64 68.99 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 114.041 -1.436 . . . . 0.0 112.891 -174.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.92 158.12 14.55 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-O 121.719 0.621 . . . . 0.0 112.092 -171.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 7.1 ptm -131.33 133.45 45.35 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 160.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.6 m -118.1 90.9 3.43 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.8 m -84.65 136.78 33.61 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.009 1.324 . . . . 0.0 109.943 -172.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.2 ptp -150.27 171.53 16.8 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.812 1.245 . . . . 0.0 109.722 172.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -142.27 147.7 36.86 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -128.69 151.99 48.9 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.6 1.545 . . . . 0.0 108.592 175.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -154.84 168.61 26.33 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.857 0.863 . . . . 0.0 111.281 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -86.85 141.39 28.82 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.672 1.123 . . . . 0.0 107.992 162.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -139.26 120.29 14.57 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.908 0.861 . . . . 0.0 110.325 160.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 63.97 11.25 5.93 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.141 1.776 . . . . 0.0 113.577 170.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.95 -9.71 18.43 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.932 1.253 . . . . 0.0 112.536 173.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -103.46 159.53 15.5 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.203 1.002 . . . . 0.0 108.71 167.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -108.9 152.54 24.78 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 169.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -141.46 160.19 40.66 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 122.939 0.496 . . . . 0.0 110.225 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.0 mp -122.31 102.52 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 C-N-CA 125.004 1.322 . . . . 0.0 108.126 -171.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -62.08 145.78 52.27 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 122.882 1.325 . . . . 0.0 111.066 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.428 ' HB2' ' HA2' ' A' ' 90' ' ' GLY . 1.0 OUTLIER -164.5 167.72 9.94 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 130.037 3.335 . . . . 0.0 105.816 -178.558 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 89' ' ' LYS . 43.9 Cg_endo -56.46 -162.13 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 124.378 3.386 . . . . 0.0 109.511 166.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -43.04 -15.07 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 129.609 3.164 . . . . 0.0 115.268 -170.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 87' ' ' PRO . 2.6 ptpt -107.06 61.83 0.62 Allowed 'General case' 0 N--CA 1.425 -1.708 0 C-N-CA 130.462 3.505 . . . . 0.0 113.818 167.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.428 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . -122.32 -0.42 10.39 Favored Glycine 0 C--O 1.224 -0.479 0 N-CA-C 116.957 1.543 . . . . 0.0 116.957 -176.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.269 4.1 mt -89.59 48.21 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 O-C-N 120.313 -1.698 . . . . 0.0 109.604 -169.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -74.3 101.83 4.16 Favored 'General case' 0 CA--C 1.504 -0.822 0 O-C-N 120.656 -1.277 . . . . 0.0 108.114 174.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -75.13 128.45 35.52 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 162.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.1 pt -114.63 171.41 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.211 1.004 . . . . 0.0 108.524 159.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -129.71 43.48 3.12 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.853 0.835 . . . . 0.0 110.467 -176.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -159.45 164.41 34.56 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 125.911 1.684 . . . . 0.0 108.389 164.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -66.52 136.71 56.05 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 162.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -80.05 -47.04 15.49 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.647 0.779 . . . . 0.0 111.598 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -58.26 -23.01 54.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.9 2.08 . . . . 0.0 113.309 -172.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -75.47 -19.31 59.5 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.952 1.251 . . . . 0.0 111.785 176.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 16.6 mmt -91.4 -14.16 31.12 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.806 1.242 . . . . 0.0 111.027 -173.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.3 pt . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.016 -1.468 . . . . 0.0 112.937 -170.92 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.544 0.732 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -62.06 171.4 5.07 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.271 2.647 . . . . 0.0 113.433 172.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.9 mm -87.27 131.01 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 160.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.84 162.55 48.03 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 127.115 2.166 . . . . 0.0 109.522 170.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.611 ' HB2' HD22 ' A' ' 10' ' ' ASN . 48.4 Cg_endo -68.36 -178.77 1.95 Allowed 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.272 2.648 . . . . 0.0 114.082 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.3 mtmt -62.85 166.97 5.03 Favored 'General case' 0 C--N 1.344 0.367 0 O-C-N 119.547 -1.971 . . . . 0.0 109.501 159.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.1 -56.44 5.59 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 162.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -64.58 -22.48 66.98 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -163.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.611 HD22 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -85.41 0.12 53.17 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.323 0.965 . . . . 0.0 113.268 176.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.6 t -74.49 147.24 8.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 171.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.22 -61.26 1.55 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 169.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.6 p -164.49 127.09 2.35 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -175.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.9 mt -90.61 127.73 42.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.0 t -103.51 125.57 50.15 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 174.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.5 mt -123.88 102.09 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 175.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.57 106.33 16.06 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 169.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -59.42 170.97 0.88 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.797 1.639 . . . . 0.0 109.718 -176.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.3 p -59.77 -38.83 82.92 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 120.969 -1.082 . . . . 0.0 111.938 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -73.83 -179.39 3.65 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 127.778 2.431 . . . . 0.0 111.399 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.9 p -71.2 21.3 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.334 2.254 . . . . 0.0 113.862 -174.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.0 mt -136.07 152.18 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 126.182 1.793 . . . . 0.0 106.431 -162.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.6 167.77 18.85 Favored 'General case' 0 N--CA 1.419 -1.987 0 C-N-CA 126.565 1.946 . . . . 0.0 108.701 176.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.64 147.44 35.79 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 165.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.07 126.32 74.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -107.72 85.95 2.21 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 -174.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -110.33 -18.45 13.26 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.631 1.572 . . . . 0.0 110.991 175.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -69.88 146.71 51.06 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 175.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.12 -45.51 83.41 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.45 0.643 . . . . 0.0 112.164 -173.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -70.23 -31.2 68.5 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.197 -0.94 . . . . 0.0 111.708 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 52.8 p -65.94 -43.74 87.12 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 70.9 mt -62.77 -56.82 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.997 1.319 . . . . 0.0 108.758 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -56.65 -37.53 70.91 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 118.66 -0.686 . . . . 0.0 112.25 -172.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.475 ' O ' ' HE3' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -55.68 -59.78 4.37 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 176.537 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.8 mt -56.38 -46.28 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 117.685 -1.15 . . . . 0.0 111.299 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.23 -20.68 2.79 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.619 1.554 . . . . 0.0 114.69 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.89 -53.73 7.98 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.95 0.9 . . . . 0.0 111.509 172.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -59.27 -35.33 73.53 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.949 -1.094 . . . . 0.0 110.342 177.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 21.2 mm -61.55 -24.46 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 120.532 -1.355 . . . . 0.0 111.168 175.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -98.09 -6.6 31.34 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.883 1.22 . . . . 0.0 113.145 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 t -70.78 -34.14 71.48 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.052 0.842 . . . . 0.0 109.652 -168.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.25 167.75 47.63 Favored Glycine 0 C--N 1.341 0.842 0 O-C-N 120.771 -1.205 . . . . 0.0 113.863 -173.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -131.59 110.25 10.81 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 -174.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.421 ' HB3' ' CE1' ' A' ' 92' ' ' TYR . 13.3 ptt-85 -60.06 -8.53 2.43 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -176.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . 0.272 1.4 p 57.36 172.52 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 127.743 2.417 . . . . 0.0 109.846 -169.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -83.24 2.29 36.57 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.421 -1.424 . . . . 0.0 111.594 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt -65.34 158.87 25.33 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 122.049 0.928 . . . . 0.0 110.182 174.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -90.55 130.04 36.63 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 165.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.1 m -75.18 158.87 32.32 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 153.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.9 pt -142.52 31.76 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 125.0 1.32 . . . . 0.0 110.336 174.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -131.15 172.54 12.0 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.953 1.701 . . . . 0.0 108.217 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.55 -0.67 2.89 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.26 1.024 . . . . 0.0 110.996 177.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -146.01 160.65 42.63 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 127.377 2.271 . . . . 0.0 108.607 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -80.33 177.99 7.59 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.452 2.768 . . . . 0.0 112.076 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.9 4.28 8.05 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.713 1.205 . . . . 0.0 112.399 175.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.41 150.72 46.96 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.306 1.042 . . . . 0.0 110.217 170.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -74.56 -28.64 61.03 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.995 0.518 . . . . 0.0 110.062 172.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -129.99 127.73 40.59 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.157 1.383 . . . . 0.0 109.183 -176.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -154.27 161.94 41.49 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.704 2.002 . . . . 0.0 108.147 176.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -90.73 159.63 27.02 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 171.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.34 137.27 38.99 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.16 130.75 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -125.07 130.21 51.8 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 163.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 62.0 mt -106.76 83.57 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 171.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.77 118.49 5.36 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.941 1.246 . . . . 0.0 109.274 167.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -144.88 119.9 10.04 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.675 1.59 . . . . 0.0 108.271 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 60.87 22.98 13.04 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.774 1.63 . . . . 0.0 112.219 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.54 -3.27 42.65 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.51 1.052 . . . . 0.0 113.224 -174.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.88 178.17 51.11 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 156.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 19.7 ptp -159.39 161.27 35.61 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.542 -0.975 . . . . 0.0 112.768 177.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.4 m -118.72 112.26 19.54 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.016 1.726 . . . . 0.0 106.914 172.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.0 m -81.19 147.27 30.09 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 168.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 2.6 ptp -160.11 171.49 19.19 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.164 1.786 . . . . 0.0 108.153 165.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -142.74 146.42 34.3 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.247 1.819 . . . . 0.0 106.474 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.402 ' CD1' HG13 ' A' ' 84' ' ' ILE . 0.6 OUTLIER -128.51 153.5 47.1 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.788 1.631 . . . . 0.0 109.807 175.857 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -153.48 174.86 13.85 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.807 1.243 . . . . 0.0 110.267 -175.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -105.98 144.02 33.29 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.429 1.892 . . . . 0.0 107.961 169.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -151.49 131.1 13.07 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 176.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 55.3 14.51 1.1 Allowed 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.89 -1.131 . . . . 0.0 113.487 -176.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.51 12.09 73.37 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 120.505 -1.372 . . . . 0.0 111.888 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.96 165.07 11.85 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.563 1.945 . . . . 0.0 107.371 163.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -112.24 150.92 30.23 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.083 0.856 . . . . 0.0 108.75 178.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -141.03 159.48 42.12 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.895 0.378 . . . . 0.0 111.167 -178.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.402 HG13 ' CD1' ' A' ' 75' ' ' TYR . 3.5 mp -117.73 129.96 73.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 125.534 1.534 . . . . 0.0 108.45 178.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -73.63 150.03 41.63 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 122.847 1.308 . . . . 0.0 109.831 169.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -169.72 167.44 5.16 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 129.24 3.016 . . . . 0.0 105.928 174.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -59.67 -160.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 125.175 3.917 . . . . 0.0 109.531 162.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -42.77 -9.24 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 128.472 2.709 . . . . 0.0 117.058 -169.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -107.46 21.97 16.67 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 173.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -105.49 44.01 1.56 Allowed Glycine 0 N--CA 1.45 -0.429 0 CA-C-O 118.587 -1.118 . . . . 0.0 115.872 -167.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.4 mt -109.35 46.56 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 119.752 1.776 . . . . 0.0 108.767 171.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.421 ' CE1' ' HB3' ' A' ' 44' ' ' ARG . 72.3 m-85 -71.89 103.57 3.21 Favored 'General case' 0 CA--C 1.51 -0.582 0 O-C-N 121.193 -0.942 . . . . 0.0 108.767 177.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -68.49 126.91 31.12 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 157.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.9 pt -117.74 161.1 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 154.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -104.39 -9.49 18.43 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.658 -0.651 . . . . 0.0 110.774 -176.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -137.81 144.78 41.69 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 124.401 1.08 . . . . 0.0 110.489 -172.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -65.4 124.31 21.91 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 126.388 1.875 . . . . 0.0 112.291 -172.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -63.72 -48.75 75.81 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.808 1.243 . . . . 0.0 110.986 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -65.13 -9.71 25.07 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -174.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -109.22 -9.0 15.03 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.889 1.222 . . . . 0.0 111.819 173.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 10.9 mmt -89.6 -19.95 24.33 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.048 1.339 . . . . 0.0 111.775 174.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 18.3 pt . . . . . 0 C--O 1.255 1.363 0 C-N-CA 124.124 0.969 . . . . 0.0 110.947 174.27 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 CA--C 1.544 0.749 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.53 -173.21 0.11 Allowed 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.842 3.028 . . . . 0.0 111.816 158.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.8 mt -124.27 119.78 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 164.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.7 157.14 76.18 Favored Pre-proline 0 C--O 1.239 0.542 0 C-N-CA 125.324 1.449 . . . . 0.0 109.135 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.516 ' HB2' HD22 ' A' ' 10' ' ' ASN . 71.6 Cg_endo -71.25 165.46 32.37 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.761 2.307 . . . . 0.0 111.513 176.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -64.46 154.78 34.77 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.335 -0.853 . . . . 0.0 111.261 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.24 -50.5 72.69 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.394 0.997 . . . . 0.0 108.963 167.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -67.45 -16.84 64.44 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -169.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.516 HD22 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -104.38 1.89 30.66 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 119.582 1.083 . . . . 0.0 113.549 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 t -83.66 135.89 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 172.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -83.82 -60.36 2.14 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.4 p -148.75 169.88 19.46 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.362 1.465 . . . . 0.0 109.553 169.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.3 mt -124.84 144.48 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 N-CA-C 104.578 -2.378 . . . . 0.0 104.578 171.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.83 145.16 49.92 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 174.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.0 mt -134.66 105.74 6.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 178.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -86.37 110.59 19.79 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 102.839 -3.023 . . . . 0.0 102.839 174.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -66.12 173.28 3.18 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 174.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.3 p -56.85 -20.32 22.24 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -103.76 -175.83 2.91 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.197 1.399 . . . . 0.0 109.413 -178.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.4 p -75.65 42.38 0.22 Allowed 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.768 2.027 . . . . 0.0 111.655 -178.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.6 mt -140.11 136.35 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 126.196 1.798 . . . . 0.0 106.313 -172.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.38 150.59 46.7 Favored 'General case' 0 N--CA 1.421 -1.918 0 C-N-CA 125.427 1.491 . . . . 0.0 109.135 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.44 ' HE2' ' CZ ' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -125.28 142.11 51.69 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.377 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.44 145.33 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.44 ' CZ ' ' HE2' ' A' ' 24' ' ' LYS . 24.3 m-85 -127.24 82.49 2.09 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -170.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -88.34 -19.53 26.55 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.378 1.471 . . . . 0.0 112.102 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.99 139.81 30.48 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.47 1.108 . . . . 0.0 111.242 -174.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.4 t -45.2 -54.57 6.77 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 126.463 1.905 . . . . 0.0 112.896 -177.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -67.14 -38.99 86.49 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.527 -0.733 . . . . 0.0 109.753 -173.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.4 m -65.9 -6.42 12.28 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.304 1.842 . . . . 0.0 113.389 171.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -100.66 -45.54 11.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 120.451 1.478 . . . . 0.0 109.316 171.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -60.38 -33.0 71.84 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.885 0.874 . . . . 0.0 112.887 -174.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.13 -52.28 43.64 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.672 0.669 . . . . 0.0 110.39 176.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.2 mt -49.24 -52.0 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 119.43 1.014 . . . . 0.0 110.546 173.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.9 mt -56.81 -21.32 27.93 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -177.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.5 t -67.19 -65.37 0.69 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.485 1.039 . . . . 0.0 108.56 168.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.39 -29.87 70.13 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.48 -0.763 . . . . 0.0 110.544 -168.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.96 -20.29 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.325 1.05 . . . . 0.0 111.141 174.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.71 -3.47 8.74 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 120.004 1.275 . . . . 0.0 114.222 -170.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 t -66.38 -40.15 89.51 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.586 0.754 . . . . 0.0 110.335 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.64 172.32 53.94 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-O 123.134 1.408 . . . . 0.0 114.19 -169.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -140.7 121.63 14.55 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 114.238 -0.981 . . . . 0.0 108.41 -173.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -63.82 -4.85 3.53 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.521 1.528 . . . . 0.0 114.796 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.1 p 59.83 -164.55 0.22 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.2 1.8 . . . . 0.0 108.379 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -100.31 8.81 43.46 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 120.235 -1.54 . . . . 0.0 112.48 173.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -64.06 154.21 35.06 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.736 -0.602 . . . . 0.0 109.93 173.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -94.81 123.76 38.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 165.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.2 t -70.98 151.73 44.34 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 147.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 pp -141.33 7.57 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.866 2.066 . . . . 0.0 109.687 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.11 162.14 24.17 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.535 1.934 . . . . 0.0 109.76 -174.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -102.3 -1.57 30.77 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.121 0.968 . . . . 0.0 110.699 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -141.55 147.32 45.56 Favored Pre-proline 0 C--O 1.235 0.305 0 CA-C-N 119.394 0.997 . . . . 0.0 111.532 -172.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -67.98 162.08 41.41 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.218 3.279 . . . . 0.0 111.402 -176.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.81 35.66 1.66 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.048 2.139 . . . . 0.0 109.235 174.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.8 152.79 41.84 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.765 1.626 . . . . 0.0 110.292 173.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -87.67 -29.32 21.23 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.681 -172.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -128.13 118.44 23.41 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 176.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -138.19 156.47 47.68 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.641 1.576 . . . . 0.0 108.209 175.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.37 -178.0 16.49 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 125.822 1.677 . . . . 0.0 110.12 171.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 36.5 m -131.75 137.17 48.1 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 117.731 0.765 . . . . 0.0 111.953 -158.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 mp -118.72 135.2 59.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 126.179 1.791 . . . . 0.0 107.018 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -127.67 125.45 40.1 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 172.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.7 mt -99.87 118.24 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.116 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 168.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -82.25 133.1 35.23 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 165.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -140.26 -162.72 1.39 Allowed 'General case' 0 C--N 1.327 -0.404 0 O-C-N 120.845 -1.159 . . . . 0.0 108.05 173.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -44.77 -35.74 2.87 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 129.886 3.275 . . . . 0.0 115.565 -157.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -176.13 20.41 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 124.895 1.235 . . . . 0.0 110.39 -167.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -165.18 170.72 40.28 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 171.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.9 ptt? -118.84 156.1 30.03 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.3 1.44 . . . . 0.0 109.834 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 m -126.87 108.02 10.63 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -176.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.4 m -108.52 143.61 37.29 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.705 0.802 . . . . 0.0 110.271 -172.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.94 165.98 33.78 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.526 1.531 . . . . 0.0 109.306 172.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -112.84 176.36 5.05 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.691 1.597 . . . . 0.0 108.928 170.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -142.7 165.62 26.88 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.278 1.431 . . . . 0.0 108.593 170.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -158.46 170.8 21.39 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.111 0.869 . . . . 0.0 112.267 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -106.53 134.29 49.9 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 162.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.31 -162.52 0.08 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 125.824 1.65 . . . . 0.0 106.888 153.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -74.28 50.97 0.41 Allowed 'General case' 0 C--N 1.321 -0.66 0 O-C-N 119.952 -1.717 . . . . 0.0 111.316 174.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 122.07 -14.97 8.91 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 125.108 1.337 . . . . 0.0 112.286 166.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -89.18 154.35 20.21 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.481 1.14 . . . . 0.0 110.728 165.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -114.79 152.68 31.7 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.776 0.716 . . . . 0.0 111.264 -178.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -152.23 163.68 38.93 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.84 0.856 . . . . 0.0 111.879 -169.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.9 mp -131.14 132.58 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.708 1.603 . . . . 0.0 109.767 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.1 tp10 -85.0 165.39 17.6 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.181 2.192 . . . . 0.0 109.994 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 174.43 168.31 0.32 Allowed Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 128.032 2.533 . . . . 0.0 107.289 -164.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.41 ' C ' ' H ' ' A' ' 89' ' ' LYS . 39.5 Cg_endo -59.2 -161.27 0.02 OUTLIER 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.338 2.692 . . . . 0.0 109.672 160.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -42.57 -6.74 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 130.397 3.479 . . . . 0.0 117.733 -170.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 87' ' ' PRO 0.266 1.2 ptpt -109.72 13.4 23.74 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 129.758 3.223 . . . . 0.0 113.285 179.531 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.18 49.98 2.17 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 123.78 0.705 . . . . 0.0 114.25 -168.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.1 mt -127.79 46.22 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 176.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -72.85 96.38 2.07 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 173.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -74.43 121.08 20.88 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 166.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 27.3 pt -115.75 169.44 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.485 1.114 . . . . 0.0 109.553 166.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -128.37 49.99 2.13 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.24 0.616 . . . . 0.0 109.951 -178.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -166.7 165.21 16.6 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.554 1.541 . . . . 0.0 110.785 165.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -73.62 131.65 41.91 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.194 0.998 . . . . 0.0 108.996 174.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -72.38 -49.14 36.16 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.798 0.727 . . . . 0.0 111.742 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -70.91 -26.13 63.07 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.337 -0.852 . . . . 0.0 113.023 -168.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -72.11 -19.58 61.77 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.153 0.888 . . . . 0.0 111.425 171.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 17.1 mmt -105.81 24.06 12.91 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.571 1.948 . . . . 0.0 111.965 -171.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.2 pt . . . . . 0 C--O 1.257 1.448 0 C-N-CA 125.188 1.395 . . . . 0.0 109.836 169.581 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 m . . . . . 0 CA--C 1.547 0.851 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.77 161.54 45.53 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 O-C-N 118.716 -1.255 . . . . 0.0 111.141 166.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.7 mt -116.45 104.79 17.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.42 158.84 68.37 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 126.986 2.114 . . . . 0.0 110.676 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.409 ' HB2' HD22 ' A' ' 10' ' ' ASN . 68.6 Cg_endo -68.77 -175.43 0.93 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.6 2.867 . . . . 0.0 112.662 177.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt -60.82 175.94 0.44 Allowed 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.109 -1.62 . . . . 0.0 109.569 162.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.18 -50.01 10.11 Favored 'General case' 0 C--O 1.221 -0.428 0 O-C-N 121.255 -0.903 . . . . 0.0 109.539 163.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -62.13 -12.31 18.94 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.683 1.593 . . . . 0.0 114.771 -168.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.409 HD22 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -104.83 -0.62 27.0 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.71 2.004 . . . . 0.0 113.187 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 66.5 t -86.01 130.17 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 172.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -67.26 -69.52 0.31 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 167.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.6 m -149.51 170.53 18.4 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.112 0.965 . . . . 0.0 109.984 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.1 mt -131.75 132.97 61.81 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.994 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 172.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.6 m -99.68 133.0 44.65 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 112.787 -2.006 . . . . 0.0 106.069 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.0 mt -133.99 103.65 5.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 170.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -93.97 98.93 11.37 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.172 1.789 . . . . 0.0 106.274 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -60.74 172.83 0.85 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.469 1.908 . . . . 0.0 111.55 -169.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.3 p -51.83 -42.59 62.66 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.962 0.905 . . . . 0.0 110.393 171.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -91.64 -179.2 5.28 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.188 1.795 . . . . 0.0 111.338 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 98.2 p -72.87 16.9 0.13 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.313 1.445 . . . . 0.0 114.818 -158.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.8 mt -120.8 139.91 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -161.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -124.19 107.13 10.89 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 174.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.26 139.85 42.81 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 166.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.0 mt -118.17 136.15 56.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 168.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -110.86 73.87 0.84 Allowed 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 104.243 -2.502 . . . . 0.0 104.243 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -82.12 16.1 2.09 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.808 1.243 . . . . 0.0 111.72 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.51 140.44 52.2 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.707 1.203 . . . . 0.0 109.94 -167.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.8 t -55.75 -46.07 77.92 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.92 0.888 . . . . 0.0 111.636 -175.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -73.66 -31.85 63.68 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.378 -0.826 . . . . 0.0 112.111 -175.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.4 m -65.8 -43.29 89.14 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 127.685 2.394 . . . . 0.0 111.036 174.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.5 mt -64.76 -52.11 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 172.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -60.81 -21.93 63.63 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.401 ' HZ3' ' C ' ' A' ' 102' ' ' ILE . 9.4 ttmt -65.16 -67.56 0.43 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 119.57 1.077 . . . . 0.0 108.495 166.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.6 mt -50.65 -44.48 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.549 1.14 . . . . 0.0 110.543 -170.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.82 -12.4 0.79 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 177.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.4 t -84.44 -62.94 1.43 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.041 2.136 . . . . 0.0 110.814 168.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -57.65 -14.7 5.88 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.646 1.112 . . . . 0.0 113.435 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.4 mm -82.3 -49.66 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 124.429 1.092 . . . . 0.0 110.736 169.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.96 -19.78 46.32 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.342 1.057 . . . . 0.0 113.713 -173.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 t -68.51 -17.4 64.16 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.668 1.187 . . . . 0.0 112.87 -176.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.62 140.2 40.37 Favored Glycine 0 C--N 1.336 0.557 0 O-C-N 119.612 -1.93 . . . . 0.0 112.389 176.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.408 ' C ' ' H ' ' A' ' 45' ' ' THR . 6.6 ptpp? -108.41 107.34 17.86 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 161.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.7 ptt85 -59.79 -6.48 1.25 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.712 1.142 . . . . 0.0 113.109 168.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.408 ' H ' ' C ' ' A' ' 43' ' ' LYS . 11.8 p 61.33 -174.85 0.13 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.688 1.595 . . . . 0.0 110.736 -178.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -74.94 -12.71 60.41 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.23 -1.544 . . . . 0.0 112.216 176.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -71.92 171.31 11.99 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.117 0.961 . . . . 0.0 111.35 -167.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -110.74 128.43 55.73 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.824 1.25 . . . . 0.0 108.173 173.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.5 t -74.94 162.58 28.48 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 156.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.9 pt -146.52 31.69 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 126.489 1.915 . . . . 0.0 109.83 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -139.63 172.23 13.09 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 120.99 -1.069 . . . . 0.0 111.64 -172.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -111.12 -20.36 12.39 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.428 1.891 . . . . 0.0 111.52 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -147.26 158.27 44.46 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 124.025 0.93 . . . . 0.0 110.676 -165.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -70.29 175.55 8.39 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.737 2.958 . . . . 0.0 111.699 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.27 -5.12 11.83 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.509 1.524 . . . . 0.0 111.539 175.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.44 157.8 36.4 Favored 'General case' 0 N--CA 1.457 -0.114 0 O-C-N 120.837 -1.165 . . . . 0.0 109.249 169.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.16 -21.66 21.05 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.602 0.761 . . . . 0.0 111.283 168.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -127.96 103.01 7.01 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -169.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -146.56 177.48 9.03 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 128.601 2.76 . . . . 0.0 106.695 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -121.61 166.24 14.45 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 168.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.96 133.07 42.1 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.159 0.984 . . . . 0.0 108.601 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.0 mp -124.33 129.93 73.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -132.64 115.47 15.45 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.0 mt -87.49 103.63 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 173.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -74.76 122.81 23.87 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 172.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -141.67 -157.21 0.75 Allowed 'General case' 0 N--CA 1.465 0.299 0 O-C-N 120.866 -1.146 . . . . 0.0 110.502 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -44.56 -21.21 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 1 C-N-CA 132.796 4.438 . . . . 0.0 116.501 -160.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 153.03 32.19 0.03 OUTLIER Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 126.048 1.785 . . . . 0.0 108.954 -162.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -172.97 174.1 45.77 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.2 ptp -117.93 160.29 21.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.909 1.684 . . . . 0.0 109.351 176.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.6 m -123.29 104.75 9.33 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 158.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.6 m -82.84 141.8 32.0 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.339 1.456 . . . . 0.0 108.591 172.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -165.32 167.99 17.31 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.355 1.862 . . . . 0.0 108.309 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -146.01 138.75 25.64 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.787 1.635 . . . . 0.0 107.421 -174.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -126.06 142.88 51.33 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 121.06 1.754 . . . . 0.0 109.732 -177.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -149.52 173.74 13.27 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.564 1.146 . . . . 0.0 111.583 -174.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -103.45 144.9 30.79 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.284 1.433 . . . . 0.0 108.883 166.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -144.97 126.98 15.52 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.033 0.933 . . . . 0.0 109.313 173.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.14 3.84 1.42 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.847 2.059 . . . . 0.0 114.824 176.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.7 -0.37 15.52 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-N 119.579 1.081 . . . . 0.0 113.315 -173.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.5 tptt -133.87 149.94 51.35 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 119.358 1.579 . . . . 0.0 110.177 -169.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -101.52 135.53 42.86 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -168.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -129.55 159.53 36.06 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.05 0.54 . . . . 0.0 111.055 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.9 mp -122.05 117.91 53.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 125.073 1.349 . . . . 0.0 108.428 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -65.25 145.6 56.03 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 122.793 1.282 . . . . 0.0 109.655 173.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -171.2 165.76 4.56 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 127.442 2.297 . . . . 0.0 106.532 175.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.404 ' O ' ' N ' ' A' ' 89' ' ' LYS . 94.2 Cg_endo -63.35 -161.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.769 1 C-N-CA 125.401 4.067 . . . . 0.0 109.517 174.49 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -43.41 -13.98 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 117.065 2.246 . . . . 0.0 117.065 -170.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 87' ' ' PRO . 2.8 mtmt -103.18 31.54 4.22 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 126.237 1.815 . . . . 0.0 114.224 169.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -118.23 69.8 0.32 Allowed Glycine 0 C--O 1.221 -0.693 0 C-N-CA 124.566 1.079 . . . . 0.0 111.963 -174.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.1 mt -133.39 53.01 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 166.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -75.44 108.67 8.4 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 121.463 -0.773 . . . . 0.0 109.029 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -83.37 125.06 31.26 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 163.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.8 pt -113.32 167.31 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.164 1.385 . . . . 0.0 108.726 164.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -124.95 46.53 2.32 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.388 0.613 . . . . 0.0 110.853 -174.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -177.13 169.63 2.29 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 127.456 2.302 . . . . 0.0 109.311 168.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -74.75 138.08 42.45 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.653 1.181 . . . . 0.0 109.739 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -79.4 -44.84 20.66 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.283 1.033 . . . . 0.0 111.819 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.0 -12.54 60.16 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.913 1.285 . . . . 0.0 113.623 -171.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -88.72 -22.47 23.34 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.374 1.47 . . . . 0.0 113.011 171.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -81.49 -29.67 33.56 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 121.092 -1.005 . . . . 0.0 110.541 -178.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.401 ' C ' ' HZ3' ' A' ' 34' ' ' LYS . 29.3 pt . . . . . 0 C--O 1.25 1.096 0 C-N-CA 123.876 0.87 . . . . 0.0 110.984 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 CA--C 1.541 0.619 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -64.14 -179.72 0.9 Allowed 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.799 2.999 . . . . 0.0 112.625 162.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.3 mt -125.58 94.7 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 127.107 2.163 . . . . 0.0 105.575 178.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.82 154.39 37.55 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 126.329 1.851 . . . . 0.0 109.36 -176.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.595 ' HB2' HD22 ' A' ' 10' ' ' ASN . 44.6 Cg_endo -68.62 159.01 55.39 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.606 2.204 . . . . 0.0 112.108 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.39 150.78 38.79 Favored 'General case' 0 C--N 1.345 0.376 0 O-C-N 121.696 -0.628 . . . . 0.0 110.496 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.2 -1.15 5.55 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -122.5 -18.03 6.81 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 119.533 1.061 . . . . 0.0 111.671 -172.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.595 HD22 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -89.11 -6.75 56.81 Favored 'General case' 0 N--CA 1.456 -0.155 0 O-C-N 121.714 -0.616 . . . . 0.0 111.141 170.517 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.8 t -69.06 138.06 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 C-N-CA 125.151 1.38 . . . . 0.0 108.573 169.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.4 -55.88 2.7 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.934 1.694 . . . . 0.0 107.787 173.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.7 p -172.67 121.47 0.41 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.508 0.595 . . . . 0.0 111.119 178.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.7 mt -75.39 129.89 36.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 173.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 t -105.58 148.73 26.97 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 166.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.7 mt -139.0 104.83 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 172.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.8 110.06 18.54 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 104.146 -2.539 . . . . 0.0 104.146 165.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -66.21 -176.43 0.42 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.222 1.009 . . . . 0.0 110.999 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.1 p -57.62 -50.55 72.79 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 120.799 -1.188 . . . . 0.0 109.96 173.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.95 -178.48 2.8 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.701 0.762 . . . . 0.0 109.644 173.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 m -80.94 17.28 1.23 Allowed 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.889 -1.132 . . . . 0.0 111.258 -175.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.7 mt -90.14 134.48 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -127.85 142.93 51.15 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.83 149.22 52.52 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 123.567 0.747 . . . . 0.0 109.214 175.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.1 mp -121.8 147.43 25.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -127.45 76.79 1.7 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 -168.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -105.01 5.21 32.41 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.804 1.241 . . . . 0.0 112.613 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -81.72 144.49 31.1 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 166.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 28.6 t -57.83 -41.35 82.08 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.421 -1.424 . . . . 0.0 111.663 174.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.44 -33.78 76.66 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 120.658 -1.276 . . . . 0.0 111.994 178.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.2 p -63.05 -43.09 99.6 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.848 0.859 . . . . 0.0 109.538 175.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 93.0 mt -68.41 -54.5 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 124.62 1.168 . . . . 0.0 108.892 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -58.09 -32.88 68.49 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.706 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -61.68 -64.32 0.98 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 118.551 -0.738 . . . . 0.0 110.233 171.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 81.4 mt -51.6 -48.68 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 119.199 -0.429 . . . . 0.0 110.072 -173.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.6 mt -53.47 -24.9 14.27 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.2 t -63.91 -63.1 1.25 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.775 1.23 . . . . 0.0 110.072 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -68.87 -24.17 64.31 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.889 0.852 . . . . 0.0 110.724 -174.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.9 mm -68.15 -13.33 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 O-C-N 120.48 -1.387 . . . . 0.0 111.21 171.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.64 -8.45 11.46 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -176.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.4 p -67.77 -40.6 84.01 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.648 1.113 . . . . 0.0 111.608 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.77 164.52 54.59 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-O 123.117 1.398 . . . . 0.0 114.299 -165.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.448 ' C ' ' H ' ' A' ' 45' ' ' THR . 91.6 mttt -115.91 110.49 19.07 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 105.107 -2.182 . . . . 0.0 105.107 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.434 ' HB3' ' CE2' ' A' ' 92' ' ' TYR . 10.3 ptt180 -56.55 -3.95 0.13 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.872 1.269 . . . . 0.0 114.36 174.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.448 ' H ' ' C ' ' A' ' 43' ' ' LYS . 27.7 p 62.7 172.95 0.14 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 128.752 2.821 . . . . 0.0 110.396 -171.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -78.37 -6.42 55.11 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.004 -1.06 . . . . 0.0 111.666 172.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -66.91 174.01 3.27 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 122.776 1.274 . . . . 0.0 111.981 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -110.75 150.18 29.45 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.23 1.812 . . . . 0.0 107.752 175.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.7 76.69 1.65 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -164.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.2 pt -90.54 36.14 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.531 1.132 . . . . 0.0 110.542 -164.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -125.35 161.63 26.57 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.295 2.238 . . . . 0.0 109.337 -172.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.99 -3.28 8.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.367 -1.288 . . . . 0.0 112.736 -178.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -150.12 164.61 20.0 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 126.262 1.825 . . . . 0.0 108.638 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.28 179.14 3.64 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.258 2.638 . . . . 0.0 112.678 173.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.66 6.29 45.66 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.154 1.381 . . . . 0.0 111.658 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.13 156.43 17.42 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 121.36 -0.837 . . . . 0.0 111.977 -175.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -86.17 -22.23 27.11 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.795 1.638 . . . . 0.0 111.221 170.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -135.1 115.95 14.01 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -143.07 159.95 41.31 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 127.207 2.203 . . . . 0.0 106.003 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.85 162.59 25.32 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 167.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.8 m -118.11 125.24 49.87 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.104 1.361 . . . . 0.0 108.233 -175.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.2 mp -121.35 132.21 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 -172.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -123.53 115.74 22.03 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 175.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.5 mt -91.17 86.08 2.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 173.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -65.45 113.66 4.29 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 173.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -140.66 135.43 31.65 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.588 1.555 . . . . 0.0 108.17 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 61.5 -4.03 0.18 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.919 2.088 . . . . 0.0 115.443 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.8 12.13 26.87 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 119.89 1.223 . . . . 0.0 112.321 -173.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -127.94 -175.96 14.28 Favored Glycine 0 C--N 1.335 0.511 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 165.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.94 138.25 22.88 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 118.122 0.961 . . . . 0.0 113.149 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 86.8 m -75.23 106.03 6.55 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 158.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.4 m -73.55 142.58 46.65 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 163.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -161.09 166.62 27.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.598 1.559 . . . . 0.0 108.727 170.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -140.99 146.88 37.87 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.619 1.568 . . . . 0.0 108.119 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.407 ' CD1' HG13 ' A' ' 84' ' ' ILE . 1.4 m-85 -128.31 147.35 50.61 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 120.211 1.369 . . . . 0.0 108.973 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -148.9 -175.37 4.92 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.97 1.308 . . . . 0.0 110.538 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -119.04 138.92 52.52 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.176 1.79 . . . . 0.0 109.47 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.461 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 7.6 tt0 -142.84 91.21 2.28 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.886 0.874 . . . . 0.0 109.31 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 70.73 19.4 5.99 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 128.214 2.606 . . . . 0.0 112.484 -174.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.15 -3.67 62.12 Favored Glycine 0 C--N 1.335 0.517 0 O-C-N 120.972 -1.08 . . . . 0.0 112.36 168.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -83.8 145.68 28.55 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 154.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -100.29 149.66 23.37 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.461 ' CE1' ' HB3' ' A' ' 78' ' ' GLU . 84.9 m-85 -134.43 135.09 42.29 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 123.173 0.589 . . . . 0.0 109.734 -171.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.407 HG13 ' CD1' ' A' ' 75' ' ' TYR . 3.0 mp -107.18 127.46 62.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -176.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -77.61 152.36 33.93 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.258 1.423 . . . . 0.0 109.943 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -172.79 168.77 2.61 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 129.131 2.972 . . . . 0.0 107.372 177.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -56.04 -161.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 125.009 3.806 . . . . 0.0 110.606 162.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -42.72 -14.69 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 128.695 2.798 . . . . 0.0 115.028 -171.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.15 66.91 0.64 Allowed 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.364 1.466 . . . . 0.0 110.616 166.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.8 53.13 0.77 Allowed Glycine 0 C--O 1.223 -0.542 0 C-N-CA 124.661 1.124 . . . . 0.0 114.953 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.5 mt -131.44 61.15 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.434 ' CE2' ' HB3' ' A' ' 44' ' ' ARG . 23.4 m-85 -87.56 98.27 11.31 Favored 'General case' 0 CA--C 1.521 -0.168 0 O-C-N 121.165 -0.959 . . . . 0.0 109.304 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -79.06 81.37 5.33 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.55 1.54 . . . . 0.0 109.049 176.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 21.8 pt -81.74 159.41 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 O-C-N 120.877 -1.14 . . . . 0.0 109.439 175.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -107.27 10.74 29.75 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -177.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -131.82 147.32 52.48 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 124.787 1.235 . . . . 0.0 112.433 -175.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -74.07 110.26 8.22 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -55.26 -43.0 74.26 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.035 0.934 . . . . 0.0 110.854 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -73.91 -13.06 60.84 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -171.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -90.43 -24.7 20.66 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.022 0.929 . . . . 0.0 110.789 165.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 12.1 mmt -96.54 6.3 49.02 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 126.124 1.77 . . . . 0.0 113.293 -172.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.4 pt . . . . . 0 C--O 1.246 0.873 0 CA-C-N 119.608 1.095 . . . . 0.0 108.343 164.234 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.543 0.68 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -70.23 173.37 11.49 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.74 2.294 . . . . 0.0 112.252 156.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.5 mt -120.89 98.06 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 175.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.56 165.06 15.42 Favored Pre-proline 0 C--O 1.239 0.532 0 C-N-CA 125.381 1.472 . . . . 0.0 110.086 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -63.14 -179.81 0.66 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.348 2.032 . . . . 0.0 111.28 161.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.418 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -64.96 -175.4 0.19 Allowed 'General case' 0 C--O 1.232 0.157 0 O-C-N 120.943 -1.098 . . . . 0.0 109.823 165.164 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.66 -42.93 13.02 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 163.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -72.62 -0.6 13.4 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.282 1.433 . . . . 0.0 113.456 -159.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.43 -0.04 8.22 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 129.919 3.287 . . . . 0.0 111.919 -170.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.2 t -84.63 128.5 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 176.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -81.66 -56.42 4.02 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 124.905 1.282 . . . . 0.0 109.416 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.29 155.38 40.45 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.598 0.759 . . . . 0.0 109.348 166.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 51.8 mt -104.14 140.95 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 162.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.8 t -127.61 132.18 49.83 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.2 mt -125.63 106.36 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 174.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.56 110.2 17.45 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 169.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -68.74 170.85 8.68 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.889 1.275 . . . . 0.0 111.255 -174.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.9 p -58.45 -29.6 66.28 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.97 1.708 . . . . 0.0 113.522 176.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.539 ' CG ' ' H ' ' A' ' 21' ' ' SER . 46.9 t30 -86.64 -154.6 0.23 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.771 1.228 . . . . 0.0 108.159 177.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.539 ' H ' ' CG ' ' A' ' 20' ' ' ASN . 23.4 t -102.57 37.33 1.94 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.603 1.961 . . . . 0.0 109.595 -177.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.9 mt -132.02 155.71 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 126.612 1.965 . . . . 0.0 106.749 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.4 164.37 25.84 Favored 'General case' 0 N--CA 1.425 -1.72 0 C-N-CA 127.225 2.21 . . . . 0.0 108.78 171.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.1 135.47 43.24 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 126.39 1.876 . . . . 0.0 106.636 173.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.6 mp -111.72 127.0 69.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 176.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -108.51 80.23 1.33 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -88.7 -5.24 58.24 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.792 1.237 . . . . 0.0 112.085 -178.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.7 150.59 20.21 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.396 1.078 . . . . 0.0 111.552 -175.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -44.71 -64.55 0.68 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.981 2.113 . . . . 0.0 110.739 172.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -62.91 -35.71 80.97 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.111 0.964 . . . . 0.0 111.603 -168.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.6 m -63.8 -49.43 72.93 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 128.41 2.684 . . . . 0.0 110.713 175.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.26 -37.09 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.057 0.943 . . . . 0.0 109.386 174.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.07 -43.07 93.37 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.811 1.244 . . . . 0.0 112.267 -176.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -57.67 -66.45 0.47 Allowed 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 124.538 1.149 . . . . 0.0 108.867 170.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.4 mt -52.16 -45.92 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.768 0.827 . . . . 0.0 111.326 -172.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.91 -7.87 2.72 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.508 -1.37 . . . . 0.0 113.171 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.19 -58.94 2.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.573 2.349 . . . . 0.0 111.029 167.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.6 pm0 -60.36 -20.09 58.1 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 121.072 1.76 . . . . 0.0 113.275 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.7 mm -85.12 -19.83 8.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 125.187 1.395 . . . . 0.0 111.694 173.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.49 -21.26 19.58 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 119.625 1.102 . . . . 0.0 113.321 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.7 t -62.18 -32.63 73.28 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.893 0.877 . . . . 0.0 111.554 -170.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.63 160.49 53.65 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-O 122.983 1.324 . . . . 0.0 113.567 -175.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -125.36 109.98 13.42 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.9 ppt_? -60.18 -10.8 4.9 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.66 1.984 . . . . 0.0 114.31 175.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.1 p 66.04 -179.77 0.2 Allowed 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 128.245 2.618 . . . . 0.0 110.958 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -82.36 2.76 30.78 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.387 -0.821 . . . . 0.0 111.936 173.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -61.92 151.27 35.27 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.994 1.27 . . . . 0.0 110.144 173.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -79.43 154.57 28.86 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.23 -1.35 . . . . 0.0 107.811 162.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.9 117.67 21.39 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 -177.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.7 pt -128.57 43.26 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 119.699 1.136 . . . . 0.0 110.548 -167.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -143.69 160.97 39.75 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.059 1.743 . . . . 0.0 108.252 -177.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.38 -10.67 13.75 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.318 1.047 . . . . 0.0 111.967 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -145.4 157.97 51.68 Favored Pre-proline 0 N--CA 1.467 0.398 0 C-N-CA 125.377 1.471 . . . . 0.0 109.849 -172.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -71.65 169.19 21.64 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.715 2.277 . . . . 0.0 112.504 177.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.6 t -92.08 -9.37 42.89 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.925 1.69 . . . . 0.0 112.442 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.04 158.77 18.52 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.978 -1.076 . . . . 0.0 112.041 -175.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -76.02 -33.51 59.67 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.992 1.317 . . . . 0.0 111.403 171.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -122.71 110.77 15.91 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.7 1.6 . . . . 0.0 106.985 -168.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -148.79 168.2 23.57 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.825 2.05 . . . . 0.0 106.448 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -109.01 167.05 12.81 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 170.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.45 123.3 44.49 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.275 1.03 . . . . 0.0 109.251 -178.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.6 137.52 51.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -128.62 146.68 50.79 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.876 0.87 . . . . 0.0 109.512 165.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.1 mt -114.95 91.36 1.75 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.5 0 N-CA-C 103.055 -2.942 . . . . 0.0 103.055 163.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -62.59 129.68 41.65 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 169.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -144.42 -155.91 0.65 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -55.43 -4.64 0.1 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 130.531 3.532 . . . . 0.0 116.514 -156.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.55 14.83 0.14 Allowed Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 126.474 1.987 . . . . 0.0 110.508 -170.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -147.92 170.42 28.58 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 118.11 0.955 . . . . 0.0 113.214 168.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 31.7 mtp -131.3 108.65 9.81 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 127.456 2.302 . . . . 0.0 106.976 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 78.4 m -74.86 87.63 2.28 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 166.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.8 m -66.31 139.37 58.04 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 172.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 2.1 ptm -160.2 166.39 29.76 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.278 1.431 . . . . 0.0 109.027 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -144.84 143.83 30.82 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.894 1.678 . . . . 0.0 106.683 -173.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -129.68 144.31 51.23 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.608 1.549 . . . . 0.0 109.016 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -146.88 178.75 8.09 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.317 1.447 . . . . 0.0 111.073 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -111.72 140.22 46.53 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.665 1.986 . . . . 0.0 107.655 171.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -138.48 112.6 8.59 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 175.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.14 15.18 3.12 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.95 1.7 . . . . 0.0 114.247 176.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.98 4.68 44.85 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.667 1.127 . . . . 0.0 112.873 172.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.98 161.51 14.4 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 157.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -119.63 154.74 33.54 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -144.04 149.27 36.4 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.783 0.325 . . . . 0.0 111.086 -168.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mp -121.2 119.76 60.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 125.453 1.501 . . . . 0.0 108.193 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -74.46 151.88 39.52 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.708 1.203 . . . . 0.0 110.773 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.407 ' HB2' ' HA2' ' A' ' 90' ' ' GLY . 0.8 OUTLIER -175.08 167.5 1.88 Allowed Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 127.366 2.266 . . . . 0.0 108.486 -177.124 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -55.73 -162.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.802 1 C-N-CA 126.126 4.551 . . . . 0.0 111.347 168.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -43.74 -8.38 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 128.13 2.572 . . . . 0.0 116.733 -175.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.92 70.29 0.77 Allowed 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 119.346 0.975 . . . . 0.0 110.697 159.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . -131.39 33.85 2.7 Favored Glycine 0 C--O 1.225 -0.439 0 N-CA-C 116.839 1.496 . . . . 0.0 116.839 -175.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.6 mt -116.98 50.11 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 118.027 0.914 . . . . 0.0 108.571 175.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -73.82 101.22 3.67 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.513 -1.367 . . . . 0.0 108.726 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -68.01 124.87 24.58 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 163.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 22.0 pt -121.14 163.64 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 124.189 0.996 . . . . 0.0 108.813 156.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -104.46 2.61 31.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.508 -175.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -132.69 154.27 50.33 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -169.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -73.15 104.2 4.14 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.835 2.054 . . . . 0.0 110.034 175.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -56.57 -36.42 69.3 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.46 1.504 . . . . 0.0 110.65 175.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -68.08 -15.86 63.77 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.681 0.792 . . . . 0.0 113.04 -172.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -90.81 -28.44 18.2 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.226 1.01 . . . . 0.0 112.105 169.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 41.4 mtt -68.5 -35.8 78.01 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 118.625 -0.702 . . . . 0.0 109.893 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 32.1 pt . . . . . 0 C--O 1.251 1.152 0 CA-C-O 117.164 -1.398 . . . . 0.0 112.312 -175.377 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.781 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.98 165.52 50.1 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 118.39 1.095 . . . . 0.0 112.448 -172.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.07 158.86 13.54 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.738 2.292 . . . . 0.0 111.723 154.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.5 mt -98.21 95.92 4.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 N-CA-C 104.724 -2.325 . . . . 0.0 104.724 165.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.9 166.15 35.36 Favored Pre-proline 0 C--O 1.237 0.428 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 172.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.48 ' HB2' HD22 ' A' ' 10' ' ' ASN . 56.0 Cg_endo -56.89 173.09 0.59 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 121.15 1.234 . . . . 0.0 111.204 157.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.409 ' HE3' ' CG ' ' A' ' 9' ' ' GLU . 11.7 mtmt -56.87 172.33 0.27 Allowed 'General case' 0 C--N 1.345 0.393 0 O-C-N 120.859 -1.15 . . . . 0.0 110.538 166.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.0 -53.97 8.89 Favored 'General case' 0 C--O 1.221 -0.438 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 158.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.409 ' CG ' ' HE3' ' A' ' 7' ' ' LYS . 1.1 pt-20 -70.56 -7.06 41.07 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 -162.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.48 HD22 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -100.02 -1.01 38.1 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.983 1.713 . . . . 0.0 112.278 177.066 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.411 ' N ' HD21 ' A' ' 10' ' ' ASN . 56.0 t -78.36 124.07 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 176.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -78.65 -54.03 6.55 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.761 1.624 . . . . 0.0 106.869 -176.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -152.47 167.31 29.19 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.524 1.13 . . . . 0.0 108.658 160.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.8 mt -120.36 127.71 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 164.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.11 136.84 45.09 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 175.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.2 mt -131.08 100.24 4.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.93 113.31 12.08 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 163.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -67.17 176.44 2.19 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.619 1.168 . . . . 0.0 110.099 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.32 -34.14 77.47 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.521 -1.362 . . . . 0.0 112.117 177.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.8 p30 -80.13 -154.69 0.1 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.922 1.689 . . . . 0.0 110.75 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.5 p -91.82 10.63 27.76 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.621 -1.3 . . . . 0.0 113.656 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.9 mt -107.16 151.26 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -170.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -136.46 149.6 48.3 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 173.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.9 143.56 50.93 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 174.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.1 mp -118.25 127.62 75.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -104.03 100.05 9.81 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 -176.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -125.98 -8.81 6.59 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.275 1.03 . . . . 0.0 111.88 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.58 149.99 36.55 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.154 0.982 . . . . 0.0 109.028 167.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.1 m -44.84 -57.02 4.02 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 124.392 1.077 . . . . 0.0 111.447 165.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.97 -29.96 70.92 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.605 0.762 . . . . 0.0 111.79 -174.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.4 p -71.09 -47.56 57.46 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 78.3 mt -63.38 -54.07 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 126.003 1.721 . . . . 0.0 109.169 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -59.19 -37.23 76.9 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 123.479 0.712 . . . . 0.0 111.332 -172.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.95 -50.48 73.6 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.741 0.816 . . . . 0.0 110.353 175.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 91.8 mt -55.49 -55.65 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 174.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.5 -12.19 2.51 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 t -78.08 -67.55 0.72 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 120.265 1.393 . . . . 0.0 109.321 166.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -66.0 -27.03 67.82 Favored 'General case' 0 C--O 1.223 -0.313 0 O-C-N 121.167 -0.958 . . . . 0.0 111.094 -171.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.1 mm -72.01 -18.3 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 O-C-N 119.998 -1.689 . . . . 0.0 111.832 173.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.81 -3.78 31.93 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.895 1.278 . . . . 0.0 113.692 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.6 t -68.78 -36.16 77.95 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.878 0.871 . . . . 0.0 111.235 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.3 170.28 53.42 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 124.232 0.92 . . . . 0.0 112.429 -170.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -119.45 111.62 18.36 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 -177.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -61.08 -12.94 13.82 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 171.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.0 p 65.57 -176.36 0.18 Allowed 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 127.681 2.392 . . . . 0.0 109.728 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -88.4 6.0 39.54 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 120.541 -1.349 . . . . 0.0 113.453 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.6 mtpt -64.62 173.46 2.17 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.681 1.192 . . . . 0.0 112.45 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -109.93 119.4 39.21 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.6 m -79.73 85.18 5.45 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 167.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.8 pt -85.81 35.94 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 125.166 1.387 . . . . 0.0 110.113 176.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -142.27 165.86 26.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 128.695 2.798 . . . . 0.0 107.34 -172.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -132.7 0.4 3.57 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.403 1.081 . . . . 0.0 111.665 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -146.45 164.72 22.91 Favored Pre-proline 0 C--O 1.238 0.457 0 C-N-CA 126.847 2.059 . . . . 0.0 108.304 -173.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -74.15 170.92 19.04 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.021 2.48 . . . . 0.0 111.039 169.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -110.9 4.18 19.48 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.296 1.038 . . . . 0.0 111.607 166.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.85 173.25 10.17 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 120.573 -1.329 . . . . 0.0 109.992 161.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.5 -22.8 4.94 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.869 1.668 . . . . 0.0 110.637 177.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -105.4 113.63 27.32 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 174.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -160.73 168.0 25.72 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.123 1.369 . . . . 0.0 108.492 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -96.34 157.06 21.35 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 168.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.6 m -103.96 130.95 51.62 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 mp -126.97 137.26 58.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 123.502 0.721 . . . . 0.0 109.909 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.12 114.52 18.49 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 168.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 72.6 mt -88.95 91.53 3.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 104.35 -2.463 . . . . 0.0 104.35 162.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -70.32 123.61 22.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 171.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -153.02 133.04 13.35 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.558 1.143 . . . . 0.0 109.637 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 55.48 31.89 17.9 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.636 1.174 . . . . 0.0 110.656 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.35 -11.42 4.04 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.904 1.716 . . . . 0.0 115.018 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.91 -173.75 45.34 Favored Glycine 0 C--N 1.332 0.337 0 O-C-N 120.5 -1.588 . . . . 0.0 110.029 166.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -145.09 157.57 44.07 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.907 -0.76 . . . . 0.0 111.507 168.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 83.5 m -96.73 109.2 21.9 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 154.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.7 m -74.53 147.12 42.08 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 160.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.9 ptm -163.07 170.74 17.48 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.009 1.724 . . . . 0.0 108.298 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -143.59 151.74 40.55 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -129.57 158.01 40.47 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 121.072 1.76 . . . . 0.0 110.655 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -159.21 178.28 10.16 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.457 1.48 . . . . 0.0 111.889 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -106.62 139.48 41.0 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.61 1.564 . . . . 0.0 108.007 167.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -141.68 131.3 24.03 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.246 1.022 . . . . 0.0 109.169 167.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 57.77 4.75 0.28 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.374 1.87 . . . . 0.0 114.769 175.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.09 2.4 21.96 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.744 1.64 . . . . 0.0 113.97 176.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -113.94 157.67 22.12 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 125.952 1.701 . . . . 0.0 108.052 167.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -103.25 159.45 15.53 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -145.63 155.06 42.78 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.682 0.793 . . . . 0.0 111.025 -172.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 mp -126.49 126.31 68.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 C-N-CA 125.973 1.709 . . . . 0.0 108.417 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -73.36 152.5 40.85 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 127.063 2.145 . . . . 0.0 110.19 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -177.16 167.53 1.26 Allowed Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 128.553 2.741 . . . . 0.0 107.973 176.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.41 ' O ' ' N ' ' A' ' 89' ' ' LYS . 41.1 Cg_endo -61.09 -162.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.815 1 C-N-CA 125.378 4.052 . . . . 0.0 109.671 166.173 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -43.06 -13.41 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.271 2.228 . . . . 0.0 116.955 -162.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.456 ' N ' ' HE3' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -115.18 45.0 1.71 Allowed 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 171.218 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -124.95 68.74 0.5 Allowed Glycine 0 C--O 1.228 -0.276 0 O-C-N 120.724 -1.235 . . . . 0.0 113.285 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.4 mt -135.23 50.97 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 168.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -74.37 91.12 2.19 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.224 -0.922 . . . . 0.0 108.569 -175.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -64.72 120.06 11.74 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 167.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.1 pt -118.44 158.36 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 125.968 1.707 . . . . 0.0 107.8 164.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -104.36 -1.5 26.8 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.522 0.729 . . . . 0.0 112.37 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -118.89 162.28 18.76 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.742 1.217 . . . . 0.0 111.22 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -74.82 153.13 38.86 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.461 0.704 . . . . 0.0 110.72 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -79.87 -57.99 3.38 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.295 -0.878 . . . . 0.0 112.395 170.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.02 -20.18 66.37 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -163.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -84.87 -17.43 37.99 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.194 0.906 . . . . 0.0 111.722 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 10.7 mmt -95.91 -18.26 20.45 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.894 1.277 . . . . 0.0 111.351 -172.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 9.4 pt . . . . . 0 C--O 1.247 0.974 0 C-N-CA 124.534 1.134 . . . . 0.0 110.103 177.481 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.042 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 m 64.29 166.65 0.11 Allowed Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.299 1.04 . . . . 0.0 110.156 -175.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.56 161.91 43.12 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 CA-C-N 121.275 1.491 . . . . 0.0 111.799 -170.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.6 mt -109.45 117.54 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 170.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.27 160.7 56.25 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 127.402 2.281 . . . . 0.0 108.396 -176.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.49 -178.33 1.83 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.038 2.492 . . . . 0.0 111.504 174.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.2 mtmt -58.42 175.88 0.21 Allowed 'General case' 0 C--N 1.349 0.546 0 O-C-N 121.223 -0.923 . . . . 0.0 109.896 167.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.51 -59.19 2.84 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 157.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -70.75 -13.6 62.12 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -159.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.427 HD21 ' N ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -88.13 -1.4 57.98 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.173 1.389 . . . . 0.0 111.926 176.098 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.427 ' N ' HD21 ' A' ' 10' ' ' ASN . 90.7 t -86.91 116.08 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 175.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -70.75 -44.03 67.6 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.991 0.807 . . . . 0.0 109.825 173.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.8 p -153.95 154.07 33.14 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 118.43 0.559 . . . . 0.0 111.671 162.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.1 mt -95.23 140.43 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 157.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.6 t -126.35 113.89 17.5 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 53.5 mt -109.5 115.46 49.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -90.04 123.16 33.68 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 167.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -77.13 174.72 10.37 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.358 1.063 . . . . 0.0 109.912 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 p -61.01 -52.48 64.82 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.334 -0.854 . . . . 0.0 109.263 171.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -66.4 153.85 41.66 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 127.101 2.16 . . . . 0.0 107.761 169.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 94.1 p -86.51 45.98 1.3 Allowed 'General case' 0 C--O 1.237 0.408 0 O-C-N 121.71 -0.619 . . . . 0.0 111.62 -152.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.2 mt -122.17 133.79 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 -171.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -126.99 111.84 14.55 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -174.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.401 ' HE2' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -103.06 138.67 39.61 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -178.332 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.7 mp -115.97 135.85 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 -175.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.401 ' CE1' ' HE2' ' A' ' 24' ' ' LYS . 69.5 m-85 -122.99 90.77 3.35 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 103.438 -2.801 . . . . 0.0 103.438 -168.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -116.62 -16.67 10.71 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.697 1.599 . . . . 0.0 110.369 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.53 136.37 56.31 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.34 1.856 . . . . 0.0 106.475 170.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.8 t -55.88 -44.05 77.79 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 120.014 1.279 . . . . 0.0 111.821 -171.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -68.99 -32.02 71.29 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.95 0.9 . . . . 0.0 110.995 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 p -61.5 -45.98 91.93 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 70.3 mt -65.0 -53.61 39.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.563 1.545 . . . . 0.0 109.042 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -48.84 -51.68 28.26 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.044 0.838 . . . . 0.0 113.045 -168.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.2 -42.38 86.04 Favored 'General case' 0 C--O 1.227 -0.1 0 C-N-CA 123.771 0.828 . . . . 0.0 111.568 -175.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.6 mt -62.3 -51.52 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -177.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 mt -59.19 -26.9 65.21 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.728 1.149 . . . . 0.0 110.913 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.38 -69.03 0.2 Allowed 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.502 1.121 . . . . 0.0 109.22 171.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -75.69 -16.78 60.12 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -171.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.8 mm -67.09 -39.86 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 O-C-N 119.929 -1.732 . . . . 0.0 109.127 171.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.13 3.02 53.25 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 120.73 -1.231 . . . . 0.0 113.907 -171.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.1 p -73.21 -45.87 53.74 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.153 173.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.13 145.22 48.54 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 123.989 0.804 . . . . 0.0 111.615 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -123.11 106.03 10.44 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 -166.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.6 ppt_? -62.72 -13.01 27.56 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 174.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.1 p 65.46 -174.85 0.18 Allowed 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 127.61 2.364 . . . . 0.0 110.436 177.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -69.89 -11.99 61.29 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 119.287 -2.133 . . . . 0.0 112.946 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -63.17 166.48 6.02 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.084 1.353 . . . . 0.0 112.135 -174.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.57 122.72 38.36 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.732 1.613 . . . . 0.0 110.731 176.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.7 t -70.46 160.37 32.51 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 127.443 2.297 . . . . 0.0 107.817 163.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.7 pt -144.6 22.88 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 126.912 2.085 . . . . 0.0 110.45 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -114.32 164.36 14.02 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 120.805 -1.184 . . . . 0.0 108.612 175.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -111.28 -20.62 12.23 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.261 175.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -143.23 160.01 53.55 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-N 119.483 1.038 . . . . 0.0 109.807 -168.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.95 171.87 15.77 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.711 2.941 . . . . 0.0 113.031 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.4 p -119.56 -15.73 8.96 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.575 1.55 . . . . 0.0 112.768 -177.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.9 159.4 33.78 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.932 0.787 . . . . 0.0 110.211 171.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -84.77 -28.31 26.28 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.381 0.672 . . . . 0.0 111.143 172.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -115.05 100.77 8.42 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -134.35 168.26 19.22 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 127.94 2.496 . . . . 0.0 106.278 171.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.52 175.1 15.7 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 169.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -107.99 142.31 38.32 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.471 1.109 . . . . 0.0 108.109 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.7 mt -113.12 133.82 57.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 158.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -128.78 144.23 51.12 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 171.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.5 mt -124.57 90.69 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 174.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -66.05 109.58 2.62 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 171.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . 0.284 3.9 p30 -133.1 -152.2 0.48 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 126.97 2.108 . . . . 0.0 107.579 -174.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -46.04 50.21 0.0 OUTLIER 'General case' 0 C--O 1.24 0.575 1 C-N-CA 136.65 5.98 . . . . 0.0 114.551 -171.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.43 31.54 68.4 Favored Glycine 0 N--CA 1.437 -1.269 0 O-C-N 120.413 -1.429 . . . . 0.0 112.084 -171.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -164.04 171.28 39.57 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 117.454 0.627 . . . . 0.0 112.353 168.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 83.2 mtp -125.15 112.23 16.23 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.597 1.559 . . . . 0.0 108.283 -176.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.4 m -69.86 109.83 4.66 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 157.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.4 m -112.99 143.2 44.69 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 124.106 0.879 . . . . 0.0 109.338 171.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.3 ptp -151.95 170.97 18.55 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 127.449 2.3 . . . . 0.0 106.311 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -129.15 174.29 9.7 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.401 1.48 . . . . 0.0 108.03 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -156.39 140.98 16.88 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.591 0.756 . . . . 0.0 109.706 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -153.6 162.86 40.86 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.748 1.219 . . . . 0.0 110.835 172.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -79.26 134.89 36.64 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 172.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -131.41 114.87 15.48 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 122.017 0.913 . . . . 0.0 110.038 171.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.02 -7.7 0.61 Allowed 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.953 2.501 . . . . 0.0 114.941 171.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.96 -6.09 5.1 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 117.635 -1.647 . . . . 0.0 113.449 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.28 166.31 10.62 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 120.454 2.127 . . . . 0.0 109.072 164.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -112.51 152.79 28.39 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -145.02 172.24 13.34 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 122.537 0.335 . . . . 0.0 110.179 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.3 mp -131.11 140.35 48.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 124.497 1.119 . . . . 0.0 109.21 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.88 165.15 25.41 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.833 1.653 . . . . 0.0 112.174 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -179.98 168.97 0.7 Allowed Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 127.82 2.448 . . . . 0.0 107.499 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -56.61 -162.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.799 2.332 . . . . 0.0 109.419 153.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -44.06 -8.26 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.994 2.518 . . . . 0.0 117.386 -169.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -98.71 15.65 24.59 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 120.173 -1.58 . . . . 0.0 114.27 168.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -88.91 65.7 3.21 Favored Glycine 0 C--O 1.226 -0.36 0 CA-C-N 120.608 1.549 . . . . 0.0 113.786 -174.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.4 mt -140.62 41.87 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 171.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -70.27 102.71 2.19 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 174.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -74.35 127.39 32.89 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 164.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.5 pt -114.28 159.67 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 157.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -108.47 5.27 25.11 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.336 -0.853 . . . . 0.0 112.349 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -133.92 157.02 47.06 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.041 0.936 . . . . 0.0 109.469 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -72.03 133.04 45.05 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.625 1.17 . . . . 0.0 110.118 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -74.03 -44.49 54.17 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.497 1.119 . . . . 0.0 113.459 -177.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -62.08 -29.68 70.48 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.258 1.39 . . . . 0.0 110.784 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -72.95 -15.6 61.56 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 125.877 1.671 . . . . 0.0 112.989 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 9.5 ptm -110.51 1.05 17.96 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.168 0.987 . . . . 0.0 113.091 -175.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 25.5 pt . . . . . 0 C--O 1.249 1.06 0 CA-C-N 119.018 0.826 . . . . 0.0 109.45 176.208 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.539 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p 51.84 165.74 0.04 OUTLIER Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 129.628 3.171 . . . . 0.0 116.496 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -67.05 169.89 14.13 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 124.388 3.392 . . . . 0.0 113.006 167.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.0 mm -94.22 91.89 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 167.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.1 152.24 39.35 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.222 176.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.525 ' HB2' HD22 ' A' ' 10' ' ' ASN . 74.5 Cg_endo -67.6 160.75 46.64 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.202 1.935 . . . . 0.0 110.602 171.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -60.05 168.8 1.74 Allowed 'General case' 0 C--N 1.344 0.335 0 C-N-CA 123.677 0.791 . . . . 0.0 112.028 174.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.03 -49.02 31.17 Favored 'General case' 0 C--O 1.219 -0.523 0 O-C-N 121.157 -0.964 . . . . 0.0 109.48 168.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -66.48 -14.79 62.73 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 -172.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.525 HD22 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -102.87 -2.74 27.32 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.037 0.935 . . . . 0.0 111.352 178.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.0 t -82.19 135.81 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.248 1.419 . . . . 0.0 107.3 170.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.83 -67.92 0.78 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 166.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.42 121.88 5.76 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.33 0.514 . . . . 0.0 110.429 -170.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.4 mt -82.27 131.22 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.7 t -107.5 139.61 41.75 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 168.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.0 mt -131.98 122.23 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 170.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -115.07 102.4 9.9 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 -173.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -63.04 171.68 2.13 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.373 0.669 . . . . 0.0 111.328 -170.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.4 p -52.43 -52.89 51.61 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.541 1.137 . . . . 0.0 109.976 168.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.05 162.6 25.78 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 126.877 2.071 . . . . 0.0 107.192 174.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 p -90.1 59.57 4.53 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 123.252 1.501 . . . . 0.0 108.896 -163.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.7 mt -124.66 142.96 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 102.502 -3.147 . . . . 0.0 102.502 176.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -140.96 143.33 34.47 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.69 122.36 23.29 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 176.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.9 mp -94.45 138.55 20.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 171.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -118.07 82.38 1.83 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 103.31 -2.848 . . . . 0.0 103.31 176.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -83.31 -19.1 36.87 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.55 1.14 . . . . 0.0 110.109 163.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.37 133.67 35.94 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.186 1.794 . . . . 0.0 109.093 -169.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.6 -55.83 17.01 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.306 1.042 . . . . 0.0 112.513 -176.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -68.58 -20.63 64.53 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.521 -0.737 . . . . 0.0 110.985 -174.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.4 m -80.12 -41.34 25.65 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.108 1.763 . . . . 0.0 110.826 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.4 mt -67.78 -45.93 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.951 1.7 . . . . 0.0 110.043 172.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.99 -24.63 67.15 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -171.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -64.29 -68.08 0.38 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 117.923 -1.037 . . . . 0.0 108.35 166.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 72.5 mt -44.85 -44.81 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 126.057 1.743 . . . . 0.0 112.039 -170.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.0 mt -54.37 -20.0 6.55 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.7 t -76.72 -58.36 3.33 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.322 2.249 . . . . 0.0 109.396 172.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.9 mp0 -63.34 -29.32 70.65 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.758 0.708 . . . . 0.0 110.896 -177.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.1 mm -61.95 -37.75 79.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 O-C-N 120.652 -1.28 . . . . 0.0 110.173 171.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.56 -10.6 26.87 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.681 1.192 . . . . 0.0 113.705 -171.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 t -62.6 -39.84 95.02 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.382 0.673 . . . . 0.0 110.829 -171.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.51 161.54 40.84 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-O 122.787 1.215 . . . . 0.0 112.316 -171.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -125.76 114.47 18.66 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -64.15 -9.28 15.79 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.753 1.621 . . . . 0.0 113.89 172.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 p 65.59 -172.9 0.18 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 128.407 2.683 . . . . 0.0 111.478 173.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -78.69 -2.2 38.09 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.164 1.786 . . . . 0.0 112.029 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -67.02 168.06 10.7 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 119.849 1.204 . . . . 0.0 109.816 172.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -120.25 156.4 31.28 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.42 1.088 . . . . 0.0 109.768 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.32 134.35 46.26 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -159.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.2 pt -133.88 28.32 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 118.958 0.799 . . . . 0.0 112.225 -164.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -147.99 166.32 28.08 Favored 'General case' 0 C--O 1.242 0.66 0 O-C-N 121.446 -0.783 . . . . 0.0 110.23 -175.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.03 -10.42 15.03 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.602 1.161 . . . . 0.0 111.926 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -143.97 159.53 52.87 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.233 1.013 . . . . 0.0 111.95 -170.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.34 178.45 7.0 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.291 3.328 . . . . 0.0 112.838 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.51 -16.66 12.37 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.503 1.521 . . . . 0.0 111.46 173.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.66 163.08 7.59 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 120.792 -1.192 . . . . 0.0 110.29 168.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -108.43 -15.28 14.49 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.206 1.403 . . . . 0.0 110.902 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -126.29 103.03 7.44 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.465 2.306 . . . . 0.0 106.815 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -150.06 162.39 40.49 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.954 2.102 . . . . 0.0 107.918 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -101.14 166.0 18.73 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 173.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.2 m -110.32 134.86 51.86 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 118.9 1.35 . . . . 0.0 108.482 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.9 mp -120.14 136.17 58.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -126.76 140.82 52.09 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 125.063 1.345 . . . . 0.0 108.9 172.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.4 mt -123.66 87.56 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 172.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -58.84 106.73 0.44 Allowed 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.303 1.041 . . . . 0.0 108.648 165.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -139.96 133.9 30.78 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.946 1.698 . . . . 0.0 109.654 175.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 52.62 28.12 5.84 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.894 1.678 . . . . 0.0 111.978 -176.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.07 13.43 69.85 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.074 1.321 . . . . 0.0 113.813 -176.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -107.58 170.35 15.4 Favored Glycine 0 C--N 1.334 0.418 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 163.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.27 136.4 27.98 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 118.707 1.253 . . . . 0.0 113.172 168.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.2 t -75.93 161.27 29.09 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 168.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.5 m -135.92 142.0 44.6 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.669 1.188 . . . . 0.0 108.164 169.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -153.43 171.51 18.55 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.794 1.638 . . . . 0.0 109.169 170.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -140.56 148.35 40.86 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.385 2.274 . . . . 0.0 106.3 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.487 ' CD1' HG13 ' A' ' 84' ' ' ILE . 1.5 m-85 -128.27 158.37 38.35 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.904 1.229 . . . . 0.0 109.51 177.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -159.53 175.51 13.18 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.892 0.877 . . . . 0.0 111.49 -178.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -102.98 144.08 31.72 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.56 1.544 . . . . 0.0 109.497 165.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -148.61 119.4 7.56 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.846 1.259 . . . . 0.0 108.719 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 62.67 -0.17 0.58 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.8 2.04 . . . . 0.0 115.237 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.94 8.43 17.88 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.754 1.169 . . . . 0.0 113.026 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.63 156.68 24.27 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 120.257 2.028 . . . . 0.0 108.821 164.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -96.79 152.45 18.67 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 168.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -139.84 167.58 21.79 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.751 0.82 . . . . 0.0 110.911 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.487 HG13 ' CD1' ' A' ' 75' ' ' TYR . 3.3 mp -123.77 128.13 74.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 125.367 1.467 . . . . 0.0 108.592 172.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -81.25 151.21 28.22 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.611 1.564 . . . . 0.0 109.213 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -176.2 166.26 1.66 Allowed Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.311 1.844 . . . . 0.0 107.638 -177.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -59.62 -161.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.762 1 C-N-CA 126.495 4.797 . . . . 0.0 110.417 172.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -42.82 -12.65 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.458 2.303 . . . . 0.0 115.86 -172.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.68 68.72 0.72 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 120.215 1.371 . . . . 0.0 112.121 161.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -140.83 67.4 0.49 Allowed Glycine 0 C--O 1.222 -0.622 0 CA-C-N 119.78 1.173 . . . . 0.0 115.287 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.6 mt -141.59 47.24 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.711 1.205 . . . . 0.0 107.846 173.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -72.23 103.85 3.49 Favored 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 120.668 -1.27 . . . . 0.0 108.267 -175.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -69.2 125.63 27.26 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 164.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 21.7 pt -119.69 175.29 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.913 1.285 . . . . 0.0 108.63 159.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -117.45 2.14 12.41 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.632 0.773 . . . . 0.0 112.096 -175.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -139.35 157.48 45.81 Favored 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 120.752 -1.217 . . . . 0.0 108.768 -168.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -80.9 114.35 19.72 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -52.77 -45.05 66.96 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.791 1.236 . . . . 0.0 110.887 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -75.33 -7.46 54.04 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -167.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -106.91 -16.87 14.35 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.172 0.989 . . . . 0.0 111.813 166.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 66.2 mmm -70.86 -37.65 73.09 Favored 'General case' 0 C--O 1.239 0.51 0 O-C-N 120.345 -1.472 . . . . 0.0 109.255 169.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.9 pt . . . . . 0 C--O 1.25 1.084 0 O-C-N 121.564 -0.71 . . . . 0.0 109.825 168.666 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.428 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.7 m -136.01 167.57 21.31 Favored Pre-proline 0 C--O 1.24 0.555 0 C-N-CA 126.835 2.054 . . . . 0.0 109.01 -174.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -52.48 167.09 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-O 122.603 1.001 . . . . 0.0 112.248 152.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.1 mt -111.61 109.41 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -107.03 162.53 19.38 Favored Pre-proline 0 C--O 1.243 0.714 0 C-N-CA 123.276 0.63 . . . . 0.0 110.361 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.516 ' HB2' HD22 ' A' ' 10' ' ' ASN . 37.3 Cg_endo -61.85 174.69 2.19 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.192 1.928 . . . . 0.0 111.61 164.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.55 169.1 1.88 Allowed 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.427 -0.796 . . . . 0.0 109.068 165.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.9 -60.32 2.31 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 153.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.37 -14.95 63.39 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -160.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.516 HD22 ' HB2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -89.45 1.2 56.18 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 120.086 1.312 . . . . 0.0 113.46 175.182 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.0 t -78.14 143.19 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.82 -62.95 1.49 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 168.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.3 p -152.47 171.22 18.41 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.45 1.1 . . . . 0.0 109.62 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.5 mt -124.23 142.21 41.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 170.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.1 t -122.71 142.98 50.11 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 165.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.1 mt -130.97 104.28 9.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 104.142 -2.54 . . . . 0.0 104.142 173.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -87.61 113.09 22.97 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 172.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -67.27 177.9 1.69 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.897 1.679 . . . . 0.0 111.033 -173.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.68 -50.77 67.43 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.712 -1.242 . . . . 0.0 111.031 171.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -76.85 160.99 28.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 127.844 2.458 . . . . 0.0 108.085 173.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 p -88.22 61.11 6.08 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 123.032 1.396 . . . . 0.0 109.062 -164.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.8 mt -140.09 139.79 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 102.335 -3.209 . . . . 0.0 102.335 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.16 157.58 41.39 Favored 'General case' 0 N--CA 1.414 -2.255 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.447 ' HE2' ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -130.04 130.26 44.7 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 175.516 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.6 mt -106.16 134.92 46.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.447 ' CE2' ' HE2' ' A' ' 24' ' ' LYS . 23.3 m-85 -115.96 97.42 6.08 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 -175.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -123.63 11.53 9.17 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 128.324 2.65 . . . . 0.0 110.556 -176.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -103.8 141.03 36.82 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 166.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.8 t -55.85 -47.68 76.85 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.128 0.971 . . . . 0.0 110.654 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -59.47 -46.29 89.21 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.896 0.878 . . . . 0.0 110.939 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.2 m -61.07 -36.55 79.91 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.354 1.462 . . . . 0.0 111.906 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 74.7 mt -66.99 -55.66 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 172.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -57.79 -32.79 67.87 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.198 0.908 . . . . 0.0 112.75 -175.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.53 -49.18 62.47 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.684 1.594 . . . . 0.0 109.346 175.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.2 mt -68.76 -51.89 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 117.602 -1.19 . . . . 0.0 110.785 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.92 -26.61 15.53 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.39 1.45 . . . . 0.0 112.469 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.97 -69.46 0.32 Allowed 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 125.688 1.595 . . . . 0.0 111.145 170.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -69.09 -7.07 32.54 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.602 1.092 . . . . 0.0 113.135 -173.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.6 mm -83.57 -29.64 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 O-C-N 120.197 -1.564 . . . . 0.0 111.046 168.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.8 -12.75 35.47 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 119.411 1.005 . . . . 0.0 113.184 -173.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.8 p -69.01 -41.4 77.82 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.737 1.615 . . . . 0.0 110.791 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.34 138.6 41.08 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt -116.94 111.69 19.97 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -175.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -61.6 -4.18 1.3 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 173.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p 58.99 -174.07 0.1 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.309 2.244 . . . . 0.0 109.693 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -89.96 5.07 48.04 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.178 -0.951 . . . . 0.0 112.339 174.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -65.96 171.29 4.6 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.33 1.052 . . . . 0.0 110.323 167.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -126.13 131.86 51.97 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.716 1.207 . . . . 0.0 110.821 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.1 m -80.57 158.13 25.84 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.483 0.713 . . . . 0.0 109.098 170.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.0 pt -141.75 32.47 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 125.813 1.645 . . . . 0.0 110.699 175.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -141.52 167.66 21.63 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.721 2.009 . . . . 0.0 107.876 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -121.53 -4.69 9.3 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.817 1.247 . . . . 0.0 111.155 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -149.53 156.48 39.18 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 125.835 1.654 . . . . 0.0 110.169 -170.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.07 176.38 9.61 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.27 3.313 . . . . 0.0 112.529 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.99 1.79 6.56 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.863 1.665 . . . . 0.0 112.245 177.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.21 149.08 43.15 Favored 'General case' 0 C--N 1.338 0.103 0 O-C-N 120.621 -1.299 . . . . 0.0 109.848 168.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.01 -31.8 44.84 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 122.564 0.346 . . . . 0.0 111.175 169.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -114.24 104.59 12.24 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.454 1.502 . . . . 0.0 107.442 -173.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -138.46 173.95 11.06 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.886 2.074 . . . . 0.0 109.623 176.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.08 165.68 12.74 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 164.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.8 m -123.37 127.55 48.63 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.415 1.086 . . . . 0.0 108.906 -166.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mp -123.72 110.82 26.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 124.909 1.284 . . . . 0.0 109.603 -166.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 58.9 m-20 -119.03 122.03 41.23 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.566 1.146 . . . . 0.0 108.763 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 74.3 mt -107.19 96.9 5.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 171.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.64 118.05 11.15 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 172.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -146.0 125.94 13.62 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.606 1.163 . . . . 0.0 110.027 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 54.53 41.83 31.7 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.035 1.734 . . . . 0.0 111.83 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.82 3.87 56.67 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.213 0.911 . . . . 0.0 114.394 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -118.95 -173.53 15.67 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 169.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -147.16 166.14 27.86 Favored 'General case' 0 CA--C 1.517 -0.296 0 O-C-N 121.68 -0.894 . . . . 0.0 111.242 172.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.0 m -106.34 133.44 51.03 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 157.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 m -106.92 145.49 32.16 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.6 ptp -154.88 174.67 14.79 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.763 1.225 . . . . 0.0 108.429 160.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.553 ' H ' ' HG3' ' A' ' 85' ' ' GLU . 34.4 m-85 -135.97 164.8 27.13 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 128.196 2.598 . . . . 0.0 106.768 174.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -134.47 156.29 48.86 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.958 1.303 . . . . 0.0 108.146 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -159.4 179.95 8.49 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 118.709 0.686 . . . . 0.0 110.34 169.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -101.62 133.08 46.88 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.942 1.697 . . . . 0.0 107.642 175.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -133.59 111.28 10.52 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.08 0.943 . . . . 0.0 109.556 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.85 -1.08 2.14 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.641 1.976 . . . . 0.0 114.111 174.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.7 -14.76 6.36 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.123 1.344 . . . . 0.0 113.547 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.78 169.71 9.82 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 120.143 1.971 . . . . 0.0 108.651 164.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -109.85 155.55 21.52 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 171.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -144.12 172.65 12.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -122.13 143.36 35.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 C-N-CA 125.266 1.426 . . . . 0.0 107.486 172.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.553 ' HG3' ' H ' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -85.41 173.75 10.04 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.018 1.327 . . . . 0.0 110.029 179.204 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 176.84 168.56 0.43 Allowed Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 128.756 2.822 . . . . 0.0 106.728 175.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 89' ' ' LYS . 93.9 Cg_endo -54.13 -160.59 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.328 1 C-N-CA 125.306 4.004 . . . . 0.0 109.639 157.731 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -42.83 -4.99 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 129.245 3.018 . . . . 0.0 117.176 -171.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 87' ' ' PRO . 5.5 ptpt -119.5 25.44 10.06 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 129.281 3.032 . . . . 0.0 115.249 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -115.14 61.23 0.38 Allowed Glycine 0 C--N 1.32 -0.331 0 N-CA-C 116.776 1.47 . . . . 0.0 116.776 -167.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.0 mt -131.58 42.69 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 117.716 0.758 . . . . 0.0 110.045 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -76.43 104.7 7.08 Favored 'General case' 0 C--O 1.222 -0.374 0 O-C-N 120.691 -1.256 . . . . 0.0 110.716 -173.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -68.81 122.88 19.51 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 165.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.5 pt -111.5 -172.61 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 126.463 1.905 . . . . 0.0 108.381 160.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -100.16 -44.61 5.91 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -147.1 176.26 10.08 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.803 1.241 . . . . 0.0 108.898 -172.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -61.8 116.6 4.96 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 118.552 0.614 . . . . 0.0 111.271 -172.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -52.78 -35.5 56.73 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.617 1.967 . . . . 0.0 112.477 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -68.06 -13.29 62.08 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 119.873 -1.767 . . . . 0.0 113.189 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -95.03 -18.6 20.89 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.64 0.776 . . . . 0.0 111.888 174.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 21.6 ptp -91.76 -10.92 38.23 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.224 0.92 . . . . 0.0 112.963 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 29.8 pt . . . . . 0 C--O 1.252 1.225 0 C-N-CA 124.593 1.157 . . . . 0.0 112.136 -179.634 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.664 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.3 p 67.7 164.94 0.13 Allowed Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 129.534 3.133 . . . . 0.0 112.974 -175.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -70.62 172.65 13.07 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.331 2.021 . . . . 0.0 113.095 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.0 mt -112.51 121.39 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 175.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.88 164.26 40.77 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 126.864 2.066 . . . . 0.0 111.544 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.479 ' HB2' HD22 ' A' ' 10' ' ' ASN . 18.9 Cg_endo -59.12 161.43 16.17 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 123.919 3.08 . . . . 0.0 113.693 175.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -59.38 156.07 13.56 Favored 'General case' 0 C--N 1.347 0.468 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 172.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.67 -34.27 77.83 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 121.331 -0.855 . . . . 0.0 109.124 165.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -80.09 -25.4 40.02 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 118.669 -1.213 . . . . 0.0 112.33 -165.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.479 HD22 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -86.31 -0.47 55.93 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.323 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 26.9 t -69.98 138.59 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 176.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -76.39 -67.35 0.7 Allowed 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 166.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 p -157.85 149.47 21.71 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.408 0.549 . . . . 0.0 111.14 164.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.2 mt -85.53 141.02 15.08 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 169.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.5 t -126.66 130.16 49.88 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 167.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.7 mt -120.32 109.08 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.43 120.51 27.85 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 173.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -68.47 173.15 5.22 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.22 1.008 . . . . 0.0 109.998 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.51 -52.11 65.98 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 121.23 -0.919 . . . . 0.0 109.752 169.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.28 169.69 15.69 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 173.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.5 p -71.66 24.7 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 129.291 3.036 . . . . 0.0 115.92 -157.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.9 mt -135.14 149.72 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 129.4 3.08 . . . . 0.0 105.781 -159.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.81 164.93 21.98 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 126.573 1.949 . . . . 0.0 109.485 175.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.403 ' HE2' ' CE1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -128.98 143.79 50.98 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 162.087 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.7 mp -114.92 130.68 68.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.403 ' CE1' ' HE2' ' A' ' 24' ' ' LYS . 3.9 m-85 -116.14 79.39 1.3 Allowed 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 103.994 -2.595 . . . . 0.0 103.994 -174.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -85.23 -17.17 37.84 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.612 1.165 . . . . 0.0 110.235 161.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.9 125.09 24.85 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -176.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.8 t -51.97 -49.57 62.96 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.872 0.869 . . . . 0.0 111.527 -172.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -75.4 -16.13 60.39 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.114 -0.991 . . . . 0.0 112.257 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.7 m -79.63 -39.24 31.97 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.453 1.901 . . . . 0.0 110.357 171.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 93.4 mt -63.33 -53.8 41.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 169.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -60.0 -32.74 71.14 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.731 1.212 . . . . 0.0 112.25 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.8 tptt -60.79 -64.97 0.77 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 119.441 1.019 . . . . 0.0 109.642 167.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 82.2 mt -53.91 -46.71 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 119.177 -0.439 . . . . 0.0 110.985 -171.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.37 -22.95 55.51 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -177.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.86 -55.7 10.26 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.255 0.934 . . . . 0.0 109.614 167.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -73.75 -16.74 61.16 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -171.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.1 mm -68.37 -21.29 26.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.829 1.652 . . . . 0.0 110.195 168.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -118.88 8.68 11.77 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.114 1.366 . . . . 0.0 113.186 -168.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.2 t -80.05 -42.2 24.18 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.221 0.464 . . . . 0.0 110.921 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.15 169.35 54.67 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 127.181 2.324 . . . . 0.0 113.766 -166.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -127.01 102.59 7.05 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -171.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.76 -13.65 61.67 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.807 1.243 . . . . 0.0 113.985 168.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 65.38 -172.82 0.18 Allowed 'General case' 0 CA--C 1.547 0.829 0 O-C-N 125.506 1.754 . . . . 0.0 110.283 173.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -83.27 0.59 44.93 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 120.242 -1.536 . . . . 0.0 113.869 172.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.0 mmmt -60.52 165.14 3.93 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 122.207 1.004 . . . . 0.0 112.111 -177.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -99.88 128.47 45.97 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 124.586 1.155 . . . . 0.0 108.332 -175.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.02 51.04 1.22 Allowed 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 123.914 0.886 . . . . 0.0 109.674 -170.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.7 pt -68.11 5.66 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 126.718 2.007 . . . . 0.0 113.532 -172.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -70.98 165.1 24.16 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 126.056 1.742 . . . . 0.0 110.697 166.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -124.48 -9.78 7.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.154 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -145.4 161.08 43.01 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 124.626 1.17 . . . . 0.0 111.367 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.429 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 18.9 Cg_endo -68.35 170.85 13.9 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 124.433 3.422 . . . . 0.0 111.681 171.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 98.8 p -99.33 -16.27 18.51 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.381 0.672 . . . . 0.0 112.499 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.03 146.24 39.61 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 121.46 -0.775 . . . . 0.0 109.418 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -81.81 -16.41 50.98 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 119.339 -0.362 . . . . 0.0 111.881 172.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -131.05 102.16 5.91 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.199 1.399 . . . . 0.0 108.937 -174.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.429 ' CE2' ' HG2' ' A' ' 54' ' ' PRO . 43.5 p90 -134.0 175.22 9.67 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 126.343 1.857 . . . . 0.0 108.708 176.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.74 -167.54 11.31 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 169.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.92 141.11 49.24 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.571 1.148 . . . . 0.0 109.321 -148.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.9 mt -115.23 136.0 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 160.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -127.81 130.2 48.26 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 171.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.9 mt -117.84 92.29 2.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 170.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -70.72 124.31 23.98 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 172.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -156.5 134.58 11.21 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.342 1.457 . . . . 0.0 108.99 -177.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 54.01 27.59 7.65 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.512 1.525 . . . . 0.0 113.321 173.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.43 13.11 63.96 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 119.571 1.078 . . . . 0.0 114.414 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -142.54 171.51 24.71 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 119.448 1.624 . . . . 0.0 110.293 176.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 31.5 mtm -131.84 126.96 35.57 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.284 1.034 . . . . 0.0 110.318 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 53.8 m -80.64 113.49 18.87 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 156.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.42 152.91 25.94 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 124.337 1.023 . . . . 0.0 108.378 163.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.5 ptp -155.19 163.92 39.54 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.059 1.744 . . . . 0.0 107.639 154.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -119.87 172.67 7.55 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.799 1.24 . . . . 0.0 109.725 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -147.16 157.69 43.69 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.31 1.844 . . . . 0.0 108.449 175.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -157.38 -164.51 1.59 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.77 1.628 . . . . 0.0 108.859 171.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -122.91 124.3 42.9 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.648 1.179 . . . . 0.0 108.214 169.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -113.52 117.43 31.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.688 0.756 . . . . 0.0 109.576 173.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 64.81 -0.75 0.93 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.018 2.127 . . . . 0.0 114.595 175.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 123.99 -17.51 7.61 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 125.586 1.565 . . . . 0.0 112.77 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -90.32 157.45 17.64 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 120.278 2.039 . . . . 0.0 109.656 169.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -101.31 143.29 31.55 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.35 1.06 . . . . 0.0 108.537 174.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -139.78 169.36 17.87 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.936 0.495 . . . . 0.0 110.208 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.1 mp -127.38 121.27 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.871 0.868 . . . . 0.0 110.782 -176.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -66.49 157.72 31.41 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.459 -1.4 . . . . 0.0 110.733 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -175.31 167.9 1.75 Allowed Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 128.592 2.757 . . . . 0.0 105.416 -172.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' A' ' 89' ' ' LYS . 66.3 Cg_endo -57.86 -160.97 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.448 0 C-N-CA 124.479 3.453 . . . . 0.0 109.657 160.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -42.68 0.75 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 130.221 3.408 . . . . 0.0 117.397 -175.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 87' ' ' PRO . 0.8 OUTLIER -124.58 30.92 5.84 Favored 'General case' 0 N--CA 1.44 -0.947 1 C-N-CA 132.117 4.167 . . . . 0.0 113.763 176.581 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -109.26 61.03 0.31 Allowed Glycine 0 C--O 1.23 -0.148 0 C-N-CA 124.858 1.218 . . . . 0.0 115.41 -176.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.4 mt -136.69 44.73 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.536 1.135 . . . . 0.0 108.101 171.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -68.87 108.11 3.34 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 175.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -75.04 130.74 39.83 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 159.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.0 pt -112.25 167.15 5.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 151.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -121.98 17.19 10.9 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.128 0.971 . . . . 0.0 112.407 -172.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -153.62 168.32 26.59 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 122.855 0.462 . . . . 0.0 110.872 165.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -67.01 118.49 10.54 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.713 0.805 . . . . 0.0 110.729 -173.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -56.39 -47.02 79.81 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.97 0.908 . . . . 0.0 110.444 173.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -66.95 -26.42 66.82 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.332 0.653 . . . . 0.0 112.514 -170.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.2 20.02 19.58 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 118.407 0.549 . . . . 0.0 112.066 173.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 16.6 ptt? -108.29 -37.3 6.04 Favored 'General case' 0 C--N 1.342 0.256 0 O-C-N 121.437 -0.789 . . . . 0.0 112.648 160.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.996 0 C-N-CA 124.137 0.975 . . . . 0.0 112.007 -174.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.043 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.8 p 55.61 165.91 0.06 OUTLIER Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 126.818 2.047 . . . . 0.0 113.666 -167.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -61.39 175.92 1.36 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.578 1.519 . . . . 0.0 111.889 165.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.4 mt -111.67 108.28 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.26 156.44 63.4 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 126.283 1.833 . . . . 0.0 110.984 -171.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.561 ' HB2' HD22 ' A' ' 10' ' ' ASN . 91.4 Cg_endo -74.15 162.18 39.28 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.732 2.954 . . . . 0.0 112.488 -178.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.0 mtmt -63.04 142.57 58.33 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 119.076 0.853 . . . . 0.0 111.269 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.12 -14.81 18.83 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -94.57 -31.3 13.95 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.831 1.196 . . . . 0.0 112.752 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.561 HD22 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -88.45 -6.07 57.87 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.47 1.032 . . . . 0.0 111.525 -174.068 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.5 t -62.48 116.36 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 C-N-CA 128.336 2.654 . . . . 0.0 107.682 160.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -71.11 -67.68 0.49 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.715 1.606 . . . . 0.0 106.784 165.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.6 p -153.91 160.23 42.05 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.936 0.789 . . . . 0.0 110.495 -177.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.3 mt -125.84 125.77 68.86 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 -176.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.4 t -108.49 132.83 53.42 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.9 mt -133.35 97.03 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.98 115.68 18.81 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 164.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -68.29 -178.46 1.08 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.542 1.537 . . . . 0.0 109.994 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.9 p -59.19 -45.89 89.88 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.972 -1.08 . . . . 0.0 112.189 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -74.3 -174.0 1.86 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.546 1.139 . . . . 0.0 110.22 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 98.4 p -67.32 5.03 0.81 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.282 1.833 . . . . 0.0 114.76 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.1 mm -113.15 153.89 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 128.144 2.578 . . . . 0.0 108.606 -159.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -143.16 162.76 34.72 Favored 'General case' 0 N--CA 1.418 -2.073 0 C-N-CA 125.968 1.707 . . . . 0.0 110.587 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.11 142.16 44.24 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 125.129 1.371 . . . . 0.0 107.358 164.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.3 mp -109.66 138.17 38.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 170.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -111.96 108.94 18.45 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 103.166 -2.901 . . . . 0.0 103.166 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -135.9 41.3 2.69 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 126.472 1.909 . . . . 0.0 106.183 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.94 123.44 17.16 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 103.614 -2.736 . . . . 0.0 103.614 -170.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.6 t -53.76 -39.6 65.49 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.684 0.794 . . . . 0.0 112.009 -171.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -77.67 -33.76 53.23 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.084 -1.01 . . . . 0.0 111.297 -177.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.2 m -57.94 -41.32 82.53 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.139 1.376 . . . . 0.0 110.491 168.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.4 mt -67.15 -54.58 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 124.716 1.206 . . . . 0.0 109.072 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -51.29 -41.76 60.69 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.131 0.572 . . . . 0.0 111.335 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -57.84 11.08 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 57.4 mt -54.68 -49.8 64.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 C-N-CA 123.392 0.677 . . . . 0.0 112.111 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.11 -17.91 30.77 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.804 0.842 . . . . 0.0 112.169 -171.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.65 -61.18 2.1 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.497 1.119 . . . . 0.0 110.913 166.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -67.24 -30.53 70.47 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.01 1.277 . . . . 0.0 111.545 -174.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.8 mm -54.87 -24.74 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.396 0.678 . . . . 0.0 110.05 172.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.19 3.64 13.49 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.139 1.776 . . . . 0.0 113.908 -174.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 t -79.4 -29.69 42.13 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.654 1.115 . . . . 0.0 111.276 -172.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.33 166.14 41.77 Favored Glycine 0 C--N 1.336 0.574 0 O-C-N 120.755 -1.215 . . . . 0.0 112.539 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -126.62 121.47 32.28 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -63.34 -3.42 1.96 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.579 1.152 . . . . 0.0 114.063 172.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p 58.04 -174.16 0.08 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 127.457 2.303 . . . . 0.0 110.761 -177.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -86.58 3.52 44.03 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.059 1.343 . . . . 0.0 111.59 176.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -69.22 164.94 21.56 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.87 1.214 . . . . 0.0 109.488 169.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -114.57 157.52 22.91 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.116 1.366 . . . . 0.0 108.182 174.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.53 150.04 50.35 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 -163.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.8 pt -145.83 17.6 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 122.457 0.303 . . . . 0.0 111.482 -163.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -131.61 167.4 19.5 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.389 1.076 . . . . 0.0 109.24 -171.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.22 -5.57 9.43 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.842 1.257 . . . . 0.0 112.334 -177.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -144.5 164.14 30.12 Favored Pre-proline 0 C--O 1.235 0.319 0 C-N-CA 126.011 1.724 . . . . 0.0 108.624 -174.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -70.69 -179.89 3.68 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.373 2.049 . . . . 0.0 110.803 174.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.0 p -110.34 -8.44 14.71 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.835 1.254 . . . . 0.0 111.911 175.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.86 159.45 20.37 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 124.266 1.026 . . . . 0.0 111.343 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -94.87 -13.6 25.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.255 1.022 . . . . 0.0 112.1 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -128.34 110.8 12.69 Favored 'General case' 0 C--O 1.231 0.083 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 175.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -147.32 160.75 42.15 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.59 1.556 . . . . 0.0 108.942 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.93 170.64 20.08 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.842 1.21 . . . . 0.0 110.315 171.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.3 m -131.98 121.1 23.39 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.031 1.732 . . . . 0.0 108.572 -163.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.2 mp -124.75 127.29 72.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 124.052 0.941 . . . . 0.0 109.266 -166.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -120.05 145.83 46.48 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 124.927 1.291 . . . . 0.0 109.244 171.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 30.5 mt -125.24 88.34 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -71.82 108.4 5.09 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.963 1.305 . . . . 0.0 108.041 177.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -137.34 134.24 35.8 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.515 1.126 . . . . 0.0 109.264 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 62.84 -3.32 0.32 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.283 1.833 . . . . 0.0 115.861 173.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.77 10.82 8.94 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 120.163 1.347 . . . . 0.0 113.692 -174.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -149.22 -178.6 24.38 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.59 145.32 24.3 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 118.653 1.227 . . . . 0.0 113.065 -173.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 t -73.72 166.09 23.93 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 162.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.8 m -142.47 142.66 32.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 163.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 17.2 ptp -156.0 169.62 24.04 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.795 2.038 . . . . 0.0 108.391 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.405 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 54.8 m-85 -139.16 148.87 43.76 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.477 1.911 . . . . 0.0 108.077 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -127.94 151.77 48.7 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.921 1.237 . . . . 0.0 110.155 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -156.99 177.77 11.13 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.033 1.333 . . . . 0.0 110.001 -171.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -107.83 147.78 30.43 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.165 1.386 . . . . 0.0 107.843 167.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.5 tp10 -142.28 117.4 10.06 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.685 0.794 . . . . 0.0 109.383 171.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 61.77 -11.95 0.06 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 127.999 2.519 . . . . 0.0 115.612 -176.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.7 2.35 3.96 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 117.76 -1.578 . . . . 0.0 115.555 -177.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -110.17 160.39 16.53 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 121.018 2.409 . . . . 0.0 109.274 159.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -97.48 145.74 25.91 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -140.36 162.43 35.33 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.883 0.873 . . . . 0.0 110.622 -174.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mp -133.08 132.29 58.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.802 1.241 . . . . 0.0 109.508 -169.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.405 ' HB3' ' H ' ' A' ' 74' ' ' PHE . 5.3 tm-20 -77.36 154.41 32.8 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.846 2.058 . . . . 0.0 110.624 177.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -173.22 167.97 2.61 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 129.276 3.03 . . . . 0.0 106.415 174.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.452 ' C ' ' H ' ' A' ' 89' ' ' LYS . 90.9 Cg_endo -54.12 -162.02 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 125.215 3.943 . . . . 0.0 110.239 162.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -43.35 -5.69 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 128.284 2.634 . . . . 0.0 116.529 -175.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.452 ' H ' ' C ' ' A' ' 87' ' ' PRO . 9.2 mmtt -120.97 52.09 1.21 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.686 1.994 . . . . 0.0 111.776 171.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -129.14 59.39 0.69 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 116.719 1.448 . . . . 0.0 116.719 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.7 mt -130.19 55.18 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 118.649 1.224 . . . . 0.0 108.131 171.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -76.32 119.14 19.79 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 177.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -87.91 113.53 23.65 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 163.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 27.9 pt -98.91 171.15 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 158.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -122.78 -13.82 7.82 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.925 -0.484 . . . . 0.0 112.032 -173.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -123.53 150.22 44.27 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 173.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -70.12 128.44 36.29 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 123.926 0.89 . . . . 0.0 109.974 -172.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -60.89 -46.13 91.84 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.665 1.186 . . . . 0.0 111.402 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -64.91 -29.48 70.43 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.945 0.898 . . . . 0.0 111.504 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -78.97 -18.94 52.86 Favored 'General case' 0 C--O 1.24 0.594 0 O-C-N 121.683 -0.636 . . . . 0.0 112.471 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 19.9 mmt -85.29 -27.29 26.07 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.233 1.013 . . . . 0.0 111.468 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 28.2 pt . . . . . 0 C--O 1.251 1.181 0 CA-C-N 119.681 1.128 . . . . 0.0 111.601 -174.289 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.592 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 p -57.98 164.22 3.55 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 125.658 1.583 . . . . 0.0 111.704 171.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -65.95 -178.4 1.03 Allowed 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 124.528 3.485 . . . . 0.0 113.875 168.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.0 mt -106.94 122.5 61.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 164.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.28 166.12 11.62 Favored Pre-proline 0 C--O 1.238 0.495 0 C-N-CA 125.669 1.588 . . . . 0.0 109.641 168.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.464 ' HB2' HD22 ' A' ' 10' ' ' ASN . 73.1 Cg_endo -62.88 -176.84 0.28 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 121.702 1.601 . . . . 0.0 111.124 167.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -55.8 169.44 0.35 Allowed 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.092 -1.005 . . . . 0.0 108.88 159.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.71 -49.96 9.85 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 161.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -66.8 -22.89 66.01 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -167.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.464 HD22 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -79.27 -3.21 44.91 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.316 0.962 . . . . 0.0 113.356 175.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.44 ' N ' HD21 ' A' ' 10' ' ' ASN . 17.0 t -85.5 122.6 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -70.48 -54.62 11.51 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.122 1.769 . . . . 0.0 108.121 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.7 p -157.22 155.93 31.7 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.183 0.516 . . . . 0.0 110.59 174.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.1 mt -109.66 139.21 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 170.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -129.71 106.13 8.5 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.6 mt -101.83 108.61 24.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -93.5 115.29 27.8 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.019 2.128 . . . . 0.0 107.32 174.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -79.8 172.1 14.23 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.809 0.844 . . . . 0.0 111.21 -172.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.95 -53.22 60.43 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.573 1.149 . . . . 0.0 110.182 170.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -71.23 149.15 46.54 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.998 1.719 . . . . 0.0 106.506 166.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.2 p -88.44 53.44 2.73 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.824 0.821 . . . . 0.0 110.627 -151.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.2 mt -126.32 134.27 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 -170.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -129.79 110.38 11.69 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -170.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.445 ' HE2' ' CE1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -101.81 130.54 48.27 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -176.193 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.1 mt -100.51 134.96 38.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.445 ' CE1' ' HE2' ' A' ' 24' ' ' LYS . 9.6 m-85 -117.16 84.59 2.18 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 103.146 -2.909 . . . . 0.0 103.146 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -94.46 -6.91 42.88 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 127.459 2.304 . . . . 0.0 110.349 170.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.59 132.27 35.3 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 t -58.03 -42.34 85.1 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.541 -0.724 . . . . 0.0 111.45 -171.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -73.53 -36.43 65.68 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.264 -0.897 . . . . 0.0 111.506 -174.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.6 m -53.53 -51.75 61.86 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 126.612 1.965 . . . . 0.0 110.756 167.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.8 mt -58.18 -50.08 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 123.526 0.73 . . . . 0.0 109.206 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -55.64 -45.57 77.6 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 118.552 -0.737 . . . . 0.0 112.051 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.46 -51.81 68.3 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-N 118.303 0.501 . . . . 0.0 109.813 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 94.2 mt -55.95 -45.12 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.955 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 mt -57.0 -25.65 58.89 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.989 1.268 . . . . 0.0 113.013 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.2 m -73.57 -52.78 12.31 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 120.244 1.384 . . . . 0.0 109.883 169.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -65.05 -24.11 67.38 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.809 1.186 . . . . 0.0 112.732 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.9 mm -83.39 -7.55 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.183 1.793 . . . . 0.0 110.754 175.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.13 1.62 9.19 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.242 1.417 . . . . 0.0 114.33 -175.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.5 p -66.36 -31.25 71.91 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.588 1.086 . . . . 0.0 111.517 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.9 163.14 43.47 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-O 122.606 1.114 . . . . 0.0 113.924 -164.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.5 pttt -112.24 97.65 6.78 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 127.183 2.193 . . . . 0.0 109.629 176.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -60.08 -11.88 7.02 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 124.746 1.218 . . . . 0.0 113.216 167.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.1 p 64.98 -175.23 0.17 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 126.738 2.015 . . . . 0.0 111.663 175.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -95.9 14.15 24.44 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.295 0.638 . . . . 0.0 112.531 165.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -64.63 147.99 51.83 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 120.558 -1.339 . . . . 0.0 110.67 156.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -83.55 121.7 27.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 168.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.1 t -73.0 147.94 44.67 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.743 -1.576 . . . . 0.0 106.743 152.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.9 pt -140.16 13.4 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 126.4 1.88 . . . . 0.0 110.024 170.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -86.39 164.17 17.19 Favored 'General case' 0 C--O 1.238 0.5 0 O-C-N 120.954 -1.091 . . . . 0.0 110.013 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.43 -15.05 10.95 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 118.088 -0.958 . . . . 0.0 112.235 175.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -153.95 165.5 17.76 Favored Pre-proline 0 N--CA 1.469 0.481 0 C-N-CA 125.331 1.452 . . . . 0.0 110.537 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -72.11 147.17 47.96 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.62 2.214 . . . . 0.0 111.591 168.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.11 -31.15 61.08 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.899 0.48 . . . . 0.0 112.103 171.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.26 155.2 25.41 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 121.799 0.809 . . . . 0.0 111.085 -173.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -84.76 -35.26 22.55 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.651 171.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -110.22 94.99 5.3 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -172.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -139.06 171.81 13.76 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 128.613 2.765 . . . . 0.0 107.063 172.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.71 -177.13 14.73 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 166.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.7 m -123.96 122.91 39.19 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.519 1.128 . . . . 0.0 109.449 -165.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mp -97.52 133.82 37.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 170.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -130.57 137.75 49.83 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.853 1.261 . . . . 0.0 107.899 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.4 mt -128.12 92.35 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 105.45 -2.055 . . . . 0.0 105.45 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -70.24 109.46 4.68 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 170.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -139.52 138.58 36.44 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.341 1.056 . . . . 0.0 108.552 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 48.8 36.18 7.64 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.246 1.018 . . . . 0.0 111.721 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.45 18.49 79.91 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 118.939 -0.923 . . . . 0.0 115.119 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.05 156.23 24.28 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 120.355 2.077 . . . . 0.0 110.328 173.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 81.4 mtp -112.33 96.76 6.2 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 123.845 0.858 . . . . 0.0 109.825 -173.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 m -62.88 105.79 0.72 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 165.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.8 m -103.65 156.16 18.0 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -176.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.8 ptp -153.88 171.05 19.58 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.828 1.651 . . . . 0.0 107.185 167.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -126.28 -177.98 4.16 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.233 1.413 . . . . 0.0 107.491 173.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -150.51 156.27 41.09 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -158.76 169.5 24.23 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 162.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -89.87 121.56 32.1 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 169.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -109.67 119.16 38.54 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 169.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.27 4.02 2.0 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.777 1.631 . . . . 0.0 114.463 164.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.01 -13.82 6.0 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.73 1.634 . . . . 0.0 113.4 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.8 tptt -115.16 163.2 15.98 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 120.034 1.917 . . . . 0.0 109.987 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -107.47 142.96 36.52 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -138.43 160.89 38.38 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.261 0.624 . . . . 0.0 109.988 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.78 133.83 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.936 0.894 . . . . 0.0 111.825 -173.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -71.98 161.33 31.08 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.121 -0.987 . . . . 0.0 112.379 -176.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -175.23 169.17 1.58 Allowed Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 126.896 2.078 . . . . 0.0 108.051 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -58.18 -162.54 0.02 OUTLIER 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.081 1.854 . . . . 0.0 110.54 155.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -43.28 -14.31 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.465 2.706 . . . . 0.0 116.705 -171.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -105.03 49.8 0.8 Allowed 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.272 -0.893 . . . . 0.0 111.888 168.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -125.16 69.18 0.5 Allowed Glycine 0 C--O 1.222 -0.608 0 CA-C-N 119.876 1.216 . . . . 0.0 112.247 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.6 mt -133.63 49.27 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 163.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -74.87 110.95 9.59 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -78.08 125.17 28.96 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 160.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.7 pt -106.93 164.48 4.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 152.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -123.65 48.21 1.9 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.351 0.661 . . . . 0.0 110.021 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -164.36 174.29 11.23 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.111 0.965 . . . . 0.0 111.757 159.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -70.2 122.94 20.45 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.091 0.956 . . . . 0.0 108.888 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -63.12 -47.88 80.87 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.511 0.596 . . . . 0.0 110.572 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -58.99 -35.03 72.54 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.451 -0.781 . . . . 0.0 112.871 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -72.69 -23.7 60.91 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.245 0.93 . . . . 0.0 110.827 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.2 mmt -70.59 -36.11 73.37 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 121.593 -0.692 . . . . 0.0 110.413 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.0 pt . . . . . 0 C--O 1.249 1.044 0 CA-C-N 119.172 0.896 . . . . 0.0 112.48 -167.677 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.992 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 m -54.27 165.11 0.89 Allowed Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 124.654 1.182 . . . . 0.0 111.051 168.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -67.29 165.04 28.19 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 CA-C-N 120.075 1.063 . . . . 0.0 111.352 167.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.6 mt -101.99 111.68 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 158.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.48 152.88 46.55 Favored Pre-proline 0 C--O 1.241 0.608 0 C-N-CA 125.878 1.671 . . . . 0.0 108.701 177.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.522 ' HB2' HD22 ' A' ' 10' ' ' ASN . 95.5 Cg_endo -73.7 159.88 44.86 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.807 2.338 . . . . 0.0 111.436 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.409 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -70.32 149.71 47.09 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 123.455 0.702 . . . . 0.0 112.048 -173.714 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.1 -12.86 43.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 118.592 -0.718 . . . . 0.0 111.945 170.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -95.13 -6.26 42.26 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.509 1.05 . . . . 0.0 112.123 -178.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.522 HD22 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -129.39 -2.54 4.95 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.58 1.152 . . . . 0.0 112.242 -173.23 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 37.5 t -78.88 111.22 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 170.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -74.8 -43.01 57.0 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.135 1.374 . . . . 0.0 108.605 176.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.8 p -160.24 171.89 18.37 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.593 1.088 . . . . 0.0 112.613 168.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.6 mt -130.02 137.69 55.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 127.335 2.254 . . . . 0.0 105.832 172.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.8 t -116.44 151.2 36.52 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 159.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.0 mt -131.41 101.64 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 168.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.3 117.39 20.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 169.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -75.33 177.02 6.88 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.262 1.029 . . . . 0.0 110.6 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.9 p -60.81 -15.29 28.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.078 2.151 . . . . 0.0 113.363 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 48.2 p30 -118.22 -166.76 1.25 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.515 1.926 . . . . 0.0 110.086 -170.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.2 p -82.44 24.95 0.65 Allowed 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.273 -1.517 . . . . 0.0 111.809 -173.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.5 mt -124.89 149.39 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.463 -1.681 . . . . 0.0 106.463 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -135.3 164.9 26.68 Favored 'General case' 0 N--CA 1.417 -2.084 0 C-N-CA 127.476 2.31 . . . . 0.0 107.906 170.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.25 134.92 30.1 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.8 mp -106.52 148.88 10.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -129.81 34.72 4.25 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.147 0.979 . . . . 0.0 109.664 -170.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -57.47 -20.65 32.17 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.384 2.274 . . . . 0.0 113.019 -175.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.97 123.85 21.74 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 129.542 3.137 . . . . 0.0 109.117 175.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.3 t -46.22 -48.08 17.79 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.133 1.373 . . . . 0.0 113.746 -175.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -69.54 -27.57 65.26 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.004 -1.06 . . . . 0.0 111.566 -175.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.6 m -72.58 -34.86 67.74 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.297 1.839 . . . . 0.0 111.019 172.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.0 mt -65.23 -52.86 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -65.37 -14.05 59.97 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -66.82 -78.66 0.06 Allowed 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 157.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.3 mt -50.58 -39.76 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 125.018 1.327 . . . . 0.0 112.578 -160.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 41.5 mt -51.64 -23.0 3.81 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.1 t -64.46 -63.83 1.03 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.168 1.387 . . . . 0.0 108.494 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 56.7 mp0 -64.5 -27.39 68.94 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.4 1.48 . . . . 0.0 111.158 -175.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.5 mm -62.26 -35.5 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 O-C-N 121.297 -0.877 . . . . 0.0 110.245 173.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.63 0.12 30.31 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 120.726 -1.234 . . . . 0.0 113.587 -169.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.7 t -64.81 -44.91 88.39 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.006 0.523 . . . . 0.0 110.919 -176.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.61 168.24 54.06 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-O 122.493 1.051 . . . . 0.0 112.432 -175.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -132.76 130.74 40.34 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 176.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -68.15 0.3 3.83 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.7 p 60.03 -172.54 0.12 Allowed 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 126.751 2.02 . . . . 0.0 108.847 -174.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -91.31 2.75 56.16 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.095 -1.003 . . . . 0.0 112.034 176.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt -69.03 170.07 10.58 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.084 0.856 . . . . 0.0 110.894 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.11 150.29 34.3 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.07 1.748 . . . . 0.0 109.019 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.87 149.87 43.64 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 -169.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 35.4 pt -138.31 17.78 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 118.957 0.799 . . . . 0.0 112.523 -165.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -139.97 -173.24 3.59 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.181 0.992 . . . . 0.0 108.761 -169.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.38 -6.38 1.56 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.481 1.112 . . . . 0.0 110.651 171.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -140.63 150.23 59.62 Favored Pre-proline 0 N--CA 1.469 0.485 0 CA-C-N 120.21 1.368 . . . . 0.0 111.29 -168.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.26 167.27 27.34 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.666 2.911 . . . . 0.0 114.928 -164.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 t -100.11 23.01 10.51 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.386 2.274 . . . . 0.0 110.72 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -126.6 150.41 48.9 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 125.268 1.427 . . . . 0.0 110.626 -174.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -90.03 -24.79 21.1 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.484 1.114 . . . . 0.0 110.871 172.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -125.34 102.44 7.43 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -145.01 166.99 23.72 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 128.383 2.673 . . . . 0.0 106.163 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.48 166.93 13.74 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 168.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.5 m -112.46 140.05 47.52 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.572 1.149 . . . . 0.0 108.553 -170.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.5 mp -125.81 128.83 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 -174.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -115.1 135.68 53.94 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.2 mt -126.03 87.65 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 171.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -70.22 116.03 10.11 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 125.418 1.487 . . . . 0.0 107.23 174.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -140.91 113.28 8.01 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.036 0.934 . . . . 0.0 109.97 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 74.52 -14.99 0.66 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 130.446 3.499 . . . . 0.0 115.639 171.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 123.21 23.68 2.14 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 118.843 0.747 . . . . 0.0 111.352 -165.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -145.1 171.7 26.14 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 106.609 -2.596 . . . . 0.0 106.609 160.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.08 139.24 34.01 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 118.772 1.286 . . . . 0.0 111.031 172.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 91.3 m -76.55 128.48 34.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 161.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.6 m -102.59 146.68 27.81 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 164.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.6 ptm -159.5 165.51 32.85 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.485 1.514 . . . . 0.0 108.47 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -144.64 140.66 28.83 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.826 1.65 . . . . 0.0 106.841 -174.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -129.21 152.24 49.0 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 120.015 1.279 . . . . 0.0 109.35 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -153.81 -175.56 5.43 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.12 0.968 . . . . 0.0 111.264 -178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -115.55 142.79 46.25 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.609 1.964 . . . . 0.0 108.586 173.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.427 ' CD ' HD21 ' A' ' 79' ' ' ASN . 14.1 tm-20 -141.71 127.68 19.47 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 125.393 1.477 . . . . 0.0 108.431 175.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.427 HD21 ' CD ' ' A' ' 78' ' ' GLU . 7.0 m-80 57.76 14.7 2.59 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.957 1.303 . . . . 0.0 112.936 -177.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.21 18.98 58.22 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 117.921 -1.488 . . . . 0.0 113.32 -175.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.26 148.43 45.91 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 128.612 2.765 . . . . 0.0 107.493 177.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -104.65 143.01 33.66 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.541 1.519 . . . . 0.0 111.305 -169.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -138.12 150.07 46.5 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.24 0.616 . . . . 0.0 111.22 -171.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mp -123.16 120.02 59.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 125.133 1.373 . . . . 0.0 108.931 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -73.69 153.19 40.19 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.419 1.088 . . . . 0.0 110.475 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -172.53 168.07 2.96 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 128.428 2.691 . . . . 0.0 106.072 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -57.92 -161.26 0.02 OUTLIER 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 125.268 3.979 . . . . 0.0 110.386 165.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -42.72 -8.82 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 127.572 2.349 . . . . 0.0 117.055 -175.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -121.13 46.74 1.97 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.016 1.326 . . . . 0.0 112.194 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -126.57 70.11 0.5 Allowed Glycine 0 C--O 1.224 -0.508 0 C-N-CA 125.762 1.648 . . . . 0.0 113.715 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.5 mt -131.09 53.07 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 164.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -75.42 125.95 30.03 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -119.31 102.47 8.71 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 -171.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.7 pt -115.75 146.71 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.655 1.582 . . . . 0.0 109.073 -175.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -91.82 -5.71 52.96 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -171.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -130.51 153.65 48.62 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.114 0.87 . . . . 0.0 112.638 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -57.86 135.72 56.9 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 126.383 1.873 . . . . 0.0 110.655 174.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -82.02 -49.86 9.76 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.029 1.332 . . . . 0.0 110.884 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -67.99 -13.81 62.47 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -165.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -97.7 -10.25 25.28 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.414 1.006 . . . . 0.0 112.576 173.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 38.7 mmm -76.81 -37.42 55.77 Favored 'General case' 0 C--O 1.233 0.222 0 O-C-N 120.626 -1.297 . . . . 0.0 111.167 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 12.8 pt . . . . . 0 C--O 1.243 0.73 0 C-N-CA 126.558 1.943 . . . . 0.0 114.229 -153.693 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.718 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.84 161.69 27.32 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 124.89 1.276 . . . . 0.0 111.76 -173.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.44 163.3 39.31 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.707 1.604 . . . . 0.0 112.157 169.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.0 mt -96.56 105.67 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 162.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.4 mt -126.19 165.64 26.43 Favored Pre-proline 0 C--O 1.24 0.585 0 C-N-CA 125.396 1.478 . . . . 0.0 108.462 174.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.417 ' HB2' HD22 ' A' ' 10' ' ' ASN . 34.4 Cg_endo -62.07 163.56 19.35 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.014 1.81 . . . . 0.0 111.248 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -61.88 179.69 0.25 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.265 0.626 . . . . 0.0 111.405 170.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.77 -45.9 33.78 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 155.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.34 3.94 3.31 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.305 1.442 . . . . 0.0 114.037 -163.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.417 HD22 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -124.96 4.13 8.02 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.298 2.239 . . . . 0.0 112.516 179.568 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 37.8 t -84.25 141.77 14.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -92.4 -52.75 4.51 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 173.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.51 161.34 42.32 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.907 0.883 . . . . 0.0 111.923 170.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.6 mt -123.89 140.81 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 164.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 54.4 m -134.42 115.74 14.36 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 -168.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.7 mt -119.55 120.11 62.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -112.06 102.42 10.63 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -72.27 168.17 18.87 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.623 1.569 . . . . 0.0 110.031 -165.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.0 p -45.87 -39.62 8.86 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.767 1.627 . . . . 0.0 112.97 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -51.09 -153.62 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 131.41 3.884 . . . . 0.0 112.07 164.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 93.3 p -122.07 25.15 9.21 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 119.863 -1.773 . . . . 0.0 110.596 160.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.3 mt -84.65 134.47 26.93 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 172.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -125.69 129.34 49.35 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.55 125.98 54.79 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 175.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.3 mp -99.8 135.64 34.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 173.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -118.26 87.12 2.66 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -118.19 52.16 1.03 Allowed 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.812 1.645 . . . . 0.0 107.148 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.45 146.49 40.14 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.614 1.566 . . . . 0.0 107.377 168.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.2 t -46.69 -53.99 10.55 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.949 1.699 . . . . 0.0 112.266 177.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -76.42 -27.5 56.29 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 121.65 -0.656 . . . . 0.0 112.027 -171.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 51.5 m -65.78 -48.76 70.71 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.428 1.491 . . . . 0.0 109.187 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 76.9 mt -57.9 -53.19 48.51 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 C-N-CA 125.599 1.56 . . . . 0.0 108.849 171.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -61.1 -28.45 69.1 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 120.541 1.519 . . . . 0.0 113.309 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.18 -60.14 3.08 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.1 mt -47.59 -49.69 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.642 1.577 . . . . 0.0 110.984 175.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.45 -28.07 12.1 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -176.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.5 t -63.93 -62.13 1.83 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.952 0.796 . . . . 0.0 109.16 172.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -63.62 -32.18 73.57 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.411 -0.805 . . . . 0.0 111.894 -174.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.0 mm -62.24 -25.85 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.801 1.24 . . . . 0.0 111.036 174.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.65 -5.73 12.17 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -175.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 t -62.15 -26.91 68.59 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.871 1.214 . . . . 0.0 112.038 -169.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.68 169.67 43.15 Favored Glycine 0 C--N 1.335 0.494 0 O-C-N 120.987 -1.07 . . . . 0.0 114.238 -167.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -112.1 106.72 15.42 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 125.907 1.683 . . . . 0.0 108.336 174.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -3.33 1.16 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.134 0.974 . . . . 0.0 112.923 165.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.1 p 66.27 -164.77 0.23 Allowed 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 125.378 1.471 . . . . 0.0 108.056 174.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -105.42 12.66 31.28 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.593 1.088 . . . . 0.0 111.473 169.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -63.67 170.53 3.22 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 122.166 0.984 . . . . 0.0 110.527 164.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -122.51 144.52 49.02 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 125.604 1.562 . . . . 0.0 110.526 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.02 157.56 16.25 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 125.028 1.331 . . . . 0.0 108.604 172.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 26.7 pt -137.77 17.36 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 125.771 1.628 . . . . 0.0 111.284 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.02 176.88 8.31 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.369 1.468 . . . . 0.0 110.701 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.9 -4.67 6.33 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.749 2.42 . . . . 0.0 110.944 -175.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -140.31 150.05 59.94 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-N 119.202 0.91 . . . . 0.0 109.814 -175.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.43 167.73 25.5 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.141 1.894 . . . . 0.0 110.06 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.2 20.19 16.45 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.401 1.08 . . . . 0.0 110.367 170.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.58 173.83 11.09 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.037 -1.04 . . . . 0.0 109.022 157.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.97 -24.04 5.7 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 127.455 2.302 . . . . 0.0 110.082 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -118.87 112.74 20.05 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.502 1.921 . . . . 0.0 106.114 174.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -149.41 173.83 13.12 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 126.956 2.103 . . . . 0.0 106.706 170.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -114.66 166.17 12.13 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 167.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.58 147.66 22.8 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.397 0.679 . . . . 0.0 109.701 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.0 mp -134.84 128.95 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 172.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -132.26 141.53 49.05 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 53.7 mt -129.24 97.39 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 -177.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -71.31 131.3 43.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 170.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -158.79 -166.04 1.78 Allowed 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -45.51 -32.83 2.4 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.724 1.609 . . . . 0.0 114.133 175.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.23 2.47 81.47 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-O 119.311 -0.716 . . . . 0.0 111.873 -173.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.47 -138.05 22.68 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 107.619 -2.192 . . . . 0.0 107.619 -153.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 11.5 mtt -105.44 112.52 25.64 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.181 0.991 . . . . 0.0 110.682 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 47.9 m -60.04 124.86 21.53 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 149.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.6 m -112.87 143.42 44.17 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.971 1.708 . . . . 0.0 107.073 173.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.5 ptm -163.94 167.71 20.24 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.539 1.535 . . . . 0.0 108.677 -172.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -149.23 129.53 13.75 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.738 1.215 . . . . 0.0 109.098 -169.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -120.18 145.43 46.98 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.751 1.614 . . . . 0.0 110.164 -172.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -151.13 179.51 8.22 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.682 1.593 . . . . 0.0 110.938 -169.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -112.86 148.72 34.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.474 1.51 . . . . 0.0 108.987 168.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -144.72 119.42 9.81 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.686 1.194 . . . . 0.0 108.398 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 58.57 5.44 0.46 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.6 1.96 . . . . 0.0 114.856 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.22 1.8 28.1 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 119.838 1.199 . . . . 0.0 113.536 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -106.17 149.93 26.34 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 119.227 1.513 . . . . 0.0 108.131 163.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -93.85 151.85 19.3 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 174.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -140.47 159.05 43.05 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.599 0.714 . . . . 0.0 111.312 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.5 mp -119.65 124.69 73.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 125.26 1.424 . . . . 0.0 108.86 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -70.71 147.65 48.83 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 122.231 1.015 . . . . 0.0 111.596 168.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -171.55 167.6 3.7 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 128.39 2.676 . . . . 0.0 107.881 174.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.41 ' O ' ' N ' ' A' ' 89' ' ' LYS . 45.9 Cg_endo -53.19 -160.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.609 1 C-N-CA 126.199 4.599 . . . . 0.0 110.672 166.002 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -42.63 -13.78 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.756 2.423 . . . . 0.0 115.58 -173.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -110.04 67.42 0.65 Allowed 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 127.875 2.47 . . . . 0.0 113.074 164.1 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -130.72 38.71 1.9 Allowed Glycine 0 N--CA 1.463 0.457 0 N-CA-C 116.251 1.26 . . . . 0.0 116.251 -173.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.3 mt -129.34 39.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 O-C-N 121.72 -0.871 . . . . 0.0 109.049 -170.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -75.84 101.62 5.19 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -171.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -72.28 125.82 28.28 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 166.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 24.5 pt -114.99 179.44 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 125.976 1.71 . . . . 0.0 108.753 165.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -107.09 -18.19 13.97 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -178.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -136.67 168.74 18.93 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.792 0.837 . . . . 0.0 111.749 -165.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -77.7 121.44 24.01 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.239 1.016 . . . . 0.0 109.937 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -62.76 -47.77 82.07 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.365 1.066 . . . . 0.0 111.781 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -62.53 -32.02 72.89 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.45 0.7 . . . . 0.0 111.881 -172.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -71.19 -21.01 62.2 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.142 -0.974 . . . . 0.0 111.738 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.1 mmt -98.57 -4.58 33.8 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.128 1.371 . . . . 0.0 112.531 -170.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 23.0 pt . . . . . 0 C--O 1.253 1.286 0 C-N-CA 124.69 1.196 . . . . 0.0 111.321 -175.663 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.655 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 m -172.4 87.85 0.42 Allowed Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 126.978 2.111 . . . . 0.0 109.308 169.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -55.21 158.63 11.59 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 CA-C-N 121.292 1.497 . . . . 0.0 111.824 164.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 mp -80.32 135.87 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 158.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.63 165.11 24.4 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 126.393 1.877 . . . . 0.0 108.851 174.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -64.8 175.8 3.41 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.096 2.531 . . . . 0.0 112.485 174.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.586 ' H ' ' HE2' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -67.16 -172.28 0.2 Allowed 'General case' 0 C--N 1.344 0.364 0 O-C-N 120.386 -1.446 . . . . 0.0 109.922 167.363 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.7 -36.81 12.73 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.548 0.739 . . . . 0.0 110.957 161.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -76.06 -17.68 59.54 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.206 -0.934 . . . . 0.0 113.223 -171.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.535 HD21 ' N ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -88.12 -3.89 58.83 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.854 1.261 . . . . 0.0 112.421 176.043 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.535 ' N ' HD21 ' A' ' 10' ' ' ASN . 29.1 t -88.3 118.48 33.95 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 -172.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -83.89 -49.43 9.03 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.081 1.352 . . . . 0.0 107.817 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.3 m -157.03 176.95 12.07 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.618 1.099 . . . . 0.0 111.523 163.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 53.9 mt -126.81 145.05 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 167.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.8 t -125.58 141.08 52.22 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.472 1.109 . . . . 0.0 108.516 169.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.6 mt -134.47 105.76 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 176.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -93.75 109.24 20.91 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 171.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -67.9 169.63 9.52 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.846 1.258 . . . . 0.0 109.846 -173.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.5 p -50.3 -35.71 28.6 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.153 0.981 . . . . 0.0 111.76 176.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -58.86 -154.75 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 131.367 3.867 . . . . 0.0 111.27 172.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.2 p -108.91 4.69 23.66 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 119.992 -1.693 . . . . 0.0 111.947 163.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.4 mt -75.63 133.62 30.91 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -132.26 110.06 10.35 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -177.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.8 125.26 50.79 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -177.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.1 mp -101.19 127.48 54.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 175.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -106.26 83.31 1.87 Allowed 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 102.023 -3.325 . . . . 0.0 102.023 174.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -89.93 -13.4 36.34 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.902 0.881 . . . . 0.0 111.337 174.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.01 135.98 33.32 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.598 1.559 . . . . 0.0 109.877 -165.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.4 t -49.17 -48.09 45.35 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.689 1.196 . . . . 0.0 113.756 -171.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -71.56 -33.48 69.14 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 120.706 -1.247 . . . . 0.0 111.425 -174.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.4 m -62.26 -34.99 77.6 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.753 2.021 . . . . 0.0 110.943 170.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.5 mt -68.2 -49.13 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -59.33 -33.4 71.08 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 117.907 -1.044 . . . . 0.0 112.133 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.438 ' HE3' ' C ' ' A' ' 102' ' ' ILE . 0.0 OUTLIER -64.61 -62.28 1.68 Allowed 'General case' 0 C--N 1.343 0.311 0 CA-C-N 119.699 1.136 . . . . 0.0 109.492 172.735 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 40.5 mt -51.95 -50.12 35.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 124.006 0.922 . . . . 0.0 111.068 -173.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.72 -16.23 10.38 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.1 0.96 . . . . 0.0 113.015 -173.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.2 t -61.42 -59.11 5.77 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.64 1.109 . . . . 0.0 110.203 168.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -65.36 -31.1 72.04 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.58 1.152 . . . . 0.0 110.697 -176.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 39.2 mm -62.13 -16.19 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 121.164 -0.96 . . . . 0.0 111.762 173.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.89 7.82 14.57 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.536 1.534 . . . . 0.0 113.074 175.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 t -78.6 -30.93 46.89 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 120.272 1.396 . . . . 0.0 109.951 -177.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.38 161.61 34.19 Favored Glycine 0 N--CA 1.447 -0.629 0 O-C-N 120.841 -1.162 . . . . 0.0 114.717 -162.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.46 99.79 7.05 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -170.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.506 ' HB3' ' CE2' ' A' ' 92' ' ' TYR . 9.5 ptt180 -60.12 -8.23 2.31 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.583 1.538 . . . . 0.0 114.311 -177.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.8 p 65.19 176.71 0.2 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.638 2.375 . . . . 0.0 110.115 -175.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -74.34 -9.95 59.1 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.607 -1.308 . . . . 0.0 111.45 172.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -58.41 161.38 4.48 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.985 1.374 . . . . 0.0 110.705 -177.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -108.44 149.95 28.06 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.007 -1.451 . . . . 0.0 107.362 165.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.86 119.98 32.15 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.45 -2.055 . . . . 0.0 105.45 -165.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.8 pt -105.28 12.13 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 119.195 -0.431 . . . . 0.0 111.939 -162.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.56 179.91 6.54 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.385 1.874 . . . . 0.0 108.553 -174.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -127.55 -7.1 5.73 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.148 2.179 . . . . 0.0 110.56 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -140.15 149.22 57.52 Favored Pre-proline 0 C--O 1.238 0.495 0 C-N-CA 124.02 0.928 . . . . 0.0 111.455 -170.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -67.7 155.35 70.35 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.677 2.251 . . . . 0.0 114.104 -171.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 m -100.43 10.39 41.27 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.783 2.033 . . . . 0.0 111.86 162.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.66 166.8 22.98 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 120.501 -1.374 . . . . 0.0 110.072 162.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -105.31 -34.78 7.76 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 127.343 2.257 . . . . 0.0 109.68 165.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -116.12 98.16 6.47 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 -165.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -154.39 162.74 40.99 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 126.05 1.74 . . . . 0.0 109.289 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.64 166.62 15.03 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.908 0.766 . . . . 0.0 111.218 175.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.6 m -107.72 124.67 50.37 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -176.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.71 135.15 56.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 124.445 1.098 . . . . 0.0 108.362 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -121.16 135.1 55.22 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 163.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.1 mt -117.1 100.5 10.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 102.718 -3.067 . . . . 0.0 102.718 166.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -78.93 107.18 11.48 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.879 1.672 . . . . 0.0 106.596 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.56 158.22 43.87 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 123.779 0.831 . . . . 0.0 108.962 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 48.94 30.03 2.59 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.616 1.566 . . . . 0.0 113.925 169.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.44 47.63 85.62 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 120.925 -1.11 . . . . 0.0 111.2 -175.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -156.89 -173.09 24.9 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 126.092 1.805 . . . . 0.0 109.37 168.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.04 137.57 53.08 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.876 0.846 . . . . 0.0 109.213 159.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.4 m -84.01 97.43 9.28 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 103.612 -2.736 . . . . 0.0 103.612 164.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.1 m -83.87 140.25 32.11 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 2.0 ptm -162.67 163.52 26.94 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.053 1.341 . . . . 0.0 108.768 -177.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -139.69 148.55 42.52 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -136.29 151.84 50.06 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 121.385 1.902 . . . . 0.0 109.528 177.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -147.02 173.4 12.49 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.278 1.031 . . . . 0.0 111.731 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -93.99 146.72 23.73 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 159.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -138.34 126.91 23.4 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 162.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 60.3 6.64 1.07 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.805 1.642 . . . . 0.0 114.412 171.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.17 3.53 31.33 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.963 1.268 . . . . 0.0 113.782 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.56 153.93 24.43 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 120.03 1.915 . . . . 0.0 108.81 161.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -98.74 155.2 17.46 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 174.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -141.25 159.88 41.28 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 119.039 -0.505 . . . . 0.0 111.882 -176.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.1 mp -124.45 131.49 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.534 1.534 . . . . 0.0 111.755 172.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -82.6 164.38 20.84 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.198 1.799 . . . . 0.0 111.457 172.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.57 169.2 0.47 Allowed Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.842 1.657 . . . . 0.0 108.656 -162.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' A' ' 89' ' ' LYS . 20.7 Cg_endo -63.23 -164.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.363 0 CA-C-N 121.904 1.716 . . . . 0.0 108.953 158.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -43.65 -5.55 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 129.121 2.969 . . . . 0.0 118.71 -165.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -113.48 43.75 1.71 Allowed 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 128.314 2.646 . . . . 0.0 111.734 170.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -113.42 53.05 0.61 Allowed Glycine 0 C--N 1.334 0.471 0 CA-C-N 120.11 1.323 . . . . 0.0 114.823 -176.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.1 mt -129.93 52.33 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 170.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.506 ' CE2' ' HB3' ' A' ' 44' ' ' ARG . 77.4 m-85 -74.39 99.37 3.5 Favored 'General case' 0 CA--C 1.499 -0.984 0 O-C-N 120.957 -1.089 . . . . 0.0 108.641 176.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -61.89 128.21 35.12 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 158.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.1 pt -128.78 152.07 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 125.413 1.485 . . . . 0.0 108.251 167.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -80.7 -39.81 26.47 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -112.09 164.75 12.8 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.843 1.257 . . . . 0.0 111.07 -169.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -71.4 131.33 43.21 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 122.377 0.271 . . . . 0.0 110.282 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -64.85 -45.97 83.84 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 122.157 -0.339 . . . . 0.0 110.58 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -69.02 -31.24 69.9 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -168.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -77.71 -25.75 49.59 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.097 -1.002 . . . . 0.0 110.686 177.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 22.7 mmt -81.89 -12.71 58.31 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.742 0.817 . . . . 0.0 112.81 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.438 ' C ' ' HE3' ' A' ' 34' ' ' LYS . 29.1 pt . . . . . 0 C--O 1.25 1.097 0 CA-C-N 120.94 1.7 . . . . 0.0 109.894 172.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.059 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.9 p -67.01 166.36 20.25 Favored Pre-proline 0 C--O 1.24 0.564 0 C-N-CA 124.322 1.049 . . . . 0.0 111.951 -178.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -47.93 153.43 2.6 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 120.654 0.902 . . . . 0.0 111.642 154.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 80.3 mt -80.7 133.33 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 157.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.04 164.43 39.1 Favored Pre-proline 0 C--O 1.242 0.701 0 C-N-CA 125.061 1.344 . . . . 0.0 107.792 176.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.521 ' HB2' HD22 ' A' ' 10' ' ' ASN . 60.7 Cg_endo -58.81 169.82 3.12 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 121.395 1.397 . . . . 0.0 109.93 160.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.462 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -55.5 175.66 0.07 Allowed 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 120.47 -1.394 . . . . 0.0 110.941 164.011 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.2 -55.3 5.86 Favored 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 156.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -62.63 -16.23 55.71 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -163.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.521 HD22 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -95.32 1.85 54.53 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.028 1.731 . . . . 0.0 114.542 176.324 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 72.3 t -84.14 130.08 36.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 177.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.42 -58.18 3.46 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 169.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 63.6 p -153.23 163.54 39.71 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.611 171.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 56.1 mt -106.08 125.65 61.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 164.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.6 t -91.56 138.36 31.63 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 163.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.0 mt -125.0 107.52 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 166.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -86.06 121.91 29.34 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 169.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -67.96 164.91 18.91 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.039 0.936 . . . . 0.0 110.734 -176.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -57.9 -27.77 63.61 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 118.512 -0.756 . . . . 0.0 112.404 168.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.427 ' CG ' ' H ' ' A' ' 21' ' ' SER . 9.6 p-10 -87.89 -79.38 0.29 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.929 1.24 . . . . 0.0 111.21 -177.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.427 ' H ' ' CG ' ' A' ' 20' ' ' ASN . 21.9 t -175.93 -3.84 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.963 2.105 . . . . 0.0 112.584 -176.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.0 mm -73.31 150.06 8.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 169.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -139.46 122.19 16.44 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.576 ' HE2' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -121.19 131.53 54.3 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -171.26 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.4 mp -112.14 145.81 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -177.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.576 ' CE1' ' HE2' ' A' ' 24' ' ' LYS . 53.4 m-85 -123.41 95.69 4.69 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 103.841 -2.652 . . . . 0.0 103.841 -172.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -123.29 49.94 1.63 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.811 2.044 . . . . 0.0 108.732 -175.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.06 163.41 34.33 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.438 1.895 . . . . 0.0 107.61 170.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.9 m -50.6 -58.52 5.62 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.445 0.698 . . . . 0.0 111.884 166.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -68.89 -35.33 76.74 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.758 -0.589 . . . . 0.0 111.487 -169.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.4 p -67.24 -43.26 82.42 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.5 mt -67.11 -48.53 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 123.575 0.75 . . . . 0.0 109.609 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -48.52 -50.39 32.08 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.364 1.866 . . . . 0.0 111.898 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.421 ' HE2' ' O ' ' A' ' 101' ' ' MET . 0.0 OUTLIER -59.46 -47.49 85.29 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 122.921 0.489 . . . . 0.0 110.386 -176.329 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.3 mt -60.68 -51.18 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.917 176.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 mt -49.59 -39.44 35.35 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.441 1.019 . . . . 0.0 111.025 -177.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.1 t -57.13 -57.05 14.29 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.428 0.691 . . . . 0.0 110.412 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -72.21 -19.05 61.79 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.435 1.094 . . . . 0.0 112.35 -175.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.1 mm -81.9 -19.57 10.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.217 1.407 . . . . 0.0 110.872 173.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.67 -12.66 13.86 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -175.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.2 t -58.07 -31.64 67.26 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.311 0.96 . . . . 0.0 111.267 176.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.42 154.92 44.78 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-O 122.783 1.213 . . . . 0.0 112.118 -171.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.44 108.79 19.43 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 174.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -63.4 -13.59 41.37 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 167.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 p 65.53 -174.0 0.18 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.826 1.329 . . . . 0.0 109.926 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -68.31 -17.22 64.22 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.013 -1.054 . . . . 0.0 112.032 175.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -64.26 154.21 35.79 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 119.354 0.979 . . . . 0.0 112.093 -171.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -100.55 133.15 45.43 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 172.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.8 160.11 33.16 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 153.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 pt -136.07 12.51 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.679 1.192 . . . . 0.0 111.164 168.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.8 178.64 4.33 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.11 1.364 . . . . 0.0 108.834 175.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -121.12 -5.32 9.49 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.176 0.99 . . . . 0.0 111.676 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -145.67 160.1 45.43 Favored Pre-proline 0 C--N 1.345 0.378 0 C-N-CA 125.626 1.57 . . . . 0.0 110.344 -171.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -69.36 160.99 47.68 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 121.304 1.336 . . . . 0.0 109.882 177.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.6 t -107.22 13.53 27.14 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.52 0.728 . . . . 0.0 110.862 172.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.03 171.9 13.68 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.523 0.677 . . . . 0.0 111.303 168.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -111.56 -29.22 7.83 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.487 1.915 . . . . 0.0 109.615 172.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -112.62 115.78 29.14 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 127.066 2.146 . . . . 0.0 105.987 172.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -149.53 167.3 26.67 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 171.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.47 169.8 15.08 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 169.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.6 m -123.42 123.14 40.0 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -158.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 mp -122.19 111.72 31.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 124.141 0.976 . . . . 0.0 108.4 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -109.54 113.9 27.07 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.931 1.692 . . . . 0.0 106.728 -175.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.4 mt -98.95 100.38 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 170.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -71.41 119.74 15.99 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 164.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -148.06 136.49 21.49 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.596 0.758 . . . . 0.0 110.172 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 53.24 23.45 3.18 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.265 1.426 . . . . 0.0 111.156 -174.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.04 -8.22 39.16 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 127.608 2.527 . . . . 0.0 114.075 -176.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -87.8 -177.29 48.01 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 108.726 -1.749 . . . . 0.0 108.726 166.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.1 ptt? -145.56 142.74 29.42 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.563 1.181 . . . . 0.0 113.248 174.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.1 m -91.41 111.1 22.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 165.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.5 m -84.12 130.73 34.84 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.572 1.949 . . . . 0.0 106.944 166.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.9 ptp -154.0 173.24 16.26 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.325 1.45 . . . . 0.0 109.36 164.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.569 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 43.0 m-85 -135.72 -179.79 5.86 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.437 1.895 . . . . 0.0 108.477 -178.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -138.79 158.04 44.95 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.375 1.07 . . . . 0.0 108.946 170.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -161.44 171.48 18.12 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.408 1.004 . . . . 0.0 110.616 163.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -99.34 139.24 35.28 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 125.681 1.593 . . . . 0.0 107.945 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -135.23 111.29 9.53 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.641 0.734 . . . . 0.0 109.625 175.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 66.96 10.73 7.89 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.381 1.872 . . . . 0.0 113.3 172.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.1 -8.7 31.31 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-O 118.021 -1.433 . . . . 0.0 113.172 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.97 157.78 15.74 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 119.342 1.571 . . . . 0.0 108.075 163.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -109.15 150.06 28.43 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -141.13 171.79 13.57 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 123.364 0.415 . . . . 0.0 110.146 178.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.2 mp -121.99 150.53 25.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 124.628 1.171 . . . . 0.0 108.057 172.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.569 ' HB3' ' H ' ' A' ' 74' ' ' PHE . 3.4 tm-20 -90.49 159.33 16.57 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.149 2.58 . . . . 0.0 110.045 -173.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 174.81 167.43 0.34 Allowed Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 128.78 2.832 . . . . 0.0 108.774 178.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.405 ' O ' ' N ' ' A' ' 89' ' ' LYS . 23.0 Cg_endo -60.45 -161.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.935 1 C-N-CA 125.446 4.097 . . . . 0.0 110.152 165.333 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -42.9 -8.79 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 128.259 2.623 . . . . 0.0 117.08 -169.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -114.43 33.28 5.4 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 120.637 1.562 . . . . 0.0 114.509 167.189 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -113.41 75.38 0.23 Allowed Glycine 0 C--O 1.223 -0.556 0 CA-C-N 119.671 1.123 . . . . 0.0 113.176 -174.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.0 mt -145.28 46.7 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 174.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -72.19 100.91 2.68 Favored 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 121.05 -1.032 . . . . 0.0 109.74 -171.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.92 122.23 18.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 170.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.2 pt -116.13 174.84 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 127.248 2.219 . . . . 0.0 108.42 162.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -106.31 -14.37 15.13 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -175.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -131.45 167.78 18.74 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.273 0.942 . . . . 0.0 110.0 -169.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -69.98 139.31 52.77 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.951 0.341 . . . . 0.0 110.324 174.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -68.12 -52.42 35.07 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.776 0.83 . . . . 0.0 112.447 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -66.01 -28.42 68.86 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.748 0.704 . . . . 0.0 112.253 -171.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -67.94 -14.51 63.02 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.866 -0.521 . . . . 0.0 111.875 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.421 ' O ' ' HE2' ' A' ' 34' ' ' LYS . 26.3 mmt -103.02 -10.51 18.87 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 117.071 -1.443 . . . . 0.0 113.322 -175.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.9 pp . . . . . 0 C--O 1.254 1.31 0 CA-C-N 121.11 1.777 . . . . 0.0 112.862 -163.86 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.129 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 p 63.42 167.47 0.1 Allowed Pre-proline 0 CA--C 1.549 0.933 0 CA-C-N 118.701 1.25 . . . . 0.0 111.531 -175.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -57.54 164.12 7.77 Favored 'Trans proline' 0 C--N 1.353 0.809 0 CA-C-N 121.58 1.6 . . . . 0.0 110.763 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.9 mm -99.21 127.25 52.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 105.31 -2.108 . . . . 0.0 105.31 171.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.22 161.5 63.38 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 126.54 1.936 . . . . 0.0 110.646 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -61.17 172.28 3.31 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.158 1.239 . . . . 0.0 110.698 170.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.17 179.11 0.21 Allowed 'General case' 0 N--CA 1.467 0.421 0 O-C-N 120.313 -1.492 . . . . 0.0 112.27 171.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.02 -50.07 17.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 155.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.82 -26.34 68.58 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -159.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.48 -5.72 57.07 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 126.414 1.886 . . . . 0.0 115.02 -178.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.2 t -76.89 108.83 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.59 -39.37 93.61 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.001 0.921 . . . . 0.0 109.607 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 p -174.44 136.89 0.48 Allowed 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.177 0.991 . . . . 0.0 108.873 158.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.9 mt -75.34 154.38 6.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 164.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.6 t -131.93 133.79 44.94 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.477 -2.046 . . . . 0.0 105.477 166.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.4 mt -128.99 110.8 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 176.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.41 119.92 22.41 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 105.245 -2.131 . . . . 0.0 105.245 166.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -63.01 -179.83 0.32 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.882 1.273 . . . . 0.0 110.49 173.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.3 p -75.17 0.39 16.5 Favored 'General case' 0 CA--C 1.549 0.904 0 O-C-N 119.97 -1.706 . . . . 0.0 112.305 171.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -122.67 158.56 29.79 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 128.616 2.766 . . . . 0.0 105.479 168.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.4 p -79.26 -2.8 42.92 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 120.243 1.383 . . . . 0.0 112.464 -154.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.4 mt -61.81 134.89 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 164.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -120.14 166.07 13.91 Favored 'General case' 0 N--CA 1.422 -1.832 0 C-N-CA 125.122 1.369 . . . . 0.0 107.505 171.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.569 ' HE2' ' CE2' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -137.1 151.72 49.19 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 170.265 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.5 mp -109.74 139.76 31.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.569 ' CE2' ' HE2' ' A' ' 24' ' ' LYS . 72.4 m-85 -128.8 91.72 3.27 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 -173.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -119.99 -7.66 9.89 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.78 2.432 . . . . 0.0 110.973 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -64.95 138.27 58.26 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 170.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.9 t -56.97 -42.84 80.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.98 0.809 . . . . 0.0 109.729 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -67.38 -36.7 81.87 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.362 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 52.2 p -55.2 -48.45 73.82 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.026 0.83 . . . . 0.0 109.038 175.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.6 mt -70.48 -54.71 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-O 118.568 -0.729 . . . . 0.0 109.093 -177.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -59.64 -30.64 68.87 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.528 1.058 . . . . 0.0 112.172 -176.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -68.64 -63.82 0.99 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 117.857 -1.068 . . . . 0.0 109.027 170.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.3 mt -47.92 -46.18 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 123.643 0.777 . . . . 0.0 109.967 -176.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -47.73 -31.22 4.53 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.007 1.723 . . . . 0.0 113.08 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.4 t -61.03 -55.15 36.11 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 119.113 0.869 . . . . 0.0 109.584 174.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -75.6 -11.59 60.04 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.021 0.828 . . . . 0.0 112.252 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.5 mm -70.55 -23.92 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 O-C-N 120.9 -1.125 . . . . 0.0 110.141 162.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.35 -18.03 11.14 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -168.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.2 p -69.57 -28.91 66.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 119.817 1.189 . . . . 0.0 112.746 -170.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.78 165.98 50.08 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 119.536 1.062 . . . . 0.0 114.381 -166.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.5 pttm -112.13 103.56 11.75 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 125.518 1.527 . . . . 0.0 111.184 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -58.03 -15.16 8.2 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 170.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.7 p 60.27 175.24 0.09 Allowed 'General case' 0 CA--C 1.551 0.99 0 O-C-N 124.162 0.914 . . . . 0.0 109.597 -171.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -85.68 3.69 39.9 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 119.363 -2.085 . . . . 0.0 111.795 176.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -60.66 156.43 16.74 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.65 0.78 . . . . 0.0 111.786 177.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -89.88 113.99 25.69 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.701 1.6 . . . . 0.0 107.2 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.9 t -80.14 140.66 36.29 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 163.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.2 pt -144.4 39.53 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.649 1.579 . . . . 0.0 107.727 176.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -116.64 177.24 4.77 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.835 1.254 . . . . 0.0 110.682 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.87 -4.58 2.82 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.172 1.389 . . . . 0.0 111.547 177.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -153.35 165.38 17.84 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 126.752 2.021 . . . . 0.0 108.089 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.28 174.3 11.7 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.381 1.387 . . . . 0.0 111.097 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 t -102.17 -7.8 21.89 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.005 1.322 . . . . 0.0 110.804 175.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.04 150.89 31.77 Favored 'General case' 0 CA--C 1.527 0.09 0 O-C-N 121.028 -1.045 . . . . 0.0 110.796 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.46 -22.25 30.39 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.248 1.019 . . . . 0.0 111.232 173.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.79 107.32 9.06 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -129.48 153.58 47.83 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 126.389 1.876 . . . . 0.0 108.943 176.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.02 154.92 25.97 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 108.17 -1.972 . . . . 0.0 108.17 167.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.2 m -127.38 131.73 50.28 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.137 0.975 . . . . 0.0 108.807 -164.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.05 125.62 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -166.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -115.42 144.76 43.34 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 161.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.0 mt -127.48 83.49 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -58.77 120.45 8.99 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 171.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -146.91 114.76 6.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 59.61 20.54 9.13 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.613 1.165 . . . . 0.0 112.375 -173.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.15 3.58 12.4 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.522 1.058 . . . . 0.0 113.506 -171.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.96 170.39 44.03 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 145.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -143.84 163.38 33.55 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 121.308 -1.113 . . . . 0.0 109.469 169.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.2 m -130.07 132.16 46.06 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 174.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -120.83 126.41 50.0 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.196 0.998 . . . . 0.0 108.686 -172.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.6 ptp -146.85 170.65 16.6 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.156 0.983 . . . . 0.0 109.207 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -146.47 148.7 32.52 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 -175.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.92 154.32 50.54 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.364 0.984 . . . . 0.0 109.758 175.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -157.77 172.61 18.18 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.813 1.645 . . . . 0.0 109.545 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -102.84 139.15 38.79 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.657 1.583 . . . . 0.0 108.072 171.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -135.85 120.46 18.27 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 172.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 55.79 -4.59 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 128.153 2.581 . . . . 0.0 117.341 -174.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 136.97 -33.48 2.31 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 125.751 1.644 . . . . 0.0 112.49 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -71.58 151.42 43.82 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 171.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -100.12 150.6 22.32 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 168.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -136.77 153.11 50.92 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.514 0.725 . . . . 0.0 111.182 -176.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mp -123.15 117.9 53.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 125.162 1.385 . . . . 0.0 107.63 -170.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.46 154.81 38.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.625 1.17 . . . . 0.0 109.736 176.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 179.79 167.73 0.73 Allowed Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 127.963 2.505 . . . . 0.0 107.443 -169.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -57.15 -163.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 124.37 3.38 . . . . 0.0 110.728 166.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -44.76 -11.78 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 117.079 2.251 . . . . 0.0 117.079 -174.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -96.78 11.64 34.89 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.023 1.729 . . . . 0.0 115.293 172.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.94 77.54 0.4 Allowed Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 120.259 1.391 . . . . 0.0 113.508 -170.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.9 mt -139.51 42.88 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 169.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -76.24 107.53 8.55 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 121.212 -0.93 . . . . 0.0 109.758 -172.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -69.66 127.26 32.31 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 159.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 41.0 pt -112.19 168.23 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 148.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -122.32 21.34 10.36 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.848 0.832 . . . . 0.0 112.871 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -140.98 167.42 22.23 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 127.149 2.18 . . . . 0.0 110.214 170.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -84.29 116.22 22.88 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.213 1.005 . . . . 0.0 109.601 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -48.97 -47.33 44.13 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.833 1.253 . . . . 0.0 109.564 172.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -68.43 -17.42 64.2 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.126 0.97 . . . . 0.0 112.692 -171.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -91.49 -13.78 31.59 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 121.334 -0.854 . . . . 0.0 109.937 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 11.9 mmt -106.66 -6.59 17.81 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.789 1.636 . . . . 0.0 112.462 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 24.3 pt . . . . . 0 C--O 1.25 1.126 0 CA-C-N 119.332 0.969 . . . . 0.0 111.397 174.092 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.805 0 CA-C-O 119.633 -0.537 . . . . 0.0 112.719 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m 69.85 165.0 0.13 Allowed Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 126.691 1.996 . . . . 0.0 113.347 174.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.02 179.89 2.07 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 124.586 3.524 . . . . 0.0 112.504 156.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 53.1 mt -108.54 131.83 58.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 126.258 1.823 . . . . 0.0 106.341 164.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.13 161.76 61.65 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 128.143 2.577 . . . . 0.0 109.959 175.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -62.17 176.62 1.43 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.998 2.466 . . . . 0.0 112.914 176.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.516 ' N ' ' HE3' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -65.35 -175.1 0.21 Allowed 'General case' 0 C--O 1.236 0.383 0 O-C-N 119.983 -1.698 . . . . 0.0 110.351 169.203 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.6 -42.75 16.39 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 118.984 -0.531 . . . . 0.0 111.219 167.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -85.69 -21.83 28.13 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 118.48 -1.288 . . . . 0.0 111.652 -164.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.491 HD21 ' N ' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -73.39 -5.96 43.19 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.64 1.176 . . . . 0.0 112.471 174.632 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.491 ' N ' HD21 ' A' ' 10' ' ' ASN . 25.0 t -80.11 131.58 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 173.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -81.75 -61.43 1.92 Allowed 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 171.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.63 130.2 5.0 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.612 1.096 . . . . 0.0 109.827 171.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.7 mt -81.25 139.38 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.4 t -116.37 140.83 48.92 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 172.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.2 mt -135.57 105.13 5.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 173.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -81.39 108.07 14.69 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 173.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -71.03 -176.76 1.46 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.549 0.69 . . . . 0.0 109.267 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.4 p -62.25 -46.75 87.42 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.492 -1.38 . . . . 0.0 111.394 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.411 ' C ' ' H ' ' A' ' 22' ' ' ILE . 51.7 t-20 -73.74 179.79 4.02 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.752 2.021 . . . . 0.0 109.952 178.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.6 p -69.84 8.01 0.79 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.239 1.416 . . . . 0.0 112.83 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.411 ' H ' ' C ' ' A' ' 20' ' ' ASN . 12.6 mt -98.5 137.25 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -170.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -145.93 137.88 25.2 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 -176.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.5 132.21 53.85 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 -173.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.5 mp -105.84 119.74 55.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 176.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.426 ' CG ' HD13 ' A' ' 35' ' ' ILE . 81.6 m-85 -93.06 81.15 4.54 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 102.657 -3.09 . . . . 0.0 102.657 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -96.9 -28.82 14.04 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.998 0.919 . . . . 0.0 110.457 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.53 141.61 53.83 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.1 t -55.03 -46.92 75.32 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.143 0.883 . . . . 0.0 112.481 -175.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -68.65 -24.84 64.58 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.591 1.156 . . . . 0.0 110.899 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.9 p -69.87 -40.97 75.41 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.766 0.712 . . . . 0.0 109.482 176.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 53.9 mt -66.06 -46.65 87.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.566 1.146 . . . . 0.0 108.304 177.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.97 -24.87 67.28 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -165.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.426 ' HE2' ' O ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -65.73 -54.85 21.68 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 123.132 0.573 . . . . 0.0 109.49 172.251 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.426 HD13 ' CG ' ' A' ' 26' ' ' TYR . 18.6 mt -57.01 -40.42 72.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 125.674 1.59 . . . . 0.0 109.307 -169.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.37 -21.48 5.88 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.837 1.655 . . . . 0.0 113.399 175.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.8 t -64.46 -68.36 0.36 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 120.434 1.47 . . . . 0.0 109.011 164.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -65.98 -24.93 66.88 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.05 0.54 . . . . 0.0 111.41 -168.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.5 mm -59.56 -29.43 42.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 O-C-N 120.751 -1.218 . . . . 0.0 110.549 172.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.33 -8.74 41.11 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 120.347 1.431 . . . . 0.0 113.441 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 t -69.93 -16.84 63.28 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.018 0.927 . . . . 0.0 113.337 -164.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.28 156.47 18.5 Favored Glycine 0 C--N 1.335 0.512 0 O-C-N 120.75 -1.219 . . . . 0.0 112.865 -171.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.7 pttm -112.83 111.2 21.8 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 175.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.8 ptt-85 -58.49 -5.11 0.48 Allowed 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.982 0.81 . . . . 0.0 112.594 169.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . 0.259 10.4 p 64.44 -164.67 0.25 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.545 1.538 . . . . 0.0 107.819 -176.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -101.21 4.5 41.97 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.909 1.231 . . . . 0.0 111.845 171.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -67.77 153.27 44.08 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 122.066 0.936 . . . . 0.0 110.357 176.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -85.77 121.32 28.27 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.989 1.716 . . . . 0.0 107.68 169.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.2 t -74.09 152.04 40.01 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 158.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.2 pt -138.14 11.79 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 126.083 1.753 . . . . 0.0 110.28 172.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -99.91 173.87 6.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.738 1.215 . . . . 0.0 109.577 178.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.55 -7.42 2.87 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.05 1.74 . . . . 0.0 110.446 174.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -151.72 158.93 33.9 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 127.329 2.251 . . . . 0.0 109.359 -174.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.01 -179.76 5.74 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.467 3.445 . . . . 0.0 112.425 178.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.87 -6.67 11.0 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.855 1.662 . . . . 0.0 112.021 176.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.14 149.82 40.8 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 120.818 -1.176 . . . . 0.0 109.496 173.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -75.03 -30.5 61.09 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.509 0.723 . . . . 0.0 109.756 169.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -114.43 108.09 16.42 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.774 1.63 . . . . 0.0 107.471 -172.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -137.15 168.72 19.06 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 126.521 1.929 . . . . 0.0 107.099 169.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.23 166.52 13.0 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 161.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 73.8 m -124.92 120.68 32.3 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.157 0.983 . . . . 0.0 108.873 -167.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.81 126.37 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -171.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -121.17 128.79 52.84 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 171.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 19.6 mt -114.94 88.61 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 171.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -56.38 106.77 0.31 Allowed 'General case' 0 C--O 1.239 0.52 0 C-N-CA 126.886 2.074 . . . . 0.0 108.217 163.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -153.43 148.68 26.94 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.671 1.189 . . . . 0.0 109.93 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 54.76 28.49 10.3 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.02 41.25 71.8 Favored Glycine 0 CA--C 1.527 0.833 0 O-C-N 121.151 -0.968 . . . . 0.0 110.768 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.69 -172.13 36.71 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 127.676 2.56 . . . . 0.0 108.458 174.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -147.15 146.73 29.99 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 119.045 1.423 . . . . 0.0 113.281 174.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.2 t -82.61 164.27 20.9 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 165.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.4 m -135.83 146.36 47.42 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 126.661 1.984 . . . . 0.0 106.912 171.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.0 ptp -165.39 167.99 17.17 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.017 1.727 . . . . 0.0 108.249 168.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -140.25 142.15 35.8 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.563 1.545 . . . . 0.0 107.96 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.435 ' CD1' HG13 ' A' ' 84' ' ' ILE . 0.3 OUTLIER -125.9 153.61 43.96 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.833 1.197 . . . . 0.0 109.623 176.791 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -155.32 -175.7 5.57 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.625 1.57 . . . . 0.0 107.554 -175.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -111.86 144.62 40.88 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.708 1.603 . . . . 0.0 108.571 170.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -144.76 110.64 5.41 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 122.524 1.154 . . . . 0.0 111.096 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 66.92 4.84 3.7 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.286 1.834 . . . . 0.0 113.995 176.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 121.77 -5.34 10.63 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.573 1.082 . . . . 0.0 113.5 171.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -105.37 157.82 17.07 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 119.132 1.466 . . . . 0.0 108.443 162.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -93.82 152.4 18.93 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 169.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -143.71 162.29 36.36 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.298 0.639 . . . . 0.0 110.648 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.435 HG13 ' CD1' ' A' ' 75' ' ' TYR . 3.9 mp -117.65 124.68 73.39 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 C-N-CA 125.581 1.552 . . . . 0.0 107.824 -178.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -68.06 151.43 47.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 122.41 1.1 . . . . 0.0 109.033 168.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -169.85 167.61 4.96 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 128.729 2.812 . . . . 0.0 106.433 167.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -56.19 -161.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.817 1 C-N-CA 125.905 4.404 . . . . 0.0 110.237 164.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -43.41 -12.16 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.682 1.993 . . . . 0.0 116.009 -172.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.9 mtmt -112.1 62.3 0.62 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 120.432 1.469 . . . . 0.0 111.869 163.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -141.55 61.89 0.53 Allowed Glycine 0 C--N 1.336 0.549 0 CA-C-N 119.679 1.127 . . . . 0.0 114.304 -175.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.2 mt -136.26 46.86 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 173.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -74.99 109.48 8.49 Favored 'General case' 0 CA--C 1.507 -0.701 0 O-C-N 120.967 -1.083 . . . . 0.0 110.851 -175.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -75.57 122.1 23.39 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 165.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.6 pt -115.87 -179.93 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 125.41 1.484 . . . . 0.0 108.157 160.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -137.5 8.82 2.88 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -170.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -135.71 166.54 23.02 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 126.332 1.853 . . . . 0.0 109.134 173.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -78.28 125.51 29.45 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 170.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -62.87 -46.42 87.95 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.93 -0.481 . . . . 0.0 110.258 -178.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -69.2 -11.68 61.01 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.239 1.015 . . . . 0.0 113.052 -175.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -91.06 -14.16 31.83 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.521 1.528 . . . . 0.0 110.642 175.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 5.6 mmt -105.95 -5.22 19.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.887 1.675 . . . . 0.0 112.448 -172.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 15.9 pt . . . . . 0 C--O 1.253 1.266 0 C-N-CA 125.843 1.657 . . . . 0.0 109.555 173.898 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.8 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 48.81 86.65 0.15 Allowed Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 126.909 2.084 . . . . 0.0 114.216 166.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -57.17 167.06 3.62 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.334 1.356 . . . . 0.0 112.051 174.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 64.3 mt -96.74 134.87 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 167.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.28 155.25 61.42 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 128.272 2.629 . . . . 0.0 108.132 -172.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.12 175.45 9.86 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.903 2.402 . . . . 0.0 112.273 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.489 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -77.71 153.63 32.83 Favored 'General case' 0 C--N 1.34 0.189 0 O-C-N 120.624 -1.298 . . . . 0.0 110.412 171.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.26 7.48 6.34 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.658 1.183 . . . . 0.0 112.645 175.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -133.86 5.47 3.63 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.811 1.244 . . . . 0.0 111.037 -169.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -122.94 0.65 9.19 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.927 2.091 . . . . 0.0 112.62 170.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 t -70.65 147.08 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 167.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -85.14 -63.5 1.32 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 161.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.6 p -153.4 170.75 19.92 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.483 0.713 . . . . 0.0 109.343 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.9 mt -125.93 126.49 69.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 173.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.9 t -100.03 133.22 44.73 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 171.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.2 mt -125.99 101.47 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 169.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.06 115.01 21.68 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 104.747 -2.316 . . . . 0.0 104.747 167.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -65.75 173.04 3.05 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.283 1.433 . . . . 0.0 109.927 176.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.0 p -69.67 -20.06 63.58 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 119.667 -1.896 . . . . 0.0 112.017 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 53.4 p30 -85.48 -165.4 1.21 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.731 0.812 . . . . 0.0 110.079 173.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.2 p -76.32 -2.51 31.99 Favored 'General case' 0 C--O 1.239 0.521 0 O-C-N 120.695 -1.253 . . . . 0.0 113.258 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.9 mt -100.47 150.52 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -166.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.78 158.79 43.51 Favored 'General case' 0 N--CA 1.417 -2.076 0 C-N-CA 125.886 1.674 . . . . 0.0 108.812 177.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.65 139.52 42.08 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 174.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.1 mp -111.17 137.77 42.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -111.26 76.12 0.96 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 103.081 -2.933 . . . . 0.0 103.081 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -82.44 -32.37 29.03 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 171.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.92 134.43 48.39 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.226 1.81 . . . . 0.0 108.334 -169.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.0 m -51.09 -47.95 61.78 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.567 0.747 . . . . 0.0 111.777 -174.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -76.82 -17.6 58.91 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.577 0.751 . . . . 0.0 111.557 -173.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 64.9 m -80.34 -38.64 30.15 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.905 1.282 . . . . 0.0 110.433 171.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.49 -53.66 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 171.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -57.79 -30.02 65.33 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.874 0.869 . . . . 0.0 112.515 -173.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.67 -61.33 2.69 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 124.008 0.923 . . . . 0.0 109.239 170.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.0 mt -45.2 -53.83 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 125.15 1.38 . . . . 0.0 111.999 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mp -53.61 -24.73 14.84 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 120.192 1.36 . . . . 0.0 114.354 -175.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.8 t -55.6 -69.74 0.13 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.054 0.843 . . . . 0.0 109.745 172.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -75.88 -10.47 59.46 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.837 1.255 . . . . 0.0 111.169 -167.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.6 mm -69.56 -37.08 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 O-C-N 121.121 -0.987 . . . . 0.0 110.316 168.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.72 -11.73 30.82 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -164.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 52.5 p -62.41 -41.06 98.41 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.541 0.61 . . . . 0.0 111.558 -173.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.89 162.93 54.11 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-O 124.006 1.892 . . . . 0.0 113.354 -166.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.415 ' C ' ' H ' ' A' ' 45' ' ' THR . 20.9 mtmm -125.51 109.08 12.26 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 -174.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 -59.61 -1.8 0.28 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 176.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.415 ' H ' ' C ' ' A' ' 43' ' ' LYS . 16.1 p 64.7 -164.19 0.25 Allowed 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.595 1.958 . . . . 0.0 107.937 -177.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -95.89 -2.54 47.1 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.577 0.626 . . . . 0.0 110.85 168.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -58.32 159.69 5.9 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 119.36 0.982 . . . . 0.0 111.506 -177.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -109.76 116.5 31.79 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.163 -169.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.1 t -98.12 68.85 1.99 Allowed 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 125.481 1.512 . . . . 0.0 108.354 -172.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.2 pt -73.59 19.59 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 126.498 1.919 . . . . 0.0 111.536 -175.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.74 173.96 7.42 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 126.264 1.825 . . . . 0.0 109.728 -167.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.12 -4.16 10.05 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.517 0.727 . . . . 0.0 110.746 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -146.79 155.85 48.14 Favored Pre-proline 0 C--O 1.234 0.266 0 CA-C-N 118.771 0.714 . . . . 0.0 110.24 -172.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -60.03 168.09 6.43 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.18 2.587 . . . . 0.0 110.376 168.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 t -104.03 23.0 13.63 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.913 1.285 . . . . 0.0 108.841 -176.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -114.66 168.95 9.43 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 128.099 2.56 . . . . 0.0 109.139 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -99.38 -29.25 12.88 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.732 1.213 . . . . 0.0 111.143 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -131.58 115.24 15.84 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -173.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -140.9 161.82 36.92 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 125.306 1.443 . . . . 0.0 107.152 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -95.78 166.7 25.15 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.24 108.21 13.02 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -159.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.1 mp -111.19 134.93 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -176.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -132.28 119.06 20.28 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 161.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.2 mt -85.99 112.23 22.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 159.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -79.85 130.28 35.18 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 167.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -149.05 127.09 11.96 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.623 1.569 . . . . 0.0 109.678 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 46.9 45.24 15.17 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.357 1.863 . . . . 0.0 111.93 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.04 -1.59 17.07 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.498 1.047 . . . . 0.0 115.008 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -105.69 -176.73 23.96 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 168.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.2 ptp -154.57 146.94 23.92 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 120.934 -1.333 . . . . 0.0 112.838 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.1 m -103.29 96.24 6.63 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.097 2.159 . . . . 0.0 106.672 176.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.1 m -80.21 151.46 29.65 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.555 0.742 . . . . 0.0 109.249 171.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.25 165.4 5.97 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.947 2.499 . . . . 0.0 108.591 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.533 ' H ' ' HG3' ' A' ' 85' ' ' GLU . 14.1 m-85 -135.78 148.33 48.72 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 127.189 2.196 . . . . 0.0 108.04 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -125.16 162.1 25.38 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.327 0.967 . . . . 0.0 108.628 171.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -158.33 169.07 25.31 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.663 1.185 . . . . 0.0 109.553 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -97.28 142.13 29.54 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.186 1.794 . . . . 0.0 108.285 163.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -148.85 145.13 27.35 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.27 1.028 . . . . 0.0 108.516 169.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 53.43 0.42 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.681 1.992 . . . . 0.0 115.052 -174.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.79 19.35 37.47 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.104 -1.387 . . . . 0.0 113.374 -169.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -118.18 169.67 9.5 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 121.022 2.411 . . . . 0.0 107.571 161.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -108.58 145.57 34.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -142.7 162.22 36.02 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.414 0.685 . . . . 0.0 109.607 -175.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.0 mp -127.38 125.14 65.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 125.533 1.533 . . . . 0.0 108.205 -172.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.533 ' HG3' ' H ' ' A' ' 74' ' ' PHE . 0.5 OUTLIER -75.24 163.62 27.31 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.999 0.904 . . . . 0.0 108.955 172.057 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 178.74 168.5 0.58 Allowed Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 130.136 3.374 . . . . 0.0 104.783 175.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -53.76 -160.45 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.623 1 C-N-CA 125.407 4.071 . . . . 0.0 110.801 164.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -42.31 -10.18 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 128.887 2.875 . . . . 0.0 115.459 -175.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.3 59.94 0.68 Allowed 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.301 1.84 . . . . 0.0 112.678 166.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -137.53 54.19 0.71 Allowed Glycine 0 C--N 1.338 0.679 0 CA-C-N 119.819 1.191 . . . . 0.0 116.04 -174.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.7 mt -137.96 48.04 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 118.32 1.06 . . . . 0.0 108.66 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -76.65 137.05 39.19 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -118.56 91.56 3.59 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -176.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 16.0 pt -95.18 152.11 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 177.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -105.56 16.24 25.74 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.804 0.812 . . . . 0.0 112.279 -173.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -146.05 160.96 41.16 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.096 1.759 . . . . 0.0 111.004 -175.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -87.1 130.32 34.55 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.443 0.565 . . . . 0.0 111.722 -176.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -66.89 -46.57 74.51 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.549 0.739 . . . . 0.0 111.538 175.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -71.52 -19.84 62.13 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -168.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -95.54 -5.7 42.13 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 121.358 -0.839 . . . . 0.0 112.023 172.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 15.5 mmt -90.75 -28.14 18.47 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 117.387 -1.292 . . . . 0.0 112.013 169.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.7 pt . . . . . 0 C--O 1.253 1.258 0 CA-C-N 120.22 1.373 . . . . 0.0 109.594 164.709 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.063 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 m -69.88 166.04 36.33 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 126.001 1.72 . . . . 0.0 112.023 173.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -65.24 177.4 2.58 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.94 2.427 . . . . 0.0 112.227 163.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.6 mm -125.47 74.88 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 127.492 2.317 . . . . 0.0 105.716 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.84 165.94 42.31 Favored Pre-proline 0 N--CA 1.469 0.509 0 O-C-N 120.687 -1.258 . . . . 0.0 110.756 -177.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.564 ' HB2' HD22 ' A' ' 10' ' ' ASN . 38.3 Cg_endo -58.7 165.09 8.55 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 120.686 0.924 . . . . 0.0 109.997 158.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.461 ' HA ' ' HE2' ' A' ' 7' ' ' LYS . 7.0 mmpt? -53.53 169.01 0.14 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.16 0.984 . . . . 0.0 111.174 169.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.9 -57.24 5.29 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 156.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -57.73 -23.04 49.93 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.411 1.484 . . . . 0.0 114.456 -165.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.564 HD22 ' HB2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -95.87 -0.59 50.82 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -178.206 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.4 t -78.83 153.17 4.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 173.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -108.63 -46.52 3.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 118.501 -0.762 . . . . 0.0 110.163 171.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.4 p -155.27 166.45 33.53 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.039 0.836 . . . . 0.0 110.812 163.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.7 mt -122.07 119.32 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 172.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -103.95 128.68 51.49 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.522 0.729 . . . . 0.0 109.703 175.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.1 mt -127.29 112.21 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -94.1 120.15 33.95 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 165.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -70.47 -171.91 0.54 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.584 1.554 . . . . 0.0 109.987 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 p -69.15 -1.15 7.09 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 119.697 -1.877 . . . . 0.0 113.927 170.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -104.04 -154.57 0.51 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.686 1.994 . . . . 0.0 109.599 -160.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.8 p -81.12 -5.01 57.18 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 129.302 3.041 . . . . 0.0 114.273 155.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.8 mt -104.05 145.63 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.676 1.59 . . . . 0.0 110.583 -159.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -140.52 134.94 31.37 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 120.897 -1.127 . . . . 0.0 109.86 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.04 141.02 47.05 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.3 mm -124.02 156.1 31.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -174.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -142.17 87.97 2.06 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 -165.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -100.53 -21.22 15.39 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.51 1.524 . . . . 0.0 111.457 178.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.12 146.02 46.0 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 t -50.51 -47.06 57.51 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.664 0.786 . . . . 0.0 110.61 171.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -68.5 -31.88 71.46 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.524 -0.735 . . . . 0.0 111.393 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 73.1 m -72.46 -47.43 48.95 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.48 1.512 . . . . 0.0 110.511 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 90.3 mt -59.4 -46.72 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.279 1.432 . . . . 0.0 108.892 174.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.47 -26.28 68.65 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 117.426 -1.273 . . . . 0.0 114.008 -175.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -63.03 -60.01 4.03 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 168.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.0 mt -52.62 -51.03 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 O-C-N 123.879 0.737 . . . . 0.0 109.378 -170.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.8 -14.69 60.02 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -178.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.9 t -76.31 -59.33 2.81 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 120.188 1.358 . . . . 0.0 108.495 163.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -61.21 -7.78 3.07 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.91 1.684 . . . . 0.0 113.558 -176.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.6 mm -114.62 -14.18 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 126.324 1.85 . . . . 0.0 111.212 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.36 -10.66 56.03 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 120.277 -1.514 . . . . 0.0 112.567 171.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.8 t -68.87 -30.4 68.9 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.845 1.258 . . . . 0.0 112.669 -170.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.56 168.41 45.89 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-O 122.089 0.827 . . . . 0.0 112.774 -176.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.98 120.83 20.79 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 124.502 1.121 . . . . 0.0 108.041 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -67.26 1.8 1.95 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.8 p 61.13 -163.8 0.25 Allowed 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 -175.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -108.86 13.18 25.03 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.333 0.653 . . . . 0.0 112.169 161.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.15 158.86 8.2 Favored 'General case' 0 C--O 1.239 0.529 0 O-C-N 120.519 -1.363 . . . . 0.0 108.534 161.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -119.83 130.01 54.7 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 121.305 -0.872 . . . . 0.0 109.222 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.36 160.01 30.35 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 161.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.9 pt -136.01 11.04 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.149 1.379 . . . . 0.0 110.808 168.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.16 175.83 6.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.768 1.227 . . . . 0.0 111.034 -172.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -116.82 -11.86 10.85 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.071 1.348 . . . . 0.0 111.194 -174.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -142.71 160.05 54.95 Favored Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 125.483 1.513 . . . . 0.0 109.857 -172.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -70.95 169.16 21.09 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.202 1.935 . . . . 0.0 112.694 -175.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.18 10.84 34.48 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.449 1.1 . . . . 0.0 111.809 -177.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -107.14 161.94 14.31 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.871 1.269 . . . . 0.0 113.469 -169.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.97 -29.89 35.23 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 126.108 1.763 . . . . 0.0 110.422 165.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -134.88 108.12 7.74 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.907 1.283 . . . . 0.0 109.623 -165.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -145.77 159.9 42.52 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.159 1.384 . . . . 0.0 109.06 -177.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.33 158.56 30.16 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 172.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.84 134.46 44.99 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.475 1.11 . . . . 0.0 108.606 174.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.96 123.64 54.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.11 137.37 46.21 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 159.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 64.7 mt -109.94 105.92 19.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 102.79 -3.041 . . . . 0.0 102.79 160.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -78.12 132.49 37.7 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 169.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -147.37 -171.94 3.9 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.839 1.656 . . . . 0.0 107.573 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.527 ' ND2' ' H ' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -60.09 80.31 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.811 1 C-N-CA 133.867 4.867 . . . . 0.0 110.469 -168.614 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.02 1.64 68.99 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 114.041 -1.436 . . . . 0.0 112.891 -174.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.92 158.12 14.55 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-O 121.719 0.621 . . . . 0.0 112.092 -171.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 7.1 ptm -131.33 133.45 45.35 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 160.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.6 m -118.1 90.9 3.43 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.8 m -84.65 136.78 33.61 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.009 1.324 . . . . 0.0 109.943 -172.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.2 ptp -150.27 171.53 16.8 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.812 1.245 . . . . 0.0 109.722 172.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -142.27 147.7 36.86 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -128.69 151.99 48.9 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.6 1.545 . . . . 0.0 108.592 175.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -154.84 168.61 26.33 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.857 0.863 . . . . 0.0 111.281 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -86.85 141.39 28.82 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.672 1.123 . . . . 0.0 107.992 162.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -139.26 120.29 14.57 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.908 0.861 . . . . 0.0 110.325 160.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 63.97 11.25 5.93 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.141 1.776 . . . . 0.0 113.577 170.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.95 -9.71 18.43 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.932 1.253 . . . . 0.0 112.536 173.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -103.46 159.53 15.5 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.203 1.002 . . . . 0.0 108.71 167.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -108.9 152.54 24.78 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 169.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -141.46 160.19 40.66 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 122.939 0.496 . . . . 0.0 110.225 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.0 mp -122.31 102.52 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 C-N-CA 125.004 1.322 . . . . 0.0 108.126 -171.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -62.08 145.78 52.27 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 122.882 1.325 . . . . 0.0 111.066 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.428 ' HB2' ' HA2' ' A' ' 90' ' ' GLY . 1.0 OUTLIER -164.5 167.72 9.94 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 130.037 3.335 . . . . 0.0 105.816 -178.558 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 89' ' ' LYS . 43.9 Cg_endo -56.46 -162.13 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 124.378 3.386 . . . . 0.0 109.511 166.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -43.04 -15.07 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 129.609 3.164 . . . . 0.0 115.268 -170.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 87' ' ' PRO . 2.6 ptpt -107.06 61.83 0.62 Allowed 'General case' 0 N--CA 1.425 -1.708 0 C-N-CA 130.462 3.505 . . . . 0.0 113.818 167.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.428 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . -122.32 -0.42 10.39 Favored Glycine 0 C--O 1.224 -0.479 0 N-CA-C 116.957 1.543 . . . . 0.0 116.957 -176.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.269 4.1 mt -89.59 48.21 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 O-C-N 120.313 -1.698 . . . . 0.0 109.604 -169.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -74.3 101.83 4.16 Favored 'General case' 0 CA--C 1.504 -0.822 0 O-C-N 120.656 -1.277 . . . . 0.0 108.114 174.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -75.13 128.45 35.52 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 162.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.1 pt -114.63 171.41 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.211 1.004 . . . . 0.0 108.524 159.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -129.71 43.48 3.12 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.853 0.835 . . . . 0.0 110.467 -176.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -159.45 164.41 34.56 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 125.911 1.684 . . . . 0.0 108.389 164.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -66.52 136.71 56.05 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 162.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -80.05 -47.04 15.49 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.647 0.779 . . . . 0.0 111.598 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -58.26 -23.01 54.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.9 2.08 . . . . 0.0 113.309 -172.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -75.47 -19.31 59.5 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.952 1.251 . . . . 0.0 111.785 176.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 16.6 mmt -91.4 -14.16 31.12 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.806 1.242 . . . . 0.0 111.027 -173.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.3 pt . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.016 -1.468 . . . . 0.0 112.937 -170.92 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.687 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.25 165.7 13.05 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 124.448 1.099 . . . . 0.0 112.046 -175.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -62.06 171.4 5.07 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.271 2.647 . . . . 0.0 113.433 172.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.9 mm -87.27 131.01 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 160.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.84 162.55 48.03 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 127.115 2.166 . . . . 0.0 109.522 170.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.611 ' HB2' HD22 ' A' ' 10' ' ' ASN . 48.4 Cg_endo -68.36 -178.77 1.95 Allowed 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.272 2.648 . . . . 0.0 114.082 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.3 mtmt -62.85 166.97 5.03 Favored 'General case' 0 C--N 1.344 0.367 0 O-C-N 119.547 -1.971 . . . . 0.0 109.501 159.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.1 -56.44 5.59 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 162.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -64.58 -22.48 66.98 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -163.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.611 HD22 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -85.41 0.12 53.17 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.323 0.965 . . . . 0.0 113.268 176.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.6 t -74.49 147.24 8.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 171.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.22 -61.26 1.55 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 169.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.6 p -164.49 127.09 2.35 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -175.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.9 mt -90.61 127.73 42.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.0 t -103.51 125.57 50.15 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 174.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.5 mt -123.88 102.09 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 175.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.57 106.33 16.06 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 169.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -59.42 170.97 0.88 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.797 1.639 . . . . 0.0 109.718 -176.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.3 p -59.77 -38.83 82.92 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 120.969 -1.082 . . . . 0.0 111.938 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -73.83 -179.39 3.65 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 127.778 2.431 . . . . 0.0 111.399 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.9 p -71.2 21.3 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.334 2.254 . . . . 0.0 113.862 -174.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.0 mt -136.07 152.18 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 126.182 1.793 . . . . 0.0 106.431 -162.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.6 167.77 18.85 Favored 'General case' 0 N--CA 1.419 -1.987 0 C-N-CA 126.565 1.946 . . . . 0.0 108.701 176.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.64 147.44 35.79 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 165.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.07 126.32 74.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -107.72 85.95 2.21 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 -174.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -110.33 -18.45 13.26 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.631 1.572 . . . . 0.0 110.991 175.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -69.88 146.71 51.06 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 175.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.12 -45.51 83.41 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.45 0.643 . . . . 0.0 112.164 -173.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -70.23 -31.2 68.5 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.197 -0.94 . . . . 0.0 111.708 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 52.8 p -65.94 -43.74 87.12 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 70.9 mt -62.77 -56.82 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.997 1.319 . . . . 0.0 108.758 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -56.65 -37.53 70.91 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 118.66 -0.686 . . . . 0.0 112.25 -172.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.475 ' O ' ' HE3' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -55.68 -59.78 4.37 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 176.537 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.8 mt -56.38 -46.28 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 117.685 -1.15 . . . . 0.0 111.299 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.23 -20.68 2.79 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.619 1.554 . . . . 0.0 114.69 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.89 -53.73 7.98 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.95 0.9 . . . . 0.0 111.509 172.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -59.27 -35.33 73.53 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.949 -1.094 . . . . 0.0 110.342 177.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 21.2 mm -61.55 -24.46 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 120.532 -1.355 . . . . 0.0 111.168 175.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -98.09 -6.6 31.34 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.883 1.22 . . . . 0.0 113.145 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 t -70.78 -34.14 71.48 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.052 0.842 . . . . 0.0 109.652 -168.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.25 167.75 47.63 Favored Glycine 0 C--N 1.341 0.842 0 O-C-N 120.771 -1.205 . . . . 0.0 113.863 -173.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -131.59 110.25 10.81 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 -174.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.421 ' HB3' ' CE1' ' A' ' 92' ' ' TYR . 13.3 ptt-85 -60.06 -8.53 2.43 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -176.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . 0.272 1.4 p 57.36 172.52 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 127.743 2.417 . . . . 0.0 109.846 -169.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -83.24 2.29 36.57 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.421 -1.424 . . . . 0.0 111.594 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt -65.34 158.87 25.33 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 122.049 0.928 . . . . 0.0 110.182 174.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -90.55 130.04 36.63 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 165.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.1 m -75.18 158.87 32.32 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 153.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.9 pt -142.52 31.76 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 125.0 1.32 . . . . 0.0 110.336 174.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -131.15 172.54 12.0 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.953 1.701 . . . . 0.0 108.217 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.55 -0.67 2.89 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.26 1.024 . . . . 0.0 110.996 177.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -146.01 160.65 42.63 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 127.377 2.271 . . . . 0.0 108.607 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -80.33 177.99 7.59 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.452 2.768 . . . . 0.0 112.076 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.9 4.28 8.05 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.713 1.205 . . . . 0.0 112.399 175.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.41 150.72 46.96 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.306 1.042 . . . . 0.0 110.217 170.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -74.56 -28.64 61.03 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.995 0.518 . . . . 0.0 110.062 172.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -129.99 127.73 40.59 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.157 1.383 . . . . 0.0 109.183 -176.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -154.27 161.94 41.49 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.704 2.002 . . . . 0.0 108.147 176.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -90.73 159.63 27.02 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 171.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.34 137.27 38.99 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.16 130.75 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -125.07 130.21 51.8 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 163.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 62.0 mt -106.76 83.57 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 171.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.77 118.49 5.36 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.941 1.246 . . . . 0.0 109.274 167.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -144.88 119.9 10.04 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.675 1.59 . . . . 0.0 108.271 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 60.87 22.98 13.04 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.774 1.63 . . . . 0.0 112.219 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.54 -3.27 42.65 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.51 1.052 . . . . 0.0 113.224 -174.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.88 178.17 51.11 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 156.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 19.7 ptp -159.39 161.27 35.61 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.542 -0.975 . . . . 0.0 112.768 177.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.4 m -118.72 112.26 19.54 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.016 1.726 . . . . 0.0 106.914 172.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.0 m -81.19 147.27 30.09 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 168.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 2.6 ptp -160.11 171.49 19.19 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.164 1.786 . . . . 0.0 108.153 165.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -142.74 146.42 34.3 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.247 1.819 . . . . 0.0 106.474 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.402 ' CD1' HG13 ' A' ' 84' ' ' ILE . 0.6 OUTLIER -128.51 153.5 47.1 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.788 1.631 . . . . 0.0 109.807 175.857 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -153.48 174.86 13.85 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.807 1.243 . . . . 0.0 110.267 -175.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -105.98 144.02 33.29 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.429 1.892 . . . . 0.0 107.961 169.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -151.49 131.1 13.07 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 176.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 55.3 14.51 1.1 Allowed 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.89 -1.131 . . . . 0.0 113.487 -176.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.51 12.09 73.37 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 120.505 -1.372 . . . . 0.0 111.888 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.96 165.07 11.85 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.563 1.945 . . . . 0.0 107.371 163.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -112.24 150.92 30.23 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.083 0.856 . . . . 0.0 108.75 178.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -141.03 159.48 42.12 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.895 0.378 . . . . 0.0 111.167 -178.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.402 HG13 ' CD1' ' A' ' 75' ' ' TYR . 3.5 mp -117.73 129.96 73.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 125.534 1.534 . . . . 0.0 108.45 178.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -73.63 150.03 41.63 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 122.847 1.308 . . . . 0.0 109.831 169.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -169.72 167.44 5.16 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 129.24 3.016 . . . . 0.0 105.928 174.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -59.67 -160.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 125.175 3.917 . . . . 0.0 109.531 162.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -42.77 -9.24 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 128.472 2.709 . . . . 0.0 117.058 -169.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -107.46 21.97 16.67 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 173.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -105.49 44.01 1.56 Allowed Glycine 0 N--CA 1.45 -0.429 0 CA-C-O 118.587 -1.118 . . . . 0.0 115.872 -167.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.4 mt -109.35 46.56 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 119.752 1.776 . . . . 0.0 108.767 171.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.421 ' CE1' ' HB3' ' A' ' 44' ' ' ARG . 72.3 m-85 -71.89 103.57 3.21 Favored 'General case' 0 CA--C 1.51 -0.582 0 O-C-N 121.193 -0.942 . . . . 0.0 108.767 177.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -68.49 126.91 31.12 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 157.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.9 pt -117.74 161.1 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 154.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -104.39 -9.49 18.43 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.658 -0.651 . . . . 0.0 110.774 -176.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -137.81 144.78 41.69 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 124.401 1.08 . . . . 0.0 110.489 -172.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -65.4 124.31 21.91 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 126.388 1.875 . . . . 0.0 112.291 -172.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -63.72 -48.75 75.81 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.808 1.243 . . . . 0.0 110.986 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -65.13 -9.71 25.07 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -174.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -109.22 -9.0 15.03 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.889 1.222 . . . . 0.0 111.819 173.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 10.9 mmt -89.6 -19.95 24.33 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.048 1.339 . . . . 0.0 111.775 174.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 18.3 pt . . . . . 0 C--O 1.255 1.363 0 C-N-CA 124.124 0.969 . . . . 0.0 110.947 174.27 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.737 0 CA-C-O 119.01 -0.884 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.4 m 75.8 165.54 0.13 Allowed Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 127.261 2.224 . . . . 0.0 112.186 -163.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.53 -173.21 0.11 Allowed 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.842 3.028 . . . . 0.0 111.816 158.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.8 mt -124.27 119.78 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 164.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.7 157.14 76.18 Favored Pre-proline 0 C--O 1.239 0.542 0 C-N-CA 125.324 1.449 . . . . 0.0 109.135 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.516 ' HB2' HD22 ' A' ' 10' ' ' ASN . 71.6 Cg_endo -71.25 165.46 32.37 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.761 2.307 . . . . 0.0 111.513 176.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -64.46 154.78 34.77 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.335 -0.853 . . . . 0.0 111.261 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.24 -50.5 72.69 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.394 0.997 . . . . 0.0 108.963 167.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -67.45 -16.84 64.44 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -169.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.516 HD22 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -104.38 1.89 30.66 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 119.582 1.083 . . . . 0.0 113.549 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 t -83.66 135.89 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 172.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -83.82 -60.36 2.14 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.4 p -148.75 169.88 19.46 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.362 1.465 . . . . 0.0 109.553 169.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.3 mt -124.84 144.48 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 N-CA-C 104.578 -2.378 . . . . 0.0 104.578 171.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.83 145.16 49.92 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 174.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.0 mt -134.66 105.74 6.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 178.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -86.37 110.59 19.79 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 102.839 -3.023 . . . . 0.0 102.839 174.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -66.12 173.28 3.18 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 174.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.3 p -56.85 -20.32 22.24 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -103.76 -175.83 2.91 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.197 1.399 . . . . 0.0 109.413 -178.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.4 p -75.65 42.38 0.22 Allowed 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.768 2.027 . . . . 0.0 111.655 -178.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.6 mt -140.11 136.35 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 126.196 1.798 . . . . 0.0 106.313 -172.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.38 150.59 46.7 Favored 'General case' 0 N--CA 1.421 -1.918 0 C-N-CA 125.427 1.491 . . . . 0.0 109.135 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.44 ' HE2' ' CZ ' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -125.28 142.11 51.69 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.377 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.44 145.33 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.44 ' CZ ' ' HE2' ' A' ' 24' ' ' LYS . 24.3 m-85 -127.24 82.49 2.09 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -170.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -88.34 -19.53 26.55 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.378 1.471 . . . . 0.0 112.102 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.99 139.81 30.48 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.47 1.108 . . . . 0.0 111.242 -174.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.4 t -45.2 -54.57 6.77 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 126.463 1.905 . . . . 0.0 112.896 -177.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -67.14 -38.99 86.49 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.527 -0.733 . . . . 0.0 109.753 -173.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.4 m -65.9 -6.42 12.28 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.304 1.842 . . . . 0.0 113.389 171.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -100.66 -45.54 11.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 120.451 1.478 . . . . 0.0 109.316 171.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -60.38 -33.0 71.84 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.885 0.874 . . . . 0.0 112.887 -174.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.13 -52.28 43.64 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.672 0.669 . . . . 0.0 110.39 176.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.2 mt -49.24 -52.0 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 119.43 1.014 . . . . 0.0 110.546 173.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.9 mt -56.81 -21.32 27.93 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -177.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.5 t -67.19 -65.37 0.69 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.485 1.039 . . . . 0.0 108.56 168.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.39 -29.87 70.13 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.48 -0.763 . . . . 0.0 110.544 -168.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.96 -20.29 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.325 1.05 . . . . 0.0 111.141 174.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.71 -3.47 8.74 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 120.004 1.275 . . . . 0.0 114.222 -170.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 t -66.38 -40.15 89.51 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.586 0.754 . . . . 0.0 110.335 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.64 172.32 53.94 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-O 123.134 1.408 . . . . 0.0 114.19 -169.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -140.7 121.63 14.55 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 114.238 -0.981 . . . . 0.0 108.41 -173.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -63.82 -4.85 3.53 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.521 1.528 . . . . 0.0 114.796 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.1 p 59.83 -164.55 0.22 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.2 1.8 . . . . 0.0 108.379 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -100.31 8.81 43.46 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 120.235 -1.54 . . . . 0.0 112.48 173.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -64.06 154.21 35.06 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.736 -0.602 . . . . 0.0 109.93 173.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -94.81 123.76 38.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 165.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.2 t -70.98 151.73 44.34 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 147.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 pp -141.33 7.57 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.866 2.066 . . . . 0.0 109.687 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.11 162.14 24.17 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.535 1.934 . . . . 0.0 109.76 -174.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -102.3 -1.57 30.77 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.121 0.968 . . . . 0.0 110.699 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -141.55 147.32 45.56 Favored Pre-proline 0 C--O 1.235 0.305 0 CA-C-N 119.394 0.997 . . . . 0.0 111.532 -172.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -67.98 162.08 41.41 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.218 3.279 . . . . 0.0 111.402 -176.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.81 35.66 1.66 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.048 2.139 . . . . 0.0 109.235 174.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.8 152.79 41.84 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.765 1.626 . . . . 0.0 110.292 173.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -87.67 -29.32 21.23 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.681 -172.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -128.13 118.44 23.41 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 176.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -138.19 156.47 47.68 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.641 1.576 . . . . 0.0 108.209 175.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.37 -178.0 16.49 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 125.822 1.677 . . . . 0.0 110.12 171.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 36.5 m -131.75 137.17 48.1 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 117.731 0.765 . . . . 0.0 111.953 -158.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 mp -118.72 135.2 59.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 126.179 1.791 . . . . 0.0 107.018 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -127.67 125.45 40.1 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 172.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.7 mt -99.87 118.24 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.116 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 168.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -82.25 133.1 35.23 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 165.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -140.26 -162.72 1.39 Allowed 'General case' 0 C--N 1.327 -0.404 0 O-C-N 120.845 -1.159 . . . . 0.0 108.05 173.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -44.77 -35.74 2.87 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 129.886 3.275 . . . . 0.0 115.565 -157.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -176.13 20.41 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 124.895 1.235 . . . . 0.0 110.39 -167.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -165.18 170.72 40.28 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 171.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.9 ptt? -118.84 156.1 30.03 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.3 1.44 . . . . 0.0 109.834 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 m -126.87 108.02 10.63 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -176.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.4 m -108.52 143.61 37.29 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.705 0.802 . . . . 0.0 110.271 -172.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.94 165.98 33.78 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.526 1.531 . . . . 0.0 109.306 172.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -112.84 176.36 5.05 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.691 1.597 . . . . 0.0 108.928 170.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -142.7 165.62 26.88 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.278 1.431 . . . . 0.0 108.593 170.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -158.46 170.8 21.39 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.111 0.869 . . . . 0.0 112.267 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -106.53 134.29 49.9 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 162.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.31 -162.52 0.08 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 125.824 1.65 . . . . 0.0 106.888 153.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -74.28 50.97 0.41 Allowed 'General case' 0 C--N 1.321 -0.66 0 O-C-N 119.952 -1.717 . . . . 0.0 111.316 174.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 122.07 -14.97 8.91 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 125.108 1.337 . . . . 0.0 112.286 166.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -89.18 154.35 20.21 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.481 1.14 . . . . 0.0 110.728 165.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -114.79 152.68 31.7 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.776 0.716 . . . . 0.0 111.264 -178.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -152.23 163.68 38.93 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.84 0.856 . . . . 0.0 111.879 -169.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.9 mp -131.14 132.58 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.708 1.603 . . . . 0.0 109.767 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.1 tp10 -85.0 165.39 17.6 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.181 2.192 . . . . 0.0 109.994 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 174.43 168.31 0.32 Allowed Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 128.032 2.533 . . . . 0.0 107.289 -164.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.41 ' C ' ' H ' ' A' ' 89' ' ' LYS . 39.5 Cg_endo -59.2 -161.27 0.02 OUTLIER 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.338 2.692 . . . . 0.0 109.672 160.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -42.57 -6.74 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 130.397 3.479 . . . . 0.0 117.733 -170.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 87' ' ' PRO 0.266 1.2 ptpt -109.72 13.4 23.74 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 129.758 3.223 . . . . 0.0 113.285 179.531 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.18 49.98 2.17 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 123.78 0.705 . . . . 0.0 114.25 -168.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.1 mt -127.79 46.22 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 176.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -72.85 96.38 2.07 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 173.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -74.43 121.08 20.88 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 166.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 27.3 pt -115.75 169.44 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.485 1.114 . . . . 0.0 109.553 166.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -128.37 49.99 2.13 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.24 0.616 . . . . 0.0 109.951 -178.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -166.7 165.21 16.6 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.554 1.541 . . . . 0.0 110.785 165.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -73.62 131.65 41.91 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.194 0.998 . . . . 0.0 108.996 174.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -72.38 -49.14 36.16 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.798 0.727 . . . . 0.0 111.742 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -70.91 -26.13 63.07 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.337 -0.852 . . . . 0.0 113.023 -168.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -72.11 -19.58 61.77 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.153 0.888 . . . . 0.0 111.425 171.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 17.1 mmt -105.81 24.06 12.91 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.571 1.948 . . . . 0.0 111.965 -171.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.2 pt . . . . . 0 C--O 1.257 1.448 0 C-N-CA 125.188 1.395 . . . . 0.0 109.836 169.581 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.954 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 m 62.59 167.19 0.1 Allowed Pre-proline 0 CA--C 1.547 0.851 0 CA-C-N 118.914 1.357 . . . . 0.0 114.298 158.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.77 161.54 45.53 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 O-C-N 118.716 -1.255 . . . . 0.0 111.141 166.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.7 mt -116.45 104.79 17.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.42 158.84 68.37 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 126.986 2.114 . . . . 0.0 110.676 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.409 ' HB2' HD22 ' A' ' 10' ' ' ASN . 68.6 Cg_endo -68.77 -175.43 0.93 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.6 2.867 . . . . 0.0 112.662 177.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt -60.82 175.94 0.44 Allowed 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.109 -1.62 . . . . 0.0 109.569 162.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.18 -50.01 10.11 Favored 'General case' 0 C--O 1.221 -0.428 0 O-C-N 121.255 -0.903 . . . . 0.0 109.539 163.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -62.13 -12.31 18.94 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.683 1.593 . . . . 0.0 114.771 -168.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.409 HD22 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -104.83 -0.62 27.0 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.71 2.004 . . . . 0.0 113.187 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 66.5 t -86.01 130.17 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 172.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -67.26 -69.52 0.31 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 167.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.6 m -149.51 170.53 18.4 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.112 0.965 . . . . 0.0 109.984 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.1 mt -131.75 132.97 61.81 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.994 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 172.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.6 m -99.68 133.0 44.65 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 112.787 -2.006 . . . . 0.0 106.069 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.0 mt -133.99 103.65 5.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 170.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -93.97 98.93 11.37 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.172 1.789 . . . . 0.0 106.274 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -60.74 172.83 0.85 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.469 1.908 . . . . 0.0 111.55 -169.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.3 p -51.83 -42.59 62.66 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.962 0.905 . . . . 0.0 110.393 171.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -91.64 -179.2 5.28 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.188 1.795 . . . . 0.0 111.338 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 98.2 p -72.87 16.9 0.13 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.313 1.445 . . . . 0.0 114.818 -158.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.8 mt -120.8 139.91 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -161.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -124.19 107.13 10.89 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 174.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.26 139.85 42.81 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 166.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.0 mt -118.17 136.15 56.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 168.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -110.86 73.87 0.84 Allowed 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 104.243 -2.502 . . . . 0.0 104.243 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -82.12 16.1 2.09 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.808 1.243 . . . . 0.0 111.72 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.51 140.44 52.2 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.707 1.203 . . . . 0.0 109.94 -167.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.8 t -55.75 -46.07 77.92 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.92 0.888 . . . . 0.0 111.636 -175.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -73.66 -31.85 63.68 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.378 -0.826 . . . . 0.0 112.111 -175.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.4 m -65.8 -43.29 89.14 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 127.685 2.394 . . . . 0.0 111.036 174.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.5 mt -64.76 -52.11 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 172.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -60.81 -21.93 63.63 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.401 ' HZ3' ' C ' ' A' ' 102' ' ' ILE . 9.4 ttmt -65.16 -67.56 0.43 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 119.57 1.077 . . . . 0.0 108.495 166.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.6 mt -50.65 -44.48 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.549 1.14 . . . . 0.0 110.543 -170.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.82 -12.4 0.79 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 177.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.4 t -84.44 -62.94 1.43 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.041 2.136 . . . . 0.0 110.814 168.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -57.65 -14.7 5.88 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.646 1.112 . . . . 0.0 113.435 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.4 mm -82.3 -49.66 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 124.429 1.092 . . . . 0.0 110.736 169.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.96 -19.78 46.32 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.342 1.057 . . . . 0.0 113.713 -173.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 t -68.51 -17.4 64.16 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.668 1.187 . . . . 0.0 112.87 -176.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.62 140.2 40.37 Favored Glycine 0 C--N 1.336 0.557 0 O-C-N 119.612 -1.93 . . . . 0.0 112.389 176.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.408 ' C ' ' H ' ' A' ' 45' ' ' THR . 6.6 ptpp? -108.41 107.34 17.86 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 161.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.7 ptt85 -59.79 -6.48 1.25 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.712 1.142 . . . . 0.0 113.109 168.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.408 ' H ' ' C ' ' A' ' 43' ' ' LYS . 11.8 p 61.33 -174.85 0.13 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.688 1.595 . . . . 0.0 110.736 -178.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -74.94 -12.71 60.41 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.23 -1.544 . . . . 0.0 112.216 176.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -71.92 171.31 11.99 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.117 0.961 . . . . 0.0 111.35 -167.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -110.74 128.43 55.73 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.824 1.25 . . . . 0.0 108.173 173.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.5 t -74.94 162.58 28.48 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 156.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.9 pt -146.52 31.69 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 126.489 1.915 . . . . 0.0 109.83 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -139.63 172.23 13.09 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 120.99 -1.069 . . . . 0.0 111.64 -172.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -111.12 -20.36 12.39 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.428 1.891 . . . . 0.0 111.52 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -147.26 158.27 44.46 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 124.025 0.93 . . . . 0.0 110.676 -165.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -70.29 175.55 8.39 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.737 2.958 . . . . 0.0 111.699 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.27 -5.12 11.83 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.509 1.524 . . . . 0.0 111.539 175.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.44 157.8 36.4 Favored 'General case' 0 N--CA 1.457 -0.114 0 O-C-N 120.837 -1.165 . . . . 0.0 109.249 169.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.16 -21.66 21.05 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.602 0.761 . . . . 0.0 111.283 168.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -127.96 103.01 7.01 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -169.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -146.56 177.48 9.03 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 128.601 2.76 . . . . 0.0 106.695 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -121.61 166.24 14.45 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 168.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.96 133.07 42.1 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.159 0.984 . . . . 0.0 108.601 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.0 mp -124.33 129.93 73.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -132.64 115.47 15.45 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.0 mt -87.49 103.63 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 173.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -74.76 122.81 23.87 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 172.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -141.67 -157.21 0.75 Allowed 'General case' 0 N--CA 1.465 0.299 0 O-C-N 120.866 -1.146 . . . . 0.0 110.502 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -44.56 -21.21 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 1 C-N-CA 132.796 4.438 . . . . 0.0 116.501 -160.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 153.03 32.19 0.03 OUTLIER Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 126.048 1.785 . . . . 0.0 108.954 -162.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -172.97 174.1 45.77 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.2 ptp -117.93 160.29 21.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.909 1.684 . . . . 0.0 109.351 176.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.6 m -123.29 104.75 9.33 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 158.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.6 m -82.84 141.8 32.0 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.339 1.456 . . . . 0.0 108.591 172.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -165.32 167.99 17.31 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.355 1.862 . . . . 0.0 108.309 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -146.01 138.75 25.64 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.787 1.635 . . . . 0.0 107.421 -174.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -126.06 142.88 51.33 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 121.06 1.754 . . . . 0.0 109.732 -177.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -149.52 173.74 13.27 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.564 1.146 . . . . 0.0 111.583 -174.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -103.45 144.9 30.79 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.284 1.433 . . . . 0.0 108.883 166.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -144.97 126.98 15.52 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.033 0.933 . . . . 0.0 109.313 173.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.14 3.84 1.42 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.847 2.059 . . . . 0.0 114.824 176.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.7 -0.37 15.52 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-N 119.579 1.081 . . . . 0.0 113.315 -173.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.5 tptt -133.87 149.94 51.35 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 119.358 1.579 . . . . 0.0 110.177 -169.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -101.52 135.53 42.86 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -168.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -129.55 159.53 36.06 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.05 0.54 . . . . 0.0 111.055 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.9 mp -122.05 117.91 53.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 125.073 1.349 . . . . 0.0 108.428 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -65.25 145.6 56.03 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 122.793 1.282 . . . . 0.0 109.655 173.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -171.2 165.76 4.56 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 127.442 2.297 . . . . 0.0 106.532 175.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.404 ' O ' ' N ' ' A' ' 89' ' ' LYS . 94.2 Cg_endo -63.35 -161.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.769 1 C-N-CA 125.401 4.067 . . . . 0.0 109.517 174.49 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -43.41 -13.98 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 117.065 2.246 . . . . 0.0 117.065 -170.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 87' ' ' PRO . 2.8 mtmt -103.18 31.54 4.22 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 126.237 1.815 . . . . 0.0 114.224 169.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -118.23 69.8 0.32 Allowed Glycine 0 C--O 1.221 -0.693 0 C-N-CA 124.566 1.079 . . . . 0.0 111.963 -174.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.1 mt -133.39 53.01 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 166.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -75.44 108.67 8.4 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 121.463 -0.773 . . . . 0.0 109.029 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -83.37 125.06 31.26 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 163.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.8 pt -113.32 167.31 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.164 1.385 . . . . 0.0 108.726 164.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -124.95 46.53 2.32 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.388 0.613 . . . . 0.0 110.853 -174.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -177.13 169.63 2.29 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 127.456 2.302 . . . . 0.0 109.311 168.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -74.75 138.08 42.45 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.653 1.181 . . . . 0.0 109.739 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -79.4 -44.84 20.66 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.283 1.033 . . . . 0.0 111.819 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.0 -12.54 60.16 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.913 1.285 . . . . 0.0 113.623 -171.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -88.72 -22.47 23.34 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.374 1.47 . . . . 0.0 113.011 171.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -81.49 -29.67 33.56 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 121.092 -1.005 . . . . 0.0 110.541 -178.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.401 ' C ' ' HZ3' ' A' ' 34' ' ' LYS . 29.3 pt . . . . . 0 C--O 1.25 1.096 0 C-N-CA 123.876 0.87 . . . . 0.0 110.984 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.888 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 m -79.56 164.55 53.16 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 117.772 0.786 . . . . 0.0 112.805 -169.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -64.14 -179.72 0.9 Allowed 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.799 2.999 . . . . 0.0 112.625 162.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.3 mt -125.58 94.7 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 127.107 2.163 . . . . 0.0 105.575 178.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.82 154.39 37.55 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 126.329 1.851 . . . . 0.0 109.36 -176.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.595 ' HB2' HD22 ' A' ' 10' ' ' ASN . 44.6 Cg_endo -68.62 159.01 55.39 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.606 2.204 . . . . 0.0 112.108 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.39 150.78 38.79 Favored 'General case' 0 C--N 1.345 0.376 0 O-C-N 121.696 -0.628 . . . . 0.0 110.496 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.2 -1.15 5.55 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -122.5 -18.03 6.81 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 119.533 1.061 . . . . 0.0 111.671 -172.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.595 HD22 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -89.11 -6.75 56.81 Favored 'General case' 0 N--CA 1.456 -0.155 0 O-C-N 121.714 -0.616 . . . . 0.0 111.141 170.517 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.8 t -69.06 138.06 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 C-N-CA 125.151 1.38 . . . . 0.0 108.573 169.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.4 -55.88 2.7 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.934 1.694 . . . . 0.0 107.787 173.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.7 p -172.67 121.47 0.41 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.508 0.595 . . . . 0.0 111.119 178.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.7 mt -75.39 129.89 36.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 173.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 t -105.58 148.73 26.97 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 166.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.7 mt -139.0 104.83 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 172.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.8 110.06 18.54 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 104.146 -2.539 . . . . 0.0 104.146 165.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -66.21 -176.43 0.42 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.222 1.009 . . . . 0.0 110.999 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.1 p -57.62 -50.55 72.79 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 120.799 -1.188 . . . . 0.0 109.96 173.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.95 -178.48 2.8 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.701 0.762 . . . . 0.0 109.644 173.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 m -80.94 17.28 1.23 Allowed 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.889 -1.132 . . . . 0.0 111.258 -175.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.7 mt -90.14 134.48 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -127.85 142.93 51.15 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.83 149.22 52.52 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 123.567 0.747 . . . . 0.0 109.214 175.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.1 mp -121.8 147.43 25.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -127.45 76.79 1.7 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 -168.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -105.01 5.21 32.41 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.804 1.241 . . . . 0.0 112.613 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -81.72 144.49 31.1 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 166.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 28.6 t -57.83 -41.35 82.08 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.421 -1.424 . . . . 0.0 111.663 174.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.44 -33.78 76.66 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 120.658 -1.276 . . . . 0.0 111.994 178.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.2 p -63.05 -43.09 99.6 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.848 0.859 . . . . 0.0 109.538 175.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 93.0 mt -68.41 -54.5 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 124.62 1.168 . . . . 0.0 108.892 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -58.09 -32.88 68.49 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.706 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -61.68 -64.32 0.98 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 118.551 -0.738 . . . . 0.0 110.233 171.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 81.4 mt -51.6 -48.68 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 119.199 -0.429 . . . . 0.0 110.072 -173.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.6 mt -53.47 -24.9 14.27 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.2 t -63.91 -63.1 1.25 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.775 1.23 . . . . 0.0 110.072 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -68.87 -24.17 64.31 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.889 0.852 . . . . 0.0 110.724 -174.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.9 mm -68.15 -13.33 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 O-C-N 120.48 -1.387 . . . . 0.0 111.21 171.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.64 -8.45 11.46 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -176.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.4 p -67.77 -40.6 84.01 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.648 1.113 . . . . 0.0 111.608 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.77 164.52 54.59 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-O 123.117 1.398 . . . . 0.0 114.299 -165.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.448 ' C ' ' H ' ' A' ' 45' ' ' THR . 91.6 mttt -115.91 110.49 19.07 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 105.107 -2.182 . . . . 0.0 105.107 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.434 ' HB3' ' CE2' ' A' ' 92' ' ' TYR . 10.3 ptt180 -56.55 -3.95 0.13 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.872 1.269 . . . . 0.0 114.36 174.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.448 ' H ' ' C ' ' A' ' 43' ' ' LYS . 27.7 p 62.7 172.95 0.14 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 128.752 2.821 . . . . 0.0 110.396 -171.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -78.37 -6.42 55.11 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.004 -1.06 . . . . 0.0 111.666 172.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -66.91 174.01 3.27 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 122.776 1.274 . . . . 0.0 111.981 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -110.75 150.18 29.45 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.23 1.812 . . . . 0.0 107.752 175.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.7 76.69 1.65 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -164.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.2 pt -90.54 36.14 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.531 1.132 . . . . 0.0 110.542 -164.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -125.35 161.63 26.57 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.295 2.238 . . . . 0.0 109.337 -172.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.99 -3.28 8.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.367 -1.288 . . . . 0.0 112.736 -178.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -150.12 164.61 20.0 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 126.262 1.825 . . . . 0.0 108.638 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.28 179.14 3.64 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.258 2.638 . . . . 0.0 112.678 173.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.66 6.29 45.66 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.154 1.381 . . . . 0.0 111.658 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.13 156.43 17.42 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 121.36 -0.837 . . . . 0.0 111.977 -175.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -86.17 -22.23 27.11 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.795 1.638 . . . . 0.0 111.221 170.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -135.1 115.95 14.01 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -143.07 159.95 41.31 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 127.207 2.203 . . . . 0.0 106.003 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.85 162.59 25.32 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 167.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.8 m -118.11 125.24 49.87 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.104 1.361 . . . . 0.0 108.233 -175.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.2 mp -121.35 132.21 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 -172.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -123.53 115.74 22.03 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 175.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.5 mt -91.17 86.08 2.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 173.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -65.45 113.66 4.29 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 173.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -140.66 135.43 31.65 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.588 1.555 . . . . 0.0 108.17 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 61.5 -4.03 0.18 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.919 2.088 . . . . 0.0 115.443 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.8 12.13 26.87 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 119.89 1.223 . . . . 0.0 112.321 -173.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -127.94 -175.96 14.28 Favored Glycine 0 C--N 1.335 0.511 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 165.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.94 138.25 22.88 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 118.122 0.961 . . . . 0.0 113.149 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 86.8 m -75.23 106.03 6.55 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 158.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.4 m -73.55 142.58 46.65 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 163.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -161.09 166.62 27.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.598 1.559 . . . . 0.0 108.727 170.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -140.99 146.88 37.87 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.619 1.568 . . . . 0.0 108.119 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.407 ' CD1' HG13 ' A' ' 84' ' ' ILE . 1.4 m-85 -128.31 147.35 50.61 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 120.211 1.369 . . . . 0.0 108.973 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -148.9 -175.37 4.92 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.97 1.308 . . . . 0.0 110.538 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -119.04 138.92 52.52 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.176 1.79 . . . . 0.0 109.47 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.461 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 7.6 tt0 -142.84 91.21 2.28 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.886 0.874 . . . . 0.0 109.31 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 70.73 19.4 5.99 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 128.214 2.606 . . . . 0.0 112.484 -174.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.15 -3.67 62.12 Favored Glycine 0 C--N 1.335 0.517 0 O-C-N 120.972 -1.08 . . . . 0.0 112.36 168.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -83.8 145.68 28.55 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 154.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -100.29 149.66 23.37 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.461 ' CE1' ' HB3' ' A' ' 78' ' ' GLU . 84.9 m-85 -134.43 135.09 42.29 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 123.173 0.589 . . . . 0.0 109.734 -171.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.407 HG13 ' CD1' ' A' ' 75' ' ' TYR . 3.0 mp -107.18 127.46 62.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -176.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -77.61 152.36 33.93 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.258 1.423 . . . . 0.0 109.943 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -172.79 168.77 2.61 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 129.131 2.972 . . . . 0.0 107.372 177.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -56.04 -161.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 125.009 3.806 . . . . 0.0 110.606 162.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -42.72 -14.69 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 128.695 2.798 . . . . 0.0 115.028 -171.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.15 66.91 0.64 Allowed 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.364 1.466 . . . . 0.0 110.616 166.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.8 53.13 0.77 Allowed Glycine 0 C--O 1.223 -0.542 0 C-N-CA 124.661 1.124 . . . . 0.0 114.953 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.5 mt -131.44 61.15 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.434 ' CE2' ' HB3' ' A' ' 44' ' ' ARG . 23.4 m-85 -87.56 98.27 11.31 Favored 'General case' 0 CA--C 1.521 -0.168 0 O-C-N 121.165 -0.959 . . . . 0.0 109.304 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -79.06 81.37 5.33 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.55 1.54 . . . . 0.0 109.049 176.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 21.8 pt -81.74 159.41 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 O-C-N 120.877 -1.14 . . . . 0.0 109.439 175.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -107.27 10.74 29.75 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -177.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -131.82 147.32 52.48 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 124.787 1.235 . . . . 0.0 112.433 -175.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -74.07 110.26 8.22 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -55.26 -43.0 74.26 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.035 0.934 . . . . 0.0 110.854 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -73.91 -13.06 60.84 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -171.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -90.43 -24.7 20.66 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.022 0.929 . . . . 0.0 110.789 165.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 12.1 mmt -96.54 6.3 49.02 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 126.124 1.77 . . . . 0.0 113.293 -172.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.4 pt . . . . . 0 C--O 1.246 0.873 0 CA-C-N 119.608 1.095 . . . . 0.0 108.343 164.234 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.635 0 CA-C-O 118.883 -0.954 . . . . 0.0 111.279 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 66.05 166.52 0.12 Allowed Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 149.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -70.23 173.37 11.49 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.74 2.294 . . . . 0.0 112.252 156.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.5 mt -120.89 98.06 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 175.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.56 165.06 15.42 Favored Pre-proline 0 C--O 1.239 0.532 0 C-N-CA 125.381 1.472 . . . . 0.0 110.086 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -63.14 -179.81 0.66 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.348 2.032 . . . . 0.0 111.28 161.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.418 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -64.96 -175.4 0.19 Allowed 'General case' 0 C--O 1.232 0.157 0 O-C-N 120.943 -1.098 . . . . 0.0 109.823 165.164 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.66 -42.93 13.02 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 163.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -72.62 -0.6 13.4 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.282 1.433 . . . . 0.0 113.456 -159.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.43 -0.04 8.22 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 129.919 3.287 . . . . 0.0 111.919 -170.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.2 t -84.63 128.5 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 176.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -81.66 -56.42 4.02 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 124.905 1.282 . . . . 0.0 109.416 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.29 155.38 40.45 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.598 0.759 . . . . 0.0 109.348 166.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 51.8 mt -104.14 140.95 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 162.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.8 t -127.61 132.18 49.83 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.2 mt -125.63 106.36 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 174.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.56 110.2 17.45 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 169.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -68.74 170.85 8.68 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.889 1.275 . . . . 0.0 111.255 -174.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.9 p -58.45 -29.6 66.28 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.97 1.708 . . . . 0.0 113.522 176.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.539 ' CG ' ' H ' ' A' ' 21' ' ' SER . 46.9 t30 -86.64 -154.6 0.23 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.771 1.228 . . . . 0.0 108.159 177.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.539 ' H ' ' CG ' ' A' ' 20' ' ' ASN . 23.4 t -102.57 37.33 1.94 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.603 1.961 . . . . 0.0 109.595 -177.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.9 mt -132.02 155.71 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 126.612 1.965 . . . . 0.0 106.749 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.4 164.37 25.84 Favored 'General case' 0 N--CA 1.425 -1.72 0 C-N-CA 127.225 2.21 . . . . 0.0 108.78 171.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.1 135.47 43.24 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 126.39 1.876 . . . . 0.0 106.636 173.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.6 mp -111.72 127.0 69.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 176.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -108.51 80.23 1.33 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -88.7 -5.24 58.24 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.792 1.237 . . . . 0.0 112.085 -178.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.7 150.59 20.21 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.396 1.078 . . . . 0.0 111.552 -175.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -44.71 -64.55 0.68 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.981 2.113 . . . . 0.0 110.739 172.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -62.91 -35.71 80.97 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.111 0.964 . . . . 0.0 111.603 -168.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.6 m -63.8 -49.43 72.93 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 128.41 2.684 . . . . 0.0 110.713 175.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.26 -37.09 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.057 0.943 . . . . 0.0 109.386 174.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.07 -43.07 93.37 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.811 1.244 . . . . 0.0 112.267 -176.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -57.67 -66.45 0.47 Allowed 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 124.538 1.149 . . . . 0.0 108.867 170.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.4 mt -52.16 -45.92 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.768 0.827 . . . . 0.0 111.326 -172.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.91 -7.87 2.72 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.508 -1.37 . . . . 0.0 113.171 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.19 -58.94 2.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.573 2.349 . . . . 0.0 111.029 167.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.6 pm0 -60.36 -20.09 58.1 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 121.072 1.76 . . . . 0.0 113.275 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.7 mm -85.12 -19.83 8.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 125.187 1.395 . . . . 0.0 111.694 173.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.49 -21.26 19.58 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 119.625 1.102 . . . . 0.0 113.321 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.7 t -62.18 -32.63 73.28 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.893 0.877 . . . . 0.0 111.554 -170.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.63 160.49 53.65 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-O 122.983 1.324 . . . . 0.0 113.567 -175.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -125.36 109.98 13.42 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.9 ppt_? -60.18 -10.8 4.9 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.66 1.984 . . . . 0.0 114.31 175.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.1 p 66.04 -179.77 0.2 Allowed 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 128.245 2.618 . . . . 0.0 110.958 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -82.36 2.76 30.78 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.387 -0.821 . . . . 0.0 111.936 173.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -61.92 151.27 35.27 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.994 1.27 . . . . 0.0 110.144 173.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -79.43 154.57 28.86 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.23 -1.35 . . . . 0.0 107.811 162.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.9 117.67 21.39 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 -177.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.7 pt -128.57 43.26 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 119.699 1.136 . . . . 0.0 110.548 -167.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -143.69 160.97 39.75 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.059 1.743 . . . . 0.0 108.252 -177.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.38 -10.67 13.75 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.318 1.047 . . . . 0.0 111.967 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -145.4 157.97 51.68 Favored Pre-proline 0 N--CA 1.467 0.398 0 C-N-CA 125.377 1.471 . . . . 0.0 109.849 -172.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -71.65 169.19 21.64 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.715 2.277 . . . . 0.0 112.504 177.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.6 t -92.08 -9.37 42.89 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.925 1.69 . . . . 0.0 112.442 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.04 158.77 18.52 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.978 -1.076 . . . . 0.0 112.041 -175.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -76.02 -33.51 59.67 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.992 1.317 . . . . 0.0 111.403 171.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -122.71 110.77 15.91 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.7 1.6 . . . . 0.0 106.985 -168.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -148.79 168.2 23.57 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.825 2.05 . . . . 0.0 106.448 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -109.01 167.05 12.81 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 170.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.45 123.3 44.49 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.275 1.03 . . . . 0.0 109.251 -178.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.6 137.52 51.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -128.62 146.68 50.79 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.876 0.87 . . . . 0.0 109.512 165.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.1 mt -114.95 91.36 1.75 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.5 0 N-CA-C 103.055 -2.942 . . . . 0.0 103.055 163.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -62.59 129.68 41.65 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 169.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -144.42 -155.91 0.65 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -55.43 -4.64 0.1 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 130.531 3.532 . . . . 0.0 116.514 -156.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.55 14.83 0.14 Allowed Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 126.474 1.987 . . . . 0.0 110.508 -170.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -147.92 170.42 28.58 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 118.11 0.955 . . . . 0.0 113.214 168.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 31.7 mtp -131.3 108.65 9.81 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 127.456 2.302 . . . . 0.0 106.976 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 78.4 m -74.86 87.63 2.28 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 166.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.8 m -66.31 139.37 58.04 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 172.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 2.1 ptm -160.2 166.39 29.76 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.278 1.431 . . . . 0.0 109.027 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -144.84 143.83 30.82 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.894 1.678 . . . . 0.0 106.683 -173.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -129.68 144.31 51.23 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.608 1.549 . . . . 0.0 109.016 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -146.88 178.75 8.09 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.317 1.447 . . . . 0.0 111.073 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -111.72 140.22 46.53 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.665 1.986 . . . . 0.0 107.655 171.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -138.48 112.6 8.59 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 175.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.14 15.18 3.12 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.95 1.7 . . . . 0.0 114.247 176.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.98 4.68 44.85 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.667 1.127 . . . . 0.0 112.873 172.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.98 161.51 14.4 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 157.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -119.63 154.74 33.54 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -144.04 149.27 36.4 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.783 0.325 . . . . 0.0 111.086 -168.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mp -121.2 119.76 60.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 125.453 1.501 . . . . 0.0 108.193 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -74.46 151.88 39.52 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.708 1.203 . . . . 0.0 110.773 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.407 ' HB2' ' HA2' ' A' ' 90' ' ' GLY . 0.8 OUTLIER -175.08 167.5 1.88 Allowed Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 127.366 2.266 . . . . 0.0 108.486 -177.124 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -55.73 -162.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.802 1 C-N-CA 126.126 4.551 . . . . 0.0 111.347 168.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -43.74 -8.38 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 128.13 2.572 . . . . 0.0 116.733 -175.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.92 70.29 0.77 Allowed 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 119.346 0.975 . . . . 0.0 110.697 159.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . -131.39 33.85 2.7 Favored Glycine 0 C--O 1.225 -0.439 0 N-CA-C 116.839 1.496 . . . . 0.0 116.839 -175.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.6 mt -116.98 50.11 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 118.027 0.914 . . . . 0.0 108.571 175.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -73.82 101.22 3.67 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.513 -1.367 . . . . 0.0 108.726 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -68.01 124.87 24.58 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 163.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 22.0 pt -121.14 163.64 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 124.189 0.996 . . . . 0.0 108.813 156.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -104.46 2.61 31.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.508 -175.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -132.69 154.27 50.33 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -169.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -73.15 104.2 4.14 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.835 2.054 . . . . 0.0 110.034 175.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -56.57 -36.42 69.3 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.46 1.504 . . . . 0.0 110.65 175.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -68.08 -15.86 63.77 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.681 0.792 . . . . 0.0 113.04 -172.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -90.81 -28.44 18.2 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.226 1.01 . . . . 0.0 112.105 169.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 41.4 mtt -68.5 -35.8 78.01 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 118.625 -0.702 . . . . 0.0 109.893 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 32.1 pt . . . . . 0 C--O 1.251 1.152 0 CA-C-O 117.164 -1.398 . . . . 0.0 112.312 -175.377 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.536 0.44 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.07 158.86 13.54 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.738 2.292 . . . . 0.0 111.723 154.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.5 mt -98.21 95.92 4.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 N-CA-C 104.724 -2.325 . . . . 0.0 104.724 165.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.9 166.15 35.36 Favored Pre-proline 0 C--O 1.237 0.428 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 172.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -56.89 173.09 0.59 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 121.15 1.234 . . . . 0.0 111.204 157.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.424 ' HE3' ' CG ' ' A' ' 9' ' ' GLU . 11.7 mtmt -56.87 172.33 0.27 Allowed 'General case' 0 C--N 1.345 0.393 0 O-C-N 120.859 -1.15 . . . . 0.0 110.538 166.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.0 -53.97 8.89 Favored 'General case' 0 C--O 1.221 -0.438 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 158.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.424 ' CG ' ' HE3' ' A' ' 7' ' ' LYS . 1.1 pt-20 -70.56 -7.06 41.07 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 -162.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 41.9 p-10 -100.02 -1.01 38.1 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.983 1.713 . . . . 0.0 112.278 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.0 t -78.36 124.07 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -78.65 -54.03 6.55 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.761 1.624 . . . . 0.0 106.869 -176.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -152.47 167.31 29.19 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.524 1.13 . . . . 0.0 108.658 160.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.8 mt -120.36 127.71 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 164.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.11 136.84 45.09 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 175.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.2 mt -131.08 100.24 4.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.93 113.31 12.08 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 163.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -67.17 176.44 2.19 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.619 1.168 . . . . 0.0 110.099 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.32 -34.14 77.47 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.521 -1.362 . . . . 0.0 112.117 177.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.8 p30 -80.13 -154.69 0.1 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.922 1.689 . . . . 0.0 110.75 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.5 p -91.82 10.63 27.76 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.621 -1.3 . . . . 0.0 113.656 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.9 mt -107.16 151.26 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -170.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -136.46 149.6 48.3 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 173.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.9 143.56 50.93 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 174.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.1 mp -118.25 127.62 75.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.68 ' CG ' HD11 ' A' ' 35' ' ' ILE . 38.6 m-85 -104.03 100.05 9.81 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 -176.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -125.98 -8.81 6.59 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.275 1.03 . . . . 0.0 111.88 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.58 149.99 36.55 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.154 0.982 . . . . 0.0 109.028 167.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.1 m -44.84 -57.02 4.02 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 124.392 1.077 . . . . 0.0 111.447 165.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.97 -29.96 70.92 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.605 0.762 . . . . 0.0 111.79 -174.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.4 p -71.09 -47.56 57.46 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 78.3 mt -63.38 -54.07 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 126.003 1.721 . . . . 0.0 109.169 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -59.19 -37.23 76.9 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 123.479 0.712 . . . . 0.0 111.332 -172.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.95 -50.48 73.6 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.741 0.816 . . . . 0.0 110.353 175.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.68 HD11 ' CG ' ' A' ' 26' ' ' TYR . 91.8 mt -55.49 -55.65 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 174.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.5 -12.19 2.51 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 t -78.08 -67.55 0.72 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 120.265 1.393 . . . . 0.0 109.321 166.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.564 ' O ' HG22 ' A' ' 41' ' ' THR . 71.7 mm-40 -66.0 -27.03 67.82 Favored 'General case' 0 C--O 1.223 -0.313 0 O-C-N 121.167 -0.958 . . . . 0.0 111.094 -171.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.402 HD11 ' CE1' ' A' ' 98' ' ' PHE . 14.1 mm -72.01 -18.3 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 O-C-N 119.998 -1.689 . . . . 0.0 111.832 173.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.81 -3.78 31.93 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.895 1.278 . . . . 0.0 113.692 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.564 HG22 ' O ' ' A' ' 38' ' ' GLU . 2.6 t -68.78 -36.16 77.95 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.878 0.871 . . . . 0.0 111.235 -178.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.3 170.28 53.42 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 124.232 0.92 . . . . 0.0 112.429 -170.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.445 ' O ' HG23 ' A' ' 45' ' ' THR . 35.4 mtmm -119.45 111.62 18.36 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.462 ' HA ' ' HA ' ' A' ' 92' ' ' TYR . 4.4 ppt_? -61.08 -12.94 13.82 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 171.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 43' ' ' LYS . 12.0 p 65.57 -176.36 0.18 Allowed 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 127.681 2.392 . . . . 0.0 109.728 177.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -88.4 6.0 39.54 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 120.541 -1.349 . . . . 0.0 113.453 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.6 mtpt -64.62 173.46 2.17 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.681 1.192 . . . . 0.0 112.45 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -109.93 119.4 39.21 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.6 m -79.73 85.18 5.45 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 167.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.8 pt -85.81 35.94 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 125.166 1.387 . . . . 0.0 110.113 176.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -142.27 165.86 26.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 128.695 2.798 . . . . 0.0 107.34 -172.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -132.7 0.4 3.57 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.403 1.081 . . . . 0.0 111.665 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -146.45 164.72 22.91 Favored Pre-proline 0 C--O 1.238 0.457 0 C-N-CA 126.847 2.059 . . . . 0.0 108.304 -173.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -74.15 170.92 19.04 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.021 2.48 . . . . 0.0 111.039 169.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -110.9 4.18 19.48 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.296 1.038 . . . . 0.0 111.607 166.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.85 173.25 10.17 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 120.573 -1.329 . . . . 0.0 109.992 161.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.5 -22.8 4.94 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.869 1.668 . . . . 0.0 110.637 177.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -105.4 113.63 27.32 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 174.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -160.73 168.0 25.72 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.123 1.369 . . . . 0.0 108.492 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -96.34 157.06 21.35 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 168.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.6 m -103.96 130.95 51.62 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 mp -126.97 137.26 58.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 123.502 0.721 . . . . 0.0 109.909 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.12 114.52 18.49 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 168.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 72.6 mt -88.95 91.53 3.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 104.35 -2.463 . . . . 0.0 104.35 162.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -70.32 123.61 22.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 171.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -153.02 133.04 13.35 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.558 1.143 . . . . 0.0 109.637 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.8 m120 55.48 31.89 17.9 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.636 1.174 . . . . 0.0 110.656 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.35 -11.42 4.04 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.904 1.716 . . . . 0.0 115.018 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.91 -173.75 45.34 Favored Glycine 0 C--N 1.332 0.337 0 O-C-N 120.5 -1.588 . . . . 0.0 110.029 166.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -145.09 157.57 44.07 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.907 -0.76 . . . . 0.0 111.507 168.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 83.5 m -96.73 109.2 21.9 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 154.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.7 m -74.53 147.12 42.08 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 160.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.9 ptm -163.07 170.74 17.48 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.009 1.724 . . . . 0.0 108.298 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -143.59 151.74 40.55 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -129.57 158.01 40.47 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 121.072 1.76 . . . . 0.0 110.655 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -159.21 178.28 10.16 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.457 1.48 . . . . 0.0 111.889 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -106.62 139.48 41.0 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.61 1.564 . . . . 0.0 108.007 167.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -141.68 131.3 24.03 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.246 1.022 . . . . 0.0 109.169 167.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 57.77 4.75 0.28 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.374 1.87 . . . . 0.0 114.769 175.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.09 2.4 21.96 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.744 1.64 . . . . 0.0 113.97 176.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -113.94 157.67 22.12 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 125.952 1.701 . . . . 0.0 108.052 167.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -103.25 159.45 15.53 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -145.63 155.06 42.78 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.682 0.793 . . . . 0.0 111.025 -172.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 mp -126.49 126.31 68.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 C-N-CA 125.973 1.709 . . . . 0.0 108.417 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -73.36 152.5 40.85 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 127.063 2.145 . . . . 0.0 110.19 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -177.16 167.53 1.26 Allowed Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 128.553 2.741 . . . . 0.0 107.973 176.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' A' ' 89' ' ' LYS . 41.1 Cg_endo -61.09 -162.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.815 1 C-N-CA 125.378 4.052 . . . . 0.0 109.671 166.173 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -43.06 -13.41 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.271 2.228 . . . . 0.0 116.955 -162.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.497 ' HE3' ' H ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -115.18 45.0 1.71 Allowed 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 171.218 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -124.95 68.74 0.5 Allowed Glycine 0 C--O 1.228 -0.276 0 O-C-N 120.724 -1.235 . . . . 0.0 113.285 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.4 mt -135.23 50.97 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 168.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 37.2 m-85 -74.37 91.12 2.19 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.224 -0.922 . . . . 0.0 108.569 -175.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -64.72 120.06 11.74 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 167.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.1 pt -118.44 158.36 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 125.968 1.707 . . . . 0.0 107.8 164.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -104.36 -1.5 26.8 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.522 0.729 . . . . 0.0 112.37 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -118.89 162.28 18.76 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.742 1.217 . . . . 0.0 111.22 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -74.82 153.13 38.86 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.461 0.704 . . . . 0.0 110.72 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.402 ' CE1' HD11 ' A' ' 39' ' ' ILE . 65.1 t80 -79.87 -57.99 3.38 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.295 -0.878 . . . . 0.0 112.395 170.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.02 -20.18 66.37 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -163.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -84.87 -17.43 37.99 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.194 0.906 . . . . 0.0 111.722 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 10.7 mmt -95.91 -18.26 20.45 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.894 1.277 . . . . 0.0 111.351 -172.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.403 ' H ' HG12 ' A' ' 102' ' ' ILE . 9.4 pt . . . . . 0 C--O 1.247 0.974 0 C-N-CA 124.534 1.134 . . . . 0.0 110.103 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 m . . . . . 0 CA--C 1.549 0.937 0 CA-C-O 119.034 -0.508 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.56 161.91 43.12 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 CA-C-N 121.275 1.491 . . . . 0.0 111.799 -170.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.6 mt -109.45 117.54 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 170.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.475 HD21 ' HB2' ' A' ' 40' ' ' ALA . 0.3 OUTLIER -126.27 160.7 56.25 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 127.402 2.281 . . . . 0.0 108.396 -176.186 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.49 -178.33 1.83 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.038 2.492 . . . . 0.0 111.504 174.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.409 ' HE3' ' HG2' ' A' ' 9' ' ' GLU . 7.2 mtmt -58.42 175.88 0.21 Allowed 'General case' 0 C--N 1.349 0.546 0 O-C-N 121.223 -0.923 . . . . 0.0 109.896 167.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.51 -59.19 2.84 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 157.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.409 ' HG2' ' HE3' ' A' ' 7' ' ' LYS . 11.0 pt-20 -70.75 -13.6 62.12 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -159.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -88.13 -1.4 57.98 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.173 1.389 . . . . 0.0 111.926 176.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 90.7 t -86.91 116.08 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 175.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -70.75 -44.03 67.6 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.991 0.807 . . . . 0.0 109.825 173.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.8 p -153.95 154.07 33.14 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 118.43 0.559 . . . . 0.0 111.671 162.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.1 mt -95.23 140.43 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 157.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.6 t -126.35 113.89 17.5 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 53.5 mt -109.5 115.46 49.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -90.04 123.16 33.68 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 167.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -77.13 174.72 10.37 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.358 1.063 . . . . 0.0 109.912 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 p -61.01 -52.48 64.82 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.334 -0.854 . . . . 0.0 109.263 171.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -66.4 153.85 41.66 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 127.101 2.16 . . . . 0.0 107.761 169.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 94.1 p -86.51 45.98 1.3 Allowed 'General case' 0 C--O 1.237 0.408 0 O-C-N 121.71 -0.619 . . . . 0.0 111.62 -152.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.2 mt -122.17 133.79 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 -171.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -126.99 111.84 14.55 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -174.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.406 ' HE2' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -103.06 138.67 39.61 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -178.332 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.7 mp -115.97 135.85 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 -175.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.436 ' CD2' HD11 ' A' ' 35' ' ' ILE . 69.5 m-85 -122.99 90.77 3.35 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 103.438 -2.801 . . . . 0.0 103.438 -168.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -116.62 -16.67 10.71 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.697 1.599 . . . . 0.0 110.369 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.53 136.37 56.31 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.34 1.856 . . . . 0.0 106.475 170.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.8 t -55.88 -44.05 77.79 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 120.014 1.279 . . . . 0.0 111.821 -171.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -68.99 -32.02 71.29 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.95 0.9 . . . . 0.0 110.995 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 p -61.5 -45.98 91.93 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.533 HG22 HD11 ' A' ' 36' ' ' LEU . 70.3 mt -65.0 -53.61 39.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.563 1.545 . . . . 0.0 109.042 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.419 ' HA ' HD12 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -48.84 -51.68 28.26 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.044 0.838 . . . . 0.0 113.045 -168.158 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.2 -42.38 86.04 Favored 'General case' 0 C--O 1.227 -0.1 0 C-N-CA 123.771 0.828 . . . . 0.0 111.568 -175.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.436 HD11 ' CD2' ' A' ' 26' ' ' TYR . 86.6 mt -62.3 -51.52 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -177.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.533 HD11 HG22 ' A' ' 32' ' ' ILE . 1.2 mt -59.19 -26.9 65.21 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.728 1.149 . . . . 0.0 110.913 177.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.38 -69.03 0.2 Allowed 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.502 1.121 . . . . 0.0 109.22 171.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -75.69 -16.78 60.12 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -171.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.8 mm -67.09 -39.86 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 O-C-N 119.929 -1.732 . . . . 0.0 109.127 171.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.475 ' HB2' HD21 ' A' ' 5' ' ' LEU . . . -89.13 3.02 53.25 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 120.73 -1.231 . . . . 0.0 113.907 -171.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.1 p -73.21 -45.87 53.74 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.153 173.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.13 145.22 48.54 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 123.989 0.804 . . . . 0.0 111.615 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -123.11 106.03 10.44 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 -166.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 92' ' ' TYR . 7.6 ppt_? -62.72 -13.01 27.56 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 174.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.1 p 65.46 -174.85 0.18 Allowed 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 127.61 2.364 . . . . 0.0 110.436 177.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -69.89 -11.99 61.29 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 119.287 -2.133 . . . . 0.0 112.946 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -63.17 166.48 6.02 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.084 1.353 . . . . 0.0 112.135 -174.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.57 122.72 38.36 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.732 1.613 . . . . 0.0 110.731 176.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.7 t -70.46 160.37 32.51 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 127.443 2.297 . . . . 0.0 107.817 163.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.7 pt -144.6 22.88 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 126.912 2.085 . . . . 0.0 110.45 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -114.32 164.36 14.02 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 120.805 -1.184 . . . . 0.0 108.612 175.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -111.28 -20.62 12.23 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.261 175.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -143.23 160.01 53.55 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-N 119.483 1.038 . . . . 0.0 109.807 -168.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.95 171.87 15.77 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.711 2.941 . . . . 0.0 113.031 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.4 p -119.56 -15.73 8.96 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.575 1.55 . . . . 0.0 112.768 -177.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.9 159.4 33.78 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.932 0.787 . . . . 0.0 110.211 171.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -84.77 -28.31 26.28 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.381 0.672 . . . . 0.0 111.143 172.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -115.05 100.77 8.42 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -134.35 168.26 19.22 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 127.94 2.496 . . . . 0.0 106.278 171.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.52 175.1 15.7 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 169.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -107.99 142.31 38.32 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.471 1.109 . . . . 0.0 108.109 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.7 mt -113.12 133.82 57.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 158.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -128.78 144.23 51.12 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 171.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.5 mt -124.57 90.69 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 174.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -66.05 109.58 2.62 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 171.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . 0.284 3.9 p30 -133.1 -152.2 0.48 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 126.97 2.108 . . . . 0.0 107.579 -174.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -46.04 50.21 0.0 OUTLIER 'General case' 0 C--O 1.24 0.575 1 C-N-CA 136.65 5.98 . . . . 0.0 114.551 -171.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.43 31.54 68.4 Favored Glycine 0 N--CA 1.437 -1.269 0 O-C-N 120.413 -1.429 . . . . 0.0 112.084 -171.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -164.04 171.28 39.57 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 117.454 0.627 . . . . 0.0 112.353 168.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 83.2 mtp -125.15 112.23 16.23 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.597 1.559 . . . . 0.0 108.283 -176.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.4 m -69.86 109.83 4.66 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 157.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.4 m -112.99 143.2 44.69 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 124.106 0.879 . . . . 0.0 109.338 171.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.3 ptp -151.95 170.97 18.55 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 127.449 2.3 . . . . 0.0 106.311 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.431 ' H ' ' HB2' ' A' ' 85' ' ' GLU . 38.9 m-85 -129.15 174.29 9.7 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.401 1.48 . . . . 0.0 108.03 -178.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -156.39 140.98 16.88 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.591 0.756 . . . . 0.0 109.706 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -153.6 162.86 40.86 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.748 1.219 . . . . 0.0 110.835 172.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -79.26 134.89 36.64 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 172.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -131.41 114.87 15.48 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 122.017 0.913 . . . . 0.0 110.038 171.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.02 -7.7 0.61 Allowed 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.953 2.501 . . . . 0.0 114.941 171.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.96 -6.09 5.1 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 117.635 -1.647 . . . . 0.0 113.449 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.28 166.31 10.62 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 120.454 2.127 . . . . 0.0 109.072 164.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -112.51 152.79 28.39 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -145.02 172.24 13.34 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 122.537 0.335 . . . . 0.0 110.179 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.3 mp -131.11 140.35 48.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 124.497 1.119 . . . . 0.0 109.21 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.431 ' HB2' ' H ' ' A' ' 74' ' ' PHE . 0.4 OUTLIER -75.88 165.15 25.41 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.833 1.653 . . . . 0.0 112.174 178.224 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -179.98 168.97 0.7 Allowed Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 127.82 2.448 . . . . 0.0 107.499 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' A' ' 89' ' ' LYS . 60.9 Cg_endo -56.61 -162.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.799 2.332 . . . . 0.0 109.419 153.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -44.06 -8.26 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.994 2.518 . . . . 0.0 117.386 -169.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.419 ' HE3' ' H ' ' A' ' 89' ' ' LYS . 0.6 OUTLIER -98.71 15.65 24.59 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 120.173 -1.58 . . . . 0.0 114.27 168.832 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -88.91 65.7 3.21 Favored Glycine 0 C--O 1.226 -0.36 0 CA-C-N 120.608 1.549 . . . . 0.0 113.786 -174.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.4 mt -140.62 41.87 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 171.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 21.8 m-85 -70.27 102.71 2.19 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 174.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -74.35 127.39 32.89 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 164.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.5 pt -114.28 159.67 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 157.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -108.47 5.27 25.11 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.336 -0.853 . . . . 0.0 112.349 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -133.92 157.02 47.06 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.041 0.936 . . . . 0.0 109.469 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -72.03 133.04 45.05 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.625 1.17 . . . . 0.0 110.118 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -74.03 -44.49 54.17 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.497 1.119 . . . . 0.0 113.459 -177.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -62.08 -29.68 70.48 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.258 1.39 . . . . 0.0 110.784 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -72.95 -15.6 61.56 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 125.877 1.671 . . . . 0.0 112.989 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 9.5 ptm -110.51 1.05 17.96 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.168 0.987 . . . . 0.0 113.091 -175.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 25.5 pt . . . . . 0 C--O 1.249 1.06 0 CA-C-N 119.018 0.826 . . . . 0.0 109.45 176.208 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p . . . . . 0 CA--C 1.551 1.014 0 N-CA-C 116.496 2.035 . . . . 0.0 116.496 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -67.05 169.89 14.13 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 124.388 3.392 . . . . 0.0 113.006 167.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.0 mm -94.22 91.89 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 167.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.1 152.24 39.35 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.222 176.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.6 160.75 46.64 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.202 1.935 . . . . 0.0 110.602 171.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -60.05 168.8 1.74 Allowed 'General case' 0 C--N 1.344 0.335 0 C-N-CA 123.677 0.791 . . . . 0.0 112.028 174.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.03 -49.02 31.17 Favored 'General case' 0 C--O 1.219 -0.523 0 O-C-N 121.157 -0.964 . . . . 0.0 109.48 168.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -66.48 -14.79 62.73 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 -172.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -102.87 -2.74 27.32 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.037 0.935 . . . . 0.0 111.352 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.0 t -82.19 135.81 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.248 1.419 . . . . 0.0 107.3 170.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.83 -67.92 0.78 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 166.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.42 121.88 5.76 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.33 0.514 . . . . 0.0 110.429 -170.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.4 mt -82.27 131.22 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.7 t -107.5 139.61 41.75 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 168.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.0 mt -131.98 122.23 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 170.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -115.07 102.4 9.9 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 -173.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -63.04 171.68 2.13 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.373 0.669 . . . . 0.0 111.328 -170.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.4 p -52.43 -52.89 51.61 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.541 1.137 . . . . 0.0 109.976 168.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.05 162.6 25.78 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 126.877 2.071 . . . . 0.0 107.192 174.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 p -90.1 59.57 4.53 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 123.252 1.501 . . . . 0.0 108.896 -163.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.7 mt -124.66 142.96 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 102.502 -3.147 . . . . 0.0 102.502 176.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -140.96 143.33 34.47 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.69 122.36 23.29 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 176.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.9 mp -94.45 138.55 20.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 171.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -118.07 82.38 1.83 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 103.31 -2.848 . . . . 0.0 103.31 176.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -83.31 -19.1 36.87 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.55 1.14 . . . . 0.0 110.109 163.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.37 133.67 35.94 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.186 1.794 . . . . 0.0 109.093 -169.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.6 -55.83 17.01 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.306 1.042 . . . . 0.0 112.513 -176.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -68.58 -20.63 64.53 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.521 -0.737 . . . . 0.0 110.985 -174.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.4 m -80.12 -41.34 25.65 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.108 1.763 . . . . 0.0 110.826 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.4 mt -67.78 -45.93 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.951 1.7 . . . . 0.0 110.043 172.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.99 -24.63 67.15 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -171.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -64.29 -68.08 0.38 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 117.923 -1.037 . . . . 0.0 108.35 166.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 72.5 mt -44.85 -44.81 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 126.057 1.743 . . . . 0.0 112.039 -170.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.0 mt -54.37 -20.0 6.55 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.7 t -76.72 -58.36 3.33 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.322 2.249 . . . . 0.0 109.396 172.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.9 mp0 -63.34 -29.32 70.65 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.758 0.708 . . . . 0.0 110.896 -177.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.1 mm -61.95 -37.75 79.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 O-C-N 120.652 -1.28 . . . . 0.0 110.173 171.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.56 -10.6 26.87 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.681 1.192 . . . . 0.0 113.705 -171.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 t -62.6 -39.84 95.02 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.382 0.673 . . . . 0.0 110.829 -171.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.51 161.54 40.84 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-O 122.787 1.215 . . . . 0.0 112.316 -171.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -125.76 114.47 18.66 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.41 ' H ' ' HG3' ' A' ' 44' ' ' ARG . 6.5 ppt_? -64.15 -9.28 15.79 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.753 1.621 . . . . 0.0 113.89 172.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 p 65.59 -172.9 0.18 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 128.407 2.683 . . . . 0.0 111.478 173.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -78.69 -2.2 38.09 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.164 1.786 . . . . 0.0 112.029 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -67.02 168.06 10.7 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 119.849 1.204 . . . . 0.0 109.816 172.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -120.25 156.4 31.28 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.42 1.088 . . . . 0.0 109.768 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.32 134.35 46.26 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -159.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.2 pt -133.88 28.32 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 118.958 0.799 . . . . 0.0 112.225 -164.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -147.99 166.32 28.08 Favored 'General case' 0 C--O 1.242 0.66 0 O-C-N 121.446 -0.783 . . . . 0.0 110.23 -175.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.03 -10.42 15.03 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.602 1.161 . . . . 0.0 111.926 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -143.97 159.53 52.87 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.233 1.013 . . . . 0.0 111.95 -170.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.34 178.45 7.0 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.291 3.328 . . . . 0.0 112.838 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.51 -16.66 12.37 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.503 1.521 . . . . 0.0 111.46 173.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.66 163.08 7.59 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 120.792 -1.192 . . . . 0.0 110.29 168.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -108.43 -15.28 14.49 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.206 1.403 . . . . 0.0 110.902 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -126.29 103.03 7.44 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.465 2.306 . . . . 0.0 106.815 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -150.06 162.39 40.49 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.954 2.102 . . . . 0.0 107.918 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -101.14 166.0 18.73 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 173.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.2 m -110.32 134.86 51.86 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 118.9 1.35 . . . . 0.0 108.482 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.9 mp -120.14 136.17 58.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -126.76 140.82 52.09 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 125.063 1.345 . . . . 0.0 108.9 172.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.433 ' HB ' HG22 ' A' ' 71' ' ' THR . 33.4 mt -123.66 87.56 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 172.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -58.84 106.73 0.44 Allowed 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.303 1.041 . . . . 0.0 108.648 165.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -139.96 133.9 30.78 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.946 1.698 . . . . 0.0 109.654 175.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.7 m120 52.62 28.12 5.84 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.894 1.678 . . . . 0.0 111.978 -176.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.07 13.43 69.85 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.074 1.321 . . . . 0.0 113.813 -176.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -107.58 170.35 15.4 Favored Glycine 0 C--N 1.334 0.418 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 163.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.27 136.4 27.98 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 118.707 1.253 . . . . 0.0 113.172 168.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.433 HG22 ' HB ' ' A' ' 64' ' ' ILE . 1.2 t -75.93 161.27 29.09 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 168.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.5 m -135.92 142.0 44.6 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.669 1.188 . . . . 0.0 108.164 169.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -153.43 171.51 18.55 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.794 1.638 . . . . 0.0 109.169 170.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -140.56 148.35 40.86 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.385 2.274 . . . . 0.0 106.3 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.517 ' CD1' HG13 ' A' ' 84' ' ' ILE . 1.5 m-85 -128.27 158.37 38.35 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.904 1.229 . . . . 0.0 109.51 177.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -159.53 175.51 13.18 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.892 0.877 . . . . 0.0 111.49 -178.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -102.98 144.08 31.72 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.56 1.544 . . . . 0.0 109.497 165.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -148.61 119.4 7.56 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.846 1.259 . . . . 0.0 108.719 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 62.67 -0.17 0.58 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.8 2.04 . . . . 0.0 115.237 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.94 8.43 17.88 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.754 1.169 . . . . 0.0 113.026 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.63 156.68 24.27 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 120.257 2.028 . . . . 0.0 108.821 164.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -96.79 152.45 18.67 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 168.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -139.84 167.58 21.79 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.751 0.82 . . . . 0.0 110.911 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.517 HG13 ' CD1' ' A' ' 75' ' ' TYR . 3.3 mp -123.77 128.13 74.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 125.367 1.467 . . . . 0.0 108.592 172.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -81.25 151.21 28.22 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.611 1.564 . . . . 0.0 109.213 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -176.2 166.26 1.66 Allowed Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.311 1.844 . . . . 0.0 107.638 -177.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -59.62 -161.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.762 1 C-N-CA 126.495 4.797 . . . . 0.0 110.417 172.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -42.82 -12.65 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.458 2.303 . . . . 0.0 115.86 -172.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.68 68.72 0.72 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 120.215 1.371 . . . . 0.0 112.121 161.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -140.83 67.4 0.49 Allowed Glycine 0 C--O 1.222 -0.622 0 CA-C-N 119.78 1.173 . . . . 0.0 115.287 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.6 mt -141.59 47.24 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.711 1.205 . . . . 0.0 107.846 173.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -72.23 103.85 3.49 Favored 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 120.668 -1.27 . . . . 0.0 108.267 -175.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -69.2 125.63 27.26 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 164.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 21.7 pt -119.69 175.29 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.913 1.285 . . . . 0.0 108.63 159.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -117.45 2.14 12.41 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.632 0.773 . . . . 0.0 112.096 -175.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -139.35 157.48 45.81 Favored 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 120.752 -1.217 . . . . 0.0 108.768 -168.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -80.9 114.35 19.72 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -52.77 -45.05 66.96 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.791 1.236 . . . . 0.0 110.887 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -75.33 -7.46 54.04 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -167.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -106.91 -16.87 14.35 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.172 0.989 . . . . 0.0 111.813 166.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 66.2 mmm -70.86 -37.65 73.09 Favored 'General case' 0 C--O 1.239 0.51 0 O-C-N 120.345 -1.472 . . . . 0.0 109.255 169.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.9 pt . . . . . 0 C--O 1.25 1.084 0 O-C-N 121.564 -0.71 . . . . 0.0 109.825 168.666 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.7 m . . . . . 0 C--O 1.24 0.555 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -52.48 167.09 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-O 122.603 1.001 . . . . 0.0 112.248 152.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.1 mt -111.61 109.41 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -107.03 162.53 19.38 Favored Pre-proline 0 C--O 1.243 0.714 0 C-N-CA 123.276 0.63 . . . . 0.0 110.361 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -61.85 174.69 2.19 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.192 1.928 . . . . 0.0 111.61 164.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.55 169.1 1.88 Allowed 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.427 -0.796 . . . . 0.0 109.068 165.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.9 -60.32 2.31 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 153.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.37 -14.95 63.39 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -160.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -89.45 1.2 56.18 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 120.086 1.312 . . . . 0.0 113.46 175.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.0 t -78.14 143.19 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.82 -62.95 1.49 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 168.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.3 p -152.47 171.22 18.41 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.45 1.1 . . . . 0.0 109.62 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.5 mt -124.23 142.21 41.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 170.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.1 t -122.71 142.98 50.11 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 165.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.1 mt -130.97 104.28 9.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 104.142 -2.54 . . . . 0.0 104.142 173.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -87.61 113.09 22.97 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 172.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -67.27 177.9 1.69 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.897 1.679 . . . . 0.0 111.033 -173.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.68 -50.77 67.43 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.712 -1.242 . . . . 0.0 111.031 171.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -76.85 160.99 28.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 127.844 2.458 . . . . 0.0 108.085 173.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 p -88.22 61.11 6.08 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 123.032 1.396 . . . . 0.0 109.062 -164.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.8 mt -140.09 139.79 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 102.335 -3.209 . . . . 0.0 102.335 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.16 157.58 41.39 Favored 'General case' 0 N--CA 1.414 -2.255 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.458 ' HE2' ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -130.04 130.26 44.7 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 175.516 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.6 mt -106.16 134.92 46.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.458 ' CE2' ' HE2' ' A' ' 24' ' ' LYS . 23.3 m-85 -115.96 97.42 6.08 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 -175.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -123.63 11.53 9.17 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 128.324 2.65 . . . . 0.0 110.556 -176.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -103.8 141.03 36.82 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 166.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.8 t -55.85 -47.68 76.85 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.128 0.971 . . . . 0.0 110.654 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -59.47 -46.29 89.21 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.896 0.878 . . . . 0.0 110.939 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.2 m -61.07 -36.55 79.91 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.354 1.462 . . . . 0.0 111.906 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 74.7 mt -66.99 -55.66 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 172.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -57.79 -32.79 67.87 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.198 0.908 . . . . 0.0 112.75 -175.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.53 -49.18 62.47 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.684 1.594 . . . . 0.0 109.346 175.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.2 mt -68.76 -51.89 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 117.602 -1.19 . . . . 0.0 110.785 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.92 -26.61 15.53 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.39 1.45 . . . . 0.0 112.469 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.97 -69.46 0.32 Allowed 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 125.688 1.595 . . . . 0.0 111.145 170.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -69.09 -7.07 32.54 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.602 1.092 . . . . 0.0 113.135 -173.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.6 mm -83.57 -29.64 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 O-C-N 120.197 -1.564 . . . . 0.0 111.046 168.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.8 -12.75 35.47 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 119.411 1.005 . . . . 0.0 113.184 -173.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.8 p -69.01 -41.4 77.82 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.737 1.615 . . . . 0.0 110.791 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.34 138.6 41.08 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt -116.94 111.69 19.97 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -175.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.402 ' HB3' ' CE2' ' A' ' 92' ' ' TYR . 20.0 ptt180 -61.6 -4.18 1.3 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 173.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p 58.99 -174.07 0.1 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.309 2.244 . . . . 0.0 109.693 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -89.96 5.07 48.04 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.178 -0.951 . . . . 0.0 112.339 174.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -65.96 171.29 4.6 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.33 1.052 . . . . 0.0 110.323 167.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -126.13 131.86 51.97 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.716 1.207 . . . . 0.0 110.821 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.1 m -80.57 158.13 25.84 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.483 0.713 . . . . 0.0 109.098 170.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.0 pt -141.75 32.47 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 125.813 1.645 . . . . 0.0 110.699 175.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -141.52 167.66 21.63 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.721 2.009 . . . . 0.0 107.876 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -121.53 -4.69 9.3 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.817 1.247 . . . . 0.0 111.155 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -149.53 156.48 39.18 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 125.835 1.654 . . . . 0.0 110.169 -170.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.07 176.38 9.61 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.27 3.313 . . . . 0.0 112.529 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.99 1.79 6.56 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.863 1.665 . . . . 0.0 112.245 177.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.21 149.08 43.15 Favored 'General case' 0 C--N 1.338 0.103 0 O-C-N 120.621 -1.299 . . . . 0.0 109.848 168.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.01 -31.8 44.84 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 122.564 0.346 . . . . 0.0 111.175 169.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -114.24 104.59 12.24 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.454 1.502 . . . . 0.0 107.442 -173.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -138.46 173.95 11.06 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.886 2.074 . . . . 0.0 109.623 176.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.08 165.68 12.74 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 164.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.8 m -123.37 127.55 48.63 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.415 1.086 . . . . 0.0 108.906 -166.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mp -123.72 110.82 26.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 124.909 1.284 . . . . 0.0 109.603 -166.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 58.9 m-20 -119.03 122.03 41.23 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.566 1.146 . . . . 0.0 108.763 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 74.3 mt -107.19 96.9 5.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 171.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.64 118.05 11.15 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 172.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -146.0 125.94 13.62 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.606 1.163 . . . . 0.0 110.027 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 m120 54.53 41.83 31.7 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.035 1.734 . . . . 0.0 111.83 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.82 3.87 56.67 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.213 0.911 . . . . 0.0 114.394 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -118.95 -173.53 15.67 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 169.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -147.16 166.14 27.86 Favored 'General case' 0 CA--C 1.517 -0.296 0 O-C-N 121.68 -0.894 . . . . 0.0 111.242 172.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.0 m -106.34 133.44 51.03 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 157.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 m -106.92 145.49 32.16 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.6 ptp -154.88 174.67 14.79 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.763 1.225 . . . . 0.0 108.429 160.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.564 ' H ' ' HG3' ' A' ' 85' ' ' GLU . 34.4 m-85 -135.97 164.8 27.13 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 128.196 2.598 . . . . 0.0 106.768 174.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -134.47 156.29 48.86 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.958 1.303 . . . . 0.0 108.146 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -159.4 179.95 8.49 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 118.709 0.686 . . . . 0.0 110.34 169.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -101.62 133.08 46.88 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.942 1.697 . . . . 0.0 107.642 175.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -133.59 111.28 10.52 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.08 0.943 . . . . 0.0 109.556 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.85 -1.08 2.14 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.641 1.976 . . . . 0.0 114.111 174.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.7 -14.76 6.36 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.123 1.344 . . . . 0.0 113.547 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.78 169.71 9.82 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 120.143 1.971 . . . . 0.0 108.651 164.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -109.85 155.55 21.52 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 171.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -144.12 172.65 12.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -122.13 143.36 35.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 C-N-CA 125.266 1.426 . . . . 0.0 107.486 172.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.564 ' HG3' ' H ' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -85.41 173.75 10.04 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.018 1.327 . . . . 0.0 110.029 179.204 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.464 ' HB2' ' CA ' ' A' ' 90' ' ' GLY . 0.5 OUTLIER 176.84 168.56 0.43 Allowed Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 128.756 2.822 . . . . 0.0 106.728 175.479 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' A' ' 86' ' ' CYS . 93.9 Cg_endo -54.13 -160.59 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.328 1 C-N-CA 125.306 4.004 . . . . 0.0 109.639 157.731 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -42.83 -4.99 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 129.245 3.018 . . . . 0.0 117.176 -171.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 87' ' ' PRO . 5.5 ptpt -119.5 25.44 10.06 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 129.281 3.032 . . . . 0.0 115.249 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.464 ' CA ' ' HB2' ' A' ' 86' ' ' CYS . . . -115.14 61.23 0.38 Allowed Glycine 0 C--N 1.32 -0.331 0 N-CA-C 116.776 1.47 . . . . 0.0 116.776 -167.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.0 mt -131.58 42.69 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 117.716 0.758 . . . . 0.0 110.045 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.402 ' CE2' ' HB3' ' A' ' 44' ' ' ARG . 15.7 m-85 -76.43 104.7 7.08 Favored 'General case' 0 C--O 1.222 -0.374 0 O-C-N 120.691 -1.256 . . . . 0.0 110.716 -173.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -68.81 122.88 19.51 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 165.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.5 pt -111.5 -172.61 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 126.463 1.905 . . . . 0.0 108.381 160.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -100.16 -44.61 5.91 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -147.1 176.26 10.08 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.803 1.241 . . . . 0.0 108.898 -172.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -61.8 116.6 4.96 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 118.552 0.614 . . . . 0.0 111.271 -172.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.43 ' HA ' ' HG2' ' A' ' 101' ' ' MET . 28.3 t80 -52.78 -35.5 56.73 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.617 1.967 . . . . 0.0 112.477 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -68.06 -13.29 62.08 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 119.873 -1.767 . . . . 0.0 113.189 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -95.03 -18.6 20.89 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.64 0.776 . . . . 0.0 111.888 174.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.43 ' HG2' ' HA ' ' A' ' 98' ' ' PHE . 21.6 ptp -91.76 -10.92 38.23 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.224 0.92 . . . . 0.0 112.963 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 29.8 pt . . . . . 0 C--O 1.252 1.225 0 C-N-CA 124.593 1.157 . . . . 0.0 112.136 -179.634 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.452 ' HB2' ' HD2' ' A' ' 3' ' ' PRO . 68.3 p . . . . . 0 CA--C 1.546 0.805 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 2' ' ' SER . 31.3 Cg_endo -70.62 172.65 13.07 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.331 2.021 . . . . 0.0 113.095 178.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.0 mt -112.51 121.39 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 175.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.88 164.26 40.77 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 126.864 2.066 . . . . 0.0 111.544 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.12 161.43 16.17 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 123.919 3.08 . . . . 0.0 113.693 175.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -59.38 156.07 13.56 Favored 'General case' 0 C--N 1.347 0.468 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 172.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.67 -34.27 77.83 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 121.331 -0.855 . . . . 0.0 109.124 165.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -80.09 -25.4 40.02 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 118.669 -1.213 . . . . 0.0 112.33 -165.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -86.31 -0.47 55.93 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 26.9 t -69.98 138.59 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 176.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -76.39 -67.35 0.7 Allowed 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 166.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 p -157.85 149.47 21.71 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.408 0.549 . . . . 0.0 111.14 164.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.2 mt -85.53 141.02 15.08 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 169.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.5 t -126.66 130.16 49.88 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 167.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.7 mt -120.32 109.08 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.43 120.51 27.85 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 173.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -68.47 173.15 5.22 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.22 1.008 . . . . 0.0 109.998 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.51 -52.11 65.98 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 121.23 -0.919 . . . . 0.0 109.752 169.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -72.28 169.69 15.69 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 173.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.5 p -71.66 24.7 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 129.291 3.036 . . . . 0.0 115.92 -157.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.9 mt -135.14 149.72 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 129.4 3.08 . . . . 0.0 105.781 -159.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.81 164.93 21.98 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 126.573 1.949 . . . . 0.0 109.485 175.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.402 ' HE2' ' CE1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -128.98 143.79 50.98 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 162.087 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.7 mp -114.92 130.68 68.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.494 ' CD2' HD11 ' A' ' 35' ' ' ILE . 3.9 m-85 -116.14 79.39 1.3 Allowed 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 103.994 -2.595 . . . . 0.0 103.994 -174.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -85.23 -17.17 37.84 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.612 1.165 . . . . 0.0 110.235 161.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.9 125.09 24.85 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -176.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.8 t -51.97 -49.57 62.96 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.872 0.869 . . . . 0.0 111.527 -172.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -75.4 -16.13 60.39 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.114 -0.991 . . . . 0.0 112.257 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.7 m -79.63 -39.24 31.97 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.453 1.901 . . . . 0.0 110.357 171.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 93.4 mt -63.33 -53.8 41.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 169.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -60.0 -32.74 71.14 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.731 1.212 . . . . 0.0 112.25 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.8 tptt -60.79 -64.97 0.77 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 119.441 1.019 . . . . 0.0 109.642 167.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.494 HD11 ' CD2' ' A' ' 26' ' ' TYR . 82.2 mt -53.91 -46.71 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 119.177 -0.439 . . . . 0.0 110.985 -171.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.37 -22.95 55.51 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -177.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.86 -55.7 10.26 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.255 0.934 . . . . 0.0 109.614 167.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -73.75 -16.74 61.16 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -171.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.1 mm -68.37 -21.29 26.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.829 1.652 . . . . 0.0 110.195 168.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -118.88 8.68 11.77 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.114 1.366 . . . . 0.0 113.186 -168.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.2 t -80.05 -42.2 24.18 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.221 0.464 . . . . 0.0 110.921 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.15 169.35 54.67 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 127.181 2.324 . . . . 0.0 113.766 -166.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -127.01 102.59 7.05 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -171.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 92' ' ' TYR . 0.7 OUTLIER -66.76 -13.65 61.67 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.807 1.243 . . . . 0.0 113.985 168.632 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 65.38 -172.82 0.18 Allowed 'General case' 0 CA--C 1.547 0.829 0 O-C-N 125.506 1.754 . . . . 0.0 110.283 173.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -83.27 0.59 44.93 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 120.242 -1.536 . . . . 0.0 113.869 172.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.0 mmmt -60.52 165.14 3.93 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 122.207 1.004 . . . . 0.0 112.111 -177.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -99.88 128.47 45.97 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 124.586 1.155 . . . . 0.0 108.332 -175.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.02 51.04 1.22 Allowed 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 123.914 0.886 . . . . 0.0 109.674 -170.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.7 pt -68.11 5.66 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 126.718 2.007 . . . . 0.0 113.532 -172.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.406 ' HG2' ' H ' ' A' ' 51' ' ' GLN . 6.5 pt20 -70.98 165.1 24.16 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 126.056 1.742 . . . . 0.0 110.697 166.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -124.48 -9.78 7.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.154 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -145.4 161.08 43.01 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 124.626 1.17 . . . . 0.0 111.367 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.459 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 18.9 Cg_endo -68.35 170.85 13.9 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 124.433 3.422 . . . . 0.0 111.681 171.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 98.8 p -99.33 -16.27 18.51 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.381 0.672 . . . . 0.0 112.499 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.412 ' HB2' ' CD2' ' A' ' 76' ' ' TYR . . . -76.03 146.24 39.61 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 121.46 -0.775 . . . . 0.0 109.418 176.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -81.81 -16.41 50.98 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 119.339 -0.362 . . . . 0.0 111.881 172.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -131.05 102.16 5.91 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.199 1.399 . . . . 0.0 108.937 -174.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.459 ' CE2' ' HG2' ' A' ' 54' ' ' PRO . 43.5 p90 -134.0 175.22 9.67 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 126.343 1.857 . . . . 0.0 108.708 176.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.74 -167.54 11.31 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 169.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.92 141.11 49.24 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.571 1.148 . . . . 0.0 109.321 -148.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.9 mt -115.23 136.0 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 160.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -127.81 130.2 48.26 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 171.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.9 mt -117.84 92.29 2.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 170.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -70.72 124.31 23.98 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 172.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -156.5 134.58 11.21 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.342 1.457 . . . . 0.0 108.99 -177.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.1 m120 54.01 27.59 7.65 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.512 1.525 . . . . 0.0 113.321 173.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.43 13.11 63.96 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 119.571 1.078 . . . . 0.0 114.414 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -142.54 171.51 24.71 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 119.448 1.624 . . . . 0.0 110.293 176.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 31.5 mtm -131.84 126.96 35.57 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.284 1.034 . . . . 0.0 110.318 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 53.8 m -80.64 113.49 18.87 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 156.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.42 152.91 25.94 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 124.337 1.023 . . . . 0.0 108.378 163.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.5 ptp -155.19 163.92 39.54 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.059 1.744 . . . . 0.0 107.639 154.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -119.87 172.67 7.55 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.799 1.24 . . . . 0.0 109.725 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -147.16 157.69 43.69 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.31 1.844 . . . . 0.0 108.449 175.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.412 ' CD2' ' HB2' ' A' ' 56' ' ' ALA . 40.9 p90 -157.38 -164.51 1.59 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.77 1.628 . . . . 0.0 108.859 171.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -122.91 124.3 42.9 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.648 1.179 . . . . 0.0 108.214 169.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -113.52 117.43 31.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.688 0.756 . . . . 0.0 109.576 173.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 64.81 -0.75 0.93 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.018 2.127 . . . . 0.0 114.595 175.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 123.99 -17.51 7.61 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 125.586 1.565 . . . . 0.0 112.77 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -90.32 157.45 17.64 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 120.278 2.039 . . . . 0.0 109.656 169.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -101.31 143.29 31.55 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.35 1.06 . . . . 0.0 108.537 174.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -139.78 169.36 17.87 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.936 0.495 . . . . 0.0 110.208 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.1 mp -127.38 121.27 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.871 0.868 . . . . 0.0 110.782 -176.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -66.49 157.72 31.41 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.459 -1.4 . . . . 0.0 110.733 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.429 ' HB2' ' HA2' ' A' ' 90' ' ' GLY . 0.8 OUTLIER -175.31 167.9 1.75 Allowed Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 128.592 2.757 . . . . 0.0 105.416 -172.655 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' A' ' 89' ' ' LYS . 66.3 Cg_endo -57.86 -160.97 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.448 0 C-N-CA 124.479 3.453 . . . . 0.0 109.657 160.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -42.68 0.75 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 130.221 3.408 . . . . 0.0 117.397 -175.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 87' ' ' PRO . 0.8 OUTLIER -124.58 30.92 5.84 Favored 'General case' 0 N--CA 1.44 -0.947 1 C-N-CA 132.117 4.167 . . . . 0.0 113.763 176.581 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.429 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . -109.26 61.03 0.31 Allowed Glycine 0 C--O 1.23 -0.148 0 C-N-CA 124.858 1.218 . . . . 0.0 115.41 -176.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.4 mt -136.69 44.73 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.536 1.135 . . . . 0.0 108.101 171.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 25.3 m-85 -68.87 108.11 3.34 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 175.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -75.04 130.74 39.83 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 159.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.0 pt -112.25 167.15 5.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 151.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -121.98 17.19 10.9 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.128 0.971 . . . . 0.0 112.407 -172.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -153.62 168.32 26.59 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 122.855 0.462 . . . . 0.0 110.872 165.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -67.01 118.49 10.54 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.713 0.805 . . . . 0.0 110.729 -173.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.429 ' HA ' ' HG2' ' A' ' 101' ' ' MET . 59.6 t80 -56.39 -47.02 79.81 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.97 0.908 . . . . 0.0 110.444 173.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -66.95 -26.42 66.82 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.332 0.653 . . . . 0.0 112.514 -170.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.2 20.02 19.58 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 118.407 0.549 . . . . 0.0 112.066 173.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.429 ' HG2' ' HA ' ' A' ' 98' ' ' PHE . 16.6 ptt? -108.29 -37.3 6.04 Favored 'General case' 0 C--N 1.342 0.256 0 O-C-N 121.437 -0.789 . . . . 0.0 112.648 160.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.996 0 C-N-CA 124.137 0.975 . . . . 0.0 112.007 -174.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.409 ' HB2' ' HD2' ' A' ' 3' ' ' PRO . 34.8 p . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 2' ' ' SER . 28.5 Cg_endo -61.39 175.92 1.36 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.578 1.519 . . . . 0.0 111.889 165.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.4 mt -111.67 108.28 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 40' ' ' ALA . 0.3 OUTLIER -123.26 156.44 63.4 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 126.283 1.833 . . . . 0.0 110.984 -171.863 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -74.15 162.18 39.28 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.732 2.954 . . . . 0.0 112.488 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.0 mtmt -63.04 142.57 58.33 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 119.076 0.853 . . . . 0.0 111.269 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.12 -14.81 18.83 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -94.57 -31.3 13.95 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.831 1.196 . . . . 0.0 112.752 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -88.45 -6.07 57.87 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.47 1.032 . . . . 0.0 111.525 -174.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.5 t -62.48 116.36 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 C-N-CA 128.336 2.654 . . . . 0.0 107.682 160.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -71.11 -67.68 0.49 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.715 1.606 . . . . 0.0 106.784 165.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.6 p -153.91 160.23 42.05 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.936 0.789 . . . . 0.0 110.495 -177.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.3 mt -125.84 125.77 68.86 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 -176.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.4 t -108.49 132.83 53.42 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.9 mt -133.35 97.03 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.98 115.68 18.81 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 164.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -68.29 -178.46 1.08 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.542 1.537 . . . . 0.0 109.994 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.9 p -59.19 -45.89 89.88 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.972 -1.08 . . . . 0.0 112.189 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -74.3 -174.0 1.86 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.546 1.139 . . . . 0.0 110.22 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 98.4 p -67.32 5.03 0.81 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.282 1.833 . . . . 0.0 114.76 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.1 mm -113.15 153.89 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 128.144 2.578 . . . . 0.0 108.606 -159.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -143.16 162.76 34.72 Favored 'General case' 0 N--CA 1.418 -2.073 0 C-N-CA 125.968 1.707 . . . . 0.0 110.587 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.11 142.16 44.24 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 125.129 1.371 . . . . 0.0 107.358 164.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.3 mp -109.66 138.17 38.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 170.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.414 ' HB3' ' HB3' ' A' ' 31' ' ' SER . 27.7 m-85 -111.96 108.94 18.45 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 103.166 -2.901 . . . . 0.0 103.166 -178.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -135.9 41.3 2.69 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 126.472 1.909 . . . . 0.0 106.183 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.94 123.44 17.16 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 103.614 -2.736 . . . . 0.0 103.614 -170.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.6 t -53.76 -39.6 65.49 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.684 0.794 . . . . 0.0 112.009 -171.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -77.67 -33.76 53.23 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.084 -1.01 . . . . 0.0 111.297 -177.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.414 ' HB3' ' HB3' ' A' ' 26' ' ' TYR . 26.2 m -57.94 -41.32 82.53 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.139 1.376 . . . . 0.0 110.491 168.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.4 mt -67.15 -54.58 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 124.716 1.206 . . . . 0.0 109.072 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -51.29 -41.76 60.69 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.131 0.572 . . . . 0.0 111.335 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -57.84 11.08 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 57.4 mt -54.68 -49.8 64.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 C-N-CA 123.392 0.677 . . . . 0.0 112.111 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.11 -17.91 30.77 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.804 0.842 . . . . 0.0 112.169 -171.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.65 -61.18 2.1 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.497 1.119 . . . . 0.0 110.913 166.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -67.24 -30.53 70.47 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.01 1.277 . . . . 0.0 111.545 -174.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.8 mm -54.87 -24.74 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.396 0.678 . . . . 0.0 110.05 172.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.405 ' HB2' HD21 ' A' ' 5' ' ' LEU . . . -116.19 3.64 13.49 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.139 1.776 . . . . 0.0 113.908 -174.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 t -79.4 -29.69 42.13 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.654 1.115 . . . . 0.0 111.276 -172.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.33 166.14 41.77 Favored Glycine 0 C--N 1.336 0.574 0 O-C-N 120.755 -1.215 . . . . 0.0 112.539 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -126.62 121.47 32.28 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.417 ' HD2' ' HB3' ' A' ' 89' ' ' LYS . 16.8 ptt180 -63.34 -3.42 1.96 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.579 1.152 . . . . 0.0 114.063 172.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p 58.04 -174.16 0.08 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 127.457 2.303 . . . . 0.0 110.761 -177.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -86.58 3.52 44.03 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.059 1.343 . . . . 0.0 111.59 176.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -69.22 164.94 21.56 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.87 1.214 . . . . 0.0 109.488 169.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -114.57 157.52 22.91 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.116 1.366 . . . . 0.0 108.182 174.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.53 150.04 50.35 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 -163.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.8 pt -145.83 17.6 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 122.457 0.303 . . . . 0.0 111.482 -163.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -131.61 167.4 19.5 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.389 1.076 . . . . 0.0 109.24 -171.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.22 -5.57 9.43 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.842 1.257 . . . . 0.0 112.334 -177.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -144.5 164.14 30.12 Favored Pre-proline 0 C--O 1.235 0.319 0 C-N-CA 126.011 1.724 . . . . 0.0 108.624 -174.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -70.69 -179.89 3.68 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.373 2.049 . . . . 0.0 110.803 174.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.0 p -110.34 -8.44 14.71 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.835 1.254 . . . . 0.0 111.911 175.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.86 159.45 20.37 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 124.266 1.026 . . . . 0.0 111.343 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -94.87 -13.6 25.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.255 1.022 . . . . 0.0 112.1 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -128.34 110.8 12.69 Favored 'General case' 0 C--O 1.231 0.083 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 175.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -147.32 160.75 42.15 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.59 1.556 . . . . 0.0 108.942 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.93 170.64 20.08 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.842 1.21 . . . . 0.0 110.315 171.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.3 m -131.98 121.1 23.39 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.031 1.732 . . . . 0.0 108.572 -163.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.2 mp -124.75 127.29 72.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 124.052 0.941 . . . . 0.0 109.266 -166.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -120.05 145.83 46.48 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 124.927 1.291 . . . . 0.0 109.244 171.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 30.5 mt -125.24 88.34 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -71.82 108.4 5.09 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.963 1.305 . . . . 0.0 108.041 177.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -137.34 134.24 35.8 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.515 1.126 . . . . 0.0 109.264 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.4 m120 62.84 -3.32 0.32 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.283 1.833 . . . . 0.0 115.861 173.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.77 10.82 8.94 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 120.163 1.347 . . . . 0.0 113.692 -174.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -149.22 -178.6 24.38 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.59 145.32 24.3 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 118.653 1.227 . . . . 0.0 113.065 -173.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 t -73.72 166.09 23.93 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 162.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.8 m -142.47 142.66 32.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 163.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 17.2 ptp -156.0 169.62 24.04 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.795 2.038 . . . . 0.0 108.391 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.41 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 54.8 m-85 -139.16 148.87 43.76 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.477 1.911 . . . . 0.0 108.077 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -127.94 151.77 48.7 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.921 1.237 . . . . 0.0 110.155 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -156.99 177.77 11.13 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.033 1.333 . . . . 0.0 110.001 -171.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -107.83 147.78 30.43 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.165 1.386 . . . . 0.0 107.843 167.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.5 tp10 -142.28 117.4 10.06 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.685 0.794 . . . . 0.0 109.383 171.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 61.77 -11.95 0.06 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 127.999 2.519 . . . . 0.0 115.612 -176.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.7 2.35 3.96 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 117.76 -1.578 . . . . 0.0 115.555 -177.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -110.17 160.39 16.53 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 121.018 2.409 . . . . 0.0 109.274 159.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -97.48 145.74 25.91 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -140.36 162.43 35.33 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.883 0.873 . . . . 0.0 110.622 -174.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mp -133.08 132.29 58.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.802 1.241 . . . . 0.0 109.508 -169.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.41 ' HB3' ' H ' ' A' ' 74' ' ' PHE . 5.3 tm-20 -77.36 154.41 32.8 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.846 2.058 . . . . 0.0 110.624 177.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -173.22 167.97 2.61 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 129.276 3.03 . . . . 0.0 106.415 174.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.408 ' O ' ' N ' ' A' ' 89' ' ' LYS . 90.9 Cg_endo -54.12 -162.02 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 125.215 3.943 . . . . 0.0 110.239 162.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -43.35 -5.69 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 128.284 2.634 . . . . 0.0 116.529 -175.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.417 ' HB3' ' HD2' ' A' ' 44' ' ' ARG . 9.2 mmtt -120.97 52.09 1.21 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.686 1.994 . . . . 0.0 111.776 171.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -129.14 59.39 0.69 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 116.719 1.448 . . . . 0.0 116.719 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.7 mt -130.19 55.18 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 118.649 1.224 . . . . 0.0 108.131 171.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -76.32 119.14 19.79 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 177.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -87.91 113.53 23.65 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 163.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 27.9 pt -98.91 171.15 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 158.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -122.78 -13.82 7.82 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.925 -0.484 . . . . 0.0 112.032 -173.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -123.53 150.22 44.27 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 173.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -70.12 128.44 36.29 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 123.926 0.89 . . . . 0.0 109.974 -172.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -60.89 -46.13 91.84 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.665 1.186 . . . . 0.0 111.402 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -64.91 -29.48 70.43 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.945 0.898 . . . . 0.0 111.504 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -78.97 -18.94 52.86 Favored 'General case' 0 C--O 1.24 0.594 0 O-C-N 121.683 -0.636 . . . . 0.0 112.471 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 19.9 mmt -85.29 -27.29 26.07 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.233 1.013 . . . . 0.0 111.468 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 28.2 pt . . . . . 0 C--O 1.251 1.181 0 CA-C-N 119.681 1.128 . . . . 0.0 111.601 -174.289 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 CA--C 1.548 0.879 0 CA-C-O 119.17 -0.443 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -65.95 -178.4 1.03 Allowed 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 124.528 3.485 . . . . 0.0 113.875 168.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.0 mt -106.94 122.5 61.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 164.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.28 166.12 11.62 Favored Pre-proline 0 C--O 1.238 0.495 0 C-N-CA 125.669 1.588 . . . . 0.0 109.641 168.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -62.88 -176.84 0.28 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 121.702 1.601 . . . . 0.0 111.124 167.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.405 ' HE3' ' HG2' ' A' ' 9' ' ' GLU . 4.7 mmmt -55.8 169.44 0.35 Allowed 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.092 -1.005 . . . . 0.0 108.88 159.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.417 ' HB2' HD13 ' A' ' 36' ' ' LEU . . . -81.71 -49.96 9.85 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 161.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.405 ' HG2' ' HE3' ' A' ' 7' ' ' LYS . 11.5 pt-20 -66.8 -22.89 66.01 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -167.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -79.27 -3.21 44.91 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.316 0.962 . . . . 0.0 113.356 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.0 t -85.5 122.6 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -70.48 -54.62 11.51 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.122 1.769 . . . . 0.0 108.121 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.7 p -157.22 155.93 31.7 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.183 0.516 . . . . 0.0 110.59 174.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.1 mt -109.66 139.21 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 170.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -129.71 106.13 8.5 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.6 mt -101.83 108.61 24.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -93.5 115.29 27.8 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.019 2.128 . . . . 0.0 107.32 174.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -79.8 172.1 14.23 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.809 0.844 . . . . 0.0 111.21 -172.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.95 -53.22 60.43 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.573 1.149 . . . . 0.0 110.182 170.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -71.23 149.15 46.54 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.998 1.719 . . . . 0.0 106.506 166.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.2 p -88.44 53.44 2.73 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.824 0.821 . . . . 0.0 110.627 -151.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.2 mt -126.32 134.27 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 -170.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -129.79 110.38 11.69 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -170.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.451 ' HE2' ' CE1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -101.81 130.54 48.27 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -176.193 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.1 mt -100.51 134.96 38.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.575 ' CD2' HD11 ' A' ' 35' ' ' ILE . 9.6 m-85 -117.16 84.59 2.18 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 103.146 -2.909 . . . . 0.0 103.146 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -94.46 -6.91 42.88 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 127.459 2.304 . . . . 0.0 110.349 170.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.59 132.27 35.3 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 t -58.03 -42.34 85.1 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.541 -0.724 . . . . 0.0 111.45 -171.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -73.53 -36.43 65.68 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.264 -0.897 . . . . 0.0 111.506 -174.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.6 m -53.53 -51.75 61.86 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 126.612 1.965 . . . . 0.0 110.756 167.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.8 mt -58.18 -50.08 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 123.526 0.73 . . . . 0.0 109.206 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -55.64 -45.57 77.6 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 118.552 -0.737 . . . . 0.0 112.051 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.46 -51.81 68.3 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-N 118.303 0.501 . . . . 0.0 109.813 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.575 HD11 ' CD2' ' A' ' 26' ' ' TYR . 94.2 mt -55.95 -45.12 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.955 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.417 HD13 ' HB2' ' A' ' 8' ' ' ALA . 3.7 mt -57.0 -25.65 58.89 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.989 1.268 . . . . 0.0 113.013 176.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.2 m -73.57 -52.78 12.31 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 120.244 1.384 . . . . 0.0 109.883 169.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -65.05 -24.11 67.38 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.809 1.186 . . . . 0.0 112.732 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.9 mm -83.39 -7.55 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.183 1.793 . . . . 0.0 110.754 175.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.13 1.62 9.19 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.242 1.417 . . . . 0.0 114.33 -175.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.5 p -66.36 -31.25 71.91 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.588 1.086 . . . . 0.0 111.517 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.9 163.14 43.47 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-O 122.606 1.114 . . . . 0.0 113.924 -164.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.416 ' O ' HG23 ' A' ' 45' ' ' THR . 23.5 pttt -112.24 97.65 6.78 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 127.183 2.193 . . . . 0.0 109.629 176.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.4 ' HB3' ' CE2' ' A' ' 92' ' ' TYR . 4.6 ppt_? -60.08 -11.88 7.02 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 124.746 1.218 . . . . 0.0 113.216 167.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 43' ' ' LYS . 27.1 p 64.98 -175.23 0.17 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 126.738 2.015 . . . . 0.0 111.663 175.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -95.9 14.15 24.44 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.295 0.638 . . . . 0.0 112.531 165.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -64.63 147.99 51.83 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 120.558 -1.339 . . . . 0.0 110.67 156.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -83.55 121.7 27.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 168.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.1 t -73.0 147.94 44.67 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.743 -1.576 . . . . 0.0 106.743 152.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.9 pt -140.16 13.4 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 126.4 1.88 . . . . 0.0 110.024 170.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -86.39 164.17 17.19 Favored 'General case' 0 C--O 1.238 0.5 0 O-C-N 120.954 -1.091 . . . . 0.0 110.013 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.43 -15.05 10.95 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 118.088 -0.958 . . . . 0.0 112.235 175.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -153.95 165.5 17.76 Favored Pre-proline 0 N--CA 1.469 0.481 0 C-N-CA 125.331 1.452 . . . . 0.0 110.537 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -72.11 147.17 47.96 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.62 2.214 . . . . 0.0 111.591 168.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.11 -31.15 61.08 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.899 0.48 . . . . 0.0 112.103 171.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.26 155.2 25.41 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 121.799 0.809 . . . . 0.0 111.085 -173.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -84.76 -35.26 22.55 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.651 171.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -110.22 94.99 5.3 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -172.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -139.06 171.81 13.76 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 128.613 2.765 . . . . 0.0 107.063 172.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.71 -177.13 14.73 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 166.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.7 m -123.96 122.91 39.19 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.519 1.128 . . . . 0.0 109.449 -165.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mp -97.52 133.82 37.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 170.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -130.57 137.75 49.83 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.853 1.261 . . . . 0.0 107.899 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.4 mt -128.12 92.35 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 105.45 -2.055 . . . . 0.0 105.45 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -70.24 109.46 4.68 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 170.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -139.52 138.58 36.44 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.341 1.056 . . . . 0.0 108.552 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.2 m120 48.8 36.18 7.64 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.246 1.018 . . . . 0.0 111.721 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.45 18.49 79.91 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 118.939 -0.923 . . . . 0.0 115.119 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.05 156.23 24.28 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 120.355 2.077 . . . . 0.0 110.328 173.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 81.4 mtp -112.33 96.76 6.2 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 123.845 0.858 . . . . 0.0 109.825 -173.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 m -62.88 105.79 0.72 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 165.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.8 m -103.65 156.16 18.0 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -176.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.8 ptp -153.88 171.05 19.58 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.828 1.651 . . . . 0.0 107.185 167.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -126.28 -177.98 4.16 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.233 1.413 . . . . 0.0 107.491 173.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -150.51 156.27 41.09 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -158.76 169.5 24.23 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 162.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -89.87 121.56 32.1 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 169.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -109.67 119.16 38.54 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 169.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.27 4.02 2.0 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.777 1.631 . . . . 0.0 114.463 164.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.01 -13.82 6.0 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.73 1.634 . . . . 0.0 113.4 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.8 tptt -115.16 163.2 15.98 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 120.034 1.917 . . . . 0.0 109.987 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -107.47 142.96 36.52 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -138.43 160.89 38.38 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.261 0.624 . . . . 0.0 109.988 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.78 133.83 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.936 0.894 . . . . 0.0 111.825 -173.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -71.98 161.33 31.08 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.121 -0.987 . . . . 0.0 112.379 -176.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -175.23 169.17 1.58 Allowed Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 126.896 2.078 . . . . 0.0 108.051 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -58.18 -162.54 0.02 OUTLIER 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.081 1.854 . . . . 0.0 110.54 155.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -43.28 -14.31 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.465 2.706 . . . . 0.0 116.705 -171.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -105.03 49.8 0.8 Allowed 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.272 -0.893 . . . . 0.0 111.888 168.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -125.16 69.18 0.5 Allowed Glycine 0 C--O 1.222 -0.608 0 CA-C-N 119.876 1.216 . . . . 0.0 112.247 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.6 mt -133.63 49.27 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 163.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.4 ' CE2' ' HB3' ' A' ' 44' ' ' ARG . 51.0 m-85 -74.87 110.95 9.59 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -78.08 125.17 28.96 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 160.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.7 pt -106.93 164.48 4.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 152.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -123.65 48.21 1.9 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.351 0.661 . . . . 0.0 110.021 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -164.36 174.29 11.23 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.111 0.965 . . . . 0.0 111.757 159.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -70.2 122.94 20.45 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.091 0.956 . . . . 0.0 108.888 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -63.12 -47.88 80.87 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.511 0.596 . . . . 0.0 110.572 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -58.99 -35.03 72.54 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.451 -0.781 . . . . 0.0 112.871 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -72.69 -23.7 60.91 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.245 0.93 . . . . 0.0 110.827 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.2 mmt -70.59 -36.11 73.37 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 121.593 -0.692 . . . . 0.0 110.413 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.0 pt . . . . . 0 C--O 1.249 1.044 0 CA-C-N 119.172 0.896 . . . . 0.0 112.48 -167.677 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 m . . . . . 0 CA--C 1.545 0.751 0 CA-C-O 119.559 -0.258 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -67.29 165.04 28.19 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 CA-C-N 120.075 1.063 . . . . 0.0 111.352 167.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.6 mt -101.99 111.68 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 158.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.48 152.88 46.55 Favored Pre-proline 0 C--O 1.241 0.608 0 C-N-CA 125.878 1.671 . . . . 0.0 108.701 177.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -73.7 159.88 44.86 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.807 2.338 . . . . 0.0 111.436 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.425 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -70.32 149.71 47.09 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 123.455 0.702 . . . . 0.0 112.048 -173.714 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.478 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . . . -64.1 -12.86 43.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 118.592 -0.718 . . . . 0.0 111.945 170.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -95.13 -6.26 42.26 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.509 1.05 . . . . 0.0 112.123 -178.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -129.39 -2.54 4.95 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.58 1.152 . . . . 0.0 112.242 -173.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 37.5 t -78.88 111.22 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 170.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -74.8 -43.01 57.0 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.135 1.374 . . . . 0.0 108.605 176.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.8 p -160.24 171.89 18.37 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.593 1.088 . . . . 0.0 112.613 168.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.6 mt -130.02 137.69 55.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 127.335 2.254 . . . . 0.0 105.832 172.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.8 t -116.44 151.2 36.52 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 159.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.0 mt -131.41 101.64 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 168.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.3 117.39 20.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 169.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -75.33 177.02 6.88 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.262 1.029 . . . . 0.0 110.6 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.9 p -60.81 -15.29 28.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.078 2.151 . . . . 0.0 113.363 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 48.2 p30 -118.22 -166.76 1.25 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.515 1.926 . . . . 0.0 110.086 -170.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.2 p -82.44 24.95 0.65 Allowed 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.273 -1.517 . . . . 0.0 111.809 -173.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.5 mt -124.89 149.39 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.463 -1.681 . . . . 0.0 106.463 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -135.3 164.9 26.68 Favored 'General case' 0 N--CA 1.417 -2.084 0 C-N-CA 127.476 2.31 . . . . 0.0 107.906 170.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.25 134.92 30.1 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.8 mp -106.52 148.88 10.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -129.81 34.72 4.25 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.147 0.979 . . . . 0.0 109.664 -170.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -57.47 -20.65 32.17 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.384 2.274 . . . . 0.0 113.019 -175.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.97 123.85 21.74 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 129.542 3.137 . . . . 0.0 109.117 175.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.3 t -46.22 -48.08 17.79 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.133 1.373 . . . . 0.0 113.746 -175.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -69.54 -27.57 65.26 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.004 -1.06 . . . . 0.0 111.566 -175.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.6 m -72.58 -34.86 67.74 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.297 1.839 . . . . 0.0 111.019 172.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.0 mt -65.23 -52.86 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -65.37 -14.05 59.97 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -66.82 -78.66 0.06 Allowed 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 157.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.3 mt -50.58 -39.76 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 125.018 1.327 . . . . 0.0 112.578 -160.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.478 ' CD1' ' HB2' ' A' ' 8' ' ' ALA . 41.5 mt -51.64 -23.0 3.81 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.1 t -64.46 -63.83 1.03 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.168 1.387 . . . . 0.0 108.494 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 56.7 mp0 -64.5 -27.39 68.94 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.4 1.48 . . . . 0.0 111.158 -175.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.5 mm -62.26 -35.5 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 O-C-N 121.297 -0.877 . . . . 0.0 110.245 173.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.63 0.12 30.31 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 120.726 -1.234 . . . . 0.0 113.587 -169.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.7 t -64.81 -44.91 88.39 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.006 0.523 . . . . 0.0 110.919 -176.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.451 ' CA ' HG22 ' A' ' 94' ' ' ILE . . . -73.61 168.24 54.06 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-O 122.493 1.051 . . . . 0.0 112.432 -175.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -132.76 130.74 40.34 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 176.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -68.15 0.3 3.83 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.7 p 60.03 -172.54 0.12 Allowed 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 126.751 2.02 . . . . 0.0 108.847 -174.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -91.31 2.75 56.16 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.095 -1.003 . . . . 0.0 112.034 176.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt -69.03 170.07 10.58 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.084 0.856 . . . . 0.0 110.894 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.11 150.29 34.3 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.07 1.748 . . . . 0.0 109.019 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.87 149.87 43.64 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 -169.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 35.4 pt -138.31 17.78 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 118.957 0.799 . . . . 0.0 112.523 -165.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -139.97 -173.24 3.59 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.181 0.992 . . . . 0.0 108.761 -169.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.38 -6.38 1.56 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.481 1.112 . . . . 0.0 110.651 171.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -140.63 150.23 59.62 Favored Pre-proline 0 N--CA 1.469 0.485 0 CA-C-N 120.21 1.368 . . . . 0.0 111.29 -168.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.26 167.27 27.34 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.666 2.911 . . . . 0.0 114.928 -164.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 t -100.11 23.01 10.51 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.386 2.274 . . . . 0.0 110.72 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -126.6 150.41 48.9 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 125.268 1.427 . . . . 0.0 110.626 -174.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -90.03 -24.79 21.1 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.484 1.114 . . . . 0.0 110.871 172.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -125.34 102.44 7.43 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -145.01 166.99 23.72 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 128.383 2.673 . . . . 0.0 106.163 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.48 166.93 13.74 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 168.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.5 m -112.46 140.05 47.52 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.572 1.149 . . . . 0.0 108.553 -170.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.5 mp -125.81 128.83 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 -174.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -115.1 135.68 53.94 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.2 mt -126.03 87.65 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 171.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -70.22 116.03 10.11 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 125.418 1.487 . . . . 0.0 107.23 174.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -140.91 113.28 8.01 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.036 0.934 . . . . 0.0 109.97 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.5 m120 74.52 -14.99 0.66 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 130.446 3.499 . . . . 0.0 115.639 171.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 123.21 23.68 2.14 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 118.843 0.747 . . . . 0.0 111.352 -165.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -145.1 171.7 26.14 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 106.609 -2.596 . . . . 0.0 106.609 160.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.08 139.24 34.01 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 118.772 1.286 . . . . 0.0 111.031 172.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 91.3 m -76.55 128.48 34.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 161.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.6 m -102.59 146.68 27.81 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 164.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.6 ptm -159.5 165.51 32.85 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.485 1.514 . . . . 0.0 108.47 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -144.64 140.66 28.83 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.826 1.65 . . . . 0.0 106.841 -174.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.427 ' CE1' HG23 ' A' ' 84' ' ' ILE . 1.8 m-85 -129.21 152.24 49.0 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 120.015 1.279 . . . . 0.0 109.35 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -153.81 -175.56 5.43 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.12 0.968 . . . . 0.0 111.264 -178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -115.55 142.79 46.25 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.609 1.964 . . . . 0.0 108.586 173.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -141.71 127.68 19.47 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 125.393 1.477 . . . . 0.0 108.431 175.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.0 m120 57.76 14.7 2.59 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.957 1.303 . . . . 0.0 112.936 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.21 18.98 58.22 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 117.921 -1.488 . . . . 0.0 113.32 -175.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.26 148.43 45.91 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 128.612 2.765 . . . . 0.0 107.493 177.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -104.65 143.01 33.66 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.541 1.519 . . . . 0.0 111.305 -169.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -138.12 150.07 46.5 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.24 0.616 . . . . 0.0 111.22 -171.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.427 HG23 ' CE1' ' A' ' 75' ' ' TYR . 3.4 mp -123.16 120.02 59.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 125.133 1.373 . . . . 0.0 108.931 -177.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -73.69 153.19 40.19 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.419 1.088 . . . . 0.0 110.475 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -172.53 168.07 2.96 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 128.428 2.691 . . . . 0.0 106.072 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -57.92 -161.26 0.02 OUTLIER 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 125.268 3.979 . . . . 0.0 110.386 165.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -42.72 -8.82 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 127.572 2.349 . . . . 0.0 117.055 -175.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -121.13 46.74 1.97 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.016 1.326 . . . . 0.0 112.194 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -126.57 70.11 0.5 Allowed Glycine 0 C--O 1.224 -0.508 0 C-N-CA 125.762 1.648 . . . . 0.0 113.715 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.5 mt -131.09 53.07 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 164.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -75.42 125.95 30.03 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -119.31 102.47 8.71 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 -171.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.451 HG22 ' CA ' ' A' ' 42' ' ' GLY . 4.7 pt -115.75 146.71 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.655 1.582 . . . . 0.0 109.073 -175.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -91.82 -5.71 52.96 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -171.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -130.51 153.65 48.62 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.114 0.87 . . . . 0.0 112.638 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -57.86 135.72 56.9 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 126.383 1.873 . . . . 0.0 110.655 174.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -82.02 -49.86 9.76 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.029 1.332 . . . . 0.0 110.884 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -67.99 -13.81 62.47 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -165.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -97.7 -10.25 25.28 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.414 1.006 . . . . 0.0 112.576 173.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 38.7 mmm -76.81 -37.42 55.77 Favored 'General case' 0 C--O 1.233 0.222 0 O-C-N 120.626 -1.297 . . . . 0.0 111.167 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 12.8 pt . . . . . 0 C--O 1.243 0.73 0 C-N-CA 126.558 1.943 . . . . 0.0 114.229 -153.693 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.54 0.577 0 CA-C-O 119.251 -0.404 . . . . 0.0 111.76 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.44 163.3 39.31 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.707 1.604 . . . . 0.0 112.157 169.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.0 mt -96.56 105.67 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 162.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.817 HD13 HG22 ' A' ' 39' ' ' ILE . 16.4 mt -126.19 165.64 26.43 Favored Pre-proline 0 C--O 1.24 0.585 0 C-N-CA 125.396 1.478 . . . . 0.0 108.462 174.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -62.07 163.56 19.35 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.014 1.81 . . . . 0.0 111.248 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.4 ' HE2' ' CG ' ' A' ' 9' ' ' GLU . 2.7 mppt? -61.88 179.69 0.25 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.265 0.626 . . . . 0.0 111.405 170.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.77 -45.9 33.78 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 155.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.4 ' CG ' ' HE2' ' A' ' 7' ' ' LYS . 11.2 pt-20 -71.34 3.94 3.31 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.305 1.442 . . . . 0.0 114.037 -163.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 -124.96 4.13 8.02 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.298 2.239 . . . . 0.0 112.516 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 37.8 t -84.25 141.77 14.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -92.4 -52.75 4.51 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 173.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.51 161.34 42.32 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.907 0.883 . . . . 0.0 111.923 170.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.6 mt -123.89 140.81 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 164.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 54.4 m -134.42 115.74 14.36 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 -168.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.7 mt -119.55 120.11 62.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -112.06 102.42 10.63 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -72.27 168.17 18.87 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.623 1.569 . . . . 0.0 110.031 -165.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.0 p -45.87 -39.62 8.86 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.767 1.627 . . . . 0.0 112.97 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -51.09 -153.62 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 131.41 3.884 . . . . 0.0 112.07 164.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 93.3 p -122.07 25.15 9.21 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 119.863 -1.773 . . . . 0.0 110.596 160.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.3 mt -84.65 134.47 26.93 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 172.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -125.69 129.34 49.35 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.55 125.98 54.79 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 175.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.3 mp -99.8 135.64 34.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 173.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -118.26 87.12 2.66 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -118.19 52.16 1.03 Allowed 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.812 1.645 . . . . 0.0 107.148 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.45 146.49 40.14 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.614 1.566 . . . . 0.0 107.377 168.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.2 t -46.69 -53.99 10.55 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.949 1.699 . . . . 0.0 112.266 177.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -76.42 -27.5 56.29 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 121.65 -0.656 . . . . 0.0 112.027 -171.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 51.5 m -65.78 -48.76 70.71 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.428 1.491 . . . . 0.0 109.187 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 76.9 mt -57.9 -53.19 48.51 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 C-N-CA 125.599 1.56 . . . . 0.0 108.849 171.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -61.1 -28.45 69.1 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 120.541 1.519 . . . . 0.0 113.309 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.18 -60.14 3.08 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.1 mt -47.59 -49.69 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.642 1.577 . . . . 0.0 110.984 175.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.45 -28.07 12.1 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -176.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.5 t -63.93 -62.13 1.83 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.952 0.796 . . . . 0.0 109.16 172.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -63.62 -32.18 73.57 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.411 -0.805 . . . . 0.0 111.894 -174.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.817 HG22 HD13 ' A' ' 5' ' ' LEU . 26.0 mm -62.24 -25.85 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.801 1.24 . . . . 0.0 111.036 174.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.65 -5.73 12.17 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -175.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 t -62.15 -26.91 68.59 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.871 1.214 . . . . 0.0 112.038 -169.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.68 169.67 43.15 Favored Glycine 0 C--N 1.335 0.494 0 O-C-N 120.987 -1.07 . . . . 0.0 114.238 -167.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -112.1 106.72 15.42 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 125.907 1.683 . . . . 0.0 108.336 174.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -3.33 1.16 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.134 0.974 . . . . 0.0 112.923 165.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.1 p 66.27 -164.77 0.23 Allowed 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 125.378 1.471 . . . . 0.0 108.056 174.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -105.42 12.66 31.28 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.593 1.088 . . . . 0.0 111.473 169.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -63.67 170.53 3.22 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 122.166 0.984 . . . . 0.0 110.527 164.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -122.51 144.52 49.02 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 125.604 1.562 . . . . 0.0 110.526 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.02 157.56 16.25 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 125.028 1.331 . . . . 0.0 108.604 172.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 26.7 pt -137.77 17.36 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 125.771 1.628 . . . . 0.0 111.284 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.02 176.88 8.31 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.369 1.468 . . . . 0.0 110.701 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.9 -4.67 6.33 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.749 2.42 . . . . 0.0 110.944 -175.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -140.31 150.05 59.94 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-N 119.202 0.91 . . . . 0.0 109.814 -175.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.43 167.73 25.5 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.141 1.894 . . . . 0.0 110.06 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.2 20.19 16.45 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.401 1.08 . . . . 0.0 110.367 170.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.58 173.83 11.09 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.037 -1.04 . . . . 0.0 109.022 157.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.97 -24.04 5.7 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 127.455 2.302 . . . . 0.0 110.082 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -118.87 112.74 20.05 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.502 1.921 . . . . 0.0 106.114 174.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -149.41 173.83 13.12 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 126.956 2.103 . . . . 0.0 106.706 170.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -114.66 166.17 12.13 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 167.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.58 147.66 22.8 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.397 0.679 . . . . 0.0 109.701 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.0 mp -134.84 128.95 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 172.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -132.26 141.53 49.05 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 53.7 mt -129.24 97.39 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 -177.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -71.31 131.3 43.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 170.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -158.79 -166.04 1.78 Allowed 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -45.51 -32.83 2.4 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.724 1.609 . . . . 0.0 114.133 175.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.23 2.47 81.47 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-O 119.311 -0.716 . . . . 0.0 111.873 -173.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.47 -138.05 22.68 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 107.619 -2.192 . . . . 0.0 107.619 -153.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 11.5 mtt -105.44 112.52 25.64 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.181 0.991 . . . . 0.0 110.682 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 47.9 m -60.04 124.86 21.53 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 149.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.6 m -112.87 143.42 44.17 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.971 1.708 . . . . 0.0 107.073 173.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.5 ptm -163.94 167.71 20.24 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.539 1.535 . . . . 0.0 108.677 -172.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -149.23 129.53 13.75 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.738 1.215 . . . . 0.0 109.098 -169.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.607 ' CE1' HG23 ' A' ' 84' ' ' ILE . 3.3 m-30 -120.18 145.43 46.98 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.751 1.614 . . . . 0.0 110.164 -172.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -151.13 179.51 8.22 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.682 1.593 . . . . 0.0 110.938 -169.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -112.86 148.72 34.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.474 1.51 . . . . 0.0 108.987 168.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -144.72 119.42 9.81 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.686 1.194 . . . . 0.0 108.398 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 58.57 5.44 0.46 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.6 1.96 . . . . 0.0 114.856 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.22 1.8 28.1 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 119.838 1.199 . . . . 0.0 113.536 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -106.17 149.93 26.34 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 119.227 1.513 . . . . 0.0 108.131 163.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -93.85 151.85 19.3 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 174.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -140.47 159.05 43.05 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.599 0.714 . . . . 0.0 111.312 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.607 HG23 ' CE1' ' A' ' 75' ' ' TYR . 2.5 mp -119.65 124.69 73.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 125.26 1.424 . . . . 0.0 108.86 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -70.71 147.65 48.83 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 122.231 1.015 . . . . 0.0 111.596 168.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.503 ' HB2' ' HA2' ' A' ' 90' ' ' GLY . 0.8 OUTLIER -171.55 167.6 3.7 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 128.39 2.676 . . . . 0.0 107.881 174.732 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.42 ' HD2' ' CB ' ' A' ' 86' ' ' CYS . 45.9 Cg_endo -53.19 -160.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.609 1 C-N-CA 126.199 4.599 . . . . 0.0 110.672 166.002 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -42.63 -13.78 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.756 2.423 . . . . 0.0 115.58 -173.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -110.04 67.42 0.65 Allowed 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 127.875 2.47 . . . . 0.0 113.074 164.1 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.503 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . -130.72 38.71 1.9 Allowed Glycine 0 N--CA 1.463 0.457 0 N-CA-C 116.251 1.26 . . . . 0.0 116.251 -173.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.3 mt -129.34 39.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 O-C-N 121.72 -0.871 . . . . 0.0 109.049 -170.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -75.84 101.62 5.19 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -171.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -72.28 125.82 28.28 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 166.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 24.5 pt -114.99 179.44 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 125.976 1.71 . . . . 0.0 108.753 165.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -107.09 -18.19 13.97 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -178.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -136.67 168.74 18.93 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.792 0.837 . . . . 0.0 111.749 -165.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -77.7 121.44 24.01 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.239 1.016 . . . . 0.0 109.937 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -62.76 -47.77 82.07 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.365 1.066 . . . . 0.0 111.781 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -62.53 -32.02 72.89 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.45 0.7 . . . . 0.0 111.881 -172.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -71.19 -21.01 62.2 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.142 -0.974 . . . . 0.0 111.738 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.1 mmt -98.57 -4.58 33.8 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.128 1.371 . . . . 0.0 112.531 -170.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 23.0 pt . . . . . 0 C--O 1.253 1.286 0 C-N-CA 124.69 1.196 . . . . 0.0 111.321 -175.663 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 CA--C 1.534 0.332 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -55.21 158.63 11.59 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 CA-C-N 121.292 1.497 . . . . 0.0 111.824 164.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 mp -80.32 135.87 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 158.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.63 165.11 24.4 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 126.393 1.877 . . . . 0.0 108.851 174.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HB2' HD21 ' A' ' 10' ' ' ASN . 47.9 Cg_endo -64.8 175.8 3.41 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.096 2.531 . . . . 0.0 112.485 174.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.698 ' H ' ' HE2' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -67.16 -172.28 0.2 Allowed 'General case' 0 C--N 1.344 0.364 0 O-C-N 120.386 -1.446 . . . . 0.0 109.922 167.363 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.7 -36.81 12.73 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.548 0.739 . . . . 0.0 110.957 161.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -76.06 -17.68 59.54 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.206 -0.934 . . . . 0.0 113.223 -171.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.496 HD22 ' N ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -88.12 -3.89 58.83 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.854 1.261 . . . . 0.0 112.421 176.043 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.496 ' N ' HD22 ' A' ' 10' ' ' ASN . 29.1 t -88.3 118.48 33.95 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 -172.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -83.89 -49.43 9.03 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.081 1.352 . . . . 0.0 107.817 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.3 m -157.03 176.95 12.07 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.618 1.099 . . . . 0.0 111.523 163.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.615 HG12 HG23 ' A' ' 64' ' ' ILE . 53.9 mt -126.81 145.05 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 167.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.8 t -125.58 141.08 52.22 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.472 1.109 . . . . 0.0 108.516 169.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.6 mt -134.47 105.76 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 176.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -93.75 109.24 20.91 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 171.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -67.9 169.63 9.52 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.846 1.258 . . . . 0.0 109.846 -173.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.5 p -50.3 -35.71 28.6 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.153 0.981 . . . . 0.0 111.76 176.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -58.86 -154.75 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 131.367 3.867 . . . . 0.0 111.27 172.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.2 p -108.91 4.69 23.66 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 119.992 -1.693 . . . . 0.0 111.947 163.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.4 mt -75.63 133.62 30.91 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -132.26 110.06 10.35 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -177.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.8 125.26 50.79 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -177.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.1 mp -101.19 127.48 54.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 175.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.413 ' CG ' HD11 ' A' ' 35' ' ' ILE . 46.4 m-85 -106.26 83.31 1.87 Allowed 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 102.023 -3.325 . . . . 0.0 102.023 174.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -89.93 -13.4 36.34 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.902 0.881 . . . . 0.0 111.337 174.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.01 135.98 33.32 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.598 1.559 . . . . 0.0 109.877 -165.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.4 t -49.17 -48.09 45.35 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.689 1.196 . . . . 0.0 113.756 -171.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -71.56 -33.48 69.14 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 120.706 -1.247 . . . . 0.0 111.425 -174.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.4 m -62.26 -34.99 77.6 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.753 2.021 . . . . 0.0 110.943 170.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.5 mt -68.2 -49.13 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -59.33 -33.4 71.08 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 117.907 -1.044 . . . . 0.0 112.133 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.449 ' HE3' ' C ' ' A' ' 102' ' ' ILE . 0.0 OUTLIER -64.61 -62.28 1.68 Allowed 'General case' 0 C--N 1.343 0.311 0 CA-C-N 119.699 1.136 . . . . 0.0 109.492 172.735 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.413 HD11 ' CG ' ' A' ' 26' ' ' TYR . 40.5 mt -51.95 -50.12 35.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 124.006 0.922 . . . . 0.0 111.068 -173.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.72 -16.23 10.38 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.1 0.96 . . . . 0.0 113.015 -173.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.2 t -61.42 -59.11 5.77 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.64 1.109 . . . . 0.0 110.203 168.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -65.36 -31.1 72.04 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.58 1.152 . . . . 0.0 110.697 -176.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 39.2 mm -62.13 -16.19 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 121.164 -0.96 . . . . 0.0 111.762 173.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.89 7.82 14.57 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.536 1.534 . . . . 0.0 113.074 175.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 t -78.6 -30.93 46.89 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 120.272 1.396 . . . . 0.0 109.951 -177.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.496 ' CA ' HG22 ' A' ' 94' ' ' ILE . . . -86.38 161.61 34.19 Favored Glycine 0 N--CA 1.447 -0.629 0 O-C-N 120.841 -1.162 . . . . 0.0 114.717 -162.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.46 99.79 7.05 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -170.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.519 ' HB3' ' CE2' ' A' ' 92' ' ' TYR . 9.5 ptt180 -60.12 -8.23 2.31 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.583 1.538 . . . . 0.0 114.311 -177.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.8 p 65.19 176.71 0.2 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.638 2.375 . . . . 0.0 110.115 -175.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -74.34 -9.95 59.1 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.607 -1.308 . . . . 0.0 111.45 172.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -58.41 161.38 4.48 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.985 1.374 . . . . 0.0 110.705 -177.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -108.44 149.95 28.06 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.007 -1.451 . . . . 0.0 107.362 165.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.86 119.98 32.15 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.45 -2.055 . . . . 0.0 105.45 -165.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.8 pt -105.28 12.13 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 119.195 -0.431 . . . . 0.0 111.939 -162.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.56 179.91 6.54 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.385 1.874 . . . . 0.0 108.553 -174.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -127.55 -7.1 5.73 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.148 2.179 . . . . 0.0 110.56 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -140.15 149.22 57.52 Favored Pre-proline 0 C--O 1.238 0.495 0 C-N-CA 124.02 0.928 . . . . 0.0 111.455 -170.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -67.7 155.35 70.35 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.677 2.251 . . . . 0.0 114.104 -171.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 m -100.43 10.39 41.27 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.783 2.033 . . . . 0.0 111.86 162.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.66 166.8 22.98 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 120.501 -1.374 . . . . 0.0 110.072 162.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -105.31 -34.78 7.76 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 127.343 2.257 . . . . 0.0 109.68 165.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -116.12 98.16 6.47 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 -165.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -154.39 162.74 40.99 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 126.05 1.74 . . . . 0.0 109.289 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.64 166.62 15.03 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.908 0.766 . . . . 0.0 111.218 175.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.6 m -107.72 124.67 50.37 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -176.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.71 135.15 56.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 124.445 1.098 . . . . 0.0 108.362 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -121.16 135.1 55.22 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 163.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.662 HG22 ' OD1' ' A' ' 66' ' ' ASN . 42.1 mt -117.1 100.5 10.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 102.718 -3.067 . . . . 0.0 102.718 166.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -78.93 107.18 11.48 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.879 1.672 . . . . 0.0 106.596 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.662 ' OD1' HG22 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -145.56 158.22 43.87 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 123.779 0.831 . . . . 0.0 108.962 179.356 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 48.94 30.03 2.59 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.616 1.566 . . . . 0.0 113.925 169.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.44 47.63 85.62 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 120.925 -1.11 . . . . 0.0 111.2 -175.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -156.89 -173.09 24.9 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 126.092 1.805 . . . . 0.0 109.37 168.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.04 137.57 53.08 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.876 0.846 . . . . 0.0 109.213 159.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.4 m -84.01 97.43 9.28 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 103.612 -2.736 . . . . 0.0 103.612 164.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.1 m -83.87 140.25 32.11 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 2.0 ptm -162.67 163.52 26.94 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.053 1.341 . . . . 0.0 108.768 -177.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -139.69 148.55 42.52 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -136.29 151.84 50.06 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 121.385 1.902 . . . . 0.0 109.528 177.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -147.02 173.4 12.49 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.278 1.031 . . . . 0.0 111.731 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -93.99 146.72 23.73 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 159.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -138.34 126.91 23.4 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 162.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 60.3 6.64 1.07 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.805 1.642 . . . . 0.0 114.412 171.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.17 3.53 31.33 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.963 1.268 . . . . 0.0 113.782 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.56 153.93 24.43 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 120.03 1.915 . . . . 0.0 108.81 161.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -98.74 155.2 17.46 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 174.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.427 ' HA ' ' O ' ' A' ' 92' ' ' TYR . 93.6 m-85 -141.25 159.88 41.28 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 119.039 -0.505 . . . . 0.0 111.882 -176.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.1 mp -124.45 131.49 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.534 1.534 . . . . 0.0 111.755 172.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -82.6 164.38 20.84 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.198 1.799 . . . . 0.0 111.457 172.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.4 ' HB2' ' HA2' ' A' ' 90' ' ' GLY . 0.1 OUTLIER 177.57 169.2 0.47 Allowed Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.842 1.657 . . . . 0.0 108.656 -162.018 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.428 ' O ' ' N ' ' A' ' 89' ' ' LYS . 20.7 Cg_endo -63.23 -164.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.363 0 CA-C-N 121.904 1.716 . . . . 0.0 108.953 158.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -43.65 -5.55 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 129.121 2.969 . . . . 0.0 118.71 -165.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -113.48 43.75 1.71 Allowed 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 128.314 2.646 . . . . 0.0 111.734 170.866 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.4 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . -113.42 53.05 0.61 Allowed Glycine 0 C--N 1.334 0.471 0 CA-C-N 120.11 1.323 . . . . 0.0 114.823 -176.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.1 mt -129.93 52.33 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 170.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.519 ' CE2' ' HB3' ' A' ' 44' ' ' ARG . 77.4 m-85 -74.39 99.37 3.5 Favored 'General case' 0 CA--C 1.499 -0.984 0 O-C-N 120.957 -1.089 . . . . 0.0 108.641 176.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -61.89 128.21 35.12 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 158.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.496 HG22 ' CA ' ' A' ' 42' ' ' GLY . 3.1 pt -128.78 152.07 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 125.413 1.485 . . . . 0.0 108.251 167.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -80.7 -39.81 26.47 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -112.09 164.75 12.8 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.843 1.257 . . . . 0.0 111.07 -169.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -71.4 131.33 43.21 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 122.377 0.271 . . . . 0.0 110.282 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -64.85 -45.97 83.84 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 122.157 -0.339 . . . . 0.0 110.58 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -69.02 -31.24 69.9 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -168.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -77.71 -25.75 49.59 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.097 -1.002 . . . . 0.0 110.686 177.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 22.7 mmt -81.89 -12.71 58.31 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.742 0.817 . . . . 0.0 112.81 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.449 ' C ' ' HE3' ' A' ' 34' ' ' LYS . 29.1 pt . . . . . 0 C--O 1.25 1.097 0 CA-C-N 120.94 1.7 . . . . 0.0 109.894 172.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.9 p . . . . . 0 C--O 1.24 0.564 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -47.93 153.43 2.6 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 120.654 0.902 . . . . 0.0 111.642 154.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 80.3 mt -80.7 133.33 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 157.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.04 164.43 39.1 Favored Pre-proline 0 C--O 1.242 0.701 0 C-N-CA 125.061 1.344 . . . . 0.0 107.792 176.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -58.81 169.82 3.12 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 121.395 1.397 . . . . 0.0 109.93 160.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.472 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -55.5 175.66 0.07 Allowed 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 120.47 -1.394 . . . . 0.0 110.941 164.011 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.2 -55.3 5.86 Favored 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 156.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -62.63 -16.23 55.71 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -163.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -95.32 1.85 54.53 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.028 1.731 . . . . 0.0 114.542 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 72.3 t -84.14 130.08 36.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 177.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.42 -58.18 3.46 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 169.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 63.6 p -153.23 163.54 39.71 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.611 171.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 56.1 mt -106.08 125.65 61.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 164.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.6 t -91.56 138.36 31.63 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 163.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.0 mt -125.0 107.52 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 166.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -86.06 121.91 29.34 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 169.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -67.96 164.91 18.91 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.039 0.936 . . . . 0.0 110.734 -176.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -57.9 -27.77 63.61 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 118.512 -0.756 . . . . 0.0 112.404 168.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -87.89 -79.38 0.29 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.929 1.24 . . . . 0.0 111.21 -177.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.9 t -175.93 -3.84 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.963 2.105 . . . . 0.0 112.584 -176.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.0 mm -73.31 150.06 8.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 169.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -139.46 122.19 16.44 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.59 ' HE2' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -121.19 131.53 54.3 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -171.26 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.4 mp -112.14 145.81 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -177.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.59 ' CE1' ' HE2' ' A' ' 24' ' ' LYS . 53.4 m-85 -123.41 95.69 4.69 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 103.841 -2.652 . . . . 0.0 103.841 -172.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -123.29 49.94 1.63 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.811 2.044 . . . . 0.0 108.732 -175.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.06 163.41 34.33 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.438 1.895 . . . . 0.0 107.61 170.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.9 m -50.6 -58.52 5.62 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.445 0.698 . . . . 0.0 111.884 166.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -68.89 -35.33 76.74 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.758 -0.589 . . . . 0.0 111.487 -169.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.4 p -67.24 -43.26 82.42 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.5 mt -67.11 -48.53 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 123.575 0.75 . . . . 0.0 109.609 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -48.52 -50.39 32.08 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.364 1.866 . . . . 0.0 111.898 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.437 ' HE2' ' O ' ' A' ' 101' ' ' MET . 0.0 OUTLIER -59.46 -47.49 85.29 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 122.921 0.489 . . . . 0.0 110.386 -176.329 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.554 HD11 ' CG ' ' A' ' 26' ' ' TYR . 86.3 mt -60.68 -51.18 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.917 176.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 mt -49.59 -39.44 35.35 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.441 1.019 . . . . 0.0 111.025 -177.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.1 t -57.13 -57.05 14.29 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.428 0.691 . . . . 0.0 110.412 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -72.21 -19.05 61.79 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.435 1.094 . . . . 0.0 112.35 -175.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.1 mm -81.9 -19.57 10.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.217 1.407 . . . . 0.0 110.872 173.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.67 -12.66 13.86 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -175.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.2 t -58.07 -31.64 67.26 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.311 0.96 . . . . 0.0 111.267 176.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.42 154.92 44.78 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-O 122.783 1.213 . . . . 0.0 112.118 -171.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.44 108.79 19.43 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 174.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' A' ' 92' ' ' TYR . 6.6 ppt_? -63.4 -13.59 41.37 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 167.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 p 65.53 -174.0 0.18 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.826 1.329 . . . . 0.0 109.926 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -68.31 -17.22 64.22 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.013 -1.054 . . . . 0.0 112.032 175.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -64.26 154.21 35.79 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 119.354 0.979 . . . . 0.0 112.093 -171.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -100.55 133.15 45.43 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 172.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.8 160.11 33.16 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 153.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 pt -136.07 12.51 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.679 1.192 . . . . 0.0 111.164 168.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.8 178.64 4.33 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.11 1.364 . . . . 0.0 108.834 175.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -121.12 -5.32 9.49 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.176 0.99 . . . . 0.0 111.676 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -145.67 160.1 45.43 Favored Pre-proline 0 C--N 1.345 0.378 0 C-N-CA 125.626 1.57 . . . . 0.0 110.344 -171.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -69.36 160.99 47.68 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 121.304 1.336 . . . . 0.0 109.882 177.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.6 t -107.22 13.53 27.14 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.52 0.728 . . . . 0.0 110.862 172.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.03 171.9 13.68 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.523 0.677 . . . . 0.0 111.303 168.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -111.56 -29.22 7.83 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.487 1.915 . . . . 0.0 109.615 172.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -112.62 115.78 29.14 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 127.066 2.146 . . . . 0.0 105.987 172.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -149.53 167.3 26.67 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 171.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.47 169.8 15.08 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 169.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.6 m -123.42 123.14 40.0 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -158.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 mp -122.19 111.72 31.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 124.141 0.976 . . . . 0.0 108.4 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -109.54 113.9 27.07 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.931 1.692 . . . . 0.0 106.728 -175.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.4 mt -98.95 100.38 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 170.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -71.41 119.74 15.99 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 164.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -148.06 136.49 21.49 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.596 0.758 . . . . 0.0 110.172 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.4 m120 53.24 23.45 3.18 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.265 1.426 . . . . 0.0 111.156 -174.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.04 -8.22 39.16 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 127.608 2.527 . . . . 0.0 114.075 -176.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -87.8 -177.29 48.01 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 108.726 -1.749 . . . . 0.0 108.726 166.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.1 ptt? -145.56 142.74 29.42 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.563 1.181 . . . . 0.0 113.248 174.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.1 m -91.41 111.1 22.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 165.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.5 m -84.12 130.73 34.84 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.572 1.949 . . . . 0.0 106.944 166.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.9 ptp -154.0 173.24 16.26 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.325 1.45 . . . . 0.0 109.36 164.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.603 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 43.0 m-85 -135.72 -179.79 5.86 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.437 1.895 . . . . 0.0 108.477 -178.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -138.79 158.04 44.95 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.375 1.07 . . . . 0.0 108.946 170.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -161.44 171.48 18.12 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.408 1.004 . . . . 0.0 110.616 163.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -99.34 139.24 35.28 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 125.681 1.593 . . . . 0.0 107.945 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -135.23 111.29 9.53 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.641 0.734 . . . . 0.0 109.625 175.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 66.96 10.73 7.89 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.381 1.872 . . . . 0.0 113.3 172.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.1 -8.7 31.31 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-O 118.021 -1.433 . . . . 0.0 113.172 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.97 157.78 15.74 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 119.342 1.571 . . . . 0.0 108.075 163.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -109.15 150.06 28.43 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -141.13 171.79 13.57 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 123.364 0.415 . . . . 0.0 110.146 178.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.422 HD11 HD13 ' A' ' 94' ' ' ILE . 5.2 mp -121.99 150.53 25.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 124.628 1.171 . . . . 0.0 108.057 172.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.603 ' HB3' ' H ' ' A' ' 74' ' ' PHE . 3.4 tm-20 -90.49 159.33 16.57 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.149 2.58 . . . . 0.0 110.045 -173.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 174.81 167.43 0.34 Allowed Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 128.78 2.832 . . . . 0.0 108.774 178.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.405 ' O ' ' N ' ' A' ' 89' ' ' LYS . 23.0 Cg_endo -60.45 -161.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.935 1 C-N-CA 125.446 4.097 . . . . 0.0 110.152 165.333 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -42.9 -8.79 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 128.259 2.623 . . . . 0.0 117.08 -169.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -114.43 33.28 5.4 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 120.637 1.562 . . . . 0.0 114.509 167.189 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -113.41 75.38 0.23 Allowed Glycine 0 C--O 1.223 -0.556 0 CA-C-N 119.671 1.123 . . . . 0.0 113.176 -174.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.0 mt -145.28 46.7 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 174.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 35.9 m-85 -72.19 100.91 2.68 Favored 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 121.05 -1.032 . . . . 0.0 109.74 -171.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.92 122.23 18.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 170.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.422 HD13 HD11 ' A' ' 84' ' ' ILE . 33.2 pt -116.13 174.84 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 127.248 2.219 . . . . 0.0 108.42 162.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -106.31 -14.37 15.13 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -175.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -131.45 167.78 18.74 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.273 0.942 . . . . 0.0 110.0 -169.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -69.98 139.31 52.77 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.951 0.341 . . . . 0.0 110.324 174.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -68.12 -52.42 35.07 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.776 0.83 . . . . 0.0 112.447 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -66.01 -28.42 68.86 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.748 0.704 . . . . 0.0 112.253 -171.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -67.94 -14.51 63.02 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.866 -0.521 . . . . 0.0 111.875 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.437 ' O ' ' HE2' ' A' ' 34' ' ' LYS . 26.3 mmt -103.02 -10.51 18.87 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 117.071 -1.443 . . . . 0.0 113.322 -175.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.9 pp . . . . . 0 C--O 1.254 1.31 0 CA-C-N 121.11 1.777 . . . . 0.0 112.862 -163.86 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.428 ' HB2' ' HD2' ' A' ' 3' ' ' PRO . 15.0 p . . . . . 0 CA--C 1.549 0.933 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.531 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 2' ' ' SER . 38.0 Cg_endo -57.54 164.12 7.77 Favored 'Trans proline' 0 C--N 1.353 0.809 0 CA-C-N 121.58 1.6 . . . . 0.0 110.763 174.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.9 mm -99.21 127.25 52.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 105.31 -2.108 . . . . 0.0 105.31 171.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.22 161.5 63.38 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 126.54 1.936 . . . . 0.0 110.646 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -61.17 172.28 3.31 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.158 1.239 . . . . 0.0 110.698 170.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.17 179.11 0.21 Allowed 'General case' 0 N--CA 1.467 0.421 0 O-C-N 120.313 -1.492 . . . . 0.0 112.27 171.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.02 -50.07 17.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 155.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.82 -26.34 68.58 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -159.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -89.48 -5.72 57.07 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 126.414 1.886 . . . . 0.0 115.02 -178.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.2 t -76.89 108.83 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.59 -39.37 93.61 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.001 0.921 . . . . 0.0 109.607 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 p -174.44 136.89 0.48 Allowed 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.177 0.991 . . . . 0.0 108.873 158.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.9 mt -75.34 154.38 6.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 164.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.6 t -131.93 133.79 44.94 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.477 -2.046 . . . . 0.0 105.477 166.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.4 mt -128.99 110.8 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 176.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.41 119.92 22.41 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 105.245 -2.131 . . . . 0.0 105.245 166.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -63.01 -179.83 0.32 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.882 1.273 . . . . 0.0 110.49 173.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.3 p -75.17 0.39 16.5 Favored 'General case' 0 CA--C 1.549 0.904 0 O-C-N 119.97 -1.706 . . . . 0.0 112.305 171.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -122.67 158.56 29.79 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 128.616 2.766 . . . . 0.0 105.479 168.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.4 p -79.26 -2.8 42.92 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 120.243 1.383 . . . . 0.0 112.464 -154.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.428 ' H ' HG13 ' A' ' 22' ' ' ILE . 5.4 mt -61.81 134.89 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 164.019 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -120.14 166.07 13.91 Favored 'General case' 0 N--CA 1.422 -1.832 0 C-N-CA 125.122 1.369 . . . . 0.0 107.505 171.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.578 ' HE2' ' CE2' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -137.1 151.72 49.19 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 170.265 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.5 mp -109.74 139.76 31.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.578 ' CE2' ' HE2' ' A' ' 24' ' ' LYS . 72.4 m-85 -128.8 91.72 3.27 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 -173.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -119.99 -7.66 9.89 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.78 2.432 . . . . 0.0 110.973 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -64.95 138.27 58.26 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 170.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.9 t -56.97 -42.84 80.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.98 0.809 . . . . 0.0 109.729 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -67.38 -36.7 81.87 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.362 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 52.2 p -55.2 -48.45 73.82 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.026 0.83 . . . . 0.0 109.038 175.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.6 mt -70.48 -54.71 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-O 118.568 -0.729 . . . . 0.0 109.093 -177.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -59.64 -30.64 68.87 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.528 1.058 . . . . 0.0 112.172 -176.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -68.64 -63.82 0.99 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 117.857 -1.068 . . . . 0.0 109.027 170.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.3 mt -47.92 -46.18 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 123.643 0.777 . . . . 0.0 109.967 -176.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -47.73 -31.22 4.53 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.007 1.723 . . . . 0.0 113.08 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.4 t -61.03 -55.15 36.11 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 119.113 0.869 . . . . 0.0 109.584 174.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -75.6 -11.59 60.04 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.021 0.828 . . . . 0.0 112.252 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.5 mm -70.55 -23.92 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 O-C-N 120.9 -1.125 . . . . 0.0 110.141 162.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.35 -18.03 11.14 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -168.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.2 p -69.57 -28.91 66.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 119.817 1.189 . . . . 0.0 112.746 -170.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.78 165.98 50.08 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 119.536 1.062 . . . . 0.0 114.381 -166.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.5 pttm -112.13 103.56 11.75 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 125.518 1.527 . . . . 0.0 111.184 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.423 ' HB3' ' CE2' ' A' ' 92' ' ' TYR . 21.6 ptt180 -58.03 -15.16 8.2 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 170.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.7 p 60.27 175.24 0.09 Allowed 'General case' 0 CA--C 1.551 0.99 0 O-C-N 124.162 0.914 . . . . 0.0 109.597 -171.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -85.68 3.69 39.9 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 119.363 -2.085 . . . . 0.0 111.795 176.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.483 ' CB ' HD12 ' A' ' 91' ' ' ILE . 4.9 mmmt -60.66 156.43 16.74 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.65 0.78 . . . . 0.0 111.786 177.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -89.88 113.99 25.69 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.701 1.6 . . . . 0.0 107.2 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.9 t -80.14 140.66 36.29 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 163.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.2 pt -144.4 39.53 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.649 1.579 . . . . 0.0 107.727 176.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -116.64 177.24 4.77 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.835 1.254 . . . . 0.0 110.682 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.87 -4.58 2.82 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.172 1.389 . . . . 0.0 111.547 177.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -153.35 165.38 17.84 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 126.752 2.021 . . . . 0.0 108.089 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.28 174.3 11.7 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.381 1.387 . . . . 0.0 111.097 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 t -102.17 -7.8 21.89 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.005 1.322 . . . . 0.0 110.804 175.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.04 150.89 31.77 Favored 'General case' 0 CA--C 1.527 0.09 0 O-C-N 121.028 -1.045 . . . . 0.0 110.796 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.46 -22.25 30.39 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.248 1.019 . . . . 0.0 111.232 173.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.79 107.32 9.06 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -129.48 153.58 47.83 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 126.389 1.876 . . . . 0.0 108.943 176.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.02 154.92 25.97 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 108.17 -1.972 . . . . 0.0 108.17 167.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.2 m -127.38 131.73 50.28 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.137 0.975 . . . . 0.0 108.807 -164.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.05 125.62 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -166.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -115.42 144.76 43.34 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 161.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.0 mt -127.48 83.49 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -58.77 120.45 8.99 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 171.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -146.91 114.76 6.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.1 m120 59.61 20.54 9.13 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.613 1.165 . . . . 0.0 112.375 -173.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.15 3.58 12.4 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.522 1.058 . . . . 0.0 113.506 -171.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.96 170.39 44.03 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 145.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -143.84 163.38 33.55 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 121.308 -1.113 . . . . 0.0 109.469 169.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.2 m -130.07 132.16 46.06 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 174.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -120.83 126.41 50.0 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.196 0.998 . . . . 0.0 108.686 -172.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.6 ptp -146.85 170.65 16.6 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.156 0.983 . . . . 0.0 109.207 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -146.47 148.7 32.52 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 -175.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.92 154.32 50.54 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.364 0.984 . . . . 0.0 109.758 175.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -157.77 172.61 18.18 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.813 1.645 . . . . 0.0 109.545 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -102.84 139.15 38.79 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.657 1.583 . . . . 0.0 108.072 171.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -135.85 120.46 18.27 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 172.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 55.79 -4.59 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 128.153 2.581 . . . . 0.0 117.341 -174.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 136.97 -33.48 2.31 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 125.751 1.644 . . . . 0.0 112.49 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -71.58 151.42 43.82 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 171.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -100.12 150.6 22.32 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 168.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -136.77 153.11 50.92 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.514 0.725 . . . . 0.0 111.182 -176.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mp -123.15 117.9 53.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 125.162 1.385 . . . . 0.0 107.63 -170.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.424 ' CD ' ' H ' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -74.46 154.81 38.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.625 1.17 . . . . 0.0 109.736 176.542 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.424 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 0.8 OUTLIER 179.79 167.73 0.73 Allowed Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 127.963 2.505 . . . . 0.0 107.443 -169.324 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -57.15 -163.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 124.37 3.38 . . . . 0.0 110.728 166.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -44.76 -11.78 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 117.079 2.251 . . . . 0.0 117.079 -174.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -96.78 11.64 34.89 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.023 1.729 . . . . 0.0 115.293 172.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.94 77.54 0.4 Allowed Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 120.259 1.391 . . . . 0.0 113.508 -170.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.483 HD12 ' CB ' ' A' ' 47' ' ' LYS . 2.9 mt -139.51 42.88 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 169.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.423 ' CE2' ' HB3' ' A' ' 44' ' ' ARG . 37.9 m-85 -76.24 107.53 8.55 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 121.212 -0.93 . . . . 0.0 109.758 -172.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -69.66 127.26 32.31 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 159.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 41.0 pt -112.19 168.23 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 148.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -122.32 21.34 10.36 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.848 0.832 . . . . 0.0 112.871 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -140.98 167.42 22.23 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 127.149 2.18 . . . . 0.0 110.214 170.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -84.29 116.22 22.88 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.213 1.005 . . . . 0.0 109.601 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -48.97 -47.33 44.13 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.833 1.253 . . . . 0.0 109.564 172.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -68.43 -17.42 64.2 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.126 0.97 . . . . 0.0 112.692 -171.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -91.49 -13.78 31.59 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 121.334 -0.854 . . . . 0.0 109.937 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 11.9 mmt -106.66 -6.59 17.81 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.789 1.636 . . . . 0.0 112.462 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 24.3 pt . . . . . 0 C--O 1.25 1.126 0 CA-C-N 119.332 0.969 . . . . 0.0 111.397 174.092 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 CA--C 1.538 0.486 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.02 179.89 2.07 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 124.586 3.524 . . . . 0.0 112.504 156.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 53.1 mt -108.54 131.83 58.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 126.258 1.823 . . . . 0.0 106.341 164.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.46 HD12 HG22 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -135.13 161.76 61.65 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 128.143 2.577 . . . . 0.0 109.959 175.227 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -62.17 176.62 1.43 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.998 2.466 . . . . 0.0 112.914 176.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.584 ' HE3' ' H ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -65.35 -175.1 0.21 Allowed 'General case' 0 C--O 1.236 0.383 0 O-C-N 119.983 -1.698 . . . . 0.0 110.351 169.203 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.6 -42.75 16.39 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 118.984 -0.531 . . . . 0.0 111.219 167.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -85.69 -21.83 28.13 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 118.48 -1.288 . . . . 0.0 111.652 -164.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.449 HD22 ' N ' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -73.39 -5.96 43.19 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.64 1.176 . . . . 0.0 112.471 174.632 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.449 ' N ' HD22 ' A' ' 10' ' ' ASN . 25.0 t -80.11 131.58 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 173.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -81.75 -61.43 1.92 Allowed 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 171.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.63 130.2 5.0 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.612 1.096 . . . . 0.0 109.827 171.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.7 mt -81.25 139.38 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.4 t -116.37 140.83 48.92 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 172.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.2 mt -135.57 105.13 5.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 173.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -81.39 108.07 14.69 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 173.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -71.03 -176.76 1.46 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.549 0.69 . . . . 0.0 109.267 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.4 p -62.25 -46.75 87.42 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.492 -1.38 . . . . 0.0 111.394 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -73.74 179.79 4.02 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.752 2.021 . . . . 0.0 109.952 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.6 p -69.84 8.01 0.79 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.239 1.416 . . . . 0.0 112.83 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.6 mt -98.5 137.25 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -170.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -145.93 137.88 25.2 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 -176.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.5 132.21 53.85 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 -173.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.5 mp -105.84 119.74 55.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 176.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.74 ' CG ' HD11 ' A' ' 35' ' ' ILE . 81.6 m-85 -93.06 81.15 4.54 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 102.657 -3.09 . . . . 0.0 102.657 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -96.9 -28.82 14.04 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.998 0.919 . . . . 0.0 110.457 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.53 141.61 53.83 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.1 t -55.03 -46.92 75.32 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.143 0.883 . . . . 0.0 112.481 -175.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -68.65 -24.84 64.58 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.591 1.156 . . . . 0.0 110.899 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.9 p -69.87 -40.97 75.41 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.766 0.712 . . . . 0.0 109.482 176.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 53.9 mt -66.06 -46.65 87.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.566 1.146 . . . . 0.0 108.304 177.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.97 -24.87 67.28 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -165.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.461 ' HE2' ' O ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -65.73 -54.85 21.68 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 123.132 0.573 . . . . 0.0 109.49 172.251 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.74 HD11 ' CG ' ' A' ' 26' ' ' TYR . 18.6 mt -57.01 -40.42 72.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 125.674 1.59 . . . . 0.0 109.307 -169.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.37 -21.48 5.88 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.837 1.655 . . . . 0.0 113.399 175.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.8 t -64.46 -68.36 0.36 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 120.434 1.47 . . . . 0.0 109.011 164.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.425 ' O ' HG22 ' A' ' 41' ' ' THR . 24.8 mm-40 -65.98 -24.93 66.88 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.05 0.54 . . . . 0.0 111.41 -168.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.46 HG22 HD12 ' A' ' 5' ' ' LEU . 14.5 mm -59.56 -29.43 42.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 O-C-N 120.751 -1.218 . . . . 0.0 110.549 172.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.33 -8.74 41.11 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 120.347 1.431 . . . . 0.0 113.441 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 38' ' ' GLU . 1.4 t -69.93 -16.84 63.28 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.018 0.927 . . . . 0.0 113.337 -164.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.28 156.47 18.5 Favored Glycine 0 C--N 1.335 0.512 0 O-C-N 120.75 -1.219 . . . . 0.0 112.865 -171.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.7 pttm -112.83 111.2 21.8 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 175.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.8 ptt-85 -58.49 -5.11 0.48 Allowed 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.982 0.81 . . . . 0.0 112.594 169.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . 0.259 10.4 p 64.44 -164.67 0.25 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.545 1.538 . . . . 0.0 107.819 -176.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -101.21 4.5 41.97 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.909 1.231 . . . . 0.0 111.845 171.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -67.77 153.27 44.08 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 122.066 0.936 . . . . 0.0 110.357 176.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -85.77 121.32 28.27 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.989 1.716 . . . . 0.0 107.68 169.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.2 t -74.09 152.04 40.01 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 158.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.2 pt -138.14 11.79 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 126.083 1.753 . . . . 0.0 110.28 172.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -99.91 173.87 6.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.738 1.215 . . . . 0.0 109.577 178.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.55 -7.42 2.87 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.05 1.74 . . . . 0.0 110.446 174.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -151.72 158.93 33.9 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 127.329 2.251 . . . . 0.0 109.359 -174.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.01 -179.76 5.74 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.467 3.445 . . . . 0.0 112.425 178.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.87 -6.67 11.0 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.855 1.662 . . . . 0.0 112.021 176.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.14 149.82 40.8 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 120.818 -1.176 . . . . 0.0 109.496 173.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -75.03 -30.5 61.09 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.509 0.723 . . . . 0.0 109.756 169.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -114.43 108.09 16.42 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.774 1.63 . . . . 0.0 107.471 -172.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -137.15 168.72 19.06 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 126.521 1.929 . . . . 0.0 107.099 169.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.23 166.52 13.0 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 161.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 73.8 m -124.92 120.68 32.3 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.157 0.983 . . . . 0.0 108.873 -167.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.81 126.37 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -171.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -121.17 128.79 52.84 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 171.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.52 ' HB ' HG22 ' A' ' 71' ' ' THR . 19.6 mt -114.94 88.61 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 171.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -56.38 106.77 0.31 Allowed 'General case' 0 C--O 1.239 0.52 0 C-N-CA 126.886 2.074 . . . . 0.0 108.217 163.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -153.43 148.68 26.94 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.671 1.189 . . . . 0.0 109.93 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 54.76 28.49 10.3 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.02 41.25 71.8 Favored Glycine 0 CA--C 1.527 0.833 0 O-C-N 121.151 -0.968 . . . . 0.0 110.768 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.69 -172.13 36.71 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 127.676 2.56 . . . . 0.0 108.458 174.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -147.15 146.73 29.99 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 119.045 1.423 . . . . 0.0 113.281 174.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.52 HG22 ' HB ' ' A' ' 64' ' ' ILE . 1.2 t -82.61 164.27 20.9 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 165.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.4 m -135.83 146.36 47.42 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 126.661 1.984 . . . . 0.0 106.912 171.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.0 ptp -165.39 167.99 17.17 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.017 1.727 . . . . 0.0 108.249 168.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -140.25 142.15 35.8 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.563 1.545 . . . . 0.0 107.96 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.464 ' CD1' HG13 ' A' ' 84' ' ' ILE . 0.3 OUTLIER -125.9 153.61 43.96 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.833 1.197 . . . . 0.0 109.623 176.791 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -155.32 -175.7 5.57 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.625 1.57 . . . . 0.0 107.554 -175.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -111.86 144.62 40.88 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.708 1.603 . . . . 0.0 108.571 170.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -144.76 110.64 5.41 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 122.524 1.154 . . . . 0.0 111.096 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 66.92 4.84 3.7 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.286 1.834 . . . . 0.0 113.995 176.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 121.77 -5.34 10.63 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.573 1.082 . . . . 0.0 113.5 171.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -105.37 157.82 17.07 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 119.132 1.466 . . . . 0.0 108.443 162.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -93.82 152.4 18.93 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 169.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -143.71 162.29 36.36 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.298 0.639 . . . . 0.0 110.648 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.464 HG13 ' CD1' ' A' ' 75' ' ' TYR . 3.9 mp -117.65 124.68 73.39 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 C-N-CA 125.581 1.552 . . . . 0.0 107.824 -178.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -68.06 151.43 47.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 122.41 1.1 . . . . 0.0 109.033 168.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -169.85 167.61 4.96 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 128.729 2.812 . . . . 0.0 106.433 167.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -56.19 -161.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.817 1 C-N-CA 125.905 4.404 . . . . 0.0 110.237 164.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -43.41 -12.16 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.682 1.993 . . . . 0.0 116.009 -172.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.9 mtmt -112.1 62.3 0.62 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 120.432 1.469 . . . . 0.0 111.869 163.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -141.55 61.89 0.53 Allowed Glycine 0 C--N 1.336 0.549 0 CA-C-N 119.679 1.127 . . . . 0.0 114.304 -175.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.2 mt -136.26 46.86 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 173.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -74.99 109.48 8.49 Favored 'General case' 0 CA--C 1.507 -0.701 0 O-C-N 120.967 -1.083 . . . . 0.0 110.851 -175.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -75.57 122.1 23.39 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 165.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.6 pt -115.87 -179.93 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 125.41 1.484 . . . . 0.0 108.157 160.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -137.5 8.82 2.88 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -170.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -135.71 166.54 23.02 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 126.332 1.853 . . . . 0.0 109.134 173.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -78.28 125.51 29.45 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 170.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -62.87 -46.42 87.95 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.93 -0.481 . . . . 0.0 110.258 -178.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -69.2 -11.68 61.01 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.239 1.015 . . . . 0.0 113.052 -175.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -91.06 -14.16 31.83 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.521 1.528 . . . . 0.0 110.642 175.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 5.6 mmt -105.95 -5.22 19.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.887 1.675 . . . . 0.0 112.448 -172.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 15.9 pt . . . . . 0 C--O 1.253 1.266 0 C-N-CA 125.843 1.657 . . . . 0.0 109.555 173.898 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.546 0.821 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -57.17 167.06 3.62 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.334 1.356 . . . . 0.0 112.051 174.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 64.3 mt -96.74 134.87 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 167.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.28 155.25 61.42 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 128.272 2.629 . . . . 0.0 108.132 -172.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.452 ' HB2' HD21 ' A' ' 10' ' ' ASN . 68.9 Cg_endo -72.12 175.45 9.86 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.903 2.402 . . . . 0.0 112.273 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.501 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -77.71 153.63 32.83 Favored 'General case' 0 C--N 1.34 0.189 0 O-C-N 120.624 -1.298 . . . . 0.0 110.412 171.946 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.412 ' HB2' HD13 ' A' ' 36' ' ' LEU . . . -78.26 7.48 6.34 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.658 1.183 . . . . 0.0 112.645 175.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -133.86 5.47 3.63 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.811 1.244 . . . . 0.0 111.037 -169.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.452 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -122.94 0.65 9.19 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.927 2.091 . . . . 0.0 112.62 170.25 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 t -70.65 147.08 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 167.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -85.14 -63.5 1.32 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 161.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.6 p -153.4 170.75 19.92 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.483 0.713 . . . . 0.0 109.343 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.9 mt -125.93 126.49 69.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 173.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.9 t -100.03 133.22 44.73 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 171.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.2 mt -125.99 101.47 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 169.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.06 115.01 21.68 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 104.747 -2.316 . . . . 0.0 104.747 167.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -65.75 173.04 3.05 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.283 1.433 . . . . 0.0 109.927 176.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.0 p -69.67 -20.06 63.58 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 119.667 -1.896 . . . . 0.0 112.017 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 53.4 p30 -85.48 -165.4 1.21 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.731 0.812 . . . . 0.0 110.079 173.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.2 p -76.32 -2.51 31.99 Favored 'General case' 0 C--O 1.239 0.521 0 O-C-N 120.695 -1.253 . . . . 0.0 113.258 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.9 mt -100.47 150.52 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -166.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.78 158.79 43.51 Favored 'General case' 0 N--CA 1.417 -2.076 0 C-N-CA 125.886 1.674 . . . . 0.0 108.812 177.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.65 139.52 42.08 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 174.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.1 mp -111.17 137.77 42.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -111.26 76.12 0.96 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 103.081 -2.933 . . . . 0.0 103.081 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -82.44 -32.37 29.03 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 171.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.92 134.43 48.39 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.226 1.81 . . . . 0.0 108.334 -169.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.0 m -51.09 -47.95 61.78 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.567 0.747 . . . . 0.0 111.777 -174.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -76.82 -17.6 58.91 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.577 0.751 . . . . 0.0 111.557 -173.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 64.9 m -80.34 -38.64 30.15 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.905 1.282 . . . . 0.0 110.433 171.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.49 -53.66 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 171.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -57.79 -30.02 65.33 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.874 0.869 . . . . 0.0 112.515 -173.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.67 -61.33 2.69 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 124.008 0.923 . . . . 0.0 109.239 170.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.0 mt -45.2 -53.83 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 125.15 1.38 . . . . 0.0 111.999 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.412 HD13 ' HB2' ' A' ' 8' ' ' ALA . 1.1 mp -53.61 -24.73 14.84 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 120.192 1.36 . . . . 0.0 114.354 -175.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.8 t -55.6 -69.74 0.13 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.054 0.843 . . . . 0.0 109.745 172.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -75.88 -10.47 59.46 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.837 1.255 . . . . 0.0 111.169 -167.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.6 mm -69.56 -37.08 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 O-C-N 121.121 -0.987 . . . . 0.0 110.316 168.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.72 -11.73 30.82 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -164.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 52.5 p -62.41 -41.06 98.41 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.541 0.61 . . . . 0.0 111.558 -173.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.89 162.93 54.11 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-O 124.006 1.892 . . . . 0.0 113.354 -166.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.9 mtmm -125.51 109.08 12.26 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 -174.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 -59.61 -1.8 0.28 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 176.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.1 p 64.7 -164.19 0.25 Allowed 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.595 1.958 . . . . 0.0 107.937 -177.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -95.89 -2.54 47.1 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.577 0.626 . . . . 0.0 110.85 168.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -58.32 159.69 5.9 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 119.36 0.982 . . . . 0.0 111.506 -177.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -109.76 116.5 31.79 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.163 -169.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.1 t -98.12 68.85 1.99 Allowed 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 125.481 1.512 . . . . 0.0 108.354 -172.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.2 pt -73.59 19.59 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 126.498 1.919 . . . . 0.0 111.536 -175.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.74 173.96 7.42 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 126.264 1.825 . . . . 0.0 109.728 -167.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.12 -4.16 10.05 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.517 0.727 . . . . 0.0 110.746 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -146.79 155.85 48.14 Favored Pre-proline 0 C--O 1.234 0.266 0 CA-C-N 118.771 0.714 . . . . 0.0 110.24 -172.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -60.03 168.09 6.43 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.18 2.587 . . . . 0.0 110.376 168.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 t -104.03 23.0 13.63 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.913 1.285 . . . . 0.0 108.841 -176.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -114.66 168.95 9.43 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 128.099 2.56 . . . . 0.0 109.139 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -99.38 -29.25 12.88 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.732 1.213 . . . . 0.0 111.143 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -131.58 115.24 15.84 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -173.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -140.9 161.82 36.92 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 125.306 1.443 . . . . 0.0 107.152 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -95.78 166.7 25.15 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.24 108.21 13.02 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -159.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.1 mp -111.19 134.93 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -176.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -132.28 119.06 20.28 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 161.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.2 mt -85.99 112.23 22.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 159.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -79.85 130.28 35.18 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 167.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.05 127.09 11.96 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.623 1.569 . . . . 0.0 109.678 -178.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 46.9 45.24 15.17 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.357 1.863 . . . . 0.0 111.93 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.04 -1.59 17.07 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.498 1.047 . . . . 0.0 115.008 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -105.69 -176.73 23.96 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 168.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.2 ptp -154.57 146.94 23.92 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 120.934 -1.333 . . . . 0.0 112.838 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.1 m -103.29 96.24 6.63 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.097 2.159 . . . . 0.0 106.672 176.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.1 m -80.21 151.46 29.65 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.555 0.742 . . . . 0.0 109.249 171.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.25 165.4 5.97 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.947 2.499 . . . . 0.0 108.591 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.538 ' H ' ' HG3' ' A' ' 85' ' ' GLU . 14.1 m-85 -135.78 148.33 48.72 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 127.189 2.196 . . . . 0.0 108.04 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -125.16 162.1 25.38 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.327 0.967 . . . . 0.0 108.628 171.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -158.33 169.07 25.31 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.663 1.185 . . . . 0.0 109.553 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -97.28 142.13 29.54 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.186 1.794 . . . . 0.0 108.285 163.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -148.85 145.13 27.35 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.27 1.028 . . . . 0.0 108.516 169.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 53.43 0.42 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.681 1.992 . . . . 0.0 115.052 -174.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.79 19.35 37.47 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.104 -1.387 . . . . 0.0 113.374 -169.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -118.18 169.67 9.5 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 121.022 2.411 . . . . 0.0 107.571 161.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -108.58 145.57 34.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -142.7 162.22 36.02 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.414 0.685 . . . . 0.0 109.607 -175.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.0 mp -127.38 125.14 65.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 125.533 1.533 . . . . 0.0 108.205 -172.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.538 ' HG3' ' H ' ' A' ' 74' ' ' PHE . 0.5 OUTLIER -75.24 163.62 27.31 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.999 0.904 . . . . 0.0 108.955 172.057 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 178.74 168.5 0.58 Allowed Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 130.136 3.374 . . . . 0.0 104.783 175.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -53.76 -160.45 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.623 1 C-N-CA 125.407 4.071 . . . . 0.0 110.801 164.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -42.31 -10.18 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 128.887 2.875 . . . . 0.0 115.459 -175.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.3 59.94 0.68 Allowed 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.301 1.84 . . . . 0.0 112.678 166.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -137.53 54.19 0.71 Allowed Glycine 0 C--N 1.338 0.679 0 CA-C-N 119.819 1.191 . . . . 0.0 116.04 -174.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.7 mt -137.96 48.04 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 118.32 1.06 . . . . 0.0 108.66 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -76.65 137.05 39.19 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -118.56 91.56 3.59 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -176.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 16.0 pt -95.18 152.11 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 177.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -105.56 16.24 25.74 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.804 0.812 . . . . 0.0 112.279 -173.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -146.05 160.96 41.16 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.096 1.759 . . . . 0.0 111.004 -175.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -87.1 130.32 34.55 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.443 0.565 . . . . 0.0 111.722 -176.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -66.89 -46.57 74.51 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.549 0.739 . . . . 0.0 111.538 175.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -71.52 -19.84 62.13 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -168.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -95.54 -5.7 42.13 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 121.358 -0.839 . . . . 0.0 112.023 172.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 15.5 mmt -90.75 -28.14 18.47 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 117.387 -1.292 . . . . 0.0 112.013 169.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.7 pt . . . . . 0 C--O 1.253 1.258 0 CA-C-N 120.22 1.373 . . . . 0.0 109.594 164.709 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 CA--C 1.546 0.806 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -65.24 177.4 2.58 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.94 2.427 . . . . 0.0 112.227 163.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.6 mm -125.47 74.88 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 127.492 2.317 . . . . 0.0 105.716 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.84 165.94 42.31 Favored Pre-proline 0 N--CA 1.469 0.509 0 O-C-N 120.687 -1.258 . . . . 0.0 110.756 -177.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -58.7 165.09 8.55 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 120.686 0.924 . . . . 0.0 109.997 158.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.465 ' HA ' ' HE2' ' A' ' 7' ' ' LYS . 7.0 mmpt? -53.53 169.01 0.14 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.16 0.984 . . . . 0.0 111.174 169.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.9 -57.24 5.29 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 156.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -57.73 -23.04 49.93 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.411 1.484 . . . . 0.0 114.456 -165.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -95.87 -0.59 50.82 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -178.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.4 t -78.83 153.17 4.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 173.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -108.63 -46.52 3.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 118.501 -0.762 . . . . 0.0 110.163 171.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.4 p -155.27 166.45 33.53 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.039 0.836 . . . . 0.0 110.812 163.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.7 mt -122.07 119.32 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 172.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.578 ' CB ' HD12 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -103.95 128.68 51.49 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.522 0.729 . . . . 0.0 109.703 175.482 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.1 mt -127.29 112.21 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -94.1 120.15 33.95 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 165.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -70.47 -171.91 0.54 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.584 1.554 . . . . 0.0 109.987 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 p -69.15 -1.15 7.09 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 119.697 -1.877 . . . . 0.0 113.927 170.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -104.04 -154.57 0.51 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.686 1.994 . . . . 0.0 109.599 -160.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.8 p -81.12 -5.01 57.18 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 129.302 3.041 . . . . 0.0 114.273 155.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.8 mt -104.05 145.63 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.676 1.59 . . . . 0.0 110.583 -159.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -140.52 134.94 31.37 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 120.897 -1.127 . . . . 0.0 109.86 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.04 141.02 47.05 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.578 HD12 ' CB ' ' A' ' 15' ' ' CYS . 10.3 mm -124.02 156.1 31.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -174.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.427 ' CG ' HD11 ' A' ' 35' ' ' ILE . 63.9 m-85 -142.17 87.97 2.06 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 -165.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -100.53 -21.22 15.39 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.51 1.524 . . . . 0.0 111.457 178.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.12 146.02 46.0 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 t -50.51 -47.06 57.51 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.664 0.786 . . . . 0.0 110.61 171.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -68.5 -31.88 71.46 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.524 -0.735 . . . . 0.0 111.393 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 73.1 m -72.46 -47.43 48.95 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.48 1.512 . . . . 0.0 110.511 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 90.3 mt -59.4 -46.72 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.279 1.432 . . . . 0.0 108.892 174.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.47 -26.28 68.65 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 117.426 -1.273 . . . . 0.0 114.008 -175.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -63.03 -60.01 4.03 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 168.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.427 HD11 ' CG ' ' A' ' 26' ' ' TYR . 74.0 mt -52.62 -51.03 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 O-C-N 123.879 0.737 . . . . 0.0 109.378 -170.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.8 -14.69 60.02 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -178.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.9 t -76.31 -59.33 2.81 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 120.188 1.358 . . . . 0.0 108.495 163.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -61.21 -7.78 3.07 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.91 1.684 . . . . 0.0 113.558 -176.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.6 mm -114.62 -14.18 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 126.324 1.85 . . . . 0.0 111.212 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.36 -10.66 56.03 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 120.277 -1.514 . . . . 0.0 112.567 171.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.8 t -68.87 -30.4 68.9 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.845 1.258 . . . . 0.0 112.669 -170.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.56 168.41 45.89 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-O 122.089 0.827 . . . . 0.0 112.774 -176.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.98 120.83 20.79 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 124.502 1.121 . . . . 0.0 108.041 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.409 ' HB3' ' CE2' ' A' ' 92' ' ' TYR . 14.8 ptt180 -67.26 1.8 1.95 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.8 p 61.13 -163.8 0.25 Allowed 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 -175.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -108.86 13.18 25.03 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.333 0.653 . . . . 0.0 112.169 161.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.15 158.86 8.2 Favored 'General case' 0 C--O 1.239 0.529 0 O-C-N 120.519 -1.363 . . . . 0.0 108.534 161.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -119.83 130.01 54.7 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 121.305 -0.872 . . . . 0.0 109.222 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.36 160.01 30.35 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 161.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.9 pt -136.01 11.04 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.149 1.379 . . . . 0.0 110.808 168.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.16 175.83 6.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.768 1.227 . . . . 0.0 111.034 -172.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -116.82 -11.86 10.85 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.071 1.348 . . . . 0.0 111.194 -174.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -142.71 160.05 54.95 Favored Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 125.483 1.513 . . . . 0.0 109.857 -172.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -70.95 169.16 21.09 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.202 1.935 . . . . 0.0 112.694 -175.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.18 10.84 34.48 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.449 1.1 . . . . 0.0 111.809 -177.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.526 ' HB2' ' CD2' ' A' ' 76' ' ' TYR . . . -107.14 161.94 14.31 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.871 1.269 . . . . 0.0 113.469 -169.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.97 -29.89 35.23 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 126.108 1.763 . . . . 0.0 110.422 165.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -134.88 108.12 7.74 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.907 1.283 . . . . 0.0 109.623 -165.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -145.77 159.9 42.52 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.159 1.384 . . . . 0.0 109.06 -177.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.33 158.56 30.16 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 172.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.84 134.46 44.99 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.475 1.11 . . . . 0.0 108.606 174.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.96 123.64 54.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.11 137.37 46.21 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 159.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 64.7 mt -109.94 105.92 19.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 102.79 -3.041 . . . . 0.0 102.79 160.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -78.12 132.49 37.7 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 169.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -147.37 -171.94 3.9 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.839 1.656 . . . . 0.0 107.573 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -60.09 80.31 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.811 1 C-N-CA 133.867 4.867 . . . . 0.0 110.469 -168.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.02 1.64 68.99 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 114.041 -1.436 . . . . 0.0 112.891 -174.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.92 158.12 14.55 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-O 121.719 0.621 . . . . 0.0 112.092 -171.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 7.1 ptm -131.33 133.45 45.35 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 160.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.6 m -118.1 90.9 3.43 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.8 m -84.65 136.78 33.61 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.009 1.324 . . . . 0.0 109.943 -172.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.2 ptp -150.27 171.53 16.8 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.812 1.245 . . . . 0.0 109.722 172.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -142.27 147.7 36.86 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.415 ' CD1' HG13 ' A' ' 84' ' ' ILE . 0.7 OUTLIER -128.69 151.99 48.9 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.6 1.545 . . . . 0.0 108.592 175.524 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.526 ' CD2' ' HB2' ' A' ' 56' ' ' ALA . 13.2 p90 -154.84 168.61 26.33 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.857 0.863 . . . . 0.0 111.281 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -86.85 141.39 28.82 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.672 1.123 . . . . 0.0 107.992 162.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -139.26 120.29 14.57 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.908 0.861 . . . . 0.0 110.325 160.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 63.97 11.25 5.93 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.141 1.776 . . . . 0.0 113.577 170.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.95 -9.71 18.43 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.932 1.253 . . . . 0.0 112.536 173.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -103.46 159.53 15.5 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.203 1.002 . . . . 0.0 108.71 167.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -108.9 152.54 24.78 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 169.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -141.46 160.19 40.66 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 122.939 0.496 . . . . 0.0 110.225 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.415 HG13 ' CD1' ' A' ' 75' ' ' TYR . 3.0 mp -122.31 102.52 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 C-N-CA 125.004 1.322 . . . . 0.0 108.126 -171.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -62.08 145.78 52.27 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 122.882 1.325 . . . . 0.0 111.066 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.591 ' HB2' ' HA2' ' A' ' 90' ' ' GLY . 1.0 OUTLIER -164.5 167.72 9.94 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 130.037 3.335 . . . . 0.0 105.816 -178.558 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 89' ' ' LYS . 43.9 Cg_endo -56.46 -162.13 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 124.378 3.386 . . . . 0.0 109.511 166.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -43.04 -15.07 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 129.609 3.164 . . . . 0.0 115.268 -170.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.475 ' H ' ' HG2' ' A' ' 89' ' ' LYS . 2.6 ptpt -107.06 61.83 0.62 Allowed 'General case' 0 N--CA 1.425 -1.708 0 C-N-CA 130.462 3.505 . . . . 0.0 113.818 167.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.591 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . -122.32 -0.42 10.39 Favored Glycine 0 C--O 1.224 -0.479 0 N-CA-C 116.957 1.543 . . . . 0.0 116.957 -176.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.269 4.1 mt -89.59 48.21 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 O-C-N 120.313 -1.698 . . . . 0.0 109.604 -169.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.409 ' CE2' ' HB3' ' A' ' 44' ' ' ARG . 34.3 m-85 -74.3 101.83 4.16 Favored 'General case' 0 CA--C 1.504 -0.822 0 O-C-N 120.656 -1.277 . . . . 0.0 108.114 174.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -75.13 128.45 35.52 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 162.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.1 pt -114.63 171.41 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.211 1.004 . . . . 0.0 108.524 159.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -129.71 43.48 3.12 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.853 0.835 . . . . 0.0 110.467 -176.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -159.45 164.41 34.56 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 125.911 1.684 . . . . 0.0 108.389 164.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -66.52 136.71 56.05 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 162.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -80.05 -47.04 15.49 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.647 0.779 . . . . 0.0 111.598 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -58.26 -23.01 54.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.9 2.08 . . . . 0.0 113.309 -172.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -75.47 -19.31 59.5 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.952 1.251 . . . . 0.0 111.785 176.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 16.6 mmt -91.4 -14.16 31.12 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.806 1.242 . . . . 0.0 111.027 -173.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.3 pt . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.016 -1.468 . . . . 0.0 112.937 -170.92 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.544 0.732 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -62.06 171.4 5.07 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.271 2.647 . . . . 0.0 113.433 172.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.9 mm -87.27 131.01 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 160.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.84 162.55 48.03 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 127.115 2.166 . . . . 0.0 109.522 170.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -68.36 -178.77 1.95 Allowed 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.272 2.648 . . . . 0.0 114.082 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.3 mtmt -62.85 166.97 5.03 Favored 'General case' 0 C--N 1.344 0.367 0 O-C-N 119.547 -1.971 . . . . 0.0 109.501 159.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.1 -56.44 5.59 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 162.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -64.58 -22.48 66.98 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -163.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -85.41 0.12 53.17 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.323 0.965 . . . . 0.0 113.268 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.6 t -74.49 147.24 8.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 171.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.22 -61.26 1.55 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 169.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.6 p -164.49 127.09 2.35 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -175.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.9 mt -90.61 127.73 42.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.0 t -103.51 125.57 50.15 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 174.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.5 mt -123.88 102.09 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 175.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.57 106.33 16.06 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 169.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -59.42 170.97 0.88 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.797 1.639 . . . . 0.0 109.718 -176.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.3 p -59.77 -38.83 82.92 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 120.969 -1.082 . . . . 0.0 111.938 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -73.83 -179.39 3.65 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 127.778 2.431 . . . . 0.0 111.399 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.9 p -71.2 21.3 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.334 2.254 . . . . 0.0 113.862 -174.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.0 mt -136.07 152.18 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 126.182 1.793 . . . . 0.0 106.431 -162.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.6 167.77 18.85 Favored 'General case' 0 N--CA 1.419 -1.987 0 C-N-CA 126.565 1.946 . . . . 0.0 108.701 176.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.434 ' HB3' ' HE2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -142.64 147.44 35.79 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 165.008 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.07 126.32 74.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.573 ' CG ' HD11 ' A' ' 35' ' ' ILE . 21.6 m-85 -107.72 85.95 2.21 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 -174.101 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -110.33 -18.45 13.26 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.631 1.572 . . . . 0.0 110.991 175.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -69.88 146.71 51.06 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 175.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.12 -45.51 83.41 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.45 0.643 . . . . 0.0 112.164 -173.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -70.23 -31.2 68.5 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.197 -0.94 . . . . 0.0 111.708 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 52.8 p -65.94 -43.74 87.12 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 70.9 mt -62.77 -56.82 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.997 1.319 . . . . 0.0 108.758 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -56.65 -37.53 70.91 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 118.66 -0.686 . . . . 0.0 112.25 -172.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.487 ' O ' ' HE3' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -55.68 -59.78 4.37 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 176.537 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.573 HD11 ' CG ' ' A' ' 26' ' ' TYR . 85.8 mt -56.38 -46.28 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 117.685 -1.15 . . . . 0.0 111.299 -176.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.23 -20.68 2.79 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.619 1.554 . . . . 0.0 114.69 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.89 -53.73 7.98 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.95 0.9 . . . . 0.0 111.509 172.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -59.27 -35.33 73.53 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.949 -1.094 . . . . 0.0 110.342 177.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 21.2 mm -61.55 -24.46 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 120.532 -1.355 . . . . 0.0 111.168 175.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -98.09 -6.6 31.34 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.883 1.22 . . . . 0.0 113.145 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 t -70.78 -34.14 71.48 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.052 0.842 . . . . 0.0 109.652 -168.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.25 167.75 47.63 Favored Glycine 0 C--N 1.341 0.842 0 O-C-N 120.771 -1.205 . . . . 0.0 113.863 -173.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -131.59 110.25 10.81 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 -174.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.427 ' HB3' ' CE1' ' A' ' 92' ' ' TYR . 13.3 ptt-85 -60.06 -8.53 2.43 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -176.268 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . 0.272 1.4 p 57.36 172.52 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 127.743 2.417 . . . . 0.0 109.846 -169.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -83.24 2.29 36.57 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.421 -1.424 . . . . 0.0 111.594 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt -65.34 158.87 25.33 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 122.049 0.928 . . . . 0.0 110.182 174.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -90.55 130.04 36.63 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 165.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.1 m -75.18 158.87 32.32 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 153.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.9 pt -142.52 31.76 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 125.0 1.32 . . . . 0.0 110.336 174.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -131.15 172.54 12.0 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.953 1.701 . . . . 0.0 108.217 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.55 -0.67 2.89 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.26 1.024 . . . . 0.0 110.996 177.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -146.01 160.65 42.63 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 127.377 2.271 . . . . 0.0 108.607 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -80.33 177.99 7.59 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.452 2.768 . . . . 0.0 112.076 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.9 4.28 8.05 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.713 1.205 . . . . 0.0 112.399 175.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.41 150.72 46.96 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.306 1.042 . . . . 0.0 110.217 170.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -74.56 -28.64 61.03 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.995 0.518 . . . . 0.0 110.062 172.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -129.99 127.73 40.59 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.157 1.383 . . . . 0.0 109.183 -176.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -154.27 161.94 41.49 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.704 2.002 . . . . 0.0 108.147 176.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -90.73 159.63 27.02 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 171.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.34 137.27 38.99 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.16 130.75 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -125.07 130.21 51.8 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 163.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 62.0 mt -106.76 83.57 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 171.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.77 118.49 5.36 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.941 1.246 . . . . 0.0 109.274 167.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -144.88 119.9 10.04 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.675 1.59 . . . . 0.0 108.271 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.5 m120 60.87 22.98 13.04 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.774 1.63 . . . . 0.0 112.219 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.54 -3.27 42.65 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.51 1.052 . . . . 0.0 113.224 -174.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.88 178.17 51.11 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 156.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 19.7 ptp -159.39 161.27 35.61 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.542 -0.975 . . . . 0.0 112.768 177.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.4 m -118.72 112.26 19.54 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.016 1.726 . . . . 0.0 106.914 172.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.0 m -81.19 147.27 30.09 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 168.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 2.6 ptp -160.11 171.49 19.19 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.164 1.786 . . . . 0.0 108.153 165.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -142.74 146.42 34.3 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.247 1.819 . . . . 0.0 106.474 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.437 ' CD1' HG13 ' A' ' 84' ' ' ILE . 0.6 OUTLIER -128.51 153.5 47.1 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.788 1.631 . . . . 0.0 109.807 175.857 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -153.48 174.86 13.85 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.807 1.243 . . . . 0.0 110.267 -175.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -105.98 144.02 33.29 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.429 1.892 . . . . 0.0 107.961 169.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -151.49 131.1 13.07 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 176.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 55.3 14.51 1.1 Allowed 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.89 -1.131 . . . . 0.0 113.487 -176.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.51 12.09 73.37 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 120.505 -1.372 . . . . 0.0 111.888 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.96 165.07 11.85 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.563 1.945 . . . . 0.0 107.371 163.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -112.24 150.92 30.23 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.083 0.856 . . . . 0.0 108.75 178.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -141.03 159.48 42.12 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.895 0.378 . . . . 0.0 111.167 -178.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.437 HG13 ' CD1' ' A' ' 75' ' ' TYR . 3.5 mp -117.73 129.96 73.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 125.534 1.534 . . . . 0.0 108.45 178.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -73.63 150.03 41.63 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 122.847 1.308 . . . . 0.0 109.831 169.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -169.72 167.44 5.16 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 129.24 3.016 . . . . 0.0 105.928 174.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -59.67 -160.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 125.175 3.917 . . . . 0.0 109.531 162.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -42.77 -9.24 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 128.472 2.709 . . . . 0.0 117.058 -169.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -107.46 21.97 16.67 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 173.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -105.49 44.01 1.56 Allowed Glycine 0 N--CA 1.45 -0.429 0 CA-C-O 118.587 -1.118 . . . . 0.0 115.872 -167.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.4 mt -109.35 46.56 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 119.752 1.776 . . . . 0.0 108.767 171.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.427 ' CE1' ' HB3' ' A' ' 44' ' ' ARG . 72.3 m-85 -71.89 103.57 3.21 Favored 'General case' 0 CA--C 1.51 -0.582 0 O-C-N 121.193 -0.942 . . . . 0.0 108.767 177.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -68.49 126.91 31.12 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 157.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.9 pt -117.74 161.1 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 154.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -104.39 -9.49 18.43 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.658 -0.651 . . . . 0.0 110.774 -176.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -137.81 144.78 41.69 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 124.401 1.08 . . . . 0.0 110.489 -172.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -65.4 124.31 21.91 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 126.388 1.875 . . . . 0.0 112.291 -172.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -63.72 -48.75 75.81 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.808 1.243 . . . . 0.0 110.986 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -65.13 -9.71 25.07 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -174.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -109.22 -9.0 15.03 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.889 1.222 . . . . 0.0 111.819 173.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 10.9 mmt -89.6 -19.95 24.33 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.048 1.339 . . . . 0.0 111.775 174.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 18.3 pt . . . . . 0 C--O 1.255 1.363 0 C-N-CA 124.124 0.969 . . . . 0.0 110.947 174.27 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 CA--C 1.544 0.749 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.53 -173.21 0.11 Allowed 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.842 3.028 . . . . 0.0 111.816 158.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.8 mt -124.27 119.78 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 164.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.7 157.14 76.18 Favored Pre-proline 0 C--O 1.239 0.542 0 C-N-CA 125.324 1.449 . . . . 0.0 109.135 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.25 165.46 32.37 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.761 2.307 . . . . 0.0 111.513 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -64.46 154.78 34.77 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.335 -0.853 . . . . 0.0 111.261 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.478 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . . . -57.24 -50.5 72.69 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.394 0.997 . . . . 0.0 108.963 167.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -67.45 -16.84 64.44 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -169.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -104.38 1.89 30.66 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 119.582 1.083 . . . . 0.0 113.549 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 t -83.66 135.89 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 172.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -83.82 -60.36 2.14 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.4 p -148.75 169.88 19.46 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.362 1.465 . . . . 0.0 109.553 169.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.3 mt -124.84 144.48 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 N-CA-C 104.578 -2.378 . . . . 0.0 104.578 171.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.83 145.16 49.92 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 174.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.0 mt -134.66 105.74 6.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 178.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -86.37 110.59 19.79 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 102.839 -3.023 . . . . 0.0 102.839 174.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -66.12 173.28 3.18 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 174.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.3 p -56.85 -20.32 22.24 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -103.76 -175.83 2.91 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.197 1.399 . . . . 0.0 109.413 -178.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.4 p -75.65 42.38 0.22 Allowed 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.768 2.027 . . . . 0.0 111.655 -178.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.6 mt -140.11 136.35 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 126.196 1.798 . . . . 0.0 106.313 -172.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.38 150.59 46.7 Favored 'General case' 0 N--CA 1.421 -1.918 0 C-N-CA 125.427 1.491 . . . . 0.0 109.135 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.451 ' HE2' ' CZ ' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -125.28 142.11 51.69 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.377 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.44 145.33 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.451 ' CZ ' ' HE2' ' A' ' 24' ' ' LYS . 24.3 m-85 -127.24 82.49 2.09 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -170.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -88.34 -19.53 26.55 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.378 1.471 . . . . 0.0 112.102 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.99 139.81 30.48 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.47 1.108 . . . . 0.0 111.242 -174.248 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.4 t -45.2 -54.57 6.77 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 126.463 1.905 . . . . 0.0 112.896 -177.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -67.14 -38.99 86.49 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.527 -0.733 . . . . 0.0 109.753 -173.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.4 m -65.9 -6.42 12.28 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.304 1.842 . . . . 0.0 113.389 171.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -100.66 -45.54 11.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 120.451 1.478 . . . . 0.0 109.316 171.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -60.38 -33.0 71.84 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.885 0.874 . . . . 0.0 112.887 -174.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.13 -52.28 43.64 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.672 0.669 . . . . 0.0 110.39 176.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.2 mt -49.24 -52.0 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 119.43 1.014 . . . . 0.0 110.546 173.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.478 ' CD1' ' HB2' ' A' ' 8' ' ' ALA . 38.9 mt -56.81 -21.32 27.93 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -177.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.5 t -67.19 -65.37 0.69 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.485 1.039 . . . . 0.0 108.56 168.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.39 -29.87 70.13 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.48 -0.763 . . . . 0.0 110.544 -168.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.96 -20.29 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.325 1.05 . . . . 0.0 111.141 174.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.71 -3.47 8.74 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 120.004 1.275 . . . . 0.0 114.222 -170.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 t -66.38 -40.15 89.51 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.586 0.754 . . . . 0.0 110.335 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.64 172.32 53.94 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-O 123.134 1.408 . . . . 0.0 114.19 -169.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -140.7 121.63 14.55 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 114.238 -0.981 . . . . 0.0 108.41 -173.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -63.82 -4.85 3.53 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.521 1.528 . . . . 0.0 114.796 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.1 p 59.83 -164.55 0.22 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.2 1.8 . . . . 0.0 108.379 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -100.31 8.81 43.46 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 120.235 -1.54 . . . . 0.0 112.48 173.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -64.06 154.21 35.06 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.736 -0.602 . . . . 0.0 109.93 173.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -94.81 123.76 38.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 165.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.2 t -70.98 151.73 44.34 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 147.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 pp -141.33 7.57 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.866 2.066 . . . . 0.0 109.687 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.11 162.14 24.17 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.535 1.934 . . . . 0.0 109.76 -174.05 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -102.3 -1.57 30.77 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.121 0.968 . . . . 0.0 110.699 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -141.55 147.32 45.56 Favored Pre-proline 0 C--O 1.235 0.305 0 CA-C-N 119.394 0.997 . . . . 0.0 111.532 -172.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.446 ' HG2' ' CD2' ' A' ' 59' ' ' TYR . 19.5 Cg_endo -67.98 162.08 41.41 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.218 3.279 . . . . 0.0 111.402 -176.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.81 35.66 1.66 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.048 2.139 . . . . 0.0 109.235 174.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.8 152.79 41.84 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.765 1.626 . . . . 0.0 110.292 173.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -87.67 -29.32 21.23 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.681 -172.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -128.13 118.44 23.41 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 176.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.446 ' CD2' ' HG2' ' A' ' 54' ' ' PRO . 49.4 p90 -138.19 156.47 47.68 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.641 1.576 . . . . 0.0 108.209 175.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.37 -178.0 16.49 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 125.822 1.677 . . . . 0.0 110.12 171.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 36.5 m -131.75 137.17 48.1 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 117.731 0.765 . . . . 0.0 111.953 -158.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 mp -118.72 135.2 59.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 126.179 1.791 . . . . 0.0 107.018 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -127.67 125.45 40.1 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 172.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.7 mt -99.87 118.24 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.116 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 168.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -82.25 133.1 35.23 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 165.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -140.26 -162.72 1.39 Allowed 'General case' 0 C--N 1.327 -0.404 0 O-C-N 120.845 -1.159 . . . . 0.0 108.05 173.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -44.77 -35.74 2.87 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 129.886 3.275 . . . . 0.0 115.565 -157.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -176.13 20.41 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 124.895 1.235 . . . . 0.0 110.39 -167.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -165.18 170.72 40.28 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 171.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.9 ptt? -118.84 156.1 30.03 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.3 1.44 . . . . 0.0 109.834 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 m -126.87 108.02 10.63 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -176.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.4 m -108.52 143.61 37.29 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.705 0.802 . . . . 0.0 110.271 -172.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.94 165.98 33.78 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.526 1.531 . . . . 0.0 109.306 172.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -112.84 176.36 5.05 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.691 1.597 . . . . 0.0 108.928 170.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -142.7 165.62 26.88 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.278 1.431 . . . . 0.0 108.593 170.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -158.46 170.8 21.39 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.111 0.869 . . . . 0.0 112.267 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -106.53 134.29 49.9 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 162.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.31 -162.52 0.08 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 125.824 1.65 . . . . 0.0 106.888 153.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -74.28 50.97 0.41 Allowed 'General case' 0 C--N 1.321 -0.66 0 O-C-N 119.952 -1.717 . . . . 0.0 111.316 174.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 122.07 -14.97 8.91 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 125.108 1.337 . . . . 0.0 112.286 166.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -89.18 154.35 20.21 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.481 1.14 . . . . 0.0 110.728 165.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -114.79 152.68 31.7 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.776 0.716 . . . . 0.0 111.264 -178.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -152.23 163.68 38.93 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.84 0.856 . . . . 0.0 111.879 -169.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.9 mp -131.14 132.58 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.708 1.603 . . . . 0.0 109.767 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.1 tp10 -85.0 165.39 17.6 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.181 2.192 . . . . 0.0 109.994 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.504 ' HB2' ' HA2' ' A' ' 90' ' ' GLY . 0.7 OUTLIER 174.43 168.31 0.32 Allowed Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 128.032 2.533 . . . . 0.0 107.289 -164.421 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.406 ' O ' ' N ' ' A' ' 89' ' ' LYS . 39.5 Cg_endo -59.2 -161.27 0.02 OUTLIER 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.338 2.692 . . . . 0.0 109.672 160.359 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -42.57 -6.74 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 130.397 3.479 . . . . 0.0 117.733 -170.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 87' ' ' PRO 0.266 1.2 ptpt -109.72 13.4 23.74 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 129.758 3.223 . . . . 0.0 113.285 179.531 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.504 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . -94.18 49.98 2.17 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 123.78 0.705 . . . . 0.0 114.25 -168.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.1 mt -127.79 46.22 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 176.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -72.85 96.38 2.07 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 173.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -74.43 121.08 20.88 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 166.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 27.3 pt -115.75 169.44 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.485 1.114 . . . . 0.0 109.553 166.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -128.37 49.99 2.13 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.24 0.616 . . . . 0.0 109.951 -178.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -166.7 165.21 16.6 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.554 1.541 . . . . 0.0 110.785 165.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -73.62 131.65 41.91 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.194 0.998 . . . . 0.0 108.996 174.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -72.38 -49.14 36.16 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.798 0.727 . . . . 0.0 111.742 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -70.91 -26.13 63.07 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.337 -0.852 . . . . 0.0 113.023 -168.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -72.11 -19.58 61.77 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.153 0.888 . . . . 0.0 111.425 171.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 17.1 mmt -105.81 24.06 12.91 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.571 1.948 . . . . 0.0 111.965 -171.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.2 pt . . . . . 0 C--O 1.257 1.448 0 C-N-CA 125.188 1.395 . . . . 0.0 109.836 169.581 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 m . . . . . 0 CA--C 1.547 0.851 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.77 161.54 45.53 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 O-C-N 118.716 -1.255 . . . . 0.0 111.141 166.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.7 mt -116.45 104.79 17.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.42 158.84 68.37 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 126.986 2.114 . . . . 0.0 110.676 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -68.77 -175.43 0.93 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.6 2.867 . . . . 0.0 112.662 177.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt -60.82 175.94 0.44 Allowed 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.109 -1.62 . . . . 0.0 109.569 162.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.18 -50.01 10.11 Favored 'General case' 0 C--O 1.221 -0.428 0 O-C-N 121.255 -0.903 . . . . 0.0 109.539 163.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -62.13 -12.31 18.94 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.683 1.593 . . . . 0.0 114.771 -168.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -104.83 -0.62 27.0 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.71 2.004 . . . . 0.0 113.187 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 66.5 t -86.01 130.17 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 172.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -67.26 -69.52 0.31 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 167.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.6 m -149.51 170.53 18.4 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.112 0.965 . . . . 0.0 109.984 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.1 mt -131.75 132.97 61.81 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.994 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 172.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.6 m -99.68 133.0 44.65 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 112.787 -2.006 . . . . 0.0 106.069 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.0 mt -133.99 103.65 5.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 170.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -93.97 98.93 11.37 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.172 1.789 . . . . 0.0 106.274 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -60.74 172.83 0.85 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.469 1.908 . . . . 0.0 111.55 -169.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.3 p -51.83 -42.59 62.66 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.962 0.905 . . . . 0.0 110.393 171.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -91.64 -179.2 5.28 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.188 1.795 . . . . 0.0 111.338 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 98.2 p -72.87 16.9 0.13 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.313 1.445 . . . . 0.0 114.818 -158.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.8 mt -120.8 139.91 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -161.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -124.19 107.13 10.89 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 174.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.26 139.85 42.81 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 166.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.0 mt -118.17 136.15 56.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 168.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -110.86 73.87 0.84 Allowed 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 104.243 -2.502 . . . . 0.0 104.243 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -82.12 16.1 2.09 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.808 1.243 . . . . 0.0 111.72 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.51 140.44 52.2 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.707 1.203 . . . . 0.0 109.94 -167.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.8 t -55.75 -46.07 77.92 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.92 0.888 . . . . 0.0 111.636 -175.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -73.66 -31.85 63.68 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.378 -0.826 . . . . 0.0 112.111 -175.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.4 m -65.8 -43.29 89.14 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 127.685 2.394 . . . . 0.0 111.036 174.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.5 mt -64.76 -52.11 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 172.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -60.81 -21.93 63.63 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -65.16 -67.56 0.43 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 119.57 1.077 . . . . 0.0 108.495 166.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.6 mt -50.65 -44.48 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.549 1.14 . . . . 0.0 110.543 -170.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.82 -12.4 0.79 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 177.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.4 t -84.44 -62.94 1.43 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.041 2.136 . . . . 0.0 110.814 168.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -57.65 -14.7 5.88 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.646 1.112 . . . . 0.0 113.435 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.4 mm -82.3 -49.66 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 124.429 1.092 . . . . 0.0 110.736 169.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.96 -19.78 46.32 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.342 1.057 . . . . 0.0 113.713 -173.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 t -68.51 -17.4 64.16 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.668 1.187 . . . . 0.0 112.87 -176.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.62 140.2 40.37 Favored Glycine 0 C--N 1.336 0.557 0 O-C-N 119.612 -1.93 . . . . 0.0 112.389 176.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -108.41 107.34 17.86 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 161.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.7 ptt85 -59.79 -6.48 1.25 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.712 1.142 . . . . 0.0 113.109 168.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.8 p 61.33 -174.85 0.13 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.688 1.595 . . . . 0.0 110.736 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -74.94 -12.71 60.41 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.23 -1.544 . . . . 0.0 112.216 176.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -71.92 171.31 11.99 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.117 0.961 . . . . 0.0 111.35 -167.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -110.74 128.43 55.73 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.824 1.25 . . . . 0.0 108.173 173.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.5 t -74.94 162.58 28.48 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 156.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.9 pt -146.52 31.69 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 126.489 1.915 . . . . 0.0 109.83 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -139.63 172.23 13.09 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 120.99 -1.069 . . . . 0.0 111.64 -172.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -111.12 -20.36 12.39 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.428 1.891 . . . . 0.0 111.52 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -147.26 158.27 44.46 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 124.025 0.93 . . . . 0.0 110.676 -165.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -70.29 175.55 8.39 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.737 2.958 . . . . 0.0 111.699 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.27 -5.12 11.83 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.509 1.524 . . . . 0.0 111.539 175.113 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.44 157.8 36.4 Favored 'General case' 0 N--CA 1.457 -0.114 0 O-C-N 120.837 -1.165 . . . . 0.0 109.249 169.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.16 -21.66 21.05 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.602 0.761 . . . . 0.0 111.283 168.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -127.96 103.01 7.01 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -169.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -146.56 177.48 9.03 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 128.601 2.76 . . . . 0.0 106.695 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -121.61 166.24 14.45 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 168.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.96 133.07 42.1 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.159 0.984 . . . . 0.0 108.601 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.0 mp -124.33 129.93 73.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -132.64 115.47 15.45 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.0 mt -87.49 103.63 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 173.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -74.76 122.81 23.87 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 172.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -141.67 -157.21 0.75 Allowed 'General case' 0 N--CA 1.465 0.299 0 O-C-N 120.866 -1.146 . . . . 0.0 110.502 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -44.56 -21.21 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 1 C-N-CA 132.796 4.438 . . . . 0.0 116.501 -160.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 153.03 32.19 0.03 OUTLIER Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 126.048 1.785 . . . . 0.0 108.954 -162.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -172.97 174.1 45.77 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.2 ptp -117.93 160.29 21.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.909 1.684 . . . . 0.0 109.351 176.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.6 m -123.29 104.75 9.33 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 158.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.6 m -82.84 141.8 32.0 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.339 1.456 . . . . 0.0 108.591 172.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -165.32 167.99 17.31 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.355 1.862 . . . . 0.0 108.309 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -146.01 138.75 25.64 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.787 1.635 . . . . 0.0 107.421 -174.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.454 ' CE1' HG23 ' A' ' 84' ' ' ILE . 1.8 m-85 -126.06 142.88 51.33 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 121.06 1.754 . . . . 0.0 109.732 -177.198 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -149.52 173.74 13.27 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.564 1.146 . . . . 0.0 111.583 -174.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -103.45 144.9 30.79 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.284 1.433 . . . . 0.0 108.883 166.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -144.97 126.98 15.52 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.033 0.933 . . . . 0.0 109.313 173.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.14 3.84 1.42 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.847 2.059 . . . . 0.0 114.824 176.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.7 -0.37 15.52 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-N 119.579 1.081 . . . . 0.0 113.315 -173.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.5 tptt -133.87 149.94 51.35 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 119.358 1.579 . . . . 0.0 110.177 -169.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -101.52 135.53 42.86 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -168.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -129.55 159.53 36.06 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.05 0.54 . . . . 0.0 111.055 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.454 HG23 ' CE1' ' A' ' 75' ' ' TYR . 2.9 mp -122.05 117.91 53.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 125.073 1.349 . . . . 0.0 108.428 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -65.25 145.6 56.03 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 122.793 1.282 . . . . 0.0 109.655 173.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -171.2 165.76 4.56 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 127.442 2.297 . . . . 0.0 106.532 175.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.404 ' O ' ' N ' ' A' ' 89' ' ' LYS . 94.2 Cg_endo -63.35 -161.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.769 1 C-N-CA 125.401 4.067 . . . . 0.0 109.517 174.49 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -43.41 -13.98 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 117.065 2.246 . . . . 0.0 117.065 -170.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 87' ' ' PRO . 2.8 mtmt -103.18 31.54 4.22 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 126.237 1.815 . . . . 0.0 114.224 169.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -118.23 69.8 0.32 Allowed Glycine 0 C--O 1.221 -0.693 0 C-N-CA 124.566 1.079 . . . . 0.0 111.963 -174.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.1 mt -133.39 53.01 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 166.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -75.44 108.67 8.4 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 121.463 -0.773 . . . . 0.0 109.029 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -83.37 125.06 31.26 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 163.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.8 pt -113.32 167.31 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.164 1.385 . . . . 0.0 108.726 164.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -124.95 46.53 2.32 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.388 0.613 . . . . 0.0 110.853 -174.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -177.13 169.63 2.29 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 127.456 2.302 . . . . 0.0 109.311 168.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -74.75 138.08 42.45 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.653 1.181 . . . . 0.0 109.739 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -79.4 -44.84 20.66 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.283 1.033 . . . . 0.0 111.819 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.0 -12.54 60.16 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.913 1.285 . . . . 0.0 113.623 -171.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -88.72 -22.47 23.34 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.374 1.47 . . . . 0.0 113.011 171.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -81.49 -29.67 33.56 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 121.092 -1.005 . . . . 0.0 110.541 -178.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 29.3 pt . . . . . 0 C--O 1.25 1.096 0 C-N-CA 123.876 0.87 . . . . 0.0 110.984 -178.29 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 CA--C 1.541 0.619 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -64.14 -179.72 0.9 Allowed 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.799 2.999 . . . . 0.0 112.625 162.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.3 mt -125.58 94.7 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 127.107 2.163 . . . . 0.0 105.575 178.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.82 154.39 37.55 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 126.329 1.851 . . . . 0.0 109.36 -176.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.62 159.01 55.39 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.606 2.204 . . . . 0.0 112.108 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.39 150.78 38.79 Favored 'General case' 0 C--N 1.345 0.376 0 O-C-N 121.696 -0.628 . . . . 0.0 110.496 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.467 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . . . -68.2 -1.15 5.55 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 177.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -122.5 -18.03 6.81 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 119.533 1.061 . . . . 0.0 111.671 -172.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -89.11 -6.75 56.81 Favored 'General case' 0 N--CA 1.456 -0.155 0 O-C-N 121.714 -0.616 . . . . 0.0 111.141 170.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.8 t -69.06 138.06 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 C-N-CA 125.151 1.38 . . . . 0.0 108.573 169.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.4 -55.88 2.7 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.934 1.694 . . . . 0.0 107.787 173.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.7 p -172.67 121.47 0.41 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.508 0.595 . . . . 0.0 111.119 178.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.7 mt -75.39 129.89 36.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 173.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 t -105.58 148.73 26.97 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 166.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.7 mt -139.0 104.83 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 172.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.8 110.06 18.54 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 104.146 -2.539 . . . . 0.0 104.146 165.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -66.21 -176.43 0.42 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.222 1.009 . . . . 0.0 110.999 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.1 p -57.62 -50.55 72.79 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 120.799 -1.188 . . . . 0.0 109.96 173.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.95 -178.48 2.8 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.701 0.762 . . . . 0.0 109.644 173.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 m -80.94 17.28 1.23 Allowed 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.889 -1.132 . . . . 0.0 111.258 -175.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.7 mt -90.14 134.48 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -127.85 142.93 51.15 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.414 ' HE2' ' CZ ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -131.83 149.22 52.52 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 123.567 0.747 . . . . 0.0 109.214 175.205 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.1 mp -121.8 147.43 25.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.414 ' CZ ' ' HE2' ' A' ' 24' ' ' LYS . 79.6 m-85 -127.45 76.79 1.7 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 -168.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -105.01 5.21 32.41 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.804 1.241 . . . . 0.0 112.613 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -81.72 144.49 31.1 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 166.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 28.6 t -57.83 -41.35 82.08 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.421 -1.424 . . . . 0.0 111.663 174.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.44 -33.78 76.66 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 120.658 -1.276 . . . . 0.0 111.994 178.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.2 p -63.05 -43.09 99.6 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.848 0.859 . . . . 0.0 109.538 175.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 93.0 mt -68.41 -54.5 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 124.62 1.168 . . . . 0.0 108.892 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -58.09 -32.88 68.49 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.706 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -61.68 -64.32 0.98 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 118.551 -0.738 . . . . 0.0 110.233 171.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 81.4 mt -51.6 -48.68 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 119.199 -0.429 . . . . 0.0 110.072 -173.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.467 ' CD1' ' HB2' ' A' ' 8' ' ' ALA . 21.6 mt -53.47 -24.9 14.27 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.2 t -63.91 -63.1 1.25 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.775 1.23 . . . . 0.0 110.072 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -68.87 -24.17 64.31 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.889 0.852 . . . . 0.0 110.724 -174.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.9 mm -68.15 -13.33 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 O-C-N 120.48 -1.387 . . . . 0.0 111.21 171.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.64 -8.45 11.46 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -176.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.4 p -67.77 -40.6 84.01 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.648 1.113 . . . . 0.0 111.608 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.77 164.52 54.59 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-O 123.117 1.398 . . . . 0.0 114.299 -165.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.42 ' C ' ' H ' ' A' ' 45' ' ' THR . 91.6 mttt -115.91 110.49 19.07 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 105.107 -2.182 . . . . 0.0 105.107 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.434 ' HB3' ' CE2' ' A' ' 92' ' ' TYR . 10.3 ptt180 -56.55 -3.95 0.13 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.872 1.269 . . . . 0.0 114.36 174.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.42 ' H ' ' C ' ' A' ' 43' ' ' LYS . 27.7 p 62.7 172.95 0.14 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 128.752 2.821 . . . . 0.0 110.396 -171.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.409 ' HG2' ' H ' ' A' ' 46' ' ' GLU . 8.6 pt-20 -78.37 -6.42 55.11 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.004 -1.06 . . . . 0.0 111.666 172.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -66.91 174.01 3.27 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 122.776 1.274 . . . . 0.0 111.981 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -110.75 150.18 29.45 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.23 1.812 . . . . 0.0 107.752 175.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.7 76.69 1.65 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -164.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.2 pt -90.54 36.14 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.531 1.132 . . . . 0.0 110.542 -164.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -125.35 161.63 26.57 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.295 2.238 . . . . 0.0 109.337 -172.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.99 -3.28 8.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.367 -1.288 . . . . 0.0 112.736 -178.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -150.12 164.61 20.0 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 126.262 1.825 . . . . 0.0 108.638 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.28 179.14 3.64 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.258 2.638 . . . . 0.0 112.678 173.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.66 6.29 45.66 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.154 1.381 . . . . 0.0 111.658 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.13 156.43 17.42 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 121.36 -0.837 . . . . 0.0 111.977 -175.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -86.17 -22.23 27.11 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.795 1.638 . . . . 0.0 111.221 170.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -135.1 115.95 14.01 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -143.07 159.95 41.31 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 127.207 2.203 . . . . 0.0 106.003 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.85 162.59 25.32 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 167.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.8 m -118.11 125.24 49.87 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.104 1.361 . . . . 0.0 108.233 -175.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.2 mp -121.35 132.21 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 -172.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -123.53 115.74 22.03 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 175.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.5 mt -91.17 86.08 2.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 173.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -65.45 113.66 4.29 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 173.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -140.66 135.43 31.65 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.588 1.555 . . . . 0.0 108.17 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.5 m120 61.5 -4.03 0.18 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.919 2.088 . . . . 0.0 115.443 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.8 12.13 26.87 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 119.89 1.223 . . . . 0.0 112.321 -173.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -127.94 -175.96 14.28 Favored Glycine 0 C--N 1.335 0.511 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 165.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.94 138.25 22.88 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 118.122 0.961 . . . . 0.0 113.149 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 86.8 m -75.23 106.03 6.55 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 158.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.4 m -73.55 142.58 46.65 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 163.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -161.09 166.62 27.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.598 1.559 . . . . 0.0 108.727 170.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -140.99 146.88 37.87 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.619 1.568 . . . . 0.0 108.119 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.426 ' CD1' HG13 ' A' ' 84' ' ' ILE . 1.4 m-85 -128.31 147.35 50.61 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 120.211 1.369 . . . . 0.0 108.973 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -148.9 -175.37 4.92 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.97 1.308 . . . . 0.0 110.538 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -119.04 138.92 52.52 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.176 1.79 . . . . 0.0 109.47 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.487 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 7.6 tt0 -142.84 91.21 2.28 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.886 0.874 . . . . 0.0 109.31 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 70.73 19.4 5.99 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 128.214 2.606 . . . . 0.0 112.484 -174.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.15 -3.67 62.12 Favored Glycine 0 C--N 1.335 0.517 0 O-C-N 120.972 -1.08 . . . . 0.0 112.36 168.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -83.8 145.68 28.55 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 154.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -100.29 149.66 23.37 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.487 ' CE1' ' HB3' ' A' ' 78' ' ' GLU . 84.9 m-85 -134.43 135.09 42.29 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 123.173 0.589 . . . . 0.0 109.734 -171.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.426 HG13 ' CD1' ' A' ' 75' ' ' TYR . 3.0 mp -107.18 127.46 62.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -176.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -77.61 152.36 33.93 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.258 1.423 . . . . 0.0 109.943 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -172.79 168.77 2.61 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 129.131 2.972 . . . . 0.0 107.372 177.336 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -56.04 -161.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 125.009 3.806 . . . . 0.0 110.606 162.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -42.72 -14.69 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 128.695 2.798 . . . . 0.0 115.028 -171.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.15 66.91 0.64 Allowed 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.364 1.466 . . . . 0.0 110.616 166.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.8 53.13 0.77 Allowed Glycine 0 C--O 1.223 -0.542 0 C-N-CA 124.661 1.124 . . . . 0.0 114.953 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.5 mt -131.44 61.15 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.434 ' CE2' ' HB3' ' A' ' 44' ' ' ARG . 23.4 m-85 -87.56 98.27 11.31 Favored 'General case' 0 CA--C 1.521 -0.168 0 O-C-N 121.165 -0.959 . . . . 0.0 109.304 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -79.06 81.37 5.33 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.55 1.54 . . . . 0.0 109.049 176.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 21.8 pt -81.74 159.41 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 O-C-N 120.877 -1.14 . . . . 0.0 109.439 175.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -107.27 10.74 29.75 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -177.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -131.82 147.32 52.48 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 124.787 1.235 . . . . 0.0 112.433 -175.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -74.07 110.26 8.22 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -55.26 -43.0 74.26 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.035 0.934 . . . . 0.0 110.854 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -73.91 -13.06 60.84 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -171.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -90.43 -24.7 20.66 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.022 0.929 . . . . 0.0 110.789 165.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 12.1 mmt -96.54 6.3 49.02 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 126.124 1.77 . . . . 0.0 113.293 -172.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.4 pt . . . . . 0 C--O 1.246 0.873 0 CA-C-N 119.608 1.095 . . . . 0.0 108.343 164.234 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.543 0.68 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -70.23 173.37 11.49 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.74 2.294 . . . . 0.0 112.252 156.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.5 mt -120.89 98.06 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 175.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.56 165.06 15.42 Favored Pre-proline 0 C--O 1.239 0.532 0 C-N-CA 125.381 1.472 . . . . 0.0 110.086 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.432 ' HB2' HD21 ' A' ' 10' ' ' ASN . 68.2 Cg_endo -63.14 -179.81 0.66 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.348 2.032 . . . . 0.0 111.28 161.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.552 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -64.96 -175.4 0.19 Allowed 'General case' 0 C--O 1.232 0.157 0 O-C-N 120.943 -1.098 . . . . 0.0 109.823 165.164 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.66 -42.93 13.02 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 163.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -72.62 -0.6 13.4 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.282 1.433 . . . . 0.0 113.456 -159.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.517 ' H ' HD22 ' A' ' 10' ' ' ASN . 0.1 OUTLIER -124.43 -0.04 8.22 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 129.919 3.287 . . . . 0.0 111.919 -170.135 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.2 t -84.63 128.5 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 176.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -81.66 -56.42 4.02 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 124.905 1.282 . . . . 0.0 109.416 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.29 155.38 40.45 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.598 0.759 . . . . 0.0 109.348 166.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 51.8 mt -104.14 140.95 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 162.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.8 t -127.61 132.18 49.83 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.2 mt -125.63 106.36 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 174.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.56 110.2 17.45 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 169.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -68.74 170.85 8.68 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.889 1.275 . . . . 0.0 111.255 -174.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.9 p -58.45 -29.6 66.28 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.97 1.708 . . . . 0.0 113.522 176.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.505 ' CG ' ' H ' ' A' ' 21' ' ' SER . 46.9 t30 -86.64 -154.6 0.23 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.771 1.228 . . . . 0.0 108.159 177.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.505 ' H ' ' CG ' ' A' ' 20' ' ' ASN . 23.4 t -102.57 37.33 1.94 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.603 1.961 . . . . 0.0 109.595 -177.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.9 mt -132.02 155.71 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 126.612 1.965 . . . . 0.0 106.749 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.4 164.37 25.84 Favored 'General case' 0 N--CA 1.425 -1.72 0 C-N-CA 127.225 2.21 . . . . 0.0 108.78 171.169 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.1 135.47 43.24 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 126.39 1.876 . . . . 0.0 106.636 173.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.6 mp -111.72 127.0 69.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 176.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -108.51 80.23 1.33 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -88.7 -5.24 58.24 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.792 1.237 . . . . 0.0 112.085 -178.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.7 150.59 20.21 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.396 1.078 . . . . 0.0 111.552 -175.349 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -44.71 -64.55 0.68 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.981 2.113 . . . . 0.0 110.739 172.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -62.91 -35.71 80.97 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.111 0.964 . . . . 0.0 111.603 -168.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.6 m -63.8 -49.43 72.93 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 128.41 2.684 . . . . 0.0 110.713 175.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.26 -37.09 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.057 0.943 . . . . 0.0 109.386 174.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.07 -43.07 93.37 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.811 1.244 . . . . 0.0 112.267 -176.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -57.67 -66.45 0.47 Allowed 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 124.538 1.149 . . . . 0.0 108.867 170.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.4 mt -52.16 -45.92 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.768 0.827 . . . . 0.0 111.326 -172.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.91 -7.87 2.72 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.508 -1.37 . . . . 0.0 113.171 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.19 -58.94 2.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.573 2.349 . . . . 0.0 111.029 167.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.6 pm0 -60.36 -20.09 58.1 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 121.072 1.76 . . . . 0.0 113.275 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.7 mm -85.12 -19.83 8.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 125.187 1.395 . . . . 0.0 111.694 173.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.49 -21.26 19.58 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 119.625 1.102 . . . . 0.0 113.321 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.7 t -62.18 -32.63 73.28 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.893 0.877 . . . . 0.0 111.554 -170.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.63 160.49 53.65 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-O 122.983 1.324 . . . . 0.0 113.567 -175.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -125.36 109.98 13.42 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.43 ' HG3' ' H ' ' A' ' 44' ' ' ARG . 4.9 ppt_? -60.18 -10.8 4.9 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.66 1.984 . . . . 0.0 114.31 175.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.1 p 66.04 -179.77 0.2 Allowed 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 128.245 2.618 . . . . 0.0 110.958 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -82.36 2.76 30.78 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.387 -0.821 . . . . 0.0 111.936 173.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -61.92 151.27 35.27 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.994 1.27 . . . . 0.0 110.144 173.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -79.43 154.57 28.86 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.23 -1.35 . . . . 0.0 107.811 162.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.9 117.67 21.39 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 -177.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.7 pt -128.57 43.26 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 119.699 1.136 . . . . 0.0 110.548 -167.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -143.69 160.97 39.75 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.059 1.743 . . . . 0.0 108.252 -177.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.38 -10.67 13.75 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.318 1.047 . . . . 0.0 111.967 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -145.4 157.97 51.68 Favored Pre-proline 0 N--CA 1.467 0.398 0 C-N-CA 125.377 1.471 . . . . 0.0 109.849 -172.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -71.65 169.19 21.64 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.715 2.277 . . . . 0.0 112.504 177.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.6 t -92.08 -9.37 42.89 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.925 1.69 . . . . 0.0 112.442 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.04 158.77 18.52 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.978 -1.076 . . . . 0.0 112.041 -175.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -76.02 -33.51 59.67 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.992 1.317 . . . . 0.0 111.403 171.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -122.71 110.77 15.91 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.7 1.6 . . . . 0.0 106.985 -168.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -148.79 168.2 23.57 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.825 2.05 . . . . 0.0 106.448 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -109.01 167.05 12.81 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 170.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.45 123.3 44.49 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.275 1.03 . . . . 0.0 109.251 -178.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.6 137.52 51.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -128.62 146.68 50.79 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.876 0.87 . . . . 0.0 109.512 165.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.1 mt -114.95 91.36 1.75 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.5 0 N-CA-C 103.055 -2.942 . . . . 0.0 103.055 163.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -62.59 129.68 41.65 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 169.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -144.42 -155.91 0.65 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -55.43 -4.64 0.1 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 130.531 3.532 . . . . 0.0 116.514 -156.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.55 14.83 0.14 Allowed Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 126.474 1.987 . . . . 0.0 110.508 -170.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -147.92 170.42 28.58 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 118.11 0.955 . . . . 0.0 113.214 168.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 31.7 mtp -131.3 108.65 9.81 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 127.456 2.302 . . . . 0.0 106.976 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 78.4 m -74.86 87.63 2.28 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 166.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.8 m -66.31 139.37 58.04 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 172.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 2.1 ptm -160.2 166.39 29.76 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.278 1.431 . . . . 0.0 109.027 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -144.84 143.83 30.82 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.894 1.678 . . . . 0.0 106.683 -173.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -129.68 144.31 51.23 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.608 1.549 . . . . 0.0 109.016 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -146.88 178.75 8.09 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.317 1.447 . . . . 0.0 111.073 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -111.72 140.22 46.53 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.665 1.986 . . . . 0.0 107.655 171.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -138.48 112.6 8.59 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 175.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.14 15.18 3.12 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.95 1.7 . . . . 0.0 114.247 176.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.98 4.68 44.85 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.667 1.127 . . . . 0.0 112.873 172.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.98 161.51 14.4 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 157.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -119.63 154.74 33.54 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -144.04 149.27 36.4 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.783 0.325 . . . . 0.0 111.086 -168.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mp -121.2 119.76 60.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 125.453 1.501 . . . . 0.0 108.193 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -74.46 151.88 39.52 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.708 1.203 . . . . 0.0 110.773 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.511 ' HB2' ' HA2' ' A' ' 90' ' ' GLY . 0.8 OUTLIER -175.08 167.5 1.88 Allowed Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 127.366 2.266 . . . . 0.0 108.486 -177.124 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -55.73 -162.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.802 1 C-N-CA 126.126 4.551 . . . . 0.0 111.347 168.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -43.74 -8.38 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 128.13 2.572 . . . . 0.0 116.733 -175.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.92 70.29 0.77 Allowed 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 119.346 0.975 . . . . 0.0 110.697 159.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.511 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . -131.39 33.85 2.7 Favored Glycine 0 C--O 1.225 -0.439 0 N-CA-C 116.839 1.496 . . . . 0.0 116.839 -175.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.6 mt -116.98 50.11 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 118.027 0.914 . . . . 0.0 108.571 175.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -73.82 101.22 3.67 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.513 -1.367 . . . . 0.0 108.726 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -68.01 124.87 24.58 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 163.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 22.0 pt -121.14 163.64 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 124.189 0.996 . . . . 0.0 108.813 156.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -104.46 2.61 31.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.508 -175.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -132.69 154.27 50.33 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -169.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -73.15 104.2 4.14 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.835 2.054 . . . . 0.0 110.034 175.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -56.57 -36.42 69.3 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.46 1.504 . . . . 0.0 110.65 175.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -68.08 -15.86 63.77 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.681 0.792 . . . . 0.0 113.04 -172.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -90.81 -28.44 18.2 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.226 1.01 . . . . 0.0 112.105 169.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 41.4 mtt -68.5 -35.8 78.01 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 118.625 -0.702 . . . . 0.0 109.893 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 32.1 pt . . . . . 0 C--O 1.251 1.152 0 CA-C-O 117.164 -1.398 . . . . 0.0 112.312 -175.377 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.781 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.98 165.52 50.1 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 118.39 1.095 . . . . 0.0 112.448 -172.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.07 158.86 13.54 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.738 2.292 . . . . 0.0 111.723 154.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.5 mt -98.21 95.92 4.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 N-CA-C 104.724 -2.325 . . . . 0.0 104.724 165.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.9 166.15 35.36 Favored Pre-proline 0 C--O 1.237 0.428 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 172.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -56.89 173.09 0.59 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 121.15 1.234 . . . . 0.0 111.204 157.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.424 ' HE3' ' CG ' ' A' ' 9' ' ' GLU . 11.7 mtmt -56.87 172.33 0.27 Allowed 'General case' 0 C--N 1.345 0.393 0 O-C-N 120.859 -1.15 . . . . 0.0 110.538 166.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.0 -53.97 8.89 Favored 'General case' 0 C--O 1.221 -0.438 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 158.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.424 ' CG ' ' HE3' ' A' ' 7' ' ' LYS . 1.1 pt-20 -70.56 -7.06 41.07 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 -162.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 41.9 p-10 -100.02 -1.01 38.1 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.983 1.713 . . . . 0.0 112.278 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.0 t -78.36 124.07 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -78.65 -54.03 6.55 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.761 1.624 . . . . 0.0 106.869 -176.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -152.47 167.31 29.19 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.524 1.13 . . . . 0.0 108.658 160.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.8 mt -120.36 127.71 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 164.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.11 136.84 45.09 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 175.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.2 mt -131.08 100.24 4.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.93 113.31 12.08 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 163.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -67.17 176.44 2.19 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.619 1.168 . . . . 0.0 110.099 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.32 -34.14 77.47 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.521 -1.362 . . . . 0.0 112.117 177.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.8 p30 -80.13 -154.69 0.1 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.922 1.689 . . . . 0.0 110.75 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.5 p -91.82 10.63 27.76 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.621 -1.3 . . . . 0.0 113.656 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.9 mt -107.16 151.26 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -170.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -136.46 149.6 48.3 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 173.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.9 143.56 50.93 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 174.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.1 mp -118.25 127.62 75.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.68 ' CG ' HD11 ' A' ' 35' ' ' ILE . 38.6 m-85 -104.03 100.05 9.81 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 -176.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -125.98 -8.81 6.59 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.275 1.03 . . . . 0.0 111.88 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.58 149.99 36.55 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.154 0.982 . . . . 0.0 109.028 167.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.1 m -44.84 -57.02 4.02 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 124.392 1.077 . . . . 0.0 111.447 165.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.97 -29.96 70.92 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.605 0.762 . . . . 0.0 111.79 -174.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.4 p -71.09 -47.56 57.46 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 78.3 mt -63.38 -54.07 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 126.003 1.721 . . . . 0.0 109.169 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -59.19 -37.23 76.9 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 123.479 0.712 . . . . 0.0 111.332 -172.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.95 -50.48 73.6 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.741 0.816 . . . . 0.0 110.353 175.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.68 HD11 ' CG ' ' A' ' 26' ' ' TYR . 91.8 mt -55.49 -55.65 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 174.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.5 -12.19 2.51 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 t -78.08 -67.55 0.72 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 120.265 1.393 . . . . 0.0 109.321 166.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.564 ' O ' HG22 ' A' ' 41' ' ' THR . 71.7 mm-40 -66.0 -27.03 67.82 Favored 'General case' 0 C--O 1.223 -0.313 0 O-C-N 121.167 -0.958 . . . . 0.0 111.094 -171.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.402 HD11 ' CE1' ' A' ' 98' ' ' PHE . 14.1 mm -72.01 -18.3 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 O-C-N 119.998 -1.689 . . . . 0.0 111.832 173.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.81 -3.78 31.93 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.895 1.278 . . . . 0.0 113.692 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.564 HG22 ' O ' ' A' ' 38' ' ' GLU . 2.6 t -68.78 -36.16 77.95 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.878 0.871 . . . . 0.0 111.235 -178.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.3 170.28 53.42 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 124.232 0.92 . . . . 0.0 112.429 -170.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.445 ' O ' HG23 ' A' ' 45' ' ' THR . 35.4 mtmm -119.45 111.62 18.36 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.462 ' HA ' ' HA ' ' A' ' 92' ' ' TYR . 4.4 ppt_? -61.08 -12.94 13.82 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 171.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 43' ' ' LYS . 12.0 p 65.57 -176.36 0.18 Allowed 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 127.681 2.392 . . . . 0.0 109.728 177.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -88.4 6.0 39.54 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 120.541 -1.349 . . . . 0.0 113.453 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.6 mtpt -64.62 173.46 2.17 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.681 1.192 . . . . 0.0 112.45 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -109.93 119.4 39.21 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.6 m -79.73 85.18 5.45 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 167.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.8 pt -85.81 35.94 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 125.166 1.387 . . . . 0.0 110.113 176.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -142.27 165.86 26.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 128.695 2.798 . . . . 0.0 107.34 -172.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -132.7 0.4 3.57 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.403 1.081 . . . . 0.0 111.665 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -146.45 164.72 22.91 Favored Pre-proline 0 C--O 1.238 0.457 0 C-N-CA 126.847 2.059 . . . . 0.0 108.304 -173.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -74.15 170.92 19.04 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.021 2.48 . . . . 0.0 111.039 169.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -110.9 4.18 19.48 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.296 1.038 . . . . 0.0 111.607 166.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.85 173.25 10.17 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 120.573 -1.329 . . . . 0.0 109.992 161.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.5 -22.8 4.94 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.869 1.668 . . . . 0.0 110.637 177.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -105.4 113.63 27.32 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 174.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -160.73 168.0 25.72 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.123 1.369 . . . . 0.0 108.492 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -96.34 157.06 21.35 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 168.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.6 m -103.96 130.95 51.62 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 mp -126.97 137.26 58.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 123.502 0.721 . . . . 0.0 109.909 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.12 114.52 18.49 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 168.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 72.6 mt -88.95 91.53 3.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 104.35 -2.463 . . . . 0.0 104.35 162.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -70.32 123.61 22.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 171.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -153.02 133.04 13.35 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.558 1.143 . . . . 0.0 109.637 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.8 m120 55.48 31.89 17.9 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.636 1.174 . . . . 0.0 110.656 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.35 -11.42 4.04 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.904 1.716 . . . . 0.0 115.018 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.91 -173.75 45.34 Favored Glycine 0 C--N 1.332 0.337 0 O-C-N 120.5 -1.588 . . . . 0.0 110.029 166.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -145.09 157.57 44.07 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.907 -0.76 . . . . 0.0 111.507 168.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 83.5 m -96.73 109.2 21.9 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 154.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.7 m -74.53 147.12 42.08 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 160.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.9 ptm -163.07 170.74 17.48 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.009 1.724 . . . . 0.0 108.298 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -143.59 151.74 40.55 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -129.57 158.01 40.47 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 121.072 1.76 . . . . 0.0 110.655 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -159.21 178.28 10.16 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.457 1.48 . . . . 0.0 111.889 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -106.62 139.48 41.0 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.61 1.564 . . . . 0.0 108.007 167.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -141.68 131.3 24.03 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.246 1.022 . . . . 0.0 109.169 167.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 57.77 4.75 0.28 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.374 1.87 . . . . 0.0 114.769 175.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.09 2.4 21.96 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.744 1.64 . . . . 0.0 113.97 176.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -113.94 157.67 22.12 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 125.952 1.701 . . . . 0.0 108.052 167.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -103.25 159.45 15.53 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -145.63 155.06 42.78 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.682 0.793 . . . . 0.0 111.025 -172.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 mp -126.49 126.31 68.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 C-N-CA 125.973 1.709 . . . . 0.0 108.417 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -73.36 152.5 40.85 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 127.063 2.145 . . . . 0.0 110.19 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -177.16 167.53 1.26 Allowed Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 128.553 2.741 . . . . 0.0 107.973 176.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' A' ' 89' ' ' LYS . 41.1 Cg_endo -61.09 -162.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.815 1 C-N-CA 125.378 4.052 . . . . 0.0 109.671 166.173 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -43.06 -13.41 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.271 2.228 . . . . 0.0 116.955 -162.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.497 ' HE3' ' H ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -115.18 45.0 1.71 Allowed 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 171.218 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -124.95 68.74 0.5 Allowed Glycine 0 C--O 1.228 -0.276 0 O-C-N 120.724 -1.235 . . . . 0.0 113.285 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.4 mt -135.23 50.97 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 168.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 37.2 m-85 -74.37 91.12 2.19 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.224 -0.922 . . . . 0.0 108.569 -175.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -64.72 120.06 11.74 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 167.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.1 pt -118.44 158.36 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 125.968 1.707 . . . . 0.0 107.8 164.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -104.36 -1.5 26.8 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.522 0.729 . . . . 0.0 112.37 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -118.89 162.28 18.76 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.742 1.217 . . . . 0.0 111.22 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -74.82 153.13 38.86 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.461 0.704 . . . . 0.0 110.72 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.402 ' CE1' HD11 ' A' ' 39' ' ' ILE . 65.1 t80 -79.87 -57.99 3.38 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.295 -0.878 . . . . 0.0 112.395 170.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.02 -20.18 66.37 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -163.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -84.87 -17.43 37.99 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.194 0.906 . . . . 0.0 111.722 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 10.7 mmt -95.91 -18.26 20.45 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.894 1.277 . . . . 0.0 111.351 -172.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.403 ' H ' HG12 ' A' ' 102' ' ' ILE . 9.4 pt . . . . . 0 C--O 1.247 0.974 0 C-N-CA 124.534 1.134 . . . . 0.0 110.103 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.042 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 m 64.29 166.65 0.11 Allowed Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.299 1.04 . . . . 0.0 110.156 -175.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.56 161.91 43.12 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 CA-C-N 121.275 1.491 . . . . 0.0 111.799 -170.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.6 mt -109.45 117.54 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 170.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.475 HD21 ' HB2' ' A' ' 40' ' ' ALA . 0.3 OUTLIER -126.27 160.7 56.25 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 127.402 2.281 . . . . 0.0 108.396 -176.186 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.49 -178.33 1.83 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.038 2.492 . . . . 0.0 111.504 174.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.409 ' HE3' ' HG2' ' A' ' 9' ' ' GLU . 7.2 mtmt -58.42 175.88 0.21 Allowed 'General case' 0 C--N 1.349 0.546 0 O-C-N 121.223 -0.923 . . . . 0.0 109.896 167.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.51 -59.19 2.84 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 157.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.409 ' HG2' ' HE3' ' A' ' 7' ' ' LYS . 11.0 pt-20 -70.75 -13.6 62.12 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -159.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -88.13 -1.4 57.98 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.173 1.389 . . . . 0.0 111.926 176.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 90.7 t -86.91 116.08 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 175.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -70.75 -44.03 67.6 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.991 0.807 . . . . 0.0 109.825 173.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.8 p -153.95 154.07 33.14 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 118.43 0.559 . . . . 0.0 111.671 162.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.1 mt -95.23 140.43 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 157.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.6 t -126.35 113.89 17.5 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 53.5 mt -109.5 115.46 49.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -90.04 123.16 33.68 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 167.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -77.13 174.72 10.37 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.358 1.063 . . . . 0.0 109.912 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 p -61.01 -52.48 64.82 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.334 -0.854 . . . . 0.0 109.263 171.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -66.4 153.85 41.66 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 127.101 2.16 . . . . 0.0 107.761 169.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 94.1 p -86.51 45.98 1.3 Allowed 'General case' 0 C--O 1.237 0.408 0 O-C-N 121.71 -0.619 . . . . 0.0 111.62 -152.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.2 mt -122.17 133.79 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 -171.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -126.99 111.84 14.55 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -174.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.406 ' HE2' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -103.06 138.67 39.61 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -178.332 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.7 mp -115.97 135.85 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 -175.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.436 ' CD2' HD11 ' A' ' 35' ' ' ILE . 69.5 m-85 -122.99 90.77 3.35 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 103.438 -2.801 . . . . 0.0 103.438 -168.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -116.62 -16.67 10.71 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.697 1.599 . . . . 0.0 110.369 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.53 136.37 56.31 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.34 1.856 . . . . 0.0 106.475 170.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.8 t -55.88 -44.05 77.79 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 120.014 1.279 . . . . 0.0 111.821 -171.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -68.99 -32.02 71.29 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.95 0.9 . . . . 0.0 110.995 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 p -61.5 -45.98 91.93 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.533 HG22 HD11 ' A' ' 36' ' ' LEU . 70.3 mt -65.0 -53.61 39.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.563 1.545 . . . . 0.0 109.042 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.419 ' HA ' HD12 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -48.84 -51.68 28.26 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.044 0.838 . . . . 0.0 113.045 -168.158 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.2 -42.38 86.04 Favored 'General case' 0 C--O 1.227 -0.1 0 C-N-CA 123.771 0.828 . . . . 0.0 111.568 -175.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.436 HD11 ' CD2' ' A' ' 26' ' ' TYR . 86.6 mt -62.3 -51.52 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -177.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.533 HD11 HG22 ' A' ' 32' ' ' ILE . 1.2 mt -59.19 -26.9 65.21 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.728 1.149 . . . . 0.0 110.913 177.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.38 -69.03 0.2 Allowed 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.502 1.121 . . . . 0.0 109.22 171.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -75.69 -16.78 60.12 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -171.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.8 mm -67.09 -39.86 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 O-C-N 119.929 -1.732 . . . . 0.0 109.127 171.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.475 ' HB2' HD21 ' A' ' 5' ' ' LEU . . . -89.13 3.02 53.25 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 120.73 -1.231 . . . . 0.0 113.907 -171.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.1 p -73.21 -45.87 53.74 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.153 173.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.13 145.22 48.54 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 123.989 0.804 . . . . 0.0 111.615 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -123.11 106.03 10.44 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 -166.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 92' ' ' TYR . 7.6 ppt_? -62.72 -13.01 27.56 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 174.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.1 p 65.46 -174.85 0.18 Allowed 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 127.61 2.364 . . . . 0.0 110.436 177.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -69.89 -11.99 61.29 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 119.287 -2.133 . . . . 0.0 112.946 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -63.17 166.48 6.02 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.084 1.353 . . . . 0.0 112.135 -174.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.57 122.72 38.36 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.732 1.613 . . . . 0.0 110.731 176.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.7 t -70.46 160.37 32.51 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 127.443 2.297 . . . . 0.0 107.817 163.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.7 pt -144.6 22.88 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 126.912 2.085 . . . . 0.0 110.45 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -114.32 164.36 14.02 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 120.805 -1.184 . . . . 0.0 108.612 175.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -111.28 -20.62 12.23 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.261 175.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -143.23 160.01 53.55 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-N 119.483 1.038 . . . . 0.0 109.807 -168.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.95 171.87 15.77 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.711 2.941 . . . . 0.0 113.031 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.4 p -119.56 -15.73 8.96 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.575 1.55 . . . . 0.0 112.768 -177.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.9 159.4 33.78 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.932 0.787 . . . . 0.0 110.211 171.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -84.77 -28.31 26.28 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.381 0.672 . . . . 0.0 111.143 172.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -115.05 100.77 8.42 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -134.35 168.26 19.22 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 127.94 2.496 . . . . 0.0 106.278 171.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.52 175.1 15.7 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 169.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -107.99 142.31 38.32 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.471 1.109 . . . . 0.0 108.109 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.7 mt -113.12 133.82 57.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 158.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -128.78 144.23 51.12 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 171.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.5 mt -124.57 90.69 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 174.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -66.05 109.58 2.62 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 171.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . 0.284 3.9 p30 -133.1 -152.2 0.48 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 126.97 2.108 . . . . 0.0 107.579 -174.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -46.04 50.21 0.0 OUTLIER 'General case' 0 C--O 1.24 0.575 1 C-N-CA 136.65 5.98 . . . . 0.0 114.551 -171.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.43 31.54 68.4 Favored Glycine 0 N--CA 1.437 -1.269 0 O-C-N 120.413 -1.429 . . . . 0.0 112.084 -171.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -164.04 171.28 39.57 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 117.454 0.627 . . . . 0.0 112.353 168.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 83.2 mtp -125.15 112.23 16.23 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.597 1.559 . . . . 0.0 108.283 -176.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.4 m -69.86 109.83 4.66 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 157.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.4 m -112.99 143.2 44.69 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 124.106 0.879 . . . . 0.0 109.338 171.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.3 ptp -151.95 170.97 18.55 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 127.449 2.3 . . . . 0.0 106.311 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.431 ' H ' ' HB2' ' A' ' 85' ' ' GLU . 38.9 m-85 -129.15 174.29 9.7 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.401 1.48 . . . . 0.0 108.03 -178.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -156.39 140.98 16.88 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.591 0.756 . . . . 0.0 109.706 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -153.6 162.86 40.86 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.748 1.219 . . . . 0.0 110.835 172.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -79.26 134.89 36.64 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 172.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -131.41 114.87 15.48 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 122.017 0.913 . . . . 0.0 110.038 171.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.02 -7.7 0.61 Allowed 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.953 2.501 . . . . 0.0 114.941 171.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.96 -6.09 5.1 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 117.635 -1.647 . . . . 0.0 113.449 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.28 166.31 10.62 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 120.454 2.127 . . . . 0.0 109.072 164.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -112.51 152.79 28.39 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -145.02 172.24 13.34 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 122.537 0.335 . . . . 0.0 110.179 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.3 mp -131.11 140.35 48.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 124.497 1.119 . . . . 0.0 109.21 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.431 ' HB2' ' H ' ' A' ' 74' ' ' PHE . 0.4 OUTLIER -75.88 165.15 25.41 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.833 1.653 . . . . 0.0 112.174 178.224 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -179.98 168.97 0.7 Allowed Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 127.82 2.448 . . . . 0.0 107.499 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' A' ' 89' ' ' LYS . 60.9 Cg_endo -56.61 -162.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.799 2.332 . . . . 0.0 109.419 153.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -44.06 -8.26 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.994 2.518 . . . . 0.0 117.386 -169.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.419 ' HE3' ' H ' ' A' ' 89' ' ' LYS . 0.6 OUTLIER -98.71 15.65 24.59 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 120.173 -1.58 . . . . 0.0 114.27 168.832 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -88.91 65.7 3.21 Favored Glycine 0 C--O 1.226 -0.36 0 CA-C-N 120.608 1.549 . . . . 0.0 113.786 -174.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.4 mt -140.62 41.87 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 171.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 21.8 m-85 -70.27 102.71 2.19 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 174.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -74.35 127.39 32.89 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 164.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.5 pt -114.28 159.67 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 157.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -108.47 5.27 25.11 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.336 -0.853 . . . . 0.0 112.349 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -133.92 157.02 47.06 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.041 0.936 . . . . 0.0 109.469 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -72.03 133.04 45.05 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.625 1.17 . . . . 0.0 110.118 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -74.03 -44.49 54.17 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.497 1.119 . . . . 0.0 113.459 -177.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -62.08 -29.68 70.48 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.258 1.39 . . . . 0.0 110.784 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -72.95 -15.6 61.56 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 125.877 1.671 . . . . 0.0 112.989 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 9.5 ptm -110.51 1.05 17.96 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.168 0.987 . . . . 0.0 113.091 -175.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 25.5 pt . . . . . 0 C--O 1.249 1.06 0 CA-C-N 119.018 0.826 . . . . 0.0 109.45 176.208 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.539 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p 51.84 165.74 0.04 OUTLIER Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 129.628 3.171 . . . . 0.0 116.496 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -67.05 169.89 14.13 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 124.388 3.392 . . . . 0.0 113.006 167.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.0 mm -94.22 91.89 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 167.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.1 152.24 39.35 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.222 176.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.6 160.75 46.64 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.202 1.935 . . . . 0.0 110.602 171.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -60.05 168.8 1.74 Allowed 'General case' 0 C--N 1.344 0.335 0 C-N-CA 123.677 0.791 . . . . 0.0 112.028 174.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.03 -49.02 31.17 Favored 'General case' 0 C--O 1.219 -0.523 0 O-C-N 121.157 -0.964 . . . . 0.0 109.48 168.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -66.48 -14.79 62.73 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 -172.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -102.87 -2.74 27.32 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.037 0.935 . . . . 0.0 111.352 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.0 t -82.19 135.81 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.248 1.419 . . . . 0.0 107.3 170.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.83 -67.92 0.78 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 166.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.42 121.88 5.76 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.33 0.514 . . . . 0.0 110.429 -170.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.4 mt -82.27 131.22 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.7 t -107.5 139.61 41.75 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 168.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.0 mt -131.98 122.23 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 170.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -115.07 102.4 9.9 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 -173.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -63.04 171.68 2.13 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.373 0.669 . . . . 0.0 111.328 -170.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.4 p -52.43 -52.89 51.61 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.541 1.137 . . . . 0.0 109.976 168.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.05 162.6 25.78 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 126.877 2.071 . . . . 0.0 107.192 174.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 p -90.1 59.57 4.53 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 123.252 1.501 . . . . 0.0 108.896 -163.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.7 mt -124.66 142.96 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 102.502 -3.147 . . . . 0.0 102.502 176.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -140.96 143.33 34.47 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.69 122.36 23.29 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 176.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.9 mp -94.45 138.55 20.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 171.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -118.07 82.38 1.83 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 103.31 -2.848 . . . . 0.0 103.31 176.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -83.31 -19.1 36.87 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.55 1.14 . . . . 0.0 110.109 163.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.37 133.67 35.94 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.186 1.794 . . . . 0.0 109.093 -169.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.6 -55.83 17.01 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.306 1.042 . . . . 0.0 112.513 -176.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -68.58 -20.63 64.53 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.521 -0.737 . . . . 0.0 110.985 -174.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.4 m -80.12 -41.34 25.65 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.108 1.763 . . . . 0.0 110.826 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.4 mt -67.78 -45.93 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.951 1.7 . . . . 0.0 110.043 172.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.99 -24.63 67.15 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -171.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -64.29 -68.08 0.38 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 117.923 -1.037 . . . . 0.0 108.35 166.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 72.5 mt -44.85 -44.81 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 126.057 1.743 . . . . 0.0 112.039 -170.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.0 mt -54.37 -20.0 6.55 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.7 t -76.72 -58.36 3.33 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.322 2.249 . . . . 0.0 109.396 172.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.9 mp0 -63.34 -29.32 70.65 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.758 0.708 . . . . 0.0 110.896 -177.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.1 mm -61.95 -37.75 79.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 O-C-N 120.652 -1.28 . . . . 0.0 110.173 171.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.56 -10.6 26.87 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.681 1.192 . . . . 0.0 113.705 -171.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 t -62.6 -39.84 95.02 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.382 0.673 . . . . 0.0 110.829 -171.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.51 161.54 40.84 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-O 122.787 1.215 . . . . 0.0 112.316 -171.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -125.76 114.47 18.66 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.41 ' H ' ' HG3' ' A' ' 44' ' ' ARG . 6.5 ppt_? -64.15 -9.28 15.79 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.753 1.621 . . . . 0.0 113.89 172.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 p 65.59 -172.9 0.18 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 128.407 2.683 . . . . 0.0 111.478 173.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -78.69 -2.2 38.09 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.164 1.786 . . . . 0.0 112.029 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -67.02 168.06 10.7 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 119.849 1.204 . . . . 0.0 109.816 172.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -120.25 156.4 31.28 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.42 1.088 . . . . 0.0 109.768 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.32 134.35 46.26 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -159.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.2 pt -133.88 28.32 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 118.958 0.799 . . . . 0.0 112.225 -164.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -147.99 166.32 28.08 Favored 'General case' 0 C--O 1.242 0.66 0 O-C-N 121.446 -0.783 . . . . 0.0 110.23 -175.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.03 -10.42 15.03 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.602 1.161 . . . . 0.0 111.926 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -143.97 159.53 52.87 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.233 1.013 . . . . 0.0 111.95 -170.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.34 178.45 7.0 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.291 3.328 . . . . 0.0 112.838 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.51 -16.66 12.37 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.503 1.521 . . . . 0.0 111.46 173.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.66 163.08 7.59 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 120.792 -1.192 . . . . 0.0 110.29 168.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -108.43 -15.28 14.49 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.206 1.403 . . . . 0.0 110.902 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -126.29 103.03 7.44 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.465 2.306 . . . . 0.0 106.815 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -150.06 162.39 40.49 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.954 2.102 . . . . 0.0 107.918 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -101.14 166.0 18.73 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 173.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.2 m -110.32 134.86 51.86 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 118.9 1.35 . . . . 0.0 108.482 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.9 mp -120.14 136.17 58.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -126.76 140.82 52.09 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 125.063 1.345 . . . . 0.0 108.9 172.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.433 ' HB ' HG22 ' A' ' 71' ' ' THR . 33.4 mt -123.66 87.56 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 172.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -58.84 106.73 0.44 Allowed 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.303 1.041 . . . . 0.0 108.648 165.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -139.96 133.9 30.78 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.946 1.698 . . . . 0.0 109.654 175.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.7 m120 52.62 28.12 5.84 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.894 1.678 . . . . 0.0 111.978 -176.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.07 13.43 69.85 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.074 1.321 . . . . 0.0 113.813 -176.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -107.58 170.35 15.4 Favored Glycine 0 C--N 1.334 0.418 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 163.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.27 136.4 27.98 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 118.707 1.253 . . . . 0.0 113.172 168.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.433 HG22 ' HB ' ' A' ' 64' ' ' ILE . 1.2 t -75.93 161.27 29.09 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 168.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.5 m -135.92 142.0 44.6 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.669 1.188 . . . . 0.0 108.164 169.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -153.43 171.51 18.55 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.794 1.638 . . . . 0.0 109.169 170.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -140.56 148.35 40.86 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.385 2.274 . . . . 0.0 106.3 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.517 ' CD1' HG13 ' A' ' 84' ' ' ILE . 1.5 m-85 -128.27 158.37 38.35 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.904 1.229 . . . . 0.0 109.51 177.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -159.53 175.51 13.18 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.892 0.877 . . . . 0.0 111.49 -178.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -102.98 144.08 31.72 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.56 1.544 . . . . 0.0 109.497 165.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -148.61 119.4 7.56 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.846 1.259 . . . . 0.0 108.719 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 62.67 -0.17 0.58 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.8 2.04 . . . . 0.0 115.237 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.94 8.43 17.88 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.754 1.169 . . . . 0.0 113.026 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.63 156.68 24.27 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 120.257 2.028 . . . . 0.0 108.821 164.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -96.79 152.45 18.67 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 168.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -139.84 167.58 21.79 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.751 0.82 . . . . 0.0 110.911 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.517 HG13 ' CD1' ' A' ' 75' ' ' TYR . 3.3 mp -123.77 128.13 74.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 125.367 1.467 . . . . 0.0 108.592 172.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -81.25 151.21 28.22 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.611 1.564 . . . . 0.0 109.213 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -176.2 166.26 1.66 Allowed Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.311 1.844 . . . . 0.0 107.638 -177.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -59.62 -161.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.762 1 C-N-CA 126.495 4.797 . . . . 0.0 110.417 172.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -42.82 -12.65 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.458 2.303 . . . . 0.0 115.86 -172.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.68 68.72 0.72 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 120.215 1.371 . . . . 0.0 112.121 161.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -140.83 67.4 0.49 Allowed Glycine 0 C--O 1.222 -0.622 0 CA-C-N 119.78 1.173 . . . . 0.0 115.287 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.6 mt -141.59 47.24 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.711 1.205 . . . . 0.0 107.846 173.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -72.23 103.85 3.49 Favored 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 120.668 -1.27 . . . . 0.0 108.267 -175.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -69.2 125.63 27.26 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 164.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 21.7 pt -119.69 175.29 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.913 1.285 . . . . 0.0 108.63 159.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -117.45 2.14 12.41 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.632 0.773 . . . . 0.0 112.096 -175.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -139.35 157.48 45.81 Favored 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 120.752 -1.217 . . . . 0.0 108.768 -168.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -80.9 114.35 19.72 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -52.77 -45.05 66.96 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.791 1.236 . . . . 0.0 110.887 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -75.33 -7.46 54.04 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -167.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -106.91 -16.87 14.35 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.172 0.989 . . . . 0.0 111.813 166.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 66.2 mmm -70.86 -37.65 73.09 Favored 'General case' 0 C--O 1.239 0.51 0 O-C-N 120.345 -1.472 . . . . 0.0 109.255 169.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.9 pt . . . . . 0 C--O 1.25 1.084 0 O-C-N 121.564 -0.71 . . . . 0.0 109.825 168.666 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.428 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.7 m -136.01 167.57 21.31 Favored Pre-proline 0 C--O 1.24 0.555 0 C-N-CA 126.835 2.054 . . . . 0.0 109.01 -174.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -52.48 167.09 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-O 122.603 1.001 . . . . 0.0 112.248 152.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.1 mt -111.61 109.41 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -107.03 162.53 19.38 Favored Pre-proline 0 C--O 1.243 0.714 0 C-N-CA 123.276 0.63 . . . . 0.0 110.361 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -61.85 174.69 2.19 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.192 1.928 . . . . 0.0 111.61 164.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.55 169.1 1.88 Allowed 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.427 -0.796 . . . . 0.0 109.068 165.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.9 -60.32 2.31 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 153.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.37 -14.95 63.39 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -160.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -89.45 1.2 56.18 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 120.086 1.312 . . . . 0.0 113.46 175.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.0 t -78.14 143.19 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.82 -62.95 1.49 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 168.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.3 p -152.47 171.22 18.41 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.45 1.1 . . . . 0.0 109.62 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.5 mt -124.23 142.21 41.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 170.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.1 t -122.71 142.98 50.11 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 165.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.1 mt -130.97 104.28 9.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 104.142 -2.54 . . . . 0.0 104.142 173.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -87.61 113.09 22.97 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 172.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -67.27 177.9 1.69 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.897 1.679 . . . . 0.0 111.033 -173.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.68 -50.77 67.43 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.712 -1.242 . . . . 0.0 111.031 171.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -76.85 160.99 28.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 127.844 2.458 . . . . 0.0 108.085 173.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 p -88.22 61.11 6.08 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 123.032 1.396 . . . . 0.0 109.062 -164.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.8 mt -140.09 139.79 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 102.335 -3.209 . . . . 0.0 102.335 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.16 157.58 41.39 Favored 'General case' 0 N--CA 1.414 -2.255 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.458 ' HE2' ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -130.04 130.26 44.7 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 175.516 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.6 mt -106.16 134.92 46.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.458 ' CE2' ' HE2' ' A' ' 24' ' ' LYS . 23.3 m-85 -115.96 97.42 6.08 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 -175.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -123.63 11.53 9.17 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 128.324 2.65 . . . . 0.0 110.556 -176.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -103.8 141.03 36.82 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 166.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.8 t -55.85 -47.68 76.85 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.128 0.971 . . . . 0.0 110.654 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -59.47 -46.29 89.21 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.896 0.878 . . . . 0.0 110.939 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.2 m -61.07 -36.55 79.91 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.354 1.462 . . . . 0.0 111.906 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 74.7 mt -66.99 -55.66 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 172.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -57.79 -32.79 67.87 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.198 0.908 . . . . 0.0 112.75 -175.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.53 -49.18 62.47 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.684 1.594 . . . . 0.0 109.346 175.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.2 mt -68.76 -51.89 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 117.602 -1.19 . . . . 0.0 110.785 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.92 -26.61 15.53 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.39 1.45 . . . . 0.0 112.469 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.97 -69.46 0.32 Allowed 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 125.688 1.595 . . . . 0.0 111.145 170.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -69.09 -7.07 32.54 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.602 1.092 . . . . 0.0 113.135 -173.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.6 mm -83.57 -29.64 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 O-C-N 120.197 -1.564 . . . . 0.0 111.046 168.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.8 -12.75 35.47 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 119.411 1.005 . . . . 0.0 113.184 -173.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.8 p -69.01 -41.4 77.82 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.737 1.615 . . . . 0.0 110.791 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.34 138.6 41.08 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt -116.94 111.69 19.97 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -175.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.402 ' HB3' ' CE2' ' A' ' 92' ' ' TYR . 20.0 ptt180 -61.6 -4.18 1.3 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 173.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p 58.99 -174.07 0.1 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.309 2.244 . . . . 0.0 109.693 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -89.96 5.07 48.04 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.178 -0.951 . . . . 0.0 112.339 174.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -65.96 171.29 4.6 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.33 1.052 . . . . 0.0 110.323 167.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -126.13 131.86 51.97 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.716 1.207 . . . . 0.0 110.821 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.1 m -80.57 158.13 25.84 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.483 0.713 . . . . 0.0 109.098 170.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.0 pt -141.75 32.47 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 125.813 1.645 . . . . 0.0 110.699 175.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -141.52 167.66 21.63 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.721 2.009 . . . . 0.0 107.876 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -121.53 -4.69 9.3 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.817 1.247 . . . . 0.0 111.155 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -149.53 156.48 39.18 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 125.835 1.654 . . . . 0.0 110.169 -170.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.07 176.38 9.61 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.27 3.313 . . . . 0.0 112.529 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.99 1.79 6.56 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.863 1.665 . . . . 0.0 112.245 177.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.21 149.08 43.15 Favored 'General case' 0 C--N 1.338 0.103 0 O-C-N 120.621 -1.299 . . . . 0.0 109.848 168.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.01 -31.8 44.84 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 122.564 0.346 . . . . 0.0 111.175 169.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -114.24 104.59 12.24 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.454 1.502 . . . . 0.0 107.442 -173.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -138.46 173.95 11.06 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.886 2.074 . . . . 0.0 109.623 176.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.08 165.68 12.74 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 164.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.8 m -123.37 127.55 48.63 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.415 1.086 . . . . 0.0 108.906 -166.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mp -123.72 110.82 26.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 124.909 1.284 . . . . 0.0 109.603 -166.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 58.9 m-20 -119.03 122.03 41.23 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.566 1.146 . . . . 0.0 108.763 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 74.3 mt -107.19 96.9 5.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 171.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.64 118.05 11.15 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 172.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -146.0 125.94 13.62 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.606 1.163 . . . . 0.0 110.027 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 m120 54.53 41.83 31.7 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.035 1.734 . . . . 0.0 111.83 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.82 3.87 56.67 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.213 0.911 . . . . 0.0 114.394 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -118.95 -173.53 15.67 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 169.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -147.16 166.14 27.86 Favored 'General case' 0 CA--C 1.517 -0.296 0 O-C-N 121.68 -0.894 . . . . 0.0 111.242 172.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.0 m -106.34 133.44 51.03 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 157.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 m -106.92 145.49 32.16 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.6 ptp -154.88 174.67 14.79 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.763 1.225 . . . . 0.0 108.429 160.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.564 ' H ' ' HG3' ' A' ' 85' ' ' GLU . 34.4 m-85 -135.97 164.8 27.13 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 128.196 2.598 . . . . 0.0 106.768 174.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -134.47 156.29 48.86 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.958 1.303 . . . . 0.0 108.146 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -159.4 179.95 8.49 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 118.709 0.686 . . . . 0.0 110.34 169.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -101.62 133.08 46.88 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.942 1.697 . . . . 0.0 107.642 175.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -133.59 111.28 10.52 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.08 0.943 . . . . 0.0 109.556 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.85 -1.08 2.14 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.641 1.976 . . . . 0.0 114.111 174.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.7 -14.76 6.36 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.123 1.344 . . . . 0.0 113.547 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.78 169.71 9.82 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 120.143 1.971 . . . . 0.0 108.651 164.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -109.85 155.55 21.52 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 171.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -144.12 172.65 12.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -122.13 143.36 35.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 C-N-CA 125.266 1.426 . . . . 0.0 107.486 172.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.564 ' HG3' ' H ' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -85.41 173.75 10.04 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.018 1.327 . . . . 0.0 110.029 179.204 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.464 ' HB2' ' CA ' ' A' ' 90' ' ' GLY . 0.5 OUTLIER 176.84 168.56 0.43 Allowed Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 128.756 2.822 . . . . 0.0 106.728 175.479 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' A' ' 86' ' ' CYS . 93.9 Cg_endo -54.13 -160.59 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.328 1 C-N-CA 125.306 4.004 . . . . 0.0 109.639 157.731 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -42.83 -4.99 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 129.245 3.018 . . . . 0.0 117.176 -171.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 87' ' ' PRO . 5.5 ptpt -119.5 25.44 10.06 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 129.281 3.032 . . . . 0.0 115.249 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.464 ' CA ' ' HB2' ' A' ' 86' ' ' CYS . . . -115.14 61.23 0.38 Allowed Glycine 0 C--N 1.32 -0.331 0 N-CA-C 116.776 1.47 . . . . 0.0 116.776 -167.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.0 mt -131.58 42.69 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 117.716 0.758 . . . . 0.0 110.045 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.402 ' CE2' ' HB3' ' A' ' 44' ' ' ARG . 15.7 m-85 -76.43 104.7 7.08 Favored 'General case' 0 C--O 1.222 -0.374 0 O-C-N 120.691 -1.256 . . . . 0.0 110.716 -173.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -68.81 122.88 19.51 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 165.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.5 pt -111.5 -172.61 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 126.463 1.905 . . . . 0.0 108.381 160.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -100.16 -44.61 5.91 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -147.1 176.26 10.08 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.803 1.241 . . . . 0.0 108.898 -172.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -61.8 116.6 4.96 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 118.552 0.614 . . . . 0.0 111.271 -172.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.43 ' HA ' ' HG2' ' A' ' 101' ' ' MET . 28.3 t80 -52.78 -35.5 56.73 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.617 1.967 . . . . 0.0 112.477 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -68.06 -13.29 62.08 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 119.873 -1.767 . . . . 0.0 113.189 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -95.03 -18.6 20.89 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.64 0.776 . . . . 0.0 111.888 174.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.43 ' HG2' ' HA ' ' A' ' 98' ' ' PHE . 21.6 ptp -91.76 -10.92 38.23 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.224 0.92 . . . . 0.0 112.963 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 29.8 pt . . . . . 0 C--O 1.252 1.225 0 C-N-CA 124.593 1.157 . . . . 0.0 112.136 -179.634 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.664 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.452 ' HB2' ' HD2' ' A' ' 3' ' ' PRO . 68.3 p 67.7 164.94 0.13 Allowed Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 129.534 3.133 . . . . 0.0 112.974 -175.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 2' ' ' SER . 31.3 Cg_endo -70.62 172.65 13.07 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.331 2.021 . . . . 0.0 113.095 178.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.0 mt -112.51 121.39 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 175.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.88 164.26 40.77 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 126.864 2.066 . . . . 0.0 111.544 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.12 161.43 16.17 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 123.919 3.08 . . . . 0.0 113.693 175.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -59.38 156.07 13.56 Favored 'General case' 0 C--N 1.347 0.468 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 172.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.67 -34.27 77.83 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 121.331 -0.855 . . . . 0.0 109.124 165.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -80.09 -25.4 40.02 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 118.669 -1.213 . . . . 0.0 112.33 -165.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -86.31 -0.47 55.93 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 26.9 t -69.98 138.59 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 176.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -76.39 -67.35 0.7 Allowed 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 166.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 p -157.85 149.47 21.71 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.408 0.549 . . . . 0.0 111.14 164.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.2 mt -85.53 141.02 15.08 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 169.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.5 t -126.66 130.16 49.88 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 167.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.7 mt -120.32 109.08 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.43 120.51 27.85 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 173.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -68.47 173.15 5.22 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.22 1.008 . . . . 0.0 109.998 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.51 -52.11 65.98 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 121.23 -0.919 . . . . 0.0 109.752 169.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -72.28 169.69 15.69 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 173.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.5 p -71.66 24.7 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 129.291 3.036 . . . . 0.0 115.92 -157.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.9 mt -135.14 149.72 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 129.4 3.08 . . . . 0.0 105.781 -159.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.81 164.93 21.98 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 126.573 1.949 . . . . 0.0 109.485 175.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.402 ' HE2' ' CE1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -128.98 143.79 50.98 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 162.087 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.7 mp -114.92 130.68 68.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.494 ' CD2' HD11 ' A' ' 35' ' ' ILE . 3.9 m-85 -116.14 79.39 1.3 Allowed 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 103.994 -2.595 . . . . 0.0 103.994 -174.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -85.23 -17.17 37.84 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.612 1.165 . . . . 0.0 110.235 161.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.9 125.09 24.85 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -176.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.8 t -51.97 -49.57 62.96 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.872 0.869 . . . . 0.0 111.527 -172.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -75.4 -16.13 60.39 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.114 -0.991 . . . . 0.0 112.257 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.7 m -79.63 -39.24 31.97 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.453 1.901 . . . . 0.0 110.357 171.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 93.4 mt -63.33 -53.8 41.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 169.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -60.0 -32.74 71.14 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.731 1.212 . . . . 0.0 112.25 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.8 tptt -60.79 -64.97 0.77 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 119.441 1.019 . . . . 0.0 109.642 167.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.494 HD11 ' CD2' ' A' ' 26' ' ' TYR . 82.2 mt -53.91 -46.71 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 119.177 -0.439 . . . . 0.0 110.985 -171.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.37 -22.95 55.51 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -177.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.86 -55.7 10.26 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.255 0.934 . . . . 0.0 109.614 167.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -73.75 -16.74 61.16 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -171.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.1 mm -68.37 -21.29 26.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.829 1.652 . . . . 0.0 110.195 168.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -118.88 8.68 11.77 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.114 1.366 . . . . 0.0 113.186 -168.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.2 t -80.05 -42.2 24.18 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.221 0.464 . . . . 0.0 110.921 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.15 169.35 54.67 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 127.181 2.324 . . . . 0.0 113.766 -166.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -127.01 102.59 7.05 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -171.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 92' ' ' TYR . 0.7 OUTLIER -66.76 -13.65 61.67 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.807 1.243 . . . . 0.0 113.985 168.632 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 65.38 -172.82 0.18 Allowed 'General case' 0 CA--C 1.547 0.829 0 O-C-N 125.506 1.754 . . . . 0.0 110.283 173.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -83.27 0.59 44.93 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 120.242 -1.536 . . . . 0.0 113.869 172.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.0 mmmt -60.52 165.14 3.93 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 122.207 1.004 . . . . 0.0 112.111 -177.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -99.88 128.47 45.97 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 124.586 1.155 . . . . 0.0 108.332 -175.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.02 51.04 1.22 Allowed 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 123.914 0.886 . . . . 0.0 109.674 -170.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.7 pt -68.11 5.66 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 126.718 2.007 . . . . 0.0 113.532 -172.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.406 ' HG2' ' H ' ' A' ' 51' ' ' GLN . 6.5 pt20 -70.98 165.1 24.16 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 126.056 1.742 . . . . 0.0 110.697 166.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -124.48 -9.78 7.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.154 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -145.4 161.08 43.01 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 124.626 1.17 . . . . 0.0 111.367 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.459 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 18.9 Cg_endo -68.35 170.85 13.9 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 124.433 3.422 . . . . 0.0 111.681 171.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 98.8 p -99.33 -16.27 18.51 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.381 0.672 . . . . 0.0 112.499 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.412 ' HB2' ' CD2' ' A' ' 76' ' ' TYR . . . -76.03 146.24 39.61 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 121.46 -0.775 . . . . 0.0 109.418 176.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -81.81 -16.41 50.98 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 119.339 -0.362 . . . . 0.0 111.881 172.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -131.05 102.16 5.91 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.199 1.399 . . . . 0.0 108.937 -174.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.459 ' CE2' ' HG2' ' A' ' 54' ' ' PRO . 43.5 p90 -134.0 175.22 9.67 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 126.343 1.857 . . . . 0.0 108.708 176.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.74 -167.54 11.31 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 169.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.92 141.11 49.24 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.571 1.148 . . . . 0.0 109.321 -148.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.9 mt -115.23 136.0 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 160.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -127.81 130.2 48.26 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 171.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.9 mt -117.84 92.29 2.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 170.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -70.72 124.31 23.98 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 172.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -156.5 134.58 11.21 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.342 1.457 . . . . 0.0 108.99 -177.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.1 m120 54.01 27.59 7.65 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.512 1.525 . . . . 0.0 113.321 173.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.43 13.11 63.96 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 119.571 1.078 . . . . 0.0 114.414 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -142.54 171.51 24.71 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 119.448 1.624 . . . . 0.0 110.293 176.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 31.5 mtm -131.84 126.96 35.57 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.284 1.034 . . . . 0.0 110.318 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 53.8 m -80.64 113.49 18.87 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 156.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.42 152.91 25.94 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 124.337 1.023 . . . . 0.0 108.378 163.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.5 ptp -155.19 163.92 39.54 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.059 1.744 . . . . 0.0 107.639 154.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -119.87 172.67 7.55 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.799 1.24 . . . . 0.0 109.725 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -147.16 157.69 43.69 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.31 1.844 . . . . 0.0 108.449 175.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.412 ' CD2' ' HB2' ' A' ' 56' ' ' ALA . 40.9 p90 -157.38 -164.51 1.59 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.77 1.628 . . . . 0.0 108.859 171.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -122.91 124.3 42.9 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.648 1.179 . . . . 0.0 108.214 169.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -113.52 117.43 31.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.688 0.756 . . . . 0.0 109.576 173.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 64.81 -0.75 0.93 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.018 2.127 . . . . 0.0 114.595 175.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 123.99 -17.51 7.61 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 125.586 1.565 . . . . 0.0 112.77 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -90.32 157.45 17.64 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 120.278 2.039 . . . . 0.0 109.656 169.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -101.31 143.29 31.55 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.35 1.06 . . . . 0.0 108.537 174.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -139.78 169.36 17.87 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.936 0.495 . . . . 0.0 110.208 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.1 mp -127.38 121.27 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.871 0.868 . . . . 0.0 110.782 -176.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -66.49 157.72 31.41 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.459 -1.4 . . . . 0.0 110.733 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.429 ' HB2' ' HA2' ' A' ' 90' ' ' GLY . 0.8 OUTLIER -175.31 167.9 1.75 Allowed Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 128.592 2.757 . . . . 0.0 105.416 -172.655 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' A' ' 89' ' ' LYS . 66.3 Cg_endo -57.86 -160.97 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.448 0 C-N-CA 124.479 3.453 . . . . 0.0 109.657 160.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -42.68 0.75 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 130.221 3.408 . . . . 0.0 117.397 -175.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 87' ' ' PRO . 0.8 OUTLIER -124.58 30.92 5.84 Favored 'General case' 0 N--CA 1.44 -0.947 1 C-N-CA 132.117 4.167 . . . . 0.0 113.763 176.581 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.429 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . -109.26 61.03 0.31 Allowed Glycine 0 C--O 1.23 -0.148 0 C-N-CA 124.858 1.218 . . . . 0.0 115.41 -176.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.4 mt -136.69 44.73 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.536 1.135 . . . . 0.0 108.101 171.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 25.3 m-85 -68.87 108.11 3.34 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 175.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -75.04 130.74 39.83 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 159.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.0 pt -112.25 167.15 5.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 151.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -121.98 17.19 10.9 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.128 0.971 . . . . 0.0 112.407 -172.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -153.62 168.32 26.59 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 122.855 0.462 . . . . 0.0 110.872 165.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -67.01 118.49 10.54 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.713 0.805 . . . . 0.0 110.729 -173.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.429 ' HA ' ' HG2' ' A' ' 101' ' ' MET . 59.6 t80 -56.39 -47.02 79.81 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.97 0.908 . . . . 0.0 110.444 173.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -66.95 -26.42 66.82 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.332 0.653 . . . . 0.0 112.514 -170.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.2 20.02 19.58 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 118.407 0.549 . . . . 0.0 112.066 173.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.429 ' HG2' ' HA ' ' A' ' 98' ' ' PHE . 16.6 ptt? -108.29 -37.3 6.04 Favored 'General case' 0 C--N 1.342 0.256 0 O-C-N 121.437 -0.789 . . . . 0.0 112.648 160.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.996 0 C-N-CA 124.137 0.975 . . . . 0.0 112.007 -174.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.043 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.409 ' HB2' ' HD2' ' A' ' 3' ' ' PRO . 34.8 p 55.61 165.91 0.06 OUTLIER Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 126.818 2.047 . . . . 0.0 113.666 -167.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 2' ' ' SER . 28.5 Cg_endo -61.39 175.92 1.36 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.578 1.519 . . . . 0.0 111.889 165.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.4 mt -111.67 108.28 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 40' ' ' ALA . 0.3 OUTLIER -123.26 156.44 63.4 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 126.283 1.833 . . . . 0.0 110.984 -171.863 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -74.15 162.18 39.28 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.732 2.954 . . . . 0.0 112.488 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.0 mtmt -63.04 142.57 58.33 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 119.076 0.853 . . . . 0.0 111.269 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.12 -14.81 18.83 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -94.57 -31.3 13.95 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.831 1.196 . . . . 0.0 112.752 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -88.45 -6.07 57.87 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.47 1.032 . . . . 0.0 111.525 -174.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.5 t -62.48 116.36 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 C-N-CA 128.336 2.654 . . . . 0.0 107.682 160.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -71.11 -67.68 0.49 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.715 1.606 . . . . 0.0 106.784 165.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.6 p -153.91 160.23 42.05 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.936 0.789 . . . . 0.0 110.495 -177.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.3 mt -125.84 125.77 68.86 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 -176.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.4 t -108.49 132.83 53.42 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.9 mt -133.35 97.03 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.98 115.68 18.81 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 164.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -68.29 -178.46 1.08 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.542 1.537 . . . . 0.0 109.994 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.9 p -59.19 -45.89 89.88 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.972 -1.08 . . . . 0.0 112.189 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -74.3 -174.0 1.86 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.546 1.139 . . . . 0.0 110.22 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 98.4 p -67.32 5.03 0.81 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.282 1.833 . . . . 0.0 114.76 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.1 mm -113.15 153.89 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 128.144 2.578 . . . . 0.0 108.606 -159.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -143.16 162.76 34.72 Favored 'General case' 0 N--CA 1.418 -2.073 0 C-N-CA 125.968 1.707 . . . . 0.0 110.587 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.11 142.16 44.24 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 125.129 1.371 . . . . 0.0 107.358 164.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.3 mp -109.66 138.17 38.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 170.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.414 ' HB3' ' HB3' ' A' ' 31' ' ' SER . 27.7 m-85 -111.96 108.94 18.45 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 103.166 -2.901 . . . . 0.0 103.166 -178.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -135.9 41.3 2.69 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 126.472 1.909 . . . . 0.0 106.183 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.94 123.44 17.16 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 103.614 -2.736 . . . . 0.0 103.614 -170.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.6 t -53.76 -39.6 65.49 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.684 0.794 . . . . 0.0 112.009 -171.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -77.67 -33.76 53.23 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.084 -1.01 . . . . 0.0 111.297 -177.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.414 ' HB3' ' HB3' ' A' ' 26' ' ' TYR . 26.2 m -57.94 -41.32 82.53 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.139 1.376 . . . . 0.0 110.491 168.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.4 mt -67.15 -54.58 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 124.716 1.206 . . . . 0.0 109.072 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -51.29 -41.76 60.69 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.131 0.572 . . . . 0.0 111.335 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -57.84 11.08 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 57.4 mt -54.68 -49.8 64.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 C-N-CA 123.392 0.677 . . . . 0.0 112.111 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.11 -17.91 30.77 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.804 0.842 . . . . 0.0 112.169 -171.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.65 -61.18 2.1 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.497 1.119 . . . . 0.0 110.913 166.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -67.24 -30.53 70.47 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.01 1.277 . . . . 0.0 111.545 -174.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.8 mm -54.87 -24.74 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.396 0.678 . . . . 0.0 110.05 172.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.405 ' HB2' HD21 ' A' ' 5' ' ' LEU . . . -116.19 3.64 13.49 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.139 1.776 . . . . 0.0 113.908 -174.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 t -79.4 -29.69 42.13 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.654 1.115 . . . . 0.0 111.276 -172.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.33 166.14 41.77 Favored Glycine 0 C--N 1.336 0.574 0 O-C-N 120.755 -1.215 . . . . 0.0 112.539 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -126.62 121.47 32.28 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.417 ' HD2' ' HB3' ' A' ' 89' ' ' LYS . 16.8 ptt180 -63.34 -3.42 1.96 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.579 1.152 . . . . 0.0 114.063 172.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p 58.04 -174.16 0.08 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 127.457 2.303 . . . . 0.0 110.761 -177.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -86.58 3.52 44.03 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.059 1.343 . . . . 0.0 111.59 176.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -69.22 164.94 21.56 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.87 1.214 . . . . 0.0 109.488 169.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -114.57 157.52 22.91 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.116 1.366 . . . . 0.0 108.182 174.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.53 150.04 50.35 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 -163.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.8 pt -145.83 17.6 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 122.457 0.303 . . . . 0.0 111.482 -163.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -131.61 167.4 19.5 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.389 1.076 . . . . 0.0 109.24 -171.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.22 -5.57 9.43 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.842 1.257 . . . . 0.0 112.334 -177.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -144.5 164.14 30.12 Favored Pre-proline 0 C--O 1.235 0.319 0 C-N-CA 126.011 1.724 . . . . 0.0 108.624 -174.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -70.69 -179.89 3.68 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.373 2.049 . . . . 0.0 110.803 174.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.0 p -110.34 -8.44 14.71 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.835 1.254 . . . . 0.0 111.911 175.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.86 159.45 20.37 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 124.266 1.026 . . . . 0.0 111.343 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -94.87 -13.6 25.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.255 1.022 . . . . 0.0 112.1 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -128.34 110.8 12.69 Favored 'General case' 0 C--O 1.231 0.083 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 175.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -147.32 160.75 42.15 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.59 1.556 . . . . 0.0 108.942 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.93 170.64 20.08 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.842 1.21 . . . . 0.0 110.315 171.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.3 m -131.98 121.1 23.39 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.031 1.732 . . . . 0.0 108.572 -163.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.2 mp -124.75 127.29 72.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 124.052 0.941 . . . . 0.0 109.266 -166.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -120.05 145.83 46.48 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 124.927 1.291 . . . . 0.0 109.244 171.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 30.5 mt -125.24 88.34 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -71.82 108.4 5.09 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.963 1.305 . . . . 0.0 108.041 177.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -137.34 134.24 35.8 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.515 1.126 . . . . 0.0 109.264 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.4 m120 62.84 -3.32 0.32 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.283 1.833 . . . . 0.0 115.861 173.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.77 10.82 8.94 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 120.163 1.347 . . . . 0.0 113.692 -174.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -149.22 -178.6 24.38 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.59 145.32 24.3 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 118.653 1.227 . . . . 0.0 113.065 -173.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 t -73.72 166.09 23.93 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 162.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.8 m -142.47 142.66 32.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 163.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 17.2 ptp -156.0 169.62 24.04 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.795 2.038 . . . . 0.0 108.391 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.41 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 54.8 m-85 -139.16 148.87 43.76 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.477 1.911 . . . . 0.0 108.077 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -127.94 151.77 48.7 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.921 1.237 . . . . 0.0 110.155 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -156.99 177.77 11.13 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.033 1.333 . . . . 0.0 110.001 -171.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -107.83 147.78 30.43 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.165 1.386 . . . . 0.0 107.843 167.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.5 tp10 -142.28 117.4 10.06 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.685 0.794 . . . . 0.0 109.383 171.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 61.77 -11.95 0.06 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 127.999 2.519 . . . . 0.0 115.612 -176.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.7 2.35 3.96 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 117.76 -1.578 . . . . 0.0 115.555 -177.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -110.17 160.39 16.53 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 121.018 2.409 . . . . 0.0 109.274 159.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -97.48 145.74 25.91 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -140.36 162.43 35.33 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.883 0.873 . . . . 0.0 110.622 -174.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mp -133.08 132.29 58.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.802 1.241 . . . . 0.0 109.508 -169.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.41 ' HB3' ' H ' ' A' ' 74' ' ' PHE . 5.3 tm-20 -77.36 154.41 32.8 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.846 2.058 . . . . 0.0 110.624 177.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -173.22 167.97 2.61 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 129.276 3.03 . . . . 0.0 106.415 174.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.408 ' O ' ' N ' ' A' ' 89' ' ' LYS . 90.9 Cg_endo -54.12 -162.02 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 125.215 3.943 . . . . 0.0 110.239 162.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -43.35 -5.69 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 128.284 2.634 . . . . 0.0 116.529 -175.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.417 ' HB3' ' HD2' ' A' ' 44' ' ' ARG . 9.2 mmtt -120.97 52.09 1.21 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.686 1.994 . . . . 0.0 111.776 171.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -129.14 59.39 0.69 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 116.719 1.448 . . . . 0.0 116.719 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.7 mt -130.19 55.18 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 118.649 1.224 . . . . 0.0 108.131 171.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -76.32 119.14 19.79 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 177.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -87.91 113.53 23.65 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 163.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 27.9 pt -98.91 171.15 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 158.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -122.78 -13.82 7.82 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.925 -0.484 . . . . 0.0 112.032 -173.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -123.53 150.22 44.27 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 173.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -70.12 128.44 36.29 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 123.926 0.89 . . . . 0.0 109.974 -172.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -60.89 -46.13 91.84 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.665 1.186 . . . . 0.0 111.402 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -64.91 -29.48 70.43 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.945 0.898 . . . . 0.0 111.504 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -78.97 -18.94 52.86 Favored 'General case' 0 C--O 1.24 0.594 0 O-C-N 121.683 -0.636 . . . . 0.0 112.471 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 19.9 mmt -85.29 -27.29 26.07 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.233 1.013 . . . . 0.0 111.468 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 28.2 pt . . . . . 0 C--O 1.251 1.181 0 CA-C-N 119.681 1.128 . . . . 0.0 111.601 -174.289 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.592 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 p -57.98 164.22 3.55 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 125.658 1.583 . . . . 0.0 111.704 171.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -65.95 -178.4 1.03 Allowed 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 124.528 3.485 . . . . 0.0 113.875 168.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.0 mt -106.94 122.5 61.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 164.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.28 166.12 11.62 Favored Pre-proline 0 C--O 1.238 0.495 0 C-N-CA 125.669 1.588 . . . . 0.0 109.641 168.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -62.88 -176.84 0.28 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 121.702 1.601 . . . . 0.0 111.124 167.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.405 ' HE3' ' HG2' ' A' ' 9' ' ' GLU . 4.7 mmmt -55.8 169.44 0.35 Allowed 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.092 -1.005 . . . . 0.0 108.88 159.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.417 ' HB2' HD13 ' A' ' 36' ' ' LEU . . . -81.71 -49.96 9.85 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 161.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.405 ' HG2' ' HE3' ' A' ' 7' ' ' LYS . 11.5 pt-20 -66.8 -22.89 66.01 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -167.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -79.27 -3.21 44.91 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.316 0.962 . . . . 0.0 113.356 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.0 t -85.5 122.6 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -70.48 -54.62 11.51 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.122 1.769 . . . . 0.0 108.121 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.7 p -157.22 155.93 31.7 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.183 0.516 . . . . 0.0 110.59 174.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.1 mt -109.66 139.21 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 170.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -129.71 106.13 8.5 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.6 mt -101.83 108.61 24.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -93.5 115.29 27.8 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.019 2.128 . . . . 0.0 107.32 174.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -79.8 172.1 14.23 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.809 0.844 . . . . 0.0 111.21 -172.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.95 -53.22 60.43 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.573 1.149 . . . . 0.0 110.182 170.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -71.23 149.15 46.54 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.998 1.719 . . . . 0.0 106.506 166.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.2 p -88.44 53.44 2.73 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.824 0.821 . . . . 0.0 110.627 -151.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.2 mt -126.32 134.27 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 -170.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -129.79 110.38 11.69 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -170.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.451 ' HE2' ' CE1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -101.81 130.54 48.27 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -176.193 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.1 mt -100.51 134.96 38.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.575 ' CD2' HD11 ' A' ' 35' ' ' ILE . 9.6 m-85 -117.16 84.59 2.18 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 103.146 -2.909 . . . . 0.0 103.146 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -94.46 -6.91 42.88 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 127.459 2.304 . . . . 0.0 110.349 170.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.59 132.27 35.3 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 t -58.03 -42.34 85.1 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.541 -0.724 . . . . 0.0 111.45 -171.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -73.53 -36.43 65.68 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.264 -0.897 . . . . 0.0 111.506 -174.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.6 m -53.53 -51.75 61.86 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 126.612 1.965 . . . . 0.0 110.756 167.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.8 mt -58.18 -50.08 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 123.526 0.73 . . . . 0.0 109.206 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -55.64 -45.57 77.6 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 118.552 -0.737 . . . . 0.0 112.051 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.46 -51.81 68.3 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-N 118.303 0.501 . . . . 0.0 109.813 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.575 HD11 ' CD2' ' A' ' 26' ' ' TYR . 94.2 mt -55.95 -45.12 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.955 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.417 HD13 ' HB2' ' A' ' 8' ' ' ALA . 3.7 mt -57.0 -25.65 58.89 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.989 1.268 . . . . 0.0 113.013 176.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.2 m -73.57 -52.78 12.31 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 120.244 1.384 . . . . 0.0 109.883 169.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -65.05 -24.11 67.38 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.809 1.186 . . . . 0.0 112.732 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.9 mm -83.39 -7.55 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.183 1.793 . . . . 0.0 110.754 175.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.13 1.62 9.19 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.242 1.417 . . . . 0.0 114.33 -175.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.5 p -66.36 -31.25 71.91 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.588 1.086 . . . . 0.0 111.517 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.9 163.14 43.47 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-O 122.606 1.114 . . . . 0.0 113.924 -164.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.416 ' O ' HG23 ' A' ' 45' ' ' THR . 23.5 pttt -112.24 97.65 6.78 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 127.183 2.193 . . . . 0.0 109.629 176.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.4 ' HB3' ' CE2' ' A' ' 92' ' ' TYR . 4.6 ppt_? -60.08 -11.88 7.02 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 124.746 1.218 . . . . 0.0 113.216 167.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 43' ' ' LYS . 27.1 p 64.98 -175.23 0.17 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 126.738 2.015 . . . . 0.0 111.663 175.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -95.9 14.15 24.44 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.295 0.638 . . . . 0.0 112.531 165.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -64.63 147.99 51.83 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 120.558 -1.339 . . . . 0.0 110.67 156.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -83.55 121.7 27.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 168.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.1 t -73.0 147.94 44.67 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.743 -1.576 . . . . 0.0 106.743 152.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.9 pt -140.16 13.4 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 126.4 1.88 . . . . 0.0 110.024 170.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -86.39 164.17 17.19 Favored 'General case' 0 C--O 1.238 0.5 0 O-C-N 120.954 -1.091 . . . . 0.0 110.013 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.43 -15.05 10.95 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 118.088 -0.958 . . . . 0.0 112.235 175.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -153.95 165.5 17.76 Favored Pre-proline 0 N--CA 1.469 0.481 0 C-N-CA 125.331 1.452 . . . . 0.0 110.537 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -72.11 147.17 47.96 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.62 2.214 . . . . 0.0 111.591 168.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.11 -31.15 61.08 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.899 0.48 . . . . 0.0 112.103 171.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.26 155.2 25.41 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 121.799 0.809 . . . . 0.0 111.085 -173.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -84.76 -35.26 22.55 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.651 171.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -110.22 94.99 5.3 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -172.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -139.06 171.81 13.76 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 128.613 2.765 . . . . 0.0 107.063 172.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.71 -177.13 14.73 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 166.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.7 m -123.96 122.91 39.19 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.519 1.128 . . . . 0.0 109.449 -165.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mp -97.52 133.82 37.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 170.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -130.57 137.75 49.83 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.853 1.261 . . . . 0.0 107.899 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.4 mt -128.12 92.35 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 105.45 -2.055 . . . . 0.0 105.45 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -70.24 109.46 4.68 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 170.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -139.52 138.58 36.44 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.341 1.056 . . . . 0.0 108.552 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.2 m120 48.8 36.18 7.64 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.246 1.018 . . . . 0.0 111.721 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.45 18.49 79.91 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 118.939 -0.923 . . . . 0.0 115.119 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.05 156.23 24.28 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 120.355 2.077 . . . . 0.0 110.328 173.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 81.4 mtp -112.33 96.76 6.2 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 123.845 0.858 . . . . 0.0 109.825 -173.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 m -62.88 105.79 0.72 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 165.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.8 m -103.65 156.16 18.0 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -176.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.8 ptp -153.88 171.05 19.58 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.828 1.651 . . . . 0.0 107.185 167.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -126.28 -177.98 4.16 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.233 1.413 . . . . 0.0 107.491 173.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -150.51 156.27 41.09 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -158.76 169.5 24.23 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 162.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -89.87 121.56 32.1 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 169.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -109.67 119.16 38.54 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 169.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.27 4.02 2.0 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.777 1.631 . . . . 0.0 114.463 164.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.01 -13.82 6.0 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.73 1.634 . . . . 0.0 113.4 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.8 tptt -115.16 163.2 15.98 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 120.034 1.917 . . . . 0.0 109.987 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -107.47 142.96 36.52 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -138.43 160.89 38.38 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.261 0.624 . . . . 0.0 109.988 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.78 133.83 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.936 0.894 . . . . 0.0 111.825 -173.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -71.98 161.33 31.08 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.121 -0.987 . . . . 0.0 112.379 -176.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -175.23 169.17 1.58 Allowed Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 126.896 2.078 . . . . 0.0 108.051 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -58.18 -162.54 0.02 OUTLIER 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.081 1.854 . . . . 0.0 110.54 155.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -43.28 -14.31 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.465 2.706 . . . . 0.0 116.705 -171.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -105.03 49.8 0.8 Allowed 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.272 -0.893 . . . . 0.0 111.888 168.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -125.16 69.18 0.5 Allowed Glycine 0 C--O 1.222 -0.608 0 CA-C-N 119.876 1.216 . . . . 0.0 112.247 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.6 mt -133.63 49.27 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 163.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.4 ' CE2' ' HB3' ' A' ' 44' ' ' ARG . 51.0 m-85 -74.87 110.95 9.59 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -78.08 125.17 28.96 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 160.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.7 pt -106.93 164.48 4.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 152.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -123.65 48.21 1.9 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.351 0.661 . . . . 0.0 110.021 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -164.36 174.29 11.23 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.111 0.965 . . . . 0.0 111.757 159.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -70.2 122.94 20.45 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.091 0.956 . . . . 0.0 108.888 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -63.12 -47.88 80.87 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.511 0.596 . . . . 0.0 110.572 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -58.99 -35.03 72.54 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.451 -0.781 . . . . 0.0 112.871 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -72.69 -23.7 60.91 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.245 0.93 . . . . 0.0 110.827 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.2 mmt -70.59 -36.11 73.37 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 121.593 -0.692 . . . . 0.0 110.413 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.0 pt . . . . . 0 C--O 1.249 1.044 0 CA-C-N 119.172 0.896 . . . . 0.0 112.48 -167.677 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.992 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 m -54.27 165.11 0.89 Allowed Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 124.654 1.182 . . . . 0.0 111.051 168.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -67.29 165.04 28.19 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 CA-C-N 120.075 1.063 . . . . 0.0 111.352 167.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.6 mt -101.99 111.68 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 158.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.48 152.88 46.55 Favored Pre-proline 0 C--O 1.241 0.608 0 C-N-CA 125.878 1.671 . . . . 0.0 108.701 177.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -73.7 159.88 44.86 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.807 2.338 . . . . 0.0 111.436 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.425 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -70.32 149.71 47.09 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 123.455 0.702 . . . . 0.0 112.048 -173.714 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.478 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . . . -64.1 -12.86 43.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 118.592 -0.718 . . . . 0.0 111.945 170.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -95.13 -6.26 42.26 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.509 1.05 . . . . 0.0 112.123 -178.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -129.39 -2.54 4.95 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.58 1.152 . . . . 0.0 112.242 -173.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 37.5 t -78.88 111.22 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 170.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -74.8 -43.01 57.0 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.135 1.374 . . . . 0.0 108.605 176.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.8 p -160.24 171.89 18.37 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.593 1.088 . . . . 0.0 112.613 168.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.6 mt -130.02 137.69 55.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 127.335 2.254 . . . . 0.0 105.832 172.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.8 t -116.44 151.2 36.52 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 159.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.0 mt -131.41 101.64 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 168.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.3 117.39 20.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 169.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -75.33 177.02 6.88 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.262 1.029 . . . . 0.0 110.6 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.9 p -60.81 -15.29 28.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.078 2.151 . . . . 0.0 113.363 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 48.2 p30 -118.22 -166.76 1.25 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.515 1.926 . . . . 0.0 110.086 -170.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.2 p -82.44 24.95 0.65 Allowed 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.273 -1.517 . . . . 0.0 111.809 -173.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.5 mt -124.89 149.39 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.463 -1.681 . . . . 0.0 106.463 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -135.3 164.9 26.68 Favored 'General case' 0 N--CA 1.417 -2.084 0 C-N-CA 127.476 2.31 . . . . 0.0 107.906 170.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.25 134.92 30.1 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.8 mp -106.52 148.88 10.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -129.81 34.72 4.25 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.147 0.979 . . . . 0.0 109.664 -170.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -57.47 -20.65 32.17 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.384 2.274 . . . . 0.0 113.019 -175.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.97 123.85 21.74 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 129.542 3.137 . . . . 0.0 109.117 175.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.3 t -46.22 -48.08 17.79 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.133 1.373 . . . . 0.0 113.746 -175.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -69.54 -27.57 65.26 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.004 -1.06 . . . . 0.0 111.566 -175.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.6 m -72.58 -34.86 67.74 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.297 1.839 . . . . 0.0 111.019 172.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.0 mt -65.23 -52.86 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -65.37 -14.05 59.97 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -66.82 -78.66 0.06 Allowed 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 157.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.3 mt -50.58 -39.76 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 125.018 1.327 . . . . 0.0 112.578 -160.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.478 ' CD1' ' HB2' ' A' ' 8' ' ' ALA . 41.5 mt -51.64 -23.0 3.81 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.1 t -64.46 -63.83 1.03 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.168 1.387 . . . . 0.0 108.494 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 56.7 mp0 -64.5 -27.39 68.94 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.4 1.48 . . . . 0.0 111.158 -175.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.5 mm -62.26 -35.5 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 O-C-N 121.297 -0.877 . . . . 0.0 110.245 173.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.63 0.12 30.31 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 120.726 -1.234 . . . . 0.0 113.587 -169.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.7 t -64.81 -44.91 88.39 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.006 0.523 . . . . 0.0 110.919 -176.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.451 ' CA ' HG22 ' A' ' 94' ' ' ILE . . . -73.61 168.24 54.06 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-O 122.493 1.051 . . . . 0.0 112.432 -175.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -132.76 130.74 40.34 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 176.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -68.15 0.3 3.83 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.7 p 60.03 -172.54 0.12 Allowed 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 126.751 2.02 . . . . 0.0 108.847 -174.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -91.31 2.75 56.16 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.095 -1.003 . . . . 0.0 112.034 176.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt -69.03 170.07 10.58 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.084 0.856 . . . . 0.0 110.894 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.11 150.29 34.3 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.07 1.748 . . . . 0.0 109.019 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.87 149.87 43.64 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 -169.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 35.4 pt -138.31 17.78 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 118.957 0.799 . . . . 0.0 112.523 -165.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -139.97 -173.24 3.59 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.181 0.992 . . . . 0.0 108.761 -169.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.38 -6.38 1.56 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.481 1.112 . . . . 0.0 110.651 171.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -140.63 150.23 59.62 Favored Pre-proline 0 N--CA 1.469 0.485 0 CA-C-N 120.21 1.368 . . . . 0.0 111.29 -168.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.26 167.27 27.34 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.666 2.911 . . . . 0.0 114.928 -164.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 t -100.11 23.01 10.51 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.386 2.274 . . . . 0.0 110.72 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -126.6 150.41 48.9 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 125.268 1.427 . . . . 0.0 110.626 -174.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -90.03 -24.79 21.1 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.484 1.114 . . . . 0.0 110.871 172.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -125.34 102.44 7.43 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -145.01 166.99 23.72 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 128.383 2.673 . . . . 0.0 106.163 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.48 166.93 13.74 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 168.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.5 m -112.46 140.05 47.52 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.572 1.149 . . . . 0.0 108.553 -170.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.5 mp -125.81 128.83 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 -174.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -115.1 135.68 53.94 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.2 mt -126.03 87.65 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 171.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -70.22 116.03 10.11 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 125.418 1.487 . . . . 0.0 107.23 174.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -140.91 113.28 8.01 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.036 0.934 . . . . 0.0 109.97 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.5 m120 74.52 -14.99 0.66 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 130.446 3.499 . . . . 0.0 115.639 171.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 123.21 23.68 2.14 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 118.843 0.747 . . . . 0.0 111.352 -165.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -145.1 171.7 26.14 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 106.609 -2.596 . . . . 0.0 106.609 160.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.08 139.24 34.01 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 118.772 1.286 . . . . 0.0 111.031 172.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 91.3 m -76.55 128.48 34.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 161.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.6 m -102.59 146.68 27.81 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 164.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.6 ptm -159.5 165.51 32.85 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.485 1.514 . . . . 0.0 108.47 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -144.64 140.66 28.83 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.826 1.65 . . . . 0.0 106.841 -174.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.427 ' CE1' HG23 ' A' ' 84' ' ' ILE . 1.8 m-85 -129.21 152.24 49.0 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 120.015 1.279 . . . . 0.0 109.35 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -153.81 -175.56 5.43 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.12 0.968 . . . . 0.0 111.264 -178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -115.55 142.79 46.25 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.609 1.964 . . . . 0.0 108.586 173.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -141.71 127.68 19.47 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 125.393 1.477 . . . . 0.0 108.431 175.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.0 m120 57.76 14.7 2.59 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.957 1.303 . . . . 0.0 112.936 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.21 18.98 58.22 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 117.921 -1.488 . . . . 0.0 113.32 -175.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.26 148.43 45.91 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 128.612 2.765 . . . . 0.0 107.493 177.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -104.65 143.01 33.66 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.541 1.519 . . . . 0.0 111.305 -169.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -138.12 150.07 46.5 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.24 0.616 . . . . 0.0 111.22 -171.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.427 HG23 ' CE1' ' A' ' 75' ' ' TYR . 3.4 mp -123.16 120.02 59.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 125.133 1.373 . . . . 0.0 108.931 -177.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -73.69 153.19 40.19 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.419 1.088 . . . . 0.0 110.475 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -172.53 168.07 2.96 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 128.428 2.691 . . . . 0.0 106.072 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -57.92 -161.26 0.02 OUTLIER 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 125.268 3.979 . . . . 0.0 110.386 165.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -42.72 -8.82 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 127.572 2.349 . . . . 0.0 117.055 -175.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -121.13 46.74 1.97 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.016 1.326 . . . . 0.0 112.194 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -126.57 70.11 0.5 Allowed Glycine 0 C--O 1.224 -0.508 0 C-N-CA 125.762 1.648 . . . . 0.0 113.715 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.5 mt -131.09 53.07 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 164.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -75.42 125.95 30.03 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -119.31 102.47 8.71 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 -171.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.451 HG22 ' CA ' ' A' ' 42' ' ' GLY . 4.7 pt -115.75 146.71 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.655 1.582 . . . . 0.0 109.073 -175.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -91.82 -5.71 52.96 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -171.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -130.51 153.65 48.62 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.114 0.87 . . . . 0.0 112.638 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -57.86 135.72 56.9 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 126.383 1.873 . . . . 0.0 110.655 174.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -82.02 -49.86 9.76 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.029 1.332 . . . . 0.0 110.884 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -67.99 -13.81 62.47 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -165.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -97.7 -10.25 25.28 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.414 1.006 . . . . 0.0 112.576 173.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 38.7 mmm -76.81 -37.42 55.77 Favored 'General case' 0 C--O 1.233 0.222 0 O-C-N 120.626 -1.297 . . . . 0.0 111.167 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 12.8 pt . . . . . 0 C--O 1.243 0.73 0 C-N-CA 126.558 1.943 . . . . 0.0 114.229 -153.693 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.718 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.84 161.69 27.32 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 124.89 1.276 . . . . 0.0 111.76 -173.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.44 163.3 39.31 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.707 1.604 . . . . 0.0 112.157 169.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.0 mt -96.56 105.67 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 162.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.817 HD13 HG22 ' A' ' 39' ' ' ILE . 16.4 mt -126.19 165.64 26.43 Favored Pre-proline 0 C--O 1.24 0.585 0 C-N-CA 125.396 1.478 . . . . 0.0 108.462 174.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -62.07 163.56 19.35 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.014 1.81 . . . . 0.0 111.248 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.4 ' HE2' ' CG ' ' A' ' 9' ' ' GLU . 2.7 mppt? -61.88 179.69 0.25 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.265 0.626 . . . . 0.0 111.405 170.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.77 -45.9 33.78 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 155.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.4 ' CG ' ' HE2' ' A' ' 7' ' ' LYS . 11.2 pt-20 -71.34 3.94 3.31 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.305 1.442 . . . . 0.0 114.037 -163.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 -124.96 4.13 8.02 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.298 2.239 . . . . 0.0 112.516 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 37.8 t -84.25 141.77 14.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -92.4 -52.75 4.51 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 173.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.51 161.34 42.32 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.907 0.883 . . . . 0.0 111.923 170.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.6 mt -123.89 140.81 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 164.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 54.4 m -134.42 115.74 14.36 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 -168.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.7 mt -119.55 120.11 62.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -112.06 102.42 10.63 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -72.27 168.17 18.87 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.623 1.569 . . . . 0.0 110.031 -165.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.0 p -45.87 -39.62 8.86 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.767 1.627 . . . . 0.0 112.97 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -51.09 -153.62 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 131.41 3.884 . . . . 0.0 112.07 164.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 93.3 p -122.07 25.15 9.21 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 119.863 -1.773 . . . . 0.0 110.596 160.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.3 mt -84.65 134.47 26.93 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 172.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -125.69 129.34 49.35 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.55 125.98 54.79 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 175.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.3 mp -99.8 135.64 34.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 173.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -118.26 87.12 2.66 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -118.19 52.16 1.03 Allowed 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.812 1.645 . . . . 0.0 107.148 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.45 146.49 40.14 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.614 1.566 . . . . 0.0 107.377 168.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.2 t -46.69 -53.99 10.55 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.949 1.699 . . . . 0.0 112.266 177.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -76.42 -27.5 56.29 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 121.65 -0.656 . . . . 0.0 112.027 -171.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 51.5 m -65.78 -48.76 70.71 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.428 1.491 . . . . 0.0 109.187 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 76.9 mt -57.9 -53.19 48.51 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 C-N-CA 125.599 1.56 . . . . 0.0 108.849 171.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -61.1 -28.45 69.1 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 120.541 1.519 . . . . 0.0 113.309 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.18 -60.14 3.08 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.1 mt -47.59 -49.69 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.642 1.577 . . . . 0.0 110.984 175.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.45 -28.07 12.1 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -176.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.5 t -63.93 -62.13 1.83 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.952 0.796 . . . . 0.0 109.16 172.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -63.62 -32.18 73.57 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.411 -0.805 . . . . 0.0 111.894 -174.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.817 HG22 HD13 ' A' ' 5' ' ' LEU . 26.0 mm -62.24 -25.85 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.801 1.24 . . . . 0.0 111.036 174.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.65 -5.73 12.17 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -175.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 t -62.15 -26.91 68.59 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.871 1.214 . . . . 0.0 112.038 -169.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.68 169.67 43.15 Favored Glycine 0 C--N 1.335 0.494 0 O-C-N 120.987 -1.07 . . . . 0.0 114.238 -167.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -112.1 106.72 15.42 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 125.907 1.683 . . . . 0.0 108.336 174.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -3.33 1.16 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.134 0.974 . . . . 0.0 112.923 165.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.1 p 66.27 -164.77 0.23 Allowed 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 125.378 1.471 . . . . 0.0 108.056 174.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -105.42 12.66 31.28 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.593 1.088 . . . . 0.0 111.473 169.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -63.67 170.53 3.22 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 122.166 0.984 . . . . 0.0 110.527 164.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -122.51 144.52 49.02 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 125.604 1.562 . . . . 0.0 110.526 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.02 157.56 16.25 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 125.028 1.331 . . . . 0.0 108.604 172.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 26.7 pt -137.77 17.36 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 125.771 1.628 . . . . 0.0 111.284 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.02 176.88 8.31 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.369 1.468 . . . . 0.0 110.701 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.9 -4.67 6.33 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.749 2.42 . . . . 0.0 110.944 -175.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -140.31 150.05 59.94 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-N 119.202 0.91 . . . . 0.0 109.814 -175.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.43 167.73 25.5 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.141 1.894 . . . . 0.0 110.06 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.2 20.19 16.45 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.401 1.08 . . . . 0.0 110.367 170.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.58 173.83 11.09 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.037 -1.04 . . . . 0.0 109.022 157.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.97 -24.04 5.7 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 127.455 2.302 . . . . 0.0 110.082 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -118.87 112.74 20.05 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.502 1.921 . . . . 0.0 106.114 174.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -149.41 173.83 13.12 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 126.956 2.103 . . . . 0.0 106.706 170.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -114.66 166.17 12.13 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 167.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.58 147.66 22.8 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.397 0.679 . . . . 0.0 109.701 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.0 mp -134.84 128.95 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 172.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -132.26 141.53 49.05 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 53.7 mt -129.24 97.39 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 -177.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -71.31 131.3 43.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 170.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -158.79 -166.04 1.78 Allowed 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -45.51 -32.83 2.4 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.724 1.609 . . . . 0.0 114.133 175.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.23 2.47 81.47 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-O 119.311 -0.716 . . . . 0.0 111.873 -173.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.47 -138.05 22.68 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 107.619 -2.192 . . . . 0.0 107.619 -153.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 11.5 mtt -105.44 112.52 25.64 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.181 0.991 . . . . 0.0 110.682 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 47.9 m -60.04 124.86 21.53 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 149.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.6 m -112.87 143.42 44.17 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.971 1.708 . . . . 0.0 107.073 173.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.5 ptm -163.94 167.71 20.24 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.539 1.535 . . . . 0.0 108.677 -172.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -149.23 129.53 13.75 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.738 1.215 . . . . 0.0 109.098 -169.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.607 ' CE1' HG23 ' A' ' 84' ' ' ILE . 3.3 m-30 -120.18 145.43 46.98 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.751 1.614 . . . . 0.0 110.164 -172.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -151.13 179.51 8.22 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.682 1.593 . . . . 0.0 110.938 -169.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -112.86 148.72 34.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.474 1.51 . . . . 0.0 108.987 168.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -144.72 119.42 9.81 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.686 1.194 . . . . 0.0 108.398 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 58.57 5.44 0.46 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.6 1.96 . . . . 0.0 114.856 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.22 1.8 28.1 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 119.838 1.199 . . . . 0.0 113.536 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -106.17 149.93 26.34 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 119.227 1.513 . . . . 0.0 108.131 163.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -93.85 151.85 19.3 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 174.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -140.47 159.05 43.05 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.599 0.714 . . . . 0.0 111.312 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.607 HG23 ' CE1' ' A' ' 75' ' ' TYR . 2.5 mp -119.65 124.69 73.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 125.26 1.424 . . . . 0.0 108.86 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -70.71 147.65 48.83 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 122.231 1.015 . . . . 0.0 111.596 168.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.503 ' HB2' ' HA2' ' A' ' 90' ' ' GLY . 0.8 OUTLIER -171.55 167.6 3.7 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 128.39 2.676 . . . . 0.0 107.881 174.732 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.42 ' HD2' ' CB ' ' A' ' 86' ' ' CYS . 45.9 Cg_endo -53.19 -160.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.609 1 C-N-CA 126.199 4.599 . . . . 0.0 110.672 166.002 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -42.63 -13.78 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.756 2.423 . . . . 0.0 115.58 -173.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -110.04 67.42 0.65 Allowed 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 127.875 2.47 . . . . 0.0 113.074 164.1 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.503 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . -130.72 38.71 1.9 Allowed Glycine 0 N--CA 1.463 0.457 0 N-CA-C 116.251 1.26 . . . . 0.0 116.251 -173.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.3 mt -129.34 39.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 O-C-N 121.72 -0.871 . . . . 0.0 109.049 -170.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -75.84 101.62 5.19 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -171.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -72.28 125.82 28.28 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 166.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 24.5 pt -114.99 179.44 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 125.976 1.71 . . . . 0.0 108.753 165.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -107.09 -18.19 13.97 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -178.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -136.67 168.74 18.93 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.792 0.837 . . . . 0.0 111.749 -165.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -77.7 121.44 24.01 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.239 1.016 . . . . 0.0 109.937 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -62.76 -47.77 82.07 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.365 1.066 . . . . 0.0 111.781 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -62.53 -32.02 72.89 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.45 0.7 . . . . 0.0 111.881 -172.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -71.19 -21.01 62.2 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.142 -0.974 . . . . 0.0 111.738 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.1 mmt -98.57 -4.58 33.8 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.128 1.371 . . . . 0.0 112.531 -170.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 23.0 pt . . . . . 0 C--O 1.253 1.286 0 C-N-CA 124.69 1.196 . . . . 0.0 111.321 -175.663 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.655 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 m -172.4 87.85 0.42 Allowed Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 126.978 2.111 . . . . 0.0 109.308 169.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -55.21 158.63 11.59 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 CA-C-N 121.292 1.497 . . . . 0.0 111.824 164.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 mp -80.32 135.87 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 158.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.63 165.11 24.4 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 126.393 1.877 . . . . 0.0 108.851 174.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HB2' HD21 ' A' ' 10' ' ' ASN . 47.9 Cg_endo -64.8 175.8 3.41 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.096 2.531 . . . . 0.0 112.485 174.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.698 ' H ' ' HE2' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -67.16 -172.28 0.2 Allowed 'General case' 0 C--N 1.344 0.364 0 O-C-N 120.386 -1.446 . . . . 0.0 109.922 167.363 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.7 -36.81 12.73 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.548 0.739 . . . . 0.0 110.957 161.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -76.06 -17.68 59.54 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.206 -0.934 . . . . 0.0 113.223 -171.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.496 HD22 ' N ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -88.12 -3.89 58.83 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.854 1.261 . . . . 0.0 112.421 176.043 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.496 ' N ' HD22 ' A' ' 10' ' ' ASN . 29.1 t -88.3 118.48 33.95 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 -172.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -83.89 -49.43 9.03 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.081 1.352 . . . . 0.0 107.817 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.3 m -157.03 176.95 12.07 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.618 1.099 . . . . 0.0 111.523 163.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.615 HG12 HG23 ' A' ' 64' ' ' ILE . 53.9 mt -126.81 145.05 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 167.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.8 t -125.58 141.08 52.22 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.472 1.109 . . . . 0.0 108.516 169.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.6 mt -134.47 105.76 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 176.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -93.75 109.24 20.91 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 171.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -67.9 169.63 9.52 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.846 1.258 . . . . 0.0 109.846 -173.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.5 p -50.3 -35.71 28.6 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.153 0.981 . . . . 0.0 111.76 176.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -58.86 -154.75 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 131.367 3.867 . . . . 0.0 111.27 172.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.2 p -108.91 4.69 23.66 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 119.992 -1.693 . . . . 0.0 111.947 163.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.4 mt -75.63 133.62 30.91 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -132.26 110.06 10.35 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -177.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.8 125.26 50.79 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -177.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.1 mp -101.19 127.48 54.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 175.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.413 ' CG ' HD11 ' A' ' 35' ' ' ILE . 46.4 m-85 -106.26 83.31 1.87 Allowed 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 102.023 -3.325 . . . . 0.0 102.023 174.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -89.93 -13.4 36.34 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.902 0.881 . . . . 0.0 111.337 174.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.01 135.98 33.32 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.598 1.559 . . . . 0.0 109.877 -165.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.4 t -49.17 -48.09 45.35 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.689 1.196 . . . . 0.0 113.756 -171.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -71.56 -33.48 69.14 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 120.706 -1.247 . . . . 0.0 111.425 -174.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.4 m -62.26 -34.99 77.6 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.753 2.021 . . . . 0.0 110.943 170.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.5 mt -68.2 -49.13 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -59.33 -33.4 71.08 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 117.907 -1.044 . . . . 0.0 112.133 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.449 ' HE3' ' C ' ' A' ' 102' ' ' ILE . 0.0 OUTLIER -64.61 -62.28 1.68 Allowed 'General case' 0 C--N 1.343 0.311 0 CA-C-N 119.699 1.136 . . . . 0.0 109.492 172.735 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.413 HD11 ' CG ' ' A' ' 26' ' ' TYR . 40.5 mt -51.95 -50.12 35.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 124.006 0.922 . . . . 0.0 111.068 -173.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.72 -16.23 10.38 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.1 0.96 . . . . 0.0 113.015 -173.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.2 t -61.42 -59.11 5.77 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.64 1.109 . . . . 0.0 110.203 168.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -65.36 -31.1 72.04 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.58 1.152 . . . . 0.0 110.697 -176.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 39.2 mm -62.13 -16.19 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 121.164 -0.96 . . . . 0.0 111.762 173.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.89 7.82 14.57 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.536 1.534 . . . . 0.0 113.074 175.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 t -78.6 -30.93 46.89 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 120.272 1.396 . . . . 0.0 109.951 -177.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.496 ' CA ' HG22 ' A' ' 94' ' ' ILE . . . -86.38 161.61 34.19 Favored Glycine 0 N--CA 1.447 -0.629 0 O-C-N 120.841 -1.162 . . . . 0.0 114.717 -162.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.46 99.79 7.05 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -170.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.519 ' HB3' ' CE2' ' A' ' 92' ' ' TYR . 9.5 ptt180 -60.12 -8.23 2.31 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.583 1.538 . . . . 0.0 114.311 -177.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.8 p 65.19 176.71 0.2 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.638 2.375 . . . . 0.0 110.115 -175.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -74.34 -9.95 59.1 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.607 -1.308 . . . . 0.0 111.45 172.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -58.41 161.38 4.48 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.985 1.374 . . . . 0.0 110.705 -177.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -108.44 149.95 28.06 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.007 -1.451 . . . . 0.0 107.362 165.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.86 119.98 32.15 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.45 -2.055 . . . . 0.0 105.45 -165.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.8 pt -105.28 12.13 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 119.195 -0.431 . . . . 0.0 111.939 -162.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.56 179.91 6.54 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.385 1.874 . . . . 0.0 108.553 -174.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -127.55 -7.1 5.73 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.148 2.179 . . . . 0.0 110.56 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -140.15 149.22 57.52 Favored Pre-proline 0 C--O 1.238 0.495 0 C-N-CA 124.02 0.928 . . . . 0.0 111.455 -170.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -67.7 155.35 70.35 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.677 2.251 . . . . 0.0 114.104 -171.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 m -100.43 10.39 41.27 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.783 2.033 . . . . 0.0 111.86 162.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.66 166.8 22.98 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 120.501 -1.374 . . . . 0.0 110.072 162.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -105.31 -34.78 7.76 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 127.343 2.257 . . . . 0.0 109.68 165.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -116.12 98.16 6.47 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 -165.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -154.39 162.74 40.99 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 126.05 1.74 . . . . 0.0 109.289 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.64 166.62 15.03 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.908 0.766 . . . . 0.0 111.218 175.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.6 m -107.72 124.67 50.37 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -176.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.71 135.15 56.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 124.445 1.098 . . . . 0.0 108.362 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -121.16 135.1 55.22 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 163.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.662 HG22 ' OD1' ' A' ' 66' ' ' ASN . 42.1 mt -117.1 100.5 10.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 102.718 -3.067 . . . . 0.0 102.718 166.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -78.93 107.18 11.48 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.879 1.672 . . . . 0.0 106.596 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.662 ' OD1' HG22 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -145.56 158.22 43.87 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 123.779 0.831 . . . . 0.0 108.962 179.356 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 48.94 30.03 2.59 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.616 1.566 . . . . 0.0 113.925 169.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.44 47.63 85.62 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 120.925 -1.11 . . . . 0.0 111.2 -175.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -156.89 -173.09 24.9 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 126.092 1.805 . . . . 0.0 109.37 168.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.04 137.57 53.08 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.876 0.846 . . . . 0.0 109.213 159.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.4 m -84.01 97.43 9.28 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 103.612 -2.736 . . . . 0.0 103.612 164.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.1 m -83.87 140.25 32.11 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 2.0 ptm -162.67 163.52 26.94 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.053 1.341 . . . . 0.0 108.768 -177.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -139.69 148.55 42.52 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -136.29 151.84 50.06 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 121.385 1.902 . . . . 0.0 109.528 177.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -147.02 173.4 12.49 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.278 1.031 . . . . 0.0 111.731 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -93.99 146.72 23.73 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 159.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -138.34 126.91 23.4 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 162.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 60.3 6.64 1.07 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.805 1.642 . . . . 0.0 114.412 171.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.17 3.53 31.33 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.963 1.268 . . . . 0.0 113.782 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.56 153.93 24.43 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 120.03 1.915 . . . . 0.0 108.81 161.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -98.74 155.2 17.46 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 174.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.427 ' HA ' ' O ' ' A' ' 92' ' ' TYR . 93.6 m-85 -141.25 159.88 41.28 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 119.039 -0.505 . . . . 0.0 111.882 -176.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.1 mp -124.45 131.49 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.534 1.534 . . . . 0.0 111.755 172.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -82.6 164.38 20.84 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.198 1.799 . . . . 0.0 111.457 172.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.4 ' HB2' ' HA2' ' A' ' 90' ' ' GLY . 0.1 OUTLIER 177.57 169.2 0.47 Allowed Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.842 1.657 . . . . 0.0 108.656 -162.018 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.428 ' O ' ' N ' ' A' ' 89' ' ' LYS . 20.7 Cg_endo -63.23 -164.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.363 0 CA-C-N 121.904 1.716 . . . . 0.0 108.953 158.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -43.65 -5.55 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 129.121 2.969 . . . . 0.0 118.71 -165.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -113.48 43.75 1.71 Allowed 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 128.314 2.646 . . . . 0.0 111.734 170.866 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.4 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . -113.42 53.05 0.61 Allowed Glycine 0 C--N 1.334 0.471 0 CA-C-N 120.11 1.323 . . . . 0.0 114.823 -176.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.1 mt -129.93 52.33 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 170.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.519 ' CE2' ' HB3' ' A' ' 44' ' ' ARG . 77.4 m-85 -74.39 99.37 3.5 Favored 'General case' 0 CA--C 1.499 -0.984 0 O-C-N 120.957 -1.089 . . . . 0.0 108.641 176.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -61.89 128.21 35.12 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 158.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.496 HG22 ' CA ' ' A' ' 42' ' ' GLY . 3.1 pt -128.78 152.07 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 125.413 1.485 . . . . 0.0 108.251 167.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -80.7 -39.81 26.47 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -112.09 164.75 12.8 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.843 1.257 . . . . 0.0 111.07 -169.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -71.4 131.33 43.21 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 122.377 0.271 . . . . 0.0 110.282 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -64.85 -45.97 83.84 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 122.157 -0.339 . . . . 0.0 110.58 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -69.02 -31.24 69.9 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -168.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -77.71 -25.75 49.59 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.097 -1.002 . . . . 0.0 110.686 177.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 22.7 mmt -81.89 -12.71 58.31 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.742 0.817 . . . . 0.0 112.81 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.449 ' C ' ' HE3' ' A' ' 34' ' ' LYS . 29.1 pt . . . . . 0 C--O 1.25 1.097 0 CA-C-N 120.94 1.7 . . . . 0.0 109.894 172.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.059 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.9 p -67.01 166.36 20.25 Favored Pre-proline 0 C--O 1.24 0.564 0 C-N-CA 124.322 1.049 . . . . 0.0 111.951 -178.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -47.93 153.43 2.6 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 120.654 0.902 . . . . 0.0 111.642 154.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 80.3 mt -80.7 133.33 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 157.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.04 164.43 39.1 Favored Pre-proline 0 C--O 1.242 0.701 0 C-N-CA 125.061 1.344 . . . . 0.0 107.792 176.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -58.81 169.82 3.12 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 121.395 1.397 . . . . 0.0 109.93 160.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.472 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -55.5 175.66 0.07 Allowed 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 120.47 -1.394 . . . . 0.0 110.941 164.011 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.2 -55.3 5.86 Favored 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 156.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -62.63 -16.23 55.71 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -163.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -95.32 1.85 54.53 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.028 1.731 . . . . 0.0 114.542 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 72.3 t -84.14 130.08 36.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 177.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.42 -58.18 3.46 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 169.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 63.6 p -153.23 163.54 39.71 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.611 171.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 56.1 mt -106.08 125.65 61.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 164.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.6 t -91.56 138.36 31.63 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 163.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.0 mt -125.0 107.52 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 166.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -86.06 121.91 29.34 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 169.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -67.96 164.91 18.91 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.039 0.936 . . . . 0.0 110.734 -176.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -57.9 -27.77 63.61 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 118.512 -0.756 . . . . 0.0 112.404 168.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -87.89 -79.38 0.29 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.929 1.24 . . . . 0.0 111.21 -177.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.9 t -175.93 -3.84 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.963 2.105 . . . . 0.0 112.584 -176.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.0 mm -73.31 150.06 8.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 169.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -139.46 122.19 16.44 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.59 ' HE2' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -121.19 131.53 54.3 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -171.26 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.4 mp -112.14 145.81 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -177.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.59 ' CE1' ' HE2' ' A' ' 24' ' ' LYS . 53.4 m-85 -123.41 95.69 4.69 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 103.841 -2.652 . . . . 0.0 103.841 -172.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -123.29 49.94 1.63 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.811 2.044 . . . . 0.0 108.732 -175.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.06 163.41 34.33 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.438 1.895 . . . . 0.0 107.61 170.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.9 m -50.6 -58.52 5.62 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.445 0.698 . . . . 0.0 111.884 166.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -68.89 -35.33 76.74 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.758 -0.589 . . . . 0.0 111.487 -169.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.4 p -67.24 -43.26 82.42 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.5 mt -67.11 -48.53 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 123.575 0.75 . . . . 0.0 109.609 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -48.52 -50.39 32.08 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.364 1.866 . . . . 0.0 111.898 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.437 ' HE2' ' O ' ' A' ' 101' ' ' MET . 0.0 OUTLIER -59.46 -47.49 85.29 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 122.921 0.489 . . . . 0.0 110.386 -176.329 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.554 HD11 ' CG ' ' A' ' 26' ' ' TYR . 86.3 mt -60.68 -51.18 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.917 176.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 mt -49.59 -39.44 35.35 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.441 1.019 . . . . 0.0 111.025 -177.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.1 t -57.13 -57.05 14.29 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.428 0.691 . . . . 0.0 110.412 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -72.21 -19.05 61.79 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.435 1.094 . . . . 0.0 112.35 -175.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.1 mm -81.9 -19.57 10.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.217 1.407 . . . . 0.0 110.872 173.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.67 -12.66 13.86 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -175.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.2 t -58.07 -31.64 67.26 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.311 0.96 . . . . 0.0 111.267 176.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.42 154.92 44.78 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-O 122.783 1.213 . . . . 0.0 112.118 -171.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.44 108.79 19.43 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 174.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' A' ' 92' ' ' TYR . 6.6 ppt_? -63.4 -13.59 41.37 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 167.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 p 65.53 -174.0 0.18 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.826 1.329 . . . . 0.0 109.926 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -68.31 -17.22 64.22 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.013 -1.054 . . . . 0.0 112.032 175.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -64.26 154.21 35.79 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 119.354 0.979 . . . . 0.0 112.093 -171.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -100.55 133.15 45.43 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 172.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.8 160.11 33.16 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 153.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 pt -136.07 12.51 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.679 1.192 . . . . 0.0 111.164 168.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.8 178.64 4.33 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.11 1.364 . . . . 0.0 108.834 175.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -121.12 -5.32 9.49 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.176 0.99 . . . . 0.0 111.676 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -145.67 160.1 45.43 Favored Pre-proline 0 C--N 1.345 0.378 0 C-N-CA 125.626 1.57 . . . . 0.0 110.344 -171.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -69.36 160.99 47.68 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 121.304 1.336 . . . . 0.0 109.882 177.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.6 t -107.22 13.53 27.14 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.52 0.728 . . . . 0.0 110.862 172.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.03 171.9 13.68 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.523 0.677 . . . . 0.0 111.303 168.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -111.56 -29.22 7.83 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.487 1.915 . . . . 0.0 109.615 172.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -112.62 115.78 29.14 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 127.066 2.146 . . . . 0.0 105.987 172.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -149.53 167.3 26.67 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 171.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.47 169.8 15.08 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 169.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.6 m -123.42 123.14 40.0 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -158.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 mp -122.19 111.72 31.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 124.141 0.976 . . . . 0.0 108.4 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -109.54 113.9 27.07 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.931 1.692 . . . . 0.0 106.728 -175.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.4 mt -98.95 100.38 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 170.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -71.41 119.74 15.99 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 164.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -148.06 136.49 21.49 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.596 0.758 . . . . 0.0 110.172 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.4 m120 53.24 23.45 3.18 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.265 1.426 . . . . 0.0 111.156 -174.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.04 -8.22 39.16 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 127.608 2.527 . . . . 0.0 114.075 -176.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -87.8 -177.29 48.01 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 108.726 -1.749 . . . . 0.0 108.726 166.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.1 ptt? -145.56 142.74 29.42 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.563 1.181 . . . . 0.0 113.248 174.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.1 m -91.41 111.1 22.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 165.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.5 m -84.12 130.73 34.84 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.572 1.949 . . . . 0.0 106.944 166.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.9 ptp -154.0 173.24 16.26 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.325 1.45 . . . . 0.0 109.36 164.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.603 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 43.0 m-85 -135.72 -179.79 5.86 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.437 1.895 . . . . 0.0 108.477 -178.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -138.79 158.04 44.95 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.375 1.07 . . . . 0.0 108.946 170.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -161.44 171.48 18.12 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.408 1.004 . . . . 0.0 110.616 163.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -99.34 139.24 35.28 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 125.681 1.593 . . . . 0.0 107.945 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -135.23 111.29 9.53 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.641 0.734 . . . . 0.0 109.625 175.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 66.96 10.73 7.89 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.381 1.872 . . . . 0.0 113.3 172.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.1 -8.7 31.31 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-O 118.021 -1.433 . . . . 0.0 113.172 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.97 157.78 15.74 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 119.342 1.571 . . . . 0.0 108.075 163.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -109.15 150.06 28.43 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -141.13 171.79 13.57 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 123.364 0.415 . . . . 0.0 110.146 178.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.422 HD11 HD13 ' A' ' 94' ' ' ILE . 5.2 mp -121.99 150.53 25.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 124.628 1.171 . . . . 0.0 108.057 172.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.603 ' HB3' ' H ' ' A' ' 74' ' ' PHE . 3.4 tm-20 -90.49 159.33 16.57 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.149 2.58 . . . . 0.0 110.045 -173.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 174.81 167.43 0.34 Allowed Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 128.78 2.832 . . . . 0.0 108.774 178.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.405 ' O ' ' N ' ' A' ' 89' ' ' LYS . 23.0 Cg_endo -60.45 -161.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.935 1 C-N-CA 125.446 4.097 . . . . 0.0 110.152 165.333 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -42.9 -8.79 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 128.259 2.623 . . . . 0.0 117.08 -169.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -114.43 33.28 5.4 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 120.637 1.562 . . . . 0.0 114.509 167.189 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -113.41 75.38 0.23 Allowed Glycine 0 C--O 1.223 -0.556 0 CA-C-N 119.671 1.123 . . . . 0.0 113.176 -174.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.0 mt -145.28 46.7 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 174.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 35.9 m-85 -72.19 100.91 2.68 Favored 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 121.05 -1.032 . . . . 0.0 109.74 -171.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.92 122.23 18.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 170.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.422 HD13 HD11 ' A' ' 84' ' ' ILE . 33.2 pt -116.13 174.84 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 127.248 2.219 . . . . 0.0 108.42 162.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -106.31 -14.37 15.13 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -175.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -131.45 167.78 18.74 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.273 0.942 . . . . 0.0 110.0 -169.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -69.98 139.31 52.77 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.951 0.341 . . . . 0.0 110.324 174.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -68.12 -52.42 35.07 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.776 0.83 . . . . 0.0 112.447 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -66.01 -28.42 68.86 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.748 0.704 . . . . 0.0 112.253 -171.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -67.94 -14.51 63.02 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.866 -0.521 . . . . 0.0 111.875 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.437 ' O ' ' HE2' ' A' ' 34' ' ' LYS . 26.3 mmt -103.02 -10.51 18.87 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 117.071 -1.443 . . . . 0.0 113.322 -175.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.9 pp . . . . . 0 C--O 1.254 1.31 0 CA-C-N 121.11 1.777 . . . . 0.0 112.862 -163.86 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.129 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.428 ' HB2' ' HD2' ' A' ' 3' ' ' PRO . 15.0 p 63.42 167.47 0.1 Allowed Pre-proline 0 CA--C 1.549 0.933 0 CA-C-N 118.701 1.25 . . . . 0.0 111.531 -175.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 2' ' ' SER . 38.0 Cg_endo -57.54 164.12 7.77 Favored 'Trans proline' 0 C--N 1.353 0.809 0 CA-C-N 121.58 1.6 . . . . 0.0 110.763 174.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.9 mm -99.21 127.25 52.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 105.31 -2.108 . . . . 0.0 105.31 171.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.22 161.5 63.38 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 126.54 1.936 . . . . 0.0 110.646 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -61.17 172.28 3.31 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.158 1.239 . . . . 0.0 110.698 170.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.17 179.11 0.21 Allowed 'General case' 0 N--CA 1.467 0.421 0 O-C-N 120.313 -1.492 . . . . 0.0 112.27 171.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.02 -50.07 17.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 155.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.82 -26.34 68.58 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -159.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -89.48 -5.72 57.07 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 126.414 1.886 . . . . 0.0 115.02 -178.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.2 t -76.89 108.83 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.59 -39.37 93.61 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.001 0.921 . . . . 0.0 109.607 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 p -174.44 136.89 0.48 Allowed 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.177 0.991 . . . . 0.0 108.873 158.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.9 mt -75.34 154.38 6.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 164.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.6 t -131.93 133.79 44.94 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.477 -2.046 . . . . 0.0 105.477 166.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.4 mt -128.99 110.8 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 176.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.41 119.92 22.41 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 105.245 -2.131 . . . . 0.0 105.245 166.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -63.01 -179.83 0.32 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.882 1.273 . . . . 0.0 110.49 173.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.3 p -75.17 0.39 16.5 Favored 'General case' 0 CA--C 1.549 0.904 0 O-C-N 119.97 -1.706 . . . . 0.0 112.305 171.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -122.67 158.56 29.79 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 128.616 2.766 . . . . 0.0 105.479 168.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.4 p -79.26 -2.8 42.92 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 120.243 1.383 . . . . 0.0 112.464 -154.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.428 ' H ' HG13 ' A' ' 22' ' ' ILE . 5.4 mt -61.81 134.89 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 164.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -120.14 166.07 13.91 Favored 'General case' 0 N--CA 1.422 -1.832 0 C-N-CA 125.122 1.369 . . . . 0.0 107.505 171.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.578 ' HE2' ' CE2' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -137.1 151.72 49.19 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 170.265 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.5 mp -109.74 139.76 31.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.578 ' CE2' ' HE2' ' A' ' 24' ' ' LYS . 72.4 m-85 -128.8 91.72 3.27 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 -173.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -119.99 -7.66 9.89 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.78 2.432 . . . . 0.0 110.973 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -64.95 138.27 58.26 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 170.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.9 t -56.97 -42.84 80.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.98 0.809 . . . . 0.0 109.729 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -67.38 -36.7 81.87 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.362 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 52.2 p -55.2 -48.45 73.82 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.026 0.83 . . . . 0.0 109.038 175.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.6 mt -70.48 -54.71 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-O 118.568 -0.729 . . . . 0.0 109.093 -177.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -59.64 -30.64 68.87 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.528 1.058 . . . . 0.0 112.172 -176.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -68.64 -63.82 0.99 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 117.857 -1.068 . . . . 0.0 109.027 170.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.3 mt -47.92 -46.18 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 123.643 0.777 . . . . 0.0 109.967 -176.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -47.73 -31.22 4.53 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.007 1.723 . . . . 0.0 113.08 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.4 t -61.03 -55.15 36.11 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 119.113 0.869 . . . . 0.0 109.584 174.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -75.6 -11.59 60.04 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.021 0.828 . . . . 0.0 112.252 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.5 mm -70.55 -23.92 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 O-C-N 120.9 -1.125 . . . . 0.0 110.141 162.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.35 -18.03 11.14 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -168.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.2 p -69.57 -28.91 66.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 119.817 1.189 . . . . 0.0 112.746 -170.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.78 165.98 50.08 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 119.536 1.062 . . . . 0.0 114.381 -166.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.5 pttm -112.13 103.56 11.75 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 125.518 1.527 . . . . 0.0 111.184 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.423 ' HB3' ' CE2' ' A' ' 92' ' ' TYR . 21.6 ptt180 -58.03 -15.16 8.2 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 170.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.7 p 60.27 175.24 0.09 Allowed 'General case' 0 CA--C 1.551 0.99 0 O-C-N 124.162 0.914 . . . . 0.0 109.597 -171.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -85.68 3.69 39.9 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 119.363 -2.085 . . . . 0.0 111.795 176.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.483 ' CB ' HD12 ' A' ' 91' ' ' ILE . 4.9 mmmt -60.66 156.43 16.74 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.65 0.78 . . . . 0.0 111.786 177.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -89.88 113.99 25.69 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.701 1.6 . . . . 0.0 107.2 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.9 t -80.14 140.66 36.29 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 163.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.2 pt -144.4 39.53 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.649 1.579 . . . . 0.0 107.727 176.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -116.64 177.24 4.77 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.835 1.254 . . . . 0.0 110.682 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.87 -4.58 2.82 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.172 1.389 . . . . 0.0 111.547 177.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -153.35 165.38 17.84 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 126.752 2.021 . . . . 0.0 108.089 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.28 174.3 11.7 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.381 1.387 . . . . 0.0 111.097 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 t -102.17 -7.8 21.89 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.005 1.322 . . . . 0.0 110.804 175.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.04 150.89 31.77 Favored 'General case' 0 CA--C 1.527 0.09 0 O-C-N 121.028 -1.045 . . . . 0.0 110.796 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.46 -22.25 30.39 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.248 1.019 . . . . 0.0 111.232 173.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.79 107.32 9.06 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -129.48 153.58 47.83 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 126.389 1.876 . . . . 0.0 108.943 176.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.02 154.92 25.97 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 108.17 -1.972 . . . . 0.0 108.17 167.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.2 m -127.38 131.73 50.28 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.137 0.975 . . . . 0.0 108.807 -164.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.05 125.62 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -166.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -115.42 144.76 43.34 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 161.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.0 mt -127.48 83.49 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -58.77 120.45 8.99 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 171.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -146.91 114.76 6.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.1 m120 59.61 20.54 9.13 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.613 1.165 . . . . 0.0 112.375 -173.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.15 3.58 12.4 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.522 1.058 . . . . 0.0 113.506 -171.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.96 170.39 44.03 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 145.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -143.84 163.38 33.55 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 121.308 -1.113 . . . . 0.0 109.469 169.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.2 m -130.07 132.16 46.06 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 174.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -120.83 126.41 50.0 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.196 0.998 . . . . 0.0 108.686 -172.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.6 ptp -146.85 170.65 16.6 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.156 0.983 . . . . 0.0 109.207 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -146.47 148.7 32.52 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 -175.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.92 154.32 50.54 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.364 0.984 . . . . 0.0 109.758 175.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -157.77 172.61 18.18 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.813 1.645 . . . . 0.0 109.545 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -102.84 139.15 38.79 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.657 1.583 . . . . 0.0 108.072 171.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -135.85 120.46 18.27 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 172.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 55.79 -4.59 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 128.153 2.581 . . . . 0.0 117.341 -174.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 136.97 -33.48 2.31 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 125.751 1.644 . . . . 0.0 112.49 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -71.58 151.42 43.82 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 171.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -100.12 150.6 22.32 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 168.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -136.77 153.11 50.92 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.514 0.725 . . . . 0.0 111.182 -176.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mp -123.15 117.9 53.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 125.162 1.385 . . . . 0.0 107.63 -170.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.424 ' CD ' ' H ' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -74.46 154.81 38.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.625 1.17 . . . . 0.0 109.736 176.542 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.424 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 0.8 OUTLIER 179.79 167.73 0.73 Allowed Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 127.963 2.505 . . . . 0.0 107.443 -169.324 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -57.15 -163.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 124.37 3.38 . . . . 0.0 110.728 166.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -44.76 -11.78 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 117.079 2.251 . . . . 0.0 117.079 -174.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -96.78 11.64 34.89 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.023 1.729 . . . . 0.0 115.293 172.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.94 77.54 0.4 Allowed Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 120.259 1.391 . . . . 0.0 113.508 -170.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.483 HD12 ' CB ' ' A' ' 47' ' ' LYS . 2.9 mt -139.51 42.88 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 169.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.423 ' CE2' ' HB3' ' A' ' 44' ' ' ARG . 37.9 m-85 -76.24 107.53 8.55 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 121.212 -0.93 . . . . 0.0 109.758 -172.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -69.66 127.26 32.31 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 159.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 41.0 pt -112.19 168.23 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 148.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -122.32 21.34 10.36 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.848 0.832 . . . . 0.0 112.871 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -140.98 167.42 22.23 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 127.149 2.18 . . . . 0.0 110.214 170.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -84.29 116.22 22.88 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.213 1.005 . . . . 0.0 109.601 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -48.97 -47.33 44.13 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.833 1.253 . . . . 0.0 109.564 172.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -68.43 -17.42 64.2 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.126 0.97 . . . . 0.0 112.692 -171.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -91.49 -13.78 31.59 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 121.334 -0.854 . . . . 0.0 109.937 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 11.9 mmt -106.66 -6.59 17.81 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.789 1.636 . . . . 0.0 112.462 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 24.3 pt . . . . . 0 C--O 1.25 1.126 0 CA-C-N 119.332 0.969 . . . . 0.0 111.397 174.092 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.805 0 CA-C-O 119.633 -0.537 . . . . 0.0 112.719 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m 69.85 165.0 0.13 Allowed Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 126.691 1.996 . . . . 0.0 113.347 174.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.02 179.89 2.07 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 124.586 3.524 . . . . 0.0 112.504 156.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 53.1 mt -108.54 131.83 58.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 126.258 1.823 . . . . 0.0 106.341 164.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.46 HD12 HG22 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -135.13 161.76 61.65 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 128.143 2.577 . . . . 0.0 109.959 175.227 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -62.17 176.62 1.43 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.998 2.466 . . . . 0.0 112.914 176.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.584 ' HE3' ' H ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -65.35 -175.1 0.21 Allowed 'General case' 0 C--O 1.236 0.383 0 O-C-N 119.983 -1.698 . . . . 0.0 110.351 169.203 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.6 -42.75 16.39 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 118.984 -0.531 . . . . 0.0 111.219 167.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -85.69 -21.83 28.13 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 118.48 -1.288 . . . . 0.0 111.652 -164.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.449 HD22 ' N ' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -73.39 -5.96 43.19 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.64 1.176 . . . . 0.0 112.471 174.632 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.449 ' N ' HD22 ' A' ' 10' ' ' ASN . 25.0 t -80.11 131.58 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 173.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -81.75 -61.43 1.92 Allowed 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 171.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.63 130.2 5.0 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.612 1.096 . . . . 0.0 109.827 171.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.7 mt -81.25 139.38 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.4 t -116.37 140.83 48.92 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 172.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.2 mt -135.57 105.13 5.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 173.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -81.39 108.07 14.69 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 173.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -71.03 -176.76 1.46 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.549 0.69 . . . . 0.0 109.267 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.4 p -62.25 -46.75 87.42 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.492 -1.38 . . . . 0.0 111.394 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -73.74 179.79 4.02 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.752 2.021 . . . . 0.0 109.952 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.6 p -69.84 8.01 0.79 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.239 1.416 . . . . 0.0 112.83 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.6 mt -98.5 137.25 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -170.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -145.93 137.88 25.2 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 -176.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.5 132.21 53.85 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 -173.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.5 mp -105.84 119.74 55.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 176.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.74 ' CG ' HD11 ' A' ' 35' ' ' ILE . 81.6 m-85 -93.06 81.15 4.54 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 102.657 -3.09 . . . . 0.0 102.657 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -96.9 -28.82 14.04 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.998 0.919 . . . . 0.0 110.457 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.53 141.61 53.83 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.1 t -55.03 -46.92 75.32 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.143 0.883 . . . . 0.0 112.481 -175.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -68.65 -24.84 64.58 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.591 1.156 . . . . 0.0 110.899 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.9 p -69.87 -40.97 75.41 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.766 0.712 . . . . 0.0 109.482 176.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 53.9 mt -66.06 -46.65 87.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.566 1.146 . . . . 0.0 108.304 177.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.97 -24.87 67.28 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -165.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.461 ' HE2' ' O ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -65.73 -54.85 21.68 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 123.132 0.573 . . . . 0.0 109.49 172.251 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.74 HD11 ' CG ' ' A' ' 26' ' ' TYR . 18.6 mt -57.01 -40.42 72.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 125.674 1.59 . . . . 0.0 109.307 -169.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.37 -21.48 5.88 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.837 1.655 . . . . 0.0 113.399 175.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.8 t -64.46 -68.36 0.36 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 120.434 1.47 . . . . 0.0 109.011 164.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.425 ' O ' HG22 ' A' ' 41' ' ' THR . 24.8 mm-40 -65.98 -24.93 66.88 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.05 0.54 . . . . 0.0 111.41 -168.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.46 HG22 HD12 ' A' ' 5' ' ' LEU . 14.5 mm -59.56 -29.43 42.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 O-C-N 120.751 -1.218 . . . . 0.0 110.549 172.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.33 -8.74 41.11 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 120.347 1.431 . . . . 0.0 113.441 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 38' ' ' GLU . 1.4 t -69.93 -16.84 63.28 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.018 0.927 . . . . 0.0 113.337 -164.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.28 156.47 18.5 Favored Glycine 0 C--N 1.335 0.512 0 O-C-N 120.75 -1.219 . . . . 0.0 112.865 -171.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.7 pttm -112.83 111.2 21.8 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 175.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.8 ptt-85 -58.49 -5.11 0.48 Allowed 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.982 0.81 . . . . 0.0 112.594 169.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . 0.259 10.4 p 64.44 -164.67 0.25 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.545 1.538 . . . . 0.0 107.819 -176.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -101.21 4.5 41.97 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.909 1.231 . . . . 0.0 111.845 171.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -67.77 153.27 44.08 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 122.066 0.936 . . . . 0.0 110.357 176.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -85.77 121.32 28.27 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.989 1.716 . . . . 0.0 107.68 169.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.2 t -74.09 152.04 40.01 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 158.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.2 pt -138.14 11.79 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 126.083 1.753 . . . . 0.0 110.28 172.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -99.91 173.87 6.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.738 1.215 . . . . 0.0 109.577 178.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.55 -7.42 2.87 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.05 1.74 . . . . 0.0 110.446 174.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -151.72 158.93 33.9 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 127.329 2.251 . . . . 0.0 109.359 -174.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.01 -179.76 5.74 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.467 3.445 . . . . 0.0 112.425 178.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.87 -6.67 11.0 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.855 1.662 . . . . 0.0 112.021 176.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.14 149.82 40.8 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 120.818 -1.176 . . . . 0.0 109.496 173.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -75.03 -30.5 61.09 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.509 0.723 . . . . 0.0 109.756 169.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -114.43 108.09 16.42 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.774 1.63 . . . . 0.0 107.471 -172.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -137.15 168.72 19.06 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 126.521 1.929 . . . . 0.0 107.099 169.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.23 166.52 13.0 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 161.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 73.8 m -124.92 120.68 32.3 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.157 0.983 . . . . 0.0 108.873 -167.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.81 126.37 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -171.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -121.17 128.79 52.84 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 171.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.52 ' HB ' HG22 ' A' ' 71' ' ' THR . 19.6 mt -114.94 88.61 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 171.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -56.38 106.77 0.31 Allowed 'General case' 0 C--O 1.239 0.52 0 C-N-CA 126.886 2.074 . . . . 0.0 108.217 163.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -153.43 148.68 26.94 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.671 1.189 . . . . 0.0 109.93 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 54.76 28.49 10.3 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.02 41.25 71.8 Favored Glycine 0 CA--C 1.527 0.833 0 O-C-N 121.151 -0.968 . . . . 0.0 110.768 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.69 -172.13 36.71 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 127.676 2.56 . . . . 0.0 108.458 174.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -147.15 146.73 29.99 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 119.045 1.423 . . . . 0.0 113.281 174.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.52 HG22 ' HB ' ' A' ' 64' ' ' ILE . 1.2 t -82.61 164.27 20.9 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 165.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.4 m -135.83 146.36 47.42 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 126.661 1.984 . . . . 0.0 106.912 171.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.0 ptp -165.39 167.99 17.17 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.017 1.727 . . . . 0.0 108.249 168.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -140.25 142.15 35.8 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.563 1.545 . . . . 0.0 107.96 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.464 ' CD1' HG13 ' A' ' 84' ' ' ILE . 0.3 OUTLIER -125.9 153.61 43.96 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.833 1.197 . . . . 0.0 109.623 176.791 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -155.32 -175.7 5.57 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.625 1.57 . . . . 0.0 107.554 -175.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -111.86 144.62 40.88 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.708 1.603 . . . . 0.0 108.571 170.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -144.76 110.64 5.41 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 122.524 1.154 . . . . 0.0 111.096 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 66.92 4.84 3.7 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.286 1.834 . . . . 0.0 113.995 176.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 121.77 -5.34 10.63 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.573 1.082 . . . . 0.0 113.5 171.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -105.37 157.82 17.07 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 119.132 1.466 . . . . 0.0 108.443 162.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -93.82 152.4 18.93 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 169.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -143.71 162.29 36.36 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.298 0.639 . . . . 0.0 110.648 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.464 HG13 ' CD1' ' A' ' 75' ' ' TYR . 3.9 mp -117.65 124.68 73.39 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 C-N-CA 125.581 1.552 . . . . 0.0 107.824 -178.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -68.06 151.43 47.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 122.41 1.1 . . . . 0.0 109.033 168.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -169.85 167.61 4.96 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 128.729 2.812 . . . . 0.0 106.433 167.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -56.19 -161.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.817 1 C-N-CA 125.905 4.404 . . . . 0.0 110.237 164.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -43.41 -12.16 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.682 1.993 . . . . 0.0 116.009 -172.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.9 mtmt -112.1 62.3 0.62 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 120.432 1.469 . . . . 0.0 111.869 163.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -141.55 61.89 0.53 Allowed Glycine 0 C--N 1.336 0.549 0 CA-C-N 119.679 1.127 . . . . 0.0 114.304 -175.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.2 mt -136.26 46.86 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 173.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -74.99 109.48 8.49 Favored 'General case' 0 CA--C 1.507 -0.701 0 O-C-N 120.967 -1.083 . . . . 0.0 110.851 -175.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -75.57 122.1 23.39 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 165.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.6 pt -115.87 -179.93 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 125.41 1.484 . . . . 0.0 108.157 160.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -137.5 8.82 2.88 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -170.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -135.71 166.54 23.02 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 126.332 1.853 . . . . 0.0 109.134 173.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -78.28 125.51 29.45 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 170.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -62.87 -46.42 87.95 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.93 -0.481 . . . . 0.0 110.258 -178.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -69.2 -11.68 61.01 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.239 1.015 . . . . 0.0 113.052 -175.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -91.06 -14.16 31.83 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.521 1.528 . . . . 0.0 110.642 175.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 5.6 mmt -105.95 -5.22 19.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.887 1.675 . . . . 0.0 112.448 -172.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 15.9 pt . . . . . 0 C--O 1.253 1.266 0 C-N-CA 125.843 1.657 . . . . 0.0 109.555 173.898 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.8 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 48.81 86.65 0.15 Allowed Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 126.909 2.084 . . . . 0.0 114.216 166.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -57.17 167.06 3.62 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.334 1.356 . . . . 0.0 112.051 174.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 64.3 mt -96.74 134.87 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 167.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.28 155.25 61.42 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 128.272 2.629 . . . . 0.0 108.132 -172.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.452 ' HB2' HD21 ' A' ' 10' ' ' ASN . 68.9 Cg_endo -72.12 175.45 9.86 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.903 2.402 . . . . 0.0 112.273 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.501 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -77.71 153.63 32.83 Favored 'General case' 0 C--N 1.34 0.189 0 O-C-N 120.624 -1.298 . . . . 0.0 110.412 171.946 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.412 ' HB2' HD13 ' A' ' 36' ' ' LEU . . . -78.26 7.48 6.34 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.658 1.183 . . . . 0.0 112.645 175.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -133.86 5.47 3.63 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.811 1.244 . . . . 0.0 111.037 -169.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.452 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -122.94 0.65 9.19 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.927 2.091 . . . . 0.0 112.62 170.25 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 t -70.65 147.08 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 167.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -85.14 -63.5 1.32 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 161.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.6 p -153.4 170.75 19.92 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.483 0.713 . . . . 0.0 109.343 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.9 mt -125.93 126.49 69.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 173.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.9 t -100.03 133.22 44.73 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 171.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.2 mt -125.99 101.47 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 169.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.06 115.01 21.68 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 104.747 -2.316 . . . . 0.0 104.747 167.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -65.75 173.04 3.05 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.283 1.433 . . . . 0.0 109.927 176.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.0 p -69.67 -20.06 63.58 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 119.667 -1.896 . . . . 0.0 112.017 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 53.4 p30 -85.48 -165.4 1.21 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.731 0.812 . . . . 0.0 110.079 173.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.2 p -76.32 -2.51 31.99 Favored 'General case' 0 C--O 1.239 0.521 0 O-C-N 120.695 -1.253 . . . . 0.0 113.258 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.9 mt -100.47 150.52 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -166.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.78 158.79 43.51 Favored 'General case' 0 N--CA 1.417 -2.076 0 C-N-CA 125.886 1.674 . . . . 0.0 108.812 177.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.65 139.52 42.08 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 174.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.1 mp -111.17 137.77 42.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -111.26 76.12 0.96 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 103.081 -2.933 . . . . 0.0 103.081 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -82.44 -32.37 29.03 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 171.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.92 134.43 48.39 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.226 1.81 . . . . 0.0 108.334 -169.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.0 m -51.09 -47.95 61.78 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.567 0.747 . . . . 0.0 111.777 -174.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -76.82 -17.6 58.91 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.577 0.751 . . . . 0.0 111.557 -173.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 64.9 m -80.34 -38.64 30.15 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.905 1.282 . . . . 0.0 110.433 171.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.49 -53.66 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 171.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -57.79 -30.02 65.33 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.874 0.869 . . . . 0.0 112.515 -173.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.67 -61.33 2.69 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 124.008 0.923 . . . . 0.0 109.239 170.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.0 mt -45.2 -53.83 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 125.15 1.38 . . . . 0.0 111.999 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.412 HD13 ' HB2' ' A' ' 8' ' ' ALA . 1.1 mp -53.61 -24.73 14.84 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 120.192 1.36 . . . . 0.0 114.354 -175.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.8 t -55.6 -69.74 0.13 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.054 0.843 . . . . 0.0 109.745 172.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -75.88 -10.47 59.46 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.837 1.255 . . . . 0.0 111.169 -167.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.6 mm -69.56 -37.08 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 O-C-N 121.121 -0.987 . . . . 0.0 110.316 168.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.72 -11.73 30.82 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -164.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 52.5 p -62.41 -41.06 98.41 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.541 0.61 . . . . 0.0 111.558 -173.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.89 162.93 54.11 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-O 124.006 1.892 . . . . 0.0 113.354 -166.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.9 mtmm -125.51 109.08 12.26 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 -174.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 -59.61 -1.8 0.28 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 176.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.1 p 64.7 -164.19 0.25 Allowed 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.595 1.958 . . . . 0.0 107.937 -177.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -95.89 -2.54 47.1 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.577 0.626 . . . . 0.0 110.85 168.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -58.32 159.69 5.9 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 119.36 0.982 . . . . 0.0 111.506 -177.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -109.76 116.5 31.79 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.163 -169.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.1 t -98.12 68.85 1.99 Allowed 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 125.481 1.512 . . . . 0.0 108.354 -172.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.2 pt -73.59 19.59 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 126.498 1.919 . . . . 0.0 111.536 -175.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.74 173.96 7.42 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 126.264 1.825 . . . . 0.0 109.728 -167.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.12 -4.16 10.05 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.517 0.727 . . . . 0.0 110.746 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -146.79 155.85 48.14 Favored Pre-proline 0 C--O 1.234 0.266 0 CA-C-N 118.771 0.714 . . . . 0.0 110.24 -172.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -60.03 168.09 6.43 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.18 2.587 . . . . 0.0 110.376 168.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 t -104.03 23.0 13.63 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.913 1.285 . . . . 0.0 108.841 -176.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -114.66 168.95 9.43 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 128.099 2.56 . . . . 0.0 109.139 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -99.38 -29.25 12.88 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.732 1.213 . . . . 0.0 111.143 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -131.58 115.24 15.84 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -173.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -140.9 161.82 36.92 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 125.306 1.443 . . . . 0.0 107.152 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -95.78 166.7 25.15 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.24 108.21 13.02 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -159.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.1 mp -111.19 134.93 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -176.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -132.28 119.06 20.28 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 161.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.2 mt -85.99 112.23 22.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 159.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -79.85 130.28 35.18 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 167.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.05 127.09 11.96 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.623 1.569 . . . . 0.0 109.678 -178.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 46.9 45.24 15.17 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.357 1.863 . . . . 0.0 111.93 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.04 -1.59 17.07 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.498 1.047 . . . . 0.0 115.008 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -105.69 -176.73 23.96 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 168.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.2 ptp -154.57 146.94 23.92 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 120.934 -1.333 . . . . 0.0 112.838 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.1 m -103.29 96.24 6.63 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.097 2.159 . . . . 0.0 106.672 176.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.1 m -80.21 151.46 29.65 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.555 0.742 . . . . 0.0 109.249 171.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.25 165.4 5.97 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.947 2.499 . . . . 0.0 108.591 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.538 ' H ' ' HG3' ' A' ' 85' ' ' GLU . 14.1 m-85 -135.78 148.33 48.72 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 127.189 2.196 . . . . 0.0 108.04 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -125.16 162.1 25.38 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.327 0.967 . . . . 0.0 108.628 171.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -158.33 169.07 25.31 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.663 1.185 . . . . 0.0 109.553 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -97.28 142.13 29.54 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.186 1.794 . . . . 0.0 108.285 163.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -148.85 145.13 27.35 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.27 1.028 . . . . 0.0 108.516 169.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 53.43 0.42 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.681 1.992 . . . . 0.0 115.052 -174.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.79 19.35 37.47 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.104 -1.387 . . . . 0.0 113.374 -169.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -118.18 169.67 9.5 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 121.022 2.411 . . . . 0.0 107.571 161.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -108.58 145.57 34.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -142.7 162.22 36.02 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.414 0.685 . . . . 0.0 109.607 -175.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.0 mp -127.38 125.14 65.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 125.533 1.533 . . . . 0.0 108.205 -172.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.538 ' HG3' ' H ' ' A' ' 74' ' ' PHE . 0.5 OUTLIER -75.24 163.62 27.31 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.999 0.904 . . . . 0.0 108.955 172.057 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 178.74 168.5 0.58 Allowed Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 130.136 3.374 . . . . 0.0 104.783 175.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -53.76 -160.45 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.623 1 C-N-CA 125.407 4.071 . . . . 0.0 110.801 164.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -42.31 -10.18 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 128.887 2.875 . . . . 0.0 115.459 -175.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.3 59.94 0.68 Allowed 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.301 1.84 . . . . 0.0 112.678 166.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -137.53 54.19 0.71 Allowed Glycine 0 C--N 1.338 0.679 0 CA-C-N 119.819 1.191 . . . . 0.0 116.04 -174.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.7 mt -137.96 48.04 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 118.32 1.06 . . . . 0.0 108.66 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -76.65 137.05 39.19 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -118.56 91.56 3.59 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -176.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 16.0 pt -95.18 152.11 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 177.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -105.56 16.24 25.74 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.804 0.812 . . . . 0.0 112.279 -173.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -146.05 160.96 41.16 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.096 1.759 . . . . 0.0 111.004 -175.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -87.1 130.32 34.55 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.443 0.565 . . . . 0.0 111.722 -176.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -66.89 -46.57 74.51 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.549 0.739 . . . . 0.0 111.538 175.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -71.52 -19.84 62.13 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -168.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -95.54 -5.7 42.13 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 121.358 -0.839 . . . . 0.0 112.023 172.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 15.5 mmt -90.75 -28.14 18.47 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 117.387 -1.292 . . . . 0.0 112.013 169.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.7 pt . . . . . 0 C--O 1.253 1.258 0 CA-C-N 120.22 1.373 . . . . 0.0 109.594 164.709 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.063 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 m -69.88 166.04 36.33 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 126.001 1.72 . . . . 0.0 112.023 173.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -65.24 177.4 2.58 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.94 2.427 . . . . 0.0 112.227 163.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.6 mm -125.47 74.88 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 127.492 2.317 . . . . 0.0 105.716 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.84 165.94 42.31 Favored Pre-proline 0 N--CA 1.469 0.509 0 O-C-N 120.687 -1.258 . . . . 0.0 110.756 -177.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -58.7 165.09 8.55 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 120.686 0.924 . . . . 0.0 109.997 158.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.465 ' HA ' ' HE2' ' A' ' 7' ' ' LYS . 7.0 mmpt? -53.53 169.01 0.14 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.16 0.984 . . . . 0.0 111.174 169.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.9 -57.24 5.29 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 156.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -57.73 -23.04 49.93 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.411 1.484 . . . . 0.0 114.456 -165.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -95.87 -0.59 50.82 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -178.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.4 t -78.83 153.17 4.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 173.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -108.63 -46.52 3.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 118.501 -0.762 . . . . 0.0 110.163 171.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.4 p -155.27 166.45 33.53 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.039 0.836 . . . . 0.0 110.812 163.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.7 mt -122.07 119.32 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 172.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.578 ' CB ' HD12 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -103.95 128.68 51.49 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.522 0.729 . . . . 0.0 109.703 175.482 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.1 mt -127.29 112.21 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -94.1 120.15 33.95 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 165.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -70.47 -171.91 0.54 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.584 1.554 . . . . 0.0 109.987 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 p -69.15 -1.15 7.09 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 119.697 -1.877 . . . . 0.0 113.927 170.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -104.04 -154.57 0.51 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.686 1.994 . . . . 0.0 109.599 -160.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.8 p -81.12 -5.01 57.18 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 129.302 3.041 . . . . 0.0 114.273 155.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.8 mt -104.05 145.63 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.676 1.59 . . . . 0.0 110.583 -159.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -140.52 134.94 31.37 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 120.897 -1.127 . . . . 0.0 109.86 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.04 141.02 47.05 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.578 HD12 ' CB ' ' A' ' 15' ' ' CYS . 10.3 mm -124.02 156.1 31.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -174.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.427 ' CG ' HD11 ' A' ' 35' ' ' ILE . 63.9 m-85 -142.17 87.97 2.06 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 -165.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -100.53 -21.22 15.39 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.51 1.524 . . . . 0.0 111.457 178.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.12 146.02 46.0 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 t -50.51 -47.06 57.51 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.664 0.786 . . . . 0.0 110.61 171.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -68.5 -31.88 71.46 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.524 -0.735 . . . . 0.0 111.393 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 73.1 m -72.46 -47.43 48.95 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.48 1.512 . . . . 0.0 110.511 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 90.3 mt -59.4 -46.72 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.279 1.432 . . . . 0.0 108.892 174.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.47 -26.28 68.65 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 117.426 -1.273 . . . . 0.0 114.008 -175.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -63.03 -60.01 4.03 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 168.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.427 HD11 ' CG ' ' A' ' 26' ' ' TYR . 74.0 mt -52.62 -51.03 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 O-C-N 123.879 0.737 . . . . 0.0 109.378 -170.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.8 -14.69 60.02 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -178.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.9 t -76.31 -59.33 2.81 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 120.188 1.358 . . . . 0.0 108.495 163.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -61.21 -7.78 3.07 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.91 1.684 . . . . 0.0 113.558 -176.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.6 mm -114.62 -14.18 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 126.324 1.85 . . . . 0.0 111.212 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.36 -10.66 56.03 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 120.277 -1.514 . . . . 0.0 112.567 171.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.8 t -68.87 -30.4 68.9 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.845 1.258 . . . . 0.0 112.669 -170.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.56 168.41 45.89 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-O 122.089 0.827 . . . . 0.0 112.774 -176.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.98 120.83 20.79 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 124.502 1.121 . . . . 0.0 108.041 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.409 ' HB3' ' CE2' ' A' ' 92' ' ' TYR . 14.8 ptt180 -67.26 1.8 1.95 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.8 p 61.13 -163.8 0.25 Allowed 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 -175.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -108.86 13.18 25.03 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.333 0.653 . . . . 0.0 112.169 161.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.15 158.86 8.2 Favored 'General case' 0 C--O 1.239 0.529 0 O-C-N 120.519 -1.363 . . . . 0.0 108.534 161.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -119.83 130.01 54.7 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 121.305 -0.872 . . . . 0.0 109.222 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.36 160.01 30.35 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 161.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.9 pt -136.01 11.04 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.149 1.379 . . . . 0.0 110.808 168.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.16 175.83 6.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.768 1.227 . . . . 0.0 111.034 -172.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -116.82 -11.86 10.85 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.071 1.348 . . . . 0.0 111.194 -174.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -142.71 160.05 54.95 Favored Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 125.483 1.513 . . . . 0.0 109.857 -172.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -70.95 169.16 21.09 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.202 1.935 . . . . 0.0 112.694 -175.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.18 10.84 34.48 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.449 1.1 . . . . 0.0 111.809 -177.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.526 ' HB2' ' CD2' ' A' ' 76' ' ' TYR . . . -107.14 161.94 14.31 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.871 1.269 . . . . 0.0 113.469 -169.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.97 -29.89 35.23 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 126.108 1.763 . . . . 0.0 110.422 165.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -134.88 108.12 7.74 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.907 1.283 . . . . 0.0 109.623 -165.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -145.77 159.9 42.52 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.159 1.384 . . . . 0.0 109.06 -177.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.33 158.56 30.16 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 172.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.84 134.46 44.99 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.475 1.11 . . . . 0.0 108.606 174.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.96 123.64 54.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.11 137.37 46.21 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 159.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 64.7 mt -109.94 105.92 19.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 102.79 -3.041 . . . . 0.0 102.79 160.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -78.12 132.49 37.7 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 169.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -147.37 -171.94 3.9 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.839 1.656 . . . . 0.0 107.573 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -60.09 80.31 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.811 1 C-N-CA 133.867 4.867 . . . . 0.0 110.469 -168.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.02 1.64 68.99 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 114.041 -1.436 . . . . 0.0 112.891 -174.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.92 158.12 14.55 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-O 121.719 0.621 . . . . 0.0 112.092 -171.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 7.1 ptm -131.33 133.45 45.35 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 160.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.6 m -118.1 90.9 3.43 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.8 m -84.65 136.78 33.61 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.009 1.324 . . . . 0.0 109.943 -172.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.2 ptp -150.27 171.53 16.8 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.812 1.245 . . . . 0.0 109.722 172.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -142.27 147.7 36.86 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.415 ' CD1' HG13 ' A' ' 84' ' ' ILE . 0.7 OUTLIER -128.69 151.99 48.9 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.6 1.545 . . . . 0.0 108.592 175.524 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.526 ' CD2' ' HB2' ' A' ' 56' ' ' ALA . 13.2 p90 -154.84 168.61 26.33 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.857 0.863 . . . . 0.0 111.281 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -86.85 141.39 28.82 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.672 1.123 . . . . 0.0 107.992 162.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -139.26 120.29 14.57 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.908 0.861 . . . . 0.0 110.325 160.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 63.97 11.25 5.93 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.141 1.776 . . . . 0.0 113.577 170.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.95 -9.71 18.43 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.932 1.253 . . . . 0.0 112.536 173.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -103.46 159.53 15.5 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.203 1.002 . . . . 0.0 108.71 167.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -108.9 152.54 24.78 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 169.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -141.46 160.19 40.66 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 122.939 0.496 . . . . 0.0 110.225 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.415 HG13 ' CD1' ' A' ' 75' ' ' TYR . 3.0 mp -122.31 102.52 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 C-N-CA 125.004 1.322 . . . . 0.0 108.126 -171.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -62.08 145.78 52.27 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 122.882 1.325 . . . . 0.0 111.066 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.591 ' HB2' ' HA2' ' A' ' 90' ' ' GLY . 1.0 OUTLIER -164.5 167.72 9.94 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 130.037 3.335 . . . . 0.0 105.816 -178.558 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 89' ' ' LYS . 43.9 Cg_endo -56.46 -162.13 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 124.378 3.386 . . . . 0.0 109.511 166.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -43.04 -15.07 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 129.609 3.164 . . . . 0.0 115.268 -170.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.475 ' H ' ' HG2' ' A' ' 89' ' ' LYS . 2.6 ptpt -107.06 61.83 0.62 Allowed 'General case' 0 N--CA 1.425 -1.708 0 C-N-CA 130.462 3.505 . . . . 0.0 113.818 167.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.591 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . -122.32 -0.42 10.39 Favored Glycine 0 C--O 1.224 -0.479 0 N-CA-C 116.957 1.543 . . . . 0.0 116.957 -176.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.269 4.1 mt -89.59 48.21 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 O-C-N 120.313 -1.698 . . . . 0.0 109.604 -169.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.409 ' CE2' ' HB3' ' A' ' 44' ' ' ARG . 34.3 m-85 -74.3 101.83 4.16 Favored 'General case' 0 CA--C 1.504 -0.822 0 O-C-N 120.656 -1.277 . . . . 0.0 108.114 174.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -75.13 128.45 35.52 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 162.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.1 pt -114.63 171.41 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.211 1.004 . . . . 0.0 108.524 159.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -129.71 43.48 3.12 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.853 0.835 . . . . 0.0 110.467 -176.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -159.45 164.41 34.56 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 125.911 1.684 . . . . 0.0 108.389 164.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -66.52 136.71 56.05 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 162.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -80.05 -47.04 15.49 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.647 0.779 . . . . 0.0 111.598 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -58.26 -23.01 54.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.9 2.08 . . . . 0.0 113.309 -172.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -75.47 -19.31 59.5 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.952 1.251 . . . . 0.0 111.785 176.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 16.6 mmt -91.4 -14.16 31.12 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.806 1.242 . . . . 0.0 111.027 -173.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.3 pt . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.016 -1.468 . . . . 0.0 112.937 -170.92 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.687 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.25 165.7 13.05 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 124.448 1.099 . . . . 0.0 112.046 -175.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -62.06 171.4 5.07 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.271 2.647 . . . . 0.0 113.433 172.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.9 mm -87.27 131.01 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 160.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.84 162.55 48.03 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 127.115 2.166 . . . . 0.0 109.522 170.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -68.36 -178.77 1.95 Allowed 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.272 2.648 . . . . 0.0 114.082 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.3 mtmt -62.85 166.97 5.03 Favored 'General case' 0 C--N 1.344 0.367 0 O-C-N 119.547 -1.971 . . . . 0.0 109.501 159.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.1 -56.44 5.59 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 162.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -64.58 -22.48 66.98 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -163.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -85.41 0.12 53.17 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.323 0.965 . . . . 0.0 113.268 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.6 t -74.49 147.24 8.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 171.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.22 -61.26 1.55 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 169.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.6 p -164.49 127.09 2.35 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -175.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.9 mt -90.61 127.73 42.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.0 t -103.51 125.57 50.15 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 174.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.5 mt -123.88 102.09 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 175.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.57 106.33 16.06 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 169.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -59.42 170.97 0.88 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.797 1.639 . . . . 0.0 109.718 -176.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.3 p -59.77 -38.83 82.92 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 120.969 -1.082 . . . . 0.0 111.938 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -73.83 -179.39 3.65 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 127.778 2.431 . . . . 0.0 111.399 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.9 p -71.2 21.3 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.334 2.254 . . . . 0.0 113.862 -174.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.0 mt -136.07 152.18 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 126.182 1.793 . . . . 0.0 106.431 -162.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.6 167.77 18.85 Favored 'General case' 0 N--CA 1.419 -1.987 0 C-N-CA 126.565 1.946 . . . . 0.0 108.701 176.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.434 ' HB3' ' HE2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -142.64 147.44 35.79 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 165.008 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.07 126.32 74.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.573 ' CG ' HD11 ' A' ' 35' ' ' ILE . 21.6 m-85 -107.72 85.95 2.21 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 -174.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -110.33 -18.45 13.26 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.631 1.572 . . . . 0.0 110.991 175.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -69.88 146.71 51.06 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 175.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.12 -45.51 83.41 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.45 0.643 . . . . 0.0 112.164 -173.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -70.23 -31.2 68.5 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.197 -0.94 . . . . 0.0 111.708 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 52.8 p -65.94 -43.74 87.12 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 70.9 mt -62.77 -56.82 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.997 1.319 . . . . 0.0 108.758 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -56.65 -37.53 70.91 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 118.66 -0.686 . . . . 0.0 112.25 -172.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.487 ' O ' ' HE3' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -55.68 -59.78 4.37 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 176.537 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.573 HD11 ' CG ' ' A' ' 26' ' ' TYR . 85.8 mt -56.38 -46.28 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 117.685 -1.15 . . . . 0.0 111.299 -176.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.23 -20.68 2.79 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.619 1.554 . . . . 0.0 114.69 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.89 -53.73 7.98 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.95 0.9 . . . . 0.0 111.509 172.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -59.27 -35.33 73.53 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.949 -1.094 . . . . 0.0 110.342 177.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 21.2 mm -61.55 -24.46 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 120.532 -1.355 . . . . 0.0 111.168 175.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -98.09 -6.6 31.34 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.883 1.22 . . . . 0.0 113.145 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 t -70.78 -34.14 71.48 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.052 0.842 . . . . 0.0 109.652 -168.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.25 167.75 47.63 Favored Glycine 0 C--N 1.341 0.842 0 O-C-N 120.771 -1.205 . . . . 0.0 113.863 -173.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -131.59 110.25 10.81 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 -174.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.427 ' HB3' ' CE1' ' A' ' 92' ' ' TYR . 13.3 ptt-85 -60.06 -8.53 2.43 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -176.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . 0.272 1.4 p 57.36 172.52 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 127.743 2.417 . . . . 0.0 109.846 -169.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -83.24 2.29 36.57 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.421 -1.424 . . . . 0.0 111.594 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt -65.34 158.87 25.33 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 122.049 0.928 . . . . 0.0 110.182 174.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -90.55 130.04 36.63 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 165.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.1 m -75.18 158.87 32.32 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 153.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.9 pt -142.52 31.76 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 125.0 1.32 . . . . 0.0 110.336 174.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -131.15 172.54 12.0 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.953 1.701 . . . . 0.0 108.217 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.55 -0.67 2.89 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.26 1.024 . . . . 0.0 110.996 177.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -146.01 160.65 42.63 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 127.377 2.271 . . . . 0.0 108.607 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -80.33 177.99 7.59 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.452 2.768 . . . . 0.0 112.076 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.9 4.28 8.05 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.713 1.205 . . . . 0.0 112.399 175.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.41 150.72 46.96 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.306 1.042 . . . . 0.0 110.217 170.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -74.56 -28.64 61.03 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.995 0.518 . . . . 0.0 110.062 172.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -129.99 127.73 40.59 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.157 1.383 . . . . 0.0 109.183 -176.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -154.27 161.94 41.49 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.704 2.002 . . . . 0.0 108.147 176.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -90.73 159.63 27.02 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 171.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.34 137.27 38.99 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.16 130.75 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -125.07 130.21 51.8 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 163.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 62.0 mt -106.76 83.57 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 171.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.77 118.49 5.36 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.941 1.246 . . . . 0.0 109.274 167.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -144.88 119.9 10.04 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.675 1.59 . . . . 0.0 108.271 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.5 m120 60.87 22.98 13.04 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.774 1.63 . . . . 0.0 112.219 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.54 -3.27 42.65 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.51 1.052 . . . . 0.0 113.224 -174.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.88 178.17 51.11 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 156.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 19.7 ptp -159.39 161.27 35.61 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.542 -0.975 . . . . 0.0 112.768 177.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.4 m -118.72 112.26 19.54 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.016 1.726 . . . . 0.0 106.914 172.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.0 m -81.19 147.27 30.09 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 168.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 2.6 ptp -160.11 171.49 19.19 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.164 1.786 . . . . 0.0 108.153 165.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -142.74 146.42 34.3 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.247 1.819 . . . . 0.0 106.474 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.437 ' CD1' HG13 ' A' ' 84' ' ' ILE . 0.6 OUTLIER -128.51 153.5 47.1 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.788 1.631 . . . . 0.0 109.807 175.857 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -153.48 174.86 13.85 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.807 1.243 . . . . 0.0 110.267 -175.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -105.98 144.02 33.29 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.429 1.892 . . . . 0.0 107.961 169.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -151.49 131.1 13.07 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 176.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 55.3 14.51 1.1 Allowed 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.89 -1.131 . . . . 0.0 113.487 -176.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.51 12.09 73.37 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 120.505 -1.372 . . . . 0.0 111.888 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.96 165.07 11.85 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.563 1.945 . . . . 0.0 107.371 163.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -112.24 150.92 30.23 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.083 0.856 . . . . 0.0 108.75 178.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -141.03 159.48 42.12 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.895 0.378 . . . . 0.0 111.167 -178.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.437 HG13 ' CD1' ' A' ' 75' ' ' TYR . 3.5 mp -117.73 129.96 73.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 125.534 1.534 . . . . 0.0 108.45 178.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -73.63 150.03 41.63 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 122.847 1.308 . . . . 0.0 109.831 169.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -169.72 167.44 5.16 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 129.24 3.016 . . . . 0.0 105.928 174.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -59.67 -160.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 125.175 3.917 . . . . 0.0 109.531 162.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -42.77 -9.24 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 128.472 2.709 . . . . 0.0 117.058 -169.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -107.46 21.97 16.67 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 173.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -105.49 44.01 1.56 Allowed Glycine 0 N--CA 1.45 -0.429 0 CA-C-O 118.587 -1.118 . . . . 0.0 115.872 -167.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.4 mt -109.35 46.56 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 119.752 1.776 . . . . 0.0 108.767 171.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.427 ' CE1' ' HB3' ' A' ' 44' ' ' ARG . 72.3 m-85 -71.89 103.57 3.21 Favored 'General case' 0 CA--C 1.51 -0.582 0 O-C-N 121.193 -0.942 . . . . 0.0 108.767 177.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -68.49 126.91 31.12 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 157.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.9 pt -117.74 161.1 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 154.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -104.39 -9.49 18.43 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.658 -0.651 . . . . 0.0 110.774 -176.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -137.81 144.78 41.69 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 124.401 1.08 . . . . 0.0 110.489 -172.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -65.4 124.31 21.91 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 126.388 1.875 . . . . 0.0 112.291 -172.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -63.72 -48.75 75.81 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.808 1.243 . . . . 0.0 110.986 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -65.13 -9.71 25.07 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -174.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -109.22 -9.0 15.03 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.889 1.222 . . . . 0.0 111.819 173.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 10.9 mmt -89.6 -19.95 24.33 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.048 1.339 . . . . 0.0 111.775 174.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 18.3 pt . . . . . 0 C--O 1.255 1.363 0 C-N-CA 124.124 0.969 . . . . 0.0 110.947 174.27 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.737 0 CA-C-O 119.01 -0.884 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.4 m 75.8 165.54 0.13 Allowed Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 127.261 2.224 . . . . 0.0 112.186 -163.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.53 -173.21 0.11 Allowed 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.842 3.028 . . . . 0.0 111.816 158.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.8 mt -124.27 119.78 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 164.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.7 157.14 76.18 Favored Pre-proline 0 C--O 1.239 0.542 0 C-N-CA 125.324 1.449 . . . . 0.0 109.135 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.25 165.46 32.37 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.761 2.307 . . . . 0.0 111.513 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -64.46 154.78 34.77 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.335 -0.853 . . . . 0.0 111.261 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.478 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . . . -57.24 -50.5 72.69 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.394 0.997 . . . . 0.0 108.963 167.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -67.45 -16.84 64.44 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -169.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -104.38 1.89 30.66 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 119.582 1.083 . . . . 0.0 113.549 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 t -83.66 135.89 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 172.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -83.82 -60.36 2.14 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.4 p -148.75 169.88 19.46 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.362 1.465 . . . . 0.0 109.553 169.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.3 mt -124.84 144.48 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 N-CA-C 104.578 -2.378 . . . . 0.0 104.578 171.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.83 145.16 49.92 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 174.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.0 mt -134.66 105.74 6.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 178.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -86.37 110.59 19.79 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 102.839 -3.023 . . . . 0.0 102.839 174.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -66.12 173.28 3.18 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 174.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.3 p -56.85 -20.32 22.24 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -103.76 -175.83 2.91 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.197 1.399 . . . . 0.0 109.413 -178.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.4 p -75.65 42.38 0.22 Allowed 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.768 2.027 . . . . 0.0 111.655 -178.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.6 mt -140.11 136.35 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 126.196 1.798 . . . . 0.0 106.313 -172.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.38 150.59 46.7 Favored 'General case' 0 N--CA 1.421 -1.918 0 C-N-CA 125.427 1.491 . . . . 0.0 109.135 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.451 ' HE2' ' CZ ' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -125.28 142.11 51.69 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.377 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.44 145.33 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.451 ' CZ ' ' HE2' ' A' ' 24' ' ' LYS . 24.3 m-85 -127.24 82.49 2.09 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -170.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -88.34 -19.53 26.55 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.378 1.471 . . . . 0.0 112.102 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.99 139.81 30.48 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.47 1.108 . . . . 0.0 111.242 -174.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.4 t -45.2 -54.57 6.77 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 126.463 1.905 . . . . 0.0 112.896 -177.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -67.14 -38.99 86.49 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.527 -0.733 . . . . 0.0 109.753 -173.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.4 m -65.9 -6.42 12.28 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.304 1.842 . . . . 0.0 113.389 171.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -100.66 -45.54 11.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 120.451 1.478 . . . . 0.0 109.316 171.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -60.38 -33.0 71.84 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.885 0.874 . . . . 0.0 112.887 -174.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.13 -52.28 43.64 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.672 0.669 . . . . 0.0 110.39 176.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.2 mt -49.24 -52.0 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 119.43 1.014 . . . . 0.0 110.546 173.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.478 ' CD1' ' HB2' ' A' ' 8' ' ' ALA . 38.9 mt -56.81 -21.32 27.93 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -177.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.5 t -67.19 -65.37 0.69 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.485 1.039 . . . . 0.0 108.56 168.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.39 -29.87 70.13 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.48 -0.763 . . . . 0.0 110.544 -168.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.96 -20.29 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.325 1.05 . . . . 0.0 111.141 174.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.71 -3.47 8.74 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 120.004 1.275 . . . . 0.0 114.222 -170.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 t -66.38 -40.15 89.51 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.586 0.754 . . . . 0.0 110.335 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.64 172.32 53.94 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-O 123.134 1.408 . . . . 0.0 114.19 -169.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -140.7 121.63 14.55 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 114.238 -0.981 . . . . 0.0 108.41 -173.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -63.82 -4.85 3.53 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.521 1.528 . . . . 0.0 114.796 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.1 p 59.83 -164.55 0.22 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.2 1.8 . . . . 0.0 108.379 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -100.31 8.81 43.46 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 120.235 -1.54 . . . . 0.0 112.48 173.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -64.06 154.21 35.06 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.736 -0.602 . . . . 0.0 109.93 173.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -94.81 123.76 38.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 165.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.2 t -70.98 151.73 44.34 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 147.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 pp -141.33 7.57 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.866 2.066 . . . . 0.0 109.687 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.11 162.14 24.17 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.535 1.934 . . . . 0.0 109.76 -174.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -102.3 -1.57 30.77 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.121 0.968 . . . . 0.0 110.699 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -141.55 147.32 45.56 Favored Pre-proline 0 C--O 1.235 0.305 0 CA-C-N 119.394 0.997 . . . . 0.0 111.532 -172.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.446 ' HG2' ' CD2' ' A' ' 59' ' ' TYR . 19.5 Cg_endo -67.98 162.08 41.41 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.218 3.279 . . . . 0.0 111.402 -176.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.81 35.66 1.66 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.048 2.139 . . . . 0.0 109.235 174.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.8 152.79 41.84 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.765 1.626 . . . . 0.0 110.292 173.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -87.67 -29.32 21.23 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.681 -172.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -128.13 118.44 23.41 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 176.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.446 ' CD2' ' HG2' ' A' ' 54' ' ' PRO . 49.4 p90 -138.19 156.47 47.68 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.641 1.576 . . . . 0.0 108.209 175.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.37 -178.0 16.49 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 125.822 1.677 . . . . 0.0 110.12 171.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 36.5 m -131.75 137.17 48.1 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 117.731 0.765 . . . . 0.0 111.953 -158.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 mp -118.72 135.2 59.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 126.179 1.791 . . . . 0.0 107.018 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -127.67 125.45 40.1 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 172.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.7 mt -99.87 118.24 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.116 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 168.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -82.25 133.1 35.23 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 165.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -140.26 -162.72 1.39 Allowed 'General case' 0 C--N 1.327 -0.404 0 O-C-N 120.845 -1.159 . . . . 0.0 108.05 173.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -44.77 -35.74 2.87 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 129.886 3.275 . . . . 0.0 115.565 -157.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -176.13 20.41 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 124.895 1.235 . . . . 0.0 110.39 -167.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -165.18 170.72 40.28 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 171.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.9 ptt? -118.84 156.1 30.03 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.3 1.44 . . . . 0.0 109.834 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 m -126.87 108.02 10.63 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -176.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.4 m -108.52 143.61 37.29 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.705 0.802 . . . . 0.0 110.271 -172.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.94 165.98 33.78 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.526 1.531 . . . . 0.0 109.306 172.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -112.84 176.36 5.05 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.691 1.597 . . . . 0.0 108.928 170.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -142.7 165.62 26.88 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.278 1.431 . . . . 0.0 108.593 170.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -158.46 170.8 21.39 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.111 0.869 . . . . 0.0 112.267 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -106.53 134.29 49.9 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 162.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.31 -162.52 0.08 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 125.824 1.65 . . . . 0.0 106.888 153.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -74.28 50.97 0.41 Allowed 'General case' 0 C--N 1.321 -0.66 0 O-C-N 119.952 -1.717 . . . . 0.0 111.316 174.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 122.07 -14.97 8.91 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 125.108 1.337 . . . . 0.0 112.286 166.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -89.18 154.35 20.21 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.481 1.14 . . . . 0.0 110.728 165.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -114.79 152.68 31.7 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.776 0.716 . . . . 0.0 111.264 -178.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -152.23 163.68 38.93 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.84 0.856 . . . . 0.0 111.879 -169.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.9 mp -131.14 132.58 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.708 1.603 . . . . 0.0 109.767 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.1 tp10 -85.0 165.39 17.6 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.181 2.192 . . . . 0.0 109.994 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.504 ' HB2' ' HA2' ' A' ' 90' ' ' GLY . 0.7 OUTLIER 174.43 168.31 0.32 Allowed Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 128.032 2.533 . . . . 0.0 107.289 -164.421 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.406 ' O ' ' N ' ' A' ' 89' ' ' LYS . 39.5 Cg_endo -59.2 -161.27 0.02 OUTLIER 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.338 2.692 . . . . 0.0 109.672 160.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -42.57 -6.74 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 130.397 3.479 . . . . 0.0 117.733 -170.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 87' ' ' PRO 0.266 1.2 ptpt -109.72 13.4 23.74 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 129.758 3.223 . . . . 0.0 113.285 179.531 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.504 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . -94.18 49.98 2.17 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 123.78 0.705 . . . . 0.0 114.25 -168.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.1 mt -127.79 46.22 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 176.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -72.85 96.38 2.07 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 173.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -74.43 121.08 20.88 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 166.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 27.3 pt -115.75 169.44 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.485 1.114 . . . . 0.0 109.553 166.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -128.37 49.99 2.13 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.24 0.616 . . . . 0.0 109.951 -178.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -166.7 165.21 16.6 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.554 1.541 . . . . 0.0 110.785 165.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -73.62 131.65 41.91 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.194 0.998 . . . . 0.0 108.996 174.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -72.38 -49.14 36.16 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.798 0.727 . . . . 0.0 111.742 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -70.91 -26.13 63.07 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.337 -0.852 . . . . 0.0 113.023 -168.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -72.11 -19.58 61.77 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.153 0.888 . . . . 0.0 111.425 171.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 17.1 mmt -105.81 24.06 12.91 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.571 1.948 . . . . 0.0 111.965 -171.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.2 pt . . . . . 0 C--O 1.257 1.448 0 C-N-CA 125.188 1.395 . . . . 0.0 109.836 169.581 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.954 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 m 62.59 167.19 0.1 Allowed Pre-proline 0 CA--C 1.547 0.851 0 CA-C-N 118.914 1.357 . . . . 0.0 114.298 158.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.77 161.54 45.53 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 O-C-N 118.716 -1.255 . . . . 0.0 111.141 166.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.7 mt -116.45 104.79 17.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.42 158.84 68.37 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 126.986 2.114 . . . . 0.0 110.676 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -68.77 -175.43 0.93 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.6 2.867 . . . . 0.0 112.662 177.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt -60.82 175.94 0.44 Allowed 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.109 -1.62 . . . . 0.0 109.569 162.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.18 -50.01 10.11 Favored 'General case' 0 C--O 1.221 -0.428 0 O-C-N 121.255 -0.903 . . . . 0.0 109.539 163.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -62.13 -12.31 18.94 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.683 1.593 . . . . 0.0 114.771 -168.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -104.83 -0.62 27.0 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.71 2.004 . . . . 0.0 113.187 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 66.5 t -86.01 130.17 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 172.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -67.26 -69.52 0.31 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 167.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.6 m -149.51 170.53 18.4 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.112 0.965 . . . . 0.0 109.984 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.1 mt -131.75 132.97 61.81 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.994 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 172.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.6 m -99.68 133.0 44.65 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 112.787 -2.006 . . . . 0.0 106.069 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.0 mt -133.99 103.65 5.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 170.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -93.97 98.93 11.37 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.172 1.789 . . . . 0.0 106.274 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -60.74 172.83 0.85 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.469 1.908 . . . . 0.0 111.55 -169.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.3 p -51.83 -42.59 62.66 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.962 0.905 . . . . 0.0 110.393 171.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -91.64 -179.2 5.28 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.188 1.795 . . . . 0.0 111.338 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 98.2 p -72.87 16.9 0.13 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.313 1.445 . . . . 0.0 114.818 -158.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.8 mt -120.8 139.91 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -161.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -124.19 107.13 10.89 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 174.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.26 139.85 42.81 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 166.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.0 mt -118.17 136.15 56.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 168.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -110.86 73.87 0.84 Allowed 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 104.243 -2.502 . . . . 0.0 104.243 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -82.12 16.1 2.09 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.808 1.243 . . . . 0.0 111.72 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.51 140.44 52.2 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.707 1.203 . . . . 0.0 109.94 -167.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.8 t -55.75 -46.07 77.92 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.92 0.888 . . . . 0.0 111.636 -175.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -73.66 -31.85 63.68 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.378 -0.826 . . . . 0.0 112.111 -175.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.4 m -65.8 -43.29 89.14 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 127.685 2.394 . . . . 0.0 111.036 174.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.5 mt -64.76 -52.11 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 172.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -60.81 -21.93 63.63 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -65.16 -67.56 0.43 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 119.57 1.077 . . . . 0.0 108.495 166.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.6 mt -50.65 -44.48 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.549 1.14 . . . . 0.0 110.543 -170.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.82 -12.4 0.79 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 177.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.4 t -84.44 -62.94 1.43 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.041 2.136 . . . . 0.0 110.814 168.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -57.65 -14.7 5.88 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.646 1.112 . . . . 0.0 113.435 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.4 mm -82.3 -49.66 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 124.429 1.092 . . . . 0.0 110.736 169.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.96 -19.78 46.32 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.342 1.057 . . . . 0.0 113.713 -173.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 t -68.51 -17.4 64.16 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.668 1.187 . . . . 0.0 112.87 -176.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.62 140.2 40.37 Favored Glycine 0 C--N 1.336 0.557 0 O-C-N 119.612 -1.93 . . . . 0.0 112.389 176.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -108.41 107.34 17.86 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 161.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.7 ptt85 -59.79 -6.48 1.25 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.712 1.142 . . . . 0.0 113.109 168.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.8 p 61.33 -174.85 0.13 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.688 1.595 . . . . 0.0 110.736 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -74.94 -12.71 60.41 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.23 -1.544 . . . . 0.0 112.216 176.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -71.92 171.31 11.99 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.117 0.961 . . . . 0.0 111.35 -167.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -110.74 128.43 55.73 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.824 1.25 . . . . 0.0 108.173 173.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.5 t -74.94 162.58 28.48 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 156.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.9 pt -146.52 31.69 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 126.489 1.915 . . . . 0.0 109.83 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -139.63 172.23 13.09 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 120.99 -1.069 . . . . 0.0 111.64 -172.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -111.12 -20.36 12.39 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.428 1.891 . . . . 0.0 111.52 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -147.26 158.27 44.46 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 124.025 0.93 . . . . 0.0 110.676 -165.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -70.29 175.55 8.39 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.737 2.958 . . . . 0.0 111.699 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.27 -5.12 11.83 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.509 1.524 . . . . 0.0 111.539 175.113 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.44 157.8 36.4 Favored 'General case' 0 N--CA 1.457 -0.114 0 O-C-N 120.837 -1.165 . . . . 0.0 109.249 169.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.16 -21.66 21.05 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.602 0.761 . . . . 0.0 111.283 168.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -127.96 103.01 7.01 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -169.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -146.56 177.48 9.03 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 128.601 2.76 . . . . 0.0 106.695 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -121.61 166.24 14.45 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 168.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.96 133.07 42.1 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.159 0.984 . . . . 0.0 108.601 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.0 mp -124.33 129.93 73.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -132.64 115.47 15.45 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.0 mt -87.49 103.63 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 173.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -74.76 122.81 23.87 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 172.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -141.67 -157.21 0.75 Allowed 'General case' 0 N--CA 1.465 0.299 0 O-C-N 120.866 -1.146 . . . . 0.0 110.502 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -44.56 -21.21 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 1 C-N-CA 132.796 4.438 . . . . 0.0 116.501 -160.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 153.03 32.19 0.03 OUTLIER Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 126.048 1.785 . . . . 0.0 108.954 -162.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -172.97 174.1 45.77 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.2 ptp -117.93 160.29 21.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.909 1.684 . . . . 0.0 109.351 176.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.6 m -123.29 104.75 9.33 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 158.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.6 m -82.84 141.8 32.0 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.339 1.456 . . . . 0.0 108.591 172.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -165.32 167.99 17.31 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.355 1.862 . . . . 0.0 108.309 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -146.01 138.75 25.64 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.787 1.635 . . . . 0.0 107.421 -174.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.454 ' CE1' HG23 ' A' ' 84' ' ' ILE . 1.8 m-85 -126.06 142.88 51.33 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 121.06 1.754 . . . . 0.0 109.732 -177.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -149.52 173.74 13.27 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.564 1.146 . . . . 0.0 111.583 -174.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -103.45 144.9 30.79 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.284 1.433 . . . . 0.0 108.883 166.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -144.97 126.98 15.52 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.033 0.933 . . . . 0.0 109.313 173.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.14 3.84 1.42 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.847 2.059 . . . . 0.0 114.824 176.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.7 -0.37 15.52 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-N 119.579 1.081 . . . . 0.0 113.315 -173.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.5 tptt -133.87 149.94 51.35 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 119.358 1.579 . . . . 0.0 110.177 -169.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -101.52 135.53 42.86 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -168.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -129.55 159.53 36.06 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.05 0.54 . . . . 0.0 111.055 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.454 HG23 ' CE1' ' A' ' 75' ' ' TYR . 2.9 mp -122.05 117.91 53.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 125.073 1.349 . . . . 0.0 108.428 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -65.25 145.6 56.03 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 122.793 1.282 . . . . 0.0 109.655 173.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -171.2 165.76 4.56 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 127.442 2.297 . . . . 0.0 106.532 175.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.404 ' O ' ' N ' ' A' ' 89' ' ' LYS . 94.2 Cg_endo -63.35 -161.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.769 1 C-N-CA 125.401 4.067 . . . . 0.0 109.517 174.49 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -43.41 -13.98 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 117.065 2.246 . . . . 0.0 117.065 -170.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 87' ' ' PRO . 2.8 mtmt -103.18 31.54 4.22 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 126.237 1.815 . . . . 0.0 114.224 169.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -118.23 69.8 0.32 Allowed Glycine 0 C--O 1.221 -0.693 0 C-N-CA 124.566 1.079 . . . . 0.0 111.963 -174.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.1 mt -133.39 53.01 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 166.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -75.44 108.67 8.4 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 121.463 -0.773 . . . . 0.0 109.029 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -83.37 125.06 31.26 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 163.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.8 pt -113.32 167.31 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.164 1.385 . . . . 0.0 108.726 164.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -124.95 46.53 2.32 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.388 0.613 . . . . 0.0 110.853 -174.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -177.13 169.63 2.29 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 127.456 2.302 . . . . 0.0 109.311 168.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -74.75 138.08 42.45 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.653 1.181 . . . . 0.0 109.739 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -79.4 -44.84 20.66 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.283 1.033 . . . . 0.0 111.819 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.0 -12.54 60.16 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.913 1.285 . . . . 0.0 113.623 -171.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -88.72 -22.47 23.34 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.374 1.47 . . . . 0.0 113.011 171.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -81.49 -29.67 33.56 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 121.092 -1.005 . . . . 0.0 110.541 -178.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 29.3 pt . . . . . 0 C--O 1.25 1.096 0 C-N-CA 123.876 0.87 . . . . 0.0 110.984 -178.29 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.888 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 m -79.56 164.55 53.16 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 117.772 0.786 . . . . 0.0 112.805 -169.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -64.14 -179.72 0.9 Allowed 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.799 2.999 . . . . 0.0 112.625 162.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.3 mt -125.58 94.7 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 127.107 2.163 . . . . 0.0 105.575 178.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.82 154.39 37.55 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 126.329 1.851 . . . . 0.0 109.36 -176.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.62 159.01 55.39 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.606 2.204 . . . . 0.0 112.108 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.39 150.78 38.79 Favored 'General case' 0 C--N 1.345 0.376 0 O-C-N 121.696 -0.628 . . . . 0.0 110.496 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.467 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . . . -68.2 -1.15 5.55 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 177.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -122.5 -18.03 6.81 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 119.533 1.061 . . . . 0.0 111.671 -172.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -89.11 -6.75 56.81 Favored 'General case' 0 N--CA 1.456 -0.155 0 O-C-N 121.714 -0.616 . . . . 0.0 111.141 170.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.8 t -69.06 138.06 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 C-N-CA 125.151 1.38 . . . . 0.0 108.573 169.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.4 -55.88 2.7 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.934 1.694 . . . . 0.0 107.787 173.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.7 p -172.67 121.47 0.41 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.508 0.595 . . . . 0.0 111.119 178.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.7 mt -75.39 129.89 36.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 173.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 t -105.58 148.73 26.97 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 166.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.7 mt -139.0 104.83 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 172.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.8 110.06 18.54 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 104.146 -2.539 . . . . 0.0 104.146 165.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -66.21 -176.43 0.42 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.222 1.009 . . . . 0.0 110.999 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.1 p -57.62 -50.55 72.79 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 120.799 -1.188 . . . . 0.0 109.96 173.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.95 -178.48 2.8 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.701 0.762 . . . . 0.0 109.644 173.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 m -80.94 17.28 1.23 Allowed 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.889 -1.132 . . . . 0.0 111.258 -175.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.7 mt -90.14 134.48 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -127.85 142.93 51.15 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.414 ' HE2' ' CZ ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -131.83 149.22 52.52 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 123.567 0.747 . . . . 0.0 109.214 175.205 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.1 mp -121.8 147.43 25.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.414 ' CZ ' ' HE2' ' A' ' 24' ' ' LYS . 79.6 m-85 -127.45 76.79 1.7 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 -168.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -105.01 5.21 32.41 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.804 1.241 . . . . 0.0 112.613 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -81.72 144.49 31.1 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 166.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 28.6 t -57.83 -41.35 82.08 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.421 -1.424 . . . . 0.0 111.663 174.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.44 -33.78 76.66 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 120.658 -1.276 . . . . 0.0 111.994 178.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.2 p -63.05 -43.09 99.6 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.848 0.859 . . . . 0.0 109.538 175.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 93.0 mt -68.41 -54.5 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 124.62 1.168 . . . . 0.0 108.892 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -58.09 -32.88 68.49 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.706 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -61.68 -64.32 0.98 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 118.551 -0.738 . . . . 0.0 110.233 171.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 81.4 mt -51.6 -48.68 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 119.199 -0.429 . . . . 0.0 110.072 -173.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.467 ' CD1' ' HB2' ' A' ' 8' ' ' ALA . 21.6 mt -53.47 -24.9 14.27 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.2 t -63.91 -63.1 1.25 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.775 1.23 . . . . 0.0 110.072 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -68.87 -24.17 64.31 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.889 0.852 . . . . 0.0 110.724 -174.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.9 mm -68.15 -13.33 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 O-C-N 120.48 -1.387 . . . . 0.0 111.21 171.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.64 -8.45 11.46 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -176.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.4 p -67.77 -40.6 84.01 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.648 1.113 . . . . 0.0 111.608 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.77 164.52 54.59 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-O 123.117 1.398 . . . . 0.0 114.299 -165.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.42 ' C ' ' H ' ' A' ' 45' ' ' THR . 91.6 mttt -115.91 110.49 19.07 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 105.107 -2.182 . . . . 0.0 105.107 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.434 ' HB3' ' CE2' ' A' ' 92' ' ' TYR . 10.3 ptt180 -56.55 -3.95 0.13 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.872 1.269 . . . . 0.0 114.36 174.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.42 ' H ' ' C ' ' A' ' 43' ' ' LYS . 27.7 p 62.7 172.95 0.14 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 128.752 2.821 . . . . 0.0 110.396 -171.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.409 ' HG2' ' H ' ' A' ' 46' ' ' GLU . 8.6 pt-20 -78.37 -6.42 55.11 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.004 -1.06 . . . . 0.0 111.666 172.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -66.91 174.01 3.27 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 122.776 1.274 . . . . 0.0 111.981 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -110.75 150.18 29.45 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.23 1.812 . . . . 0.0 107.752 175.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.7 76.69 1.65 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -164.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.2 pt -90.54 36.14 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.531 1.132 . . . . 0.0 110.542 -164.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -125.35 161.63 26.57 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.295 2.238 . . . . 0.0 109.337 -172.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.99 -3.28 8.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.367 -1.288 . . . . 0.0 112.736 -178.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -150.12 164.61 20.0 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 126.262 1.825 . . . . 0.0 108.638 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.28 179.14 3.64 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.258 2.638 . . . . 0.0 112.678 173.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.66 6.29 45.66 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.154 1.381 . . . . 0.0 111.658 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.13 156.43 17.42 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 121.36 -0.837 . . . . 0.0 111.977 -175.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -86.17 -22.23 27.11 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.795 1.638 . . . . 0.0 111.221 170.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -135.1 115.95 14.01 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -143.07 159.95 41.31 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 127.207 2.203 . . . . 0.0 106.003 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.85 162.59 25.32 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 167.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.8 m -118.11 125.24 49.87 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.104 1.361 . . . . 0.0 108.233 -175.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.2 mp -121.35 132.21 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 -172.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -123.53 115.74 22.03 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 175.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.5 mt -91.17 86.08 2.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 173.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -65.45 113.66 4.29 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 173.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -140.66 135.43 31.65 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.588 1.555 . . . . 0.0 108.17 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.5 m120 61.5 -4.03 0.18 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.919 2.088 . . . . 0.0 115.443 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.8 12.13 26.87 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 119.89 1.223 . . . . 0.0 112.321 -173.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -127.94 -175.96 14.28 Favored Glycine 0 C--N 1.335 0.511 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 165.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.94 138.25 22.88 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 118.122 0.961 . . . . 0.0 113.149 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 86.8 m -75.23 106.03 6.55 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 158.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.4 m -73.55 142.58 46.65 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 163.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -161.09 166.62 27.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.598 1.559 . . . . 0.0 108.727 170.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -140.99 146.88 37.87 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.619 1.568 . . . . 0.0 108.119 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.426 ' CD1' HG13 ' A' ' 84' ' ' ILE . 1.4 m-85 -128.31 147.35 50.61 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 120.211 1.369 . . . . 0.0 108.973 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -148.9 -175.37 4.92 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.97 1.308 . . . . 0.0 110.538 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -119.04 138.92 52.52 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.176 1.79 . . . . 0.0 109.47 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.487 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 7.6 tt0 -142.84 91.21 2.28 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.886 0.874 . . . . 0.0 109.31 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 70.73 19.4 5.99 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 128.214 2.606 . . . . 0.0 112.484 -174.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.15 -3.67 62.12 Favored Glycine 0 C--N 1.335 0.517 0 O-C-N 120.972 -1.08 . . . . 0.0 112.36 168.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -83.8 145.68 28.55 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 154.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -100.29 149.66 23.37 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.487 ' CE1' ' HB3' ' A' ' 78' ' ' GLU . 84.9 m-85 -134.43 135.09 42.29 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 123.173 0.589 . . . . 0.0 109.734 -171.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.426 HG13 ' CD1' ' A' ' 75' ' ' TYR . 3.0 mp -107.18 127.46 62.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -176.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -77.61 152.36 33.93 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.258 1.423 . . . . 0.0 109.943 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -172.79 168.77 2.61 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 129.131 2.972 . . . . 0.0 107.372 177.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -56.04 -161.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 125.009 3.806 . . . . 0.0 110.606 162.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -42.72 -14.69 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 128.695 2.798 . . . . 0.0 115.028 -171.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.15 66.91 0.64 Allowed 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.364 1.466 . . . . 0.0 110.616 166.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.8 53.13 0.77 Allowed Glycine 0 C--O 1.223 -0.542 0 C-N-CA 124.661 1.124 . . . . 0.0 114.953 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.5 mt -131.44 61.15 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.434 ' CE2' ' HB3' ' A' ' 44' ' ' ARG . 23.4 m-85 -87.56 98.27 11.31 Favored 'General case' 0 CA--C 1.521 -0.168 0 O-C-N 121.165 -0.959 . . . . 0.0 109.304 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -79.06 81.37 5.33 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.55 1.54 . . . . 0.0 109.049 176.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 21.8 pt -81.74 159.41 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 O-C-N 120.877 -1.14 . . . . 0.0 109.439 175.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -107.27 10.74 29.75 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -177.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -131.82 147.32 52.48 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 124.787 1.235 . . . . 0.0 112.433 -175.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -74.07 110.26 8.22 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -55.26 -43.0 74.26 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.035 0.934 . . . . 0.0 110.854 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -73.91 -13.06 60.84 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -171.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -90.43 -24.7 20.66 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.022 0.929 . . . . 0.0 110.789 165.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 12.1 mmt -96.54 6.3 49.02 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 126.124 1.77 . . . . 0.0 113.293 -172.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.4 pt . . . . . 0 C--O 1.246 0.873 0 CA-C-N 119.608 1.095 . . . . 0.0 108.343 164.234 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.635 0 CA-C-O 118.883 -0.954 . . . . 0.0 111.279 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 66.05 166.52 0.12 Allowed Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 149.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -70.23 173.37 11.49 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.74 2.294 . . . . 0.0 112.252 156.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.5 mt -120.89 98.06 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 175.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.56 165.06 15.42 Favored Pre-proline 0 C--O 1.239 0.532 0 C-N-CA 125.381 1.472 . . . . 0.0 110.086 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.432 ' HB2' HD21 ' A' ' 10' ' ' ASN . 68.2 Cg_endo -63.14 -179.81 0.66 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.348 2.032 . . . . 0.0 111.28 161.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.552 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -64.96 -175.4 0.19 Allowed 'General case' 0 C--O 1.232 0.157 0 O-C-N 120.943 -1.098 . . . . 0.0 109.823 165.164 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.66 -42.93 13.02 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 163.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -72.62 -0.6 13.4 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.282 1.433 . . . . 0.0 113.456 -159.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.517 ' H ' HD22 ' A' ' 10' ' ' ASN . 0.1 OUTLIER -124.43 -0.04 8.22 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 129.919 3.287 . . . . 0.0 111.919 -170.135 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.2 t -84.63 128.5 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 176.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -81.66 -56.42 4.02 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 124.905 1.282 . . . . 0.0 109.416 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.29 155.38 40.45 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.598 0.759 . . . . 0.0 109.348 166.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 51.8 mt -104.14 140.95 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 162.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.8 t -127.61 132.18 49.83 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.2 mt -125.63 106.36 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 174.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.56 110.2 17.45 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 169.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -68.74 170.85 8.68 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.889 1.275 . . . . 0.0 111.255 -174.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.9 p -58.45 -29.6 66.28 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.97 1.708 . . . . 0.0 113.522 176.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.505 ' CG ' ' H ' ' A' ' 21' ' ' SER . 46.9 t30 -86.64 -154.6 0.23 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.771 1.228 . . . . 0.0 108.159 177.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.505 ' H ' ' CG ' ' A' ' 20' ' ' ASN . 23.4 t -102.57 37.33 1.94 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.603 1.961 . . . . 0.0 109.595 -177.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.9 mt -132.02 155.71 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 126.612 1.965 . . . . 0.0 106.749 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.4 164.37 25.84 Favored 'General case' 0 N--CA 1.425 -1.72 0 C-N-CA 127.225 2.21 . . . . 0.0 108.78 171.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.1 135.47 43.24 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 126.39 1.876 . . . . 0.0 106.636 173.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.6 mp -111.72 127.0 69.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 176.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -108.51 80.23 1.33 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -88.7 -5.24 58.24 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.792 1.237 . . . . 0.0 112.085 -178.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.7 150.59 20.21 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.396 1.078 . . . . 0.0 111.552 -175.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -44.71 -64.55 0.68 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.981 2.113 . . . . 0.0 110.739 172.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -62.91 -35.71 80.97 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.111 0.964 . . . . 0.0 111.603 -168.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.6 m -63.8 -49.43 72.93 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 128.41 2.684 . . . . 0.0 110.713 175.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.26 -37.09 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.057 0.943 . . . . 0.0 109.386 174.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.07 -43.07 93.37 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.811 1.244 . . . . 0.0 112.267 -176.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -57.67 -66.45 0.47 Allowed 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 124.538 1.149 . . . . 0.0 108.867 170.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.4 mt -52.16 -45.92 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.768 0.827 . . . . 0.0 111.326 -172.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.91 -7.87 2.72 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.508 -1.37 . . . . 0.0 113.171 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.19 -58.94 2.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.573 2.349 . . . . 0.0 111.029 167.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.6 pm0 -60.36 -20.09 58.1 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 121.072 1.76 . . . . 0.0 113.275 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.7 mm -85.12 -19.83 8.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 125.187 1.395 . . . . 0.0 111.694 173.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.49 -21.26 19.58 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 119.625 1.102 . . . . 0.0 113.321 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.7 t -62.18 -32.63 73.28 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.893 0.877 . . . . 0.0 111.554 -170.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.63 160.49 53.65 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-O 122.983 1.324 . . . . 0.0 113.567 -175.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -125.36 109.98 13.42 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.43 ' HG3' ' H ' ' A' ' 44' ' ' ARG . 4.9 ppt_? -60.18 -10.8 4.9 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.66 1.984 . . . . 0.0 114.31 175.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.1 p 66.04 -179.77 0.2 Allowed 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 128.245 2.618 . . . . 0.0 110.958 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -82.36 2.76 30.78 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.387 -0.821 . . . . 0.0 111.936 173.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -61.92 151.27 35.27 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.994 1.27 . . . . 0.0 110.144 173.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -79.43 154.57 28.86 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.23 -1.35 . . . . 0.0 107.811 162.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.9 117.67 21.39 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 -177.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.7 pt -128.57 43.26 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 119.699 1.136 . . . . 0.0 110.548 -167.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -143.69 160.97 39.75 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.059 1.743 . . . . 0.0 108.252 -177.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.38 -10.67 13.75 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.318 1.047 . . . . 0.0 111.967 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -145.4 157.97 51.68 Favored Pre-proline 0 N--CA 1.467 0.398 0 C-N-CA 125.377 1.471 . . . . 0.0 109.849 -172.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -71.65 169.19 21.64 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.715 2.277 . . . . 0.0 112.504 177.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.6 t -92.08 -9.37 42.89 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.925 1.69 . . . . 0.0 112.442 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.04 158.77 18.52 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.978 -1.076 . . . . 0.0 112.041 -175.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -76.02 -33.51 59.67 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.992 1.317 . . . . 0.0 111.403 171.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -122.71 110.77 15.91 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.7 1.6 . . . . 0.0 106.985 -168.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -148.79 168.2 23.57 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.825 2.05 . . . . 0.0 106.448 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -109.01 167.05 12.81 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 170.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.45 123.3 44.49 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.275 1.03 . . . . 0.0 109.251 -178.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.6 137.52 51.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -128.62 146.68 50.79 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.876 0.87 . . . . 0.0 109.512 165.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.1 mt -114.95 91.36 1.75 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.5 0 N-CA-C 103.055 -2.942 . . . . 0.0 103.055 163.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -62.59 129.68 41.65 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 169.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -144.42 -155.91 0.65 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -55.43 -4.64 0.1 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 130.531 3.532 . . . . 0.0 116.514 -156.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.55 14.83 0.14 Allowed Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 126.474 1.987 . . . . 0.0 110.508 -170.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -147.92 170.42 28.58 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 118.11 0.955 . . . . 0.0 113.214 168.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 31.7 mtp -131.3 108.65 9.81 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 127.456 2.302 . . . . 0.0 106.976 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 78.4 m -74.86 87.63 2.28 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 166.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.8 m -66.31 139.37 58.04 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 172.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 2.1 ptm -160.2 166.39 29.76 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.278 1.431 . . . . 0.0 109.027 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -144.84 143.83 30.82 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.894 1.678 . . . . 0.0 106.683 -173.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -129.68 144.31 51.23 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.608 1.549 . . . . 0.0 109.016 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -146.88 178.75 8.09 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.317 1.447 . . . . 0.0 111.073 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -111.72 140.22 46.53 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.665 1.986 . . . . 0.0 107.655 171.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -138.48 112.6 8.59 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 175.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.14 15.18 3.12 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.95 1.7 . . . . 0.0 114.247 176.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.98 4.68 44.85 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.667 1.127 . . . . 0.0 112.873 172.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.98 161.51 14.4 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 157.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -119.63 154.74 33.54 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -144.04 149.27 36.4 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.783 0.325 . . . . 0.0 111.086 -168.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mp -121.2 119.76 60.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 125.453 1.501 . . . . 0.0 108.193 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -74.46 151.88 39.52 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.708 1.203 . . . . 0.0 110.773 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.511 ' HB2' ' HA2' ' A' ' 90' ' ' GLY . 0.8 OUTLIER -175.08 167.5 1.88 Allowed Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 127.366 2.266 . . . . 0.0 108.486 -177.124 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -55.73 -162.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.802 1 C-N-CA 126.126 4.551 . . . . 0.0 111.347 168.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -43.74 -8.38 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 128.13 2.572 . . . . 0.0 116.733 -175.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.92 70.29 0.77 Allowed 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 119.346 0.975 . . . . 0.0 110.697 159.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.511 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . -131.39 33.85 2.7 Favored Glycine 0 C--O 1.225 -0.439 0 N-CA-C 116.839 1.496 . . . . 0.0 116.839 -175.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.6 mt -116.98 50.11 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 118.027 0.914 . . . . 0.0 108.571 175.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -73.82 101.22 3.67 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.513 -1.367 . . . . 0.0 108.726 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -68.01 124.87 24.58 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 163.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 22.0 pt -121.14 163.64 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 124.189 0.996 . . . . 0.0 108.813 156.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -104.46 2.61 31.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.508 -175.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -132.69 154.27 50.33 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -169.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -73.15 104.2 4.14 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.835 2.054 . . . . 0.0 110.034 175.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -56.57 -36.42 69.3 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.46 1.504 . . . . 0.0 110.65 175.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -68.08 -15.86 63.77 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.681 0.792 . . . . 0.0 113.04 -172.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -90.81 -28.44 18.2 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.226 1.01 . . . . 0.0 112.105 169.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 41.4 mtt -68.5 -35.8 78.01 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 118.625 -0.702 . . . . 0.0 109.893 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 32.1 pt . . . . . 0 C--O 1.251 1.152 0 CA-C-O 117.164 -1.398 . . . . 0.0 112.312 -175.377 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.536 0.44 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.07 158.86 13.54 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.738 2.292 . . . . 0.0 111.723 154.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.5 mt -98.21 95.92 4.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 N-CA-C 104.724 -2.325 . . . . 0.0 104.724 165.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.9 166.15 35.36 Favored Pre-proline 0 C--O 1.237 0.428 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 172.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.549 ' HB2' HD21 ' A' ' 10' ' ' ASN . 56.0 Cg_endo -56.89 173.09 0.59 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 121.15 1.234 . . . . 0.0 111.204 157.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.424 ' HE3' ' CG ' ' A' ' 9' ' ' GLU . 11.7 mtmt -56.87 172.33 0.27 Allowed 'General case' 0 C--N 1.345 0.393 0 O-C-N 120.859 -1.15 . . . . 0.0 110.538 166.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.0 -53.97 8.89 Favored 'General case' 0 C--O 1.221 -0.438 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 158.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.424 ' CG ' ' HE3' ' A' ' 7' ' ' LYS . 1.1 pt-20 -70.56 -7.06 41.07 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 -162.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.549 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -100.02 -1.01 38.1 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.983 1.713 . . . . 0.0 112.278 177.066 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.0 t -78.36 124.07 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -78.65 -54.03 6.55 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.761 1.624 . . . . 0.0 106.869 -176.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -152.47 167.31 29.19 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.524 1.13 . . . . 0.0 108.658 160.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.8 mt -120.36 127.71 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 164.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.11 136.84 45.09 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 175.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.2 mt -131.08 100.24 4.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.93 113.31 12.08 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 163.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -67.17 176.44 2.19 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.619 1.168 . . . . 0.0 110.099 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.32 -34.14 77.47 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.521 -1.362 . . . . 0.0 112.117 177.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.8 p30 -80.13 -154.69 0.1 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.922 1.689 . . . . 0.0 110.75 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.5 p -91.82 10.63 27.76 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.621 -1.3 . . . . 0.0 113.656 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.9 mt -107.16 151.26 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -170.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -136.46 149.6 48.3 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 173.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.9 143.56 50.93 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 174.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.1 mp -118.25 127.62 75.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.68 ' CG ' HD11 ' A' ' 35' ' ' ILE . 38.6 m-85 -104.03 100.05 9.81 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 -176.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -125.98 -8.81 6.59 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.275 1.03 . . . . 0.0 111.88 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.58 149.99 36.55 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.154 0.982 . . . . 0.0 109.028 167.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.1 m -44.84 -57.02 4.02 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 124.392 1.077 . . . . 0.0 111.447 165.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.97 -29.96 70.92 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.605 0.762 . . . . 0.0 111.79 -174.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.4 p -71.09 -47.56 57.46 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 78.3 mt -63.38 -54.07 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 126.003 1.721 . . . . 0.0 109.169 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -59.19 -37.23 76.9 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 123.479 0.712 . . . . 0.0 111.332 -172.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.95 -50.48 73.6 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.741 0.816 . . . . 0.0 110.353 175.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.68 HD11 ' CG ' ' A' ' 26' ' ' TYR . 91.8 mt -55.49 -55.65 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 174.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.5 -12.19 2.51 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 t -78.08 -67.55 0.72 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 120.265 1.393 . . . . 0.0 109.321 166.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.564 ' O ' HG22 ' A' ' 41' ' ' THR . 71.7 mm-40 -66.0 -27.03 67.82 Favored 'General case' 0 C--O 1.223 -0.313 0 O-C-N 121.167 -0.958 . . . . 0.0 111.094 -171.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.402 HD11 ' CE1' ' A' ' 98' ' ' PHE . 14.1 mm -72.01 -18.3 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 O-C-N 119.998 -1.689 . . . . 0.0 111.832 173.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.81 -3.78 31.93 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.895 1.278 . . . . 0.0 113.692 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.564 HG22 ' O ' ' A' ' 38' ' ' GLU . 2.6 t -68.78 -36.16 77.95 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.878 0.871 . . . . 0.0 111.235 -178.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.3 170.28 53.42 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 124.232 0.92 . . . . 0.0 112.429 -170.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.445 ' O ' HG23 ' A' ' 45' ' ' THR . 35.4 mtmm -119.45 111.62 18.36 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.462 ' HA ' ' HA ' ' A' ' 92' ' ' TYR . 4.4 ppt_? -61.08 -12.94 13.82 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 171.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 43' ' ' LYS . 12.0 p 65.57 -176.36 0.18 Allowed 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 127.681 2.392 . . . . 0.0 109.728 177.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -88.4 6.0 39.54 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 120.541 -1.349 . . . . 0.0 113.453 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.6 mtpt -64.62 173.46 2.17 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.681 1.192 . . . . 0.0 112.45 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -109.93 119.4 39.21 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.6 m -79.73 85.18 5.45 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 167.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.8 pt -85.81 35.94 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 125.166 1.387 . . . . 0.0 110.113 176.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -142.27 165.86 26.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 128.695 2.798 . . . . 0.0 107.34 -172.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -132.7 0.4 3.57 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.403 1.081 . . . . 0.0 111.665 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -146.45 164.72 22.91 Favored Pre-proline 0 C--O 1.238 0.457 0 C-N-CA 126.847 2.059 . . . . 0.0 108.304 -173.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -74.15 170.92 19.04 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.021 2.48 . . . . 0.0 111.039 169.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -110.9 4.18 19.48 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.296 1.038 . . . . 0.0 111.607 166.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.85 173.25 10.17 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 120.573 -1.329 . . . . 0.0 109.992 161.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.5 -22.8 4.94 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.869 1.668 . . . . 0.0 110.637 177.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -105.4 113.63 27.32 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 174.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -160.73 168.0 25.72 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.123 1.369 . . . . 0.0 108.492 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -96.34 157.06 21.35 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 168.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.6 m -103.96 130.95 51.62 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 mp -126.97 137.26 58.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 123.502 0.721 . . . . 0.0 109.909 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.12 114.52 18.49 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 168.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 72.6 mt -88.95 91.53 3.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 104.35 -2.463 . . . . 0.0 104.35 162.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -70.32 123.61 22.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 171.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -153.02 133.04 13.35 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.558 1.143 . . . . 0.0 109.637 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 55.48 31.89 17.9 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.636 1.174 . . . . 0.0 110.656 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.35 -11.42 4.04 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.904 1.716 . . . . 0.0 115.018 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.91 -173.75 45.34 Favored Glycine 0 C--N 1.332 0.337 0 O-C-N 120.5 -1.588 . . . . 0.0 110.029 166.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -145.09 157.57 44.07 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.907 -0.76 . . . . 0.0 111.507 168.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 83.5 m -96.73 109.2 21.9 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 154.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.7 m -74.53 147.12 42.08 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 160.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.9 ptm -163.07 170.74 17.48 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.009 1.724 . . . . 0.0 108.298 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -143.59 151.74 40.55 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -129.57 158.01 40.47 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 121.072 1.76 . . . . 0.0 110.655 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -159.21 178.28 10.16 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.457 1.48 . . . . 0.0 111.889 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -106.62 139.48 41.0 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.61 1.564 . . . . 0.0 108.007 167.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -141.68 131.3 24.03 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.246 1.022 . . . . 0.0 109.169 167.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 57.77 4.75 0.28 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.374 1.87 . . . . 0.0 114.769 175.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.09 2.4 21.96 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.744 1.64 . . . . 0.0 113.97 176.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -113.94 157.67 22.12 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 125.952 1.701 . . . . 0.0 108.052 167.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -103.25 159.45 15.53 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -145.63 155.06 42.78 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.682 0.793 . . . . 0.0 111.025 -172.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 mp -126.49 126.31 68.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 C-N-CA 125.973 1.709 . . . . 0.0 108.417 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -73.36 152.5 40.85 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 127.063 2.145 . . . . 0.0 110.19 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -177.16 167.53 1.26 Allowed Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 128.553 2.741 . . . . 0.0 107.973 176.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' A' ' 89' ' ' LYS . 41.1 Cg_endo -61.09 -162.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.815 1 C-N-CA 125.378 4.052 . . . . 0.0 109.671 166.173 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -43.06 -13.41 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.271 2.228 . . . . 0.0 116.955 -162.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.497 ' HE3' ' H ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -115.18 45.0 1.71 Allowed 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 171.218 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -124.95 68.74 0.5 Allowed Glycine 0 C--O 1.228 -0.276 0 O-C-N 120.724 -1.235 . . . . 0.0 113.285 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.4 mt -135.23 50.97 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 168.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 37.2 m-85 -74.37 91.12 2.19 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.224 -0.922 . . . . 0.0 108.569 -175.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -64.72 120.06 11.74 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 167.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.1 pt -118.44 158.36 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 125.968 1.707 . . . . 0.0 107.8 164.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -104.36 -1.5 26.8 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.522 0.729 . . . . 0.0 112.37 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -118.89 162.28 18.76 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.742 1.217 . . . . 0.0 111.22 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -74.82 153.13 38.86 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.461 0.704 . . . . 0.0 110.72 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.402 ' CE1' HD11 ' A' ' 39' ' ' ILE . 65.1 t80 -79.87 -57.99 3.38 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.295 -0.878 . . . . 0.0 112.395 170.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.02 -20.18 66.37 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -163.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -84.87 -17.43 37.99 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.194 0.906 . . . . 0.0 111.722 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 10.7 mmt -95.91 -18.26 20.45 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.894 1.277 . . . . 0.0 111.351 -172.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.403 ' H ' HG12 ' A' ' 102' ' ' ILE . 9.4 pt . . . . . 0 C--O 1.247 0.974 0 C-N-CA 124.534 1.134 . . . . 0.0 110.103 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 m . . . . . 0 CA--C 1.549 0.937 0 CA-C-O 119.034 -0.508 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.56 161.91 43.12 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 CA-C-N 121.275 1.491 . . . . 0.0 111.799 -170.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.6 mt -109.45 117.54 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 170.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.475 HD21 ' HB2' ' A' ' 40' ' ' ALA . 0.3 OUTLIER -126.27 160.7 56.25 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 127.402 2.281 . . . . 0.0 108.396 -176.186 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.461 ' HB2' HD21 ' A' ' 10' ' ' ASN . 73.8 Cg_endo -68.49 -178.33 1.83 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.038 2.492 . . . . 0.0 111.504 174.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.409 ' HE3' ' HG2' ' A' ' 9' ' ' GLU . 7.2 mtmt -58.42 175.88 0.21 Allowed 'General case' 0 C--N 1.349 0.546 0 O-C-N 121.223 -0.923 . . . . 0.0 109.896 167.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.51 -59.19 2.84 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 157.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.409 ' HG2' ' HE3' ' A' ' 7' ' ' LYS . 11.0 pt-20 -70.75 -13.6 62.12 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -159.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.461 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -88.13 -1.4 57.98 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.173 1.389 . . . . 0.0 111.926 176.098 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.403 ' N ' HD22 ' A' ' 10' ' ' ASN . 90.7 t -86.91 116.08 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 175.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -70.75 -44.03 67.6 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.991 0.807 . . . . 0.0 109.825 173.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.8 p -153.95 154.07 33.14 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 118.43 0.559 . . . . 0.0 111.671 162.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.1 mt -95.23 140.43 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 157.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.6 t -126.35 113.89 17.5 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 53.5 mt -109.5 115.46 49.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -90.04 123.16 33.68 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 167.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -77.13 174.72 10.37 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.358 1.063 . . . . 0.0 109.912 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 p -61.01 -52.48 64.82 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.334 -0.854 . . . . 0.0 109.263 171.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -66.4 153.85 41.66 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 127.101 2.16 . . . . 0.0 107.761 169.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 94.1 p -86.51 45.98 1.3 Allowed 'General case' 0 C--O 1.237 0.408 0 O-C-N 121.71 -0.619 . . . . 0.0 111.62 -152.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.2 mt -122.17 133.79 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 -171.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -126.99 111.84 14.55 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -174.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.406 ' HE2' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -103.06 138.67 39.61 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -178.332 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.7 mp -115.97 135.85 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 -175.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.436 ' CD2' HD11 ' A' ' 35' ' ' ILE . 69.5 m-85 -122.99 90.77 3.35 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 103.438 -2.801 . . . . 0.0 103.438 -168.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -116.62 -16.67 10.71 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.697 1.599 . . . . 0.0 110.369 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.53 136.37 56.31 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.34 1.856 . . . . 0.0 106.475 170.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.8 t -55.88 -44.05 77.79 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 120.014 1.279 . . . . 0.0 111.821 -171.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -68.99 -32.02 71.29 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.95 0.9 . . . . 0.0 110.995 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 p -61.5 -45.98 91.93 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.533 HG22 HD11 ' A' ' 36' ' ' LEU . 70.3 mt -65.0 -53.61 39.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.563 1.545 . . . . 0.0 109.042 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.419 ' HA ' HD12 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -48.84 -51.68 28.26 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.044 0.838 . . . . 0.0 113.045 -168.158 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.2 -42.38 86.04 Favored 'General case' 0 C--O 1.227 -0.1 0 C-N-CA 123.771 0.828 . . . . 0.0 111.568 -175.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.436 HD11 ' CD2' ' A' ' 26' ' ' TYR . 86.6 mt -62.3 -51.52 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -177.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.533 HD11 HG22 ' A' ' 32' ' ' ILE . 1.2 mt -59.19 -26.9 65.21 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.728 1.149 . . . . 0.0 110.913 177.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.38 -69.03 0.2 Allowed 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.502 1.121 . . . . 0.0 109.22 171.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -75.69 -16.78 60.12 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -171.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.8 mm -67.09 -39.86 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 O-C-N 119.929 -1.732 . . . . 0.0 109.127 171.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.475 ' HB2' HD21 ' A' ' 5' ' ' LEU . . . -89.13 3.02 53.25 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 120.73 -1.231 . . . . 0.0 113.907 -171.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.1 p -73.21 -45.87 53.74 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.153 173.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.13 145.22 48.54 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 123.989 0.804 . . . . 0.0 111.615 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -123.11 106.03 10.44 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 -166.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 92' ' ' TYR . 7.6 ppt_? -62.72 -13.01 27.56 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 174.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.1 p 65.46 -174.85 0.18 Allowed 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 127.61 2.364 . . . . 0.0 110.436 177.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -69.89 -11.99 61.29 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 119.287 -2.133 . . . . 0.0 112.946 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -63.17 166.48 6.02 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.084 1.353 . . . . 0.0 112.135 -174.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.57 122.72 38.36 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.732 1.613 . . . . 0.0 110.731 176.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.7 t -70.46 160.37 32.51 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 127.443 2.297 . . . . 0.0 107.817 163.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.7 pt -144.6 22.88 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 126.912 2.085 . . . . 0.0 110.45 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -114.32 164.36 14.02 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 120.805 -1.184 . . . . 0.0 108.612 175.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -111.28 -20.62 12.23 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.261 175.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -143.23 160.01 53.55 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-N 119.483 1.038 . . . . 0.0 109.807 -168.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.95 171.87 15.77 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.711 2.941 . . . . 0.0 113.031 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.4 p -119.56 -15.73 8.96 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.575 1.55 . . . . 0.0 112.768 -177.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.9 159.4 33.78 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.932 0.787 . . . . 0.0 110.211 171.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -84.77 -28.31 26.28 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.381 0.672 . . . . 0.0 111.143 172.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -115.05 100.77 8.42 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -134.35 168.26 19.22 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 127.94 2.496 . . . . 0.0 106.278 171.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.52 175.1 15.7 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 169.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -107.99 142.31 38.32 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.471 1.109 . . . . 0.0 108.109 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.7 mt -113.12 133.82 57.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 158.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -128.78 144.23 51.12 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 171.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.5 mt -124.57 90.69 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 174.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -66.05 109.58 2.62 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 171.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . 0.284 3.9 p30 -133.1 -152.2 0.48 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 126.97 2.108 . . . . 0.0 107.579 -174.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -46.04 50.21 0.0 OUTLIER 'General case' 0 C--O 1.24 0.575 1 C-N-CA 136.65 5.98 . . . . 0.0 114.551 -171.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.43 31.54 68.4 Favored Glycine 0 N--CA 1.437 -1.269 0 O-C-N 120.413 -1.429 . . . . 0.0 112.084 -171.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -164.04 171.28 39.57 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 117.454 0.627 . . . . 0.0 112.353 168.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 83.2 mtp -125.15 112.23 16.23 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.597 1.559 . . . . 0.0 108.283 -176.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.4 m -69.86 109.83 4.66 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 157.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.4 m -112.99 143.2 44.69 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 124.106 0.879 . . . . 0.0 109.338 171.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.3 ptp -151.95 170.97 18.55 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 127.449 2.3 . . . . 0.0 106.311 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.431 ' H ' ' HB2' ' A' ' 85' ' ' GLU . 38.9 m-85 -129.15 174.29 9.7 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.401 1.48 . . . . 0.0 108.03 -178.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -156.39 140.98 16.88 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.591 0.756 . . . . 0.0 109.706 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -153.6 162.86 40.86 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.748 1.219 . . . . 0.0 110.835 172.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -79.26 134.89 36.64 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 172.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -131.41 114.87 15.48 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 122.017 0.913 . . . . 0.0 110.038 171.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.02 -7.7 0.61 Allowed 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.953 2.501 . . . . 0.0 114.941 171.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.96 -6.09 5.1 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 117.635 -1.647 . . . . 0.0 113.449 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.28 166.31 10.62 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 120.454 2.127 . . . . 0.0 109.072 164.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -112.51 152.79 28.39 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -145.02 172.24 13.34 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 122.537 0.335 . . . . 0.0 110.179 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.3 mp -131.11 140.35 48.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 124.497 1.119 . . . . 0.0 109.21 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.431 ' HB2' ' H ' ' A' ' 74' ' ' PHE . 0.4 OUTLIER -75.88 165.15 25.41 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.833 1.653 . . . . 0.0 112.174 178.224 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -179.98 168.97 0.7 Allowed Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 127.82 2.448 . . . . 0.0 107.499 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' A' ' 89' ' ' LYS . 60.9 Cg_endo -56.61 -162.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.799 2.332 . . . . 0.0 109.419 153.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -44.06 -8.26 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.994 2.518 . . . . 0.0 117.386 -169.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.419 ' HE3' ' H ' ' A' ' 89' ' ' LYS . 0.6 OUTLIER -98.71 15.65 24.59 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 120.173 -1.58 . . . . 0.0 114.27 168.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -88.91 65.7 3.21 Favored Glycine 0 C--O 1.226 -0.36 0 CA-C-N 120.608 1.549 . . . . 0.0 113.786 -174.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.4 mt -140.62 41.87 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 171.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 21.8 m-85 -70.27 102.71 2.19 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 174.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -74.35 127.39 32.89 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 164.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.5 pt -114.28 159.67 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 157.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -108.47 5.27 25.11 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.336 -0.853 . . . . 0.0 112.349 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -133.92 157.02 47.06 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.041 0.936 . . . . 0.0 109.469 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -72.03 133.04 45.05 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.625 1.17 . . . . 0.0 110.118 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -74.03 -44.49 54.17 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.497 1.119 . . . . 0.0 113.459 -177.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -62.08 -29.68 70.48 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.258 1.39 . . . . 0.0 110.784 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -72.95 -15.6 61.56 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 125.877 1.671 . . . . 0.0 112.989 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 9.5 ptm -110.51 1.05 17.96 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.168 0.987 . . . . 0.0 113.091 -175.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 25.5 pt . . . . . 0 C--O 1.249 1.06 0 CA-C-N 119.018 0.826 . . . . 0.0 109.45 176.208 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p . . . . . 0 CA--C 1.551 1.014 0 N-CA-C 116.496 2.035 . . . . 0.0 116.496 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -67.05 169.89 14.13 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 124.388 3.392 . . . . 0.0 113.006 167.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.0 mm -94.22 91.89 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 167.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.1 152.24 39.35 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.222 176.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.605 ' HB2' HD21 ' A' ' 10' ' ' ASN . 74.5 Cg_endo -67.6 160.75 46.64 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.202 1.935 . . . . 0.0 110.602 171.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -60.05 168.8 1.74 Allowed 'General case' 0 C--N 1.344 0.335 0 C-N-CA 123.677 0.791 . . . . 0.0 112.028 174.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.03 -49.02 31.17 Favored 'General case' 0 C--O 1.219 -0.523 0 O-C-N 121.157 -0.964 . . . . 0.0 109.48 168.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -66.48 -14.79 62.73 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 -172.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.605 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -102.87 -2.74 27.32 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.037 0.935 . . . . 0.0 111.352 178.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.0 t -82.19 135.81 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.248 1.419 . . . . 0.0 107.3 170.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.83 -67.92 0.78 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 166.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.42 121.88 5.76 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.33 0.514 . . . . 0.0 110.429 -170.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.4 mt -82.27 131.22 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.7 t -107.5 139.61 41.75 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 168.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.0 mt -131.98 122.23 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 170.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -115.07 102.4 9.9 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 -173.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -63.04 171.68 2.13 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.373 0.669 . . . . 0.0 111.328 -170.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.4 p -52.43 -52.89 51.61 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.541 1.137 . . . . 0.0 109.976 168.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.05 162.6 25.78 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 126.877 2.071 . . . . 0.0 107.192 174.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 p -90.1 59.57 4.53 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 123.252 1.501 . . . . 0.0 108.896 -163.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.7 mt -124.66 142.96 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 102.502 -3.147 . . . . 0.0 102.502 176.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -140.96 143.33 34.47 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.69 122.36 23.29 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 176.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.9 mp -94.45 138.55 20.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 171.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -118.07 82.38 1.83 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 103.31 -2.848 . . . . 0.0 103.31 176.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -83.31 -19.1 36.87 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.55 1.14 . . . . 0.0 110.109 163.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.37 133.67 35.94 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.186 1.794 . . . . 0.0 109.093 -169.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.6 -55.83 17.01 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.306 1.042 . . . . 0.0 112.513 -176.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -68.58 -20.63 64.53 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.521 -0.737 . . . . 0.0 110.985 -174.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.4 m -80.12 -41.34 25.65 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.108 1.763 . . . . 0.0 110.826 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.4 mt -67.78 -45.93 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.951 1.7 . . . . 0.0 110.043 172.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.99 -24.63 67.15 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -171.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -64.29 -68.08 0.38 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 117.923 -1.037 . . . . 0.0 108.35 166.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 72.5 mt -44.85 -44.81 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 126.057 1.743 . . . . 0.0 112.039 -170.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.0 mt -54.37 -20.0 6.55 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.7 t -76.72 -58.36 3.33 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.322 2.249 . . . . 0.0 109.396 172.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.9 mp0 -63.34 -29.32 70.65 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.758 0.708 . . . . 0.0 110.896 -177.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.1 mm -61.95 -37.75 79.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 O-C-N 120.652 -1.28 . . . . 0.0 110.173 171.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.56 -10.6 26.87 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.681 1.192 . . . . 0.0 113.705 -171.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 t -62.6 -39.84 95.02 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.382 0.673 . . . . 0.0 110.829 -171.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.51 161.54 40.84 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-O 122.787 1.215 . . . . 0.0 112.316 -171.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -125.76 114.47 18.66 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.41 ' H ' ' HG3' ' A' ' 44' ' ' ARG . 6.5 ppt_? -64.15 -9.28 15.79 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.753 1.621 . . . . 0.0 113.89 172.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 p 65.59 -172.9 0.18 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 128.407 2.683 . . . . 0.0 111.478 173.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -78.69 -2.2 38.09 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.164 1.786 . . . . 0.0 112.029 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -67.02 168.06 10.7 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 119.849 1.204 . . . . 0.0 109.816 172.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -120.25 156.4 31.28 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.42 1.088 . . . . 0.0 109.768 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.32 134.35 46.26 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -159.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.2 pt -133.88 28.32 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 118.958 0.799 . . . . 0.0 112.225 -164.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -147.99 166.32 28.08 Favored 'General case' 0 C--O 1.242 0.66 0 O-C-N 121.446 -0.783 . . . . 0.0 110.23 -175.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.03 -10.42 15.03 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.602 1.161 . . . . 0.0 111.926 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -143.97 159.53 52.87 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.233 1.013 . . . . 0.0 111.95 -170.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.34 178.45 7.0 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.291 3.328 . . . . 0.0 112.838 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.51 -16.66 12.37 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.503 1.521 . . . . 0.0 111.46 173.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.66 163.08 7.59 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 120.792 -1.192 . . . . 0.0 110.29 168.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -108.43 -15.28 14.49 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.206 1.403 . . . . 0.0 110.902 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -126.29 103.03 7.44 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.465 2.306 . . . . 0.0 106.815 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -150.06 162.39 40.49 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.954 2.102 . . . . 0.0 107.918 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -101.14 166.0 18.73 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 173.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.2 m -110.32 134.86 51.86 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 118.9 1.35 . . . . 0.0 108.482 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.9 mp -120.14 136.17 58.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -126.76 140.82 52.09 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 125.063 1.345 . . . . 0.0 108.9 172.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.433 ' HB ' HG22 ' A' ' 71' ' ' THR . 33.4 mt -123.66 87.56 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 172.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -58.84 106.73 0.44 Allowed 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.303 1.041 . . . . 0.0 108.648 165.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -139.96 133.9 30.78 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.946 1.698 . . . . 0.0 109.654 175.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 52.62 28.12 5.84 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.894 1.678 . . . . 0.0 111.978 -176.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.07 13.43 69.85 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.074 1.321 . . . . 0.0 113.813 -176.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -107.58 170.35 15.4 Favored Glycine 0 C--N 1.334 0.418 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 163.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.27 136.4 27.98 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 118.707 1.253 . . . . 0.0 113.172 168.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.433 HG22 ' HB ' ' A' ' 64' ' ' ILE . 1.2 t -75.93 161.27 29.09 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 168.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.5 m -135.92 142.0 44.6 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.669 1.188 . . . . 0.0 108.164 169.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -153.43 171.51 18.55 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.794 1.638 . . . . 0.0 109.169 170.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -140.56 148.35 40.86 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.385 2.274 . . . . 0.0 106.3 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.517 ' CD1' HG13 ' A' ' 84' ' ' ILE . 1.5 m-85 -128.27 158.37 38.35 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.904 1.229 . . . . 0.0 109.51 177.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -159.53 175.51 13.18 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.892 0.877 . . . . 0.0 111.49 -178.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -102.98 144.08 31.72 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.56 1.544 . . . . 0.0 109.497 165.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -148.61 119.4 7.56 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.846 1.259 . . . . 0.0 108.719 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 62.67 -0.17 0.58 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.8 2.04 . . . . 0.0 115.237 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.94 8.43 17.88 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.754 1.169 . . . . 0.0 113.026 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.63 156.68 24.27 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 120.257 2.028 . . . . 0.0 108.821 164.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -96.79 152.45 18.67 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 168.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -139.84 167.58 21.79 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.751 0.82 . . . . 0.0 110.911 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.517 HG13 ' CD1' ' A' ' 75' ' ' TYR . 3.3 mp -123.77 128.13 74.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 125.367 1.467 . . . . 0.0 108.592 172.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -81.25 151.21 28.22 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.611 1.564 . . . . 0.0 109.213 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -176.2 166.26 1.66 Allowed Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.311 1.844 . . . . 0.0 107.638 -177.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -59.62 -161.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.762 1 C-N-CA 126.495 4.797 . . . . 0.0 110.417 172.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -42.82 -12.65 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.458 2.303 . . . . 0.0 115.86 -172.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.68 68.72 0.72 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 120.215 1.371 . . . . 0.0 112.121 161.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -140.83 67.4 0.49 Allowed Glycine 0 C--O 1.222 -0.622 0 CA-C-N 119.78 1.173 . . . . 0.0 115.287 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.6 mt -141.59 47.24 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.711 1.205 . . . . 0.0 107.846 173.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -72.23 103.85 3.49 Favored 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 120.668 -1.27 . . . . 0.0 108.267 -175.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -69.2 125.63 27.26 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 164.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 21.7 pt -119.69 175.29 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.913 1.285 . . . . 0.0 108.63 159.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -117.45 2.14 12.41 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.632 0.773 . . . . 0.0 112.096 -175.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -139.35 157.48 45.81 Favored 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 120.752 -1.217 . . . . 0.0 108.768 -168.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -80.9 114.35 19.72 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -52.77 -45.05 66.96 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.791 1.236 . . . . 0.0 110.887 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -75.33 -7.46 54.04 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -167.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -106.91 -16.87 14.35 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.172 0.989 . . . . 0.0 111.813 166.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 66.2 mmm -70.86 -37.65 73.09 Favored 'General case' 0 C--O 1.239 0.51 0 O-C-N 120.345 -1.472 . . . . 0.0 109.255 169.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.9 pt . . . . . 0 C--O 1.25 1.084 0 O-C-N 121.564 -0.71 . . . . 0.0 109.825 168.666 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.7 m . . . . . 0 C--O 1.24 0.555 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -52.48 167.09 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-O 122.603 1.001 . . . . 0.0 112.248 152.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.1 mt -111.61 109.41 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -107.03 162.53 19.38 Favored Pre-proline 0 C--O 1.243 0.714 0 C-N-CA 123.276 0.63 . . . . 0.0 110.361 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.524 ' HB2' HD21 ' A' ' 10' ' ' ASN . 37.3 Cg_endo -61.85 174.69 2.19 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.192 1.928 . . . . 0.0 111.61 164.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.55 169.1 1.88 Allowed 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.427 -0.796 . . . . 0.0 109.068 165.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.9 -60.32 2.31 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 153.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.37 -14.95 63.39 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -160.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.524 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -89.45 1.2 56.18 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 120.086 1.312 . . . . 0.0 113.46 175.182 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.0 t -78.14 143.19 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.82 -62.95 1.49 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 168.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.3 p -152.47 171.22 18.41 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.45 1.1 . . . . 0.0 109.62 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.5 mt -124.23 142.21 41.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 170.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.1 t -122.71 142.98 50.11 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 165.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.1 mt -130.97 104.28 9.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 104.142 -2.54 . . . . 0.0 104.142 173.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -87.61 113.09 22.97 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 172.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -67.27 177.9 1.69 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.897 1.679 . . . . 0.0 111.033 -173.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.68 -50.77 67.43 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.712 -1.242 . . . . 0.0 111.031 171.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -76.85 160.99 28.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 127.844 2.458 . . . . 0.0 108.085 173.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 p -88.22 61.11 6.08 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 123.032 1.396 . . . . 0.0 109.062 -164.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.8 mt -140.09 139.79 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 102.335 -3.209 . . . . 0.0 102.335 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.16 157.58 41.39 Favored 'General case' 0 N--CA 1.414 -2.255 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.458 ' HE2' ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -130.04 130.26 44.7 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 175.516 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.6 mt -106.16 134.92 46.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.458 ' CE2' ' HE2' ' A' ' 24' ' ' LYS . 23.3 m-85 -115.96 97.42 6.08 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 -175.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -123.63 11.53 9.17 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 128.324 2.65 . . . . 0.0 110.556 -176.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -103.8 141.03 36.82 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 166.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.8 t -55.85 -47.68 76.85 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.128 0.971 . . . . 0.0 110.654 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -59.47 -46.29 89.21 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.896 0.878 . . . . 0.0 110.939 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.2 m -61.07 -36.55 79.91 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.354 1.462 . . . . 0.0 111.906 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 74.7 mt -66.99 -55.66 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 172.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -57.79 -32.79 67.87 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.198 0.908 . . . . 0.0 112.75 -175.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.53 -49.18 62.47 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.684 1.594 . . . . 0.0 109.346 175.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.2 mt -68.76 -51.89 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 117.602 -1.19 . . . . 0.0 110.785 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.92 -26.61 15.53 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.39 1.45 . . . . 0.0 112.469 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.97 -69.46 0.32 Allowed 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 125.688 1.595 . . . . 0.0 111.145 170.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -69.09 -7.07 32.54 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.602 1.092 . . . . 0.0 113.135 -173.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.6 mm -83.57 -29.64 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 O-C-N 120.197 -1.564 . . . . 0.0 111.046 168.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.8 -12.75 35.47 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 119.411 1.005 . . . . 0.0 113.184 -173.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.8 p -69.01 -41.4 77.82 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.737 1.615 . . . . 0.0 110.791 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.34 138.6 41.08 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt -116.94 111.69 19.97 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -175.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.402 ' HB3' ' CE2' ' A' ' 92' ' ' TYR . 20.0 ptt180 -61.6 -4.18 1.3 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 173.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p 58.99 -174.07 0.1 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.309 2.244 . . . . 0.0 109.693 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -89.96 5.07 48.04 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.178 -0.951 . . . . 0.0 112.339 174.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -65.96 171.29 4.6 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.33 1.052 . . . . 0.0 110.323 167.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -126.13 131.86 51.97 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.716 1.207 . . . . 0.0 110.821 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.1 m -80.57 158.13 25.84 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.483 0.713 . . . . 0.0 109.098 170.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.0 pt -141.75 32.47 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 125.813 1.645 . . . . 0.0 110.699 175.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -141.52 167.66 21.63 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.721 2.009 . . . . 0.0 107.876 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -121.53 -4.69 9.3 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.817 1.247 . . . . 0.0 111.155 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -149.53 156.48 39.18 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 125.835 1.654 . . . . 0.0 110.169 -170.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.07 176.38 9.61 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.27 3.313 . . . . 0.0 112.529 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.99 1.79 6.56 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.863 1.665 . . . . 0.0 112.245 177.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.21 149.08 43.15 Favored 'General case' 0 C--N 1.338 0.103 0 O-C-N 120.621 -1.299 . . . . 0.0 109.848 168.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.01 -31.8 44.84 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 122.564 0.346 . . . . 0.0 111.175 169.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -114.24 104.59 12.24 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.454 1.502 . . . . 0.0 107.442 -173.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -138.46 173.95 11.06 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.886 2.074 . . . . 0.0 109.623 176.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.08 165.68 12.74 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 164.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.8 m -123.37 127.55 48.63 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.415 1.086 . . . . 0.0 108.906 -166.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mp -123.72 110.82 26.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 124.909 1.284 . . . . 0.0 109.603 -166.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 58.9 m-20 -119.03 122.03 41.23 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.566 1.146 . . . . 0.0 108.763 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 74.3 mt -107.19 96.9 5.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 171.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.64 118.05 11.15 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 172.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -146.0 125.94 13.62 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.606 1.163 . . . . 0.0 110.027 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 54.53 41.83 31.7 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.035 1.734 . . . . 0.0 111.83 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.82 3.87 56.67 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.213 0.911 . . . . 0.0 114.394 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -118.95 -173.53 15.67 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 169.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -147.16 166.14 27.86 Favored 'General case' 0 CA--C 1.517 -0.296 0 O-C-N 121.68 -0.894 . . . . 0.0 111.242 172.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.0 m -106.34 133.44 51.03 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 157.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 m -106.92 145.49 32.16 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.6 ptp -154.88 174.67 14.79 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.763 1.225 . . . . 0.0 108.429 160.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.564 ' H ' ' HG3' ' A' ' 85' ' ' GLU . 34.4 m-85 -135.97 164.8 27.13 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 128.196 2.598 . . . . 0.0 106.768 174.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -134.47 156.29 48.86 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.958 1.303 . . . . 0.0 108.146 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -159.4 179.95 8.49 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 118.709 0.686 . . . . 0.0 110.34 169.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -101.62 133.08 46.88 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.942 1.697 . . . . 0.0 107.642 175.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -133.59 111.28 10.52 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.08 0.943 . . . . 0.0 109.556 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.85 -1.08 2.14 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.641 1.976 . . . . 0.0 114.111 174.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.7 -14.76 6.36 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.123 1.344 . . . . 0.0 113.547 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.78 169.71 9.82 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 120.143 1.971 . . . . 0.0 108.651 164.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -109.85 155.55 21.52 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 171.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -144.12 172.65 12.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -122.13 143.36 35.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 C-N-CA 125.266 1.426 . . . . 0.0 107.486 172.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.564 ' HG3' ' H ' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -85.41 173.75 10.04 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.018 1.327 . . . . 0.0 110.029 179.204 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.464 ' HB2' ' CA ' ' A' ' 90' ' ' GLY . 0.5 OUTLIER 176.84 168.56 0.43 Allowed Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 128.756 2.822 . . . . 0.0 106.728 175.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' A' ' 86' ' ' CYS . 93.9 Cg_endo -54.13 -160.59 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.328 1 C-N-CA 125.306 4.004 . . . . 0.0 109.639 157.731 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -42.83 -4.99 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 129.245 3.018 . . . . 0.0 117.176 -171.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 87' ' ' PRO . 5.5 ptpt -119.5 25.44 10.06 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 129.281 3.032 . . . . 0.0 115.249 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.464 ' CA ' ' HB2' ' A' ' 86' ' ' CYS . . . -115.14 61.23 0.38 Allowed Glycine 0 C--N 1.32 -0.331 0 N-CA-C 116.776 1.47 . . . . 0.0 116.776 -167.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.0 mt -131.58 42.69 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 117.716 0.758 . . . . 0.0 110.045 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.402 ' CE2' ' HB3' ' A' ' 44' ' ' ARG . 15.7 m-85 -76.43 104.7 7.08 Favored 'General case' 0 C--O 1.222 -0.374 0 O-C-N 120.691 -1.256 . . . . 0.0 110.716 -173.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -68.81 122.88 19.51 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 165.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.5 pt -111.5 -172.61 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 126.463 1.905 . . . . 0.0 108.381 160.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -100.16 -44.61 5.91 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -147.1 176.26 10.08 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.803 1.241 . . . . 0.0 108.898 -172.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -61.8 116.6 4.96 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 118.552 0.614 . . . . 0.0 111.271 -172.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.43 ' HA ' ' HG2' ' A' ' 101' ' ' MET . 28.3 t80 -52.78 -35.5 56.73 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.617 1.967 . . . . 0.0 112.477 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -68.06 -13.29 62.08 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 119.873 -1.767 . . . . 0.0 113.189 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -95.03 -18.6 20.89 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.64 0.776 . . . . 0.0 111.888 174.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.43 ' HG2' ' HA ' ' A' ' 98' ' ' PHE . 21.6 ptp -91.76 -10.92 38.23 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.224 0.92 . . . . 0.0 112.963 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 29.8 pt . . . . . 0 C--O 1.252 1.225 0 C-N-CA 124.593 1.157 . . . . 0.0 112.136 -179.634 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.452 ' HB2' ' HD2' ' A' ' 3' ' ' PRO . 68.3 p . . . . . 0 CA--C 1.546 0.805 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 2' ' ' SER . 31.3 Cg_endo -70.62 172.65 13.07 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.331 2.021 . . . . 0.0 113.095 178.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.0 mt -112.51 121.39 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 175.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.88 164.26 40.77 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 126.864 2.066 . . . . 0.0 111.544 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.537 ' HB2' HD21 ' A' ' 10' ' ' ASN . 18.9 Cg_endo -59.12 161.43 16.17 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 123.919 3.08 . . . . 0.0 113.693 175.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -59.38 156.07 13.56 Favored 'General case' 0 C--N 1.347 0.468 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 172.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.67 -34.27 77.83 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 121.331 -0.855 . . . . 0.0 109.124 165.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -80.09 -25.4 40.02 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 118.669 -1.213 . . . . 0.0 112.33 -165.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.537 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -86.31 -0.47 55.93 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.323 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 26.9 t -69.98 138.59 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 176.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -76.39 -67.35 0.7 Allowed 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 166.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 p -157.85 149.47 21.71 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.408 0.549 . . . . 0.0 111.14 164.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.2 mt -85.53 141.02 15.08 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 169.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.5 t -126.66 130.16 49.88 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 167.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.7 mt -120.32 109.08 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.43 120.51 27.85 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 173.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -68.47 173.15 5.22 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.22 1.008 . . . . 0.0 109.998 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.51 -52.11 65.98 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 121.23 -0.919 . . . . 0.0 109.752 169.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.28 169.69 15.69 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 173.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.5 p -71.66 24.7 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 129.291 3.036 . . . . 0.0 115.92 -157.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.9 mt -135.14 149.72 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 129.4 3.08 . . . . 0.0 105.781 -159.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.81 164.93 21.98 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 126.573 1.949 . . . . 0.0 109.485 175.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.402 ' HE2' ' CE1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -128.98 143.79 50.98 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 162.087 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.7 mp -114.92 130.68 68.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.494 ' CD2' HD11 ' A' ' 35' ' ' ILE . 3.9 m-85 -116.14 79.39 1.3 Allowed 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 103.994 -2.595 . . . . 0.0 103.994 -174.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -85.23 -17.17 37.84 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.612 1.165 . . . . 0.0 110.235 161.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.9 125.09 24.85 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -176.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.8 t -51.97 -49.57 62.96 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.872 0.869 . . . . 0.0 111.527 -172.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -75.4 -16.13 60.39 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.114 -0.991 . . . . 0.0 112.257 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.7 m -79.63 -39.24 31.97 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.453 1.901 . . . . 0.0 110.357 171.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 93.4 mt -63.33 -53.8 41.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 169.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -60.0 -32.74 71.14 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.731 1.212 . . . . 0.0 112.25 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.8 tptt -60.79 -64.97 0.77 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 119.441 1.019 . . . . 0.0 109.642 167.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.494 HD11 ' CD2' ' A' ' 26' ' ' TYR . 82.2 mt -53.91 -46.71 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 119.177 -0.439 . . . . 0.0 110.985 -171.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.37 -22.95 55.51 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -177.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.86 -55.7 10.26 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.255 0.934 . . . . 0.0 109.614 167.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -73.75 -16.74 61.16 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -171.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.1 mm -68.37 -21.29 26.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.829 1.652 . . . . 0.0 110.195 168.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -118.88 8.68 11.77 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.114 1.366 . . . . 0.0 113.186 -168.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.2 t -80.05 -42.2 24.18 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.221 0.464 . . . . 0.0 110.921 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.15 169.35 54.67 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 127.181 2.324 . . . . 0.0 113.766 -166.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -127.01 102.59 7.05 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -171.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 92' ' ' TYR . 0.7 OUTLIER -66.76 -13.65 61.67 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.807 1.243 . . . . 0.0 113.985 168.632 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 65.38 -172.82 0.18 Allowed 'General case' 0 CA--C 1.547 0.829 0 O-C-N 125.506 1.754 . . . . 0.0 110.283 173.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -83.27 0.59 44.93 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 120.242 -1.536 . . . . 0.0 113.869 172.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.0 mmmt -60.52 165.14 3.93 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 122.207 1.004 . . . . 0.0 112.111 -177.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -99.88 128.47 45.97 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 124.586 1.155 . . . . 0.0 108.332 -175.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.02 51.04 1.22 Allowed 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 123.914 0.886 . . . . 0.0 109.674 -170.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.7 pt -68.11 5.66 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 126.718 2.007 . . . . 0.0 113.532 -172.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.406 ' HG2' ' H ' ' A' ' 51' ' ' GLN . 6.5 pt20 -70.98 165.1 24.16 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 126.056 1.742 . . . . 0.0 110.697 166.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -124.48 -9.78 7.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.154 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -145.4 161.08 43.01 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 124.626 1.17 . . . . 0.0 111.367 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.459 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 18.9 Cg_endo -68.35 170.85 13.9 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 124.433 3.422 . . . . 0.0 111.681 171.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 98.8 p -99.33 -16.27 18.51 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.381 0.672 . . . . 0.0 112.499 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.412 ' HB2' ' CD2' ' A' ' 76' ' ' TYR . . . -76.03 146.24 39.61 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 121.46 -0.775 . . . . 0.0 109.418 176.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -81.81 -16.41 50.98 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 119.339 -0.362 . . . . 0.0 111.881 172.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -131.05 102.16 5.91 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.199 1.399 . . . . 0.0 108.937 -174.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.459 ' CE2' ' HG2' ' A' ' 54' ' ' PRO . 43.5 p90 -134.0 175.22 9.67 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 126.343 1.857 . . . . 0.0 108.708 176.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.74 -167.54 11.31 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 169.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.92 141.11 49.24 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.571 1.148 . . . . 0.0 109.321 -148.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.9 mt -115.23 136.0 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 160.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -127.81 130.2 48.26 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 171.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.9 mt -117.84 92.29 2.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 170.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -70.72 124.31 23.98 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 172.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -156.5 134.58 11.21 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.342 1.457 . . . . 0.0 108.99 -177.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 54.01 27.59 7.65 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.512 1.525 . . . . 0.0 113.321 173.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.43 13.11 63.96 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 119.571 1.078 . . . . 0.0 114.414 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -142.54 171.51 24.71 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 119.448 1.624 . . . . 0.0 110.293 176.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 31.5 mtm -131.84 126.96 35.57 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.284 1.034 . . . . 0.0 110.318 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 53.8 m -80.64 113.49 18.87 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 156.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.42 152.91 25.94 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 124.337 1.023 . . . . 0.0 108.378 163.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.5 ptp -155.19 163.92 39.54 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.059 1.744 . . . . 0.0 107.639 154.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -119.87 172.67 7.55 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.799 1.24 . . . . 0.0 109.725 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -147.16 157.69 43.69 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.31 1.844 . . . . 0.0 108.449 175.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.412 ' CD2' ' HB2' ' A' ' 56' ' ' ALA . 40.9 p90 -157.38 -164.51 1.59 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.77 1.628 . . . . 0.0 108.859 171.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -122.91 124.3 42.9 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.648 1.179 . . . . 0.0 108.214 169.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -113.52 117.43 31.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.688 0.756 . . . . 0.0 109.576 173.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 64.81 -0.75 0.93 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.018 2.127 . . . . 0.0 114.595 175.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 123.99 -17.51 7.61 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 125.586 1.565 . . . . 0.0 112.77 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -90.32 157.45 17.64 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 120.278 2.039 . . . . 0.0 109.656 169.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -101.31 143.29 31.55 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.35 1.06 . . . . 0.0 108.537 174.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -139.78 169.36 17.87 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.936 0.495 . . . . 0.0 110.208 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.1 mp -127.38 121.27 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.871 0.868 . . . . 0.0 110.782 -176.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -66.49 157.72 31.41 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.459 -1.4 . . . . 0.0 110.733 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.429 ' HB2' ' HA2' ' A' ' 90' ' ' GLY . 0.8 OUTLIER -175.31 167.9 1.75 Allowed Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 128.592 2.757 . . . . 0.0 105.416 -172.655 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' A' ' 89' ' ' LYS . 66.3 Cg_endo -57.86 -160.97 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.448 0 C-N-CA 124.479 3.453 . . . . 0.0 109.657 160.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -42.68 0.75 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 130.221 3.408 . . . . 0.0 117.397 -175.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 87' ' ' PRO . 0.8 OUTLIER -124.58 30.92 5.84 Favored 'General case' 0 N--CA 1.44 -0.947 1 C-N-CA 132.117 4.167 . . . . 0.0 113.763 176.581 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.429 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . -109.26 61.03 0.31 Allowed Glycine 0 C--O 1.23 -0.148 0 C-N-CA 124.858 1.218 . . . . 0.0 115.41 -176.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.4 mt -136.69 44.73 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.536 1.135 . . . . 0.0 108.101 171.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 25.3 m-85 -68.87 108.11 3.34 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 175.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -75.04 130.74 39.83 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 159.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.0 pt -112.25 167.15 5.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 151.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -121.98 17.19 10.9 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.128 0.971 . . . . 0.0 112.407 -172.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -153.62 168.32 26.59 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 122.855 0.462 . . . . 0.0 110.872 165.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -67.01 118.49 10.54 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.713 0.805 . . . . 0.0 110.729 -173.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.429 ' HA ' ' HG2' ' A' ' 101' ' ' MET . 59.6 t80 -56.39 -47.02 79.81 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.97 0.908 . . . . 0.0 110.444 173.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -66.95 -26.42 66.82 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.332 0.653 . . . . 0.0 112.514 -170.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.2 20.02 19.58 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 118.407 0.549 . . . . 0.0 112.066 173.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.429 ' HG2' ' HA ' ' A' ' 98' ' ' PHE . 16.6 ptt? -108.29 -37.3 6.04 Favored 'General case' 0 C--N 1.342 0.256 0 O-C-N 121.437 -0.789 . . . . 0.0 112.648 160.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.996 0 C-N-CA 124.137 0.975 . . . . 0.0 112.007 -174.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.409 ' HB2' ' HD2' ' A' ' 3' ' ' PRO . 34.8 p . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 2' ' ' SER . 28.5 Cg_endo -61.39 175.92 1.36 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.578 1.519 . . . . 0.0 111.889 165.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.4 mt -111.67 108.28 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 40' ' ' ALA . 0.3 OUTLIER -123.26 156.44 63.4 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 126.283 1.833 . . . . 0.0 110.984 -171.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.597 ' HB2' HD21 ' A' ' 10' ' ' ASN . 91.4 Cg_endo -74.15 162.18 39.28 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.732 2.954 . . . . 0.0 112.488 -178.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.0 mtmt -63.04 142.57 58.33 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 119.076 0.853 . . . . 0.0 111.269 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.12 -14.81 18.83 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -94.57 -31.3 13.95 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.831 1.196 . . . . 0.0 112.752 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.597 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -88.45 -6.07 57.87 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.47 1.032 . . . . 0.0 111.525 -174.068 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.5 t -62.48 116.36 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 C-N-CA 128.336 2.654 . . . . 0.0 107.682 160.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -71.11 -67.68 0.49 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.715 1.606 . . . . 0.0 106.784 165.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.6 p -153.91 160.23 42.05 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.936 0.789 . . . . 0.0 110.495 -177.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.3 mt -125.84 125.77 68.86 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 -176.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.4 t -108.49 132.83 53.42 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.9 mt -133.35 97.03 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.98 115.68 18.81 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 164.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -68.29 -178.46 1.08 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.542 1.537 . . . . 0.0 109.994 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.9 p -59.19 -45.89 89.88 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.972 -1.08 . . . . 0.0 112.189 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -74.3 -174.0 1.86 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.546 1.139 . . . . 0.0 110.22 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 98.4 p -67.32 5.03 0.81 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.282 1.833 . . . . 0.0 114.76 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.1 mm -113.15 153.89 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 128.144 2.578 . . . . 0.0 108.606 -159.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -143.16 162.76 34.72 Favored 'General case' 0 N--CA 1.418 -2.073 0 C-N-CA 125.968 1.707 . . . . 0.0 110.587 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.11 142.16 44.24 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 125.129 1.371 . . . . 0.0 107.358 164.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.3 mp -109.66 138.17 38.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 170.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.414 ' HB3' ' HB3' ' A' ' 31' ' ' SER . 27.7 m-85 -111.96 108.94 18.45 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 103.166 -2.901 . . . . 0.0 103.166 -178.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -135.9 41.3 2.69 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 126.472 1.909 . . . . 0.0 106.183 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.94 123.44 17.16 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 103.614 -2.736 . . . . 0.0 103.614 -170.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.6 t -53.76 -39.6 65.49 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.684 0.794 . . . . 0.0 112.009 -171.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -77.67 -33.76 53.23 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.084 -1.01 . . . . 0.0 111.297 -177.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.414 ' HB3' ' HB3' ' A' ' 26' ' ' TYR . 26.2 m -57.94 -41.32 82.53 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.139 1.376 . . . . 0.0 110.491 168.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.4 mt -67.15 -54.58 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 124.716 1.206 . . . . 0.0 109.072 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -51.29 -41.76 60.69 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.131 0.572 . . . . 0.0 111.335 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -57.84 11.08 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 57.4 mt -54.68 -49.8 64.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 C-N-CA 123.392 0.677 . . . . 0.0 112.111 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.11 -17.91 30.77 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.804 0.842 . . . . 0.0 112.169 -171.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.65 -61.18 2.1 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.497 1.119 . . . . 0.0 110.913 166.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -67.24 -30.53 70.47 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.01 1.277 . . . . 0.0 111.545 -174.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.8 mm -54.87 -24.74 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.396 0.678 . . . . 0.0 110.05 172.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.405 ' HB2' HD21 ' A' ' 5' ' ' LEU . . . -116.19 3.64 13.49 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.139 1.776 . . . . 0.0 113.908 -174.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 t -79.4 -29.69 42.13 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.654 1.115 . . . . 0.0 111.276 -172.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.33 166.14 41.77 Favored Glycine 0 C--N 1.336 0.574 0 O-C-N 120.755 -1.215 . . . . 0.0 112.539 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -126.62 121.47 32.28 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.417 ' HD2' ' HB3' ' A' ' 89' ' ' LYS . 16.8 ptt180 -63.34 -3.42 1.96 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.579 1.152 . . . . 0.0 114.063 172.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p 58.04 -174.16 0.08 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 127.457 2.303 . . . . 0.0 110.761 -177.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -86.58 3.52 44.03 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.059 1.343 . . . . 0.0 111.59 176.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -69.22 164.94 21.56 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.87 1.214 . . . . 0.0 109.488 169.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -114.57 157.52 22.91 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.116 1.366 . . . . 0.0 108.182 174.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.53 150.04 50.35 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 -163.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.8 pt -145.83 17.6 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 122.457 0.303 . . . . 0.0 111.482 -163.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -131.61 167.4 19.5 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.389 1.076 . . . . 0.0 109.24 -171.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.22 -5.57 9.43 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.842 1.257 . . . . 0.0 112.334 -177.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -144.5 164.14 30.12 Favored Pre-proline 0 C--O 1.235 0.319 0 C-N-CA 126.011 1.724 . . . . 0.0 108.624 -174.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -70.69 -179.89 3.68 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.373 2.049 . . . . 0.0 110.803 174.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.0 p -110.34 -8.44 14.71 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.835 1.254 . . . . 0.0 111.911 175.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.86 159.45 20.37 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 124.266 1.026 . . . . 0.0 111.343 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -94.87 -13.6 25.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.255 1.022 . . . . 0.0 112.1 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -128.34 110.8 12.69 Favored 'General case' 0 C--O 1.231 0.083 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 175.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -147.32 160.75 42.15 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.59 1.556 . . . . 0.0 108.942 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.93 170.64 20.08 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.842 1.21 . . . . 0.0 110.315 171.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.3 m -131.98 121.1 23.39 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.031 1.732 . . . . 0.0 108.572 -163.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.2 mp -124.75 127.29 72.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 124.052 0.941 . . . . 0.0 109.266 -166.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -120.05 145.83 46.48 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 124.927 1.291 . . . . 0.0 109.244 171.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 30.5 mt -125.24 88.34 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -71.82 108.4 5.09 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.963 1.305 . . . . 0.0 108.041 177.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -137.34 134.24 35.8 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.515 1.126 . . . . 0.0 109.264 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 62.84 -3.32 0.32 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.283 1.833 . . . . 0.0 115.861 173.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.77 10.82 8.94 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 120.163 1.347 . . . . 0.0 113.692 -174.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -149.22 -178.6 24.38 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.59 145.32 24.3 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 118.653 1.227 . . . . 0.0 113.065 -173.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 t -73.72 166.09 23.93 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 162.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.8 m -142.47 142.66 32.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 163.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 17.2 ptp -156.0 169.62 24.04 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.795 2.038 . . . . 0.0 108.391 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.41 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 54.8 m-85 -139.16 148.87 43.76 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.477 1.911 . . . . 0.0 108.077 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -127.94 151.77 48.7 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.921 1.237 . . . . 0.0 110.155 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -156.99 177.77 11.13 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.033 1.333 . . . . 0.0 110.001 -171.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -107.83 147.78 30.43 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.165 1.386 . . . . 0.0 107.843 167.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.5 tp10 -142.28 117.4 10.06 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.685 0.794 . . . . 0.0 109.383 171.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 61.77 -11.95 0.06 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 127.999 2.519 . . . . 0.0 115.612 -176.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.7 2.35 3.96 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 117.76 -1.578 . . . . 0.0 115.555 -177.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -110.17 160.39 16.53 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 121.018 2.409 . . . . 0.0 109.274 159.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -97.48 145.74 25.91 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -140.36 162.43 35.33 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.883 0.873 . . . . 0.0 110.622 -174.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mp -133.08 132.29 58.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.802 1.241 . . . . 0.0 109.508 -169.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.41 ' HB3' ' H ' ' A' ' 74' ' ' PHE . 5.3 tm-20 -77.36 154.41 32.8 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.846 2.058 . . . . 0.0 110.624 177.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -173.22 167.97 2.61 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 129.276 3.03 . . . . 0.0 106.415 174.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.408 ' O ' ' N ' ' A' ' 89' ' ' LYS . 90.9 Cg_endo -54.12 -162.02 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 125.215 3.943 . . . . 0.0 110.239 162.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -43.35 -5.69 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 128.284 2.634 . . . . 0.0 116.529 -175.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.417 ' HB3' ' HD2' ' A' ' 44' ' ' ARG . 9.2 mmtt -120.97 52.09 1.21 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.686 1.994 . . . . 0.0 111.776 171.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -129.14 59.39 0.69 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 116.719 1.448 . . . . 0.0 116.719 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.7 mt -130.19 55.18 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 118.649 1.224 . . . . 0.0 108.131 171.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -76.32 119.14 19.79 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 177.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -87.91 113.53 23.65 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 163.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 27.9 pt -98.91 171.15 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 158.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -122.78 -13.82 7.82 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.925 -0.484 . . . . 0.0 112.032 -173.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -123.53 150.22 44.27 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 173.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -70.12 128.44 36.29 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 123.926 0.89 . . . . 0.0 109.974 -172.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -60.89 -46.13 91.84 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.665 1.186 . . . . 0.0 111.402 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -64.91 -29.48 70.43 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.945 0.898 . . . . 0.0 111.504 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -78.97 -18.94 52.86 Favored 'General case' 0 C--O 1.24 0.594 0 O-C-N 121.683 -0.636 . . . . 0.0 112.471 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 19.9 mmt -85.29 -27.29 26.07 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.233 1.013 . . . . 0.0 111.468 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 28.2 pt . . . . . 0 C--O 1.251 1.181 0 CA-C-N 119.681 1.128 . . . . 0.0 111.601 -174.289 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 CA--C 1.548 0.879 0 CA-C-O 119.17 -0.443 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -65.95 -178.4 1.03 Allowed 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 124.528 3.485 . . . . 0.0 113.875 168.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.0 mt -106.94 122.5 61.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 164.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.28 166.12 11.62 Favored Pre-proline 0 C--O 1.238 0.495 0 C-N-CA 125.669 1.588 . . . . 0.0 109.641 168.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.547 ' HB2' HD21 ' A' ' 10' ' ' ASN . 73.1 Cg_endo -62.88 -176.84 0.28 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 121.702 1.601 . . . . 0.0 111.124 167.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.405 ' HE3' ' HG2' ' A' ' 9' ' ' GLU . 4.7 mmmt -55.8 169.44 0.35 Allowed 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.092 -1.005 . . . . 0.0 108.88 159.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.417 ' HB2' HD13 ' A' ' 36' ' ' LEU . . . -81.71 -49.96 9.85 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 161.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.405 ' HG2' ' HE3' ' A' ' 7' ' ' LYS . 11.5 pt-20 -66.8 -22.89 66.01 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -167.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.547 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -79.27 -3.21 44.91 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.316 0.962 . . . . 0.0 113.356 175.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.412 ' N ' HD22 ' A' ' 10' ' ' ASN . 17.0 t -85.5 122.6 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -70.48 -54.62 11.51 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.122 1.769 . . . . 0.0 108.121 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.7 p -157.22 155.93 31.7 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.183 0.516 . . . . 0.0 110.59 174.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.1 mt -109.66 139.21 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 170.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -129.71 106.13 8.5 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.6 mt -101.83 108.61 24.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -93.5 115.29 27.8 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.019 2.128 . . . . 0.0 107.32 174.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -79.8 172.1 14.23 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.809 0.844 . . . . 0.0 111.21 -172.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.95 -53.22 60.43 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.573 1.149 . . . . 0.0 110.182 170.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -71.23 149.15 46.54 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.998 1.719 . . . . 0.0 106.506 166.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.2 p -88.44 53.44 2.73 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.824 0.821 . . . . 0.0 110.627 -151.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.2 mt -126.32 134.27 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 -170.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -129.79 110.38 11.69 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -170.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.451 ' HE2' ' CE1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -101.81 130.54 48.27 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -176.193 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.1 mt -100.51 134.96 38.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.575 ' CD2' HD11 ' A' ' 35' ' ' ILE . 9.6 m-85 -117.16 84.59 2.18 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 103.146 -2.909 . . . . 0.0 103.146 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -94.46 -6.91 42.88 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 127.459 2.304 . . . . 0.0 110.349 170.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.59 132.27 35.3 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 t -58.03 -42.34 85.1 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.541 -0.724 . . . . 0.0 111.45 -171.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -73.53 -36.43 65.68 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.264 -0.897 . . . . 0.0 111.506 -174.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.6 m -53.53 -51.75 61.86 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 126.612 1.965 . . . . 0.0 110.756 167.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.8 mt -58.18 -50.08 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 123.526 0.73 . . . . 0.0 109.206 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -55.64 -45.57 77.6 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 118.552 -0.737 . . . . 0.0 112.051 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.46 -51.81 68.3 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-N 118.303 0.501 . . . . 0.0 109.813 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.575 HD11 ' CD2' ' A' ' 26' ' ' TYR . 94.2 mt -55.95 -45.12 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.955 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.417 HD13 ' HB2' ' A' ' 8' ' ' ALA . 3.7 mt -57.0 -25.65 58.89 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.989 1.268 . . . . 0.0 113.013 176.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.2 m -73.57 -52.78 12.31 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 120.244 1.384 . . . . 0.0 109.883 169.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -65.05 -24.11 67.38 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.809 1.186 . . . . 0.0 112.732 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.9 mm -83.39 -7.55 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.183 1.793 . . . . 0.0 110.754 175.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.13 1.62 9.19 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.242 1.417 . . . . 0.0 114.33 -175.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.5 p -66.36 -31.25 71.91 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.588 1.086 . . . . 0.0 111.517 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.9 163.14 43.47 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-O 122.606 1.114 . . . . 0.0 113.924 -164.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.416 ' O ' HG23 ' A' ' 45' ' ' THR . 23.5 pttt -112.24 97.65 6.78 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 127.183 2.193 . . . . 0.0 109.629 176.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.4 ' HB3' ' CE2' ' A' ' 92' ' ' TYR . 4.6 ppt_? -60.08 -11.88 7.02 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 124.746 1.218 . . . . 0.0 113.216 167.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 43' ' ' LYS . 27.1 p 64.98 -175.23 0.17 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 126.738 2.015 . . . . 0.0 111.663 175.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -95.9 14.15 24.44 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.295 0.638 . . . . 0.0 112.531 165.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -64.63 147.99 51.83 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 120.558 -1.339 . . . . 0.0 110.67 156.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -83.55 121.7 27.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 168.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.1 t -73.0 147.94 44.67 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.743 -1.576 . . . . 0.0 106.743 152.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.9 pt -140.16 13.4 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 126.4 1.88 . . . . 0.0 110.024 170.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -86.39 164.17 17.19 Favored 'General case' 0 C--O 1.238 0.5 0 O-C-N 120.954 -1.091 . . . . 0.0 110.013 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.43 -15.05 10.95 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 118.088 -0.958 . . . . 0.0 112.235 175.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -153.95 165.5 17.76 Favored Pre-proline 0 N--CA 1.469 0.481 0 C-N-CA 125.331 1.452 . . . . 0.0 110.537 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -72.11 147.17 47.96 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.62 2.214 . . . . 0.0 111.591 168.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.11 -31.15 61.08 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.899 0.48 . . . . 0.0 112.103 171.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.26 155.2 25.41 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 121.799 0.809 . . . . 0.0 111.085 -173.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -84.76 -35.26 22.55 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.651 171.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -110.22 94.99 5.3 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -172.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -139.06 171.81 13.76 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 128.613 2.765 . . . . 0.0 107.063 172.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.71 -177.13 14.73 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 166.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.7 m -123.96 122.91 39.19 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.519 1.128 . . . . 0.0 109.449 -165.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mp -97.52 133.82 37.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 170.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -130.57 137.75 49.83 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.853 1.261 . . . . 0.0 107.899 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.4 mt -128.12 92.35 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 105.45 -2.055 . . . . 0.0 105.45 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -70.24 109.46 4.68 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 170.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -139.52 138.58 36.44 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.341 1.056 . . . . 0.0 108.552 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 48.8 36.18 7.64 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.246 1.018 . . . . 0.0 111.721 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.45 18.49 79.91 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 118.939 -0.923 . . . . 0.0 115.119 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.05 156.23 24.28 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 120.355 2.077 . . . . 0.0 110.328 173.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 81.4 mtp -112.33 96.76 6.2 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 123.845 0.858 . . . . 0.0 109.825 -173.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 m -62.88 105.79 0.72 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 165.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.8 m -103.65 156.16 18.0 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -176.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.8 ptp -153.88 171.05 19.58 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.828 1.651 . . . . 0.0 107.185 167.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -126.28 -177.98 4.16 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.233 1.413 . . . . 0.0 107.491 173.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -150.51 156.27 41.09 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -158.76 169.5 24.23 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 162.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -89.87 121.56 32.1 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 169.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -109.67 119.16 38.54 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 169.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.27 4.02 2.0 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.777 1.631 . . . . 0.0 114.463 164.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.01 -13.82 6.0 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.73 1.634 . . . . 0.0 113.4 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.8 tptt -115.16 163.2 15.98 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 120.034 1.917 . . . . 0.0 109.987 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -107.47 142.96 36.52 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -138.43 160.89 38.38 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.261 0.624 . . . . 0.0 109.988 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.78 133.83 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.936 0.894 . . . . 0.0 111.825 -173.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -71.98 161.33 31.08 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.121 -0.987 . . . . 0.0 112.379 -176.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -175.23 169.17 1.58 Allowed Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 126.896 2.078 . . . . 0.0 108.051 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -58.18 -162.54 0.02 OUTLIER 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.081 1.854 . . . . 0.0 110.54 155.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -43.28 -14.31 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.465 2.706 . . . . 0.0 116.705 -171.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -105.03 49.8 0.8 Allowed 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.272 -0.893 . . . . 0.0 111.888 168.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -125.16 69.18 0.5 Allowed Glycine 0 C--O 1.222 -0.608 0 CA-C-N 119.876 1.216 . . . . 0.0 112.247 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.6 mt -133.63 49.27 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 163.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.4 ' CE2' ' HB3' ' A' ' 44' ' ' ARG . 51.0 m-85 -74.87 110.95 9.59 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -78.08 125.17 28.96 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 160.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.7 pt -106.93 164.48 4.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 152.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -123.65 48.21 1.9 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.351 0.661 . . . . 0.0 110.021 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -164.36 174.29 11.23 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.111 0.965 . . . . 0.0 111.757 159.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -70.2 122.94 20.45 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.091 0.956 . . . . 0.0 108.888 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -63.12 -47.88 80.87 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.511 0.596 . . . . 0.0 110.572 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -58.99 -35.03 72.54 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.451 -0.781 . . . . 0.0 112.871 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -72.69 -23.7 60.91 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.245 0.93 . . . . 0.0 110.827 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.2 mmt -70.59 -36.11 73.37 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 121.593 -0.692 . . . . 0.0 110.413 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.0 pt . . . . . 0 C--O 1.249 1.044 0 CA-C-N 119.172 0.896 . . . . 0.0 112.48 -167.677 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 m . . . . . 0 CA--C 1.545 0.751 0 CA-C-O 119.559 -0.258 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -67.29 165.04 28.19 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 CA-C-N 120.075 1.063 . . . . 0.0 111.352 167.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.6 mt -101.99 111.68 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 158.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.48 152.88 46.55 Favored Pre-proline 0 C--O 1.241 0.608 0 C-N-CA 125.878 1.671 . . . . 0.0 108.701 177.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.476 ' HB2' HD21 ' A' ' 10' ' ' ASN . 95.5 Cg_endo -73.7 159.88 44.86 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.807 2.338 . . . . 0.0 111.436 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.425 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -70.32 149.71 47.09 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 123.455 0.702 . . . . 0.0 112.048 -173.714 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.478 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . . . -64.1 -12.86 43.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 118.592 -0.718 . . . . 0.0 111.945 170.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -95.13 -6.26 42.26 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.509 1.05 . . . . 0.0 112.123 -178.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.476 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -129.39 -2.54 4.95 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.58 1.152 . . . . 0.0 112.242 -173.23 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 37.5 t -78.88 111.22 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 170.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -74.8 -43.01 57.0 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.135 1.374 . . . . 0.0 108.605 176.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.8 p -160.24 171.89 18.37 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.593 1.088 . . . . 0.0 112.613 168.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.6 mt -130.02 137.69 55.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 127.335 2.254 . . . . 0.0 105.832 172.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.8 t -116.44 151.2 36.52 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 159.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.0 mt -131.41 101.64 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 168.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.3 117.39 20.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 169.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -75.33 177.02 6.88 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.262 1.029 . . . . 0.0 110.6 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.9 p -60.81 -15.29 28.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.078 2.151 . . . . 0.0 113.363 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 48.2 p30 -118.22 -166.76 1.25 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.515 1.926 . . . . 0.0 110.086 -170.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.2 p -82.44 24.95 0.65 Allowed 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.273 -1.517 . . . . 0.0 111.809 -173.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.5 mt -124.89 149.39 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.463 -1.681 . . . . 0.0 106.463 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -135.3 164.9 26.68 Favored 'General case' 0 N--CA 1.417 -2.084 0 C-N-CA 127.476 2.31 . . . . 0.0 107.906 170.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.25 134.92 30.1 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.8 mp -106.52 148.88 10.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -129.81 34.72 4.25 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.147 0.979 . . . . 0.0 109.664 -170.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -57.47 -20.65 32.17 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.384 2.274 . . . . 0.0 113.019 -175.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.97 123.85 21.74 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 129.542 3.137 . . . . 0.0 109.117 175.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.3 t -46.22 -48.08 17.79 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.133 1.373 . . . . 0.0 113.746 -175.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -69.54 -27.57 65.26 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.004 -1.06 . . . . 0.0 111.566 -175.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.6 m -72.58 -34.86 67.74 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.297 1.839 . . . . 0.0 111.019 172.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.0 mt -65.23 -52.86 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -65.37 -14.05 59.97 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -66.82 -78.66 0.06 Allowed 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 157.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.3 mt -50.58 -39.76 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 125.018 1.327 . . . . 0.0 112.578 -160.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.478 ' CD1' ' HB2' ' A' ' 8' ' ' ALA . 41.5 mt -51.64 -23.0 3.81 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.1 t -64.46 -63.83 1.03 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.168 1.387 . . . . 0.0 108.494 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 56.7 mp0 -64.5 -27.39 68.94 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.4 1.48 . . . . 0.0 111.158 -175.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.5 mm -62.26 -35.5 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 O-C-N 121.297 -0.877 . . . . 0.0 110.245 173.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.63 0.12 30.31 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 120.726 -1.234 . . . . 0.0 113.587 -169.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.7 t -64.81 -44.91 88.39 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.006 0.523 . . . . 0.0 110.919 -176.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.451 ' CA ' HG22 ' A' ' 94' ' ' ILE . . . -73.61 168.24 54.06 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-O 122.493 1.051 . . . . 0.0 112.432 -175.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -132.76 130.74 40.34 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 176.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -68.15 0.3 3.83 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.7 p 60.03 -172.54 0.12 Allowed 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 126.751 2.02 . . . . 0.0 108.847 -174.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -91.31 2.75 56.16 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.095 -1.003 . . . . 0.0 112.034 176.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt -69.03 170.07 10.58 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.084 0.856 . . . . 0.0 110.894 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.11 150.29 34.3 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.07 1.748 . . . . 0.0 109.019 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.87 149.87 43.64 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 -169.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 35.4 pt -138.31 17.78 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 118.957 0.799 . . . . 0.0 112.523 -165.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -139.97 -173.24 3.59 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.181 0.992 . . . . 0.0 108.761 -169.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.38 -6.38 1.56 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.481 1.112 . . . . 0.0 110.651 171.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -140.63 150.23 59.62 Favored Pre-proline 0 N--CA 1.469 0.485 0 CA-C-N 120.21 1.368 . . . . 0.0 111.29 -168.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.26 167.27 27.34 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.666 2.911 . . . . 0.0 114.928 -164.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 t -100.11 23.01 10.51 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.386 2.274 . . . . 0.0 110.72 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -126.6 150.41 48.9 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 125.268 1.427 . . . . 0.0 110.626 -174.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -90.03 -24.79 21.1 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.484 1.114 . . . . 0.0 110.871 172.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -125.34 102.44 7.43 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -145.01 166.99 23.72 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 128.383 2.673 . . . . 0.0 106.163 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.48 166.93 13.74 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 168.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.5 m -112.46 140.05 47.52 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.572 1.149 . . . . 0.0 108.553 -170.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.5 mp -125.81 128.83 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 -174.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -115.1 135.68 53.94 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.2 mt -126.03 87.65 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 171.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -70.22 116.03 10.11 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 125.418 1.487 . . . . 0.0 107.23 174.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -140.91 113.28 8.01 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.036 0.934 . . . . 0.0 109.97 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 74.52 -14.99 0.66 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 130.446 3.499 . . . . 0.0 115.639 171.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 123.21 23.68 2.14 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 118.843 0.747 . . . . 0.0 111.352 -165.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -145.1 171.7 26.14 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 106.609 -2.596 . . . . 0.0 106.609 160.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.08 139.24 34.01 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 118.772 1.286 . . . . 0.0 111.031 172.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 91.3 m -76.55 128.48 34.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 161.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.6 m -102.59 146.68 27.81 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 164.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.6 ptm -159.5 165.51 32.85 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.485 1.514 . . . . 0.0 108.47 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -144.64 140.66 28.83 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.826 1.65 . . . . 0.0 106.841 -174.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.427 ' CE1' HG23 ' A' ' 84' ' ' ILE . 1.8 m-85 -129.21 152.24 49.0 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 120.015 1.279 . . . . 0.0 109.35 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -153.81 -175.56 5.43 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.12 0.968 . . . . 0.0 111.264 -178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -115.55 142.79 46.25 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.609 1.964 . . . . 0.0 108.586 173.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -141.71 127.68 19.47 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 125.393 1.477 . . . . 0.0 108.431 175.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 57.76 14.7 2.59 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.957 1.303 . . . . 0.0 112.936 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.21 18.98 58.22 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 117.921 -1.488 . . . . 0.0 113.32 -175.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.26 148.43 45.91 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 128.612 2.765 . . . . 0.0 107.493 177.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -104.65 143.01 33.66 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.541 1.519 . . . . 0.0 111.305 -169.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -138.12 150.07 46.5 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.24 0.616 . . . . 0.0 111.22 -171.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.427 HG23 ' CE1' ' A' ' 75' ' ' TYR . 3.4 mp -123.16 120.02 59.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 125.133 1.373 . . . . 0.0 108.931 -177.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -73.69 153.19 40.19 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.419 1.088 . . . . 0.0 110.475 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -172.53 168.07 2.96 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 128.428 2.691 . . . . 0.0 106.072 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -57.92 -161.26 0.02 OUTLIER 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 125.268 3.979 . . . . 0.0 110.386 165.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -42.72 -8.82 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 127.572 2.349 . . . . 0.0 117.055 -175.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -121.13 46.74 1.97 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.016 1.326 . . . . 0.0 112.194 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -126.57 70.11 0.5 Allowed Glycine 0 C--O 1.224 -0.508 0 C-N-CA 125.762 1.648 . . . . 0.0 113.715 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.5 mt -131.09 53.07 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 164.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -75.42 125.95 30.03 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -119.31 102.47 8.71 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 -171.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.451 HG22 ' CA ' ' A' ' 42' ' ' GLY . 4.7 pt -115.75 146.71 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.655 1.582 . . . . 0.0 109.073 -175.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -91.82 -5.71 52.96 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -171.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -130.51 153.65 48.62 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.114 0.87 . . . . 0.0 112.638 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -57.86 135.72 56.9 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 126.383 1.873 . . . . 0.0 110.655 174.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -82.02 -49.86 9.76 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.029 1.332 . . . . 0.0 110.884 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -67.99 -13.81 62.47 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -165.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -97.7 -10.25 25.28 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.414 1.006 . . . . 0.0 112.576 173.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 38.7 mmm -76.81 -37.42 55.77 Favored 'General case' 0 C--O 1.233 0.222 0 O-C-N 120.626 -1.297 . . . . 0.0 111.167 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 12.8 pt . . . . . 0 C--O 1.243 0.73 0 C-N-CA 126.558 1.943 . . . . 0.0 114.229 -153.693 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.54 0.577 0 CA-C-O 119.251 -0.404 . . . . 0.0 111.76 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.44 163.3 39.31 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.707 1.604 . . . . 0.0 112.157 169.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.0 mt -96.56 105.67 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 162.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.817 HD13 HG22 ' A' ' 39' ' ' ILE . 16.4 mt -126.19 165.64 26.43 Favored Pre-proline 0 C--O 1.24 0.585 0 C-N-CA 125.396 1.478 . . . . 0.0 108.462 174.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.5 ' HB2' HD21 ' A' ' 10' ' ' ASN . 34.4 Cg_endo -62.07 163.56 19.35 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.014 1.81 . . . . 0.0 111.248 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.4 ' HE2' ' CG ' ' A' ' 9' ' ' GLU . 2.7 mppt? -61.88 179.69 0.25 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.265 0.626 . . . . 0.0 111.405 170.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.77 -45.9 33.78 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 155.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.4 ' CG ' ' HE2' ' A' ' 7' ' ' LYS . 11.2 pt-20 -71.34 3.94 3.31 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.305 1.442 . . . . 0.0 114.037 -163.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.5 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -124.96 4.13 8.02 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.298 2.239 . . . . 0.0 112.516 179.568 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 37.8 t -84.25 141.77 14.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -92.4 -52.75 4.51 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 173.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.51 161.34 42.32 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.907 0.883 . . . . 0.0 111.923 170.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.6 mt -123.89 140.81 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 164.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 54.4 m -134.42 115.74 14.36 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 -168.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.7 mt -119.55 120.11 62.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -112.06 102.42 10.63 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -72.27 168.17 18.87 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.623 1.569 . . . . 0.0 110.031 -165.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.0 p -45.87 -39.62 8.86 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.767 1.627 . . . . 0.0 112.97 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -51.09 -153.62 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 131.41 3.884 . . . . 0.0 112.07 164.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 93.3 p -122.07 25.15 9.21 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 119.863 -1.773 . . . . 0.0 110.596 160.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.3 mt -84.65 134.47 26.93 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 172.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -125.69 129.34 49.35 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.55 125.98 54.79 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 175.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.3 mp -99.8 135.64 34.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 173.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -118.26 87.12 2.66 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -118.19 52.16 1.03 Allowed 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.812 1.645 . . . . 0.0 107.148 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.45 146.49 40.14 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.614 1.566 . . . . 0.0 107.377 168.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.2 t -46.69 -53.99 10.55 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.949 1.699 . . . . 0.0 112.266 177.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -76.42 -27.5 56.29 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 121.65 -0.656 . . . . 0.0 112.027 -171.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 51.5 m -65.78 -48.76 70.71 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.428 1.491 . . . . 0.0 109.187 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 76.9 mt -57.9 -53.19 48.51 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 C-N-CA 125.599 1.56 . . . . 0.0 108.849 171.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -61.1 -28.45 69.1 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 120.541 1.519 . . . . 0.0 113.309 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.18 -60.14 3.08 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.1 mt -47.59 -49.69 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.642 1.577 . . . . 0.0 110.984 175.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.45 -28.07 12.1 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -176.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.5 t -63.93 -62.13 1.83 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.952 0.796 . . . . 0.0 109.16 172.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -63.62 -32.18 73.57 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.411 -0.805 . . . . 0.0 111.894 -174.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.817 HG22 HD13 ' A' ' 5' ' ' LEU . 26.0 mm -62.24 -25.85 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.801 1.24 . . . . 0.0 111.036 174.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.65 -5.73 12.17 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -175.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 t -62.15 -26.91 68.59 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.871 1.214 . . . . 0.0 112.038 -169.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.68 169.67 43.15 Favored Glycine 0 C--N 1.335 0.494 0 O-C-N 120.987 -1.07 . . . . 0.0 114.238 -167.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -112.1 106.72 15.42 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 125.907 1.683 . . . . 0.0 108.336 174.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -3.33 1.16 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.134 0.974 . . . . 0.0 112.923 165.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.1 p 66.27 -164.77 0.23 Allowed 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 125.378 1.471 . . . . 0.0 108.056 174.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -105.42 12.66 31.28 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.593 1.088 . . . . 0.0 111.473 169.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -63.67 170.53 3.22 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 122.166 0.984 . . . . 0.0 110.527 164.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -122.51 144.52 49.02 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 125.604 1.562 . . . . 0.0 110.526 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.02 157.56 16.25 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 125.028 1.331 . . . . 0.0 108.604 172.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 26.7 pt -137.77 17.36 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 125.771 1.628 . . . . 0.0 111.284 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.02 176.88 8.31 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.369 1.468 . . . . 0.0 110.701 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.9 -4.67 6.33 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.749 2.42 . . . . 0.0 110.944 -175.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -140.31 150.05 59.94 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-N 119.202 0.91 . . . . 0.0 109.814 -175.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.43 167.73 25.5 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.141 1.894 . . . . 0.0 110.06 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.2 20.19 16.45 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.401 1.08 . . . . 0.0 110.367 170.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.58 173.83 11.09 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.037 -1.04 . . . . 0.0 109.022 157.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.97 -24.04 5.7 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 127.455 2.302 . . . . 0.0 110.082 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -118.87 112.74 20.05 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.502 1.921 . . . . 0.0 106.114 174.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -149.41 173.83 13.12 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 126.956 2.103 . . . . 0.0 106.706 170.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -114.66 166.17 12.13 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 167.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.58 147.66 22.8 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.397 0.679 . . . . 0.0 109.701 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.0 mp -134.84 128.95 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 172.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -132.26 141.53 49.05 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 53.7 mt -129.24 97.39 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 -177.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -71.31 131.3 43.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 170.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -158.79 -166.04 1.78 Allowed 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -45.51 -32.83 2.4 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.724 1.609 . . . . 0.0 114.133 175.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.23 2.47 81.47 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-O 119.311 -0.716 . . . . 0.0 111.873 -173.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.47 -138.05 22.68 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 107.619 -2.192 . . . . 0.0 107.619 -153.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 11.5 mtt -105.44 112.52 25.64 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.181 0.991 . . . . 0.0 110.682 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 47.9 m -60.04 124.86 21.53 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 149.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.6 m -112.87 143.42 44.17 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.971 1.708 . . . . 0.0 107.073 173.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.5 ptm -163.94 167.71 20.24 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.539 1.535 . . . . 0.0 108.677 -172.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -149.23 129.53 13.75 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.738 1.215 . . . . 0.0 109.098 -169.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.607 ' CE1' HG23 ' A' ' 84' ' ' ILE . 3.3 m-30 -120.18 145.43 46.98 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.751 1.614 . . . . 0.0 110.164 -172.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -151.13 179.51 8.22 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.682 1.593 . . . . 0.0 110.938 -169.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -112.86 148.72 34.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.474 1.51 . . . . 0.0 108.987 168.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -144.72 119.42 9.81 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.686 1.194 . . . . 0.0 108.398 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 58.57 5.44 0.46 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.6 1.96 . . . . 0.0 114.856 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.22 1.8 28.1 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 119.838 1.199 . . . . 0.0 113.536 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -106.17 149.93 26.34 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 119.227 1.513 . . . . 0.0 108.131 163.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -93.85 151.85 19.3 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 174.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -140.47 159.05 43.05 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.599 0.714 . . . . 0.0 111.312 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.607 HG23 ' CE1' ' A' ' 75' ' ' TYR . 2.5 mp -119.65 124.69 73.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 125.26 1.424 . . . . 0.0 108.86 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -70.71 147.65 48.83 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 122.231 1.015 . . . . 0.0 111.596 168.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.503 ' HB2' ' HA2' ' A' ' 90' ' ' GLY . 0.8 OUTLIER -171.55 167.6 3.7 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 128.39 2.676 . . . . 0.0 107.881 174.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.42 ' HD2' ' CB ' ' A' ' 86' ' ' CYS . 45.9 Cg_endo -53.19 -160.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.609 1 C-N-CA 126.199 4.599 . . . . 0.0 110.672 166.002 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -42.63 -13.78 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.756 2.423 . . . . 0.0 115.58 -173.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -110.04 67.42 0.65 Allowed 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 127.875 2.47 . . . . 0.0 113.074 164.1 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.503 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . -130.72 38.71 1.9 Allowed Glycine 0 N--CA 1.463 0.457 0 N-CA-C 116.251 1.26 . . . . 0.0 116.251 -173.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.3 mt -129.34 39.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 O-C-N 121.72 -0.871 . . . . 0.0 109.049 -170.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -75.84 101.62 5.19 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -171.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -72.28 125.82 28.28 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 166.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 24.5 pt -114.99 179.44 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 125.976 1.71 . . . . 0.0 108.753 165.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -107.09 -18.19 13.97 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -178.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -136.67 168.74 18.93 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.792 0.837 . . . . 0.0 111.749 -165.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -77.7 121.44 24.01 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.239 1.016 . . . . 0.0 109.937 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -62.76 -47.77 82.07 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.365 1.066 . . . . 0.0 111.781 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -62.53 -32.02 72.89 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.45 0.7 . . . . 0.0 111.881 -172.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -71.19 -21.01 62.2 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.142 -0.974 . . . . 0.0 111.738 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.1 mmt -98.57 -4.58 33.8 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.128 1.371 . . . . 0.0 112.531 -170.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 23.0 pt . . . . . 0 C--O 1.253 1.286 0 C-N-CA 124.69 1.196 . . . . 0.0 111.321 -175.663 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 CA--C 1.534 0.332 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -55.21 158.63 11.59 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 CA-C-N 121.292 1.497 . . . . 0.0 111.824 164.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 mp -80.32 135.87 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 158.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.63 165.11 24.4 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 126.393 1.877 . . . . 0.0 108.851 174.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HB2' HD21 ' A' ' 10' ' ' ASN . 47.9 Cg_endo -64.8 175.8 3.41 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.096 2.531 . . . . 0.0 112.485 174.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.698 ' H ' ' HE2' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -67.16 -172.28 0.2 Allowed 'General case' 0 C--N 1.344 0.364 0 O-C-N 120.386 -1.446 . . . . 0.0 109.922 167.363 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.7 -36.81 12.73 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.548 0.739 . . . . 0.0 110.957 161.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -76.06 -17.68 59.54 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.206 -0.934 . . . . 0.0 113.223 -171.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.496 HD22 ' N ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -88.12 -3.89 58.83 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.854 1.261 . . . . 0.0 112.421 176.043 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.496 ' N ' HD22 ' A' ' 10' ' ' ASN . 29.1 t -88.3 118.48 33.95 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 -172.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -83.89 -49.43 9.03 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.081 1.352 . . . . 0.0 107.817 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.3 m -157.03 176.95 12.07 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.618 1.099 . . . . 0.0 111.523 163.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.615 HG12 HG23 ' A' ' 64' ' ' ILE . 53.9 mt -126.81 145.05 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 167.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.8 t -125.58 141.08 52.22 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.472 1.109 . . . . 0.0 108.516 169.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.6 mt -134.47 105.76 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 176.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -93.75 109.24 20.91 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 171.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -67.9 169.63 9.52 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.846 1.258 . . . . 0.0 109.846 -173.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.5 p -50.3 -35.71 28.6 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.153 0.981 . . . . 0.0 111.76 176.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -58.86 -154.75 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 131.367 3.867 . . . . 0.0 111.27 172.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.2 p -108.91 4.69 23.66 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 119.992 -1.693 . . . . 0.0 111.947 163.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.4 mt -75.63 133.62 30.91 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -132.26 110.06 10.35 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -177.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.8 125.26 50.79 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -177.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.1 mp -101.19 127.48 54.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 175.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.413 ' CG ' HD11 ' A' ' 35' ' ' ILE . 46.4 m-85 -106.26 83.31 1.87 Allowed 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 102.023 -3.325 . . . . 0.0 102.023 174.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -89.93 -13.4 36.34 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.902 0.881 . . . . 0.0 111.337 174.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.01 135.98 33.32 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.598 1.559 . . . . 0.0 109.877 -165.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.4 t -49.17 -48.09 45.35 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.689 1.196 . . . . 0.0 113.756 -171.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -71.56 -33.48 69.14 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 120.706 -1.247 . . . . 0.0 111.425 -174.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.4 m -62.26 -34.99 77.6 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.753 2.021 . . . . 0.0 110.943 170.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.5 mt -68.2 -49.13 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -59.33 -33.4 71.08 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 117.907 -1.044 . . . . 0.0 112.133 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.449 ' HE3' ' C ' ' A' ' 102' ' ' ILE . 0.0 OUTLIER -64.61 -62.28 1.68 Allowed 'General case' 0 C--N 1.343 0.311 0 CA-C-N 119.699 1.136 . . . . 0.0 109.492 172.735 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.413 HD11 ' CG ' ' A' ' 26' ' ' TYR . 40.5 mt -51.95 -50.12 35.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 124.006 0.922 . . . . 0.0 111.068 -173.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.72 -16.23 10.38 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.1 0.96 . . . . 0.0 113.015 -173.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.2 t -61.42 -59.11 5.77 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.64 1.109 . . . . 0.0 110.203 168.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -65.36 -31.1 72.04 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.58 1.152 . . . . 0.0 110.697 -176.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 39.2 mm -62.13 -16.19 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 121.164 -0.96 . . . . 0.0 111.762 173.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.89 7.82 14.57 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.536 1.534 . . . . 0.0 113.074 175.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 t -78.6 -30.93 46.89 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 120.272 1.396 . . . . 0.0 109.951 -177.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.496 ' CA ' HG22 ' A' ' 94' ' ' ILE . . . -86.38 161.61 34.19 Favored Glycine 0 N--CA 1.447 -0.629 0 O-C-N 120.841 -1.162 . . . . 0.0 114.717 -162.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.46 99.79 7.05 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -170.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.519 ' HB3' ' CE2' ' A' ' 92' ' ' TYR . 9.5 ptt180 -60.12 -8.23 2.31 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.583 1.538 . . . . 0.0 114.311 -177.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.8 p 65.19 176.71 0.2 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.638 2.375 . . . . 0.0 110.115 -175.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -74.34 -9.95 59.1 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.607 -1.308 . . . . 0.0 111.45 172.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -58.41 161.38 4.48 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.985 1.374 . . . . 0.0 110.705 -177.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -108.44 149.95 28.06 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.007 -1.451 . . . . 0.0 107.362 165.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.86 119.98 32.15 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.45 -2.055 . . . . 0.0 105.45 -165.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.8 pt -105.28 12.13 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 119.195 -0.431 . . . . 0.0 111.939 -162.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.56 179.91 6.54 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.385 1.874 . . . . 0.0 108.553 -174.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -127.55 -7.1 5.73 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.148 2.179 . . . . 0.0 110.56 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -140.15 149.22 57.52 Favored Pre-proline 0 C--O 1.238 0.495 0 C-N-CA 124.02 0.928 . . . . 0.0 111.455 -170.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -67.7 155.35 70.35 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.677 2.251 . . . . 0.0 114.104 -171.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 m -100.43 10.39 41.27 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.783 2.033 . . . . 0.0 111.86 162.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.66 166.8 22.98 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 120.501 -1.374 . . . . 0.0 110.072 162.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -105.31 -34.78 7.76 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 127.343 2.257 . . . . 0.0 109.68 165.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -116.12 98.16 6.47 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 -165.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -154.39 162.74 40.99 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 126.05 1.74 . . . . 0.0 109.289 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.64 166.62 15.03 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.908 0.766 . . . . 0.0 111.218 175.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.6 m -107.72 124.67 50.37 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -176.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.71 135.15 56.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 124.445 1.098 . . . . 0.0 108.362 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -121.16 135.1 55.22 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 163.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.662 HG22 ' OD1' ' A' ' 66' ' ' ASN . 42.1 mt -117.1 100.5 10.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 102.718 -3.067 . . . . 0.0 102.718 166.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -78.93 107.18 11.48 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.879 1.672 . . . . 0.0 106.596 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.662 ' OD1' HG22 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -145.56 158.22 43.87 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 123.779 0.831 . . . . 0.0 108.962 179.356 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 48.94 30.03 2.59 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.616 1.566 . . . . 0.0 113.925 169.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.44 47.63 85.62 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 120.925 -1.11 . . . . 0.0 111.2 -175.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -156.89 -173.09 24.9 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 126.092 1.805 . . . . 0.0 109.37 168.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.04 137.57 53.08 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.876 0.846 . . . . 0.0 109.213 159.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.4 m -84.01 97.43 9.28 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 103.612 -2.736 . . . . 0.0 103.612 164.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.1 m -83.87 140.25 32.11 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 2.0 ptm -162.67 163.52 26.94 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.053 1.341 . . . . 0.0 108.768 -177.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -139.69 148.55 42.52 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -136.29 151.84 50.06 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 121.385 1.902 . . . . 0.0 109.528 177.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -147.02 173.4 12.49 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.278 1.031 . . . . 0.0 111.731 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -93.99 146.72 23.73 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 159.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -138.34 126.91 23.4 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 162.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 60.3 6.64 1.07 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.805 1.642 . . . . 0.0 114.412 171.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.17 3.53 31.33 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.963 1.268 . . . . 0.0 113.782 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.56 153.93 24.43 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 120.03 1.915 . . . . 0.0 108.81 161.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -98.74 155.2 17.46 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 174.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.427 ' HA ' ' O ' ' A' ' 92' ' ' TYR . 93.6 m-85 -141.25 159.88 41.28 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 119.039 -0.505 . . . . 0.0 111.882 -176.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.1 mp -124.45 131.49 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.534 1.534 . . . . 0.0 111.755 172.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -82.6 164.38 20.84 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.198 1.799 . . . . 0.0 111.457 172.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.4 ' HB2' ' HA2' ' A' ' 90' ' ' GLY . 0.1 OUTLIER 177.57 169.2 0.47 Allowed Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.842 1.657 . . . . 0.0 108.656 -162.018 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.428 ' O ' ' N ' ' A' ' 89' ' ' LYS . 20.7 Cg_endo -63.23 -164.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.363 0 CA-C-N 121.904 1.716 . . . . 0.0 108.953 158.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -43.65 -5.55 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 129.121 2.969 . . . . 0.0 118.71 -165.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -113.48 43.75 1.71 Allowed 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 128.314 2.646 . . . . 0.0 111.734 170.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.4 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . -113.42 53.05 0.61 Allowed Glycine 0 C--N 1.334 0.471 0 CA-C-N 120.11 1.323 . . . . 0.0 114.823 -176.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.1 mt -129.93 52.33 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 170.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.519 ' CE2' ' HB3' ' A' ' 44' ' ' ARG . 77.4 m-85 -74.39 99.37 3.5 Favored 'General case' 0 CA--C 1.499 -0.984 0 O-C-N 120.957 -1.089 . . . . 0.0 108.641 176.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -61.89 128.21 35.12 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 158.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.496 HG22 ' CA ' ' A' ' 42' ' ' GLY . 3.1 pt -128.78 152.07 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 125.413 1.485 . . . . 0.0 108.251 167.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -80.7 -39.81 26.47 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -112.09 164.75 12.8 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.843 1.257 . . . . 0.0 111.07 -169.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -71.4 131.33 43.21 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 122.377 0.271 . . . . 0.0 110.282 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -64.85 -45.97 83.84 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 122.157 -0.339 . . . . 0.0 110.58 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -69.02 -31.24 69.9 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -168.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -77.71 -25.75 49.59 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.097 -1.002 . . . . 0.0 110.686 177.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 22.7 mmt -81.89 -12.71 58.31 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.742 0.817 . . . . 0.0 112.81 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.449 ' C ' ' HE3' ' A' ' 34' ' ' LYS . 29.1 pt . . . . . 0 C--O 1.25 1.097 0 CA-C-N 120.94 1.7 . . . . 0.0 109.894 172.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.9 p . . . . . 0 C--O 1.24 0.564 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -47.93 153.43 2.6 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 120.654 0.902 . . . . 0.0 111.642 154.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 80.3 mt -80.7 133.33 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 157.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.04 164.43 39.1 Favored Pre-proline 0 C--O 1.242 0.701 0 C-N-CA 125.061 1.344 . . . . 0.0 107.792 176.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.513 ' HB2' HD21 ' A' ' 10' ' ' ASN . 60.7 Cg_endo -58.81 169.82 3.12 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 121.395 1.397 . . . . 0.0 109.93 160.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.472 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -55.5 175.66 0.07 Allowed 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 120.47 -1.394 . . . . 0.0 110.941 164.011 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.2 -55.3 5.86 Favored 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 156.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -62.63 -16.23 55.71 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -163.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.513 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -95.32 1.85 54.53 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.028 1.731 . . . . 0.0 114.542 176.324 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 72.3 t -84.14 130.08 36.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 177.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.42 -58.18 3.46 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 169.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 63.6 p -153.23 163.54 39.71 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.611 171.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 56.1 mt -106.08 125.65 61.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 164.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.6 t -91.56 138.36 31.63 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 163.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.0 mt -125.0 107.52 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 166.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -86.06 121.91 29.34 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 169.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -67.96 164.91 18.91 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.039 0.936 . . . . 0.0 110.734 -176.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -57.9 -27.77 63.61 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 118.512 -0.756 . . . . 0.0 112.404 168.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -87.89 -79.38 0.29 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.929 1.24 . . . . 0.0 111.21 -177.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.9 t -175.93 -3.84 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.963 2.105 . . . . 0.0 112.584 -176.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.0 mm -73.31 150.06 8.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 169.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -139.46 122.19 16.44 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.59 ' HE2' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -121.19 131.53 54.3 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -171.26 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.4 mp -112.14 145.81 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -177.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.59 ' CE1' ' HE2' ' A' ' 24' ' ' LYS . 53.4 m-85 -123.41 95.69 4.69 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 103.841 -2.652 . . . . 0.0 103.841 -172.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -123.29 49.94 1.63 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.811 2.044 . . . . 0.0 108.732 -175.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.06 163.41 34.33 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.438 1.895 . . . . 0.0 107.61 170.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.9 m -50.6 -58.52 5.62 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.445 0.698 . . . . 0.0 111.884 166.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -68.89 -35.33 76.74 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.758 -0.589 . . . . 0.0 111.487 -169.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.4 p -67.24 -43.26 82.42 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.5 mt -67.11 -48.53 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 123.575 0.75 . . . . 0.0 109.609 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -48.52 -50.39 32.08 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.364 1.866 . . . . 0.0 111.898 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.437 ' HE2' ' O ' ' A' ' 101' ' ' MET . 0.0 OUTLIER -59.46 -47.49 85.29 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 122.921 0.489 . . . . 0.0 110.386 -176.329 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.554 HD11 ' CG ' ' A' ' 26' ' ' TYR . 86.3 mt -60.68 -51.18 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.917 176.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 mt -49.59 -39.44 35.35 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.441 1.019 . . . . 0.0 111.025 -177.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.1 t -57.13 -57.05 14.29 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.428 0.691 . . . . 0.0 110.412 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -72.21 -19.05 61.79 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.435 1.094 . . . . 0.0 112.35 -175.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.1 mm -81.9 -19.57 10.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.217 1.407 . . . . 0.0 110.872 173.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.67 -12.66 13.86 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -175.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.2 t -58.07 -31.64 67.26 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.311 0.96 . . . . 0.0 111.267 176.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.42 154.92 44.78 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-O 122.783 1.213 . . . . 0.0 112.118 -171.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.44 108.79 19.43 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 174.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' A' ' 92' ' ' TYR . 6.6 ppt_? -63.4 -13.59 41.37 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 167.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 p 65.53 -174.0 0.18 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.826 1.329 . . . . 0.0 109.926 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -68.31 -17.22 64.22 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.013 -1.054 . . . . 0.0 112.032 175.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -64.26 154.21 35.79 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 119.354 0.979 . . . . 0.0 112.093 -171.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -100.55 133.15 45.43 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 172.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.8 160.11 33.16 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 153.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 pt -136.07 12.51 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.679 1.192 . . . . 0.0 111.164 168.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.8 178.64 4.33 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.11 1.364 . . . . 0.0 108.834 175.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -121.12 -5.32 9.49 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.176 0.99 . . . . 0.0 111.676 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -145.67 160.1 45.43 Favored Pre-proline 0 C--N 1.345 0.378 0 C-N-CA 125.626 1.57 . . . . 0.0 110.344 -171.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -69.36 160.99 47.68 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 121.304 1.336 . . . . 0.0 109.882 177.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.6 t -107.22 13.53 27.14 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.52 0.728 . . . . 0.0 110.862 172.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.03 171.9 13.68 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.523 0.677 . . . . 0.0 111.303 168.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -111.56 -29.22 7.83 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.487 1.915 . . . . 0.0 109.615 172.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -112.62 115.78 29.14 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 127.066 2.146 . . . . 0.0 105.987 172.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -149.53 167.3 26.67 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 171.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.47 169.8 15.08 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 169.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.6 m -123.42 123.14 40.0 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -158.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 mp -122.19 111.72 31.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 124.141 0.976 . . . . 0.0 108.4 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -109.54 113.9 27.07 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.931 1.692 . . . . 0.0 106.728 -175.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.4 mt -98.95 100.38 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 170.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -71.41 119.74 15.99 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 164.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -148.06 136.49 21.49 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.596 0.758 . . . . 0.0 110.172 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 53.24 23.45 3.18 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.265 1.426 . . . . 0.0 111.156 -174.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.04 -8.22 39.16 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 127.608 2.527 . . . . 0.0 114.075 -176.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -87.8 -177.29 48.01 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 108.726 -1.749 . . . . 0.0 108.726 166.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.1 ptt? -145.56 142.74 29.42 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.563 1.181 . . . . 0.0 113.248 174.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.1 m -91.41 111.1 22.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 165.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.5 m -84.12 130.73 34.84 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.572 1.949 . . . . 0.0 106.944 166.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.9 ptp -154.0 173.24 16.26 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.325 1.45 . . . . 0.0 109.36 164.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.603 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 43.0 m-85 -135.72 -179.79 5.86 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.437 1.895 . . . . 0.0 108.477 -178.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -138.79 158.04 44.95 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.375 1.07 . . . . 0.0 108.946 170.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -161.44 171.48 18.12 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.408 1.004 . . . . 0.0 110.616 163.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -99.34 139.24 35.28 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 125.681 1.593 . . . . 0.0 107.945 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -135.23 111.29 9.53 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.641 0.734 . . . . 0.0 109.625 175.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 66.96 10.73 7.89 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.381 1.872 . . . . 0.0 113.3 172.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.1 -8.7 31.31 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-O 118.021 -1.433 . . . . 0.0 113.172 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.97 157.78 15.74 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 119.342 1.571 . . . . 0.0 108.075 163.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -109.15 150.06 28.43 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -141.13 171.79 13.57 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 123.364 0.415 . . . . 0.0 110.146 178.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.422 HD11 HD13 ' A' ' 94' ' ' ILE . 5.2 mp -121.99 150.53 25.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 124.628 1.171 . . . . 0.0 108.057 172.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.603 ' HB3' ' H ' ' A' ' 74' ' ' PHE . 3.4 tm-20 -90.49 159.33 16.57 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.149 2.58 . . . . 0.0 110.045 -173.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 174.81 167.43 0.34 Allowed Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 128.78 2.832 . . . . 0.0 108.774 178.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.405 ' O ' ' N ' ' A' ' 89' ' ' LYS . 23.0 Cg_endo -60.45 -161.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.935 1 C-N-CA 125.446 4.097 . . . . 0.0 110.152 165.333 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -42.9 -8.79 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 128.259 2.623 . . . . 0.0 117.08 -169.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -114.43 33.28 5.4 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 120.637 1.562 . . . . 0.0 114.509 167.189 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -113.41 75.38 0.23 Allowed Glycine 0 C--O 1.223 -0.556 0 CA-C-N 119.671 1.123 . . . . 0.0 113.176 -174.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.0 mt -145.28 46.7 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 174.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 35.9 m-85 -72.19 100.91 2.68 Favored 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 121.05 -1.032 . . . . 0.0 109.74 -171.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.92 122.23 18.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 170.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.422 HD13 HD11 ' A' ' 84' ' ' ILE . 33.2 pt -116.13 174.84 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 127.248 2.219 . . . . 0.0 108.42 162.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -106.31 -14.37 15.13 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -175.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -131.45 167.78 18.74 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.273 0.942 . . . . 0.0 110.0 -169.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -69.98 139.31 52.77 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.951 0.341 . . . . 0.0 110.324 174.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -68.12 -52.42 35.07 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.776 0.83 . . . . 0.0 112.447 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -66.01 -28.42 68.86 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.748 0.704 . . . . 0.0 112.253 -171.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -67.94 -14.51 63.02 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.866 -0.521 . . . . 0.0 111.875 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.437 ' O ' ' HE2' ' A' ' 34' ' ' LYS . 26.3 mmt -103.02 -10.51 18.87 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 117.071 -1.443 . . . . 0.0 113.322 -175.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.9 pp . . . . . 0 C--O 1.254 1.31 0 CA-C-N 121.11 1.777 . . . . 0.0 112.862 -163.86 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.428 ' HB2' ' HD2' ' A' ' 3' ' ' PRO . 15.0 p . . . . . 0 CA--C 1.549 0.933 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.531 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 2' ' ' SER . 38.0 Cg_endo -57.54 164.12 7.77 Favored 'Trans proline' 0 C--N 1.353 0.809 0 CA-C-N 121.58 1.6 . . . . 0.0 110.763 174.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.9 mm -99.21 127.25 52.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 105.31 -2.108 . . . . 0.0 105.31 171.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.22 161.5 63.38 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 126.54 1.936 . . . . 0.0 110.646 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.409 ' HB2' HD21 ' A' ' 10' ' ' ASN . 14.5 Cg_endo -61.17 172.28 3.31 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.158 1.239 . . . . 0.0 110.698 170.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.17 179.11 0.21 Allowed 'General case' 0 N--CA 1.467 0.421 0 O-C-N 120.313 -1.492 . . . . 0.0 112.27 171.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.02 -50.07 17.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 155.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.82 -26.34 68.58 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -159.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.409 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -89.48 -5.72 57.07 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 126.414 1.886 . . . . 0.0 115.02 -178.316 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.2 t -76.89 108.83 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.59 -39.37 93.61 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.001 0.921 . . . . 0.0 109.607 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 p -174.44 136.89 0.48 Allowed 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.177 0.991 . . . . 0.0 108.873 158.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.9 mt -75.34 154.38 6.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 164.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.6 t -131.93 133.79 44.94 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.477 -2.046 . . . . 0.0 105.477 166.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.4 mt -128.99 110.8 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 176.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.41 119.92 22.41 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 105.245 -2.131 . . . . 0.0 105.245 166.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -63.01 -179.83 0.32 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.882 1.273 . . . . 0.0 110.49 173.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.3 p -75.17 0.39 16.5 Favored 'General case' 0 CA--C 1.549 0.904 0 O-C-N 119.97 -1.706 . . . . 0.0 112.305 171.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -122.67 158.56 29.79 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 128.616 2.766 . . . . 0.0 105.479 168.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.4 p -79.26 -2.8 42.92 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 120.243 1.383 . . . . 0.0 112.464 -154.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.428 ' H ' HG13 ' A' ' 22' ' ' ILE . 5.4 mt -61.81 134.89 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 164.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -120.14 166.07 13.91 Favored 'General case' 0 N--CA 1.422 -1.832 0 C-N-CA 125.122 1.369 . . . . 0.0 107.505 171.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.578 ' HE2' ' CE2' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -137.1 151.72 49.19 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 170.265 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.5 mp -109.74 139.76 31.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.578 ' CE2' ' HE2' ' A' ' 24' ' ' LYS . 72.4 m-85 -128.8 91.72 3.27 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 -173.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -119.99 -7.66 9.89 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.78 2.432 . . . . 0.0 110.973 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -64.95 138.27 58.26 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 170.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.9 t -56.97 -42.84 80.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.98 0.809 . . . . 0.0 109.729 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -67.38 -36.7 81.87 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.362 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 52.2 p -55.2 -48.45 73.82 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.026 0.83 . . . . 0.0 109.038 175.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.6 mt -70.48 -54.71 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-O 118.568 -0.729 . . . . 0.0 109.093 -177.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -59.64 -30.64 68.87 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.528 1.058 . . . . 0.0 112.172 -176.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -68.64 -63.82 0.99 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 117.857 -1.068 . . . . 0.0 109.027 170.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.3 mt -47.92 -46.18 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 123.643 0.777 . . . . 0.0 109.967 -176.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -47.73 -31.22 4.53 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.007 1.723 . . . . 0.0 113.08 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.4 t -61.03 -55.15 36.11 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 119.113 0.869 . . . . 0.0 109.584 174.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -75.6 -11.59 60.04 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.021 0.828 . . . . 0.0 112.252 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.5 mm -70.55 -23.92 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 O-C-N 120.9 -1.125 . . . . 0.0 110.141 162.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.35 -18.03 11.14 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -168.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.2 p -69.57 -28.91 66.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 119.817 1.189 . . . . 0.0 112.746 -170.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.78 165.98 50.08 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 119.536 1.062 . . . . 0.0 114.381 -166.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.5 pttm -112.13 103.56 11.75 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 125.518 1.527 . . . . 0.0 111.184 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.423 ' HB3' ' CE2' ' A' ' 92' ' ' TYR . 21.6 ptt180 -58.03 -15.16 8.2 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 170.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.7 p 60.27 175.24 0.09 Allowed 'General case' 0 CA--C 1.551 0.99 0 O-C-N 124.162 0.914 . . . . 0.0 109.597 -171.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -85.68 3.69 39.9 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 119.363 -2.085 . . . . 0.0 111.795 176.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.483 ' CB ' HD12 ' A' ' 91' ' ' ILE . 4.9 mmmt -60.66 156.43 16.74 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.65 0.78 . . . . 0.0 111.786 177.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -89.88 113.99 25.69 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.701 1.6 . . . . 0.0 107.2 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.9 t -80.14 140.66 36.29 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 163.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.2 pt -144.4 39.53 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.649 1.579 . . . . 0.0 107.727 176.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -116.64 177.24 4.77 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.835 1.254 . . . . 0.0 110.682 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.87 -4.58 2.82 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.172 1.389 . . . . 0.0 111.547 177.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -153.35 165.38 17.84 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 126.752 2.021 . . . . 0.0 108.089 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.28 174.3 11.7 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.381 1.387 . . . . 0.0 111.097 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 t -102.17 -7.8 21.89 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.005 1.322 . . . . 0.0 110.804 175.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.04 150.89 31.77 Favored 'General case' 0 CA--C 1.527 0.09 0 O-C-N 121.028 -1.045 . . . . 0.0 110.796 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.46 -22.25 30.39 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.248 1.019 . . . . 0.0 111.232 173.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.79 107.32 9.06 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -129.48 153.58 47.83 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 126.389 1.876 . . . . 0.0 108.943 176.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.02 154.92 25.97 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 108.17 -1.972 . . . . 0.0 108.17 167.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.2 m -127.38 131.73 50.28 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.137 0.975 . . . . 0.0 108.807 -164.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.05 125.62 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -166.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -115.42 144.76 43.34 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 161.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.0 mt -127.48 83.49 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -58.77 120.45 8.99 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 171.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -146.91 114.76 6.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 59.61 20.54 9.13 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.613 1.165 . . . . 0.0 112.375 -173.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.15 3.58 12.4 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.522 1.058 . . . . 0.0 113.506 -171.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.96 170.39 44.03 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 145.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -143.84 163.38 33.55 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 121.308 -1.113 . . . . 0.0 109.469 169.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.2 m -130.07 132.16 46.06 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 174.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -120.83 126.41 50.0 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.196 0.998 . . . . 0.0 108.686 -172.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.6 ptp -146.85 170.65 16.6 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.156 0.983 . . . . 0.0 109.207 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -146.47 148.7 32.52 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 -175.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.92 154.32 50.54 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.364 0.984 . . . . 0.0 109.758 175.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -157.77 172.61 18.18 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.813 1.645 . . . . 0.0 109.545 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -102.84 139.15 38.79 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.657 1.583 . . . . 0.0 108.072 171.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -135.85 120.46 18.27 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 172.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 55.79 -4.59 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 128.153 2.581 . . . . 0.0 117.341 -174.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 136.97 -33.48 2.31 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 125.751 1.644 . . . . 0.0 112.49 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -71.58 151.42 43.82 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 171.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -100.12 150.6 22.32 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 168.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -136.77 153.11 50.92 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.514 0.725 . . . . 0.0 111.182 -176.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mp -123.15 117.9 53.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 125.162 1.385 . . . . 0.0 107.63 -170.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.424 ' CD ' ' H ' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -74.46 154.81 38.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.625 1.17 . . . . 0.0 109.736 176.542 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.424 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 0.8 OUTLIER 179.79 167.73 0.73 Allowed Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 127.963 2.505 . . . . 0.0 107.443 -169.324 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -57.15 -163.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 124.37 3.38 . . . . 0.0 110.728 166.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -44.76 -11.78 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 117.079 2.251 . . . . 0.0 117.079 -174.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -96.78 11.64 34.89 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.023 1.729 . . . . 0.0 115.293 172.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.94 77.54 0.4 Allowed Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 120.259 1.391 . . . . 0.0 113.508 -170.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.483 HD12 ' CB ' ' A' ' 47' ' ' LYS . 2.9 mt -139.51 42.88 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 169.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.423 ' CE2' ' HB3' ' A' ' 44' ' ' ARG . 37.9 m-85 -76.24 107.53 8.55 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 121.212 -0.93 . . . . 0.0 109.758 -172.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -69.66 127.26 32.31 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 159.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 41.0 pt -112.19 168.23 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 148.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -122.32 21.34 10.36 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.848 0.832 . . . . 0.0 112.871 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -140.98 167.42 22.23 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 127.149 2.18 . . . . 0.0 110.214 170.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -84.29 116.22 22.88 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.213 1.005 . . . . 0.0 109.601 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -48.97 -47.33 44.13 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.833 1.253 . . . . 0.0 109.564 172.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -68.43 -17.42 64.2 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.126 0.97 . . . . 0.0 112.692 -171.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -91.49 -13.78 31.59 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 121.334 -0.854 . . . . 0.0 109.937 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 11.9 mmt -106.66 -6.59 17.81 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.789 1.636 . . . . 0.0 112.462 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 24.3 pt . . . . . 0 C--O 1.25 1.126 0 CA-C-N 119.332 0.969 . . . . 0.0 111.397 174.092 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 CA--C 1.538 0.486 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.02 179.89 2.07 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 124.586 3.524 . . . . 0.0 112.504 156.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 53.1 mt -108.54 131.83 58.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 126.258 1.823 . . . . 0.0 106.341 164.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.46 HD12 HG22 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -135.13 161.76 61.65 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 128.143 2.577 . . . . 0.0 109.959 175.227 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -62.17 176.62 1.43 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.998 2.466 . . . . 0.0 112.914 176.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.584 ' HE3' ' H ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -65.35 -175.1 0.21 Allowed 'General case' 0 C--O 1.236 0.383 0 O-C-N 119.983 -1.698 . . . . 0.0 110.351 169.203 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.6 -42.75 16.39 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 118.984 -0.531 . . . . 0.0 111.219 167.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -85.69 -21.83 28.13 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 118.48 -1.288 . . . . 0.0 111.652 -164.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.449 HD22 ' N ' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -73.39 -5.96 43.19 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.64 1.176 . . . . 0.0 112.471 174.632 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.449 ' N ' HD22 ' A' ' 10' ' ' ASN . 25.0 t -80.11 131.58 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 173.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -81.75 -61.43 1.92 Allowed 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 171.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.63 130.2 5.0 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.612 1.096 . . . . 0.0 109.827 171.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.7 mt -81.25 139.38 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.4 t -116.37 140.83 48.92 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 172.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.2 mt -135.57 105.13 5.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 173.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -81.39 108.07 14.69 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 173.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -71.03 -176.76 1.46 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.549 0.69 . . . . 0.0 109.267 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.4 p -62.25 -46.75 87.42 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.492 -1.38 . . . . 0.0 111.394 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -73.74 179.79 4.02 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.752 2.021 . . . . 0.0 109.952 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.6 p -69.84 8.01 0.79 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.239 1.416 . . . . 0.0 112.83 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.6 mt -98.5 137.25 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -170.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -145.93 137.88 25.2 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 -176.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.5 132.21 53.85 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 -173.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.5 mp -105.84 119.74 55.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 176.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.74 ' CG ' HD11 ' A' ' 35' ' ' ILE . 81.6 m-85 -93.06 81.15 4.54 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 102.657 -3.09 . . . . 0.0 102.657 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -96.9 -28.82 14.04 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.998 0.919 . . . . 0.0 110.457 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.53 141.61 53.83 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.1 t -55.03 -46.92 75.32 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.143 0.883 . . . . 0.0 112.481 -175.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -68.65 -24.84 64.58 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.591 1.156 . . . . 0.0 110.899 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.9 p -69.87 -40.97 75.41 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.766 0.712 . . . . 0.0 109.482 176.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 53.9 mt -66.06 -46.65 87.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.566 1.146 . . . . 0.0 108.304 177.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.97 -24.87 67.28 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -165.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.461 ' HE2' ' O ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -65.73 -54.85 21.68 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 123.132 0.573 . . . . 0.0 109.49 172.251 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.74 HD11 ' CG ' ' A' ' 26' ' ' TYR . 18.6 mt -57.01 -40.42 72.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 125.674 1.59 . . . . 0.0 109.307 -169.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.37 -21.48 5.88 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.837 1.655 . . . . 0.0 113.399 175.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.8 t -64.46 -68.36 0.36 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 120.434 1.47 . . . . 0.0 109.011 164.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.425 ' O ' HG22 ' A' ' 41' ' ' THR . 24.8 mm-40 -65.98 -24.93 66.88 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.05 0.54 . . . . 0.0 111.41 -168.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.46 HG22 HD12 ' A' ' 5' ' ' LEU . 14.5 mm -59.56 -29.43 42.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 O-C-N 120.751 -1.218 . . . . 0.0 110.549 172.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.33 -8.74 41.11 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 120.347 1.431 . . . . 0.0 113.441 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 38' ' ' GLU . 1.4 t -69.93 -16.84 63.28 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.018 0.927 . . . . 0.0 113.337 -164.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.28 156.47 18.5 Favored Glycine 0 C--N 1.335 0.512 0 O-C-N 120.75 -1.219 . . . . 0.0 112.865 -171.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.7 pttm -112.83 111.2 21.8 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 175.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.8 ptt-85 -58.49 -5.11 0.48 Allowed 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.982 0.81 . . . . 0.0 112.594 169.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . 0.259 10.4 p 64.44 -164.67 0.25 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.545 1.538 . . . . 0.0 107.819 -176.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -101.21 4.5 41.97 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.909 1.231 . . . . 0.0 111.845 171.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -67.77 153.27 44.08 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 122.066 0.936 . . . . 0.0 110.357 176.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -85.77 121.32 28.27 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.989 1.716 . . . . 0.0 107.68 169.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.2 t -74.09 152.04 40.01 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 158.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.2 pt -138.14 11.79 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 126.083 1.753 . . . . 0.0 110.28 172.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -99.91 173.87 6.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.738 1.215 . . . . 0.0 109.577 178.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.55 -7.42 2.87 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.05 1.74 . . . . 0.0 110.446 174.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -151.72 158.93 33.9 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 127.329 2.251 . . . . 0.0 109.359 -174.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.01 -179.76 5.74 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.467 3.445 . . . . 0.0 112.425 178.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.87 -6.67 11.0 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.855 1.662 . . . . 0.0 112.021 176.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.14 149.82 40.8 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 120.818 -1.176 . . . . 0.0 109.496 173.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -75.03 -30.5 61.09 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.509 0.723 . . . . 0.0 109.756 169.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -114.43 108.09 16.42 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.774 1.63 . . . . 0.0 107.471 -172.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -137.15 168.72 19.06 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 126.521 1.929 . . . . 0.0 107.099 169.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.23 166.52 13.0 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 161.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 73.8 m -124.92 120.68 32.3 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.157 0.983 . . . . 0.0 108.873 -167.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.81 126.37 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -171.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -121.17 128.79 52.84 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 171.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.52 ' HB ' HG22 ' A' ' 71' ' ' THR . 19.6 mt -114.94 88.61 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 171.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -56.38 106.77 0.31 Allowed 'General case' 0 C--O 1.239 0.52 0 C-N-CA 126.886 2.074 . . . . 0.0 108.217 163.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -153.43 148.68 26.94 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.671 1.189 . . . . 0.0 109.93 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 54.76 28.49 10.3 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.02 41.25 71.8 Favored Glycine 0 CA--C 1.527 0.833 0 O-C-N 121.151 -0.968 . . . . 0.0 110.768 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.69 -172.13 36.71 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 127.676 2.56 . . . . 0.0 108.458 174.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -147.15 146.73 29.99 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 119.045 1.423 . . . . 0.0 113.281 174.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.52 HG22 ' HB ' ' A' ' 64' ' ' ILE . 1.2 t -82.61 164.27 20.9 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 165.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.4 m -135.83 146.36 47.42 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 126.661 1.984 . . . . 0.0 106.912 171.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.0 ptp -165.39 167.99 17.17 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.017 1.727 . . . . 0.0 108.249 168.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -140.25 142.15 35.8 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.563 1.545 . . . . 0.0 107.96 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.464 ' CD1' HG13 ' A' ' 84' ' ' ILE . 0.3 OUTLIER -125.9 153.61 43.96 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.833 1.197 . . . . 0.0 109.623 176.791 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -155.32 -175.7 5.57 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.625 1.57 . . . . 0.0 107.554 -175.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -111.86 144.62 40.88 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.708 1.603 . . . . 0.0 108.571 170.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -144.76 110.64 5.41 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 122.524 1.154 . . . . 0.0 111.096 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 66.92 4.84 3.7 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.286 1.834 . . . . 0.0 113.995 176.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 121.77 -5.34 10.63 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.573 1.082 . . . . 0.0 113.5 171.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -105.37 157.82 17.07 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 119.132 1.466 . . . . 0.0 108.443 162.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -93.82 152.4 18.93 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 169.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -143.71 162.29 36.36 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.298 0.639 . . . . 0.0 110.648 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.464 HG13 ' CD1' ' A' ' 75' ' ' TYR . 3.9 mp -117.65 124.68 73.39 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 C-N-CA 125.581 1.552 . . . . 0.0 107.824 -178.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -68.06 151.43 47.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 122.41 1.1 . . . . 0.0 109.033 168.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -169.85 167.61 4.96 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 128.729 2.812 . . . . 0.0 106.433 167.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -56.19 -161.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.817 1 C-N-CA 125.905 4.404 . . . . 0.0 110.237 164.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -43.41 -12.16 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.682 1.993 . . . . 0.0 116.009 -172.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.9 mtmt -112.1 62.3 0.62 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 120.432 1.469 . . . . 0.0 111.869 163.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -141.55 61.89 0.53 Allowed Glycine 0 C--N 1.336 0.549 0 CA-C-N 119.679 1.127 . . . . 0.0 114.304 -175.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.2 mt -136.26 46.86 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 173.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -74.99 109.48 8.49 Favored 'General case' 0 CA--C 1.507 -0.701 0 O-C-N 120.967 -1.083 . . . . 0.0 110.851 -175.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -75.57 122.1 23.39 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 165.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.6 pt -115.87 -179.93 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 125.41 1.484 . . . . 0.0 108.157 160.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -137.5 8.82 2.88 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -170.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -135.71 166.54 23.02 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 126.332 1.853 . . . . 0.0 109.134 173.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -78.28 125.51 29.45 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 170.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -62.87 -46.42 87.95 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.93 -0.481 . . . . 0.0 110.258 -178.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -69.2 -11.68 61.01 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.239 1.015 . . . . 0.0 113.052 -175.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -91.06 -14.16 31.83 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.521 1.528 . . . . 0.0 110.642 175.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 5.6 mmt -105.95 -5.22 19.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.887 1.675 . . . . 0.0 112.448 -172.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 15.9 pt . . . . . 0 C--O 1.253 1.266 0 C-N-CA 125.843 1.657 . . . . 0.0 109.555 173.898 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.546 0.821 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -57.17 167.06 3.62 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.334 1.356 . . . . 0.0 112.051 174.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 64.3 mt -96.74 134.87 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 167.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.28 155.25 61.42 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 128.272 2.629 . . . . 0.0 108.132 -172.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.452 ' HB2' HD21 ' A' ' 10' ' ' ASN . 68.9 Cg_endo -72.12 175.45 9.86 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.903 2.402 . . . . 0.0 112.273 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.501 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -77.71 153.63 32.83 Favored 'General case' 0 C--N 1.34 0.189 0 O-C-N 120.624 -1.298 . . . . 0.0 110.412 171.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.412 ' HB2' HD13 ' A' ' 36' ' ' LEU . . . -78.26 7.48 6.34 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.658 1.183 . . . . 0.0 112.645 175.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -133.86 5.47 3.63 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.811 1.244 . . . . 0.0 111.037 -169.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.452 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -122.94 0.65 9.19 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.927 2.091 . . . . 0.0 112.62 170.25 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 t -70.65 147.08 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 167.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -85.14 -63.5 1.32 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 161.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.6 p -153.4 170.75 19.92 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.483 0.713 . . . . 0.0 109.343 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.9 mt -125.93 126.49 69.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 173.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.9 t -100.03 133.22 44.73 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 171.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.2 mt -125.99 101.47 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 169.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.06 115.01 21.68 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 104.747 -2.316 . . . . 0.0 104.747 167.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -65.75 173.04 3.05 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.283 1.433 . . . . 0.0 109.927 176.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.0 p -69.67 -20.06 63.58 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 119.667 -1.896 . . . . 0.0 112.017 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 53.4 p30 -85.48 -165.4 1.21 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.731 0.812 . . . . 0.0 110.079 173.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.2 p -76.32 -2.51 31.99 Favored 'General case' 0 C--O 1.239 0.521 0 O-C-N 120.695 -1.253 . . . . 0.0 113.258 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.9 mt -100.47 150.52 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -166.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.78 158.79 43.51 Favored 'General case' 0 N--CA 1.417 -2.076 0 C-N-CA 125.886 1.674 . . . . 0.0 108.812 177.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.65 139.52 42.08 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 174.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.1 mp -111.17 137.77 42.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -111.26 76.12 0.96 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 103.081 -2.933 . . . . 0.0 103.081 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -82.44 -32.37 29.03 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 171.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.92 134.43 48.39 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.226 1.81 . . . . 0.0 108.334 -169.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.0 m -51.09 -47.95 61.78 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.567 0.747 . . . . 0.0 111.777 -174.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -76.82 -17.6 58.91 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.577 0.751 . . . . 0.0 111.557 -173.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 64.9 m -80.34 -38.64 30.15 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.905 1.282 . . . . 0.0 110.433 171.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.49 -53.66 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 171.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -57.79 -30.02 65.33 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.874 0.869 . . . . 0.0 112.515 -173.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.67 -61.33 2.69 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 124.008 0.923 . . . . 0.0 109.239 170.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.0 mt -45.2 -53.83 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 125.15 1.38 . . . . 0.0 111.999 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.412 HD13 ' HB2' ' A' ' 8' ' ' ALA . 1.1 mp -53.61 -24.73 14.84 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 120.192 1.36 . . . . 0.0 114.354 -175.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.8 t -55.6 -69.74 0.13 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.054 0.843 . . . . 0.0 109.745 172.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -75.88 -10.47 59.46 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.837 1.255 . . . . 0.0 111.169 -167.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.6 mm -69.56 -37.08 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 O-C-N 121.121 -0.987 . . . . 0.0 110.316 168.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.72 -11.73 30.82 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -164.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 52.5 p -62.41 -41.06 98.41 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.541 0.61 . . . . 0.0 111.558 -173.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.89 162.93 54.11 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-O 124.006 1.892 . . . . 0.0 113.354 -166.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.9 mtmm -125.51 109.08 12.26 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 -174.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 -59.61 -1.8 0.28 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 176.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.1 p 64.7 -164.19 0.25 Allowed 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.595 1.958 . . . . 0.0 107.937 -177.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -95.89 -2.54 47.1 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.577 0.626 . . . . 0.0 110.85 168.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -58.32 159.69 5.9 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 119.36 0.982 . . . . 0.0 111.506 -177.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -109.76 116.5 31.79 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.163 -169.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.1 t -98.12 68.85 1.99 Allowed 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 125.481 1.512 . . . . 0.0 108.354 -172.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.2 pt -73.59 19.59 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 126.498 1.919 . . . . 0.0 111.536 -175.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.74 173.96 7.42 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 126.264 1.825 . . . . 0.0 109.728 -167.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.12 -4.16 10.05 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.517 0.727 . . . . 0.0 110.746 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -146.79 155.85 48.14 Favored Pre-proline 0 C--O 1.234 0.266 0 CA-C-N 118.771 0.714 . . . . 0.0 110.24 -172.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -60.03 168.09 6.43 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.18 2.587 . . . . 0.0 110.376 168.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 t -104.03 23.0 13.63 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.913 1.285 . . . . 0.0 108.841 -176.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -114.66 168.95 9.43 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 128.099 2.56 . . . . 0.0 109.139 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -99.38 -29.25 12.88 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.732 1.213 . . . . 0.0 111.143 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -131.58 115.24 15.84 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -173.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -140.9 161.82 36.92 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 125.306 1.443 . . . . 0.0 107.152 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -95.78 166.7 25.15 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.24 108.21 13.02 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -159.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.1 mp -111.19 134.93 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -176.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -132.28 119.06 20.28 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 161.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.462 HG22 HD22 ' A' ' 66' ' ' ASN . 37.2 mt -85.99 112.23 22.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 159.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -79.85 130.28 35.18 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 167.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.462 HD22 HG22 ' A' ' 64' ' ' ILE . 5.4 p30 -149.05 127.09 11.96 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.623 1.569 . . . . 0.0 109.678 -178.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 46.9 45.24 15.17 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.357 1.863 . . . . 0.0 111.93 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.04 -1.59 17.07 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.498 1.047 . . . . 0.0 115.008 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -105.69 -176.73 23.96 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 168.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.2 ptp -154.57 146.94 23.92 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 120.934 -1.333 . . . . 0.0 112.838 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.1 m -103.29 96.24 6.63 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.097 2.159 . . . . 0.0 106.672 176.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.1 m -80.21 151.46 29.65 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.555 0.742 . . . . 0.0 109.249 171.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.25 165.4 5.97 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.947 2.499 . . . . 0.0 108.591 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.538 ' H ' ' HG3' ' A' ' 85' ' ' GLU . 14.1 m-85 -135.78 148.33 48.72 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 127.189 2.196 . . . . 0.0 108.04 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -125.16 162.1 25.38 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.327 0.967 . . . . 0.0 108.628 171.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -158.33 169.07 25.31 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.663 1.185 . . . . 0.0 109.553 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -97.28 142.13 29.54 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.186 1.794 . . . . 0.0 108.285 163.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -148.85 145.13 27.35 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.27 1.028 . . . . 0.0 108.516 169.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 53.43 0.42 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.681 1.992 . . . . 0.0 115.052 -174.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.79 19.35 37.47 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.104 -1.387 . . . . 0.0 113.374 -169.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -118.18 169.67 9.5 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 121.022 2.411 . . . . 0.0 107.571 161.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -108.58 145.57 34.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -142.7 162.22 36.02 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.414 0.685 . . . . 0.0 109.607 -175.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.0 mp -127.38 125.14 65.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 125.533 1.533 . . . . 0.0 108.205 -172.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.538 ' HG3' ' H ' ' A' ' 74' ' ' PHE . 0.5 OUTLIER -75.24 163.62 27.31 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.999 0.904 . . . . 0.0 108.955 172.057 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 178.74 168.5 0.58 Allowed Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 130.136 3.374 . . . . 0.0 104.783 175.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -53.76 -160.45 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.623 1 C-N-CA 125.407 4.071 . . . . 0.0 110.801 164.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -42.31 -10.18 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 128.887 2.875 . . . . 0.0 115.459 -175.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.3 59.94 0.68 Allowed 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.301 1.84 . . . . 0.0 112.678 166.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -137.53 54.19 0.71 Allowed Glycine 0 C--N 1.338 0.679 0 CA-C-N 119.819 1.191 . . . . 0.0 116.04 -174.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.7 mt -137.96 48.04 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 118.32 1.06 . . . . 0.0 108.66 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -76.65 137.05 39.19 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -118.56 91.56 3.59 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -176.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 16.0 pt -95.18 152.11 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 177.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -105.56 16.24 25.74 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.804 0.812 . . . . 0.0 112.279 -173.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -146.05 160.96 41.16 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.096 1.759 . . . . 0.0 111.004 -175.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -87.1 130.32 34.55 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.443 0.565 . . . . 0.0 111.722 -176.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -66.89 -46.57 74.51 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.549 0.739 . . . . 0.0 111.538 175.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -71.52 -19.84 62.13 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -168.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -95.54 -5.7 42.13 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 121.358 -0.839 . . . . 0.0 112.023 172.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 15.5 mmt -90.75 -28.14 18.47 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 117.387 -1.292 . . . . 0.0 112.013 169.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.7 pt . . . . . 0 C--O 1.253 1.258 0 CA-C-N 120.22 1.373 . . . . 0.0 109.594 164.709 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 CA--C 1.546 0.806 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -65.24 177.4 2.58 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.94 2.427 . . . . 0.0 112.227 163.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.6 mm -125.47 74.88 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 127.492 2.317 . . . . 0.0 105.716 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.84 165.94 42.31 Favored Pre-proline 0 N--CA 1.469 0.509 0 O-C-N 120.687 -1.258 . . . . 0.0 110.756 -177.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.608 ' HB2' HD21 ' A' ' 10' ' ' ASN . 38.3 Cg_endo -58.7 165.09 8.55 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 120.686 0.924 . . . . 0.0 109.997 158.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.465 ' HA ' ' HE2' ' A' ' 7' ' ' LYS . 7.0 mmpt? -53.53 169.01 0.14 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.16 0.984 . . . . 0.0 111.174 169.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.9 -57.24 5.29 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 156.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -57.73 -23.04 49.93 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.411 1.484 . . . . 0.0 114.456 -165.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.608 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -95.87 -0.59 50.82 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -178.206 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.4 t -78.83 153.17 4.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 173.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -108.63 -46.52 3.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 118.501 -0.762 . . . . 0.0 110.163 171.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.4 p -155.27 166.45 33.53 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.039 0.836 . . . . 0.0 110.812 163.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.7 mt -122.07 119.32 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 172.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.578 ' CB ' HD12 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -103.95 128.68 51.49 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.522 0.729 . . . . 0.0 109.703 175.482 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.1 mt -127.29 112.21 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -94.1 120.15 33.95 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 165.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -70.47 -171.91 0.54 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.584 1.554 . . . . 0.0 109.987 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 p -69.15 -1.15 7.09 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 119.697 -1.877 . . . . 0.0 113.927 170.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -104.04 -154.57 0.51 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.686 1.994 . . . . 0.0 109.599 -160.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.8 p -81.12 -5.01 57.18 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 129.302 3.041 . . . . 0.0 114.273 155.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.8 mt -104.05 145.63 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.676 1.59 . . . . 0.0 110.583 -159.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -140.52 134.94 31.37 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 120.897 -1.127 . . . . 0.0 109.86 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.04 141.02 47.05 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.578 HD12 ' CB ' ' A' ' 15' ' ' CYS . 10.3 mm -124.02 156.1 31.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -174.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.427 ' CG ' HD11 ' A' ' 35' ' ' ILE . 63.9 m-85 -142.17 87.97 2.06 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 -165.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -100.53 -21.22 15.39 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.51 1.524 . . . . 0.0 111.457 178.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.12 146.02 46.0 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 t -50.51 -47.06 57.51 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.664 0.786 . . . . 0.0 110.61 171.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -68.5 -31.88 71.46 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.524 -0.735 . . . . 0.0 111.393 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 73.1 m -72.46 -47.43 48.95 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.48 1.512 . . . . 0.0 110.511 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 90.3 mt -59.4 -46.72 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.279 1.432 . . . . 0.0 108.892 174.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.47 -26.28 68.65 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 117.426 -1.273 . . . . 0.0 114.008 -175.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -63.03 -60.01 4.03 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 168.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.427 HD11 ' CG ' ' A' ' 26' ' ' TYR . 74.0 mt -52.62 -51.03 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 O-C-N 123.879 0.737 . . . . 0.0 109.378 -170.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.8 -14.69 60.02 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -178.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.9 t -76.31 -59.33 2.81 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 120.188 1.358 . . . . 0.0 108.495 163.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -61.21 -7.78 3.07 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.91 1.684 . . . . 0.0 113.558 -176.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.6 mm -114.62 -14.18 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 126.324 1.85 . . . . 0.0 111.212 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.36 -10.66 56.03 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 120.277 -1.514 . . . . 0.0 112.567 171.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.8 t -68.87 -30.4 68.9 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.845 1.258 . . . . 0.0 112.669 -170.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.56 168.41 45.89 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-O 122.089 0.827 . . . . 0.0 112.774 -176.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.98 120.83 20.79 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 124.502 1.121 . . . . 0.0 108.041 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.409 ' HB3' ' CE2' ' A' ' 92' ' ' TYR . 14.8 ptt180 -67.26 1.8 1.95 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.8 p 61.13 -163.8 0.25 Allowed 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 -175.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -108.86 13.18 25.03 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.333 0.653 . . . . 0.0 112.169 161.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.15 158.86 8.2 Favored 'General case' 0 C--O 1.239 0.529 0 O-C-N 120.519 -1.363 . . . . 0.0 108.534 161.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -119.83 130.01 54.7 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 121.305 -0.872 . . . . 0.0 109.222 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.36 160.01 30.35 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 161.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.9 pt -136.01 11.04 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.149 1.379 . . . . 0.0 110.808 168.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.16 175.83 6.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.768 1.227 . . . . 0.0 111.034 -172.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -116.82 -11.86 10.85 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.071 1.348 . . . . 0.0 111.194 -174.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -142.71 160.05 54.95 Favored Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 125.483 1.513 . . . . 0.0 109.857 -172.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -70.95 169.16 21.09 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.202 1.935 . . . . 0.0 112.694 -175.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.18 10.84 34.48 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.449 1.1 . . . . 0.0 111.809 -177.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.526 ' HB2' ' CD2' ' A' ' 76' ' ' TYR . . . -107.14 161.94 14.31 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.871 1.269 . . . . 0.0 113.469 -169.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.97 -29.89 35.23 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 126.108 1.763 . . . . 0.0 110.422 165.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -134.88 108.12 7.74 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.907 1.283 . . . . 0.0 109.623 -165.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -145.77 159.9 42.52 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.159 1.384 . . . . 0.0 109.06 -177.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.33 158.56 30.16 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 172.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.84 134.46 44.99 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.475 1.11 . . . . 0.0 108.606 174.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.96 123.64 54.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.11 137.37 46.21 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 159.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 64.7 mt -109.94 105.92 19.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 102.79 -3.041 . . . . 0.0 102.79 160.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -78.12 132.49 37.7 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 169.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -147.37 -171.94 3.9 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.839 1.656 . . . . 0.0 107.573 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.582 ' ND2' ' H ' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -60.09 80.31 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.811 1 C-N-CA 133.867 4.867 . . . . 0.0 110.469 -168.614 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.02 1.64 68.99 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 114.041 -1.436 . . . . 0.0 112.891 -174.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.92 158.12 14.55 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-O 121.719 0.621 . . . . 0.0 112.092 -171.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 7.1 ptm -131.33 133.45 45.35 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 160.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.6 m -118.1 90.9 3.43 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.8 m -84.65 136.78 33.61 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.009 1.324 . . . . 0.0 109.943 -172.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.2 ptp -150.27 171.53 16.8 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.812 1.245 . . . . 0.0 109.722 172.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -142.27 147.7 36.86 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.415 ' CD1' HG13 ' A' ' 84' ' ' ILE . 0.7 OUTLIER -128.69 151.99 48.9 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.6 1.545 . . . . 0.0 108.592 175.524 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.526 ' CD2' ' HB2' ' A' ' 56' ' ' ALA . 13.2 p90 -154.84 168.61 26.33 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.857 0.863 . . . . 0.0 111.281 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -86.85 141.39 28.82 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.672 1.123 . . . . 0.0 107.992 162.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -139.26 120.29 14.57 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.908 0.861 . . . . 0.0 110.325 160.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 63.97 11.25 5.93 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.141 1.776 . . . . 0.0 113.577 170.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.95 -9.71 18.43 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.932 1.253 . . . . 0.0 112.536 173.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -103.46 159.53 15.5 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.203 1.002 . . . . 0.0 108.71 167.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -108.9 152.54 24.78 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 169.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -141.46 160.19 40.66 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 122.939 0.496 . . . . 0.0 110.225 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.415 HG13 ' CD1' ' A' ' 75' ' ' TYR . 3.0 mp -122.31 102.52 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 C-N-CA 125.004 1.322 . . . . 0.0 108.126 -171.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -62.08 145.78 52.27 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 122.882 1.325 . . . . 0.0 111.066 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.591 ' HB2' ' HA2' ' A' ' 90' ' ' GLY . 1.0 OUTLIER -164.5 167.72 9.94 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 130.037 3.335 . . . . 0.0 105.816 -178.558 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 89' ' ' LYS . 43.9 Cg_endo -56.46 -162.13 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 124.378 3.386 . . . . 0.0 109.511 166.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -43.04 -15.07 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 129.609 3.164 . . . . 0.0 115.268 -170.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.475 ' H ' ' HG2' ' A' ' 89' ' ' LYS . 2.6 ptpt -107.06 61.83 0.62 Allowed 'General case' 0 N--CA 1.425 -1.708 0 C-N-CA 130.462 3.505 . . . . 0.0 113.818 167.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.591 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . -122.32 -0.42 10.39 Favored Glycine 0 C--O 1.224 -0.479 0 N-CA-C 116.957 1.543 . . . . 0.0 116.957 -176.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.269 4.1 mt -89.59 48.21 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 O-C-N 120.313 -1.698 . . . . 0.0 109.604 -169.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.409 ' CE2' ' HB3' ' A' ' 44' ' ' ARG . 34.3 m-85 -74.3 101.83 4.16 Favored 'General case' 0 CA--C 1.504 -0.822 0 O-C-N 120.656 -1.277 . . . . 0.0 108.114 174.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -75.13 128.45 35.52 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 162.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.1 pt -114.63 171.41 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.211 1.004 . . . . 0.0 108.524 159.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -129.71 43.48 3.12 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.853 0.835 . . . . 0.0 110.467 -176.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -159.45 164.41 34.56 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 125.911 1.684 . . . . 0.0 108.389 164.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -66.52 136.71 56.05 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 162.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -80.05 -47.04 15.49 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.647 0.779 . . . . 0.0 111.598 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -58.26 -23.01 54.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.9 2.08 . . . . 0.0 113.309 -172.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -75.47 -19.31 59.5 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.952 1.251 . . . . 0.0 111.785 176.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 16.6 mmt -91.4 -14.16 31.12 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.806 1.242 . . . . 0.0 111.027 -173.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.3 pt . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.016 -1.468 . . . . 0.0 112.937 -170.92 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.544 0.732 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -62.06 171.4 5.07 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.271 2.647 . . . . 0.0 113.433 172.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.9 mm -87.27 131.01 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 160.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.84 162.55 48.03 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 127.115 2.166 . . . . 0.0 109.522 170.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.651 ' HB2' HD21 ' A' ' 10' ' ' ASN . 48.4 Cg_endo -68.36 -178.77 1.95 Allowed 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.272 2.648 . . . . 0.0 114.082 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.3 mtmt -62.85 166.97 5.03 Favored 'General case' 0 C--N 1.344 0.367 0 O-C-N 119.547 -1.971 . . . . 0.0 109.501 159.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.1 -56.44 5.59 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 162.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -64.58 -22.48 66.98 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -163.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.651 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -85.41 0.12 53.17 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.323 0.965 . . . . 0.0 113.268 176.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.6 t -74.49 147.24 8.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 171.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.22 -61.26 1.55 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 169.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.6 p -164.49 127.09 2.35 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -175.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.9 mt -90.61 127.73 42.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.0 t -103.51 125.57 50.15 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 174.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.5 mt -123.88 102.09 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 175.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.57 106.33 16.06 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 169.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -59.42 170.97 0.88 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.797 1.639 . . . . 0.0 109.718 -176.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.3 p -59.77 -38.83 82.92 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 120.969 -1.082 . . . . 0.0 111.938 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -73.83 -179.39 3.65 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 127.778 2.431 . . . . 0.0 111.399 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.9 p -71.2 21.3 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.334 2.254 . . . . 0.0 113.862 -174.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.0 mt -136.07 152.18 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 126.182 1.793 . . . . 0.0 106.431 -162.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.6 167.77 18.85 Favored 'General case' 0 N--CA 1.419 -1.987 0 C-N-CA 126.565 1.946 . . . . 0.0 108.701 176.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.434 ' HB3' ' HE2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -142.64 147.44 35.79 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 165.008 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.07 126.32 74.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.573 ' CG ' HD11 ' A' ' 35' ' ' ILE . 21.6 m-85 -107.72 85.95 2.21 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 -174.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -110.33 -18.45 13.26 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.631 1.572 . . . . 0.0 110.991 175.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -69.88 146.71 51.06 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 175.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.12 -45.51 83.41 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.45 0.643 . . . . 0.0 112.164 -173.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -70.23 -31.2 68.5 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.197 -0.94 . . . . 0.0 111.708 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 52.8 p -65.94 -43.74 87.12 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 70.9 mt -62.77 -56.82 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.997 1.319 . . . . 0.0 108.758 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -56.65 -37.53 70.91 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 118.66 -0.686 . . . . 0.0 112.25 -172.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.487 ' O ' ' HE3' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -55.68 -59.78 4.37 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 176.537 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.573 HD11 ' CG ' ' A' ' 26' ' ' TYR . 85.8 mt -56.38 -46.28 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 117.685 -1.15 . . . . 0.0 111.299 -176.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.23 -20.68 2.79 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.619 1.554 . . . . 0.0 114.69 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.89 -53.73 7.98 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.95 0.9 . . . . 0.0 111.509 172.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -59.27 -35.33 73.53 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.949 -1.094 . . . . 0.0 110.342 177.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 21.2 mm -61.55 -24.46 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 120.532 -1.355 . . . . 0.0 111.168 175.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -98.09 -6.6 31.34 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.883 1.22 . . . . 0.0 113.145 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 t -70.78 -34.14 71.48 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.052 0.842 . . . . 0.0 109.652 -168.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.25 167.75 47.63 Favored Glycine 0 C--N 1.341 0.842 0 O-C-N 120.771 -1.205 . . . . 0.0 113.863 -173.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -131.59 110.25 10.81 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 -174.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.427 ' HB3' ' CE1' ' A' ' 92' ' ' TYR . 13.3 ptt-85 -60.06 -8.53 2.43 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -176.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . 0.272 1.4 p 57.36 172.52 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 127.743 2.417 . . . . 0.0 109.846 -169.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -83.24 2.29 36.57 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.421 -1.424 . . . . 0.0 111.594 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt -65.34 158.87 25.33 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 122.049 0.928 . . . . 0.0 110.182 174.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -90.55 130.04 36.63 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 165.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.1 m -75.18 158.87 32.32 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 153.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.9 pt -142.52 31.76 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 125.0 1.32 . . . . 0.0 110.336 174.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -131.15 172.54 12.0 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.953 1.701 . . . . 0.0 108.217 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.55 -0.67 2.89 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.26 1.024 . . . . 0.0 110.996 177.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -146.01 160.65 42.63 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 127.377 2.271 . . . . 0.0 108.607 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -80.33 177.99 7.59 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.452 2.768 . . . . 0.0 112.076 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.9 4.28 8.05 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.713 1.205 . . . . 0.0 112.399 175.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.41 150.72 46.96 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.306 1.042 . . . . 0.0 110.217 170.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -74.56 -28.64 61.03 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.995 0.518 . . . . 0.0 110.062 172.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -129.99 127.73 40.59 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.157 1.383 . . . . 0.0 109.183 -176.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -154.27 161.94 41.49 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.704 2.002 . . . . 0.0 108.147 176.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -90.73 159.63 27.02 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 171.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.34 137.27 38.99 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.16 130.75 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -125.07 130.21 51.8 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 163.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 62.0 mt -106.76 83.57 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 171.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.77 118.49 5.36 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.941 1.246 . . . . 0.0 109.274 167.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -144.88 119.9 10.04 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.675 1.59 . . . . 0.0 108.271 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 60.87 22.98 13.04 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.774 1.63 . . . . 0.0 112.219 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.54 -3.27 42.65 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.51 1.052 . . . . 0.0 113.224 -174.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.88 178.17 51.11 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 156.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 19.7 ptp -159.39 161.27 35.61 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.542 -0.975 . . . . 0.0 112.768 177.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.4 m -118.72 112.26 19.54 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.016 1.726 . . . . 0.0 106.914 172.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.0 m -81.19 147.27 30.09 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 168.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 2.6 ptp -160.11 171.49 19.19 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.164 1.786 . . . . 0.0 108.153 165.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -142.74 146.42 34.3 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.247 1.819 . . . . 0.0 106.474 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.437 ' CD1' HG13 ' A' ' 84' ' ' ILE . 0.6 OUTLIER -128.51 153.5 47.1 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.788 1.631 . . . . 0.0 109.807 175.857 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -153.48 174.86 13.85 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.807 1.243 . . . . 0.0 110.267 -175.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -105.98 144.02 33.29 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.429 1.892 . . . . 0.0 107.961 169.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -151.49 131.1 13.07 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 176.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 55.3 14.51 1.1 Allowed 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.89 -1.131 . . . . 0.0 113.487 -176.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.51 12.09 73.37 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 120.505 -1.372 . . . . 0.0 111.888 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.96 165.07 11.85 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.563 1.945 . . . . 0.0 107.371 163.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -112.24 150.92 30.23 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.083 0.856 . . . . 0.0 108.75 178.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -141.03 159.48 42.12 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.895 0.378 . . . . 0.0 111.167 -178.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.437 HG13 ' CD1' ' A' ' 75' ' ' TYR . 3.5 mp -117.73 129.96 73.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 125.534 1.534 . . . . 0.0 108.45 178.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -73.63 150.03 41.63 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 122.847 1.308 . . . . 0.0 109.831 169.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -169.72 167.44 5.16 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 129.24 3.016 . . . . 0.0 105.928 174.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -59.67 -160.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 125.175 3.917 . . . . 0.0 109.531 162.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -42.77 -9.24 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 128.472 2.709 . . . . 0.0 117.058 -169.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -107.46 21.97 16.67 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 173.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -105.49 44.01 1.56 Allowed Glycine 0 N--CA 1.45 -0.429 0 CA-C-O 118.587 -1.118 . . . . 0.0 115.872 -167.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.4 mt -109.35 46.56 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 119.752 1.776 . . . . 0.0 108.767 171.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.427 ' CE1' ' HB3' ' A' ' 44' ' ' ARG . 72.3 m-85 -71.89 103.57 3.21 Favored 'General case' 0 CA--C 1.51 -0.582 0 O-C-N 121.193 -0.942 . . . . 0.0 108.767 177.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -68.49 126.91 31.12 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 157.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.9 pt -117.74 161.1 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 154.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -104.39 -9.49 18.43 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.658 -0.651 . . . . 0.0 110.774 -176.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -137.81 144.78 41.69 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 124.401 1.08 . . . . 0.0 110.489 -172.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -65.4 124.31 21.91 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 126.388 1.875 . . . . 0.0 112.291 -172.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -63.72 -48.75 75.81 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.808 1.243 . . . . 0.0 110.986 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -65.13 -9.71 25.07 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -174.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -109.22 -9.0 15.03 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.889 1.222 . . . . 0.0 111.819 173.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 10.9 mmt -89.6 -19.95 24.33 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.048 1.339 . . . . 0.0 111.775 174.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 18.3 pt . . . . . 0 C--O 1.255 1.363 0 C-N-CA 124.124 0.969 . . . . 0.0 110.947 174.27 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 CA--C 1.544 0.749 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.53 -173.21 0.11 Allowed 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.842 3.028 . . . . 0.0 111.816 158.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.8 mt -124.27 119.78 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 164.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.7 157.14 76.18 Favored Pre-proline 0 C--O 1.239 0.542 0 C-N-CA 125.324 1.449 . . . . 0.0 109.135 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.573 ' HB2' HD21 ' A' ' 10' ' ' ASN . 71.6 Cg_endo -71.25 165.46 32.37 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.761 2.307 . . . . 0.0 111.513 176.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -64.46 154.78 34.77 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.335 -0.853 . . . . 0.0 111.261 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.478 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . . . -57.24 -50.5 72.69 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.394 0.997 . . . . 0.0 108.963 167.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -67.45 -16.84 64.44 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -169.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.573 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -104.38 1.89 30.66 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 119.582 1.083 . . . . 0.0 113.549 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 t -83.66 135.89 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 172.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -83.82 -60.36 2.14 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.4 p -148.75 169.88 19.46 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.362 1.465 . . . . 0.0 109.553 169.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.3 mt -124.84 144.48 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 N-CA-C 104.578 -2.378 . . . . 0.0 104.578 171.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.83 145.16 49.92 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 174.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.0 mt -134.66 105.74 6.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 178.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -86.37 110.59 19.79 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 102.839 -3.023 . . . . 0.0 102.839 174.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -66.12 173.28 3.18 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 174.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.3 p -56.85 -20.32 22.24 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -103.76 -175.83 2.91 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.197 1.399 . . . . 0.0 109.413 -178.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.4 p -75.65 42.38 0.22 Allowed 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.768 2.027 . . . . 0.0 111.655 -178.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.6 mt -140.11 136.35 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 126.196 1.798 . . . . 0.0 106.313 -172.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.38 150.59 46.7 Favored 'General case' 0 N--CA 1.421 -1.918 0 C-N-CA 125.427 1.491 . . . . 0.0 109.135 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.451 ' HE2' ' CZ ' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -125.28 142.11 51.69 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.377 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.44 145.33 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.451 ' CZ ' ' HE2' ' A' ' 24' ' ' LYS . 24.3 m-85 -127.24 82.49 2.09 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -170.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -88.34 -19.53 26.55 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.378 1.471 . . . . 0.0 112.102 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.99 139.81 30.48 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.47 1.108 . . . . 0.0 111.242 -174.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.4 t -45.2 -54.57 6.77 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 126.463 1.905 . . . . 0.0 112.896 -177.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -67.14 -38.99 86.49 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.527 -0.733 . . . . 0.0 109.753 -173.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.4 m -65.9 -6.42 12.28 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.304 1.842 . . . . 0.0 113.389 171.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -100.66 -45.54 11.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 120.451 1.478 . . . . 0.0 109.316 171.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -60.38 -33.0 71.84 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.885 0.874 . . . . 0.0 112.887 -174.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.13 -52.28 43.64 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.672 0.669 . . . . 0.0 110.39 176.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.2 mt -49.24 -52.0 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 119.43 1.014 . . . . 0.0 110.546 173.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.478 ' CD1' ' HB2' ' A' ' 8' ' ' ALA . 38.9 mt -56.81 -21.32 27.93 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -177.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.5 t -67.19 -65.37 0.69 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.485 1.039 . . . . 0.0 108.56 168.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.39 -29.87 70.13 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.48 -0.763 . . . . 0.0 110.544 -168.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.96 -20.29 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.325 1.05 . . . . 0.0 111.141 174.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.71 -3.47 8.74 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 120.004 1.275 . . . . 0.0 114.222 -170.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 t -66.38 -40.15 89.51 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.586 0.754 . . . . 0.0 110.335 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.64 172.32 53.94 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-O 123.134 1.408 . . . . 0.0 114.19 -169.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -140.7 121.63 14.55 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 114.238 -0.981 . . . . 0.0 108.41 -173.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -63.82 -4.85 3.53 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.521 1.528 . . . . 0.0 114.796 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.1 p 59.83 -164.55 0.22 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.2 1.8 . . . . 0.0 108.379 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -100.31 8.81 43.46 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 120.235 -1.54 . . . . 0.0 112.48 173.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -64.06 154.21 35.06 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.736 -0.602 . . . . 0.0 109.93 173.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -94.81 123.76 38.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 165.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.2 t -70.98 151.73 44.34 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 147.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 pp -141.33 7.57 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.866 2.066 . . . . 0.0 109.687 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.11 162.14 24.17 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.535 1.934 . . . . 0.0 109.76 -174.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -102.3 -1.57 30.77 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.121 0.968 . . . . 0.0 110.699 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -141.55 147.32 45.56 Favored Pre-proline 0 C--O 1.235 0.305 0 CA-C-N 119.394 0.997 . . . . 0.0 111.532 -172.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.446 ' HG2' ' CD2' ' A' ' 59' ' ' TYR . 19.5 Cg_endo -67.98 162.08 41.41 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.218 3.279 . . . . 0.0 111.402 -176.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.81 35.66 1.66 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.048 2.139 . . . . 0.0 109.235 174.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.8 152.79 41.84 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.765 1.626 . . . . 0.0 110.292 173.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -87.67 -29.32 21.23 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.681 -172.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -128.13 118.44 23.41 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 176.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.446 ' CD2' ' HG2' ' A' ' 54' ' ' PRO . 49.4 p90 -138.19 156.47 47.68 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.641 1.576 . . . . 0.0 108.209 175.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.37 -178.0 16.49 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 125.822 1.677 . . . . 0.0 110.12 171.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 36.5 m -131.75 137.17 48.1 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 117.731 0.765 . . . . 0.0 111.953 -158.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 mp -118.72 135.2 59.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 126.179 1.791 . . . . 0.0 107.018 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -127.67 125.45 40.1 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 172.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.7 mt -99.87 118.24 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.116 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 168.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -82.25 133.1 35.23 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 165.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -140.26 -162.72 1.39 Allowed 'General case' 0 C--N 1.327 -0.404 0 O-C-N 120.845 -1.159 . . . . 0.0 108.05 173.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -44.77 -35.74 2.87 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 129.886 3.275 . . . . 0.0 115.565 -157.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -176.13 20.41 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 124.895 1.235 . . . . 0.0 110.39 -167.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -165.18 170.72 40.28 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 171.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.9 ptt? -118.84 156.1 30.03 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.3 1.44 . . . . 0.0 109.834 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 m -126.87 108.02 10.63 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -176.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.4 m -108.52 143.61 37.29 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.705 0.802 . . . . 0.0 110.271 -172.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.94 165.98 33.78 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.526 1.531 . . . . 0.0 109.306 172.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -112.84 176.36 5.05 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.691 1.597 . . . . 0.0 108.928 170.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -142.7 165.62 26.88 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.278 1.431 . . . . 0.0 108.593 170.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -158.46 170.8 21.39 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.111 0.869 . . . . 0.0 112.267 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -106.53 134.29 49.9 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 162.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.31 -162.52 0.08 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 125.824 1.65 . . . . 0.0 106.888 153.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -74.28 50.97 0.41 Allowed 'General case' 0 C--N 1.321 -0.66 0 O-C-N 119.952 -1.717 . . . . 0.0 111.316 174.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 122.07 -14.97 8.91 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 125.108 1.337 . . . . 0.0 112.286 166.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -89.18 154.35 20.21 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.481 1.14 . . . . 0.0 110.728 165.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -114.79 152.68 31.7 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.776 0.716 . . . . 0.0 111.264 -178.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -152.23 163.68 38.93 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.84 0.856 . . . . 0.0 111.879 -169.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.9 mp -131.14 132.58 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.708 1.603 . . . . 0.0 109.767 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.1 tp10 -85.0 165.39 17.6 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.181 2.192 . . . . 0.0 109.994 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.504 ' HB2' ' HA2' ' A' ' 90' ' ' GLY . 0.7 OUTLIER 174.43 168.31 0.32 Allowed Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 128.032 2.533 . . . . 0.0 107.289 -164.421 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.406 ' O ' ' N ' ' A' ' 89' ' ' LYS . 39.5 Cg_endo -59.2 -161.27 0.02 OUTLIER 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.338 2.692 . . . . 0.0 109.672 160.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -42.57 -6.74 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 130.397 3.479 . . . . 0.0 117.733 -170.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 87' ' ' PRO 0.266 1.2 ptpt -109.72 13.4 23.74 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 129.758 3.223 . . . . 0.0 113.285 179.531 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.504 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . -94.18 49.98 2.17 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 123.78 0.705 . . . . 0.0 114.25 -168.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.1 mt -127.79 46.22 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 176.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -72.85 96.38 2.07 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 173.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -74.43 121.08 20.88 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 166.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 27.3 pt -115.75 169.44 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.485 1.114 . . . . 0.0 109.553 166.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -128.37 49.99 2.13 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.24 0.616 . . . . 0.0 109.951 -178.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -166.7 165.21 16.6 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.554 1.541 . . . . 0.0 110.785 165.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -73.62 131.65 41.91 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.194 0.998 . . . . 0.0 108.996 174.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -72.38 -49.14 36.16 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.798 0.727 . . . . 0.0 111.742 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -70.91 -26.13 63.07 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.337 -0.852 . . . . 0.0 113.023 -168.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -72.11 -19.58 61.77 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.153 0.888 . . . . 0.0 111.425 171.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 17.1 mmt -105.81 24.06 12.91 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.571 1.948 . . . . 0.0 111.965 -171.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.2 pt . . . . . 0 C--O 1.257 1.448 0 C-N-CA 125.188 1.395 . . . . 0.0 109.836 169.581 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 m . . . . . 0 CA--C 1.547 0.851 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.77 161.54 45.53 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 O-C-N 118.716 -1.255 . . . . 0.0 111.141 166.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.7 mt -116.45 104.79 17.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.42 158.84 68.37 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 126.986 2.114 . . . . 0.0 110.676 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.496 ' HB2' HD21 ' A' ' 10' ' ' ASN . 68.6 Cg_endo -68.77 -175.43 0.93 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.6 2.867 . . . . 0.0 112.662 177.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt -60.82 175.94 0.44 Allowed 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.109 -1.62 . . . . 0.0 109.569 162.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.18 -50.01 10.11 Favored 'General case' 0 C--O 1.221 -0.428 0 O-C-N 121.255 -0.903 . . . . 0.0 109.539 163.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -62.13 -12.31 18.94 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.683 1.593 . . . . 0.0 114.771 -168.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.496 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -104.83 -0.62 27.0 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.71 2.004 . . . . 0.0 113.187 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 66.5 t -86.01 130.17 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 172.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -67.26 -69.52 0.31 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 167.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.6 m -149.51 170.53 18.4 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.112 0.965 . . . . 0.0 109.984 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.1 mt -131.75 132.97 61.81 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.994 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 172.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.6 m -99.68 133.0 44.65 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 112.787 -2.006 . . . . 0.0 106.069 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.0 mt -133.99 103.65 5.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 170.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -93.97 98.93 11.37 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.172 1.789 . . . . 0.0 106.274 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -60.74 172.83 0.85 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.469 1.908 . . . . 0.0 111.55 -169.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.3 p -51.83 -42.59 62.66 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.962 0.905 . . . . 0.0 110.393 171.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -91.64 -179.2 5.28 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.188 1.795 . . . . 0.0 111.338 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 98.2 p -72.87 16.9 0.13 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.313 1.445 . . . . 0.0 114.818 -158.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.8 mt -120.8 139.91 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -161.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -124.19 107.13 10.89 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 174.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.26 139.85 42.81 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 166.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.0 mt -118.17 136.15 56.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 168.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -110.86 73.87 0.84 Allowed 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 104.243 -2.502 . . . . 0.0 104.243 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -82.12 16.1 2.09 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.808 1.243 . . . . 0.0 111.72 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.51 140.44 52.2 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.707 1.203 . . . . 0.0 109.94 -167.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.8 t -55.75 -46.07 77.92 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.92 0.888 . . . . 0.0 111.636 -175.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -73.66 -31.85 63.68 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.378 -0.826 . . . . 0.0 112.111 -175.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.4 m -65.8 -43.29 89.14 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 127.685 2.394 . . . . 0.0 111.036 174.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.5 mt -64.76 -52.11 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 172.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -60.81 -21.93 63.63 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -65.16 -67.56 0.43 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 119.57 1.077 . . . . 0.0 108.495 166.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.6 mt -50.65 -44.48 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.549 1.14 . . . . 0.0 110.543 -170.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.82 -12.4 0.79 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 177.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.4 t -84.44 -62.94 1.43 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.041 2.136 . . . . 0.0 110.814 168.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -57.65 -14.7 5.88 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.646 1.112 . . . . 0.0 113.435 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.4 mm -82.3 -49.66 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 124.429 1.092 . . . . 0.0 110.736 169.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.96 -19.78 46.32 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.342 1.057 . . . . 0.0 113.713 -173.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 t -68.51 -17.4 64.16 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.668 1.187 . . . . 0.0 112.87 -176.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.62 140.2 40.37 Favored Glycine 0 C--N 1.336 0.557 0 O-C-N 119.612 -1.93 . . . . 0.0 112.389 176.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -108.41 107.34 17.86 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 161.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.7 ptt85 -59.79 -6.48 1.25 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.712 1.142 . . . . 0.0 113.109 168.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.8 p 61.33 -174.85 0.13 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.688 1.595 . . . . 0.0 110.736 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -74.94 -12.71 60.41 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.23 -1.544 . . . . 0.0 112.216 176.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -71.92 171.31 11.99 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.117 0.961 . . . . 0.0 111.35 -167.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -110.74 128.43 55.73 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.824 1.25 . . . . 0.0 108.173 173.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.5 t -74.94 162.58 28.48 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 156.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.9 pt -146.52 31.69 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 126.489 1.915 . . . . 0.0 109.83 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -139.63 172.23 13.09 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 120.99 -1.069 . . . . 0.0 111.64 -172.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -111.12 -20.36 12.39 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.428 1.891 . . . . 0.0 111.52 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -147.26 158.27 44.46 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 124.025 0.93 . . . . 0.0 110.676 -165.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -70.29 175.55 8.39 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.737 2.958 . . . . 0.0 111.699 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.27 -5.12 11.83 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.509 1.524 . . . . 0.0 111.539 175.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.44 157.8 36.4 Favored 'General case' 0 N--CA 1.457 -0.114 0 O-C-N 120.837 -1.165 . . . . 0.0 109.249 169.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.16 -21.66 21.05 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.602 0.761 . . . . 0.0 111.283 168.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -127.96 103.01 7.01 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -169.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -146.56 177.48 9.03 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 128.601 2.76 . . . . 0.0 106.695 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -121.61 166.24 14.45 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 168.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.96 133.07 42.1 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.159 0.984 . . . . 0.0 108.601 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.0 mp -124.33 129.93 73.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -132.64 115.47 15.45 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.0 mt -87.49 103.63 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 173.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -74.76 122.81 23.87 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 172.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -141.67 -157.21 0.75 Allowed 'General case' 0 N--CA 1.465 0.299 0 O-C-N 120.866 -1.146 . . . . 0.0 110.502 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -44.56 -21.21 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 1 C-N-CA 132.796 4.438 . . . . 0.0 116.501 -160.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 153.03 32.19 0.03 OUTLIER Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 126.048 1.785 . . . . 0.0 108.954 -162.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -172.97 174.1 45.77 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.2 ptp -117.93 160.29 21.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.909 1.684 . . . . 0.0 109.351 176.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.6 m -123.29 104.75 9.33 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 158.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.6 m -82.84 141.8 32.0 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.339 1.456 . . . . 0.0 108.591 172.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -165.32 167.99 17.31 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.355 1.862 . . . . 0.0 108.309 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -146.01 138.75 25.64 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.787 1.635 . . . . 0.0 107.421 -174.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.454 ' CE1' HG23 ' A' ' 84' ' ' ILE . 1.8 m-85 -126.06 142.88 51.33 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 121.06 1.754 . . . . 0.0 109.732 -177.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -149.52 173.74 13.27 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.564 1.146 . . . . 0.0 111.583 -174.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -103.45 144.9 30.79 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.284 1.433 . . . . 0.0 108.883 166.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -144.97 126.98 15.52 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.033 0.933 . . . . 0.0 109.313 173.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.14 3.84 1.42 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.847 2.059 . . . . 0.0 114.824 176.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.7 -0.37 15.52 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-N 119.579 1.081 . . . . 0.0 113.315 -173.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.5 tptt -133.87 149.94 51.35 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 119.358 1.579 . . . . 0.0 110.177 -169.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -101.52 135.53 42.86 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -168.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -129.55 159.53 36.06 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.05 0.54 . . . . 0.0 111.055 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.454 HG23 ' CE1' ' A' ' 75' ' ' TYR . 2.9 mp -122.05 117.91 53.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 125.073 1.349 . . . . 0.0 108.428 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -65.25 145.6 56.03 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 122.793 1.282 . . . . 0.0 109.655 173.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -171.2 165.76 4.56 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 127.442 2.297 . . . . 0.0 106.532 175.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.404 ' O ' ' N ' ' A' ' 89' ' ' LYS . 94.2 Cg_endo -63.35 -161.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.769 1 C-N-CA 125.401 4.067 . . . . 0.0 109.517 174.49 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -43.41 -13.98 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 117.065 2.246 . . . . 0.0 117.065 -170.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 87' ' ' PRO . 2.8 mtmt -103.18 31.54 4.22 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 126.237 1.815 . . . . 0.0 114.224 169.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -118.23 69.8 0.32 Allowed Glycine 0 C--O 1.221 -0.693 0 C-N-CA 124.566 1.079 . . . . 0.0 111.963 -174.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.1 mt -133.39 53.01 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 166.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -75.44 108.67 8.4 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 121.463 -0.773 . . . . 0.0 109.029 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -83.37 125.06 31.26 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 163.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.8 pt -113.32 167.31 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.164 1.385 . . . . 0.0 108.726 164.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -124.95 46.53 2.32 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.388 0.613 . . . . 0.0 110.853 -174.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -177.13 169.63 2.29 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 127.456 2.302 . . . . 0.0 109.311 168.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -74.75 138.08 42.45 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.653 1.181 . . . . 0.0 109.739 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -79.4 -44.84 20.66 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.283 1.033 . . . . 0.0 111.819 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.0 -12.54 60.16 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.913 1.285 . . . . 0.0 113.623 -171.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -88.72 -22.47 23.34 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.374 1.47 . . . . 0.0 113.011 171.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -81.49 -29.67 33.56 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 121.092 -1.005 . . . . 0.0 110.541 -178.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 29.3 pt . . . . . 0 C--O 1.25 1.096 0 C-N-CA 123.876 0.87 . . . . 0.0 110.984 -178.29 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 CA--C 1.541 0.619 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -64.14 -179.72 0.9 Allowed 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.799 2.999 . . . . 0.0 112.625 162.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.3 mt -125.58 94.7 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 127.107 2.163 . . . . 0.0 105.575 178.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.82 154.39 37.55 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 126.329 1.851 . . . . 0.0 109.36 -176.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.634 ' HB2' HD21 ' A' ' 10' ' ' ASN . 44.6 Cg_endo -68.62 159.01 55.39 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.606 2.204 . . . . 0.0 112.108 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.39 150.78 38.79 Favored 'General case' 0 C--N 1.345 0.376 0 O-C-N 121.696 -0.628 . . . . 0.0 110.496 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.467 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . . . -68.2 -1.15 5.55 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 177.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -122.5 -18.03 6.81 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 119.533 1.061 . . . . 0.0 111.671 -172.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.634 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -89.11 -6.75 56.81 Favored 'General case' 0 N--CA 1.456 -0.155 0 O-C-N 121.714 -0.616 . . . . 0.0 111.141 170.517 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.8 t -69.06 138.06 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 C-N-CA 125.151 1.38 . . . . 0.0 108.573 169.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.4 -55.88 2.7 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.934 1.694 . . . . 0.0 107.787 173.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.7 p -172.67 121.47 0.41 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.508 0.595 . . . . 0.0 111.119 178.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.7 mt -75.39 129.89 36.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 173.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 t -105.58 148.73 26.97 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 166.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.7 mt -139.0 104.83 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 172.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.8 110.06 18.54 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 104.146 -2.539 . . . . 0.0 104.146 165.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -66.21 -176.43 0.42 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.222 1.009 . . . . 0.0 110.999 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.1 p -57.62 -50.55 72.79 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 120.799 -1.188 . . . . 0.0 109.96 173.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.95 -178.48 2.8 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.701 0.762 . . . . 0.0 109.644 173.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 m -80.94 17.28 1.23 Allowed 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.889 -1.132 . . . . 0.0 111.258 -175.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.7 mt -90.14 134.48 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -127.85 142.93 51.15 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.414 ' HE2' ' CZ ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -131.83 149.22 52.52 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 123.567 0.747 . . . . 0.0 109.214 175.205 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.1 mp -121.8 147.43 25.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.414 ' CZ ' ' HE2' ' A' ' 24' ' ' LYS . 79.6 m-85 -127.45 76.79 1.7 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 -168.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -105.01 5.21 32.41 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.804 1.241 . . . . 0.0 112.613 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -81.72 144.49 31.1 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 166.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 28.6 t -57.83 -41.35 82.08 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.421 -1.424 . . . . 0.0 111.663 174.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.44 -33.78 76.66 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 120.658 -1.276 . . . . 0.0 111.994 178.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.2 p -63.05 -43.09 99.6 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.848 0.859 . . . . 0.0 109.538 175.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 93.0 mt -68.41 -54.5 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 124.62 1.168 . . . . 0.0 108.892 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -58.09 -32.88 68.49 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.706 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -61.68 -64.32 0.98 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 118.551 -0.738 . . . . 0.0 110.233 171.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 81.4 mt -51.6 -48.68 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 119.199 -0.429 . . . . 0.0 110.072 -173.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.467 ' CD1' ' HB2' ' A' ' 8' ' ' ALA . 21.6 mt -53.47 -24.9 14.27 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.2 t -63.91 -63.1 1.25 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.775 1.23 . . . . 0.0 110.072 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -68.87 -24.17 64.31 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.889 0.852 . . . . 0.0 110.724 -174.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.9 mm -68.15 -13.33 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 O-C-N 120.48 -1.387 . . . . 0.0 111.21 171.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.64 -8.45 11.46 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -176.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.4 p -67.77 -40.6 84.01 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.648 1.113 . . . . 0.0 111.608 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.77 164.52 54.59 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-O 123.117 1.398 . . . . 0.0 114.299 -165.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.42 ' C ' ' H ' ' A' ' 45' ' ' THR . 91.6 mttt -115.91 110.49 19.07 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 105.107 -2.182 . . . . 0.0 105.107 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.434 ' HB3' ' CE2' ' A' ' 92' ' ' TYR . 10.3 ptt180 -56.55 -3.95 0.13 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.872 1.269 . . . . 0.0 114.36 174.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.42 ' H ' ' C ' ' A' ' 43' ' ' LYS . 27.7 p 62.7 172.95 0.14 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 128.752 2.821 . . . . 0.0 110.396 -171.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.409 ' HG2' ' H ' ' A' ' 46' ' ' GLU . 8.6 pt-20 -78.37 -6.42 55.11 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.004 -1.06 . . . . 0.0 111.666 172.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -66.91 174.01 3.27 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 122.776 1.274 . . . . 0.0 111.981 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -110.75 150.18 29.45 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.23 1.812 . . . . 0.0 107.752 175.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.7 76.69 1.65 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -164.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.2 pt -90.54 36.14 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.531 1.132 . . . . 0.0 110.542 -164.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -125.35 161.63 26.57 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.295 2.238 . . . . 0.0 109.337 -172.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.99 -3.28 8.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.367 -1.288 . . . . 0.0 112.736 -178.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -150.12 164.61 20.0 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 126.262 1.825 . . . . 0.0 108.638 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.28 179.14 3.64 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.258 2.638 . . . . 0.0 112.678 173.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.66 6.29 45.66 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.154 1.381 . . . . 0.0 111.658 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.13 156.43 17.42 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 121.36 -0.837 . . . . 0.0 111.977 -175.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -86.17 -22.23 27.11 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.795 1.638 . . . . 0.0 111.221 170.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -135.1 115.95 14.01 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -143.07 159.95 41.31 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 127.207 2.203 . . . . 0.0 106.003 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.85 162.59 25.32 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 167.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.8 m -118.11 125.24 49.87 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.104 1.361 . . . . 0.0 108.233 -175.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.2 mp -121.35 132.21 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 -172.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -123.53 115.74 22.03 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 175.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.5 mt -91.17 86.08 2.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 173.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -65.45 113.66 4.29 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 173.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -140.66 135.43 31.65 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.588 1.555 . . . . 0.0 108.17 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 61.5 -4.03 0.18 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.919 2.088 . . . . 0.0 115.443 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.8 12.13 26.87 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 119.89 1.223 . . . . 0.0 112.321 -173.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -127.94 -175.96 14.28 Favored Glycine 0 C--N 1.335 0.511 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 165.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.94 138.25 22.88 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 118.122 0.961 . . . . 0.0 113.149 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 86.8 m -75.23 106.03 6.55 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 158.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.4 m -73.55 142.58 46.65 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 163.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -161.09 166.62 27.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.598 1.559 . . . . 0.0 108.727 170.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -140.99 146.88 37.87 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.619 1.568 . . . . 0.0 108.119 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.426 ' CD1' HG13 ' A' ' 84' ' ' ILE . 1.4 m-85 -128.31 147.35 50.61 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 120.211 1.369 . . . . 0.0 108.973 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -148.9 -175.37 4.92 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.97 1.308 . . . . 0.0 110.538 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -119.04 138.92 52.52 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.176 1.79 . . . . 0.0 109.47 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.487 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 7.6 tt0 -142.84 91.21 2.28 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.886 0.874 . . . . 0.0 109.31 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 70.73 19.4 5.99 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 128.214 2.606 . . . . 0.0 112.484 -174.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.15 -3.67 62.12 Favored Glycine 0 C--N 1.335 0.517 0 O-C-N 120.972 -1.08 . . . . 0.0 112.36 168.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -83.8 145.68 28.55 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 154.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -100.29 149.66 23.37 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.487 ' CE1' ' HB3' ' A' ' 78' ' ' GLU . 84.9 m-85 -134.43 135.09 42.29 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 123.173 0.589 . . . . 0.0 109.734 -171.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.426 HG13 ' CD1' ' A' ' 75' ' ' TYR . 3.0 mp -107.18 127.46 62.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -176.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -77.61 152.36 33.93 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.258 1.423 . . . . 0.0 109.943 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -172.79 168.77 2.61 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 129.131 2.972 . . . . 0.0 107.372 177.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -56.04 -161.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 125.009 3.806 . . . . 0.0 110.606 162.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -42.72 -14.69 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 128.695 2.798 . . . . 0.0 115.028 -171.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.15 66.91 0.64 Allowed 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.364 1.466 . . . . 0.0 110.616 166.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.8 53.13 0.77 Allowed Glycine 0 C--O 1.223 -0.542 0 C-N-CA 124.661 1.124 . . . . 0.0 114.953 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.5 mt -131.44 61.15 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.434 ' CE2' ' HB3' ' A' ' 44' ' ' ARG . 23.4 m-85 -87.56 98.27 11.31 Favored 'General case' 0 CA--C 1.521 -0.168 0 O-C-N 121.165 -0.959 . . . . 0.0 109.304 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -79.06 81.37 5.33 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.55 1.54 . . . . 0.0 109.049 176.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 21.8 pt -81.74 159.41 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 O-C-N 120.877 -1.14 . . . . 0.0 109.439 175.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -107.27 10.74 29.75 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -177.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -131.82 147.32 52.48 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 124.787 1.235 . . . . 0.0 112.433 -175.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -74.07 110.26 8.22 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -55.26 -43.0 74.26 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.035 0.934 . . . . 0.0 110.854 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -73.91 -13.06 60.84 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -171.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -90.43 -24.7 20.66 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.022 0.929 . . . . 0.0 110.789 165.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 12.1 mmt -96.54 6.3 49.02 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 126.124 1.77 . . . . 0.0 113.293 -172.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.4 pt . . . . . 0 C--O 1.246 0.873 0 CA-C-N 119.608 1.095 . . . . 0.0 108.343 164.234 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.543 0.68 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -70.23 173.37 11.49 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.74 2.294 . . . . 0.0 112.252 156.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.5 mt -120.89 98.06 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 175.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.56 165.06 15.42 Favored Pre-proline 0 C--O 1.239 0.532 0 C-N-CA 125.381 1.472 . . . . 0.0 110.086 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.432 ' HB2' HD21 ' A' ' 10' ' ' ASN . 68.2 Cg_endo -63.14 -179.81 0.66 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.348 2.032 . . . . 0.0 111.28 161.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.552 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -64.96 -175.4 0.19 Allowed 'General case' 0 C--O 1.232 0.157 0 O-C-N 120.943 -1.098 . . . . 0.0 109.823 165.164 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.66 -42.93 13.02 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 163.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -72.62 -0.6 13.4 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.282 1.433 . . . . 0.0 113.456 -159.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.517 ' H ' HD22 ' A' ' 10' ' ' ASN . 0.1 OUTLIER -124.43 -0.04 8.22 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 129.919 3.287 . . . . 0.0 111.919 -170.135 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.2 t -84.63 128.5 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 176.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -81.66 -56.42 4.02 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 124.905 1.282 . . . . 0.0 109.416 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.29 155.38 40.45 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.598 0.759 . . . . 0.0 109.348 166.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 51.8 mt -104.14 140.95 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 162.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.8 t -127.61 132.18 49.83 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.2 mt -125.63 106.36 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 174.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.56 110.2 17.45 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 169.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -68.74 170.85 8.68 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.889 1.275 . . . . 0.0 111.255 -174.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.9 p -58.45 -29.6 66.28 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.97 1.708 . . . . 0.0 113.522 176.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.505 ' CG ' ' H ' ' A' ' 21' ' ' SER . 46.9 t30 -86.64 -154.6 0.23 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.771 1.228 . . . . 0.0 108.159 177.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.505 ' H ' ' CG ' ' A' ' 20' ' ' ASN . 23.4 t -102.57 37.33 1.94 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.603 1.961 . . . . 0.0 109.595 -177.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.9 mt -132.02 155.71 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 126.612 1.965 . . . . 0.0 106.749 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.4 164.37 25.84 Favored 'General case' 0 N--CA 1.425 -1.72 0 C-N-CA 127.225 2.21 . . . . 0.0 108.78 171.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.1 135.47 43.24 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 126.39 1.876 . . . . 0.0 106.636 173.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.6 mp -111.72 127.0 69.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 176.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -108.51 80.23 1.33 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -88.7 -5.24 58.24 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.792 1.237 . . . . 0.0 112.085 -178.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.7 150.59 20.21 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.396 1.078 . . . . 0.0 111.552 -175.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -44.71 -64.55 0.68 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.981 2.113 . . . . 0.0 110.739 172.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -62.91 -35.71 80.97 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.111 0.964 . . . . 0.0 111.603 -168.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.6 m -63.8 -49.43 72.93 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 128.41 2.684 . . . . 0.0 110.713 175.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.26 -37.09 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.057 0.943 . . . . 0.0 109.386 174.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.07 -43.07 93.37 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.811 1.244 . . . . 0.0 112.267 -176.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -57.67 -66.45 0.47 Allowed 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 124.538 1.149 . . . . 0.0 108.867 170.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.4 mt -52.16 -45.92 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.768 0.827 . . . . 0.0 111.326 -172.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.91 -7.87 2.72 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.508 -1.37 . . . . 0.0 113.171 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.19 -58.94 2.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.573 2.349 . . . . 0.0 111.029 167.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.6 pm0 -60.36 -20.09 58.1 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 121.072 1.76 . . . . 0.0 113.275 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.7 mm -85.12 -19.83 8.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 125.187 1.395 . . . . 0.0 111.694 173.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.49 -21.26 19.58 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 119.625 1.102 . . . . 0.0 113.321 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.7 t -62.18 -32.63 73.28 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.893 0.877 . . . . 0.0 111.554 -170.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.63 160.49 53.65 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-O 122.983 1.324 . . . . 0.0 113.567 -175.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -125.36 109.98 13.42 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.43 ' HG3' ' H ' ' A' ' 44' ' ' ARG . 4.9 ppt_? -60.18 -10.8 4.9 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.66 1.984 . . . . 0.0 114.31 175.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.1 p 66.04 -179.77 0.2 Allowed 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 128.245 2.618 . . . . 0.0 110.958 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -82.36 2.76 30.78 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.387 -0.821 . . . . 0.0 111.936 173.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -61.92 151.27 35.27 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.994 1.27 . . . . 0.0 110.144 173.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -79.43 154.57 28.86 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.23 -1.35 . . . . 0.0 107.811 162.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.9 117.67 21.39 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 -177.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.7 pt -128.57 43.26 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 119.699 1.136 . . . . 0.0 110.548 -167.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -143.69 160.97 39.75 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.059 1.743 . . . . 0.0 108.252 -177.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.38 -10.67 13.75 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.318 1.047 . . . . 0.0 111.967 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -145.4 157.97 51.68 Favored Pre-proline 0 N--CA 1.467 0.398 0 C-N-CA 125.377 1.471 . . . . 0.0 109.849 -172.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -71.65 169.19 21.64 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.715 2.277 . . . . 0.0 112.504 177.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.6 t -92.08 -9.37 42.89 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.925 1.69 . . . . 0.0 112.442 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.04 158.77 18.52 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.978 -1.076 . . . . 0.0 112.041 -175.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -76.02 -33.51 59.67 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.992 1.317 . . . . 0.0 111.403 171.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -122.71 110.77 15.91 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.7 1.6 . . . . 0.0 106.985 -168.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -148.79 168.2 23.57 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.825 2.05 . . . . 0.0 106.448 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -109.01 167.05 12.81 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 170.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.45 123.3 44.49 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.275 1.03 . . . . 0.0 109.251 -178.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.6 137.52 51.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -128.62 146.68 50.79 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.876 0.87 . . . . 0.0 109.512 165.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.1 mt -114.95 91.36 1.75 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.5 0 N-CA-C 103.055 -2.942 . . . . 0.0 103.055 163.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -62.59 129.68 41.65 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 169.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -144.42 -155.91 0.65 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -55.43 -4.64 0.1 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 130.531 3.532 . . . . 0.0 116.514 -156.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.55 14.83 0.14 Allowed Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 126.474 1.987 . . . . 0.0 110.508 -170.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -147.92 170.42 28.58 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 118.11 0.955 . . . . 0.0 113.214 168.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 31.7 mtp -131.3 108.65 9.81 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 127.456 2.302 . . . . 0.0 106.976 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 78.4 m -74.86 87.63 2.28 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 166.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.8 m -66.31 139.37 58.04 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 172.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 2.1 ptm -160.2 166.39 29.76 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.278 1.431 . . . . 0.0 109.027 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -144.84 143.83 30.82 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.894 1.678 . . . . 0.0 106.683 -173.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -129.68 144.31 51.23 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.608 1.549 . . . . 0.0 109.016 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -146.88 178.75 8.09 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.317 1.447 . . . . 0.0 111.073 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -111.72 140.22 46.53 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.665 1.986 . . . . 0.0 107.655 171.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -138.48 112.6 8.59 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 175.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.14 15.18 3.12 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.95 1.7 . . . . 0.0 114.247 176.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.98 4.68 44.85 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.667 1.127 . . . . 0.0 112.873 172.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.98 161.51 14.4 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 157.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -119.63 154.74 33.54 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -144.04 149.27 36.4 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.783 0.325 . . . . 0.0 111.086 -168.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mp -121.2 119.76 60.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 125.453 1.501 . . . . 0.0 108.193 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -74.46 151.88 39.52 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.708 1.203 . . . . 0.0 110.773 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.511 ' HB2' ' HA2' ' A' ' 90' ' ' GLY . 0.8 OUTLIER -175.08 167.5 1.88 Allowed Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 127.366 2.266 . . . . 0.0 108.486 -177.124 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -55.73 -162.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.802 1 C-N-CA 126.126 4.551 . . . . 0.0 111.347 168.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -43.74 -8.38 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 128.13 2.572 . . . . 0.0 116.733 -175.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.92 70.29 0.77 Allowed 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 119.346 0.975 . . . . 0.0 110.697 159.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.511 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . -131.39 33.85 2.7 Favored Glycine 0 C--O 1.225 -0.439 0 N-CA-C 116.839 1.496 . . . . 0.0 116.839 -175.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.6 mt -116.98 50.11 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 118.027 0.914 . . . . 0.0 108.571 175.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -73.82 101.22 3.67 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.513 -1.367 . . . . 0.0 108.726 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -68.01 124.87 24.58 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 163.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 22.0 pt -121.14 163.64 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 124.189 0.996 . . . . 0.0 108.813 156.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -104.46 2.61 31.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.508 -175.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -132.69 154.27 50.33 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -169.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -73.15 104.2 4.14 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.835 2.054 . . . . 0.0 110.034 175.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -56.57 -36.42 69.3 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.46 1.504 . . . . 0.0 110.65 175.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -68.08 -15.86 63.77 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.681 0.792 . . . . 0.0 113.04 -172.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -90.81 -28.44 18.2 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.226 1.01 . . . . 0.0 112.105 169.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 41.4 mtt -68.5 -35.8 78.01 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 118.625 -0.702 . . . . 0.0 109.893 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 32.1 pt . . . . . 0 C--O 1.251 1.152 0 CA-C-O 117.164 -1.398 . . . . 0.0 112.312 -175.377 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.781 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.98 165.52 50.1 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 118.39 1.095 . . . . 0.0 112.448 -172.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.07 158.86 13.54 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.738 2.292 . . . . 0.0 111.723 154.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.5 mt -98.21 95.92 4.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 N-CA-C 104.724 -2.325 . . . . 0.0 104.724 165.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.9 166.15 35.36 Favored Pre-proline 0 C--O 1.237 0.428 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 172.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.549 ' HB2' HD21 ' A' ' 10' ' ' ASN . 56.0 Cg_endo -56.89 173.09 0.59 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 121.15 1.234 . . . . 0.0 111.204 157.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.424 ' HE3' ' CG ' ' A' ' 9' ' ' GLU . 11.7 mtmt -56.87 172.33 0.27 Allowed 'General case' 0 C--N 1.345 0.393 0 O-C-N 120.859 -1.15 . . . . 0.0 110.538 166.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.0 -53.97 8.89 Favored 'General case' 0 C--O 1.221 -0.438 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 158.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.424 ' CG ' ' HE3' ' A' ' 7' ' ' LYS . 1.1 pt-20 -70.56 -7.06 41.07 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 -162.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.549 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -100.02 -1.01 38.1 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.983 1.713 . . . . 0.0 112.278 177.066 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.0 t -78.36 124.07 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -78.65 -54.03 6.55 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.761 1.624 . . . . 0.0 106.869 -176.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -152.47 167.31 29.19 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.524 1.13 . . . . 0.0 108.658 160.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.8 mt -120.36 127.71 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 164.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.11 136.84 45.09 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 175.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.2 mt -131.08 100.24 4.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.93 113.31 12.08 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 163.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -67.17 176.44 2.19 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.619 1.168 . . . . 0.0 110.099 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.32 -34.14 77.47 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.521 -1.362 . . . . 0.0 112.117 177.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.8 p30 -80.13 -154.69 0.1 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.922 1.689 . . . . 0.0 110.75 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.5 p -91.82 10.63 27.76 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.621 -1.3 . . . . 0.0 113.656 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.9 mt -107.16 151.26 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -170.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -136.46 149.6 48.3 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 173.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.9 143.56 50.93 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 174.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.1 mp -118.25 127.62 75.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.68 ' CG ' HD11 ' A' ' 35' ' ' ILE . 38.6 m-85 -104.03 100.05 9.81 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 -176.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -125.98 -8.81 6.59 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.275 1.03 . . . . 0.0 111.88 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.58 149.99 36.55 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.154 0.982 . . . . 0.0 109.028 167.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.1 m -44.84 -57.02 4.02 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 124.392 1.077 . . . . 0.0 111.447 165.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.97 -29.96 70.92 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.605 0.762 . . . . 0.0 111.79 -174.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.4 p -71.09 -47.56 57.46 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 78.3 mt -63.38 -54.07 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 126.003 1.721 . . . . 0.0 109.169 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -59.19 -37.23 76.9 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 123.479 0.712 . . . . 0.0 111.332 -172.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.95 -50.48 73.6 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.741 0.816 . . . . 0.0 110.353 175.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.68 HD11 ' CG ' ' A' ' 26' ' ' TYR . 91.8 mt -55.49 -55.65 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 174.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.5 -12.19 2.51 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 t -78.08 -67.55 0.72 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 120.265 1.393 . . . . 0.0 109.321 166.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.564 ' O ' HG22 ' A' ' 41' ' ' THR . 71.7 mm-40 -66.0 -27.03 67.82 Favored 'General case' 0 C--O 1.223 -0.313 0 O-C-N 121.167 -0.958 . . . . 0.0 111.094 -171.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.402 HD11 ' CE1' ' A' ' 98' ' ' PHE . 14.1 mm -72.01 -18.3 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 O-C-N 119.998 -1.689 . . . . 0.0 111.832 173.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.81 -3.78 31.93 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.895 1.278 . . . . 0.0 113.692 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.564 HG22 ' O ' ' A' ' 38' ' ' GLU . 2.6 t -68.78 -36.16 77.95 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.878 0.871 . . . . 0.0 111.235 -178.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.3 170.28 53.42 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 124.232 0.92 . . . . 0.0 112.429 -170.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.445 ' O ' HG23 ' A' ' 45' ' ' THR . 35.4 mtmm -119.45 111.62 18.36 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.462 ' HA ' ' HA ' ' A' ' 92' ' ' TYR . 4.4 ppt_? -61.08 -12.94 13.82 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 171.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 43' ' ' LYS . 12.0 p 65.57 -176.36 0.18 Allowed 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 127.681 2.392 . . . . 0.0 109.728 177.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -88.4 6.0 39.54 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 120.541 -1.349 . . . . 0.0 113.453 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.6 mtpt -64.62 173.46 2.17 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.681 1.192 . . . . 0.0 112.45 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -109.93 119.4 39.21 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.6 m -79.73 85.18 5.45 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 167.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.8 pt -85.81 35.94 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 125.166 1.387 . . . . 0.0 110.113 176.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -142.27 165.86 26.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 128.695 2.798 . . . . 0.0 107.34 -172.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -132.7 0.4 3.57 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.403 1.081 . . . . 0.0 111.665 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -146.45 164.72 22.91 Favored Pre-proline 0 C--O 1.238 0.457 0 C-N-CA 126.847 2.059 . . . . 0.0 108.304 -173.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -74.15 170.92 19.04 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.021 2.48 . . . . 0.0 111.039 169.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -110.9 4.18 19.48 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.296 1.038 . . . . 0.0 111.607 166.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.85 173.25 10.17 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 120.573 -1.329 . . . . 0.0 109.992 161.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.5 -22.8 4.94 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.869 1.668 . . . . 0.0 110.637 177.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -105.4 113.63 27.32 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 174.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -160.73 168.0 25.72 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.123 1.369 . . . . 0.0 108.492 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -96.34 157.06 21.35 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 168.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.6 m -103.96 130.95 51.62 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 mp -126.97 137.26 58.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 123.502 0.721 . . . . 0.0 109.909 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.12 114.52 18.49 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 168.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 72.6 mt -88.95 91.53 3.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 104.35 -2.463 . . . . 0.0 104.35 162.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -70.32 123.61 22.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 171.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -153.02 133.04 13.35 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.558 1.143 . . . . 0.0 109.637 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 55.48 31.89 17.9 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.636 1.174 . . . . 0.0 110.656 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.35 -11.42 4.04 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.904 1.716 . . . . 0.0 115.018 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.91 -173.75 45.34 Favored Glycine 0 C--N 1.332 0.337 0 O-C-N 120.5 -1.588 . . . . 0.0 110.029 166.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -145.09 157.57 44.07 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.907 -0.76 . . . . 0.0 111.507 168.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 83.5 m -96.73 109.2 21.9 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 154.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.7 m -74.53 147.12 42.08 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 160.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.9 ptm -163.07 170.74 17.48 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.009 1.724 . . . . 0.0 108.298 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -143.59 151.74 40.55 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -129.57 158.01 40.47 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 121.072 1.76 . . . . 0.0 110.655 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -159.21 178.28 10.16 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.457 1.48 . . . . 0.0 111.889 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -106.62 139.48 41.0 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.61 1.564 . . . . 0.0 108.007 167.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -141.68 131.3 24.03 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.246 1.022 . . . . 0.0 109.169 167.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 57.77 4.75 0.28 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.374 1.87 . . . . 0.0 114.769 175.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.09 2.4 21.96 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.744 1.64 . . . . 0.0 113.97 176.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -113.94 157.67 22.12 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 125.952 1.701 . . . . 0.0 108.052 167.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -103.25 159.45 15.53 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -145.63 155.06 42.78 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.682 0.793 . . . . 0.0 111.025 -172.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 mp -126.49 126.31 68.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 C-N-CA 125.973 1.709 . . . . 0.0 108.417 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -73.36 152.5 40.85 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 127.063 2.145 . . . . 0.0 110.19 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -177.16 167.53 1.26 Allowed Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 128.553 2.741 . . . . 0.0 107.973 176.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' A' ' 89' ' ' LYS . 41.1 Cg_endo -61.09 -162.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.815 1 C-N-CA 125.378 4.052 . . . . 0.0 109.671 166.173 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -43.06 -13.41 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.271 2.228 . . . . 0.0 116.955 -162.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.497 ' HE3' ' H ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -115.18 45.0 1.71 Allowed 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 171.218 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -124.95 68.74 0.5 Allowed Glycine 0 C--O 1.228 -0.276 0 O-C-N 120.724 -1.235 . . . . 0.0 113.285 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.4 mt -135.23 50.97 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 168.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 37.2 m-85 -74.37 91.12 2.19 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.224 -0.922 . . . . 0.0 108.569 -175.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -64.72 120.06 11.74 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 167.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.1 pt -118.44 158.36 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 125.968 1.707 . . . . 0.0 107.8 164.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -104.36 -1.5 26.8 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.522 0.729 . . . . 0.0 112.37 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -118.89 162.28 18.76 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.742 1.217 . . . . 0.0 111.22 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -74.82 153.13 38.86 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.461 0.704 . . . . 0.0 110.72 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.402 ' CE1' HD11 ' A' ' 39' ' ' ILE . 65.1 t80 -79.87 -57.99 3.38 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.295 -0.878 . . . . 0.0 112.395 170.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.02 -20.18 66.37 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -163.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -84.87 -17.43 37.99 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.194 0.906 . . . . 0.0 111.722 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 10.7 mmt -95.91 -18.26 20.45 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.894 1.277 . . . . 0.0 111.351 -172.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.403 ' H ' HG12 ' A' ' 102' ' ' ILE . 9.4 pt . . . . . 0 C--O 1.247 0.974 0 C-N-CA 124.534 1.134 . . . . 0.0 110.103 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.042 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 m 64.29 166.65 0.11 Allowed Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.299 1.04 . . . . 0.0 110.156 -175.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.56 161.91 43.12 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 CA-C-N 121.275 1.491 . . . . 0.0 111.799 -170.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.6 mt -109.45 117.54 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 170.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.475 HD21 ' HB2' ' A' ' 40' ' ' ALA . 0.3 OUTLIER -126.27 160.7 56.25 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 127.402 2.281 . . . . 0.0 108.396 -176.186 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.461 ' HB2' HD21 ' A' ' 10' ' ' ASN . 73.8 Cg_endo -68.49 -178.33 1.83 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.038 2.492 . . . . 0.0 111.504 174.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.409 ' HE3' ' HG2' ' A' ' 9' ' ' GLU . 7.2 mtmt -58.42 175.88 0.21 Allowed 'General case' 0 C--N 1.349 0.546 0 O-C-N 121.223 -0.923 . . . . 0.0 109.896 167.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.51 -59.19 2.84 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 157.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.409 ' HG2' ' HE3' ' A' ' 7' ' ' LYS . 11.0 pt-20 -70.75 -13.6 62.12 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -159.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.461 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -88.13 -1.4 57.98 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.173 1.389 . . . . 0.0 111.926 176.098 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.403 ' N ' HD22 ' A' ' 10' ' ' ASN . 90.7 t -86.91 116.08 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 175.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -70.75 -44.03 67.6 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.991 0.807 . . . . 0.0 109.825 173.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.8 p -153.95 154.07 33.14 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 118.43 0.559 . . . . 0.0 111.671 162.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.1 mt -95.23 140.43 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 157.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.6 t -126.35 113.89 17.5 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 53.5 mt -109.5 115.46 49.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -90.04 123.16 33.68 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 167.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -77.13 174.72 10.37 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.358 1.063 . . . . 0.0 109.912 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 p -61.01 -52.48 64.82 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.334 -0.854 . . . . 0.0 109.263 171.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -66.4 153.85 41.66 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 127.101 2.16 . . . . 0.0 107.761 169.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 94.1 p -86.51 45.98 1.3 Allowed 'General case' 0 C--O 1.237 0.408 0 O-C-N 121.71 -0.619 . . . . 0.0 111.62 -152.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.2 mt -122.17 133.79 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 -171.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -126.99 111.84 14.55 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -174.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.406 ' HE2' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -103.06 138.67 39.61 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -178.332 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.7 mp -115.97 135.85 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 -175.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.436 ' CD2' HD11 ' A' ' 35' ' ' ILE . 69.5 m-85 -122.99 90.77 3.35 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 103.438 -2.801 . . . . 0.0 103.438 -168.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -116.62 -16.67 10.71 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.697 1.599 . . . . 0.0 110.369 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.53 136.37 56.31 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.34 1.856 . . . . 0.0 106.475 170.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.8 t -55.88 -44.05 77.79 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 120.014 1.279 . . . . 0.0 111.821 -171.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -68.99 -32.02 71.29 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.95 0.9 . . . . 0.0 110.995 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 p -61.5 -45.98 91.93 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.533 HG22 HD11 ' A' ' 36' ' ' LEU . 70.3 mt -65.0 -53.61 39.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.563 1.545 . . . . 0.0 109.042 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.419 ' HA ' HD12 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -48.84 -51.68 28.26 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.044 0.838 . . . . 0.0 113.045 -168.158 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.2 -42.38 86.04 Favored 'General case' 0 C--O 1.227 -0.1 0 C-N-CA 123.771 0.828 . . . . 0.0 111.568 -175.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.436 HD11 ' CD2' ' A' ' 26' ' ' TYR . 86.6 mt -62.3 -51.52 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -177.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.533 HD11 HG22 ' A' ' 32' ' ' ILE . 1.2 mt -59.19 -26.9 65.21 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.728 1.149 . . . . 0.0 110.913 177.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.38 -69.03 0.2 Allowed 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.502 1.121 . . . . 0.0 109.22 171.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -75.69 -16.78 60.12 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -171.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.8 mm -67.09 -39.86 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 O-C-N 119.929 -1.732 . . . . 0.0 109.127 171.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.475 ' HB2' HD21 ' A' ' 5' ' ' LEU . . . -89.13 3.02 53.25 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 120.73 -1.231 . . . . 0.0 113.907 -171.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.1 p -73.21 -45.87 53.74 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.153 173.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.13 145.22 48.54 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 123.989 0.804 . . . . 0.0 111.615 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -123.11 106.03 10.44 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 -166.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 92' ' ' TYR . 7.6 ppt_? -62.72 -13.01 27.56 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 174.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.1 p 65.46 -174.85 0.18 Allowed 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 127.61 2.364 . . . . 0.0 110.436 177.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -69.89 -11.99 61.29 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 119.287 -2.133 . . . . 0.0 112.946 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -63.17 166.48 6.02 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.084 1.353 . . . . 0.0 112.135 -174.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.57 122.72 38.36 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.732 1.613 . . . . 0.0 110.731 176.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.7 t -70.46 160.37 32.51 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 127.443 2.297 . . . . 0.0 107.817 163.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.7 pt -144.6 22.88 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 126.912 2.085 . . . . 0.0 110.45 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -114.32 164.36 14.02 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 120.805 -1.184 . . . . 0.0 108.612 175.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -111.28 -20.62 12.23 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.261 175.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -143.23 160.01 53.55 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-N 119.483 1.038 . . . . 0.0 109.807 -168.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.95 171.87 15.77 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.711 2.941 . . . . 0.0 113.031 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.4 p -119.56 -15.73 8.96 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.575 1.55 . . . . 0.0 112.768 -177.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.9 159.4 33.78 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.932 0.787 . . . . 0.0 110.211 171.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -84.77 -28.31 26.28 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.381 0.672 . . . . 0.0 111.143 172.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -115.05 100.77 8.42 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -134.35 168.26 19.22 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 127.94 2.496 . . . . 0.0 106.278 171.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.52 175.1 15.7 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 169.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -107.99 142.31 38.32 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.471 1.109 . . . . 0.0 108.109 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.7 mt -113.12 133.82 57.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 158.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -128.78 144.23 51.12 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 171.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.5 mt -124.57 90.69 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 174.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -66.05 109.58 2.62 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 171.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . 0.284 3.9 p30 -133.1 -152.2 0.48 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 126.97 2.108 . . . . 0.0 107.579 -174.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -46.04 50.21 0.0 OUTLIER 'General case' 0 C--O 1.24 0.575 1 C-N-CA 136.65 5.98 . . . . 0.0 114.551 -171.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.43 31.54 68.4 Favored Glycine 0 N--CA 1.437 -1.269 0 O-C-N 120.413 -1.429 . . . . 0.0 112.084 -171.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -164.04 171.28 39.57 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 117.454 0.627 . . . . 0.0 112.353 168.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 83.2 mtp -125.15 112.23 16.23 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.597 1.559 . . . . 0.0 108.283 -176.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.4 m -69.86 109.83 4.66 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 157.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.4 m -112.99 143.2 44.69 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 124.106 0.879 . . . . 0.0 109.338 171.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.3 ptp -151.95 170.97 18.55 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 127.449 2.3 . . . . 0.0 106.311 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.431 ' H ' ' HB2' ' A' ' 85' ' ' GLU . 38.9 m-85 -129.15 174.29 9.7 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.401 1.48 . . . . 0.0 108.03 -178.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -156.39 140.98 16.88 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.591 0.756 . . . . 0.0 109.706 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -153.6 162.86 40.86 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.748 1.219 . . . . 0.0 110.835 172.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -79.26 134.89 36.64 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 172.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -131.41 114.87 15.48 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 122.017 0.913 . . . . 0.0 110.038 171.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.02 -7.7 0.61 Allowed 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.953 2.501 . . . . 0.0 114.941 171.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.96 -6.09 5.1 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 117.635 -1.647 . . . . 0.0 113.449 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.28 166.31 10.62 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 120.454 2.127 . . . . 0.0 109.072 164.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -112.51 152.79 28.39 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -145.02 172.24 13.34 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 122.537 0.335 . . . . 0.0 110.179 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.3 mp -131.11 140.35 48.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 124.497 1.119 . . . . 0.0 109.21 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.431 ' HB2' ' H ' ' A' ' 74' ' ' PHE . 0.4 OUTLIER -75.88 165.15 25.41 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.833 1.653 . . . . 0.0 112.174 178.224 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -179.98 168.97 0.7 Allowed Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 127.82 2.448 . . . . 0.0 107.499 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' A' ' 89' ' ' LYS . 60.9 Cg_endo -56.61 -162.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.799 2.332 . . . . 0.0 109.419 153.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -44.06 -8.26 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.994 2.518 . . . . 0.0 117.386 -169.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.419 ' HE3' ' H ' ' A' ' 89' ' ' LYS . 0.6 OUTLIER -98.71 15.65 24.59 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 120.173 -1.58 . . . . 0.0 114.27 168.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -88.91 65.7 3.21 Favored Glycine 0 C--O 1.226 -0.36 0 CA-C-N 120.608 1.549 . . . . 0.0 113.786 -174.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.4 mt -140.62 41.87 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 171.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 21.8 m-85 -70.27 102.71 2.19 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 174.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -74.35 127.39 32.89 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 164.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.5 pt -114.28 159.67 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 157.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -108.47 5.27 25.11 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.336 -0.853 . . . . 0.0 112.349 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -133.92 157.02 47.06 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.041 0.936 . . . . 0.0 109.469 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -72.03 133.04 45.05 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.625 1.17 . . . . 0.0 110.118 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -74.03 -44.49 54.17 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.497 1.119 . . . . 0.0 113.459 -177.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -62.08 -29.68 70.48 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.258 1.39 . . . . 0.0 110.784 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -72.95 -15.6 61.56 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 125.877 1.671 . . . . 0.0 112.989 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 9.5 ptm -110.51 1.05 17.96 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.168 0.987 . . . . 0.0 113.091 -175.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 25.5 pt . . . . . 0 C--O 1.249 1.06 0 CA-C-N 119.018 0.826 . . . . 0.0 109.45 176.208 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.539 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p 51.84 165.74 0.04 OUTLIER Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 129.628 3.171 . . . . 0.0 116.496 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -67.05 169.89 14.13 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 124.388 3.392 . . . . 0.0 113.006 167.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.0 mm -94.22 91.89 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 167.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.1 152.24 39.35 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.222 176.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.605 ' HB2' HD21 ' A' ' 10' ' ' ASN . 74.5 Cg_endo -67.6 160.75 46.64 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.202 1.935 . . . . 0.0 110.602 171.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -60.05 168.8 1.74 Allowed 'General case' 0 C--N 1.344 0.335 0 C-N-CA 123.677 0.791 . . . . 0.0 112.028 174.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.03 -49.02 31.17 Favored 'General case' 0 C--O 1.219 -0.523 0 O-C-N 121.157 -0.964 . . . . 0.0 109.48 168.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -66.48 -14.79 62.73 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 -172.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.605 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -102.87 -2.74 27.32 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.037 0.935 . . . . 0.0 111.352 178.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.0 t -82.19 135.81 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.248 1.419 . . . . 0.0 107.3 170.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.83 -67.92 0.78 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 166.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.42 121.88 5.76 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.33 0.514 . . . . 0.0 110.429 -170.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.4 mt -82.27 131.22 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.7 t -107.5 139.61 41.75 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 168.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.0 mt -131.98 122.23 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 170.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -115.07 102.4 9.9 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 -173.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -63.04 171.68 2.13 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.373 0.669 . . . . 0.0 111.328 -170.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.4 p -52.43 -52.89 51.61 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.541 1.137 . . . . 0.0 109.976 168.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.05 162.6 25.78 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 126.877 2.071 . . . . 0.0 107.192 174.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 p -90.1 59.57 4.53 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 123.252 1.501 . . . . 0.0 108.896 -163.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.7 mt -124.66 142.96 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 102.502 -3.147 . . . . 0.0 102.502 176.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -140.96 143.33 34.47 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.69 122.36 23.29 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 176.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.9 mp -94.45 138.55 20.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 171.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -118.07 82.38 1.83 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 103.31 -2.848 . . . . 0.0 103.31 176.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -83.31 -19.1 36.87 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.55 1.14 . . . . 0.0 110.109 163.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.37 133.67 35.94 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.186 1.794 . . . . 0.0 109.093 -169.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.6 -55.83 17.01 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.306 1.042 . . . . 0.0 112.513 -176.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -68.58 -20.63 64.53 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.521 -0.737 . . . . 0.0 110.985 -174.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.4 m -80.12 -41.34 25.65 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.108 1.763 . . . . 0.0 110.826 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.4 mt -67.78 -45.93 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.951 1.7 . . . . 0.0 110.043 172.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.99 -24.63 67.15 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -171.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -64.29 -68.08 0.38 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 117.923 -1.037 . . . . 0.0 108.35 166.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 72.5 mt -44.85 -44.81 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 126.057 1.743 . . . . 0.0 112.039 -170.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.0 mt -54.37 -20.0 6.55 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.7 t -76.72 -58.36 3.33 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.322 2.249 . . . . 0.0 109.396 172.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.9 mp0 -63.34 -29.32 70.65 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.758 0.708 . . . . 0.0 110.896 -177.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.1 mm -61.95 -37.75 79.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 O-C-N 120.652 -1.28 . . . . 0.0 110.173 171.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.56 -10.6 26.87 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.681 1.192 . . . . 0.0 113.705 -171.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 t -62.6 -39.84 95.02 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.382 0.673 . . . . 0.0 110.829 -171.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.51 161.54 40.84 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-O 122.787 1.215 . . . . 0.0 112.316 -171.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -125.76 114.47 18.66 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.41 ' H ' ' HG3' ' A' ' 44' ' ' ARG . 6.5 ppt_? -64.15 -9.28 15.79 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.753 1.621 . . . . 0.0 113.89 172.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 p 65.59 -172.9 0.18 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 128.407 2.683 . . . . 0.0 111.478 173.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -78.69 -2.2 38.09 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.164 1.786 . . . . 0.0 112.029 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -67.02 168.06 10.7 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 119.849 1.204 . . . . 0.0 109.816 172.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -120.25 156.4 31.28 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.42 1.088 . . . . 0.0 109.768 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.32 134.35 46.26 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -159.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.2 pt -133.88 28.32 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 118.958 0.799 . . . . 0.0 112.225 -164.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -147.99 166.32 28.08 Favored 'General case' 0 C--O 1.242 0.66 0 O-C-N 121.446 -0.783 . . . . 0.0 110.23 -175.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.03 -10.42 15.03 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.602 1.161 . . . . 0.0 111.926 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -143.97 159.53 52.87 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.233 1.013 . . . . 0.0 111.95 -170.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.34 178.45 7.0 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.291 3.328 . . . . 0.0 112.838 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.51 -16.66 12.37 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.503 1.521 . . . . 0.0 111.46 173.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.66 163.08 7.59 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 120.792 -1.192 . . . . 0.0 110.29 168.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -108.43 -15.28 14.49 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.206 1.403 . . . . 0.0 110.902 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -126.29 103.03 7.44 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.465 2.306 . . . . 0.0 106.815 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -150.06 162.39 40.49 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.954 2.102 . . . . 0.0 107.918 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -101.14 166.0 18.73 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 173.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.2 m -110.32 134.86 51.86 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 118.9 1.35 . . . . 0.0 108.482 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.9 mp -120.14 136.17 58.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -126.76 140.82 52.09 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 125.063 1.345 . . . . 0.0 108.9 172.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.433 ' HB ' HG22 ' A' ' 71' ' ' THR . 33.4 mt -123.66 87.56 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 172.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -58.84 106.73 0.44 Allowed 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.303 1.041 . . . . 0.0 108.648 165.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -139.96 133.9 30.78 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.946 1.698 . . . . 0.0 109.654 175.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 52.62 28.12 5.84 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.894 1.678 . . . . 0.0 111.978 -176.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.07 13.43 69.85 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.074 1.321 . . . . 0.0 113.813 -176.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -107.58 170.35 15.4 Favored Glycine 0 C--N 1.334 0.418 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 163.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.27 136.4 27.98 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 118.707 1.253 . . . . 0.0 113.172 168.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.433 HG22 ' HB ' ' A' ' 64' ' ' ILE . 1.2 t -75.93 161.27 29.09 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 168.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.5 m -135.92 142.0 44.6 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.669 1.188 . . . . 0.0 108.164 169.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -153.43 171.51 18.55 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.794 1.638 . . . . 0.0 109.169 170.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -140.56 148.35 40.86 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.385 2.274 . . . . 0.0 106.3 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.517 ' CD1' HG13 ' A' ' 84' ' ' ILE . 1.5 m-85 -128.27 158.37 38.35 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.904 1.229 . . . . 0.0 109.51 177.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -159.53 175.51 13.18 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.892 0.877 . . . . 0.0 111.49 -178.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -102.98 144.08 31.72 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.56 1.544 . . . . 0.0 109.497 165.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -148.61 119.4 7.56 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.846 1.259 . . . . 0.0 108.719 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 62.67 -0.17 0.58 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.8 2.04 . . . . 0.0 115.237 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.94 8.43 17.88 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.754 1.169 . . . . 0.0 113.026 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.63 156.68 24.27 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 120.257 2.028 . . . . 0.0 108.821 164.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -96.79 152.45 18.67 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 168.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -139.84 167.58 21.79 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.751 0.82 . . . . 0.0 110.911 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.517 HG13 ' CD1' ' A' ' 75' ' ' TYR . 3.3 mp -123.77 128.13 74.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 125.367 1.467 . . . . 0.0 108.592 172.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -81.25 151.21 28.22 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.611 1.564 . . . . 0.0 109.213 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -176.2 166.26 1.66 Allowed Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.311 1.844 . . . . 0.0 107.638 -177.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -59.62 -161.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.762 1 C-N-CA 126.495 4.797 . . . . 0.0 110.417 172.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -42.82 -12.65 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.458 2.303 . . . . 0.0 115.86 -172.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.68 68.72 0.72 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 120.215 1.371 . . . . 0.0 112.121 161.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -140.83 67.4 0.49 Allowed Glycine 0 C--O 1.222 -0.622 0 CA-C-N 119.78 1.173 . . . . 0.0 115.287 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.6 mt -141.59 47.24 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.711 1.205 . . . . 0.0 107.846 173.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -72.23 103.85 3.49 Favored 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 120.668 -1.27 . . . . 0.0 108.267 -175.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -69.2 125.63 27.26 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 164.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 21.7 pt -119.69 175.29 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.913 1.285 . . . . 0.0 108.63 159.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -117.45 2.14 12.41 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.632 0.773 . . . . 0.0 112.096 -175.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -139.35 157.48 45.81 Favored 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 120.752 -1.217 . . . . 0.0 108.768 -168.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -80.9 114.35 19.72 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -52.77 -45.05 66.96 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.791 1.236 . . . . 0.0 110.887 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -75.33 -7.46 54.04 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -167.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -106.91 -16.87 14.35 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.172 0.989 . . . . 0.0 111.813 166.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 66.2 mmm -70.86 -37.65 73.09 Favored 'General case' 0 C--O 1.239 0.51 0 O-C-N 120.345 -1.472 . . . . 0.0 109.255 169.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.9 pt . . . . . 0 C--O 1.25 1.084 0 O-C-N 121.564 -0.71 . . . . 0.0 109.825 168.666 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.428 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.7 m -136.01 167.57 21.31 Favored Pre-proline 0 C--O 1.24 0.555 0 C-N-CA 126.835 2.054 . . . . 0.0 109.01 -174.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -52.48 167.09 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-O 122.603 1.001 . . . . 0.0 112.248 152.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.1 mt -111.61 109.41 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -107.03 162.53 19.38 Favored Pre-proline 0 C--O 1.243 0.714 0 C-N-CA 123.276 0.63 . . . . 0.0 110.361 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.524 ' HB2' HD21 ' A' ' 10' ' ' ASN . 37.3 Cg_endo -61.85 174.69 2.19 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.192 1.928 . . . . 0.0 111.61 164.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.55 169.1 1.88 Allowed 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.427 -0.796 . . . . 0.0 109.068 165.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.9 -60.32 2.31 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 153.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.37 -14.95 63.39 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -160.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.524 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -89.45 1.2 56.18 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 120.086 1.312 . . . . 0.0 113.46 175.182 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.0 t -78.14 143.19 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.82 -62.95 1.49 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 168.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.3 p -152.47 171.22 18.41 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.45 1.1 . . . . 0.0 109.62 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.5 mt -124.23 142.21 41.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 170.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.1 t -122.71 142.98 50.11 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 165.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.1 mt -130.97 104.28 9.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 104.142 -2.54 . . . . 0.0 104.142 173.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -87.61 113.09 22.97 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 172.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -67.27 177.9 1.69 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.897 1.679 . . . . 0.0 111.033 -173.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.68 -50.77 67.43 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.712 -1.242 . . . . 0.0 111.031 171.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -76.85 160.99 28.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 127.844 2.458 . . . . 0.0 108.085 173.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 p -88.22 61.11 6.08 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 123.032 1.396 . . . . 0.0 109.062 -164.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.8 mt -140.09 139.79 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 102.335 -3.209 . . . . 0.0 102.335 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.16 157.58 41.39 Favored 'General case' 0 N--CA 1.414 -2.255 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.458 ' HE2' ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -130.04 130.26 44.7 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 175.516 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.6 mt -106.16 134.92 46.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.458 ' CE2' ' HE2' ' A' ' 24' ' ' LYS . 23.3 m-85 -115.96 97.42 6.08 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 -175.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -123.63 11.53 9.17 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 128.324 2.65 . . . . 0.0 110.556 -176.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -103.8 141.03 36.82 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 166.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.8 t -55.85 -47.68 76.85 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.128 0.971 . . . . 0.0 110.654 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -59.47 -46.29 89.21 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.896 0.878 . . . . 0.0 110.939 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.2 m -61.07 -36.55 79.91 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.354 1.462 . . . . 0.0 111.906 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 74.7 mt -66.99 -55.66 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 172.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -57.79 -32.79 67.87 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.198 0.908 . . . . 0.0 112.75 -175.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.53 -49.18 62.47 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.684 1.594 . . . . 0.0 109.346 175.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.2 mt -68.76 -51.89 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 117.602 -1.19 . . . . 0.0 110.785 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.92 -26.61 15.53 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.39 1.45 . . . . 0.0 112.469 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.97 -69.46 0.32 Allowed 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 125.688 1.595 . . . . 0.0 111.145 170.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -69.09 -7.07 32.54 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.602 1.092 . . . . 0.0 113.135 -173.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.6 mm -83.57 -29.64 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 O-C-N 120.197 -1.564 . . . . 0.0 111.046 168.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.8 -12.75 35.47 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 119.411 1.005 . . . . 0.0 113.184 -173.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.8 p -69.01 -41.4 77.82 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.737 1.615 . . . . 0.0 110.791 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.34 138.6 41.08 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt -116.94 111.69 19.97 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -175.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.402 ' HB3' ' CE2' ' A' ' 92' ' ' TYR . 20.0 ptt180 -61.6 -4.18 1.3 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 173.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p 58.99 -174.07 0.1 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.309 2.244 . . . . 0.0 109.693 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -89.96 5.07 48.04 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.178 -0.951 . . . . 0.0 112.339 174.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -65.96 171.29 4.6 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.33 1.052 . . . . 0.0 110.323 167.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -126.13 131.86 51.97 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.716 1.207 . . . . 0.0 110.821 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.1 m -80.57 158.13 25.84 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.483 0.713 . . . . 0.0 109.098 170.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.0 pt -141.75 32.47 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 125.813 1.645 . . . . 0.0 110.699 175.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -141.52 167.66 21.63 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.721 2.009 . . . . 0.0 107.876 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -121.53 -4.69 9.3 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.817 1.247 . . . . 0.0 111.155 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -149.53 156.48 39.18 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 125.835 1.654 . . . . 0.0 110.169 -170.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.07 176.38 9.61 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.27 3.313 . . . . 0.0 112.529 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.99 1.79 6.56 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.863 1.665 . . . . 0.0 112.245 177.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.21 149.08 43.15 Favored 'General case' 0 C--N 1.338 0.103 0 O-C-N 120.621 -1.299 . . . . 0.0 109.848 168.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.01 -31.8 44.84 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 122.564 0.346 . . . . 0.0 111.175 169.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -114.24 104.59 12.24 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.454 1.502 . . . . 0.0 107.442 -173.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -138.46 173.95 11.06 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.886 2.074 . . . . 0.0 109.623 176.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.08 165.68 12.74 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 164.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.8 m -123.37 127.55 48.63 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.415 1.086 . . . . 0.0 108.906 -166.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mp -123.72 110.82 26.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 124.909 1.284 . . . . 0.0 109.603 -166.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 58.9 m-20 -119.03 122.03 41.23 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.566 1.146 . . . . 0.0 108.763 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 74.3 mt -107.19 96.9 5.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 171.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.64 118.05 11.15 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 172.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -146.0 125.94 13.62 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.606 1.163 . . . . 0.0 110.027 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 54.53 41.83 31.7 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.035 1.734 . . . . 0.0 111.83 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.82 3.87 56.67 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.213 0.911 . . . . 0.0 114.394 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -118.95 -173.53 15.67 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 169.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -147.16 166.14 27.86 Favored 'General case' 0 CA--C 1.517 -0.296 0 O-C-N 121.68 -0.894 . . . . 0.0 111.242 172.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.0 m -106.34 133.44 51.03 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 157.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 m -106.92 145.49 32.16 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.6 ptp -154.88 174.67 14.79 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.763 1.225 . . . . 0.0 108.429 160.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.564 ' H ' ' HG3' ' A' ' 85' ' ' GLU . 34.4 m-85 -135.97 164.8 27.13 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 128.196 2.598 . . . . 0.0 106.768 174.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -134.47 156.29 48.86 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.958 1.303 . . . . 0.0 108.146 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -159.4 179.95 8.49 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 118.709 0.686 . . . . 0.0 110.34 169.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -101.62 133.08 46.88 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.942 1.697 . . . . 0.0 107.642 175.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -133.59 111.28 10.52 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.08 0.943 . . . . 0.0 109.556 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.85 -1.08 2.14 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.641 1.976 . . . . 0.0 114.111 174.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.7 -14.76 6.36 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.123 1.344 . . . . 0.0 113.547 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.78 169.71 9.82 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 120.143 1.971 . . . . 0.0 108.651 164.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -109.85 155.55 21.52 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 171.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -144.12 172.65 12.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -122.13 143.36 35.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 C-N-CA 125.266 1.426 . . . . 0.0 107.486 172.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.564 ' HG3' ' H ' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -85.41 173.75 10.04 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.018 1.327 . . . . 0.0 110.029 179.204 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.464 ' HB2' ' CA ' ' A' ' 90' ' ' GLY . 0.5 OUTLIER 176.84 168.56 0.43 Allowed Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 128.756 2.822 . . . . 0.0 106.728 175.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' A' ' 86' ' ' CYS . 93.9 Cg_endo -54.13 -160.59 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.328 1 C-N-CA 125.306 4.004 . . . . 0.0 109.639 157.731 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -42.83 -4.99 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 129.245 3.018 . . . . 0.0 117.176 -171.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 87' ' ' PRO . 5.5 ptpt -119.5 25.44 10.06 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 129.281 3.032 . . . . 0.0 115.249 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.464 ' CA ' ' HB2' ' A' ' 86' ' ' CYS . . . -115.14 61.23 0.38 Allowed Glycine 0 C--N 1.32 -0.331 0 N-CA-C 116.776 1.47 . . . . 0.0 116.776 -167.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.0 mt -131.58 42.69 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 117.716 0.758 . . . . 0.0 110.045 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.402 ' CE2' ' HB3' ' A' ' 44' ' ' ARG . 15.7 m-85 -76.43 104.7 7.08 Favored 'General case' 0 C--O 1.222 -0.374 0 O-C-N 120.691 -1.256 . . . . 0.0 110.716 -173.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -68.81 122.88 19.51 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 165.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.5 pt -111.5 -172.61 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 126.463 1.905 . . . . 0.0 108.381 160.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -100.16 -44.61 5.91 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -147.1 176.26 10.08 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.803 1.241 . . . . 0.0 108.898 -172.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -61.8 116.6 4.96 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 118.552 0.614 . . . . 0.0 111.271 -172.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.43 ' HA ' ' HG2' ' A' ' 101' ' ' MET . 28.3 t80 -52.78 -35.5 56.73 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.617 1.967 . . . . 0.0 112.477 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -68.06 -13.29 62.08 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 119.873 -1.767 . . . . 0.0 113.189 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -95.03 -18.6 20.89 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.64 0.776 . . . . 0.0 111.888 174.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.43 ' HG2' ' HA ' ' A' ' 98' ' ' PHE . 21.6 ptp -91.76 -10.92 38.23 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.224 0.92 . . . . 0.0 112.963 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 29.8 pt . . . . . 0 C--O 1.252 1.225 0 C-N-CA 124.593 1.157 . . . . 0.0 112.136 -179.634 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.664 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.452 ' HB2' ' HD2' ' A' ' 3' ' ' PRO . 68.3 p 67.7 164.94 0.13 Allowed Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 129.534 3.133 . . . . 0.0 112.974 -175.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 2' ' ' SER . 31.3 Cg_endo -70.62 172.65 13.07 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.331 2.021 . . . . 0.0 113.095 178.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.0 mt -112.51 121.39 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 175.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.88 164.26 40.77 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 126.864 2.066 . . . . 0.0 111.544 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.537 ' HB2' HD21 ' A' ' 10' ' ' ASN . 18.9 Cg_endo -59.12 161.43 16.17 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 123.919 3.08 . . . . 0.0 113.693 175.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -59.38 156.07 13.56 Favored 'General case' 0 C--N 1.347 0.468 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 172.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.67 -34.27 77.83 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 121.331 -0.855 . . . . 0.0 109.124 165.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -80.09 -25.4 40.02 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 118.669 -1.213 . . . . 0.0 112.33 -165.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.537 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -86.31 -0.47 55.93 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.323 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 26.9 t -69.98 138.59 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 176.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -76.39 -67.35 0.7 Allowed 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 166.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 p -157.85 149.47 21.71 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.408 0.549 . . . . 0.0 111.14 164.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.2 mt -85.53 141.02 15.08 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 169.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.5 t -126.66 130.16 49.88 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 167.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.7 mt -120.32 109.08 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.43 120.51 27.85 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 173.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -68.47 173.15 5.22 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.22 1.008 . . . . 0.0 109.998 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.51 -52.11 65.98 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 121.23 -0.919 . . . . 0.0 109.752 169.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.28 169.69 15.69 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 173.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.5 p -71.66 24.7 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 129.291 3.036 . . . . 0.0 115.92 -157.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.9 mt -135.14 149.72 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 129.4 3.08 . . . . 0.0 105.781 -159.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.81 164.93 21.98 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 126.573 1.949 . . . . 0.0 109.485 175.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.402 ' HE2' ' CE1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -128.98 143.79 50.98 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 162.087 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.7 mp -114.92 130.68 68.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.494 ' CD2' HD11 ' A' ' 35' ' ' ILE . 3.9 m-85 -116.14 79.39 1.3 Allowed 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 103.994 -2.595 . . . . 0.0 103.994 -174.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -85.23 -17.17 37.84 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.612 1.165 . . . . 0.0 110.235 161.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.9 125.09 24.85 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -176.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.8 t -51.97 -49.57 62.96 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.872 0.869 . . . . 0.0 111.527 -172.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -75.4 -16.13 60.39 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.114 -0.991 . . . . 0.0 112.257 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.7 m -79.63 -39.24 31.97 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.453 1.901 . . . . 0.0 110.357 171.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 93.4 mt -63.33 -53.8 41.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 169.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -60.0 -32.74 71.14 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.731 1.212 . . . . 0.0 112.25 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.8 tptt -60.79 -64.97 0.77 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 119.441 1.019 . . . . 0.0 109.642 167.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.494 HD11 ' CD2' ' A' ' 26' ' ' TYR . 82.2 mt -53.91 -46.71 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 119.177 -0.439 . . . . 0.0 110.985 -171.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.37 -22.95 55.51 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -177.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.86 -55.7 10.26 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.255 0.934 . . . . 0.0 109.614 167.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -73.75 -16.74 61.16 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -171.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.1 mm -68.37 -21.29 26.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.829 1.652 . . . . 0.0 110.195 168.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -118.88 8.68 11.77 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.114 1.366 . . . . 0.0 113.186 -168.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.2 t -80.05 -42.2 24.18 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.221 0.464 . . . . 0.0 110.921 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.15 169.35 54.67 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 127.181 2.324 . . . . 0.0 113.766 -166.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -127.01 102.59 7.05 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -171.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 92' ' ' TYR . 0.7 OUTLIER -66.76 -13.65 61.67 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.807 1.243 . . . . 0.0 113.985 168.632 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 65.38 -172.82 0.18 Allowed 'General case' 0 CA--C 1.547 0.829 0 O-C-N 125.506 1.754 . . . . 0.0 110.283 173.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -83.27 0.59 44.93 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 120.242 -1.536 . . . . 0.0 113.869 172.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.0 mmmt -60.52 165.14 3.93 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 122.207 1.004 . . . . 0.0 112.111 -177.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -99.88 128.47 45.97 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 124.586 1.155 . . . . 0.0 108.332 -175.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.02 51.04 1.22 Allowed 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 123.914 0.886 . . . . 0.0 109.674 -170.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.7 pt -68.11 5.66 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 126.718 2.007 . . . . 0.0 113.532 -172.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.406 ' HG2' ' H ' ' A' ' 51' ' ' GLN . 6.5 pt20 -70.98 165.1 24.16 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 126.056 1.742 . . . . 0.0 110.697 166.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -124.48 -9.78 7.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.154 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -145.4 161.08 43.01 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 124.626 1.17 . . . . 0.0 111.367 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.459 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 18.9 Cg_endo -68.35 170.85 13.9 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 124.433 3.422 . . . . 0.0 111.681 171.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 98.8 p -99.33 -16.27 18.51 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.381 0.672 . . . . 0.0 112.499 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.412 ' HB2' ' CD2' ' A' ' 76' ' ' TYR . . . -76.03 146.24 39.61 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 121.46 -0.775 . . . . 0.0 109.418 176.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -81.81 -16.41 50.98 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 119.339 -0.362 . . . . 0.0 111.881 172.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -131.05 102.16 5.91 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.199 1.399 . . . . 0.0 108.937 -174.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.459 ' CE2' ' HG2' ' A' ' 54' ' ' PRO . 43.5 p90 -134.0 175.22 9.67 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 126.343 1.857 . . . . 0.0 108.708 176.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.74 -167.54 11.31 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 169.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.92 141.11 49.24 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.571 1.148 . . . . 0.0 109.321 -148.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.9 mt -115.23 136.0 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 160.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -127.81 130.2 48.26 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 171.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.9 mt -117.84 92.29 2.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 170.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -70.72 124.31 23.98 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 172.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -156.5 134.58 11.21 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.342 1.457 . . . . 0.0 108.99 -177.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 54.01 27.59 7.65 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.512 1.525 . . . . 0.0 113.321 173.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.43 13.11 63.96 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 119.571 1.078 . . . . 0.0 114.414 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -142.54 171.51 24.71 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 119.448 1.624 . . . . 0.0 110.293 176.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 31.5 mtm -131.84 126.96 35.57 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.284 1.034 . . . . 0.0 110.318 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 53.8 m -80.64 113.49 18.87 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 156.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.42 152.91 25.94 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 124.337 1.023 . . . . 0.0 108.378 163.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.5 ptp -155.19 163.92 39.54 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.059 1.744 . . . . 0.0 107.639 154.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -119.87 172.67 7.55 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.799 1.24 . . . . 0.0 109.725 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -147.16 157.69 43.69 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.31 1.844 . . . . 0.0 108.449 175.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.412 ' CD2' ' HB2' ' A' ' 56' ' ' ALA . 40.9 p90 -157.38 -164.51 1.59 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.77 1.628 . . . . 0.0 108.859 171.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -122.91 124.3 42.9 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.648 1.179 . . . . 0.0 108.214 169.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -113.52 117.43 31.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.688 0.756 . . . . 0.0 109.576 173.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 64.81 -0.75 0.93 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.018 2.127 . . . . 0.0 114.595 175.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 123.99 -17.51 7.61 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 125.586 1.565 . . . . 0.0 112.77 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -90.32 157.45 17.64 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 120.278 2.039 . . . . 0.0 109.656 169.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -101.31 143.29 31.55 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.35 1.06 . . . . 0.0 108.537 174.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -139.78 169.36 17.87 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.936 0.495 . . . . 0.0 110.208 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.1 mp -127.38 121.27 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.871 0.868 . . . . 0.0 110.782 -176.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -66.49 157.72 31.41 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.459 -1.4 . . . . 0.0 110.733 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.429 ' HB2' ' HA2' ' A' ' 90' ' ' GLY . 0.8 OUTLIER -175.31 167.9 1.75 Allowed Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 128.592 2.757 . . . . 0.0 105.416 -172.655 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' A' ' 89' ' ' LYS . 66.3 Cg_endo -57.86 -160.97 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.448 0 C-N-CA 124.479 3.453 . . . . 0.0 109.657 160.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -42.68 0.75 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 130.221 3.408 . . . . 0.0 117.397 -175.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 87' ' ' PRO . 0.8 OUTLIER -124.58 30.92 5.84 Favored 'General case' 0 N--CA 1.44 -0.947 1 C-N-CA 132.117 4.167 . . . . 0.0 113.763 176.581 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.429 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . -109.26 61.03 0.31 Allowed Glycine 0 C--O 1.23 -0.148 0 C-N-CA 124.858 1.218 . . . . 0.0 115.41 -176.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.4 mt -136.69 44.73 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.536 1.135 . . . . 0.0 108.101 171.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 25.3 m-85 -68.87 108.11 3.34 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 175.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -75.04 130.74 39.83 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 159.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.0 pt -112.25 167.15 5.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 151.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -121.98 17.19 10.9 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.128 0.971 . . . . 0.0 112.407 -172.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -153.62 168.32 26.59 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 122.855 0.462 . . . . 0.0 110.872 165.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -67.01 118.49 10.54 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.713 0.805 . . . . 0.0 110.729 -173.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.429 ' HA ' ' HG2' ' A' ' 101' ' ' MET . 59.6 t80 -56.39 -47.02 79.81 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.97 0.908 . . . . 0.0 110.444 173.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -66.95 -26.42 66.82 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.332 0.653 . . . . 0.0 112.514 -170.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.2 20.02 19.58 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 118.407 0.549 . . . . 0.0 112.066 173.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.429 ' HG2' ' HA ' ' A' ' 98' ' ' PHE . 16.6 ptt? -108.29 -37.3 6.04 Favored 'General case' 0 C--N 1.342 0.256 0 O-C-N 121.437 -0.789 . . . . 0.0 112.648 160.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.996 0 C-N-CA 124.137 0.975 . . . . 0.0 112.007 -174.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.043 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.409 ' HB2' ' HD2' ' A' ' 3' ' ' PRO . 34.8 p 55.61 165.91 0.06 OUTLIER Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 126.818 2.047 . . . . 0.0 113.666 -167.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 2' ' ' SER . 28.5 Cg_endo -61.39 175.92 1.36 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.578 1.519 . . . . 0.0 111.889 165.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.4 mt -111.67 108.28 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 40' ' ' ALA . 0.3 OUTLIER -123.26 156.44 63.4 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 126.283 1.833 . . . . 0.0 110.984 -171.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.597 ' HB2' HD21 ' A' ' 10' ' ' ASN . 91.4 Cg_endo -74.15 162.18 39.28 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.732 2.954 . . . . 0.0 112.488 -178.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.0 mtmt -63.04 142.57 58.33 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 119.076 0.853 . . . . 0.0 111.269 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.12 -14.81 18.83 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -94.57 -31.3 13.95 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.831 1.196 . . . . 0.0 112.752 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.597 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -88.45 -6.07 57.87 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.47 1.032 . . . . 0.0 111.525 -174.068 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.5 t -62.48 116.36 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 C-N-CA 128.336 2.654 . . . . 0.0 107.682 160.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -71.11 -67.68 0.49 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.715 1.606 . . . . 0.0 106.784 165.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.6 p -153.91 160.23 42.05 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.936 0.789 . . . . 0.0 110.495 -177.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.3 mt -125.84 125.77 68.86 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 -176.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.4 t -108.49 132.83 53.42 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.9 mt -133.35 97.03 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.98 115.68 18.81 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 164.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -68.29 -178.46 1.08 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.542 1.537 . . . . 0.0 109.994 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.9 p -59.19 -45.89 89.88 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.972 -1.08 . . . . 0.0 112.189 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -74.3 -174.0 1.86 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.546 1.139 . . . . 0.0 110.22 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 98.4 p -67.32 5.03 0.81 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.282 1.833 . . . . 0.0 114.76 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.1 mm -113.15 153.89 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 128.144 2.578 . . . . 0.0 108.606 -159.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -143.16 162.76 34.72 Favored 'General case' 0 N--CA 1.418 -2.073 0 C-N-CA 125.968 1.707 . . . . 0.0 110.587 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.11 142.16 44.24 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 125.129 1.371 . . . . 0.0 107.358 164.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.3 mp -109.66 138.17 38.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 170.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.414 ' HB3' ' HB3' ' A' ' 31' ' ' SER . 27.7 m-85 -111.96 108.94 18.45 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 103.166 -2.901 . . . . 0.0 103.166 -178.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -135.9 41.3 2.69 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 126.472 1.909 . . . . 0.0 106.183 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.94 123.44 17.16 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 103.614 -2.736 . . . . 0.0 103.614 -170.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.6 t -53.76 -39.6 65.49 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.684 0.794 . . . . 0.0 112.009 -171.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -77.67 -33.76 53.23 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.084 -1.01 . . . . 0.0 111.297 -177.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.414 ' HB3' ' HB3' ' A' ' 26' ' ' TYR . 26.2 m -57.94 -41.32 82.53 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.139 1.376 . . . . 0.0 110.491 168.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.4 mt -67.15 -54.58 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 124.716 1.206 . . . . 0.0 109.072 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -51.29 -41.76 60.69 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.131 0.572 . . . . 0.0 111.335 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -57.84 11.08 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 57.4 mt -54.68 -49.8 64.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 C-N-CA 123.392 0.677 . . . . 0.0 112.111 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.11 -17.91 30.77 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.804 0.842 . . . . 0.0 112.169 -171.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.65 -61.18 2.1 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.497 1.119 . . . . 0.0 110.913 166.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -67.24 -30.53 70.47 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.01 1.277 . . . . 0.0 111.545 -174.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.8 mm -54.87 -24.74 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.396 0.678 . . . . 0.0 110.05 172.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.405 ' HB2' HD21 ' A' ' 5' ' ' LEU . . . -116.19 3.64 13.49 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.139 1.776 . . . . 0.0 113.908 -174.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 t -79.4 -29.69 42.13 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.654 1.115 . . . . 0.0 111.276 -172.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.33 166.14 41.77 Favored Glycine 0 C--N 1.336 0.574 0 O-C-N 120.755 -1.215 . . . . 0.0 112.539 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -126.62 121.47 32.28 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.417 ' HD2' ' HB3' ' A' ' 89' ' ' LYS . 16.8 ptt180 -63.34 -3.42 1.96 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.579 1.152 . . . . 0.0 114.063 172.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p 58.04 -174.16 0.08 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 127.457 2.303 . . . . 0.0 110.761 -177.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -86.58 3.52 44.03 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.059 1.343 . . . . 0.0 111.59 176.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -69.22 164.94 21.56 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.87 1.214 . . . . 0.0 109.488 169.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -114.57 157.52 22.91 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.116 1.366 . . . . 0.0 108.182 174.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.53 150.04 50.35 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 -163.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.8 pt -145.83 17.6 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 122.457 0.303 . . . . 0.0 111.482 -163.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -131.61 167.4 19.5 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.389 1.076 . . . . 0.0 109.24 -171.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.22 -5.57 9.43 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.842 1.257 . . . . 0.0 112.334 -177.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -144.5 164.14 30.12 Favored Pre-proline 0 C--O 1.235 0.319 0 C-N-CA 126.011 1.724 . . . . 0.0 108.624 -174.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -70.69 -179.89 3.68 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.373 2.049 . . . . 0.0 110.803 174.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.0 p -110.34 -8.44 14.71 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.835 1.254 . . . . 0.0 111.911 175.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.86 159.45 20.37 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 124.266 1.026 . . . . 0.0 111.343 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -94.87 -13.6 25.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.255 1.022 . . . . 0.0 112.1 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -128.34 110.8 12.69 Favored 'General case' 0 C--O 1.231 0.083 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 175.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -147.32 160.75 42.15 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.59 1.556 . . . . 0.0 108.942 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.93 170.64 20.08 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.842 1.21 . . . . 0.0 110.315 171.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.3 m -131.98 121.1 23.39 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.031 1.732 . . . . 0.0 108.572 -163.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.2 mp -124.75 127.29 72.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 124.052 0.941 . . . . 0.0 109.266 -166.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -120.05 145.83 46.48 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 124.927 1.291 . . . . 0.0 109.244 171.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 30.5 mt -125.24 88.34 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -71.82 108.4 5.09 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.963 1.305 . . . . 0.0 108.041 177.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -137.34 134.24 35.8 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.515 1.126 . . . . 0.0 109.264 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 62.84 -3.32 0.32 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.283 1.833 . . . . 0.0 115.861 173.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.77 10.82 8.94 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 120.163 1.347 . . . . 0.0 113.692 -174.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -149.22 -178.6 24.38 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.59 145.32 24.3 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 118.653 1.227 . . . . 0.0 113.065 -173.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 t -73.72 166.09 23.93 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 162.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.8 m -142.47 142.66 32.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 163.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 17.2 ptp -156.0 169.62 24.04 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.795 2.038 . . . . 0.0 108.391 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.41 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 54.8 m-85 -139.16 148.87 43.76 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.477 1.911 . . . . 0.0 108.077 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -127.94 151.77 48.7 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.921 1.237 . . . . 0.0 110.155 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -156.99 177.77 11.13 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.033 1.333 . . . . 0.0 110.001 -171.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -107.83 147.78 30.43 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.165 1.386 . . . . 0.0 107.843 167.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.5 tp10 -142.28 117.4 10.06 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.685 0.794 . . . . 0.0 109.383 171.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 61.77 -11.95 0.06 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 127.999 2.519 . . . . 0.0 115.612 -176.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.7 2.35 3.96 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 117.76 -1.578 . . . . 0.0 115.555 -177.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -110.17 160.39 16.53 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 121.018 2.409 . . . . 0.0 109.274 159.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -97.48 145.74 25.91 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -140.36 162.43 35.33 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.883 0.873 . . . . 0.0 110.622 -174.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mp -133.08 132.29 58.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.802 1.241 . . . . 0.0 109.508 -169.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.41 ' HB3' ' H ' ' A' ' 74' ' ' PHE . 5.3 tm-20 -77.36 154.41 32.8 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.846 2.058 . . . . 0.0 110.624 177.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -173.22 167.97 2.61 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 129.276 3.03 . . . . 0.0 106.415 174.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.408 ' O ' ' N ' ' A' ' 89' ' ' LYS . 90.9 Cg_endo -54.12 -162.02 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 125.215 3.943 . . . . 0.0 110.239 162.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -43.35 -5.69 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 128.284 2.634 . . . . 0.0 116.529 -175.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.417 ' HB3' ' HD2' ' A' ' 44' ' ' ARG . 9.2 mmtt -120.97 52.09 1.21 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.686 1.994 . . . . 0.0 111.776 171.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -129.14 59.39 0.69 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 116.719 1.448 . . . . 0.0 116.719 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.7 mt -130.19 55.18 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 118.649 1.224 . . . . 0.0 108.131 171.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -76.32 119.14 19.79 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 177.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -87.91 113.53 23.65 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 163.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 27.9 pt -98.91 171.15 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 158.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -122.78 -13.82 7.82 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.925 -0.484 . . . . 0.0 112.032 -173.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -123.53 150.22 44.27 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 173.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -70.12 128.44 36.29 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 123.926 0.89 . . . . 0.0 109.974 -172.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -60.89 -46.13 91.84 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.665 1.186 . . . . 0.0 111.402 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -64.91 -29.48 70.43 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.945 0.898 . . . . 0.0 111.504 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -78.97 -18.94 52.86 Favored 'General case' 0 C--O 1.24 0.594 0 O-C-N 121.683 -0.636 . . . . 0.0 112.471 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 19.9 mmt -85.29 -27.29 26.07 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.233 1.013 . . . . 0.0 111.468 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 28.2 pt . . . . . 0 C--O 1.251 1.181 0 CA-C-N 119.681 1.128 . . . . 0.0 111.601 -174.289 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.592 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 p -57.98 164.22 3.55 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 125.658 1.583 . . . . 0.0 111.704 171.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -65.95 -178.4 1.03 Allowed 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 124.528 3.485 . . . . 0.0 113.875 168.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.0 mt -106.94 122.5 61.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 164.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.28 166.12 11.62 Favored Pre-proline 0 C--O 1.238 0.495 0 C-N-CA 125.669 1.588 . . . . 0.0 109.641 168.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.547 ' HB2' HD21 ' A' ' 10' ' ' ASN . 73.1 Cg_endo -62.88 -176.84 0.28 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 121.702 1.601 . . . . 0.0 111.124 167.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.405 ' HE3' ' HG2' ' A' ' 9' ' ' GLU . 4.7 mmmt -55.8 169.44 0.35 Allowed 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.092 -1.005 . . . . 0.0 108.88 159.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.417 ' HB2' HD13 ' A' ' 36' ' ' LEU . . . -81.71 -49.96 9.85 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 161.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.405 ' HG2' ' HE3' ' A' ' 7' ' ' LYS . 11.5 pt-20 -66.8 -22.89 66.01 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -167.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.547 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -79.27 -3.21 44.91 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.316 0.962 . . . . 0.0 113.356 175.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.412 ' N ' HD22 ' A' ' 10' ' ' ASN . 17.0 t -85.5 122.6 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -70.48 -54.62 11.51 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.122 1.769 . . . . 0.0 108.121 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.7 p -157.22 155.93 31.7 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.183 0.516 . . . . 0.0 110.59 174.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.1 mt -109.66 139.21 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 170.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -129.71 106.13 8.5 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.6 mt -101.83 108.61 24.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -93.5 115.29 27.8 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.019 2.128 . . . . 0.0 107.32 174.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -79.8 172.1 14.23 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.809 0.844 . . . . 0.0 111.21 -172.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.95 -53.22 60.43 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.573 1.149 . . . . 0.0 110.182 170.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -71.23 149.15 46.54 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.998 1.719 . . . . 0.0 106.506 166.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.2 p -88.44 53.44 2.73 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.824 0.821 . . . . 0.0 110.627 -151.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.2 mt -126.32 134.27 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 -170.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -129.79 110.38 11.69 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -170.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.451 ' HE2' ' CE1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -101.81 130.54 48.27 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -176.193 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.1 mt -100.51 134.96 38.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.575 ' CD2' HD11 ' A' ' 35' ' ' ILE . 9.6 m-85 -117.16 84.59 2.18 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 103.146 -2.909 . . . . 0.0 103.146 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -94.46 -6.91 42.88 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 127.459 2.304 . . . . 0.0 110.349 170.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.59 132.27 35.3 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 t -58.03 -42.34 85.1 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.541 -0.724 . . . . 0.0 111.45 -171.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -73.53 -36.43 65.68 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.264 -0.897 . . . . 0.0 111.506 -174.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.6 m -53.53 -51.75 61.86 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 126.612 1.965 . . . . 0.0 110.756 167.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.8 mt -58.18 -50.08 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 123.526 0.73 . . . . 0.0 109.206 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -55.64 -45.57 77.6 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 118.552 -0.737 . . . . 0.0 112.051 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.46 -51.81 68.3 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-N 118.303 0.501 . . . . 0.0 109.813 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.575 HD11 ' CD2' ' A' ' 26' ' ' TYR . 94.2 mt -55.95 -45.12 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.955 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.417 HD13 ' HB2' ' A' ' 8' ' ' ALA . 3.7 mt -57.0 -25.65 58.89 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.989 1.268 . . . . 0.0 113.013 176.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.2 m -73.57 -52.78 12.31 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 120.244 1.384 . . . . 0.0 109.883 169.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -65.05 -24.11 67.38 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.809 1.186 . . . . 0.0 112.732 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.9 mm -83.39 -7.55 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.183 1.793 . . . . 0.0 110.754 175.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.13 1.62 9.19 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.242 1.417 . . . . 0.0 114.33 -175.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.5 p -66.36 -31.25 71.91 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.588 1.086 . . . . 0.0 111.517 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.9 163.14 43.47 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-O 122.606 1.114 . . . . 0.0 113.924 -164.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.416 ' O ' HG23 ' A' ' 45' ' ' THR . 23.5 pttt -112.24 97.65 6.78 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 127.183 2.193 . . . . 0.0 109.629 176.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.4 ' HB3' ' CE2' ' A' ' 92' ' ' TYR . 4.6 ppt_? -60.08 -11.88 7.02 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 124.746 1.218 . . . . 0.0 113.216 167.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 43' ' ' LYS . 27.1 p 64.98 -175.23 0.17 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 126.738 2.015 . . . . 0.0 111.663 175.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -95.9 14.15 24.44 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.295 0.638 . . . . 0.0 112.531 165.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -64.63 147.99 51.83 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 120.558 -1.339 . . . . 0.0 110.67 156.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -83.55 121.7 27.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 168.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.1 t -73.0 147.94 44.67 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.743 -1.576 . . . . 0.0 106.743 152.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.9 pt -140.16 13.4 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 126.4 1.88 . . . . 0.0 110.024 170.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -86.39 164.17 17.19 Favored 'General case' 0 C--O 1.238 0.5 0 O-C-N 120.954 -1.091 . . . . 0.0 110.013 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.43 -15.05 10.95 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 118.088 -0.958 . . . . 0.0 112.235 175.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -153.95 165.5 17.76 Favored Pre-proline 0 N--CA 1.469 0.481 0 C-N-CA 125.331 1.452 . . . . 0.0 110.537 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -72.11 147.17 47.96 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.62 2.214 . . . . 0.0 111.591 168.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.11 -31.15 61.08 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.899 0.48 . . . . 0.0 112.103 171.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.26 155.2 25.41 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 121.799 0.809 . . . . 0.0 111.085 -173.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -84.76 -35.26 22.55 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.651 171.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -110.22 94.99 5.3 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -172.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -139.06 171.81 13.76 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 128.613 2.765 . . . . 0.0 107.063 172.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.71 -177.13 14.73 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 166.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.7 m -123.96 122.91 39.19 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.519 1.128 . . . . 0.0 109.449 -165.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mp -97.52 133.82 37.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 170.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -130.57 137.75 49.83 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.853 1.261 . . . . 0.0 107.899 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.4 mt -128.12 92.35 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 105.45 -2.055 . . . . 0.0 105.45 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -70.24 109.46 4.68 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 170.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -139.52 138.58 36.44 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.341 1.056 . . . . 0.0 108.552 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 48.8 36.18 7.64 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.246 1.018 . . . . 0.0 111.721 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.45 18.49 79.91 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 118.939 -0.923 . . . . 0.0 115.119 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.05 156.23 24.28 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 120.355 2.077 . . . . 0.0 110.328 173.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 81.4 mtp -112.33 96.76 6.2 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 123.845 0.858 . . . . 0.0 109.825 -173.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 m -62.88 105.79 0.72 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 165.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.8 m -103.65 156.16 18.0 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -176.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.8 ptp -153.88 171.05 19.58 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.828 1.651 . . . . 0.0 107.185 167.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -126.28 -177.98 4.16 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.233 1.413 . . . . 0.0 107.491 173.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -150.51 156.27 41.09 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -158.76 169.5 24.23 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 162.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -89.87 121.56 32.1 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 169.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -109.67 119.16 38.54 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 169.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.27 4.02 2.0 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.777 1.631 . . . . 0.0 114.463 164.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.01 -13.82 6.0 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.73 1.634 . . . . 0.0 113.4 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.8 tptt -115.16 163.2 15.98 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 120.034 1.917 . . . . 0.0 109.987 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -107.47 142.96 36.52 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -138.43 160.89 38.38 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.261 0.624 . . . . 0.0 109.988 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.78 133.83 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.936 0.894 . . . . 0.0 111.825 -173.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -71.98 161.33 31.08 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.121 -0.987 . . . . 0.0 112.379 -176.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -175.23 169.17 1.58 Allowed Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 126.896 2.078 . . . . 0.0 108.051 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -58.18 -162.54 0.02 OUTLIER 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.081 1.854 . . . . 0.0 110.54 155.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -43.28 -14.31 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.465 2.706 . . . . 0.0 116.705 -171.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -105.03 49.8 0.8 Allowed 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.272 -0.893 . . . . 0.0 111.888 168.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -125.16 69.18 0.5 Allowed Glycine 0 C--O 1.222 -0.608 0 CA-C-N 119.876 1.216 . . . . 0.0 112.247 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.6 mt -133.63 49.27 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 163.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.4 ' CE2' ' HB3' ' A' ' 44' ' ' ARG . 51.0 m-85 -74.87 110.95 9.59 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -78.08 125.17 28.96 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 160.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.7 pt -106.93 164.48 4.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 152.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -123.65 48.21 1.9 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.351 0.661 . . . . 0.0 110.021 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -164.36 174.29 11.23 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.111 0.965 . . . . 0.0 111.757 159.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -70.2 122.94 20.45 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.091 0.956 . . . . 0.0 108.888 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -63.12 -47.88 80.87 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.511 0.596 . . . . 0.0 110.572 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -58.99 -35.03 72.54 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.451 -0.781 . . . . 0.0 112.871 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -72.69 -23.7 60.91 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.245 0.93 . . . . 0.0 110.827 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.2 mmt -70.59 -36.11 73.37 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 121.593 -0.692 . . . . 0.0 110.413 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.0 pt . . . . . 0 C--O 1.249 1.044 0 CA-C-N 119.172 0.896 . . . . 0.0 112.48 -167.677 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.992 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 m -54.27 165.11 0.89 Allowed Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 124.654 1.182 . . . . 0.0 111.051 168.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -67.29 165.04 28.19 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 CA-C-N 120.075 1.063 . . . . 0.0 111.352 167.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.6 mt -101.99 111.68 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 158.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.48 152.88 46.55 Favored Pre-proline 0 C--O 1.241 0.608 0 C-N-CA 125.878 1.671 . . . . 0.0 108.701 177.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.476 ' HB2' HD21 ' A' ' 10' ' ' ASN . 95.5 Cg_endo -73.7 159.88 44.86 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.807 2.338 . . . . 0.0 111.436 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.425 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -70.32 149.71 47.09 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 123.455 0.702 . . . . 0.0 112.048 -173.714 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.478 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . . . -64.1 -12.86 43.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 118.592 -0.718 . . . . 0.0 111.945 170.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -95.13 -6.26 42.26 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.509 1.05 . . . . 0.0 112.123 -178.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.476 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -129.39 -2.54 4.95 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.58 1.152 . . . . 0.0 112.242 -173.23 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 37.5 t -78.88 111.22 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 170.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -74.8 -43.01 57.0 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.135 1.374 . . . . 0.0 108.605 176.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.8 p -160.24 171.89 18.37 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.593 1.088 . . . . 0.0 112.613 168.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.6 mt -130.02 137.69 55.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 127.335 2.254 . . . . 0.0 105.832 172.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.8 t -116.44 151.2 36.52 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 159.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.0 mt -131.41 101.64 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 168.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.3 117.39 20.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 169.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -75.33 177.02 6.88 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.262 1.029 . . . . 0.0 110.6 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.9 p -60.81 -15.29 28.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.078 2.151 . . . . 0.0 113.363 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 48.2 p30 -118.22 -166.76 1.25 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.515 1.926 . . . . 0.0 110.086 -170.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.2 p -82.44 24.95 0.65 Allowed 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.273 -1.517 . . . . 0.0 111.809 -173.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.5 mt -124.89 149.39 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.463 -1.681 . . . . 0.0 106.463 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -135.3 164.9 26.68 Favored 'General case' 0 N--CA 1.417 -2.084 0 C-N-CA 127.476 2.31 . . . . 0.0 107.906 170.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.25 134.92 30.1 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.8 mp -106.52 148.88 10.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -129.81 34.72 4.25 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.147 0.979 . . . . 0.0 109.664 -170.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -57.47 -20.65 32.17 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.384 2.274 . . . . 0.0 113.019 -175.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.97 123.85 21.74 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 129.542 3.137 . . . . 0.0 109.117 175.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.3 t -46.22 -48.08 17.79 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.133 1.373 . . . . 0.0 113.746 -175.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -69.54 -27.57 65.26 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.004 -1.06 . . . . 0.0 111.566 -175.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.6 m -72.58 -34.86 67.74 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.297 1.839 . . . . 0.0 111.019 172.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.0 mt -65.23 -52.86 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -65.37 -14.05 59.97 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -66.82 -78.66 0.06 Allowed 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 157.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.3 mt -50.58 -39.76 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 125.018 1.327 . . . . 0.0 112.578 -160.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.478 ' CD1' ' HB2' ' A' ' 8' ' ' ALA . 41.5 mt -51.64 -23.0 3.81 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.1 t -64.46 -63.83 1.03 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.168 1.387 . . . . 0.0 108.494 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 56.7 mp0 -64.5 -27.39 68.94 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.4 1.48 . . . . 0.0 111.158 -175.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.5 mm -62.26 -35.5 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 O-C-N 121.297 -0.877 . . . . 0.0 110.245 173.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.63 0.12 30.31 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 120.726 -1.234 . . . . 0.0 113.587 -169.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.7 t -64.81 -44.91 88.39 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.006 0.523 . . . . 0.0 110.919 -176.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.451 ' CA ' HG22 ' A' ' 94' ' ' ILE . . . -73.61 168.24 54.06 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-O 122.493 1.051 . . . . 0.0 112.432 -175.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -132.76 130.74 40.34 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 176.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -68.15 0.3 3.83 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.7 p 60.03 -172.54 0.12 Allowed 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 126.751 2.02 . . . . 0.0 108.847 -174.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -91.31 2.75 56.16 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.095 -1.003 . . . . 0.0 112.034 176.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt -69.03 170.07 10.58 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.084 0.856 . . . . 0.0 110.894 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.11 150.29 34.3 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.07 1.748 . . . . 0.0 109.019 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.87 149.87 43.64 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 -169.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 35.4 pt -138.31 17.78 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 118.957 0.799 . . . . 0.0 112.523 -165.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -139.97 -173.24 3.59 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.181 0.992 . . . . 0.0 108.761 -169.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.38 -6.38 1.56 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.481 1.112 . . . . 0.0 110.651 171.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -140.63 150.23 59.62 Favored Pre-proline 0 N--CA 1.469 0.485 0 CA-C-N 120.21 1.368 . . . . 0.0 111.29 -168.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.26 167.27 27.34 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.666 2.911 . . . . 0.0 114.928 -164.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 t -100.11 23.01 10.51 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.386 2.274 . . . . 0.0 110.72 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -126.6 150.41 48.9 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 125.268 1.427 . . . . 0.0 110.626 -174.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -90.03 -24.79 21.1 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.484 1.114 . . . . 0.0 110.871 172.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -125.34 102.44 7.43 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -145.01 166.99 23.72 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 128.383 2.673 . . . . 0.0 106.163 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.48 166.93 13.74 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 168.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.5 m -112.46 140.05 47.52 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.572 1.149 . . . . 0.0 108.553 -170.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.5 mp -125.81 128.83 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 -174.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -115.1 135.68 53.94 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.2 mt -126.03 87.65 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 171.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -70.22 116.03 10.11 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 125.418 1.487 . . . . 0.0 107.23 174.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -140.91 113.28 8.01 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.036 0.934 . . . . 0.0 109.97 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 74.52 -14.99 0.66 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 130.446 3.499 . . . . 0.0 115.639 171.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 123.21 23.68 2.14 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 118.843 0.747 . . . . 0.0 111.352 -165.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -145.1 171.7 26.14 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 106.609 -2.596 . . . . 0.0 106.609 160.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.08 139.24 34.01 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 118.772 1.286 . . . . 0.0 111.031 172.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 91.3 m -76.55 128.48 34.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 161.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.6 m -102.59 146.68 27.81 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 164.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.6 ptm -159.5 165.51 32.85 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.485 1.514 . . . . 0.0 108.47 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -144.64 140.66 28.83 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.826 1.65 . . . . 0.0 106.841 -174.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.427 ' CE1' HG23 ' A' ' 84' ' ' ILE . 1.8 m-85 -129.21 152.24 49.0 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 120.015 1.279 . . . . 0.0 109.35 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -153.81 -175.56 5.43 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.12 0.968 . . . . 0.0 111.264 -178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -115.55 142.79 46.25 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.609 1.964 . . . . 0.0 108.586 173.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -141.71 127.68 19.47 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 125.393 1.477 . . . . 0.0 108.431 175.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 57.76 14.7 2.59 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.957 1.303 . . . . 0.0 112.936 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.21 18.98 58.22 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 117.921 -1.488 . . . . 0.0 113.32 -175.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.26 148.43 45.91 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 128.612 2.765 . . . . 0.0 107.493 177.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -104.65 143.01 33.66 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.541 1.519 . . . . 0.0 111.305 -169.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -138.12 150.07 46.5 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.24 0.616 . . . . 0.0 111.22 -171.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.427 HG23 ' CE1' ' A' ' 75' ' ' TYR . 3.4 mp -123.16 120.02 59.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 125.133 1.373 . . . . 0.0 108.931 -177.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -73.69 153.19 40.19 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.419 1.088 . . . . 0.0 110.475 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -172.53 168.07 2.96 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 128.428 2.691 . . . . 0.0 106.072 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -57.92 -161.26 0.02 OUTLIER 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 125.268 3.979 . . . . 0.0 110.386 165.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -42.72 -8.82 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 127.572 2.349 . . . . 0.0 117.055 -175.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -121.13 46.74 1.97 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.016 1.326 . . . . 0.0 112.194 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -126.57 70.11 0.5 Allowed Glycine 0 C--O 1.224 -0.508 0 C-N-CA 125.762 1.648 . . . . 0.0 113.715 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.5 mt -131.09 53.07 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 164.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -75.42 125.95 30.03 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -119.31 102.47 8.71 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 -171.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.451 HG22 ' CA ' ' A' ' 42' ' ' GLY . 4.7 pt -115.75 146.71 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.655 1.582 . . . . 0.0 109.073 -175.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -91.82 -5.71 52.96 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -171.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -130.51 153.65 48.62 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.114 0.87 . . . . 0.0 112.638 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -57.86 135.72 56.9 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 126.383 1.873 . . . . 0.0 110.655 174.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -82.02 -49.86 9.76 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.029 1.332 . . . . 0.0 110.884 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -67.99 -13.81 62.47 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -165.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -97.7 -10.25 25.28 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.414 1.006 . . . . 0.0 112.576 173.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 38.7 mmm -76.81 -37.42 55.77 Favored 'General case' 0 C--O 1.233 0.222 0 O-C-N 120.626 -1.297 . . . . 0.0 111.167 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 12.8 pt . . . . . 0 C--O 1.243 0.73 0 C-N-CA 126.558 1.943 . . . . 0.0 114.229 -153.693 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.718 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.84 161.69 27.32 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 124.89 1.276 . . . . 0.0 111.76 -173.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.44 163.3 39.31 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.707 1.604 . . . . 0.0 112.157 169.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.0 mt -96.56 105.67 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 162.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.817 HD13 HG22 ' A' ' 39' ' ' ILE . 16.4 mt -126.19 165.64 26.43 Favored Pre-proline 0 C--O 1.24 0.585 0 C-N-CA 125.396 1.478 . . . . 0.0 108.462 174.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.5 ' HB2' HD21 ' A' ' 10' ' ' ASN . 34.4 Cg_endo -62.07 163.56 19.35 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.014 1.81 . . . . 0.0 111.248 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.4 ' HE2' ' CG ' ' A' ' 9' ' ' GLU . 2.7 mppt? -61.88 179.69 0.25 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.265 0.626 . . . . 0.0 111.405 170.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.77 -45.9 33.78 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 155.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.4 ' CG ' ' HE2' ' A' ' 7' ' ' LYS . 11.2 pt-20 -71.34 3.94 3.31 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.305 1.442 . . . . 0.0 114.037 -163.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.5 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -124.96 4.13 8.02 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.298 2.239 . . . . 0.0 112.516 179.568 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 37.8 t -84.25 141.77 14.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -92.4 -52.75 4.51 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 173.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.51 161.34 42.32 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.907 0.883 . . . . 0.0 111.923 170.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.6 mt -123.89 140.81 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 164.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 54.4 m -134.42 115.74 14.36 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 -168.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.7 mt -119.55 120.11 62.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -112.06 102.42 10.63 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -72.27 168.17 18.87 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.623 1.569 . . . . 0.0 110.031 -165.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.0 p -45.87 -39.62 8.86 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.767 1.627 . . . . 0.0 112.97 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -51.09 -153.62 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 131.41 3.884 . . . . 0.0 112.07 164.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 93.3 p -122.07 25.15 9.21 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 119.863 -1.773 . . . . 0.0 110.596 160.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.3 mt -84.65 134.47 26.93 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 172.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -125.69 129.34 49.35 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.55 125.98 54.79 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 175.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.3 mp -99.8 135.64 34.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 173.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -118.26 87.12 2.66 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -118.19 52.16 1.03 Allowed 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.812 1.645 . . . . 0.0 107.148 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.45 146.49 40.14 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.614 1.566 . . . . 0.0 107.377 168.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.2 t -46.69 -53.99 10.55 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.949 1.699 . . . . 0.0 112.266 177.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -76.42 -27.5 56.29 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 121.65 -0.656 . . . . 0.0 112.027 -171.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 51.5 m -65.78 -48.76 70.71 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.428 1.491 . . . . 0.0 109.187 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 76.9 mt -57.9 -53.19 48.51 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 C-N-CA 125.599 1.56 . . . . 0.0 108.849 171.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -61.1 -28.45 69.1 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 120.541 1.519 . . . . 0.0 113.309 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.18 -60.14 3.08 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.1 mt -47.59 -49.69 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.642 1.577 . . . . 0.0 110.984 175.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.45 -28.07 12.1 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -176.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.5 t -63.93 -62.13 1.83 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.952 0.796 . . . . 0.0 109.16 172.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -63.62 -32.18 73.57 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.411 -0.805 . . . . 0.0 111.894 -174.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.817 HG22 HD13 ' A' ' 5' ' ' LEU . 26.0 mm -62.24 -25.85 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.801 1.24 . . . . 0.0 111.036 174.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.65 -5.73 12.17 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -175.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 t -62.15 -26.91 68.59 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.871 1.214 . . . . 0.0 112.038 -169.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.68 169.67 43.15 Favored Glycine 0 C--N 1.335 0.494 0 O-C-N 120.987 -1.07 . . . . 0.0 114.238 -167.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -112.1 106.72 15.42 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 125.907 1.683 . . . . 0.0 108.336 174.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -3.33 1.16 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.134 0.974 . . . . 0.0 112.923 165.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.1 p 66.27 -164.77 0.23 Allowed 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 125.378 1.471 . . . . 0.0 108.056 174.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -105.42 12.66 31.28 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.593 1.088 . . . . 0.0 111.473 169.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -63.67 170.53 3.22 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 122.166 0.984 . . . . 0.0 110.527 164.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -122.51 144.52 49.02 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 125.604 1.562 . . . . 0.0 110.526 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.02 157.56 16.25 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 125.028 1.331 . . . . 0.0 108.604 172.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 26.7 pt -137.77 17.36 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 125.771 1.628 . . . . 0.0 111.284 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.02 176.88 8.31 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.369 1.468 . . . . 0.0 110.701 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.9 -4.67 6.33 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.749 2.42 . . . . 0.0 110.944 -175.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -140.31 150.05 59.94 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-N 119.202 0.91 . . . . 0.0 109.814 -175.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.43 167.73 25.5 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.141 1.894 . . . . 0.0 110.06 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.2 20.19 16.45 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.401 1.08 . . . . 0.0 110.367 170.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.58 173.83 11.09 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.037 -1.04 . . . . 0.0 109.022 157.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.97 -24.04 5.7 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 127.455 2.302 . . . . 0.0 110.082 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -118.87 112.74 20.05 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.502 1.921 . . . . 0.0 106.114 174.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -149.41 173.83 13.12 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 126.956 2.103 . . . . 0.0 106.706 170.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -114.66 166.17 12.13 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 167.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.58 147.66 22.8 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.397 0.679 . . . . 0.0 109.701 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.0 mp -134.84 128.95 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 172.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -132.26 141.53 49.05 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 53.7 mt -129.24 97.39 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 -177.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -71.31 131.3 43.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 170.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -158.79 -166.04 1.78 Allowed 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -45.51 -32.83 2.4 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.724 1.609 . . . . 0.0 114.133 175.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.23 2.47 81.47 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-O 119.311 -0.716 . . . . 0.0 111.873 -173.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.47 -138.05 22.68 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 107.619 -2.192 . . . . 0.0 107.619 -153.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 11.5 mtt -105.44 112.52 25.64 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.181 0.991 . . . . 0.0 110.682 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 47.9 m -60.04 124.86 21.53 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 149.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.6 m -112.87 143.42 44.17 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.971 1.708 . . . . 0.0 107.073 173.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.5 ptm -163.94 167.71 20.24 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.539 1.535 . . . . 0.0 108.677 -172.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -149.23 129.53 13.75 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.738 1.215 . . . . 0.0 109.098 -169.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.607 ' CE1' HG23 ' A' ' 84' ' ' ILE . 3.3 m-30 -120.18 145.43 46.98 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.751 1.614 . . . . 0.0 110.164 -172.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -151.13 179.51 8.22 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.682 1.593 . . . . 0.0 110.938 -169.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -112.86 148.72 34.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.474 1.51 . . . . 0.0 108.987 168.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -144.72 119.42 9.81 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.686 1.194 . . . . 0.0 108.398 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 58.57 5.44 0.46 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.6 1.96 . . . . 0.0 114.856 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.22 1.8 28.1 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 119.838 1.199 . . . . 0.0 113.536 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -106.17 149.93 26.34 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 119.227 1.513 . . . . 0.0 108.131 163.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -93.85 151.85 19.3 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 174.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -140.47 159.05 43.05 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.599 0.714 . . . . 0.0 111.312 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.607 HG23 ' CE1' ' A' ' 75' ' ' TYR . 2.5 mp -119.65 124.69 73.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 125.26 1.424 . . . . 0.0 108.86 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -70.71 147.65 48.83 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 122.231 1.015 . . . . 0.0 111.596 168.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.503 ' HB2' ' HA2' ' A' ' 90' ' ' GLY . 0.8 OUTLIER -171.55 167.6 3.7 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 128.39 2.676 . . . . 0.0 107.881 174.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.42 ' HD2' ' CB ' ' A' ' 86' ' ' CYS . 45.9 Cg_endo -53.19 -160.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.609 1 C-N-CA 126.199 4.599 . . . . 0.0 110.672 166.002 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -42.63 -13.78 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.756 2.423 . . . . 0.0 115.58 -173.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -110.04 67.42 0.65 Allowed 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 127.875 2.47 . . . . 0.0 113.074 164.1 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.503 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . -130.72 38.71 1.9 Allowed Glycine 0 N--CA 1.463 0.457 0 N-CA-C 116.251 1.26 . . . . 0.0 116.251 -173.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.3 mt -129.34 39.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 O-C-N 121.72 -0.871 . . . . 0.0 109.049 -170.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -75.84 101.62 5.19 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -171.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -72.28 125.82 28.28 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 166.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 24.5 pt -114.99 179.44 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 125.976 1.71 . . . . 0.0 108.753 165.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -107.09 -18.19 13.97 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -178.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -136.67 168.74 18.93 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.792 0.837 . . . . 0.0 111.749 -165.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -77.7 121.44 24.01 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.239 1.016 . . . . 0.0 109.937 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -62.76 -47.77 82.07 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.365 1.066 . . . . 0.0 111.781 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -62.53 -32.02 72.89 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.45 0.7 . . . . 0.0 111.881 -172.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -71.19 -21.01 62.2 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.142 -0.974 . . . . 0.0 111.738 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.1 mmt -98.57 -4.58 33.8 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.128 1.371 . . . . 0.0 112.531 -170.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 23.0 pt . . . . . 0 C--O 1.253 1.286 0 C-N-CA 124.69 1.196 . . . . 0.0 111.321 -175.663 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.655 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 m -172.4 87.85 0.42 Allowed Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 126.978 2.111 . . . . 0.0 109.308 169.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -55.21 158.63 11.59 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 CA-C-N 121.292 1.497 . . . . 0.0 111.824 164.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 mp -80.32 135.87 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 158.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.63 165.11 24.4 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 126.393 1.877 . . . . 0.0 108.851 174.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HB2' HD21 ' A' ' 10' ' ' ASN . 47.9 Cg_endo -64.8 175.8 3.41 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.096 2.531 . . . . 0.0 112.485 174.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.698 ' H ' ' HE2' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -67.16 -172.28 0.2 Allowed 'General case' 0 C--N 1.344 0.364 0 O-C-N 120.386 -1.446 . . . . 0.0 109.922 167.363 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.7 -36.81 12.73 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.548 0.739 . . . . 0.0 110.957 161.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -76.06 -17.68 59.54 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.206 -0.934 . . . . 0.0 113.223 -171.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.496 HD22 ' N ' ' A' ' 11' ' ' VAL . 0.1 OUTLIER -88.12 -3.89 58.83 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.854 1.261 . . . . 0.0 112.421 176.043 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.496 ' N ' HD22 ' A' ' 10' ' ' ASN . 29.1 t -88.3 118.48 33.95 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 -172.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -83.89 -49.43 9.03 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.081 1.352 . . . . 0.0 107.817 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.3 m -157.03 176.95 12.07 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.618 1.099 . . . . 0.0 111.523 163.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.615 HG12 HG23 ' A' ' 64' ' ' ILE . 53.9 mt -126.81 145.05 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 167.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.8 t -125.58 141.08 52.22 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.472 1.109 . . . . 0.0 108.516 169.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.6 mt -134.47 105.76 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 176.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -93.75 109.24 20.91 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 171.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -67.9 169.63 9.52 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.846 1.258 . . . . 0.0 109.846 -173.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.5 p -50.3 -35.71 28.6 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.153 0.981 . . . . 0.0 111.76 176.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -58.86 -154.75 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 131.367 3.867 . . . . 0.0 111.27 172.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.2 p -108.91 4.69 23.66 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 119.992 -1.693 . . . . 0.0 111.947 163.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.4 mt -75.63 133.62 30.91 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -132.26 110.06 10.35 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -177.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.8 125.26 50.79 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -177.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.1 mp -101.19 127.48 54.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 175.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.413 ' CG ' HD11 ' A' ' 35' ' ' ILE . 46.4 m-85 -106.26 83.31 1.87 Allowed 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 102.023 -3.325 . . . . 0.0 102.023 174.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -89.93 -13.4 36.34 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.902 0.881 . . . . 0.0 111.337 174.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.01 135.98 33.32 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.598 1.559 . . . . 0.0 109.877 -165.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.4 t -49.17 -48.09 45.35 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.689 1.196 . . . . 0.0 113.756 -171.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -71.56 -33.48 69.14 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 120.706 -1.247 . . . . 0.0 111.425 -174.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.4 m -62.26 -34.99 77.6 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.753 2.021 . . . . 0.0 110.943 170.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.5 mt -68.2 -49.13 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -59.33 -33.4 71.08 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 117.907 -1.044 . . . . 0.0 112.133 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.449 ' HE3' ' C ' ' A' ' 102' ' ' ILE . 0.0 OUTLIER -64.61 -62.28 1.68 Allowed 'General case' 0 C--N 1.343 0.311 0 CA-C-N 119.699 1.136 . . . . 0.0 109.492 172.735 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.413 HD11 ' CG ' ' A' ' 26' ' ' TYR . 40.5 mt -51.95 -50.12 35.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 124.006 0.922 . . . . 0.0 111.068 -173.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.72 -16.23 10.38 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.1 0.96 . . . . 0.0 113.015 -173.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.2 t -61.42 -59.11 5.77 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.64 1.109 . . . . 0.0 110.203 168.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -65.36 -31.1 72.04 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.58 1.152 . . . . 0.0 110.697 -176.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 39.2 mm -62.13 -16.19 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 121.164 -0.96 . . . . 0.0 111.762 173.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.89 7.82 14.57 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.536 1.534 . . . . 0.0 113.074 175.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 t -78.6 -30.93 46.89 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 120.272 1.396 . . . . 0.0 109.951 -177.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.496 ' CA ' HG22 ' A' ' 94' ' ' ILE . . . -86.38 161.61 34.19 Favored Glycine 0 N--CA 1.447 -0.629 0 O-C-N 120.841 -1.162 . . . . 0.0 114.717 -162.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.46 99.79 7.05 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -170.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.519 ' HB3' ' CE2' ' A' ' 92' ' ' TYR . 9.5 ptt180 -60.12 -8.23 2.31 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.583 1.538 . . . . 0.0 114.311 -177.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.8 p 65.19 176.71 0.2 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.638 2.375 . . . . 0.0 110.115 -175.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -74.34 -9.95 59.1 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.607 -1.308 . . . . 0.0 111.45 172.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -58.41 161.38 4.48 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.985 1.374 . . . . 0.0 110.705 -177.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -108.44 149.95 28.06 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.007 -1.451 . . . . 0.0 107.362 165.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.86 119.98 32.15 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.45 -2.055 . . . . 0.0 105.45 -165.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.8 pt -105.28 12.13 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 119.195 -0.431 . . . . 0.0 111.939 -162.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.56 179.91 6.54 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.385 1.874 . . . . 0.0 108.553 -174.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -127.55 -7.1 5.73 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.148 2.179 . . . . 0.0 110.56 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -140.15 149.22 57.52 Favored Pre-proline 0 C--O 1.238 0.495 0 C-N-CA 124.02 0.928 . . . . 0.0 111.455 -170.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -67.7 155.35 70.35 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.677 2.251 . . . . 0.0 114.104 -171.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 m -100.43 10.39 41.27 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.783 2.033 . . . . 0.0 111.86 162.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.66 166.8 22.98 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 120.501 -1.374 . . . . 0.0 110.072 162.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -105.31 -34.78 7.76 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 127.343 2.257 . . . . 0.0 109.68 165.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -116.12 98.16 6.47 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 -165.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -154.39 162.74 40.99 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 126.05 1.74 . . . . 0.0 109.289 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.64 166.62 15.03 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.908 0.766 . . . . 0.0 111.218 175.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.6 m -107.72 124.67 50.37 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -176.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.71 135.15 56.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 124.445 1.098 . . . . 0.0 108.362 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -121.16 135.1 55.22 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 163.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.662 HG22 ' OD1' ' A' ' 66' ' ' ASN . 42.1 mt -117.1 100.5 10.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 102.718 -3.067 . . . . 0.0 102.718 166.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -78.93 107.18 11.48 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.879 1.672 . . . . 0.0 106.596 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.662 ' OD1' HG22 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -145.56 158.22 43.87 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 123.779 0.831 . . . . 0.0 108.962 179.356 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 48.94 30.03 2.59 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.616 1.566 . . . . 0.0 113.925 169.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.44 47.63 85.62 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 120.925 -1.11 . . . . 0.0 111.2 -175.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -156.89 -173.09 24.9 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 126.092 1.805 . . . . 0.0 109.37 168.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.04 137.57 53.08 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.876 0.846 . . . . 0.0 109.213 159.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.4 m -84.01 97.43 9.28 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 103.612 -2.736 . . . . 0.0 103.612 164.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.1 m -83.87 140.25 32.11 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 2.0 ptm -162.67 163.52 26.94 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.053 1.341 . . . . 0.0 108.768 -177.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -139.69 148.55 42.52 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -136.29 151.84 50.06 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 121.385 1.902 . . . . 0.0 109.528 177.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -147.02 173.4 12.49 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.278 1.031 . . . . 0.0 111.731 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -93.99 146.72 23.73 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 159.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -138.34 126.91 23.4 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 162.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 60.3 6.64 1.07 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.805 1.642 . . . . 0.0 114.412 171.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.17 3.53 31.33 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.963 1.268 . . . . 0.0 113.782 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.56 153.93 24.43 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 120.03 1.915 . . . . 0.0 108.81 161.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -98.74 155.2 17.46 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 174.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.427 ' HA ' ' O ' ' A' ' 92' ' ' TYR . 93.6 m-85 -141.25 159.88 41.28 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 119.039 -0.505 . . . . 0.0 111.882 -176.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.1 mp -124.45 131.49 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.534 1.534 . . . . 0.0 111.755 172.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -82.6 164.38 20.84 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.198 1.799 . . . . 0.0 111.457 172.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.4 ' HB2' ' HA2' ' A' ' 90' ' ' GLY . 0.1 OUTLIER 177.57 169.2 0.47 Allowed Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.842 1.657 . . . . 0.0 108.656 -162.018 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.428 ' O ' ' N ' ' A' ' 89' ' ' LYS . 20.7 Cg_endo -63.23 -164.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.363 0 CA-C-N 121.904 1.716 . . . . 0.0 108.953 158.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -43.65 -5.55 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 129.121 2.969 . . . . 0.0 118.71 -165.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -113.48 43.75 1.71 Allowed 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 128.314 2.646 . . . . 0.0 111.734 170.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.4 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . -113.42 53.05 0.61 Allowed Glycine 0 C--N 1.334 0.471 0 CA-C-N 120.11 1.323 . . . . 0.0 114.823 -176.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.1 mt -129.93 52.33 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 170.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.519 ' CE2' ' HB3' ' A' ' 44' ' ' ARG . 77.4 m-85 -74.39 99.37 3.5 Favored 'General case' 0 CA--C 1.499 -0.984 0 O-C-N 120.957 -1.089 . . . . 0.0 108.641 176.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -61.89 128.21 35.12 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 158.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.496 HG22 ' CA ' ' A' ' 42' ' ' GLY . 3.1 pt -128.78 152.07 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 125.413 1.485 . . . . 0.0 108.251 167.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -80.7 -39.81 26.47 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -112.09 164.75 12.8 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.843 1.257 . . . . 0.0 111.07 -169.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -71.4 131.33 43.21 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 122.377 0.271 . . . . 0.0 110.282 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -64.85 -45.97 83.84 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 122.157 -0.339 . . . . 0.0 110.58 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -69.02 -31.24 69.9 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -168.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -77.71 -25.75 49.59 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.097 -1.002 . . . . 0.0 110.686 177.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 22.7 mmt -81.89 -12.71 58.31 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.742 0.817 . . . . 0.0 112.81 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.449 ' C ' ' HE3' ' A' ' 34' ' ' LYS . 29.1 pt . . . . . 0 C--O 1.25 1.097 0 CA-C-N 120.94 1.7 . . . . 0.0 109.894 172.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.059 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.9 p -67.01 166.36 20.25 Favored Pre-proline 0 C--O 1.24 0.564 0 C-N-CA 124.322 1.049 . . . . 0.0 111.951 -178.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -47.93 153.43 2.6 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 120.654 0.902 . . . . 0.0 111.642 154.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 80.3 mt -80.7 133.33 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 157.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.04 164.43 39.1 Favored Pre-proline 0 C--O 1.242 0.701 0 C-N-CA 125.061 1.344 . . . . 0.0 107.792 176.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.513 ' HB2' HD21 ' A' ' 10' ' ' ASN . 60.7 Cg_endo -58.81 169.82 3.12 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 121.395 1.397 . . . . 0.0 109.93 160.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.472 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -55.5 175.66 0.07 Allowed 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 120.47 -1.394 . . . . 0.0 110.941 164.011 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.2 -55.3 5.86 Favored 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 156.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -62.63 -16.23 55.71 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -163.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.513 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -95.32 1.85 54.53 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.028 1.731 . . . . 0.0 114.542 176.324 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 72.3 t -84.14 130.08 36.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 177.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.42 -58.18 3.46 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 169.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 63.6 p -153.23 163.54 39.71 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.611 171.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 56.1 mt -106.08 125.65 61.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 164.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.6 t -91.56 138.36 31.63 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 163.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.0 mt -125.0 107.52 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 166.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -86.06 121.91 29.34 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 169.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -67.96 164.91 18.91 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.039 0.936 . . . . 0.0 110.734 -176.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -57.9 -27.77 63.61 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 118.512 -0.756 . . . . 0.0 112.404 168.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -87.89 -79.38 0.29 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.929 1.24 . . . . 0.0 111.21 -177.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.9 t -175.93 -3.84 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.963 2.105 . . . . 0.0 112.584 -176.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.0 mm -73.31 150.06 8.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 169.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -139.46 122.19 16.44 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.59 ' HE2' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -121.19 131.53 54.3 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -171.26 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.4 mp -112.14 145.81 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -177.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.59 ' CE1' ' HE2' ' A' ' 24' ' ' LYS . 53.4 m-85 -123.41 95.69 4.69 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 103.841 -2.652 . . . . 0.0 103.841 -172.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -123.29 49.94 1.63 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.811 2.044 . . . . 0.0 108.732 -175.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.06 163.41 34.33 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.438 1.895 . . . . 0.0 107.61 170.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.9 m -50.6 -58.52 5.62 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.445 0.698 . . . . 0.0 111.884 166.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -68.89 -35.33 76.74 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.758 -0.589 . . . . 0.0 111.487 -169.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.4 p -67.24 -43.26 82.42 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.5 mt -67.11 -48.53 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 123.575 0.75 . . . . 0.0 109.609 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -48.52 -50.39 32.08 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.364 1.866 . . . . 0.0 111.898 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.437 ' HE2' ' O ' ' A' ' 101' ' ' MET . 0.0 OUTLIER -59.46 -47.49 85.29 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 122.921 0.489 . . . . 0.0 110.386 -176.329 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.554 HD11 ' CG ' ' A' ' 26' ' ' TYR . 86.3 mt -60.68 -51.18 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.917 176.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 mt -49.59 -39.44 35.35 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.441 1.019 . . . . 0.0 111.025 -177.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.1 t -57.13 -57.05 14.29 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.428 0.691 . . . . 0.0 110.412 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -72.21 -19.05 61.79 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.435 1.094 . . . . 0.0 112.35 -175.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.1 mm -81.9 -19.57 10.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.217 1.407 . . . . 0.0 110.872 173.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.67 -12.66 13.86 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -175.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.2 t -58.07 -31.64 67.26 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.311 0.96 . . . . 0.0 111.267 176.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.42 154.92 44.78 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-O 122.783 1.213 . . . . 0.0 112.118 -171.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.44 108.79 19.43 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 174.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' A' ' 92' ' ' TYR . 6.6 ppt_? -63.4 -13.59 41.37 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 167.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 p 65.53 -174.0 0.18 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.826 1.329 . . . . 0.0 109.926 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -68.31 -17.22 64.22 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.013 -1.054 . . . . 0.0 112.032 175.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -64.26 154.21 35.79 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 119.354 0.979 . . . . 0.0 112.093 -171.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -100.55 133.15 45.43 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 172.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.8 160.11 33.16 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 153.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 pt -136.07 12.51 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.679 1.192 . . . . 0.0 111.164 168.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.8 178.64 4.33 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.11 1.364 . . . . 0.0 108.834 175.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -121.12 -5.32 9.49 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.176 0.99 . . . . 0.0 111.676 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -145.67 160.1 45.43 Favored Pre-proline 0 C--N 1.345 0.378 0 C-N-CA 125.626 1.57 . . . . 0.0 110.344 -171.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -69.36 160.99 47.68 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 121.304 1.336 . . . . 0.0 109.882 177.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.6 t -107.22 13.53 27.14 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.52 0.728 . . . . 0.0 110.862 172.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.03 171.9 13.68 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.523 0.677 . . . . 0.0 111.303 168.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -111.56 -29.22 7.83 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.487 1.915 . . . . 0.0 109.615 172.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -112.62 115.78 29.14 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 127.066 2.146 . . . . 0.0 105.987 172.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -149.53 167.3 26.67 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 171.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.47 169.8 15.08 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 169.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.6 m -123.42 123.14 40.0 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -158.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 mp -122.19 111.72 31.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 124.141 0.976 . . . . 0.0 108.4 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -109.54 113.9 27.07 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.931 1.692 . . . . 0.0 106.728 -175.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.4 mt -98.95 100.38 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 170.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -71.41 119.74 15.99 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 164.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -148.06 136.49 21.49 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.596 0.758 . . . . 0.0 110.172 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 53.24 23.45 3.18 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.265 1.426 . . . . 0.0 111.156 -174.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.04 -8.22 39.16 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 127.608 2.527 . . . . 0.0 114.075 -176.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -87.8 -177.29 48.01 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 108.726 -1.749 . . . . 0.0 108.726 166.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.1 ptt? -145.56 142.74 29.42 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.563 1.181 . . . . 0.0 113.248 174.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.1 m -91.41 111.1 22.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 165.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.5 m -84.12 130.73 34.84 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.572 1.949 . . . . 0.0 106.944 166.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.9 ptp -154.0 173.24 16.26 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.325 1.45 . . . . 0.0 109.36 164.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.603 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 43.0 m-85 -135.72 -179.79 5.86 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.437 1.895 . . . . 0.0 108.477 -178.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -138.79 158.04 44.95 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.375 1.07 . . . . 0.0 108.946 170.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -161.44 171.48 18.12 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.408 1.004 . . . . 0.0 110.616 163.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -99.34 139.24 35.28 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 125.681 1.593 . . . . 0.0 107.945 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -135.23 111.29 9.53 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.641 0.734 . . . . 0.0 109.625 175.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 66.96 10.73 7.89 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.381 1.872 . . . . 0.0 113.3 172.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.1 -8.7 31.31 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-O 118.021 -1.433 . . . . 0.0 113.172 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.97 157.78 15.74 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 119.342 1.571 . . . . 0.0 108.075 163.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -109.15 150.06 28.43 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -141.13 171.79 13.57 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 123.364 0.415 . . . . 0.0 110.146 178.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.422 HD11 HD13 ' A' ' 94' ' ' ILE . 5.2 mp -121.99 150.53 25.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 124.628 1.171 . . . . 0.0 108.057 172.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.603 ' HB3' ' H ' ' A' ' 74' ' ' PHE . 3.4 tm-20 -90.49 159.33 16.57 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.149 2.58 . . . . 0.0 110.045 -173.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 174.81 167.43 0.34 Allowed Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 128.78 2.832 . . . . 0.0 108.774 178.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.405 ' O ' ' N ' ' A' ' 89' ' ' LYS . 23.0 Cg_endo -60.45 -161.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.935 1 C-N-CA 125.446 4.097 . . . . 0.0 110.152 165.333 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -42.9 -8.79 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 128.259 2.623 . . . . 0.0 117.08 -169.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -114.43 33.28 5.4 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 120.637 1.562 . . . . 0.0 114.509 167.189 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -113.41 75.38 0.23 Allowed Glycine 0 C--O 1.223 -0.556 0 CA-C-N 119.671 1.123 . . . . 0.0 113.176 -174.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.0 mt -145.28 46.7 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 174.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 35.9 m-85 -72.19 100.91 2.68 Favored 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 121.05 -1.032 . . . . 0.0 109.74 -171.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.92 122.23 18.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 170.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.422 HD13 HD11 ' A' ' 84' ' ' ILE . 33.2 pt -116.13 174.84 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 127.248 2.219 . . . . 0.0 108.42 162.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -106.31 -14.37 15.13 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -175.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -131.45 167.78 18.74 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.273 0.942 . . . . 0.0 110.0 -169.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -69.98 139.31 52.77 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.951 0.341 . . . . 0.0 110.324 174.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -68.12 -52.42 35.07 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.776 0.83 . . . . 0.0 112.447 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -66.01 -28.42 68.86 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.748 0.704 . . . . 0.0 112.253 -171.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -67.94 -14.51 63.02 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.866 -0.521 . . . . 0.0 111.875 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.437 ' O ' ' HE2' ' A' ' 34' ' ' LYS . 26.3 mmt -103.02 -10.51 18.87 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 117.071 -1.443 . . . . 0.0 113.322 -175.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.9 pp . . . . . 0 C--O 1.254 1.31 0 CA-C-N 121.11 1.777 . . . . 0.0 112.862 -163.86 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.129 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.428 ' HB2' ' HD2' ' A' ' 3' ' ' PRO . 15.0 p 63.42 167.47 0.1 Allowed Pre-proline 0 CA--C 1.549 0.933 0 CA-C-N 118.701 1.25 . . . . 0.0 111.531 -175.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 2' ' ' SER . 38.0 Cg_endo -57.54 164.12 7.77 Favored 'Trans proline' 0 C--N 1.353 0.809 0 CA-C-N 121.58 1.6 . . . . 0.0 110.763 174.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.9 mm -99.21 127.25 52.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 105.31 -2.108 . . . . 0.0 105.31 171.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.22 161.5 63.38 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 126.54 1.936 . . . . 0.0 110.646 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.409 ' HB2' HD21 ' A' ' 10' ' ' ASN . 14.5 Cg_endo -61.17 172.28 3.31 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.158 1.239 . . . . 0.0 110.698 170.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.17 179.11 0.21 Allowed 'General case' 0 N--CA 1.467 0.421 0 O-C-N 120.313 -1.492 . . . . 0.0 112.27 171.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.02 -50.07 17.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 155.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.82 -26.34 68.58 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -159.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.409 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -89.48 -5.72 57.07 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 126.414 1.886 . . . . 0.0 115.02 -178.316 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.2 t -76.89 108.83 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.59 -39.37 93.61 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.001 0.921 . . . . 0.0 109.607 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 p -174.44 136.89 0.48 Allowed 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.177 0.991 . . . . 0.0 108.873 158.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.9 mt -75.34 154.38 6.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 164.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.6 t -131.93 133.79 44.94 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.477 -2.046 . . . . 0.0 105.477 166.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.4 mt -128.99 110.8 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 176.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.41 119.92 22.41 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 105.245 -2.131 . . . . 0.0 105.245 166.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -63.01 -179.83 0.32 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.882 1.273 . . . . 0.0 110.49 173.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.3 p -75.17 0.39 16.5 Favored 'General case' 0 CA--C 1.549 0.904 0 O-C-N 119.97 -1.706 . . . . 0.0 112.305 171.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -122.67 158.56 29.79 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 128.616 2.766 . . . . 0.0 105.479 168.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.4 p -79.26 -2.8 42.92 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 120.243 1.383 . . . . 0.0 112.464 -154.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.428 ' H ' HG13 ' A' ' 22' ' ' ILE . 5.4 mt -61.81 134.89 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 164.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -120.14 166.07 13.91 Favored 'General case' 0 N--CA 1.422 -1.832 0 C-N-CA 125.122 1.369 . . . . 0.0 107.505 171.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.578 ' HE2' ' CE2' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -137.1 151.72 49.19 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 170.265 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.5 mp -109.74 139.76 31.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.578 ' CE2' ' HE2' ' A' ' 24' ' ' LYS . 72.4 m-85 -128.8 91.72 3.27 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 -173.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -119.99 -7.66 9.89 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.78 2.432 . . . . 0.0 110.973 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -64.95 138.27 58.26 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 170.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.9 t -56.97 -42.84 80.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.98 0.809 . . . . 0.0 109.729 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -67.38 -36.7 81.87 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.362 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 52.2 p -55.2 -48.45 73.82 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.026 0.83 . . . . 0.0 109.038 175.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.6 mt -70.48 -54.71 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-O 118.568 -0.729 . . . . 0.0 109.093 -177.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -59.64 -30.64 68.87 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.528 1.058 . . . . 0.0 112.172 -176.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -68.64 -63.82 0.99 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 117.857 -1.068 . . . . 0.0 109.027 170.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.3 mt -47.92 -46.18 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 123.643 0.777 . . . . 0.0 109.967 -176.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -47.73 -31.22 4.53 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.007 1.723 . . . . 0.0 113.08 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.4 t -61.03 -55.15 36.11 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 119.113 0.869 . . . . 0.0 109.584 174.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -75.6 -11.59 60.04 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.021 0.828 . . . . 0.0 112.252 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.5 mm -70.55 -23.92 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 O-C-N 120.9 -1.125 . . . . 0.0 110.141 162.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.35 -18.03 11.14 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -168.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.2 p -69.57 -28.91 66.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 119.817 1.189 . . . . 0.0 112.746 -170.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.78 165.98 50.08 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 119.536 1.062 . . . . 0.0 114.381 -166.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.5 pttm -112.13 103.56 11.75 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 125.518 1.527 . . . . 0.0 111.184 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.423 ' HB3' ' CE2' ' A' ' 92' ' ' TYR . 21.6 ptt180 -58.03 -15.16 8.2 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 170.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.7 p 60.27 175.24 0.09 Allowed 'General case' 0 CA--C 1.551 0.99 0 O-C-N 124.162 0.914 . . . . 0.0 109.597 -171.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -85.68 3.69 39.9 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 119.363 -2.085 . . . . 0.0 111.795 176.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.483 ' CB ' HD12 ' A' ' 91' ' ' ILE . 4.9 mmmt -60.66 156.43 16.74 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.65 0.78 . . . . 0.0 111.786 177.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -89.88 113.99 25.69 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.701 1.6 . . . . 0.0 107.2 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.9 t -80.14 140.66 36.29 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 163.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.2 pt -144.4 39.53 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.649 1.579 . . . . 0.0 107.727 176.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -116.64 177.24 4.77 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.835 1.254 . . . . 0.0 110.682 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.87 -4.58 2.82 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.172 1.389 . . . . 0.0 111.547 177.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -153.35 165.38 17.84 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 126.752 2.021 . . . . 0.0 108.089 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.28 174.3 11.7 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.381 1.387 . . . . 0.0 111.097 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 t -102.17 -7.8 21.89 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.005 1.322 . . . . 0.0 110.804 175.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.04 150.89 31.77 Favored 'General case' 0 CA--C 1.527 0.09 0 O-C-N 121.028 -1.045 . . . . 0.0 110.796 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.46 -22.25 30.39 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.248 1.019 . . . . 0.0 111.232 173.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.79 107.32 9.06 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -129.48 153.58 47.83 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 126.389 1.876 . . . . 0.0 108.943 176.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.02 154.92 25.97 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 108.17 -1.972 . . . . 0.0 108.17 167.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.2 m -127.38 131.73 50.28 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.137 0.975 . . . . 0.0 108.807 -164.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.05 125.62 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -166.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -115.42 144.76 43.34 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 161.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.0 mt -127.48 83.49 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -58.77 120.45 8.99 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 171.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -146.91 114.76 6.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 59.61 20.54 9.13 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.613 1.165 . . . . 0.0 112.375 -173.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.15 3.58 12.4 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.522 1.058 . . . . 0.0 113.506 -171.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.96 170.39 44.03 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 145.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -143.84 163.38 33.55 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 121.308 -1.113 . . . . 0.0 109.469 169.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.2 m -130.07 132.16 46.06 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 174.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -120.83 126.41 50.0 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.196 0.998 . . . . 0.0 108.686 -172.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.6 ptp -146.85 170.65 16.6 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.156 0.983 . . . . 0.0 109.207 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -146.47 148.7 32.52 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 -175.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.92 154.32 50.54 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.364 0.984 . . . . 0.0 109.758 175.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -157.77 172.61 18.18 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.813 1.645 . . . . 0.0 109.545 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -102.84 139.15 38.79 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.657 1.583 . . . . 0.0 108.072 171.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -135.85 120.46 18.27 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 172.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 55.79 -4.59 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 128.153 2.581 . . . . 0.0 117.341 -174.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 136.97 -33.48 2.31 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 125.751 1.644 . . . . 0.0 112.49 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -71.58 151.42 43.82 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 171.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -100.12 150.6 22.32 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 168.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -136.77 153.11 50.92 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.514 0.725 . . . . 0.0 111.182 -176.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mp -123.15 117.9 53.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 125.162 1.385 . . . . 0.0 107.63 -170.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.424 ' CD ' ' H ' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -74.46 154.81 38.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.625 1.17 . . . . 0.0 109.736 176.542 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.424 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 0.8 OUTLIER 179.79 167.73 0.73 Allowed Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 127.963 2.505 . . . . 0.0 107.443 -169.324 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -57.15 -163.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 124.37 3.38 . . . . 0.0 110.728 166.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -44.76 -11.78 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 117.079 2.251 . . . . 0.0 117.079 -174.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -96.78 11.64 34.89 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.023 1.729 . . . . 0.0 115.293 172.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.94 77.54 0.4 Allowed Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 120.259 1.391 . . . . 0.0 113.508 -170.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.483 HD12 ' CB ' ' A' ' 47' ' ' LYS . 2.9 mt -139.51 42.88 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 169.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.423 ' CE2' ' HB3' ' A' ' 44' ' ' ARG . 37.9 m-85 -76.24 107.53 8.55 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 121.212 -0.93 . . . . 0.0 109.758 -172.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -69.66 127.26 32.31 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 159.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 41.0 pt -112.19 168.23 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 148.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -122.32 21.34 10.36 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.848 0.832 . . . . 0.0 112.871 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -140.98 167.42 22.23 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 127.149 2.18 . . . . 0.0 110.214 170.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -84.29 116.22 22.88 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.213 1.005 . . . . 0.0 109.601 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -48.97 -47.33 44.13 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.833 1.253 . . . . 0.0 109.564 172.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -68.43 -17.42 64.2 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.126 0.97 . . . . 0.0 112.692 -171.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -91.49 -13.78 31.59 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 121.334 -0.854 . . . . 0.0 109.937 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 11.9 mmt -106.66 -6.59 17.81 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.789 1.636 . . . . 0.0 112.462 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 24.3 pt . . . . . 0 C--O 1.25 1.126 0 CA-C-N 119.332 0.969 . . . . 0.0 111.397 174.092 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.805 0 CA-C-O 119.633 -0.537 . . . . 0.0 112.719 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m 69.85 165.0 0.13 Allowed Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 126.691 1.996 . . . . 0.0 113.347 174.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.02 179.89 2.07 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 124.586 3.524 . . . . 0.0 112.504 156.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 53.1 mt -108.54 131.83 58.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 126.258 1.823 . . . . 0.0 106.341 164.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.46 HD12 HG22 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -135.13 161.76 61.65 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 128.143 2.577 . . . . 0.0 109.959 175.227 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -62.17 176.62 1.43 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.998 2.466 . . . . 0.0 112.914 176.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.584 ' HE3' ' H ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -65.35 -175.1 0.21 Allowed 'General case' 0 C--O 1.236 0.383 0 O-C-N 119.983 -1.698 . . . . 0.0 110.351 169.203 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.6 -42.75 16.39 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 118.984 -0.531 . . . . 0.0 111.219 167.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -85.69 -21.83 28.13 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 118.48 -1.288 . . . . 0.0 111.652 -164.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.449 HD22 ' N ' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -73.39 -5.96 43.19 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.64 1.176 . . . . 0.0 112.471 174.632 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.449 ' N ' HD22 ' A' ' 10' ' ' ASN . 25.0 t -80.11 131.58 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 173.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -81.75 -61.43 1.92 Allowed 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 171.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.63 130.2 5.0 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.612 1.096 . . . . 0.0 109.827 171.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.7 mt -81.25 139.38 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.4 t -116.37 140.83 48.92 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 172.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.2 mt -135.57 105.13 5.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 173.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -81.39 108.07 14.69 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 173.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -71.03 -176.76 1.46 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.549 0.69 . . . . 0.0 109.267 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.4 p -62.25 -46.75 87.42 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.492 -1.38 . . . . 0.0 111.394 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -73.74 179.79 4.02 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.752 2.021 . . . . 0.0 109.952 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.6 p -69.84 8.01 0.79 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.239 1.416 . . . . 0.0 112.83 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.6 mt -98.5 137.25 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -170.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -145.93 137.88 25.2 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 -176.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.5 132.21 53.85 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 -173.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.5 mp -105.84 119.74 55.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 176.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.74 ' CG ' HD11 ' A' ' 35' ' ' ILE . 81.6 m-85 -93.06 81.15 4.54 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 102.657 -3.09 . . . . 0.0 102.657 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -96.9 -28.82 14.04 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.998 0.919 . . . . 0.0 110.457 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.53 141.61 53.83 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.1 t -55.03 -46.92 75.32 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.143 0.883 . . . . 0.0 112.481 -175.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -68.65 -24.84 64.58 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.591 1.156 . . . . 0.0 110.899 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.9 p -69.87 -40.97 75.41 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.766 0.712 . . . . 0.0 109.482 176.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 53.9 mt -66.06 -46.65 87.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.566 1.146 . . . . 0.0 108.304 177.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.97 -24.87 67.28 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -165.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.461 ' HE2' ' O ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -65.73 -54.85 21.68 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 123.132 0.573 . . . . 0.0 109.49 172.251 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.74 HD11 ' CG ' ' A' ' 26' ' ' TYR . 18.6 mt -57.01 -40.42 72.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 125.674 1.59 . . . . 0.0 109.307 -169.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.37 -21.48 5.88 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.837 1.655 . . . . 0.0 113.399 175.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.8 t -64.46 -68.36 0.36 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 120.434 1.47 . . . . 0.0 109.011 164.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.425 ' O ' HG22 ' A' ' 41' ' ' THR . 24.8 mm-40 -65.98 -24.93 66.88 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.05 0.54 . . . . 0.0 111.41 -168.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.46 HG22 HD12 ' A' ' 5' ' ' LEU . 14.5 mm -59.56 -29.43 42.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 O-C-N 120.751 -1.218 . . . . 0.0 110.549 172.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.33 -8.74 41.11 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 120.347 1.431 . . . . 0.0 113.441 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 38' ' ' GLU . 1.4 t -69.93 -16.84 63.28 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.018 0.927 . . . . 0.0 113.337 -164.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.28 156.47 18.5 Favored Glycine 0 C--N 1.335 0.512 0 O-C-N 120.75 -1.219 . . . . 0.0 112.865 -171.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.7 pttm -112.83 111.2 21.8 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 175.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.8 ptt-85 -58.49 -5.11 0.48 Allowed 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.982 0.81 . . . . 0.0 112.594 169.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . 0.259 10.4 p 64.44 -164.67 0.25 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.545 1.538 . . . . 0.0 107.819 -176.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -101.21 4.5 41.97 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.909 1.231 . . . . 0.0 111.845 171.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -67.77 153.27 44.08 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 122.066 0.936 . . . . 0.0 110.357 176.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -85.77 121.32 28.27 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.989 1.716 . . . . 0.0 107.68 169.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.2 t -74.09 152.04 40.01 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 158.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.2 pt -138.14 11.79 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 126.083 1.753 . . . . 0.0 110.28 172.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -99.91 173.87 6.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.738 1.215 . . . . 0.0 109.577 178.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.55 -7.42 2.87 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.05 1.74 . . . . 0.0 110.446 174.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -151.72 158.93 33.9 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 127.329 2.251 . . . . 0.0 109.359 -174.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.01 -179.76 5.74 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.467 3.445 . . . . 0.0 112.425 178.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.87 -6.67 11.0 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.855 1.662 . . . . 0.0 112.021 176.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.14 149.82 40.8 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 120.818 -1.176 . . . . 0.0 109.496 173.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -75.03 -30.5 61.09 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.509 0.723 . . . . 0.0 109.756 169.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -114.43 108.09 16.42 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.774 1.63 . . . . 0.0 107.471 -172.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -137.15 168.72 19.06 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 126.521 1.929 . . . . 0.0 107.099 169.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.23 166.52 13.0 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 161.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 73.8 m -124.92 120.68 32.3 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.157 0.983 . . . . 0.0 108.873 -167.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.81 126.37 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -171.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -121.17 128.79 52.84 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 171.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.52 ' HB ' HG22 ' A' ' 71' ' ' THR . 19.6 mt -114.94 88.61 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 171.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -56.38 106.77 0.31 Allowed 'General case' 0 C--O 1.239 0.52 0 C-N-CA 126.886 2.074 . . . . 0.0 108.217 163.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -153.43 148.68 26.94 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.671 1.189 . . . . 0.0 109.93 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 54.76 28.49 10.3 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.02 41.25 71.8 Favored Glycine 0 CA--C 1.527 0.833 0 O-C-N 121.151 -0.968 . . . . 0.0 110.768 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.69 -172.13 36.71 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 127.676 2.56 . . . . 0.0 108.458 174.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -147.15 146.73 29.99 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 119.045 1.423 . . . . 0.0 113.281 174.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.52 HG22 ' HB ' ' A' ' 64' ' ' ILE . 1.2 t -82.61 164.27 20.9 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 165.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.4 m -135.83 146.36 47.42 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 126.661 1.984 . . . . 0.0 106.912 171.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.0 ptp -165.39 167.99 17.17 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.017 1.727 . . . . 0.0 108.249 168.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -140.25 142.15 35.8 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.563 1.545 . . . . 0.0 107.96 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.464 ' CD1' HG13 ' A' ' 84' ' ' ILE . 0.3 OUTLIER -125.9 153.61 43.96 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.833 1.197 . . . . 0.0 109.623 176.791 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -155.32 -175.7 5.57 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.625 1.57 . . . . 0.0 107.554 -175.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -111.86 144.62 40.88 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.708 1.603 . . . . 0.0 108.571 170.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -144.76 110.64 5.41 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 122.524 1.154 . . . . 0.0 111.096 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 66.92 4.84 3.7 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.286 1.834 . . . . 0.0 113.995 176.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 121.77 -5.34 10.63 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.573 1.082 . . . . 0.0 113.5 171.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -105.37 157.82 17.07 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 119.132 1.466 . . . . 0.0 108.443 162.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -93.82 152.4 18.93 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 169.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -143.71 162.29 36.36 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.298 0.639 . . . . 0.0 110.648 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.464 HG13 ' CD1' ' A' ' 75' ' ' TYR . 3.9 mp -117.65 124.68 73.39 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 C-N-CA 125.581 1.552 . . . . 0.0 107.824 -178.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -68.06 151.43 47.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 122.41 1.1 . . . . 0.0 109.033 168.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -169.85 167.61 4.96 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 128.729 2.812 . . . . 0.0 106.433 167.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -56.19 -161.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.817 1 C-N-CA 125.905 4.404 . . . . 0.0 110.237 164.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -43.41 -12.16 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.682 1.993 . . . . 0.0 116.009 -172.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.9 mtmt -112.1 62.3 0.62 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 120.432 1.469 . . . . 0.0 111.869 163.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -141.55 61.89 0.53 Allowed Glycine 0 C--N 1.336 0.549 0 CA-C-N 119.679 1.127 . . . . 0.0 114.304 -175.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.2 mt -136.26 46.86 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 173.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -74.99 109.48 8.49 Favored 'General case' 0 CA--C 1.507 -0.701 0 O-C-N 120.967 -1.083 . . . . 0.0 110.851 -175.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -75.57 122.1 23.39 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 165.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.6 pt -115.87 -179.93 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 125.41 1.484 . . . . 0.0 108.157 160.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -137.5 8.82 2.88 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -170.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -135.71 166.54 23.02 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 126.332 1.853 . . . . 0.0 109.134 173.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -78.28 125.51 29.45 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 170.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -62.87 -46.42 87.95 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.93 -0.481 . . . . 0.0 110.258 -178.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -69.2 -11.68 61.01 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.239 1.015 . . . . 0.0 113.052 -175.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -91.06 -14.16 31.83 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.521 1.528 . . . . 0.0 110.642 175.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 5.6 mmt -105.95 -5.22 19.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.887 1.675 . . . . 0.0 112.448 -172.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 15.9 pt . . . . . 0 C--O 1.253 1.266 0 C-N-CA 125.843 1.657 . . . . 0.0 109.555 173.898 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.8 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 48.81 86.65 0.15 Allowed Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 126.909 2.084 . . . . 0.0 114.216 166.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -57.17 167.06 3.62 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.334 1.356 . . . . 0.0 112.051 174.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 64.3 mt -96.74 134.87 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 167.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.28 155.25 61.42 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 128.272 2.629 . . . . 0.0 108.132 -172.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.452 ' HB2' HD21 ' A' ' 10' ' ' ASN . 68.9 Cg_endo -72.12 175.45 9.86 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.903 2.402 . . . . 0.0 112.273 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.501 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -77.71 153.63 32.83 Favored 'General case' 0 C--N 1.34 0.189 0 O-C-N 120.624 -1.298 . . . . 0.0 110.412 171.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.412 ' HB2' HD13 ' A' ' 36' ' ' LEU . . . -78.26 7.48 6.34 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.658 1.183 . . . . 0.0 112.645 175.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -133.86 5.47 3.63 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.811 1.244 . . . . 0.0 111.037 -169.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.452 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -122.94 0.65 9.19 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.927 2.091 . . . . 0.0 112.62 170.25 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 t -70.65 147.08 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 167.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -85.14 -63.5 1.32 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 161.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.6 p -153.4 170.75 19.92 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.483 0.713 . . . . 0.0 109.343 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.9 mt -125.93 126.49 69.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 173.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.9 t -100.03 133.22 44.73 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 171.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.2 mt -125.99 101.47 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 169.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.06 115.01 21.68 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 104.747 -2.316 . . . . 0.0 104.747 167.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -65.75 173.04 3.05 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.283 1.433 . . . . 0.0 109.927 176.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.0 p -69.67 -20.06 63.58 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 119.667 -1.896 . . . . 0.0 112.017 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 53.4 p30 -85.48 -165.4 1.21 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.731 0.812 . . . . 0.0 110.079 173.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.2 p -76.32 -2.51 31.99 Favored 'General case' 0 C--O 1.239 0.521 0 O-C-N 120.695 -1.253 . . . . 0.0 113.258 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.9 mt -100.47 150.52 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -166.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.78 158.79 43.51 Favored 'General case' 0 N--CA 1.417 -2.076 0 C-N-CA 125.886 1.674 . . . . 0.0 108.812 177.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.65 139.52 42.08 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 174.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.1 mp -111.17 137.77 42.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -111.26 76.12 0.96 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 103.081 -2.933 . . . . 0.0 103.081 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -82.44 -32.37 29.03 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 171.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.92 134.43 48.39 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.226 1.81 . . . . 0.0 108.334 -169.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.0 m -51.09 -47.95 61.78 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.567 0.747 . . . . 0.0 111.777 -174.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -76.82 -17.6 58.91 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.577 0.751 . . . . 0.0 111.557 -173.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 64.9 m -80.34 -38.64 30.15 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.905 1.282 . . . . 0.0 110.433 171.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.49 -53.66 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 171.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -57.79 -30.02 65.33 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.874 0.869 . . . . 0.0 112.515 -173.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.67 -61.33 2.69 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 124.008 0.923 . . . . 0.0 109.239 170.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.0 mt -45.2 -53.83 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 125.15 1.38 . . . . 0.0 111.999 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.412 HD13 ' HB2' ' A' ' 8' ' ' ALA . 1.1 mp -53.61 -24.73 14.84 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 120.192 1.36 . . . . 0.0 114.354 -175.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.8 t -55.6 -69.74 0.13 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.054 0.843 . . . . 0.0 109.745 172.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -75.88 -10.47 59.46 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.837 1.255 . . . . 0.0 111.169 -167.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.6 mm -69.56 -37.08 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 O-C-N 121.121 -0.987 . . . . 0.0 110.316 168.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.72 -11.73 30.82 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -164.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 52.5 p -62.41 -41.06 98.41 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.541 0.61 . . . . 0.0 111.558 -173.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.89 162.93 54.11 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-O 124.006 1.892 . . . . 0.0 113.354 -166.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.9 mtmm -125.51 109.08 12.26 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 -174.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 -59.61 -1.8 0.28 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 176.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.1 p 64.7 -164.19 0.25 Allowed 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.595 1.958 . . . . 0.0 107.937 -177.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -95.89 -2.54 47.1 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.577 0.626 . . . . 0.0 110.85 168.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -58.32 159.69 5.9 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 119.36 0.982 . . . . 0.0 111.506 -177.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -109.76 116.5 31.79 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.163 -169.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.1 t -98.12 68.85 1.99 Allowed 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 125.481 1.512 . . . . 0.0 108.354 -172.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.2 pt -73.59 19.59 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 126.498 1.919 . . . . 0.0 111.536 -175.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.74 173.96 7.42 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 126.264 1.825 . . . . 0.0 109.728 -167.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.12 -4.16 10.05 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.517 0.727 . . . . 0.0 110.746 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -146.79 155.85 48.14 Favored Pre-proline 0 C--O 1.234 0.266 0 CA-C-N 118.771 0.714 . . . . 0.0 110.24 -172.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -60.03 168.09 6.43 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.18 2.587 . . . . 0.0 110.376 168.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 t -104.03 23.0 13.63 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.913 1.285 . . . . 0.0 108.841 -176.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -114.66 168.95 9.43 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 128.099 2.56 . . . . 0.0 109.139 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -99.38 -29.25 12.88 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.732 1.213 . . . . 0.0 111.143 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -131.58 115.24 15.84 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -173.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -140.9 161.82 36.92 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 125.306 1.443 . . . . 0.0 107.152 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -95.78 166.7 25.15 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.24 108.21 13.02 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -159.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.1 mp -111.19 134.93 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -176.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -132.28 119.06 20.28 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 161.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.462 HG22 HD22 ' A' ' 66' ' ' ASN . 37.2 mt -85.99 112.23 22.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 159.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -79.85 130.28 35.18 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 167.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.462 HD22 HG22 ' A' ' 64' ' ' ILE . 5.4 p30 -149.05 127.09 11.96 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.623 1.569 . . . . 0.0 109.678 -178.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 46.9 45.24 15.17 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.357 1.863 . . . . 0.0 111.93 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.04 -1.59 17.07 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.498 1.047 . . . . 0.0 115.008 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -105.69 -176.73 23.96 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 168.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.2 ptp -154.57 146.94 23.92 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 120.934 -1.333 . . . . 0.0 112.838 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.1 m -103.29 96.24 6.63 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.097 2.159 . . . . 0.0 106.672 176.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.1 m -80.21 151.46 29.65 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.555 0.742 . . . . 0.0 109.249 171.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.25 165.4 5.97 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.947 2.499 . . . . 0.0 108.591 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.538 ' H ' ' HG3' ' A' ' 85' ' ' GLU . 14.1 m-85 -135.78 148.33 48.72 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 127.189 2.196 . . . . 0.0 108.04 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -125.16 162.1 25.38 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.327 0.967 . . . . 0.0 108.628 171.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -158.33 169.07 25.31 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.663 1.185 . . . . 0.0 109.553 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -97.28 142.13 29.54 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.186 1.794 . . . . 0.0 108.285 163.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -148.85 145.13 27.35 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.27 1.028 . . . . 0.0 108.516 169.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 53.43 0.42 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.681 1.992 . . . . 0.0 115.052 -174.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.79 19.35 37.47 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.104 -1.387 . . . . 0.0 113.374 -169.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -118.18 169.67 9.5 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 121.022 2.411 . . . . 0.0 107.571 161.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -108.58 145.57 34.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -142.7 162.22 36.02 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.414 0.685 . . . . 0.0 109.607 -175.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.0 mp -127.38 125.14 65.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 125.533 1.533 . . . . 0.0 108.205 -172.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.538 ' HG3' ' H ' ' A' ' 74' ' ' PHE . 0.5 OUTLIER -75.24 163.62 27.31 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.999 0.904 . . . . 0.0 108.955 172.057 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 178.74 168.5 0.58 Allowed Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 130.136 3.374 . . . . 0.0 104.783 175.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -53.76 -160.45 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.623 1 C-N-CA 125.407 4.071 . . . . 0.0 110.801 164.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -42.31 -10.18 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 128.887 2.875 . . . . 0.0 115.459 -175.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.3 59.94 0.68 Allowed 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.301 1.84 . . . . 0.0 112.678 166.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -137.53 54.19 0.71 Allowed Glycine 0 C--N 1.338 0.679 0 CA-C-N 119.819 1.191 . . . . 0.0 116.04 -174.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.7 mt -137.96 48.04 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 118.32 1.06 . . . . 0.0 108.66 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -76.65 137.05 39.19 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -118.56 91.56 3.59 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -176.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 16.0 pt -95.18 152.11 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 177.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -105.56 16.24 25.74 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.804 0.812 . . . . 0.0 112.279 -173.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -146.05 160.96 41.16 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.096 1.759 . . . . 0.0 111.004 -175.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -87.1 130.32 34.55 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.443 0.565 . . . . 0.0 111.722 -176.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -66.89 -46.57 74.51 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.549 0.739 . . . . 0.0 111.538 175.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -71.52 -19.84 62.13 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -168.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -95.54 -5.7 42.13 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 121.358 -0.839 . . . . 0.0 112.023 172.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 15.5 mmt -90.75 -28.14 18.47 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 117.387 -1.292 . . . . 0.0 112.013 169.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.7 pt . . . . . 0 C--O 1.253 1.258 0 CA-C-N 120.22 1.373 . . . . 0.0 109.594 164.709 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.063 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 m -69.88 166.04 36.33 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 126.001 1.72 . . . . 0.0 112.023 173.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -65.24 177.4 2.58 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.94 2.427 . . . . 0.0 112.227 163.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.6 mm -125.47 74.88 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 127.492 2.317 . . . . 0.0 105.716 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.84 165.94 42.31 Favored Pre-proline 0 N--CA 1.469 0.509 0 O-C-N 120.687 -1.258 . . . . 0.0 110.756 -177.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.608 ' HB2' HD21 ' A' ' 10' ' ' ASN . 38.3 Cg_endo -58.7 165.09 8.55 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 120.686 0.924 . . . . 0.0 109.997 158.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.465 ' HA ' ' HE2' ' A' ' 7' ' ' LYS . 7.0 mmpt? -53.53 169.01 0.14 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.16 0.984 . . . . 0.0 111.174 169.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.9 -57.24 5.29 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 156.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -57.73 -23.04 49.93 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.411 1.484 . . . . 0.0 114.456 -165.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.608 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -95.87 -0.59 50.82 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -178.206 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.4 t -78.83 153.17 4.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 173.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -108.63 -46.52 3.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 118.501 -0.762 . . . . 0.0 110.163 171.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.4 p -155.27 166.45 33.53 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.039 0.836 . . . . 0.0 110.812 163.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.7 mt -122.07 119.32 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 172.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.578 ' CB ' HD12 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -103.95 128.68 51.49 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.522 0.729 . . . . 0.0 109.703 175.482 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.1 mt -127.29 112.21 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -94.1 120.15 33.95 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 165.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -70.47 -171.91 0.54 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.584 1.554 . . . . 0.0 109.987 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 p -69.15 -1.15 7.09 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 119.697 -1.877 . . . . 0.0 113.927 170.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -104.04 -154.57 0.51 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.686 1.994 . . . . 0.0 109.599 -160.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.8 p -81.12 -5.01 57.18 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 129.302 3.041 . . . . 0.0 114.273 155.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.8 mt -104.05 145.63 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.676 1.59 . . . . 0.0 110.583 -159.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -140.52 134.94 31.37 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 120.897 -1.127 . . . . 0.0 109.86 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.04 141.02 47.05 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.578 HD12 ' CB ' ' A' ' 15' ' ' CYS . 10.3 mm -124.02 156.1 31.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -174.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.427 ' CG ' HD11 ' A' ' 35' ' ' ILE . 63.9 m-85 -142.17 87.97 2.06 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 -165.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -100.53 -21.22 15.39 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.51 1.524 . . . . 0.0 111.457 178.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.12 146.02 46.0 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 t -50.51 -47.06 57.51 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.664 0.786 . . . . 0.0 110.61 171.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -68.5 -31.88 71.46 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.524 -0.735 . . . . 0.0 111.393 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 73.1 m -72.46 -47.43 48.95 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.48 1.512 . . . . 0.0 110.511 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 90.3 mt -59.4 -46.72 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.279 1.432 . . . . 0.0 108.892 174.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.47 -26.28 68.65 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 117.426 -1.273 . . . . 0.0 114.008 -175.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -63.03 -60.01 4.03 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 168.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.427 HD11 ' CG ' ' A' ' 26' ' ' TYR . 74.0 mt -52.62 -51.03 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 O-C-N 123.879 0.737 . . . . 0.0 109.378 -170.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.8 -14.69 60.02 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -178.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.9 t -76.31 -59.33 2.81 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 120.188 1.358 . . . . 0.0 108.495 163.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -61.21 -7.78 3.07 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.91 1.684 . . . . 0.0 113.558 -176.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.6 mm -114.62 -14.18 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 126.324 1.85 . . . . 0.0 111.212 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.36 -10.66 56.03 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 120.277 -1.514 . . . . 0.0 112.567 171.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.8 t -68.87 -30.4 68.9 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.845 1.258 . . . . 0.0 112.669 -170.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.56 168.41 45.89 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-O 122.089 0.827 . . . . 0.0 112.774 -176.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.98 120.83 20.79 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 124.502 1.121 . . . . 0.0 108.041 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.409 ' HB3' ' CE2' ' A' ' 92' ' ' TYR . 14.8 ptt180 -67.26 1.8 1.95 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.8 p 61.13 -163.8 0.25 Allowed 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 -175.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -108.86 13.18 25.03 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.333 0.653 . . . . 0.0 112.169 161.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.15 158.86 8.2 Favored 'General case' 0 C--O 1.239 0.529 0 O-C-N 120.519 -1.363 . . . . 0.0 108.534 161.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -119.83 130.01 54.7 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 121.305 -0.872 . . . . 0.0 109.222 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.36 160.01 30.35 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 161.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.9 pt -136.01 11.04 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.149 1.379 . . . . 0.0 110.808 168.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.16 175.83 6.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.768 1.227 . . . . 0.0 111.034 -172.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -116.82 -11.86 10.85 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.071 1.348 . . . . 0.0 111.194 -174.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -142.71 160.05 54.95 Favored Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 125.483 1.513 . . . . 0.0 109.857 -172.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -70.95 169.16 21.09 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.202 1.935 . . . . 0.0 112.694 -175.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.18 10.84 34.48 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.449 1.1 . . . . 0.0 111.809 -177.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.526 ' HB2' ' CD2' ' A' ' 76' ' ' TYR . . . -107.14 161.94 14.31 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.871 1.269 . . . . 0.0 113.469 -169.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.97 -29.89 35.23 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 126.108 1.763 . . . . 0.0 110.422 165.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -134.88 108.12 7.74 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.907 1.283 . . . . 0.0 109.623 -165.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -145.77 159.9 42.52 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.159 1.384 . . . . 0.0 109.06 -177.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.33 158.56 30.16 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 172.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.84 134.46 44.99 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.475 1.11 . . . . 0.0 108.606 174.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.96 123.64 54.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.11 137.37 46.21 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 159.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 64.7 mt -109.94 105.92 19.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 102.79 -3.041 . . . . 0.0 102.79 160.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -78.12 132.49 37.7 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 169.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -147.37 -171.94 3.9 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.839 1.656 . . . . 0.0 107.573 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.582 ' ND2' ' H ' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -60.09 80.31 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.811 1 C-N-CA 133.867 4.867 . . . . 0.0 110.469 -168.614 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.02 1.64 68.99 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 114.041 -1.436 . . . . 0.0 112.891 -174.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.92 158.12 14.55 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-O 121.719 0.621 . . . . 0.0 112.092 -171.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 7.1 ptm -131.33 133.45 45.35 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 160.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.6 m -118.1 90.9 3.43 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.8 m -84.65 136.78 33.61 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.009 1.324 . . . . 0.0 109.943 -172.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.2 ptp -150.27 171.53 16.8 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.812 1.245 . . . . 0.0 109.722 172.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -142.27 147.7 36.86 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.415 ' CD1' HG13 ' A' ' 84' ' ' ILE . 0.7 OUTLIER -128.69 151.99 48.9 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.6 1.545 . . . . 0.0 108.592 175.524 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.526 ' CD2' ' HB2' ' A' ' 56' ' ' ALA . 13.2 p90 -154.84 168.61 26.33 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.857 0.863 . . . . 0.0 111.281 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -86.85 141.39 28.82 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.672 1.123 . . . . 0.0 107.992 162.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -139.26 120.29 14.57 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.908 0.861 . . . . 0.0 110.325 160.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 63.97 11.25 5.93 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.141 1.776 . . . . 0.0 113.577 170.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.95 -9.71 18.43 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.932 1.253 . . . . 0.0 112.536 173.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -103.46 159.53 15.5 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.203 1.002 . . . . 0.0 108.71 167.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -108.9 152.54 24.78 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 169.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -141.46 160.19 40.66 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 122.939 0.496 . . . . 0.0 110.225 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.415 HG13 ' CD1' ' A' ' 75' ' ' TYR . 3.0 mp -122.31 102.52 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 C-N-CA 125.004 1.322 . . . . 0.0 108.126 -171.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -62.08 145.78 52.27 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 122.882 1.325 . . . . 0.0 111.066 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.591 ' HB2' ' HA2' ' A' ' 90' ' ' GLY . 1.0 OUTLIER -164.5 167.72 9.94 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 130.037 3.335 . . . . 0.0 105.816 -178.558 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 89' ' ' LYS . 43.9 Cg_endo -56.46 -162.13 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 124.378 3.386 . . . . 0.0 109.511 166.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -43.04 -15.07 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 129.609 3.164 . . . . 0.0 115.268 -170.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.475 ' H ' ' HG2' ' A' ' 89' ' ' LYS . 2.6 ptpt -107.06 61.83 0.62 Allowed 'General case' 0 N--CA 1.425 -1.708 0 C-N-CA 130.462 3.505 . . . . 0.0 113.818 167.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.591 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . -122.32 -0.42 10.39 Favored Glycine 0 C--O 1.224 -0.479 0 N-CA-C 116.957 1.543 . . . . 0.0 116.957 -176.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.269 4.1 mt -89.59 48.21 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 O-C-N 120.313 -1.698 . . . . 0.0 109.604 -169.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.409 ' CE2' ' HB3' ' A' ' 44' ' ' ARG . 34.3 m-85 -74.3 101.83 4.16 Favored 'General case' 0 CA--C 1.504 -0.822 0 O-C-N 120.656 -1.277 . . . . 0.0 108.114 174.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -75.13 128.45 35.52 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 162.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.1 pt -114.63 171.41 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.211 1.004 . . . . 0.0 108.524 159.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -129.71 43.48 3.12 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.853 0.835 . . . . 0.0 110.467 -176.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -159.45 164.41 34.56 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 125.911 1.684 . . . . 0.0 108.389 164.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -66.52 136.71 56.05 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 162.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -80.05 -47.04 15.49 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.647 0.779 . . . . 0.0 111.598 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -58.26 -23.01 54.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.9 2.08 . . . . 0.0 113.309 -172.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -75.47 -19.31 59.5 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.952 1.251 . . . . 0.0 111.785 176.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 16.6 mmt -91.4 -14.16 31.12 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.806 1.242 . . . . 0.0 111.027 -173.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.3 pt . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.016 -1.468 . . . . 0.0 112.937 -170.92 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.687 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.25 165.7 13.05 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 124.448 1.099 . . . . 0.0 112.046 -175.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -62.06 171.4 5.07 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.271 2.647 . . . . 0.0 113.433 172.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.9 mm -87.27 131.01 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 160.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.84 162.55 48.03 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 127.115 2.166 . . . . 0.0 109.522 170.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.651 ' HB2' HD21 ' A' ' 10' ' ' ASN . 48.4 Cg_endo -68.36 -178.77 1.95 Allowed 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.272 2.648 . . . . 0.0 114.082 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.3 mtmt -62.85 166.97 5.03 Favored 'General case' 0 C--N 1.344 0.367 0 O-C-N 119.547 -1.971 . . . . 0.0 109.501 159.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.1 -56.44 5.59 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 162.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -64.58 -22.48 66.98 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -163.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.651 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -85.41 0.12 53.17 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.323 0.965 . . . . 0.0 113.268 176.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.6 t -74.49 147.24 8.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 171.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.22 -61.26 1.55 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 169.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.6 p -164.49 127.09 2.35 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -175.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.9 mt -90.61 127.73 42.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.0 t -103.51 125.57 50.15 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 174.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.5 mt -123.88 102.09 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 175.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.57 106.33 16.06 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 169.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -59.42 170.97 0.88 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.797 1.639 . . . . 0.0 109.718 -176.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.3 p -59.77 -38.83 82.92 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 120.969 -1.082 . . . . 0.0 111.938 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -73.83 -179.39 3.65 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 127.778 2.431 . . . . 0.0 111.399 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.9 p -71.2 21.3 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.334 2.254 . . . . 0.0 113.862 -174.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.0 mt -136.07 152.18 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 126.182 1.793 . . . . 0.0 106.431 -162.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.6 167.77 18.85 Favored 'General case' 0 N--CA 1.419 -1.987 0 C-N-CA 126.565 1.946 . . . . 0.0 108.701 176.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.434 ' HB3' ' HE2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -142.64 147.44 35.79 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 165.008 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.07 126.32 74.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.573 ' CG ' HD11 ' A' ' 35' ' ' ILE . 21.6 m-85 -107.72 85.95 2.21 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 -174.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -110.33 -18.45 13.26 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.631 1.572 . . . . 0.0 110.991 175.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -69.88 146.71 51.06 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 175.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.12 -45.51 83.41 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.45 0.643 . . . . 0.0 112.164 -173.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -70.23 -31.2 68.5 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.197 -0.94 . . . . 0.0 111.708 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 52.8 p -65.94 -43.74 87.12 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 70.9 mt -62.77 -56.82 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.997 1.319 . . . . 0.0 108.758 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -56.65 -37.53 70.91 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 118.66 -0.686 . . . . 0.0 112.25 -172.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.487 ' O ' ' HE3' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -55.68 -59.78 4.37 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 176.537 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.573 HD11 ' CG ' ' A' ' 26' ' ' TYR . 85.8 mt -56.38 -46.28 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 117.685 -1.15 . . . . 0.0 111.299 -176.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.23 -20.68 2.79 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.619 1.554 . . . . 0.0 114.69 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.89 -53.73 7.98 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.95 0.9 . . . . 0.0 111.509 172.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -59.27 -35.33 73.53 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.949 -1.094 . . . . 0.0 110.342 177.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 21.2 mm -61.55 -24.46 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 120.532 -1.355 . . . . 0.0 111.168 175.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -98.09 -6.6 31.34 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.883 1.22 . . . . 0.0 113.145 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 t -70.78 -34.14 71.48 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.052 0.842 . . . . 0.0 109.652 -168.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.25 167.75 47.63 Favored Glycine 0 C--N 1.341 0.842 0 O-C-N 120.771 -1.205 . . . . 0.0 113.863 -173.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -131.59 110.25 10.81 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 -174.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.427 ' HB3' ' CE1' ' A' ' 92' ' ' TYR . 13.3 ptt-85 -60.06 -8.53 2.43 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -176.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . 0.272 1.4 p 57.36 172.52 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 127.743 2.417 . . . . 0.0 109.846 -169.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -83.24 2.29 36.57 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.421 -1.424 . . . . 0.0 111.594 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt -65.34 158.87 25.33 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 122.049 0.928 . . . . 0.0 110.182 174.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -90.55 130.04 36.63 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 165.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.1 m -75.18 158.87 32.32 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 153.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.9 pt -142.52 31.76 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 125.0 1.32 . . . . 0.0 110.336 174.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -131.15 172.54 12.0 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.953 1.701 . . . . 0.0 108.217 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.55 -0.67 2.89 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.26 1.024 . . . . 0.0 110.996 177.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -146.01 160.65 42.63 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 127.377 2.271 . . . . 0.0 108.607 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -80.33 177.99 7.59 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.452 2.768 . . . . 0.0 112.076 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.9 4.28 8.05 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.713 1.205 . . . . 0.0 112.399 175.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.41 150.72 46.96 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.306 1.042 . . . . 0.0 110.217 170.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -74.56 -28.64 61.03 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.995 0.518 . . . . 0.0 110.062 172.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -129.99 127.73 40.59 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.157 1.383 . . . . 0.0 109.183 -176.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -154.27 161.94 41.49 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.704 2.002 . . . . 0.0 108.147 176.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -90.73 159.63 27.02 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 171.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.34 137.27 38.99 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.16 130.75 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -125.07 130.21 51.8 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 163.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 62.0 mt -106.76 83.57 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 171.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.77 118.49 5.36 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.941 1.246 . . . . 0.0 109.274 167.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -144.88 119.9 10.04 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.675 1.59 . . . . 0.0 108.271 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 60.87 22.98 13.04 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.774 1.63 . . . . 0.0 112.219 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.54 -3.27 42.65 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.51 1.052 . . . . 0.0 113.224 -174.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.88 178.17 51.11 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 156.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 19.7 ptp -159.39 161.27 35.61 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.542 -0.975 . . . . 0.0 112.768 177.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.4 m -118.72 112.26 19.54 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.016 1.726 . . . . 0.0 106.914 172.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.0 m -81.19 147.27 30.09 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 168.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 2.6 ptp -160.11 171.49 19.19 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.164 1.786 . . . . 0.0 108.153 165.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -142.74 146.42 34.3 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.247 1.819 . . . . 0.0 106.474 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.437 ' CD1' HG13 ' A' ' 84' ' ' ILE . 0.6 OUTLIER -128.51 153.5 47.1 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.788 1.631 . . . . 0.0 109.807 175.857 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -153.48 174.86 13.85 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.807 1.243 . . . . 0.0 110.267 -175.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -105.98 144.02 33.29 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.429 1.892 . . . . 0.0 107.961 169.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -151.49 131.1 13.07 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 176.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 55.3 14.51 1.1 Allowed 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.89 -1.131 . . . . 0.0 113.487 -176.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.51 12.09 73.37 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 120.505 -1.372 . . . . 0.0 111.888 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.96 165.07 11.85 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.563 1.945 . . . . 0.0 107.371 163.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -112.24 150.92 30.23 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.083 0.856 . . . . 0.0 108.75 178.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -141.03 159.48 42.12 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.895 0.378 . . . . 0.0 111.167 -178.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.437 HG13 ' CD1' ' A' ' 75' ' ' TYR . 3.5 mp -117.73 129.96 73.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 125.534 1.534 . . . . 0.0 108.45 178.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -73.63 150.03 41.63 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 122.847 1.308 . . . . 0.0 109.831 169.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -169.72 167.44 5.16 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 129.24 3.016 . . . . 0.0 105.928 174.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -59.67 -160.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 125.175 3.917 . . . . 0.0 109.531 162.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -42.77 -9.24 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 128.472 2.709 . . . . 0.0 117.058 -169.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -107.46 21.97 16.67 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 173.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -105.49 44.01 1.56 Allowed Glycine 0 N--CA 1.45 -0.429 0 CA-C-O 118.587 -1.118 . . . . 0.0 115.872 -167.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.4 mt -109.35 46.56 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 119.752 1.776 . . . . 0.0 108.767 171.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.427 ' CE1' ' HB3' ' A' ' 44' ' ' ARG . 72.3 m-85 -71.89 103.57 3.21 Favored 'General case' 0 CA--C 1.51 -0.582 0 O-C-N 121.193 -0.942 . . . . 0.0 108.767 177.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -68.49 126.91 31.12 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 157.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.9 pt -117.74 161.1 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 154.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -104.39 -9.49 18.43 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.658 -0.651 . . . . 0.0 110.774 -176.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -137.81 144.78 41.69 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 124.401 1.08 . . . . 0.0 110.489 -172.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -65.4 124.31 21.91 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 126.388 1.875 . . . . 0.0 112.291 -172.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -63.72 -48.75 75.81 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.808 1.243 . . . . 0.0 110.986 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -65.13 -9.71 25.07 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -174.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -109.22 -9.0 15.03 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.889 1.222 . . . . 0.0 111.819 173.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 10.9 mmt -89.6 -19.95 24.33 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.048 1.339 . . . . 0.0 111.775 174.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 18.3 pt . . . . . 0 C--O 1.255 1.363 0 C-N-CA 124.124 0.969 . . . . 0.0 110.947 174.27 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.737 0 CA-C-O 119.01 -0.884 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.4 m 75.8 165.54 0.13 Allowed Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 127.261 2.224 . . . . 0.0 112.186 -163.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.53 -173.21 0.11 Allowed 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.842 3.028 . . . . 0.0 111.816 158.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.8 mt -124.27 119.78 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 164.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.7 157.14 76.18 Favored Pre-proline 0 C--O 1.239 0.542 0 C-N-CA 125.324 1.449 . . . . 0.0 109.135 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.573 ' HB2' HD21 ' A' ' 10' ' ' ASN . 71.6 Cg_endo -71.25 165.46 32.37 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.761 2.307 . . . . 0.0 111.513 176.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -64.46 154.78 34.77 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.335 -0.853 . . . . 0.0 111.261 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.478 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . . . -57.24 -50.5 72.69 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.394 0.997 . . . . 0.0 108.963 167.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -67.45 -16.84 64.44 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -169.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.573 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -104.38 1.89 30.66 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 119.582 1.083 . . . . 0.0 113.549 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 t -83.66 135.89 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 172.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -83.82 -60.36 2.14 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.4 p -148.75 169.88 19.46 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.362 1.465 . . . . 0.0 109.553 169.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.3 mt -124.84 144.48 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 N-CA-C 104.578 -2.378 . . . . 0.0 104.578 171.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.83 145.16 49.92 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 174.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.0 mt -134.66 105.74 6.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 178.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -86.37 110.59 19.79 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 102.839 -3.023 . . . . 0.0 102.839 174.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -66.12 173.28 3.18 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 174.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.3 p -56.85 -20.32 22.24 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -103.76 -175.83 2.91 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.197 1.399 . . . . 0.0 109.413 -178.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.4 p -75.65 42.38 0.22 Allowed 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.768 2.027 . . . . 0.0 111.655 -178.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.6 mt -140.11 136.35 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 126.196 1.798 . . . . 0.0 106.313 -172.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.38 150.59 46.7 Favored 'General case' 0 N--CA 1.421 -1.918 0 C-N-CA 125.427 1.491 . . . . 0.0 109.135 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.451 ' HE2' ' CZ ' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -125.28 142.11 51.69 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.377 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.44 145.33 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.451 ' CZ ' ' HE2' ' A' ' 24' ' ' LYS . 24.3 m-85 -127.24 82.49 2.09 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -170.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -88.34 -19.53 26.55 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.378 1.471 . . . . 0.0 112.102 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.99 139.81 30.48 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.47 1.108 . . . . 0.0 111.242 -174.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.4 t -45.2 -54.57 6.77 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 126.463 1.905 . . . . 0.0 112.896 -177.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -67.14 -38.99 86.49 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.527 -0.733 . . . . 0.0 109.753 -173.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.4 m -65.9 -6.42 12.28 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.304 1.842 . . . . 0.0 113.389 171.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -100.66 -45.54 11.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 120.451 1.478 . . . . 0.0 109.316 171.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -60.38 -33.0 71.84 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.885 0.874 . . . . 0.0 112.887 -174.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.13 -52.28 43.64 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.672 0.669 . . . . 0.0 110.39 176.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.2 mt -49.24 -52.0 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 119.43 1.014 . . . . 0.0 110.546 173.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.478 ' CD1' ' HB2' ' A' ' 8' ' ' ALA . 38.9 mt -56.81 -21.32 27.93 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -177.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.5 t -67.19 -65.37 0.69 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.485 1.039 . . . . 0.0 108.56 168.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.39 -29.87 70.13 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.48 -0.763 . . . . 0.0 110.544 -168.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.7 mm -63.96 -20.29 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.325 1.05 . . . . 0.0 111.141 174.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.71 -3.47 8.74 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 120.004 1.275 . . . . 0.0 114.222 -170.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 t -66.38 -40.15 89.51 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.586 0.754 . . . . 0.0 110.335 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.64 172.32 53.94 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-O 123.134 1.408 . . . . 0.0 114.19 -169.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -140.7 121.63 14.55 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 114.238 -0.981 . . . . 0.0 108.41 -173.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -63.82 -4.85 3.53 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.521 1.528 . . . . 0.0 114.796 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.1 p 59.83 -164.55 0.22 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.2 1.8 . . . . 0.0 108.379 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -100.31 8.81 43.46 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 120.235 -1.54 . . . . 0.0 112.48 173.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -64.06 154.21 35.06 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.736 -0.602 . . . . 0.0 109.93 173.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -94.81 123.76 38.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 165.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.2 t -70.98 151.73 44.34 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 147.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 pp -141.33 7.57 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.866 2.066 . . . . 0.0 109.687 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.11 162.14 24.17 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.535 1.934 . . . . 0.0 109.76 -174.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -102.3 -1.57 30.77 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.121 0.968 . . . . 0.0 110.699 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -141.55 147.32 45.56 Favored Pre-proline 0 C--O 1.235 0.305 0 CA-C-N 119.394 0.997 . . . . 0.0 111.532 -172.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.446 ' HG2' ' CD2' ' A' ' 59' ' ' TYR . 19.5 Cg_endo -67.98 162.08 41.41 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.218 3.279 . . . . 0.0 111.402 -176.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.81 35.66 1.66 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.048 2.139 . . . . 0.0 109.235 174.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.8 152.79 41.84 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.765 1.626 . . . . 0.0 110.292 173.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -87.67 -29.32 21.23 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.681 -172.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -128.13 118.44 23.41 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 176.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.446 ' CD2' ' HG2' ' A' ' 54' ' ' PRO . 49.4 p90 -138.19 156.47 47.68 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.641 1.576 . . . . 0.0 108.209 175.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.37 -178.0 16.49 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 125.822 1.677 . . . . 0.0 110.12 171.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 36.5 m -131.75 137.17 48.1 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 117.731 0.765 . . . . 0.0 111.953 -158.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 mp -118.72 135.2 59.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 126.179 1.791 . . . . 0.0 107.018 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -127.67 125.45 40.1 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 172.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.7 mt -99.87 118.24 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.116 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 168.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -82.25 133.1 35.23 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 165.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -140.26 -162.72 1.39 Allowed 'General case' 0 C--N 1.327 -0.404 0 O-C-N 120.845 -1.159 . . . . 0.0 108.05 173.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -44.77 -35.74 2.87 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 129.886 3.275 . . . . 0.0 115.565 -157.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -176.13 20.41 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 124.895 1.235 . . . . 0.0 110.39 -167.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -165.18 170.72 40.28 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 171.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.9 ptt? -118.84 156.1 30.03 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.3 1.44 . . . . 0.0 109.834 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 m -126.87 108.02 10.63 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -176.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.4 m -108.52 143.61 37.29 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.705 0.802 . . . . 0.0 110.271 -172.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.94 165.98 33.78 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.526 1.531 . . . . 0.0 109.306 172.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -112.84 176.36 5.05 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.691 1.597 . . . . 0.0 108.928 170.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -142.7 165.62 26.88 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.278 1.431 . . . . 0.0 108.593 170.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -158.46 170.8 21.39 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.111 0.869 . . . . 0.0 112.267 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -106.53 134.29 49.9 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 162.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.31 -162.52 0.08 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 125.824 1.65 . . . . 0.0 106.888 153.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -74.28 50.97 0.41 Allowed 'General case' 0 C--N 1.321 -0.66 0 O-C-N 119.952 -1.717 . . . . 0.0 111.316 174.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 122.07 -14.97 8.91 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 125.108 1.337 . . . . 0.0 112.286 166.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -89.18 154.35 20.21 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.481 1.14 . . . . 0.0 110.728 165.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -114.79 152.68 31.7 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.776 0.716 . . . . 0.0 111.264 -178.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -152.23 163.68 38.93 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.84 0.856 . . . . 0.0 111.879 -169.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.9 mp -131.14 132.58 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.708 1.603 . . . . 0.0 109.767 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.1 tp10 -85.0 165.39 17.6 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.181 2.192 . . . . 0.0 109.994 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.504 ' HB2' ' HA2' ' A' ' 90' ' ' GLY . 0.7 OUTLIER 174.43 168.31 0.32 Allowed Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 128.032 2.533 . . . . 0.0 107.289 -164.421 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.406 ' O ' ' N ' ' A' ' 89' ' ' LYS . 39.5 Cg_endo -59.2 -161.27 0.02 OUTLIER 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.338 2.692 . . . . 0.0 109.672 160.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -42.57 -6.74 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 130.397 3.479 . . . . 0.0 117.733 -170.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 87' ' ' PRO 0.266 1.2 ptpt -109.72 13.4 23.74 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 129.758 3.223 . . . . 0.0 113.285 179.531 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.504 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . -94.18 49.98 2.17 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 123.78 0.705 . . . . 0.0 114.25 -168.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.1 mt -127.79 46.22 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 176.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -72.85 96.38 2.07 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 173.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -74.43 121.08 20.88 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 166.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 27.3 pt -115.75 169.44 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.485 1.114 . . . . 0.0 109.553 166.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -128.37 49.99 2.13 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.24 0.616 . . . . 0.0 109.951 -178.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -166.7 165.21 16.6 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.554 1.541 . . . . 0.0 110.785 165.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -73.62 131.65 41.91 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.194 0.998 . . . . 0.0 108.996 174.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -72.38 -49.14 36.16 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.798 0.727 . . . . 0.0 111.742 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -70.91 -26.13 63.07 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.337 -0.852 . . . . 0.0 113.023 -168.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -72.11 -19.58 61.77 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.153 0.888 . . . . 0.0 111.425 171.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 17.1 mmt -105.81 24.06 12.91 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.571 1.948 . . . . 0.0 111.965 -171.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 10.2 pt . . . . . 0 C--O 1.257 1.448 0 C-N-CA 125.188 1.395 . . . . 0.0 109.836 169.581 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.954 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 m 62.59 167.19 0.1 Allowed Pre-proline 0 CA--C 1.547 0.851 0 CA-C-N 118.914 1.357 . . . . 0.0 114.298 158.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.77 161.54 45.53 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 O-C-N 118.716 -1.255 . . . . 0.0 111.141 166.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.7 mt -116.45 104.79 17.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.42 158.84 68.37 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 126.986 2.114 . . . . 0.0 110.676 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.496 ' HB2' HD21 ' A' ' 10' ' ' ASN . 68.6 Cg_endo -68.77 -175.43 0.93 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.6 2.867 . . . . 0.0 112.662 177.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt -60.82 175.94 0.44 Allowed 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.109 -1.62 . . . . 0.0 109.569 162.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.18 -50.01 10.11 Favored 'General case' 0 C--O 1.221 -0.428 0 O-C-N 121.255 -0.903 . . . . 0.0 109.539 163.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -62.13 -12.31 18.94 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.683 1.593 . . . . 0.0 114.771 -168.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.496 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -104.83 -0.62 27.0 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.71 2.004 . . . . 0.0 113.187 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 66.5 t -86.01 130.17 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 172.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -67.26 -69.52 0.31 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 167.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.6 m -149.51 170.53 18.4 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.112 0.965 . . . . 0.0 109.984 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.1 mt -131.75 132.97 61.81 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.994 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 172.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.6 m -99.68 133.0 44.65 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 112.787 -2.006 . . . . 0.0 106.069 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.0 mt -133.99 103.65 5.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 170.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -93.97 98.93 11.37 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.172 1.789 . . . . 0.0 106.274 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -60.74 172.83 0.85 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.469 1.908 . . . . 0.0 111.55 -169.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.3 p -51.83 -42.59 62.66 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.962 0.905 . . . . 0.0 110.393 171.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -91.64 -179.2 5.28 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.188 1.795 . . . . 0.0 111.338 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 98.2 p -72.87 16.9 0.13 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.313 1.445 . . . . 0.0 114.818 -158.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.8 mt -120.8 139.91 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -161.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -124.19 107.13 10.89 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 174.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.26 139.85 42.81 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 166.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.0 mt -118.17 136.15 56.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 168.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -110.86 73.87 0.84 Allowed 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 104.243 -2.502 . . . . 0.0 104.243 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -82.12 16.1 2.09 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.808 1.243 . . . . 0.0 111.72 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.51 140.44 52.2 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.707 1.203 . . . . 0.0 109.94 -167.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.8 t -55.75 -46.07 77.92 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.92 0.888 . . . . 0.0 111.636 -175.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -73.66 -31.85 63.68 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.378 -0.826 . . . . 0.0 112.111 -175.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.4 m -65.8 -43.29 89.14 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 127.685 2.394 . . . . 0.0 111.036 174.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.5 mt -64.76 -52.11 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 172.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -60.81 -21.93 63.63 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -65.16 -67.56 0.43 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 119.57 1.077 . . . . 0.0 108.495 166.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.6 mt -50.65 -44.48 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.549 1.14 . . . . 0.0 110.543 -170.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.82 -12.4 0.79 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 177.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.4 t -84.44 -62.94 1.43 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.041 2.136 . . . . 0.0 110.814 168.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -57.65 -14.7 5.88 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.646 1.112 . . . . 0.0 113.435 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.4 mm -82.3 -49.66 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 124.429 1.092 . . . . 0.0 110.736 169.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.96 -19.78 46.32 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.342 1.057 . . . . 0.0 113.713 -173.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 t -68.51 -17.4 64.16 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.668 1.187 . . . . 0.0 112.87 -176.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.62 140.2 40.37 Favored Glycine 0 C--N 1.336 0.557 0 O-C-N 119.612 -1.93 . . . . 0.0 112.389 176.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -108.41 107.34 17.86 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 161.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.7 ptt85 -59.79 -6.48 1.25 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.712 1.142 . . . . 0.0 113.109 168.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.8 p 61.33 -174.85 0.13 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.688 1.595 . . . . 0.0 110.736 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -74.94 -12.71 60.41 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.23 -1.544 . . . . 0.0 112.216 176.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -71.92 171.31 11.99 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.117 0.961 . . . . 0.0 111.35 -167.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -110.74 128.43 55.73 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.824 1.25 . . . . 0.0 108.173 173.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.5 t -74.94 162.58 28.48 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 156.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.9 pt -146.52 31.69 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 126.489 1.915 . . . . 0.0 109.83 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -139.63 172.23 13.09 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 120.99 -1.069 . . . . 0.0 111.64 -172.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -111.12 -20.36 12.39 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.428 1.891 . . . . 0.0 111.52 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -147.26 158.27 44.46 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 124.025 0.93 . . . . 0.0 110.676 -165.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -70.29 175.55 8.39 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.737 2.958 . . . . 0.0 111.699 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.27 -5.12 11.83 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.509 1.524 . . . . 0.0 111.539 175.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.44 157.8 36.4 Favored 'General case' 0 N--CA 1.457 -0.114 0 O-C-N 120.837 -1.165 . . . . 0.0 109.249 169.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.16 -21.66 21.05 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.602 0.761 . . . . 0.0 111.283 168.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -127.96 103.01 7.01 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -169.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -146.56 177.48 9.03 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 128.601 2.76 . . . . 0.0 106.695 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -121.61 166.24 14.45 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 168.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.96 133.07 42.1 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.159 0.984 . . . . 0.0 108.601 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.0 mp -124.33 129.93 73.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -132.64 115.47 15.45 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.0 mt -87.49 103.63 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 173.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -74.76 122.81 23.87 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 172.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -141.67 -157.21 0.75 Allowed 'General case' 0 N--CA 1.465 0.299 0 O-C-N 120.866 -1.146 . . . . 0.0 110.502 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -44.56 -21.21 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 1 C-N-CA 132.796 4.438 . . . . 0.0 116.501 -160.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 153.03 32.19 0.03 OUTLIER Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 126.048 1.785 . . . . 0.0 108.954 -162.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -172.97 174.1 45.77 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.2 ptp -117.93 160.29 21.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.909 1.684 . . . . 0.0 109.351 176.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.6 m -123.29 104.75 9.33 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 158.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.6 m -82.84 141.8 32.0 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.339 1.456 . . . . 0.0 108.591 172.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -165.32 167.99 17.31 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.355 1.862 . . . . 0.0 108.309 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -146.01 138.75 25.64 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.787 1.635 . . . . 0.0 107.421 -174.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.454 ' CE1' HG23 ' A' ' 84' ' ' ILE . 1.8 m-85 -126.06 142.88 51.33 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 121.06 1.754 . . . . 0.0 109.732 -177.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -149.52 173.74 13.27 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.564 1.146 . . . . 0.0 111.583 -174.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -103.45 144.9 30.79 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.284 1.433 . . . . 0.0 108.883 166.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -144.97 126.98 15.52 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.033 0.933 . . . . 0.0 109.313 173.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.14 3.84 1.42 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.847 2.059 . . . . 0.0 114.824 176.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.7 -0.37 15.52 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-N 119.579 1.081 . . . . 0.0 113.315 -173.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.5 tptt -133.87 149.94 51.35 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 119.358 1.579 . . . . 0.0 110.177 -169.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -101.52 135.53 42.86 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -168.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -129.55 159.53 36.06 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.05 0.54 . . . . 0.0 111.055 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.454 HG23 ' CE1' ' A' ' 75' ' ' TYR . 2.9 mp -122.05 117.91 53.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 125.073 1.349 . . . . 0.0 108.428 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -65.25 145.6 56.03 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 122.793 1.282 . . . . 0.0 109.655 173.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -171.2 165.76 4.56 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 127.442 2.297 . . . . 0.0 106.532 175.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.404 ' O ' ' N ' ' A' ' 89' ' ' LYS . 94.2 Cg_endo -63.35 -161.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.769 1 C-N-CA 125.401 4.067 . . . . 0.0 109.517 174.49 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -43.41 -13.98 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 117.065 2.246 . . . . 0.0 117.065 -170.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 87' ' ' PRO . 2.8 mtmt -103.18 31.54 4.22 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 126.237 1.815 . . . . 0.0 114.224 169.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -118.23 69.8 0.32 Allowed Glycine 0 C--O 1.221 -0.693 0 C-N-CA 124.566 1.079 . . . . 0.0 111.963 -174.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.1 mt -133.39 53.01 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 166.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -75.44 108.67 8.4 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 121.463 -0.773 . . . . 0.0 109.029 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -83.37 125.06 31.26 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 163.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.8 pt -113.32 167.31 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.164 1.385 . . . . 0.0 108.726 164.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -124.95 46.53 2.32 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.388 0.613 . . . . 0.0 110.853 -174.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -177.13 169.63 2.29 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 127.456 2.302 . . . . 0.0 109.311 168.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -74.75 138.08 42.45 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.653 1.181 . . . . 0.0 109.739 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -79.4 -44.84 20.66 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.283 1.033 . . . . 0.0 111.819 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.0 -12.54 60.16 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.913 1.285 . . . . 0.0 113.623 -171.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -88.72 -22.47 23.34 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.374 1.47 . . . . 0.0 113.011 171.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -81.49 -29.67 33.56 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 121.092 -1.005 . . . . 0.0 110.541 -178.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 29.3 pt . . . . . 0 C--O 1.25 1.096 0 C-N-CA 123.876 0.87 . . . . 0.0 110.984 -178.29 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.888 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 m -79.56 164.55 53.16 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 117.772 0.786 . . . . 0.0 112.805 -169.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -64.14 -179.72 0.9 Allowed 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.799 2.999 . . . . 0.0 112.625 162.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.3 mt -125.58 94.7 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 127.107 2.163 . . . . 0.0 105.575 178.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.82 154.39 37.55 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 126.329 1.851 . . . . 0.0 109.36 -176.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.634 ' HB2' HD21 ' A' ' 10' ' ' ASN . 44.6 Cg_endo -68.62 159.01 55.39 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.606 2.204 . . . . 0.0 112.108 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.39 150.78 38.79 Favored 'General case' 0 C--N 1.345 0.376 0 O-C-N 121.696 -0.628 . . . . 0.0 110.496 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.467 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . . . -68.2 -1.15 5.55 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 177.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -122.5 -18.03 6.81 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 119.533 1.061 . . . . 0.0 111.671 -172.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.634 HD21 ' HB2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -89.11 -6.75 56.81 Favored 'General case' 0 N--CA 1.456 -0.155 0 O-C-N 121.714 -0.616 . . . . 0.0 111.141 170.517 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.8 t -69.06 138.06 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 C-N-CA 125.151 1.38 . . . . 0.0 108.573 169.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.4 -55.88 2.7 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.934 1.694 . . . . 0.0 107.787 173.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.7 p -172.67 121.47 0.41 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.508 0.595 . . . . 0.0 111.119 178.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.7 mt -75.39 129.89 36.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 173.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 t -105.58 148.73 26.97 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 166.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.7 mt -139.0 104.83 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 172.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.8 110.06 18.54 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 104.146 -2.539 . . . . 0.0 104.146 165.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -66.21 -176.43 0.42 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.222 1.009 . . . . 0.0 110.999 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.1 p -57.62 -50.55 72.79 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 120.799 -1.188 . . . . 0.0 109.96 173.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.95 -178.48 2.8 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.701 0.762 . . . . 0.0 109.644 173.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 m -80.94 17.28 1.23 Allowed 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.889 -1.132 . . . . 0.0 111.258 -175.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.7 mt -90.14 134.48 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -127.85 142.93 51.15 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.414 ' HE2' ' CZ ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -131.83 149.22 52.52 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 123.567 0.747 . . . . 0.0 109.214 175.205 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.1 mp -121.8 147.43 25.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.414 ' CZ ' ' HE2' ' A' ' 24' ' ' LYS . 79.6 m-85 -127.45 76.79 1.7 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 -168.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -105.01 5.21 32.41 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.804 1.241 . . . . 0.0 112.613 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -81.72 144.49 31.1 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 166.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 28.6 t -57.83 -41.35 82.08 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.421 -1.424 . . . . 0.0 111.663 174.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.44 -33.78 76.66 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 120.658 -1.276 . . . . 0.0 111.994 178.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.2 p -63.05 -43.09 99.6 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.848 0.859 . . . . 0.0 109.538 175.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 93.0 mt -68.41 -54.5 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 124.62 1.168 . . . . 0.0 108.892 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -58.09 -32.88 68.49 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.706 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -61.68 -64.32 0.98 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 118.551 -0.738 . . . . 0.0 110.233 171.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 81.4 mt -51.6 -48.68 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 119.199 -0.429 . . . . 0.0 110.072 -173.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.467 ' CD1' ' HB2' ' A' ' 8' ' ' ALA . 21.6 mt -53.47 -24.9 14.27 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.2 t -63.91 -63.1 1.25 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.775 1.23 . . . . 0.0 110.072 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -68.87 -24.17 64.31 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.889 0.852 . . . . 0.0 110.724 -174.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.9 mm -68.15 -13.33 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 O-C-N 120.48 -1.387 . . . . 0.0 111.21 171.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.64 -8.45 11.46 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -176.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.4 p -67.77 -40.6 84.01 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.648 1.113 . . . . 0.0 111.608 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.77 164.52 54.59 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-O 123.117 1.398 . . . . 0.0 114.299 -165.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.42 ' C ' ' H ' ' A' ' 45' ' ' THR . 91.6 mttt -115.91 110.49 19.07 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 105.107 -2.182 . . . . 0.0 105.107 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.434 ' HB3' ' CE2' ' A' ' 92' ' ' TYR . 10.3 ptt180 -56.55 -3.95 0.13 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.872 1.269 . . . . 0.0 114.36 174.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.42 ' H ' ' C ' ' A' ' 43' ' ' LYS . 27.7 p 62.7 172.95 0.14 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 128.752 2.821 . . . . 0.0 110.396 -171.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.409 ' HG2' ' H ' ' A' ' 46' ' ' GLU . 8.6 pt-20 -78.37 -6.42 55.11 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.004 -1.06 . . . . 0.0 111.666 172.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -66.91 174.01 3.27 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 122.776 1.274 . . . . 0.0 111.981 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -110.75 150.18 29.45 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.23 1.812 . . . . 0.0 107.752 175.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.7 76.69 1.65 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -164.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.2 pt -90.54 36.14 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.531 1.132 . . . . 0.0 110.542 -164.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -125.35 161.63 26.57 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.295 2.238 . . . . 0.0 109.337 -172.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.99 -3.28 8.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.367 -1.288 . . . . 0.0 112.736 -178.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -150.12 164.61 20.0 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 126.262 1.825 . . . . 0.0 108.638 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.28 179.14 3.64 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.258 2.638 . . . . 0.0 112.678 173.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.66 6.29 45.66 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.154 1.381 . . . . 0.0 111.658 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.13 156.43 17.42 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 121.36 -0.837 . . . . 0.0 111.977 -175.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -86.17 -22.23 27.11 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.795 1.638 . . . . 0.0 111.221 170.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -135.1 115.95 14.01 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -143.07 159.95 41.31 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 127.207 2.203 . . . . 0.0 106.003 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.85 162.59 25.32 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 167.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.8 m -118.11 125.24 49.87 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.104 1.361 . . . . 0.0 108.233 -175.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.2 mp -121.35 132.21 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 -172.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -123.53 115.74 22.03 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 175.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.5 mt -91.17 86.08 2.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 173.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -65.45 113.66 4.29 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 173.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -140.66 135.43 31.65 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.588 1.555 . . . . 0.0 108.17 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 61.5 -4.03 0.18 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.919 2.088 . . . . 0.0 115.443 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.8 12.13 26.87 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 119.89 1.223 . . . . 0.0 112.321 -173.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -127.94 -175.96 14.28 Favored Glycine 0 C--N 1.335 0.511 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 165.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.94 138.25 22.88 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 118.122 0.961 . . . . 0.0 113.149 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 86.8 m -75.23 106.03 6.55 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 158.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.4 m -73.55 142.58 46.65 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 163.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -161.09 166.62 27.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.598 1.559 . . . . 0.0 108.727 170.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -140.99 146.88 37.87 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.619 1.568 . . . . 0.0 108.119 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.426 ' CD1' HG13 ' A' ' 84' ' ' ILE . 1.4 m-85 -128.31 147.35 50.61 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 120.211 1.369 . . . . 0.0 108.973 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -148.9 -175.37 4.92 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.97 1.308 . . . . 0.0 110.538 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -119.04 138.92 52.52 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.176 1.79 . . . . 0.0 109.47 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.487 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 7.6 tt0 -142.84 91.21 2.28 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.886 0.874 . . . . 0.0 109.31 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 70.73 19.4 5.99 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 128.214 2.606 . . . . 0.0 112.484 -174.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.15 -3.67 62.12 Favored Glycine 0 C--N 1.335 0.517 0 O-C-N 120.972 -1.08 . . . . 0.0 112.36 168.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -83.8 145.68 28.55 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 154.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -100.29 149.66 23.37 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.487 ' CE1' ' HB3' ' A' ' 78' ' ' GLU . 84.9 m-85 -134.43 135.09 42.29 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 123.173 0.589 . . . . 0.0 109.734 -171.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.426 HG13 ' CD1' ' A' ' 75' ' ' TYR . 3.0 mp -107.18 127.46 62.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -176.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -77.61 152.36 33.93 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.258 1.423 . . . . 0.0 109.943 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -172.79 168.77 2.61 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 129.131 2.972 . . . . 0.0 107.372 177.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -56.04 -161.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 125.009 3.806 . . . . 0.0 110.606 162.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -42.72 -14.69 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 128.695 2.798 . . . . 0.0 115.028 -171.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.15 66.91 0.64 Allowed 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.364 1.466 . . . . 0.0 110.616 166.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.8 53.13 0.77 Allowed Glycine 0 C--O 1.223 -0.542 0 C-N-CA 124.661 1.124 . . . . 0.0 114.953 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.5 mt -131.44 61.15 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.434 ' CE2' ' HB3' ' A' ' 44' ' ' ARG . 23.4 m-85 -87.56 98.27 11.31 Favored 'General case' 0 CA--C 1.521 -0.168 0 O-C-N 121.165 -0.959 . . . . 0.0 109.304 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -79.06 81.37 5.33 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.55 1.54 . . . . 0.0 109.049 176.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 21.8 pt -81.74 159.41 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 O-C-N 120.877 -1.14 . . . . 0.0 109.439 175.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -107.27 10.74 29.75 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -177.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -131.82 147.32 52.48 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 124.787 1.235 . . . . 0.0 112.433 -175.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -74.07 110.26 8.22 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -55.26 -43.0 74.26 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.035 0.934 . . . . 0.0 110.854 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -73.91 -13.06 60.84 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -171.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -90.43 -24.7 20.66 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.022 0.929 . . . . 0.0 110.789 165.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 12.1 mmt -96.54 6.3 49.02 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 126.124 1.77 . . . . 0.0 113.293 -172.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.4 pt . . . . . 0 C--O 1.246 0.873 0 CA-C-N 119.608 1.095 . . . . 0.0 108.343 164.234 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.635 0 CA-C-O 118.883 -0.954 . . . . 0.0 111.279 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 66.05 166.52 0.12 Allowed Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 149.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -70.23 173.37 11.49 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.74 2.294 . . . . 0.0 112.252 156.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.5 mt -120.89 98.06 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 175.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.56 165.06 15.42 Favored Pre-proline 0 C--O 1.239 0.532 0 C-N-CA 125.381 1.472 . . . . 0.0 110.086 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.432 ' HB2' HD21 ' A' ' 10' ' ' ASN . 68.2 Cg_endo -63.14 -179.81 0.66 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.348 2.032 . . . . 0.0 111.28 161.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.552 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -64.96 -175.4 0.19 Allowed 'General case' 0 C--O 1.232 0.157 0 O-C-N 120.943 -1.098 . . . . 0.0 109.823 165.164 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.66 -42.93 13.02 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 163.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -72.62 -0.6 13.4 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.282 1.433 . . . . 0.0 113.456 -159.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.517 ' H ' HD22 ' A' ' 10' ' ' ASN . 0.1 OUTLIER -124.43 -0.04 8.22 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 129.919 3.287 . . . . 0.0 111.919 -170.135 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.2 t -84.63 128.5 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 176.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -81.66 -56.42 4.02 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 124.905 1.282 . . . . 0.0 109.416 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.29 155.38 40.45 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.598 0.759 . . . . 0.0 109.348 166.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 51.8 mt -104.14 140.95 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 162.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.8 t -127.61 132.18 49.83 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.2 mt -125.63 106.36 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 174.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.56 110.2 17.45 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 169.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -68.74 170.85 8.68 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.889 1.275 . . . . 0.0 111.255 -174.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.9 p -58.45 -29.6 66.28 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.97 1.708 . . . . 0.0 113.522 176.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.505 ' CG ' ' H ' ' A' ' 21' ' ' SER . 46.9 t30 -86.64 -154.6 0.23 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.771 1.228 . . . . 0.0 108.159 177.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.505 ' H ' ' CG ' ' A' ' 20' ' ' ASN . 23.4 t -102.57 37.33 1.94 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.603 1.961 . . . . 0.0 109.595 -177.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.9 mt -132.02 155.71 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 126.612 1.965 . . . . 0.0 106.749 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.4 164.37 25.84 Favored 'General case' 0 N--CA 1.425 -1.72 0 C-N-CA 127.225 2.21 . . . . 0.0 108.78 171.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.1 135.47 43.24 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 126.39 1.876 . . . . 0.0 106.636 173.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.6 mp -111.72 127.0 69.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 176.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -108.51 80.23 1.33 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -88.7 -5.24 58.24 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.792 1.237 . . . . 0.0 112.085 -178.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.7 150.59 20.21 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.396 1.078 . . . . 0.0 111.552 -175.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -44.71 -64.55 0.68 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.981 2.113 . . . . 0.0 110.739 172.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -62.91 -35.71 80.97 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.111 0.964 . . . . 0.0 111.603 -168.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.6 m -63.8 -49.43 72.93 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 128.41 2.684 . . . . 0.0 110.713 175.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.26 -37.09 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.057 0.943 . . . . 0.0 109.386 174.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.07 -43.07 93.37 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.811 1.244 . . . . 0.0 112.267 -176.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -57.67 -66.45 0.47 Allowed 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 124.538 1.149 . . . . 0.0 108.867 170.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.4 mt -52.16 -45.92 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.768 0.827 . . . . 0.0 111.326 -172.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.91 -7.87 2.72 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.508 -1.37 . . . . 0.0 113.171 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.19 -58.94 2.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.573 2.349 . . . . 0.0 111.029 167.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.6 pm0 -60.36 -20.09 58.1 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 121.072 1.76 . . . . 0.0 113.275 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.7 mm -85.12 -19.83 8.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 125.187 1.395 . . . . 0.0 111.694 173.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.49 -21.26 19.58 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 119.625 1.102 . . . . 0.0 113.321 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.7 t -62.18 -32.63 73.28 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.893 0.877 . . . . 0.0 111.554 -170.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.63 160.49 53.65 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-O 122.983 1.324 . . . . 0.0 113.567 -175.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -125.36 109.98 13.42 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.43 ' HG3' ' H ' ' A' ' 44' ' ' ARG . 4.9 ppt_? -60.18 -10.8 4.9 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.66 1.984 . . . . 0.0 114.31 175.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.1 p 66.04 -179.77 0.2 Allowed 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 128.245 2.618 . . . . 0.0 110.958 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -82.36 2.76 30.78 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.387 -0.821 . . . . 0.0 111.936 173.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -61.92 151.27 35.27 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.994 1.27 . . . . 0.0 110.144 173.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -79.43 154.57 28.86 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.23 -1.35 . . . . 0.0 107.811 162.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.9 117.67 21.39 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 -177.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.7 pt -128.57 43.26 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 119.699 1.136 . . . . 0.0 110.548 -167.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -143.69 160.97 39.75 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.059 1.743 . . . . 0.0 108.252 -177.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.38 -10.67 13.75 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.318 1.047 . . . . 0.0 111.967 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -145.4 157.97 51.68 Favored Pre-proline 0 N--CA 1.467 0.398 0 C-N-CA 125.377 1.471 . . . . 0.0 109.849 -172.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -71.65 169.19 21.64 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.715 2.277 . . . . 0.0 112.504 177.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.6 t -92.08 -9.37 42.89 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.925 1.69 . . . . 0.0 112.442 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.04 158.77 18.52 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.978 -1.076 . . . . 0.0 112.041 -175.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -76.02 -33.51 59.67 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.992 1.317 . . . . 0.0 111.403 171.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -122.71 110.77 15.91 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.7 1.6 . . . . 0.0 106.985 -168.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -148.79 168.2 23.57 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.825 2.05 . . . . 0.0 106.448 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -109.01 167.05 12.81 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 170.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.45 123.3 44.49 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.275 1.03 . . . . 0.0 109.251 -178.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.6 137.52 51.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -128.62 146.68 50.79 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.876 0.87 . . . . 0.0 109.512 165.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.1 mt -114.95 91.36 1.75 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.5 0 N-CA-C 103.055 -2.942 . . . . 0.0 103.055 163.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -62.59 129.68 41.65 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 169.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -144.42 -155.91 0.65 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -55.43 -4.64 0.1 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 130.531 3.532 . . . . 0.0 116.514 -156.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.55 14.83 0.14 Allowed Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 126.474 1.987 . . . . 0.0 110.508 -170.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -147.92 170.42 28.58 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 118.11 0.955 . . . . 0.0 113.214 168.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 31.7 mtp -131.3 108.65 9.81 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 127.456 2.302 . . . . 0.0 106.976 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 78.4 m -74.86 87.63 2.28 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 166.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.8 m -66.31 139.37 58.04 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 172.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 2.1 ptm -160.2 166.39 29.76 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.278 1.431 . . . . 0.0 109.027 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -144.84 143.83 30.82 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.894 1.678 . . . . 0.0 106.683 -173.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -129.68 144.31 51.23 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.608 1.549 . . . . 0.0 109.016 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -146.88 178.75 8.09 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.317 1.447 . . . . 0.0 111.073 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -111.72 140.22 46.53 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.665 1.986 . . . . 0.0 107.655 171.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -138.48 112.6 8.59 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 175.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.14 15.18 3.12 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.95 1.7 . . . . 0.0 114.247 176.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.98 4.68 44.85 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.667 1.127 . . . . 0.0 112.873 172.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.98 161.51 14.4 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 157.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -119.63 154.74 33.54 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -144.04 149.27 36.4 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.783 0.325 . . . . 0.0 111.086 -168.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mp -121.2 119.76 60.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 125.453 1.501 . . . . 0.0 108.193 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -74.46 151.88 39.52 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.708 1.203 . . . . 0.0 110.773 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.511 ' HB2' ' HA2' ' A' ' 90' ' ' GLY . 0.8 OUTLIER -175.08 167.5 1.88 Allowed Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 127.366 2.266 . . . . 0.0 108.486 -177.124 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -55.73 -162.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.802 1 C-N-CA 126.126 4.551 . . . . 0.0 111.347 168.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -43.74 -8.38 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 128.13 2.572 . . . . 0.0 116.733 -175.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.92 70.29 0.77 Allowed 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 119.346 0.975 . . . . 0.0 110.697 159.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.511 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . -131.39 33.85 2.7 Favored Glycine 0 C--O 1.225 -0.439 0 N-CA-C 116.839 1.496 . . . . 0.0 116.839 -175.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.6 mt -116.98 50.11 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 118.027 0.914 . . . . 0.0 108.571 175.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -73.82 101.22 3.67 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.513 -1.367 . . . . 0.0 108.726 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -68.01 124.87 24.58 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 163.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 22.0 pt -121.14 163.64 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 124.189 0.996 . . . . 0.0 108.813 156.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -104.46 2.61 31.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.508 -175.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -132.69 154.27 50.33 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -169.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -73.15 104.2 4.14 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.835 2.054 . . . . 0.0 110.034 175.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -56.57 -36.42 69.3 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.46 1.504 . . . . 0.0 110.65 175.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -68.08 -15.86 63.77 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.681 0.792 . . . . 0.0 113.04 -172.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -90.81 -28.44 18.2 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.226 1.01 . . . . 0.0 112.105 169.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 41.4 mtt -68.5 -35.8 78.01 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 118.625 -0.702 . . . . 0.0 109.893 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 32.1 pt . . . . . 0 C--O 1.251 1.152 0 CA-C-O 117.164 -1.398 . . . . 0.0 112.312 -175.377 . . . . . . . . 0 0 . 1 stop_ save_